




assay in epidermal growth factor
concentrations determination
Yastrabava, H1; Karpenka, T1; Tsishkevich, M1; Piven,
N1; Lukhverchyk, L1; Burakovski, A1
1Laboratory of Medical Microanalysis, Institute of
Bioorganic Chemistry of Belarus National Academy of
Sciences, Minsk, Belarus
Background: Epidermal growth factor
(EGF) is one of the perspective clinical,
diagnostic, pathogenetic and prognostic
markers in various forms of cancer, associ-
ated with its overexpression. Abnormalities
in signaling system of EGF and its recep-
tor cause more than 70% of all malignant
tumors. The EGF concentration estimation
(its overexpression) can be performed only
with the use of modern highly sensitive
methods, which includes immunochemical
assays, and in particular, the immunochro-
matographic assay.
Method: A new express immunochromato-
graphic assay of epidermal growth factor
in serum was elaborated.
Results: The developed method based on
the usage of two types of specific antibod-
ies and multimembrane complex – test
strips, on which monoclonal antibodies to
EGF (analytical zone) and anti-specific
antibodies controlling the validity of the
test (control zone) were immobilised. The
method has the following analytical char-
acteristics: sensitivity (the detectable mini-
mum of EGF concentration) – 1 ng/ml,
analysis duration – 10–15 min. The appro-
bation of the developed method was car-
ried out on the clinical material from the
patients with cancer of various localisation
with obtained ELISA data comparison. A
comparative analysis of two methods has
shown the comparability of the obtained
data that indicate the clinical and diag-
nostic value of new method and confirm
the possibility of its usage in medical
practice.
Conclusion: The new method allows with
high accuracy and specificity to detect an
increased EGF concentration and to diag-
nose initial stages of cancer development,
associated with its overexpression. It also
provide researchers with express quantita-
tive criterion of the pathological process
manifestation control, therapy effectiveness
and prognosis of the disease.
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The cytotoxicity of aflatoxin B1 in human
lymphocytes
Al-Hammadi, S1; Marzouqi, F1; Al-Mansouri, A1; Shahin,
A2; Al-Shamsi, M2; Mensah-Brown, E3; Souid, A-K1
1Department of Pediatrics, UAE University, Al-Ain,
United Arab Emirates; 2Medical Microbiology, UAE
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Background and Method: Aflatoxins are
naturally occurring carcinogenic and
immunosuppressive compounds. In this
study, phosphorescence oxygen analyzer
that measured glucose-driven cellular respi-
ration (mitochondrial oxygen consump-
tion) as a function of time was used to
monitor the effects of aflatoxin B1 on the
human lymphocyte. Oxygen concentration
[O2] was determined from the phosphores-
cence decay rate of Pd(II)-meso-tetra-(4-
sulfonatophenyl)-tetra-benzoporphyrin.
Findings: Cyanide inhibited cellular O2
consumption, confirming the oxidation
occurred in the respiratory chain. In sealed
vials, O2 consumption was linear with
time, verifying its zero-order kinetics. The
rate of respiration (lM O2/min) was, thus,
the negative of the slope of [O2] vs time. In
the presence of aflatoxin B1, O2 consump-
tion by peripheral blood mononuclear cells
was unaffected in the first hour; thereafter,
it became exponential with time. This
effect was blocked by the pan-caspase
inhibitor benzyloxycarbonyl-val-ala-DL-
asp-fluoro-methylketone (zVAD-fmk), con-
firming caspases were responsible for the
mitochondrial disturbances. Intracellular
cleavage of the caspase-3 substrate N-ace-
tyl-asp-glu-val-asp-7-amino-4-methyl cou-
marin (Ac-DEVD-AMC) was noted within
2 h of incubation with aflatoxin B1;
zVAD-fmk blocked the release of AMC
moiety, confirming caspases were responsi-
ble for the cleavage. Apoptosis was also
monitored by flow cytometry, using phos-
phatidylserine exposure and membrane
permeability to propidium iodide (PI). The
number of annexin-V positive cells
increased as a function of aflatoxin B1
concentration and incubation time. At the
highest concentration employed, a signifi-
cant number of the mononuclear cells
become necrotic (annexin-V+PI+) after
24 h.
Conclusion: The results clearly show that
aflatoxin B1 is toxic to human lymphocytes
and its effect is mediated, at least in part,
by caspase activity.
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C-reactive protein and antiendotoxin
immunity in patients with chronic kidney
disease receiving hemodialysis
Biloglazov, V1; Klimchuk, A1; Gordienko, A1; DuBuske,
L2
1Crimean State Medical University, Simferopol,
Ukraine; 2Immunology Research Institute of New
England, Gardner, MA, United States
Background: Uncontrolled inflammation
may be associated with cardiovascular dis-
ease in patients receiving hemodialysis.
This study investigated the level of C-reac-
tive protein and anti-endotoxin immunity
in patients with chronic kidney disease
who are treated with hemodialysis (HD).
Method: This study was done in two
stages over a 4 year interval. Initially 46
patients 30–68 years old with chronic
kidney disease receiving HD were assessed.
C-reactive protein and levels of serum anti-
endotoxin antibodies (anti-ET IgA, anti-
ET IgM, anti-ET IgG) were determined by
ELISA. Blood samples were obtained from
patients before HD. In 4 years in the sec-
ond stage, only 32 patients were studied
again, as 14 (30.4%) had died. Seven
patients (15.2%) died during the first year
after start of the study. Levels of anti-ET
IgA, anti-ET IgM, anti-ET IgG from 38
healthy individuals served as controls.
Results: The seven patients who died in
the first year after the start of the study
had levels of C-reactive protein 3.1 fold
(P < 0.001) greater than healthy controls
and in 1.2 fold (P = 0.019) greater than
other subjects. Anti-ET IgA, anti-ET IgM,
anti-ET IgG were similar to healthy con-
trols and anti-ET IgG was 1.7 fold
(P = 0.031) and anti-ET IgM 2.1 fold
(P = 0.045) less than other study subjects.
Chronic kidney disease patients receiving
hemodialysis had C-reactive protein levels
2.5 fold (P < 0.001) greater than healthy
controls with a 4.6 fold (P < 0.001)
increase over 4 years. Anti-ET IgG
increased by 2.6 fold (P < 0.001) more
than in healthy controls. During 4 years,
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levels of anti-ET IgA, anti-ET IgM, anti-
ET IgG in the HD patients did not
change.
Conclusion: Increased C-reactive protein
and decreased anti-ET IgM, anti-ET IgG
predicted a lethal outcome in 7 HD
patients. Four years of monitoring chronic
kidney disease hemodialysis patients
showed a 4.6 fold increase in C-reactive
protein (P < 0.001) but no change in indi-
cators of humoral anti-endotoxin immu-
nity.
418
Content and immunophenotype of
antigen presenting cells in patients with
multiple drug resistant pulmonary
tuberculosis
Titov, LP1; Ramanava, IU1; Hancharou, AY1; Solodovnik-
ova, VV2; Vetushko, DA2; DuBuske, LM3
1Republican Scientific and Practical Center for
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Background: Functional impairment and
improper maturation of the antigen-pre-
senting cells (APC) may lead to severe pul-
monary tuberculosis (TB). This study
investigates the content and immunophe-
notype of APC from the patients with
severe multiple drug resistant pulmonary
tuberculosis (MDR TB).
Method: Peripheral blood samples were
obtained from patients with MDR TB
(n = 15) matched by age. The control
group (C) included 15 healthy subjects.
Analysis of content and immunophenotype
of blood monocytes, and monocytic and
plasmacytoid dendritic cells (mDC, pDC)
was performed by flow cytometer using
four-color antibody panels.
Results: Increase in absolute number and
relative content of monocytes in the
peripheral blood of patients with MDR TB
compared with the C (P = 0.001 and
P = 0.02 respectively) was observed. The
monocyte population was characterised by
significantly decreased expression of CD80
in the MDR TB patients group compared
to the C (P = 0.000041). The absolute
number of pDC in patients with MDR TB
was significantly decreased vs the C
(P = 0.0001) while mDC number was
unchanged (P = 0.087). Numbers of mDC
were greater than pDC in the MDR TB
patients, while in the C numbers of pDC
were more than mDC. However relative
numbers of both mDC and pDC were
decreased in the patients with MDR TB
compared to the C (P = 0.005 and
P = 0.0006 respectively). The decrease of
CD80 expression by mDC (MDR TB –
2.17(0.71–4.73)%; C – 14.2(2.7–37.4)%;
P = 0.0004) and reduction of the intensity
expression of co-stimulatory molecules
CD86 by mDC and pDC (P = 0.03 and
P = 0.0005 respectively) were noted in
MDR TB patients. There were no changes
in the expression of CD54 molecules by
either pDC and mDC in MDR TB
patients.
Conclusion: The increased number of
monocytes and mDC in the peripheral
blood in association with decreased expres-
sion of co-stimulatory molecules on their
surface probably reflects damage not only
in functional ability, but also in migration
DC from the blood into the regional
lymph nodes and lungs of MDR TB
patients.
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Serum adenosine deaminase activity and
T cell IFN-gamma production in patients
with tuberculosis
Yanovich, OO1; Titov, LP1; Shpakovskaya, NS2; Dy-
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Background: Adenosine deaminase (ADA)
is important enzyme for immunoinflamma-
tory responses and serves as a marker of
activated leukocytes. ADA is required for
proliferation and differentiation of T-lym-
phocytes Its deficiency mainly affects T cell
activation and cell-mediated immunity.
This investigation assesses serum ADA
activity and IFN-gamma production in vi-
tro by T cells in patients with tuberculosis.
Method: Serum adenosine deaminase levels
were measured with a colorimetric method
described by Giusti in patients with tuber-
culosis (n = 22) and healthy controls
(n = 20). For in vitro stimulation PBMCs
(1 9 l06/ml) were cultured in RPMI-1640
medium with L-glutamine and 10% serum
in the presence of 20 lg/ml PHA using 96-
well plates. Culture supernatants were har-
vested after l day of cell culture. IFN-
gamma levels were determined by enzyme
immunoassay kit (Vector-Best, Russia).
Results: Patients with tuberculosis had sig-
nificantly higher levels of ADA in serum
(25.2  3.7 U/l) than healthy controls
(13.2  0.9 U/l), (P < 0.05). Patients with
tuberculosis were divided into two groups:
Group1 – ADA level in the normal range
or was moderately increased (up to 23 U/
l), the Group 2 – ADA activity signifi-
cantly above normal (>23 U/l). In vitro
IFN-gamma production by lymphocytes of
tuberculosis patients in these two groups
was investigated. In Group1, spontaneous
levels of IFN-gamma were less compared
with Group 2 (8.8  3.2 vs 18.3  4.8 pg/
ml). After PHA-stimulation the same ten-
dency was noted 267.7  102.8 pg/ml in
the Group 1 and 418.4  196.5 pg/ml in
Group 2. In Group 2, 30% of patients had
decreased IFN-gamma production after
PHA stimulation, that significantly differ-
ent from Group1 (30% vs 0%, P < 0.05).
Conclusion: Elevated levels of ADA activ-
ity occur in the serum patients with tuber-
culosis and indicate an association between
ADA activity and T cell function.
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Characterisation of mucosal immunity
are correlated to inflammation in infertile
patients with chronic abacterial
prostatitis
Drannik, GN1; Gorpynchenko, II1; Poroshina, TV1;
Drannik, AG2; Kurchenko, AI3; DuBuske, LM4,5
1Institute of Urology, AMS of Ukraine, Kiev, Ukraine;
2McMaster University, Hamilton, ON, Canada; 3National
Medical University, Kiev, Ukraine; 4Immunology
Research Institute of New England, Gardner, MA,
United States; 5The George Washington University
School of Medicine, Washington, DC, United States
Background: Cytokines and other immune
factors are intrinsically involved in repro-
ductive physiology with local or systemic
perturbation of these factors due to inflam-
mation or infection negatively affecting fer-
tility.
Method: Semen samples from 20 healthy
males as well as 136 infertile patients with
chronic prostatitis/chronic pelvic pain syn-
drome (CP/CPPS) were assessed by ELI-
SAs to determine the levels of sIgA, SLPI,
PSA, IL-8, TNF-a, IL-17, and TGF-b1.
After liquefaction, semen microscopy was
performed to analyze sperm concentration
and percentage of motility using WHO
classification. Smears of neat semen were
also prepared for sperm morphology
assessment. Spearman rank correlation
analysis was performed to assess interrela-
tions between morphological abnormalities
of sperm as well as cytokines and other
immunologic factors in the seminal plasma
from infertile men with chronic abacterial
prostatitis.
Results: CP/CPPS patients had higher con-
centrations of sIgA, SLPI, IL-8, TNF-a
and reduced levels of TGF-b1 in ejaculate,
compared to healthy subjects. A direct cor-
relation between PSA (rK = 0.09), SLPI
(rK = 0.116) and percentage of motile
sperm in category ‘a’ (P < 0.05) was noted
in the healthy group; in CP/CPPS patients
such correlation (P > 0.05) was absent.
CP/CPPS patients had an inverse correla-
tion (P < 0.05) between concentrations of
TGF-b1 in the ejaculate and the relative
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amount of abnormal sperm morphology
(head), (rK = 0.266); a direct correlation
between IL-17 and the relative number of
actively motile sperm with progressive
movement (rK = 0.428); and an inverse
correlation between IL-17 and fixed sperm
category ‘d’ (rK = 0.366), P < 0.05.
Conclusion: As sIgA, SLPI, PSA, IL-6, IL-
8, TNF-a and TGF-b1 in the ejaculate are
mainly produced by epithelial cells of the
prostate ducts, immunological changes in
local mucosal immunity may promote the
formation or advancement of infertility in
patients with CP/CPPS.
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An erythmogenic strategy of narrowband
ultraviolet B (311 nm) therapy increased
overall immunosuppression in
comparison to a sub-erythmogenic
strategy as treatment for psoriasis
Babanin, VA1; Pritulo, OA1; Bisyuk, YA1; DuBuske, LM2
1Crimean State Medical University, Simferopol,
Ukraine; 2Immunology Research Institute of New
England, Gardner, MA, United States
Background: Psoriasis affects 1–2% of the
European population. Narrow-band ultra-
violet B (311 nm) therapy causes transient
immunosuppression in psoriasis patients.
Method: Ninety-six patients with psoriasis
were divided into 2 groups:
(1) the comparison group of 27 patients
using only standard treatment while
(2) 69 patients used NB-UVB (311 nm)
therapy.
The control group included 28 healthy
subjects. NB-UVB was administered three
times a week using erythmogenic and sub-
erythmogenic strategies starting at 70% of
the minimal erythema dose. Cytokine levels
in serum were determined on days 1, 6 and
12 weeks by ELISA. At day 21, the study
group was divided into four groups:
Group 1–20 patients (regression of index
PASI over 50%, erythmogenic strategy);
Group 2–21 patients (regression of index
PASI over 50%, sub-erythmogenic strat-
egy);
Group 3–14 patients (regression of index
PASI <50%, erythmogenic strategy) and
Group 4–14 patients (regression of index
PASI <50%, sub-erythmogenic strategy).
Results: On day 1 the levels of TNF-a, IL-
6, IL-22 in the study (TNF-a – 26.82 
1.86 pg/ml, IL-6 – 15.38  2.35 pg/ml, IL-
22 – 36.21  5.09 pg/ml) and comparison
group (TNF-a – 25.77  2.14 pg/ml, IL-6
– 12.90  3.22 pg/ml, IL-22 – 37.25 
6.20 pg/ml) were significantly greater than
the control group (TNF-a – 3.65 
0.40 pg/ml, IL-6 – 2.63  0.37 pg/ml, IL-
22 – 5.38  0.64 pg/ml, P < 0.01). In
Groups 1, 2, 3 at 6 weeks, levels of TNF-a
and IL-6 were significantly less (P < 0.05)
compared to the comparison group (TNF-
a -20.43  1.77 pg/ml, IL-6 – 9.11 
4.50 pg/ml), but these cytokines in Group
4 (TNF-a – 19.82  4.14 pg/ml, IL-6 –
7.97  1.77 pg/ml) did not significantly
differ (P > 0.05). At 12 weeks the cytokine
levels did not differ from the control
group, except Group 4 where levels (TNF-
a – 6.05  1.23 pg/ml, IL-6 – 4.14 
1.24 pg/ml, IL-22 – 12.48  1.21 pg/ml)
were significantly greater than the controls
(P < 0.05) and Group 3 (TNF-a –
4.90  0.87 pg/ml, IL-6 – 2.83  0.98 pg/
ml, IL-22 – 7.51  1.66 pg/ml).
Conclusion: NB-UVB therapy over
12 weeks significantly reduced the levels of
TNF-a, IL-6, IL-22 in comparison to the
group of patients receiving only standard
treatment. In patients resistant to narrow-
band ultraviolet B therapy (regression of
index PASI <50%) an erythmogenic strat-
egy of NB-UVB led to increased immuno-
suppressive effect on systemic




aggressive phenotypes of patients with
oral mucosa lichen planus
Drannik, GN1; Kurchenko, AI1; Rehuretska, RA1; Drannik,
AG2; DuBuske, LM3,4
1National Medical University, Kiev, Ukraine; 2McMaster
University, Hamilton, ON, Canada; 3Immunology
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United States; 4Allergy and Immunology, The George
Washington University School of Medicine,
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Background: Lichen planus is the most
common and most important systemic im-
munodependent disease of the oral
mucosa. This study investigates the major
histocompatibility complex antigens (HLA)
related to development of complicated
forms of lichen planus.
Method: Seventy-five patients age 18–
60 years with lichen planus were assessed.
HLA were determined by a standard mi-
crolymphocytotoxic test on the Terasaki’s
planchettes using special panels of anti-
HLA serums. The control group consisted
of 230 healthy donors.
Results: The expression of HLA – A,
HLA – B and HLA – DR antigens by lym-
phocytes in patients with erosion and ulcer
forms of lichen planus by locus A shows a
relatively high risk degree of disease in car-
riers of HLA – A28 expression
(RRI = 2.11 when r1 = 1.33). This associa-
tion is absent in patients with the hyper-
keratosis form of lichen planus. There is a
significant increase of HLA – B8 antigen
expression (RRI = 2.06 when r1 = 1.12) in
patients with erosion and ulcer forms of
lichen planus. Increasing HLA – B27 fre-
quency (RRI = 2.32 when r1 = 0.6) in
patients with erosion and ulcer forms of
lichen planus is of particular importance as
HLA- B27 is associated with diseases
involving infectious antigens with super-
antigen properties. There was frequent
expression of HLA – DR1 (19.2%), HLA
– DR3 (10.2%) and HLA – DR7 (8.2%)
antigens.
Conclusion: Steady progress of erosive and
ulcerative forms of lichen planus is related
to genetic factors including histocompati-
bility (HLA) Types I and II antigens: HLA
– A28, HLA – B8, HLA – B27, and HLA
– DR1. The treatment of these aggressive
forms of lichen planus needs new
approaches.
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Immune modulatory properties of
selected bacterial strains on human
dendritic cells
Hiller, J1; Lehmann, S1; Back, W2; van Bergenhenegou-
wen, J3,4; Ring, J5; Behrendt, H1; Schmidt-Weber, C1;
Knippels, L3,4; Garssen, J3,4; Traidl-Hoffmann, C1,5
1ZAUM- Center of Allergy and Environment, Technische
Universit€at and Helmholtz Zentrum M€unchen, Munich,
Germany; 2Brewing and Beverage Technology,
Technische Universit€at M€unchen, Weihenstephan,
Germany; 3Department of Immunology, Danone
Research Centre for Specialised Nutrition, Wageningen,
The Netherlands; 4Division of Pharmacology, Utrecht
Institute for Pharmaceutical Science, Faculty of Science,
Utrecht University, Utrecht, The Netherlands;
5Department of Dermatology and Allergology,
Technische Universit€at M€unchen, Munich, Germany
Background: Lactic acid bacteria (LAB)
are important immune regulatory microor-
ganisms and are considered to entertain
health promoting effects which are of spe-
cial interest in the view of the growing
application of LAB in prevention and
treatment of diseases. Aim of the study
was to investigate the influence of different
bacterial strains on the cytokine release by
human monocyte-derived dendritic cells
(MoDC).
Method: Immature MoDC generated from
peripheral blood monocytes of healthy
non-atopic volunteers were stimulated with
different Lactobacillus and Bifidobacterium
strains in different concentrations (107–
105 cfu/ml). The cytokine profile (including
IL-12p70, IL-10, IL-1b, IL-23, IL-6, TGF-
b) of stimulated MoDC was analyzed in
supernatants after 24 h.
Results: Stimulation of MoDC with bacte-
ria revealed a highly strain-dependent
induction of antiinflammatory IL-10 and
pro-inflammatory cytokines such as IL-
12p70. High amounts of IL-10 produced
by selected bacterial strains points to the
induction of potentially functional regula-
tory T cell responses.
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Conclusion: The tested Lactobacillus and
Bifidobacterium strains show specific strain-
dependent immune modulatory capacities
inducing a more pro- or antiinflammatory
cytokine profile in human MoDC. Experi-
ments of this study and future in vivo
research in this field could contribute to
the identification of a potential role for
specific lactic acid bacteria as immune
modulators in the prevention and treat-
ment of several immune regulatory disor-
ders and open new aspects for the
application of bacterial strains as health
promoting ingredients in food.
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State of cytokine status in small airways
diseases in children
Mustafayev, IA1
1Pulmonology, Research Institute of Lung Diseases,
Baku, Azerbaijan
Background: To study the dependence of
the state of cytokines on the stage of the
pathological process in asthma (BA) and
chronic bronchiolitis obliterans (BO).
Method: One hundred and twelve children
with BA and 139 patients with BO were
observed in age from 1 to 15 years. Studies
were conducted in the period of exacerba-
tion and remission. Bronchial obstruction
is a common symptom of BA and BO,
which differ in etiology and pathogenesis.
This was the reason for the diagnostic and
therapeutic errors. For each patient was
prepared test-card containing the data of
family-genetic, obstetric history, prenatal
and postnatal periods of life, clinical
course, results of radiological, functional
and laboratory studies. The degree of air-
flow obstruction measured by spirometry.
Interleukins IL4, IL8, TNF, c-interferon
were determined by ELISA.
Results: The concentrations of interleukins
in BA are at the upper limit, or slightly
higher than the norm (_IL4-12.7  0.3; _IL8-
28, 2  0.6; TNF-5.39  0.12; c-inter-
feron-11, 5  0.3). The marked increase in
the level of interleukins observed in BO
(_IL4-28, 1  0.5; _IL8-33, 2  0.5; TNF-19,
54  0.29; c-interferon 18.7  0.4). Cyto-
kine status in BA was normal in remission
(IL- 49  0.2; IL-814.9  0.5; TNF-
2.92  0.15; c-interferon 7.5  0.8) BO
was tendency to their normalisation (IL4-
19.5  0.3; IL8- 28.9  0.5; TNF-
13.25  0.43; c-interferon-11.6  0.2).
Conclusion: Cytokine status in BA charac-
terised by a slight increase in levels of in-
terleukins to the upper limit of normal,
and its stabilisation in remission. In
patients with BO levels of proinflammatory
and antiinflammatory interleukins signifi-
cantly higher than normal. The distinctive
feature of the state of cytokines COB is
the preservation of their high content in
remission, which is manifested in the fre-
quent recurrence and preservation of the
inflammatory process in the small bronchi.
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A good start means everything: in vitro
Th1 and Th2 cell differentiation is greatly
influenced by the initial ratio of na€ıve
and memory CD4+ T cells
Blom, L1; Poulsen, L.K.1
1Copenhagen University Hospital Gentofte, Allergy
Clinic, Hellerup, Denmark
Background: Robust in vitro systems are
important in elucidating mechanisms
regarding the heterogenetic nature of in
vivo allergic immune responses and con-
tribute with knowledge to design good in
vivo experiments. This study seeks to inves-
tigate, by using low tech methods, basic
parameters as strength of TCR activation
as well as purity of the initial na€ıve CD4+
T-cells in relation to in vitro differentiation
of T helper type 1 (Th1) and Th2 cells.
Method: Human CD4+ T-cells and na€ıve
CD4+CD45RA+CD45ROCD25 T-cells
(>95% or >99%) were isolated, from the
PBMC fraction of healthy individuals
(n = 4), by 1 or 3 negative bead selection
rounds. The isolated cells were TCR acti-
vated with either 30/30 (weak) or 1000/
1000 (strong) ng/ml anti-CD3/CD28 and
cultured under Th0, Th1 and Th2 condi-
tions for 1, 3 and 5 days. The cultures
were restimulated prior to flow cytometry
for intracellular transcription factors, cyto-
kines and supernatant multiplex cytokine
analysis.
Results: Using initial cultures of (>99%)
na€ıve CD4+ T-cells but not (>95%) na€ıve
CD4+ T-cells differentiated under Th2 con-
ditions resulted in an expected significantly
decreased frequency memory IFN-c+ T-
cells at day 1 as well as most GATA3+ T-
cells, about 70%, at day 5. Interestingly,
comparing the initial (>99%) na€ıve CD4+
T-cells with the (>95%) na€ıve CD4+ T-cells
cultured under Th2 conditions showed an
increased ratio, of more than fourfold, of
IL-4/IFN-c as well as GATA3/Tbet posi-
tive cells all days. Furthermore, in the Th2
cultures of initial na€ıve CD4+ T-cells a ten-
dency towards a higher IL-4/IFN-c ratio
as well as GATA3/Tbet positive CD4+ T-
cells was observed comparing weak with
strong TCR activation. Th1 cultures of
>99% initially na€ıve CD4+ T-cells showed
highest IFN-c/IL-4 ratio and Tbet/GATA-
3 positive cells as well as more Tbet+ T-
cells compared with the >95% na€ıve and
CD4+ T-cells. For the Th1 cultures, how-
ever, the strength of TCR activation did
not influence the ratio IFN-c/IL-4 and
Tbet/GATA-3 positive cells.
Conclusion: Taken together, it is essential
to use rigorously purified (>99%) na€ıve
CD4+ T-cells for an optimal in vitro differ-
entiation of CD4+ T-cells towards a Th1
or Th2 phenotypes. Additionally, a moder-
ate TCR activation results in better Th2
differentiation.
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Clusterin inhibits secretion of CCL20 in
human bronchial epithelial cells
Kwon, H-S1; Moon, K-A2; Park, S-Y1; Yoon, SY1; Kim,
S-J1; Kim, T-B1; Cho, YS1; Moon, H-B1
1Department of Allergy and Clinical Immunology, Asan
Medical Center, University of Ulsan College of
Medicine, Seoul, Korea; 2Asan Institute for Life Science,
Seoul, Korea
Background: Clusterin, a ubiquitous glyco-
protein, has been recently suggested to rep-
resent redox state in our bodies as a
sensitive indicator of oxidative stress.
Method: Human bronchial epithelial cells
(BEAS-2B) were cultured with house dust
mite (HDM) extract to evaluate the cellu-
lar response to the most common exoge-
nous allergen in airway.
Results: As shown before, production of
CCL20, a critical chemokine in HDM
induced airway inflammation, was
increased remarkably with HDM extract
stimulation. Moreover, the levels of
secreted clusterin determined in culture su-
pernatants were significantly enhanced with
HDM stimuli. To further investigate the
role of clusterin in CCL20 secretion, we
generated clusterin over-expressed BEAS-
2B cells by transfection with adenovirus-
containing clusterin gene. In response to
HDM stimulation, the CCL20 secretion
was remarkably suppressed in those clus-
terin over-expressed BEAS-2B cells.
Conclusion: In conclusion, it is speculated
that the induction of over-expression
of clusterin in bronchial epithelium may
play a protective role in the airway
inflammation.
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Validation of a unique mobile
environmental exposure chamber system
for use in multiple locations in a
multicenter allergy trial demonstrates
accuracy and reproducibility in grass
pollen aerosolization after mobile
chamber disassembly, relocation and
reassembly
Nandkeshore, H1; Shields, K1; Patel, P1
1Inflamax Research Inc., Mississauga, ON, Canada
Background: Controlled allergen challenge
in fixed environmental exposure chambers
(EECs) has proven benefits in single center
allergy trials. Our goal was to develop a
mobile EEC system (mEEC) which was
suitable for use in multiple geographically
diverse locations in multicenter allergy tri-
als. Towards this, we designed a transport-
able EEC system which demonstrates
accuracy and precision in pollen aerosoli-
zation after mEEC disassembly, relocation
and reassembly.
Method: Our proprietary mEEC design
comprises inflatable shelter technologies
built to clean room specifications and a
patented mobile Environmental Control
Unit (ECU) which controls allergen aero-
solization characteristics. mEEC’s were
built to our design specifications in Eur-
ope, disassembled, relocated and reassem-
bled at our headquarters in Toronto,
Canada. Installation and Operational qual-
ifications (IQ, OQ) were performed. Perfor-
mance Qualification (PQ) testing in which
grass pollen mix was aerosolized at
3500  500 grains/m3 and acceptance cri-
teria set out a priori were performed to
demonstrate spatial and temporal airborne
allergen uniformity across multiple sam-
plers across the patient seating area. In
phase I, ease and robustness of mEEC re-
assembly after shipping and relocation was
tested as well as IQ, OQ, PQ and critical
element failure. In phase II, the mEEC was
disassembled and reassembled to test for
IQ, OQ and PQ reproducibility.
Results: After disassembly, pack-up, and
shipping of >5000 km, the mEEC was
reassembled in Toronto, Canada. The
mEEC inflation was complete in 1 h with
ECU hook-up and configuration over
2 days. The system was robust with no
damage sustained during travel and easily
configurable. In Phase I, mEEC was shown
to aerosolize grass pollen within specifica-
tions that demonstrated spatial and tempo-
ral uniformity across the patient seating
area over triplicate testing, and simulation
of critical element failure showed timely
instrument switch and rectification. In
Phase II, after disassembly-reassembly, PQ
testing showed that mEEC performed iden-
tically and within specification.
Conclusion: The mEEC system testing
demonstrates that the mEEC are suitable
for use in multicenter allergy trials where
multiple mEECs will be located in geo-
graphically diverse locales. This will allow
for improved patient screening and
endpoint measurement where all patients
are exposed to controlled and consistent
allergen levels throughout the duration of
the clinical trial.
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Cohort profile: the Barwon Infant Study
Vuillermin, P1,2,3; Carlin, J2,3; Tang, M2,4,5; Saffery, R2,5;
Allen, K2,4,5; Ranganathan, S2,4,5; Burgner, D2; Dwyer,
T2; Ponsonby, A-L2; BIS Investigator Group
1Barwon Health, Child Health Research Unit, Geelong,
Vic., Australia; 2Murdoch Childrens Research Institute,
The Royal Children’s Hospital, Parkville, The University
of Melbourne, Melbourne, Vic., Australia; 3Deakin
University, Geelong, Vic., Australia; 4The Royal
Childrens Hospital, Parkville, Vic., Australia; 5The
University of Melbourne, Melbourne, Vic., Australia
Objectives: The Barwon Infant Study
(BIS) is an unselected prebirth cohort
study, with a unique array of longitudi-
nally assembled biological samples, physio-
logical measures and clinical outcomes.
The objective of BIS is to investigate the
interplay between the modern environment,
the microbiome, the epigenome, abnormal
immune development and the early life ori-
gins of eczema, food allergy, asthma and
atherosclerosis. The initial hypotheses
under investigation are that:
1 Reduced gut microbiota diversity at
1 month of age is associated with (a)
persisting methylation (epigenetic
silencing) of the interferon gamma
(IFNc) promoter of na€ıve T cells; (b)
diminished IFNc response capacity;
and (c) increased risk of eczema and
food allergy.
2 (a) Reduced IFNc response capacity of
na€ıve T cells during infancy, (b) higher
incidence of lower respiratory tract
infections, and (c) aeroallergen sensiti-
sation, are associated with deterioration
in lung function between 1 and
36 months of age.
3 Perinatal and early life factors, includ-
ing an increased microbial burden, are
associated with increased early markers
of atherosclerosis development between
1 and 36 months of age.
Methods: BIS is located in the Barwon
region of Victoria, Australia. Using an
unselected sampling frame, women are
recruited before 28 weeks of pregnancy
(target n = 1250 over 3 years). Participants
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are reviewed 6 monthly. In addition to
extensive questionnaire data, biospecimen
collection includes: stool (maternal at
36 weeks of pregnancy; infant at birth, 1,
6, 12, 24 and 36 months), and blood
(maternal at 28 weeks of pregnancy; infant
at birth, 6, 12 and 36 months). Physiologi-
cal measurements include: lung function
(via Multiple Breath Washout) at 1 month
and 3 years, and aortic intima media thick-
ness (via transabdominal ultrasound).
Food allergy status is defined by formal
challenge. A nested case-cohort design will
be used to assess the biological hypotheses
requiring resource intensive laboratory pro-
cedures.
Progress: Fieldwork commenced in June
2010. As of November 2012: there were 911
women enrolled (on target); 756 live born
infants; among eligible infants the retention
rate to 1 year was 246/293 (84%); biosam-
ples were successfully collected on more
than 90% of occasions for each timepoint/
sample; and at the 1 month review 535/670
(80%) had undergone transabdominal ultra-




mechanism implicated in atopic march
using an original mouse model of food
and respiratory combined allergy
Bouchaud, G1; Gourbeyre, P1; Bihouee-Roussey, T2;
Aubert, P3; Lair, D2; Denery-Papini, S1; Neunlist, M3;
Magnan, A2; Bodinier, M1
1UR 1268 BIA INRA, Equipe Allergie, Nantes, France;
2INSERM U915 IRS-UN, Institut du Thorax, Nantes,
France; 3INSERM U913, IMAD, Nantes, France
Background: The increase prevalence of
atopic disease has become a major chal-
lenge for allergists and public health
authorities. The natural history of the ato-
pic march including mechanism implicated
and modifiable determinants are still very
poorly understood. Information provides
by clinical studies and mouse model can
only generate hypotheses. Establishment of
a new mouse model combining food and
respiratory allergy define a way to analyse
the atopic march by investigating immuno-
logical and physiological parameters.
Methods: Mice were sensitised to wheat
allergens by intraperitoneal and oral
administration and then exposed to house
dust mite allergens in intranasal. Allergic
reaction was monitored by measuring lev-
els of IgE and histamine. Then, immune
response was evaluated by cell number and
cytokine production in lymphoid organs
(spleen and thymus), gastro-intestinal tract
(Peyer patches) and respiratory tract (lung
and broncho-alveolar fluid). Physiological
parameters were also analysed by exploring
paracellular and transcellular permeability
as well as feces humidity in the gut and
airway hyperesponsiveness in the lung.
Results: Our model revealed influence of
combined allergy on the physiopathology
of allergy. After food and respiratory aller-
gen exposures, our data demonstrate a
higher level of IgE specific to each allergen
and histamine. Moreover, we observed an
increase level of IL-4 and IL-17 accompa-
nied by a decrease level of IL-10, IFNc
and TGF-b in Peyer patches. In parallel,
we show higher paracellular and transcellu-
lar permeability in proximal colon and
jejunum respectively. Surprisingly, airway
parameters (hyper-responsiveness and
inflammatory cells) exhibited no significant
changes when compared to mice only
exposed to respiratory allergens.
Conclusions: Our new mouse model dis-
played an increase of allergenic biomarkers
including specific IgE and histamine levels,
as well as Th2 and Th17 cytokines com-
pared to a single allergy. In consistent with
these results, we show a decrease of toler-
ance-related biomarkers especially Th1 and
Treg cytokine suggesting interplay within
immune allergic mechanism implicated in
both allergies. Within this line, combined
allergies induce stronger alteration of gut
functions which contrasts with the absence
of major changes on airway functions.
Taken together, our results demonstrate a
relationship in mechanism implicated in
food and respiratory allergy in atopic
march.
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Correlation between serum total IgE and
asthma severity in patients with allergic
asthma in Spain
Da´vila, I1; Entrenas, LM2; Valero, A3; Herraez, L4
1Hospital Universitario de Salamanca, Servicio de
Inmunoalergia, Salamanca, Spain; 2Hospital
Universitario de Reina Sofıa, Cordoba, Servicio de
Neumologıa, Cordoba, Spain; 3Hospital Clınic de
Barcelona, Unidad de Alergia, Barcelona, Spain;
4Departamento Medico, Novartis Farmaceutica,
Barcelona, Spain
Background: Immunoglobulin E (IgE) has
a key role in the pathogenesis of allergy.
The close association between IgE, allergy,
and asthma has been long recognised.
Although the inflammatory pathways
involving IgE are now better understood,
its relationship to the asthma severity is
still controversial. The aim of our study is
to assess the possible association between
serum concentration of total IgE and
asthma severity.
Methods: An observational, retrospective,
multicenter and national study was carried
out in 63 Pneumology and Allergy centers.
Data have been collected retrospectively on
all patients aged ≥18, who have been diag-
nosed with persistent asthma (minimun a
year of evolution) and positive skin prick-
test or specific lgE (at least one aeroaller-
gen). Acording to GEMA 2009 asthma
was stratified by mild, moderate and
severe. Patients with high IgE level not
related to asthma, active smokers, ex-
smokers (>10 pack/year) or ex-smokers
(<2 years previous to the study) were
excluded. The comparison between the
three severity asthma groups of serum total
IgE (logarithmic scale) was performed
using univariate and multivariate analyses,
adjusted for confounding variables (age,
sex, atopy, smoking, onset of asthma, ill-
ness duration and severity of the disease
according to GEMA). Furthermore, associ-
ation of serum total IgE with FEV1, exac-
erbations or geographical site was
evaluated.
Results: The study included 383 patients
with a mean age of 43.0  15.6 years,
mainly men (58%) and 57.4% presented
overweight/obesity. The disease had been
made its debut earlier among patients with
highest level of asthma severity, number of
exacerbations and number of steroid treat-
ment batches (P < 0.05, in all cases). The
mean serum concentration of IgE (loga-
rithmic scale) was similar between the three
asthma severity groups (5.4  1.1 UI/ml
mild asthma [n = 129], 5.4  1.0 UI/ml
moderate asthma [n = 82] and
5.4  1.3 UI/ml severe asthma [n = 172]).
Asthma severity did not show statistical
association to IgE levels after adjusting for
confounding variables in univariate and
multivariate analyses. Nevertheless, lower
age and male sex ended up being statisti-
cally linked to highest IgE levels
(P < 0.05). Finally, no associations of IgE
with FEV1, exacerbations or geographical
site were found.
Conclusion: Results from this study show
there is no association between serum con-
centration of total IgE and asthma sever-
ity. However lower age and male sex were
significantly connected to highest IgE lev-
els.
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Defective epithelial barrier function
related to zonula occludens proteins of
nasal mucosa in subjects with atopy
Yilmaz, O1; Inan, S2; Pinar, E3; Turkeli, A1; Turkoz, E2;
Toprak Kanik, E1; Yuksel, H1
1Department of Pediatric Allergy and Pulmonology,
Celal Bayar University, Manisa, Turkey; 2Department of
Histology and Embryology, Celal Bayar University,
Manisa, Turkey; 3Izmir Ataturk Training and Research
Hospital, ENT, Izmir, Turkey
Background: Most important proteins of
the tight junctions, which are important
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for epithelial barrier dysfunction in patho-
genesis of allergic sensitisation due to their
direct influence on antigen permeability,
include occludin, claudin and junctional
adhesion molecule (JAM). We aimed to
investigate integrity of tight junctions via
immunohistochemical determination of
nasal mucosal occludin, claudin and JAM
levels in atopic individuals.
Methods: This cross-sectional study
enrolled 68 consecutive patients without
allergic rhinitis symptoms who had nasal
septum deviation surgery. Age and gender
of were recorded and skin prick test (SPT)
with major inhalant allergen extracts was
performed according to EAACI guidelines.
Mucosal biopsy specimens, taken from
lower concha medial surface during nasal
septum surgery, were immunostained with
primary antibodies for occludin, claudin
and JAM using indirect avidin-biotin per-
oxidase method and intensities were semi-
quantified with H-score.
Results: Among patients enrolled, 14 had
SPT positivity. Age and gender were simi-
lar between atopic and nonatopic patients
(P = 0.56 and P = 0.13 respectively). Med-
ian occludin H-score was significantly
lower in nasal mucosa of atopic than non-
atopic patients (142.5 vs 290 respectively,
P < 0.001). Median claudin H-score was
153 in atopic compared to 296 in nonatop-
ic patients (P < 0.001). Moreover, nasal
mucosal JAM was significantly different
between the two groups (median H-scores
156 and 312 respectively, P < 0.001).
Conclusion: Expressions of occludin, clau-
din and JAM which are tight junction pro-
teins of nasal mucosal epithelial cells are
lower in atopic individuals suggesting a
primary role of epithelial barrier dysfunc-
tion in development of atopic response.
This finding carries the potential basis for
new therapeutic modalities.
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Visualisation of allergen uptake by
dendritic cells
Ashjaei, K1; Lengger, N1; Bublin, M1; Ellinger, I1;
Wagner, S1; Hoffmann-Sommergruber, K1
1Department of Pathophysiology and Allergy Research,
Center for Pathophysiology, Infectiology and
Immunology, Medical University of Vienna, Vienna,
Austria
Background: Dendritic cells (DCs) are
highly specialised antigen-presenting cells
that regulate innate and adaptive immune
responses and have been shown recently to
play a key role in inducing T helper type 2
responses in allergic patients. Early events
at the interface of allergens and DCs play
a key role in downstream events leading to
allergic reactions. Therefore, identifying
mechanisms and receptors that are
involved in the initial recognition and
uptake of allergen by DCs would lead to
better understanding of the molecular basis
of allergy and the rational design of novel
intervention strategies. In this study we
have studied allergen uptake by DCs,
derived from allergic and nonallergic
donors.
Method: Heparinised blood samples were
obtained from grass pollen allergic and
nonallergic donors and immature mono-
cyte-derived dendritic cells (MoDCs) were
generated as previously described. Purified
rPhl p 5 and control allergens (sunflower
LTP and transferrin) were labelled with
Cy3, Alexa fluor 488 and FITC, respec-
tively. On day 7, MoDCs were tested for
surface binding (4°C) and internalization
(37°C) of the allergens. Co-localisation of
FceRI, CD23 and Phl p 5 was also investi-
gated. The cells were analyzed using fluo-
rescence microscopy (Imager. ZI, ZEISS).
For qualitative and quantitative assess-
ment, Tissue-FAXS (Tissue-Genostic) and
Tissue-Quest software was used.
Results and Conclusion: In this study sup-
ported by SFB F46-B19 (KHS) from the
Austrian Science Fund, we have studied
allergen uptake by DCs. The data demon-
strated Phl p 5 binding and internalization
by MoDCs from both, allergic and nonal-
lergic individuals. In competitive uptake of
mixed allergens (Phl p 5+LTP), MoDCs
from allergic subjects showed preferential
uptake of Phl p 5 as compared to LTP.
Co-localisation experiments (CD23, FceRI,
Phl p 5) suggest that more than one mech-
anism facilitate the allergen uptake by
MoDCs.
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Potential antiallergic effect of pleuran
(beta-glucan isolated from Pleurotus
ostreatus)
Jesenak, M1; Banovcin, P1; Sanislo, L2; Rennerova, Z3;
Majtan, J4
1Department of Paediatrics, Jessenius Faculty of
Medicine in Martin, Comenius University in Bratislava,
Martin, Slovakia; 2Department of Clinical Immunology
and Allergology, St. Elizabeth’s Oncology Institute,
Bratislava, Slovakia; 3Pneumo-Alergo Centrum s.r.o.,
Bratislava, Slovakia; 4Slovak Academy of Sciences,
Institute of Zoology, Bratislava, Slovakia
Background: The prevalence of allergic dis-
eases is steadily increasing. There is a
search for complementary alternatives to
standard antiallergic treatments. Beta-glu-
cans are a group of biologically active
polysaccharides of natural origin with a
proven pleiotropic immunomodulation
effect. Several studies suggest possible an-
tiallergic therapeutic and preventive effects
of beta-glucans. We studied the possible
effects of pleuran on nonspecific markers
of allergy (total IgE, peripheral blood
eosinophilia) and on the production of
cytokines in vitro.
Method: In a double-blind, placebo-con-
trolled study, we investigated a group of
175 children (aged 5.65  2.39 years).
Children were randomised into an active
group (treated with pleuran in the form of
syrup for 6 months) and a placebo group.
During three visits (V0 – at the beginning,
V1 – after 6 months, V3 – after
12 months) blood was sampled for the
examination of the nonspecific allergic
markers. In a subgroup of the subjects the
sampling for stimulated in vitro cytokine
production was performed.
Results: Whereas in the active group, the
level of total IgE in serum remained stable
across the whole study, in the placebo
group the levels of total IgE increased
gradually from V1 to V3. The eosinophilia
in peripheral blood decreased significantly
as a result of active treatment, but in the
placebo group, we did not detect any
changes of this parameter. In a subgroup
of allergic patients, we studied the poten-
tial effect of pleuran in vitro. After 24 h of
stimulation of whole blood with either
pleuran or lipopolysaccharide (TLR agon-
ists), we observed a significant increase of
IL-10 and GM-CSF production and a
decreased TNF-a production in the pleu-
ran group vs the lipopolysaccharide group.
Other cytokines did not show significant
changes.
Conclusion: Our study provides relevant
evidence of the potential antiallergic effect
of pleuran. This supports the use of pleu-
ran (beta-glucans) as a complementary
treatment in allergic diseases. Our study
opens new perspectives on the use of this
widespread and popular group of natural
substances. This effect needs further
investigation.
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Patient serum sensitivity profiles for
allergens prevalent in Italy is
geographically relevant
Swan, NJ1; Hewings, SJ1; Hutchings, JW1; Mwange,
JD1; Skinner, MA1
1Allergy Therapeutics, R&D, Worthing, United Kingdom
Background: Suitable serum is required for
adequate characterisation and standardisa-
tion of allergen SCIT products. Olive,
Parietaria and Cypress species are more
prevalent in Southern Europe though sen-
sitised patients exist worldwide. This study
compares the sensitivity profile of serum
sourced within and outside Italy.
Method: Patients allergic to Olive, Parie-
taria and Cypress pollens were enrolled
during the pollen season as they sought
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treatment. Blood was taken prior to treat-
ment and components separated. Individ-
ual patient serum was then tested
quantitatively using total allergenicity titre
and qualitatively using Western blotting of
Olive, Parietaria and Cypress pollen
extracts. The individual patient serum sam-
ples were analysed alongside a serum pool
generated outside the region.
Results: Western blotting demonstrated a
response in all patients to the relevant spe-
cies, however it was noted that the patients
react with differing intensities. In addition
patients’ serum reacted to different aller-
gens or combinations of allergens. This
variation in responses was also observed in
the comparative total allergen titres with a
range of dose response curves identified.
Conclusion: The study has shown diversity
in patient sensitivity profiles for allergens.
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Modification of the allergic response in
patients undergoing autologous
hematopoietic stem cell transplantation
Izquierdo Dominguez, A1; Labrador Horrillo, M1; Sala
Cunill, A1; Guilarte Clavero, M1; Barba, P1; Cardona
Dahl, V1
1Hospital Vall d’Hebron, Universitat Autonoma de
Barcelona, Barcelona, Spain
Background: During to the procedure of
hematopoietic transplant, a modification
and restructuring of the immune system
occurs in the patient. This ‘reset’ of the
immune system has been studied in differ-
ent autoimmune diseases, but not in aller-
gic conditions. The objective of this study
was to evaluate whether allergic patients
undergoing autologous hematopoietic stem
cell transplantation (ASCT) showed
changes in sensitisation and/or improved
their allergic symptoms.
Method: Prospective observational study.
Adult patients undergoing ASCT from
May 2010 to March 2012 at Hospital Vall
d’Hebron, Barcelona, Spain were invited to
participate; patients were assessed by medi-
cal history, total IgE, specific IgE and
component resolved diagnosis (Immuno-
CAP & ImmunoISAC, ThermofisherScien-
tific, Sweden) before and 4–6 months after
autotransplantation. Informed consent was
obtained from patients and the protocol
was approved by the ethics committee.
Results: Out of 28 patients included, only
6 (21%) showed some allergic sensitisation
pre-ASCT; in 5 (83%), specific IgE levels
decreased or became negative and allergic
symptoms disappeared post-ASCT. While
there was a significant difference in serum
total IgE between allergic [median 68.10,
interquartile range (IQR) 12.5–850 KU/l)]
and non-allergic (median 2.91, IQR 2-
85 KU/l) patients pre-ASCT (P = 0.013),
this difference disappeared after the proce-
dure.
Conclusion: In this pilot study, allergic
sensitisation was diminished after ASCT,
and this was in parallel to clinical improve-
ment.
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Allergic reaction in Japanese patients
with obstructive sleep apnea syndrome
(OSAS) and upper airway resistance
syndrome (UARS)
Inaba, Y1; Suzuki, Y1; Tokano, H1; Iwasaki, A1; Tsunoda,
A1; Kitamura, K1
1Department of Otorhinolaryngology, Tokyo Medical
and Dental University, Tokyo, Japan
Background: In most cases with OSAS,
obstruction occurs in pharyngeal space. In
contrast, obstruction remains unclear in
some Japanese patients because of short
length of facial anteroposterior diameter
and they demonstrate low score of apnea-
hypopnea index (AHI) on polysomnogra-
phy. They might be diagnosed UARS
because they experience sleep disorder and
demonstrate lowered SpO2 level during
sleep. In the present study we analyzed
allergic reaction in Japanese patients with
OSAS and UARS and we studied if the
allergic reaction could influence the clinical
findings in patients with OSAS and UARS.
Method: The subjects were 24 Japanese
patients with OSAS and/or UARS who
undertook treatment including three cases
of oral aid, six cases of medication, five
cases of CPAP, and 10 cases of surgery.
The data of allergic reaction, such as num-
ber of eosinophils, and serum levels of
RIST and RAST were measured and their
correlation with sleep disorder was evalu-
ated.
Results: Elevated levels of specific antibod-
ies against house dust and mite were seen
in almost all groups.
Conclusion: These results suggested that
elevated levels of specific antibodies against
house dust and mite correlate sleep disor-
der regardless of the degree of AHI or low-
ered SpO2 level.
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Allergic rhinitis is associated with
increased levels of regulatory T cells
Kaidashev, IP1; Sakevich, V1; DuBuske, LM2
1Ukrainian Medical Stomatological Academy, Poltava,
Ukraine; 2Immunology Research Institute of New
England, Gardner, MA, United States
Background: CD4+CD25+ regulatory T
cells (T reg), which regulate the functions
of T cells, provide the directions for vari-
ous types of immune responses. The mech-
anism of allergic rhinitis development is
the imbalance among different populations
of Th1/Th2 lymphocytes with Th2 cells
prevalence. The natural regulatory T cells
(nTreg) as the key immunoregulatory cells
are able to suppress the Th1-dependent
immune responses. The specific intracellu-
lar marker for identifying Tregs is known
as transcription factor (FoxP3), which is
also important for the development and
functioning of these regulatory cells.
Method: A group of 45 persons (23 men,
22 women), age 19–65 years old, with aller-
gic rhinitis was assessed. The levels of
expression of CD4+, CD4+/25+, CD4+/
25+/Foxp3 were determined in mononu-
clear suspensions of peripheral blood (Sor-
bent, Russia; eBioscience, USA).
Results: According to the results of im-
munogram, the levels of CD4+ did not sig-
nificantly differ from healthy controls
being 40.5  1.2%. There was a growth in
the relative number of
CD4+CD25+Foxp3+Treg (4.66  0.38%)
of total lymphocytes in comparison with
healthy controls. To assess the imbalance
of the immune system and establish the
presence of statistical relationships between
the immunological parameters of patients
with allergic rhinitis vs healthy controls,
correlation analysis using the Spearman’s
method was done, demonstrating a moder-
ate positive correlation between the param-
eters: CD4+CD25+Foxp3 and CD4+
(R = 0.43; P = 0.00); CD4+ CD25+ Foxp3
and the number of eosinophils (R = 0.35;
P = 0.03).
Conclusion: These derived data confirm
the close relationship between the allergic
inflammation and the numbers of regula-
tory T cells.
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Szakos, E1; Szontagh, E1; Vamosi, I2; Vizi, J1; Tamasi,
K1; Barkai, L1
1Borsod County University Hospital, University of
Debrecen, Postgraduate Institute of Pediatrics, Miskolc,
Hungary; 2Borsod County University Hospital, Clinical
Laboratory, Miskolc, Hungary
Background: Microbiological agents are
suspected launching the development of
sterile inflammatory processes in geneti-
cally predisposed individuals by molecular
mimicry. The authors tested possible
etiological role of Helicobacter pylori (HP)




Patients and Methods: Authors followed
up clinical and laboratory data of 165 indi-
viduals with sterile inflammatory diseases
examined at Dermatology-immunologic
outpatient’s Department. They performed
analysis of data collected by prospective
and retrospective ways. Blood chemistry,
autoantibody, Helicobacter pylori serology
testing are also done. Upper gastrointesti-
nal endoscopic procedures and HP immune
histochemistry were performed in some
cases with suspected active HP infection.
Fifty control patients (32 girls, 18 boys)
tested with HP serology presented gastroin-
testinal symptoms.
Results: One hundred and thirty (71 girls,
41 boys) of 165 patients aged 2–18 years,
52 of them (43 women, 9 men) aged 19–
52 years. 40 of 165 patients (18 children: 9
boys, 9 girls, 22 adults: 6 male, 16 female)
presented HP serologic positivity. Occur-
rence was 15.8% in children, (12.65 in
girls, 21.45 in boys) 42.3% (37.7 in women,
66.6 in man) in adults with sterile inflam-
mation. HP positivity in controls was: 32/
50 64% (21/32 girls 65.6%, 11/18 boys
61.1%). 85 of sterile inflammatory pro-
cesses occurred in 40 patients with HP pos-
itivity: arthritis-arthralgy 18, thyroiditis 16,
idiopathic urticaria 8, alopecia areata 7,
cutan vasculitis 5, psoriasis 5, habitual
aphtha 5, vitiligo 4, Raynaud syndrome 3,
habitual abortus 3, scleroderma 2, lichen
sclerosus 2, coeliakia 2, granuloma anulare
1. Type I diabetes mellitus 1, acne conglo-
bata 1, obesity 1, rosacea 1. ENA was the
most frequent autoantibody: 17/40 in cases
with HP positivity, in 25/125 with HP neg-
ativity. Odds ratio: 1.875. Anti smRNP
occurred: 2/40 and 20/125. Odds ratio:
0.31, anti double strained DNA positivity
5/40 and 28/125, Odds ratio 0.55.
Conclusion: Higher frequency of HP posi-
tivity among male with sterile inflamma-
tion could be new information, waiting for
confirmation. Likely linked occurrence of
ENA and HP positivity in these patients
with non polyserositic sterile inflammation
arises the possible role of HP colonization
in initiation of sterile inflammation. More




– a national scientific research
Yakovliev, PH1; Nikolov, K2; Baleva, M2; Shomov, G3;
Kishkina-Takovska, N4
1Consulting Room of Allergology, Stara Zagora,
Bulgaria; 2Medical University, Sofia, Bulgaria; 3Medical
University, Stara Zagora, Bulgaria; 4Consulting Room
of Allergology, Blagoevgrad, Bulgaria
Background: We examined and monitored
56 patients with SLE vasculitis, at the age
of 24–73 years, being treated in the hospi-
tal in Stara Zagora, Bulgaria, with dura-
tion of the illness from 1 to 17 years.
Method: From the immunological parame-
ters we examined: IgG, M, A; C3 and C4
complement fractions – Radial immunodif-
fusion; antibodies to nuclear antigens
DNA; Sm; RNP – with Counter electro-
phoresis; ANA and ANCA antibodies with
Immunofluorescence method; anti-cardioli-
pin antibodies – with ELISA, RF – with
Agglutination and ELISA, as well as CIC
(circulating immune complexes), histones,
crioglobulins; Ro and La.
Results: Most frequently observed clinical
symptom in the monitored ills was joint
affection, reported in 38 ills (67.9%), fol-
lowed by skin lesions manifested by pete-
chiae, palpable purpura, urticaria, nodules,
bullae, ulcerations and others in 37
patients (66.1%). Kidney damage was also
often observed, in 31 (55.4%) from the
monitored patients, and high temperature
was measured in 30 ills (54%). According
to our data, mean values of immunoglobu-
lins in the serum of investigated patients
with SLE vasculitis are higher than in
healthy people, but statistically significant
(P < 0.001) is only elevation of IgG and
IgA. Elevated levels of IgG we found in 25
ills, and of IgA – in 27. Levels of IgM
were not elevated in our patients. Our data
shows that values of serum C3 and C4 in
ills with lupus vasculitis are significantly
lower than in healthy people (P < 0.001).
In 42 of our patients anti-cardiolipin anti-
bodies were above upper limit of reference
range for immunoglobulin classes IgG and
IgM and compared to the control group of
healthy people there is a statistically signifi-
cant difference (P < 0.001). In 15 of our
patients with high acL titer we observed
more often phlebothromboses, insults and
infarctions, as well as skin vasculitis, as
opposed to ills with low titer of these anti-
bodies. Mean values of CIC for our
patients with SLE vasculitis are higher
from those in healthy people, and the dif-
ference is statistically significant
(P < 0.001) according to PEG and C1q
method.
Conclusion: In our opinion, determining
the composition of CIC is important, espe-
cially in cases when ANA are not found in
the serum of ills with SLE vasculitis. The
majority of our patients with SLE vasculi-
tis were with positive ANA (76%) and
DNA (60%). DNA antibodies are impor-
tant criteria for diagnosis of systemic
lupus, accompanied with vasculitis.
451
Raynaud’s Syndrome and vasculitis
Yakovliev, PH1; Nikolov, K2; Baleva, M2; Shomov, G3;
Kishkina-Takovska, N4
1Consulting Room of Allergology, Stara Zagora,
Bulgaria; 2Medical University, Sofia, Bulgaria; 3Medical
University, Stara Zagora, Bulgaria; 4Consulting Room
of Allergology, Blagoevgrad, Bulgaria
Background: Totally 65 ills have been
examined: 35 had only Raynaud’s syn-
drome (group I), and other 30 were with
Raynaud’s syndrome included in another
disease, respectively: with SLE (16), with
scleroderma (10) and with mixed connec-
tive tissue disease (4) – group II. The
patients that we examined were at the age
of 18–73 years and duration of the illness
from 6 months to 12 years.
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Method: Distributions of positive ANA, as
well as their specificity differ between the
two groups. It is important to note that
positive ANA are suggestive for the need
of further examinations.
Results: In the first group are prevalent the
negative results and those with low titers –
70% from the ill, and the antibodies are
mainly to extractable nuclear antigens
(EHA) – anticentromere, anti-RNP, anti-
Scl-70. On the opposite – 80% from the
patients from group II had high titers of
ANA, and their characteristic is heteroge-
neous – half of them are anti-DNA, and the
other half – anti-EHA. Major clinical symp-
toms in ills with Raynaud’s syndrome are:
bruising on the fingers (80) and formication
and tingling sensation of the affected limbs
(97%). With livedo reticularis were 51% of
the ills from group I. Significant diagnostic
features are ulcerations and necroses on dis-
tal phalangae, observed in 31% of the exam-
ined patients with Raynaud’s syndrome. In
group II symptoms such as arthritis/arthral-
gia (86%), myalgia and bruising on fingers
(66%), photosensibility, distinctive rash,
habitual abortions and other were prevalent.
Conclusion: Major clinical symptoms of
Raynaud’s disease are:
• Vascular attacks, induced by chill and
excitement;
• Localisation of vascular attacks is sym-
metric;
• Arterial pulsation of all reachable
accesses is normal;
• Gangrene of the skin on distal parts of
the limbs;
• Vasospasm is observed during a period
of at least 2 years;
The main laboratory and instrumental
parameters are:
• In our patients, angiography of vessels
of distal parts of the limbs shows areas
of irregular stenosis, partial or total
obliteration and lack of additional cap-
illary anastomoses/72%/;
• By capillaroscopy of the nail bed or
bulbar conjunctiva we observed altera-
tions of the shape and permeability of
capillaries and microvessels/56%/,
reduction in their number or dilatation/
32%/. Severity of the changes corre-
sponds to microcirculatory disorders.
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Anti-PM/Scl and hypomyopathic
dermatomyositis: a novel association
Allegro, E1; Fassio, F1; Salvati, G1; De Giorgi, G1; Troilo,
A1; Parronchi, P1; Maggi, E1
1Immunology and Cell Therapies Unit, AOU Careggi,
Florence, Italy
Case Report: We report the case of a
73 years old man, who referred to our
Unit for infiltrated erythematous skin
lesions localised on the face, neck and
proximal limbs.
Routine blood tests demonstrated
increased values of CPK, myoglobine and
ALT. Search for autoantibodies revealed
the presence of antinuclear antibodies
(ANA 1:320 speckled) and anti-PM/Scl.
The patient subsequently underwent fur-
ther investigations for connective tissue dis-
ease, even if he didn’t complain for any
other symptom at the time of consultation
and physical examination, except for the
above mentioned skin lesions, was unre-
markable.
Physical tests, electromiography and
muscle NMR didn’t show any sign of mus-
cle involvement. Arterial blood gas analy-
sis, pulmonary function tests, including
DLCO, and chest HRCT didn’t show any
sign of interstitial lung disease. Renal func-
tion was normal with no proteinuria.
We therefore performed skin biopsy
which showed lichenoid tissue reaction
consisting of vacuolization of basal layer
cells and oedema of papillary dermis, asso-
ciated with dilatation of superficial vessels
and dermal infiltration predominantly con-
sisting of lymphocytes and minimal num-
bers of neutrophils and eosinophils.
Being these findings consistent with a
diagnosis of dermatomyositis (DM), and
excluding any muscle involvement, we con-
cluded for a diagnosis of hypomyopatic
DM. This clinical entity is a rare subset of
dermatomyositis which is characterised by
DM-specific skin disease and subclinical
evidence of myositis on laboratory, electro-
physyologic and/or radiologic evaluation.
Anti-PM/Scl are autoantibodies which
can be found in polymyositis/systemic scle-
rosis overlap syndromes. To date, no other
cases of hypomyopathic dermatomyositis
have been reported in association with
anti-PM/Scl. The patient is currently being
followed up as he may develop myositic
and/or systemic sclerosis manifestations in
the future.
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Eosinophilia with organ involvement in
two siblings
Lishchuk-Yakymovych, K1; Pukalyak, R1; DuBuske, I2;
DuBuske, L2
1Department of Clinical Immunology and Allergology,
Danylo Halytskyy Lviv National Medical University,
Lviv, Ukraine; 2Immunology Research Institute of New
England, Gardner, MA, United States
Background: Churg-Strauss syndrome
(CSS) is a rare, autoimmune small and
medium vessel vasculitis, accompanied by
asthma and involves mainly the blood ves-
sels of the lungs, and peripheral nerves,
skin, kidneys, and heart with marked
blood eosinophilia.
Method: Two siblings who suffered from
marked eosinophilia with organ involve-
ment are described.
Results: One sibling experienced erythema
multiforme, cervical lymphadenopathy,
peripheral neuropathy, arthritis with eosin-
ophilia (1.8 cells/ll) following bronchial
asthma, was pANCA-positive and was
diagnosed with Churg-Strauss syndrome
(CSS) according to the criteria of the
American College of Rheumatology. Glu-
cocorticoid treatment with an initial daily
dose of 40 mg of prednisone relieved eosin-
ophilia, while combination of glucocorti-
coid with azathioprine using a daily dose
of 100 mg relieved organ involvement
symptoms. Another sibling, who suffered
from severe asthma with persistent polyar-
thritis and eosinophilia (5.2 cells/ll), was
cANCA-positive but did not fulfil the
widely used criteria for CSS or hypereosin-
ophilic syndrome (HES). This sibling was
treated with 60 mg of prednisone daily
dose with minimal reduction of eosino-
philia.
Conclusion: Increased C-reactive protein
and decreased anti-ET IgM, anti-ET IgG
predicted a lethal outcome in 7 HD
patients. Four years of monitoring chronic
kidney disease hemodialysis patients
showed a 4.6 fold increase in C-reactive
protein (P < 0.001) but no change in indi-
cators of humoral anti-endotoxin immu-
nity.
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Increased peripheral TH17 Cells in SAPHO
syndrome: a novel target for treatment?
Firinu, D1; Lorrai, MM1; Barca, MP1; Peralta, MM1; Mura,
MN1; Perra, S2; Cabras, S2; Manconi, PE1; Del Giacco,
SR1
1Department of Medical Sciences ‘M. Aresu’, Unit of
Internal Medicine, Allergy and Clinical Immunology,
University of Cagliari, Monserrato, Italy; 2University of
Cagliari, Monserrato, Italy
Background: SAPHO syndrome, character-
ised by a variable combination of Synovi-
tis, Acne, Pustulosis, Hyperostosis and
Osteitis, is a rare, often unrecognised dis-
ease with prominent inflammatory cutane-
ous and articular features. Recent
evidences lead to consider SAPHO in the
spectrum of Auto-Inflammatory Diseases
(AID). Treatments with steroids, NSAIDS
or TNF-a antagonists have been effectively
employed. In humans, a key role of IL-1b
as a pro-inflammatory regulator in the
priming and differentiation of TH17 lineage
and the central role of IL-1b hypersecre-
tion in AID is well established. In some
AID IL-1b has been implicated to lead
towards a severe systemic inflammatory
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syndrome, possibly mediated by a TH17
skewed phenotype. The inflammatory
P2X7-IL1b axis has been previously shown
to be dysregulated in SAPHO syndrome.
Method: We checked if the IL-1b derange-
ment observed in SAPHO syndrome could
affect the peripheral TH1, TH2 or TH17 fre-
quency, in comparison with groups of
healthy individuals and rheumatic disease
controls, which were matched for sex, age,
disease duration and treatment status.
Results: TH17 levels for the two groups of
SAPHO and not-SAPHO patients are sig-
nificantly different (P = 0.009). We also
studied the interaction between the vari-
ables SAPHO and treatment by means of a
Fisher′s exact test which showed no signifi-
cative dependence. TH1 and TH2 levels for
the two groups of SAPHO and not-SAPH-
O patients are not significantly different.
SAPHO patients showed significantly
increased numbers of IL-17 producing T-
cells by flow-cytometry after PMA/iono-
mycin stimulation as compared to healthy
controls. The frequency of TH17 cells
between SAPHO patients and rheumatic
controls, matched for sex, age, disease sta-
tus and treated with the same drug (Meth-
otrexate plus Adalimumab) was
significantly increased, irrespectively of dis-
ease status or treatment. We observed no
correlation between TH1 or TH2 and TH17.
Conclusion: Our results suggest that acti-
vation of TH17 axis, but not of TH1 and
TH2, is characteristic of SAPHO syndrome
with protracted course, and that this find-
ing is independent from remission status
and/or from concurrent treatment with
DMARDs or anti-TNF-a. Our preliminary
data shed light on the possible involvement
of TH17 cells in the immunopathogenesis
of SAPHO, irrespectively from the patient′
s disease status.
Targeting IL-1b or IL-17 blockade may
be considered in SAPHO patients on the
basis of these results.
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Patient with three years of papular
lesions evolution
Egu¨ez Hidalgo, MF1; De Luque Pi~nana, V1; Botello
Borrego, MD1; Cabeza Rodriguez, N1; Guardia Martinez, P1
1Allergy and Clinical Immunology Department, Virgen
Macarena University Hospital, Seville, Spain
Background: Dermatitis herpetiformis is a
chronic autoimmune disease that causes a
rash pruritic vesicular papulo predomi-
nantly in extensor surfaces and character-
ised histologically by papillary
microabscesses of neutrophils.
It is associated with gluten sensitive
enteropathy and resolves after introducing
a diet free thereof. It can occur at any age,
with a peak in the third decade. It is more
common in males.
Method: A 72 year old male, ex-smoker,
occasional drinker, diabetes mellitus.
Derived for 3 years of infiltrated papular
lesions on elbow extension area, arms and
face a few hours earlier with residual hy-
perpigmentation and lichenification with
intense itching. Originally relate to making
the gliclazide (sulfonylurea), however when
removing limbs injuries persist. No altera-
tions in bowel concerns. He had been trea-
ted as an atopic dermatitis.
Also referred sneezing clinic, no seasonal
predominance hydrorrhea and unrelated to
any trigger also associated with hyposmia.
Physical examination: Lichenified lesions
on the back of his elbows.
Results: Basic blood analysis: 270 eosin-
ophils/ml, Biochemistry: glucose 148 mg/
dl, triglycerides 188 mg/dl, glycosylated
hemoglobin 7.2. Urine: normal, PSA: nor-
mal.
Skin tests to aeroallergens, wheat, rye
and barley: Negative
Epicutaneous test (true test): Negative
Total IgE: 267 U/l, specific IgE to aero-
allergens: negative.
Transglutaminase IgA antibodies 112 U/l.
Skin biopsy with direct immunofluores-
cence study: granular deposits of papillary
dermis at dermoepidermal junction and
IgA, complement C3 and fibrinogen posi-
tive findings consistent with dermatitis her-
petiformis.
Conclusion: We report a patient with inju-
ries described as compatible with this con-
dition over 3 years had been treated as an
atopic dermatitis. Obviously this is a dis-
ease in which in their differential diagnoses
include scabies, atopic eczema, contact
eczema, and other autoimmune diseases
such as bullous dermatosis linear IgA bul-
lous pemphigoid, so it is important that we
know a wide range of dermatological
pathology related to an allergic or autoim-
mune mechanism, in which we can make
differential diagnoses, which can sometimes
go unnoticed as in our case as the patient
had no digestive symptoms. As we
reviewed the literature on the clinical pre-
sentation can be variable and associated
digestive symptoms.
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Association of KIR receptors
polymorphism and MHC-class I alleles in
Colombian Caribbean patients with lupus
nephritis class IV
Garavito, G1; Olier, D1; Aroca, G1,2,3; Iglesias-Gamarra,
A4; Garcıa, R2; Egea, E5,6
1Universidad del Norte, Barranquilla, Colombia; 2Clinica
de la Costa, Barranquilla, Colombia; 3Universidad
Simon Bolivar, Barranquilla, Colombia; 4Universidad
Nacional de Colombia, Bogota, Colombia; 5Universidad
del Norte, Division Ciencias de la Salud, Barranquilla,
Colombia; 6CliniAlergia, Unidad de Alergia,
Barranquilla, Colombia
Background: Lupus nephritis (LN) is the
most frequent complication in patients
with SLE. To date it not has been defined
any specific polymorphisms or haplotypes
of KIR and MHC-Class I system as a mar-
ker of protection or susceptibility in
admixed latin ethnic population. Given
that genetic load of each ethnic group is
very important in diseases association we
designed this study in patients expressing
the lupus nephritis class IV endophenotype
in order to characterise an association
between these genetic markers and the
presence of this severe morbility.
Method: This was a case-control study
approved by the ethics committee of the
University of North involving 50 individu-
als with class IV LN and 100 normal con-
trol subjects, none of them related
familiarly and all residents on the same
area Genotyping of KIR alleles was done
by PCR-SSP and oligotipificacion of HLA-
B and HLA-C alleles by Luminex technol-
ogy (HLA-SSO). Statistical analysis was
done using SPSSv19 and Arlequin v3.11.
Results: The most frecuent inhibitory KIR
alleles were 2DL4 (100%), 2DL1 (98%)
and 3DL2 (92%). Activators KIR alleles
expressed were 2DS4 del (74%), 2DS4ins
(46%) and 2DS1 (44%). Only statistical
association was found as predisposing fac-
tors for alleles KIR3DL1 (P = 0.001) and
KIR3DL2 (P = 0.0001) The activator
alleles KIR3DL3 (P = 0.0001) and
KIR2DS1 (P = 0.0001), KIR2DS2
(P = 0.0001), KIR2DS3 (P = 0.0001),
KIR2DS4del (P = 0.003), KIR2DS4ins
(P = 0.0001) and KIR2DS5 (P = 0.0001)
were showing as protective factors. The
HLA alleles more expressed were HLA-
B*07 (30%), HLA-B*35 (30%), HLA-
B*08 (20%), HLA-C*07 (60%) and HLA-
C*04 (30%). Association as predisposing
factors for developing class IV LN, was
only found for the HLA-B*07 (P = 0.002)
and HLA-C*07 (P = 0.020). The haplo-
types with higher expression were
HLA-B*07/HLA-C*07 (14%), HLA-B*35/
HLA-C*04 (9%), HLA-B*08/HLA-C*07
(9%), HLA-B*40/HLA-C*03 (8%) and
HLA-B*15/HLA-C*02 (6%) A protective
factors was associated with the haplotypes
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HLA-B*07/C*07 (P = 0.0001), HLA-B*08/
C*07 (P = 0.010) and HLA-B*35/C*07
(P = 0.030).
Conclusion: This is the first study in SLE
latin American patients done with these
genetic markers in search an association
between those markers and the endopheno-
type class IV LN. The results suggest that
These genetic markers could be used as
predictive markers for this severe SLE
morbility. More study sould be performed
for the validation of this results.
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Validation of a monoclonal antibody-
based method for measuring olive pollen
major allergen, Ole e 1
Arilla, C1; Ibarrola, I1; Brena, S1; Santos, M1; Zamarre~no,
J1; Martınez, A1; Asturias, JA1
1Bial Arıstegui, R&D, Zamudio, Spain
Background: We developed a sensitive and
specific two-site sandwich ELISA for the
quantification of Ole e 1. It represents an
important tool for quality control of aller-
gen preparations from olive tree pollen
intended for clinical use. The aim of this
study was to demonstrate that the method
is valid for the quantification of Ole e 1 in
extracts according the ‘Guideline on Aller-
gen Products: Production and Quality
Issues’ (CHMP/BWP/304831/2007) and for
the use in verifying the batch to batch con-
sistency.
Method: The assay was based on 5A3
mAb as capture and biotinylated nOle e 1
specific rabbit polyclonal antibody as
detector. The in-house reference extract
from Olea europaea was analyzed and its
allergen content was calculated using puri-
fied Ole e 1 as standard for the valida-
tion. The studied parameters were
repeatability, intermediate precision, accu-
racy, limit of quantification and robust-
ness. Ole e 1 content was also determined
in extracts obtained from different pollen
suppliers.
Results: The assay met the repeatability
requirement since the CV for the percent-
ages of Ole e 1 was 4.6%. None of the
variables had a statistically significant
effect on the test result, with a 95% confi-
dence interval (minimum P-value 0.176). It
fulfilled the requirement of accuracy since
the texp = 0.828 calculated for the recovery
test was less than the ttab. The limit of
quantification was determined in 9.8 ng/ml
for the extract and fulfilled the require-
ments of precision (CV = 14.8%) and
accuracy (relative error = 3.9%). The tech-
nique was robust for the effect of tempera-
ture and incubation time, so that the
method complied with the specifications
established for its use. Ole e 1 content
among six batches of Olea pollen extracts
showed good consistency with a coefficient
variation of less than 25%.
Conclusion: The validated ELISA comple-
ments the biological standardisation of
different manufacturing batches by evalu-
ating the major allergen in mass units.
463
Identification of relevant allergens by
mass spectrometry: a new tool for
standardisation of allergen preparations
Augustin, S1; Reese, G1; Klysner, S1; Nandy, A1
1Allergopharma GmbH & Co. KG, Reinbek, Germany
Background: Traditionally, in vitro allergen
standardisation has been conducted mainly
by IgE-based assays. However, these tests
are not appropriate to demonstrate the
presence of all relevant allergens in a given
allergen preparation. Assays based on
allergen-specific animal antibodies can
overcome this deficiency, but are depen-
dent on the availability of these antibodies.
As an alternative, mass spectrometry (MS)
was tested for its applicability to identify
allergens in various complex allergen prep-
arations.
Methods: MS was applied for identifica-
tion of relevant allergens in different aller-
gen preparations from mites and pollens
(derived from trees, grasses, cereals, and
weeds). All investigated preparations were
manufactured by Allergopharma. Analyses
were conducted with production batches of
allergen extracts used for allergoid produc-
tion and with production batches of alu-
minium hydroxide-adsorbed extracts. In
parallel current in house references (IHRs)
were analysed. First, samples were sub-
jected to enzymatic digestion. Resulting
peptides were separated by liquid chroma-
tography and subsequently analysed by
tandem MS (LC-MS/MS). Allergen identi-
fication was performed by searching an
individually designed allergen database
containing all allergen sequences known
from the analysed species.
Results: All current IHRs, three batches of
each allergen extract and of each alumin-
ium hydroxide-adsorbed allergen extract
were analysed. The relevant allergens were
identified in all samples by detection of
peptides covering large parts of the respec-
tive proteins, leading to statistically signifi-
cant protein scores. This included the
allergens Der p 1, Der p 2, Der f 1, Der f
2, Bet v 1, Aln g 1, Cor a 1, Fag s 1, Ole e
1, Phl p 1, Phl p 5, Tri a 5, Sec c 5, Hor v
5, Ave s 5, Amb a 1, Art v 1, Par o 1, Par
o 2, and Pla l 1. Furthermore, the majority
of minor allergens known from the individ-
ual species were successfully identified.
Conclusions: Relevant allergens were iden-
tified reproducibly by MS in all analysed
allergen preparations. These results demon-
strate the quality of the investigated prepa-
rations and document that MS is a suitable
technique to fulfil the demands of the
current regulatory guidelines regarding
identification of relevant allergens in phar-
maceutical allergen preparations. Further-
more our data show that MS is applicable
for comprehensive protein profiling of het-
erogeneous allergen preparations, provided
protein sequence information is available.
466
Tyrosine as a biodegradable depot
adjuvant for use in immunotherapy
Bullimore, AD1; Hewings, SJ1; Skinner, MA1
1Allergy Therapeutics, R&D, Worthing, United Kingdom
Background: An adjuvant is a material
added to vaccine preparations to boost
clinical efficacy. An ideal adjuvant should
increase efficacy by prolonging exposure
and/or boosting appropriate immune path-
ways. An adjuvant should not stimulate
inappropriate immune mechanisms and
should have minimal side effects. Addition-
ally there should be efficient and complete
elimination from the body after metabo-
lism. The benefits of a tyrosine adjuvant
platform have been investigated.
Methods: Data regarding the in vivo reten-
tion and elimination times of tyrosine
when used as a depot adjuvant has been
generated. In addition, specific IgG1 and
IgG2 have been measured as indicators of
whether Tyrosine can favourably balance
the immune response.
Results: Candidate allergy therapies have
been evaluated to consider the benefits of
using the natural product tyrosine as a
depot adjuvant in subcutaneous immuno-
therapy (SCIT). Tyrosine is naturally me-
tabolised and the pharmacokinetics of
tyrosine show that tyrosine has a half-life
at the injection site of 48 h; this is a partic-
ular benefit for allergy SCIT, a tradition-
ally long course treatment, minimising the
need for accumulation of non-biodegrad-
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able adjuvant. Data suggests that the speed
of this elimination compared to alternative
adjuvants leads to less likelihood of persis-
tent nodule formation and injection site
irritation. We have demonstrated that tyro-
sine can act as an adjuvant to induce
increased IgG1 and IgG2 antibody produc-
tion when the tyrosine is adsorbed to aller-
gen preparations. Using specific IgG1 and
IgG2 as a measure of response, it has been
identified that tyrosine promotes re-balanc-
ing of the immune reaction. In vivo studies
indicate a stronger Th1 inducing effect
compared with that observed with alterna-
tive adjuvants and additionally suggests no
IgE stimulation consistent with a Th2
response.
Conclusion: Tyrosine elimination and
removal rates are greater than alternative
adjuvants and tyrosine is effectively dis-
persed from the injection site, minimising
the risk of injection site irritation. Stimula-
tion of IgG1 and IgG2 is indicative of a
Th1 response and, coupled with a lack of
IgE induction, leads to the conclusion that
tyrosine can be considered an ideal depot
adjuvant. These findings form the basis for
using tyrosine as a SCIT platform applica-
ble for treatment of any allergy.
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Satisfaction of patients with moderate/
severe allergic rhino conjunctivitis
treated with specific immunotherapy as
oral lyophilisate under routine clinical
practice conditions
Chivato, T1; De la Torre, F2; Martınez, E2; OPTIMAL
Study
1School of Medicine, Boadilla (Madrid), Spain; 2ALK,
Madrid, Spain
Background: There are two therapeutic
options for allergic rhino conjunctivitis
(AR). One is symptomatic treatment using
drugs and the other allergen-specific immu-
notherapy. Furthermore, between the dif-
ferent routes of administration currently
used in AR treatment (subcutaneous and
sublingual).
Objective: To identify the expectations,
clinical management and satisfaction of
patients with moderate/severe AR treated
with specific immunotherapy as oral lyo-
philisate.
Methods: A non-interventional, observa-
tional, multi-center, open-label study.
Adult patients with a confirmed diagnosis
of moderate/severe grass pollen-induced
AR and treated with oral lyophilisate SIT
between June 2010 and April 2011. Num-
ber of subjects planned and analyzed: 161
planned, 131 enrolled, 131 completed, 2
not evaluable and 129 analyzed. Age:
mean: 33.95, DT: 12.9. Sex: Male: 60
(46.5%) Female: 69 (53.5%).
Results: The expected result of the vaccine
for each patient varies by AR type such
that 2/3 of patients with a moderate/severe
AR expect to ‘recover completely’ whereas
those patients with a mild AR are less
‘demanding’. Regarding the degree of satis-
faction with the tablet-based vaccine, as
assessed using horizontal and graduated
visual analogue scales, should be noted:
Symptoms remission and perceived effi-
cacy: ranging between 72.3/100 and 77.4/;
Occurrence of side-effects: ranging between
67.9/100 and 74.8/100; Vaccine cost and
availability is lower than above, ranging
between 33.2/100 and 42.7/100; Comfort
and ease of taking the vaccine: ranging
between 82.4/100 and 89.1/100 and the
overall degree of patient satisfaction is
high, ranging between 77.1/100 and 79.9/
100. The level of treatment adherence pre-
sented by the study sample for the tablet-
based vaccine is either high or very high
(more than 80% in the worst group). The
degree of patient satisfaction does not dif-
fer significantly on the basis of the patient′
s expectations.
Safety results: Oral lyophilisate was per-
fectly tolerated. All adverse events (AE)
registered were mil/moderate and no seri-
ous AEs were registered.
Conclusions: It is feasible to initially treat
the interpretation of the relationship
between patient satisfaction during treat-
ment with SIT in tablet form, the under-
standing/expectations of SIT in general
and the clinical management/amount of
information received from the attending
physician in a two-way manner between
each element of this trial.
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Characterisation of Parietaria allergoids
with physicochemical techniques
de Bruijn, J1; van den Hout, R1; Cordewener, J2;
America, T2; Luykx, D1
1HAL Allergy BV, Development, Leiden, The
Netherlands; 2Plant Research International,
Wageningen, The Netherlands
Background: Parietaria allergoids are drug
substances for the Parietaria allergy vac-
cine. Until now these allergoids have been
poorly characterised due to their complex-
ity. Nevertheless, a better characterisation
is needed. This includes identification of
the relevant allergens and determination of
the degree of polymerisation and cross-
linking. Several physicochemical techniques
were tested for their suitability to analyse
these characteristics in the allergoid and
corresponding allergen extract: Mass Spec-
trometry, SDS-PAGE, HPLC-SEC, lysine
determination and fluorescence spectros-
copy.
Method: Allergoids: Allergen extracts from
Parietaria judaica and Parietaria officiniales
pollen were treated with glutaraldehyde to
obtain Parietaria allergoids.
MS: Preparation of tryptic digests and
peptide separation via nano-LC before
electrospray ionisation. Ionised peptides
were fragmented revealing sequences.
SDS-PAGE: 10–20% gels with Coomas-
sie Blue staining and reduced samples.
HPLC: A GF250 SEC column was used
combined with UV-detection.
Lysine determination: Samples were hy-
drolysed into amino acids followed by free
lysine determination with HPLC.
Fluorescence: Emission spectra were
recorded from 290 to 400 nm, with excita-
tion at 280 nm.
Results: Relevant Parietaria allergens Par j
1 and Par j 2 were identified in the Parie-
taria allergoids with MS. SDS-PAGE
showed for the allergoids the formation of
various high molecular weight molecules
including masses ≥250 kDa. HPLC-SEC
showed for the allergoids the formation of
molecules ≥670 kDa. For the Parietaria
extracts a minority of HPLC peaks were
corresponding to proteins with a molecular
mass >44 kDa (11%). For the correspond-
ing allergoids the majority of peaks (52%)
were corresponding to proteins with a
molecular mass >44 kDa. Determination
of free lysines showed that the majority of
the lysines were modified in the Parietaria
allergoids (76%). Fluorescence intensities
obtained for the allergoids were very low
indicating quenching.
Conclusion: Applying a combination of
physicochemical techniques was shown to
be a suitable approach to characterise the
Parietaria allergoids well: Identification of
the relevant allergens and determination of
the degree of polymerisation and cross-
linking were accomplished. Fluorescence
spectroscopy appeared to be not suitable
to analyse the protein structures of the
Parietaria allergoids.
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Development of a novel mite allergoid
product for use in immunotherapy
Depreux, N1; Jurgens, Y1; Basagana, M1; Roger, A1;
Garcia Cadena, G2; Bullimore, AD3; Skinner, MA3
1H.U. Germans Trias Pujol, Unitat Allergia, Badalona,
Spain; 2Allergy Therapeutics Iberica, Barcelona, Spain;
3Allergy Therapeutics, R&D, Worthing, United Kingdom
Background: Dermatophagoides pteronyssi-
nus is recognised as one of the main causa-
tive agents of allergic rhinitis and allergic
asthma in Europe and therefore there is a
need for efficacious immunotherapy. A
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tyrosine adsorbed, modified-allergen prod-
uct has been developed for treatment of
perennial mite allergy. The product has
been standardised to meet a dose regime
consistent with patient convenience and a
prospective observational clinical study has
been performed.
Methods: The product was designed with
ICH (International Conference on Har-
monisation) recognised Quality by Design
(QbD) principles published. A prospective
observational study of safety, tolerability
and short-term effectiveness assessed by
nasal provocation test and in vitro immu-
nological changes is being conducted.
Adult patients (18–65 years) with a his-
tory of house-dust mite induced allergic
rhinitis/rhinoconjunctivitis with or without
clinically stable mild or moderate asthma,
were treated with subcutaneous immuno-
therapy containing 3000 SU/ml of modified
Dermatophagoides pteronyssinus allergen
extract. Tolerability and safety during dose
escalation of 0.05, 0.1, 0.3 and 0.5 ml
administered at 7 days interval were
assessed. Nasal provocation data were col-
lected 1 week before starting the treatment
and 1 week after reaching maintenance
dose. Flow-cytometry was used to deter-
mine cytokine activity 1 week before start-
ing the treatment and 1 week after
reaching maintenance dose.
Results: Fourteen patients were included:
six females and eight males, average age of
37 (range 25–62). All patients followed the
dose escalation schedule as it was origi-
nally prescribed. No local or systemic reac-
tions occurred in patients during the dose
escalation phase. Data on short term effec-
tiveness (nasal provocation test and flow
cytometry) will be presented in the future.
Conclusion: A novel product to treat aller-
gic respiratory patients with modified
D. pteronyssinus allergen preparation has
been developed according to QbD princi-
ples. Adult patients receiving this D. pter-
onyssinus vaccine showed a good
tolerability during the initiation dose esca-
lation phase that permitted the completion
of the dosage regime schedule as it was
originally prescribed.
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Diagnosis in betalaktam allergy;
comparison between commercial reagent
kit and classical method
Kalpaklioglu, AF1; Kavut, AB2; Kalkan, IK1
1Immunology and Allergic Diseases, Kirikkale
University, Kirikkale, Turkey; 2Immunology and Allergy
Clinic, Erzurum State Training and Research Hospital,
Erzurum, Turkey
Background: Skin testing represents the
first-line method for diagnosing betalactam
hypersensitivity. Although various studies
have been performed with major and minor
determinants of benzylpenicillin, in subjects
with suspected betalactam allergy, relatively
few comparable reports exist. Our aim was
to evaluate the commercial kit of poly-l-
lysine (PPL) and minor determinant mixture
(MDM), to compare with the classical
method using commercial drugs, and to test
the results in potency, sensitivity, and speci-
ficity, as well as applicability.
Method: All patients >16 years old
referred for a compatible history of allergic
reaction to betalactams were included. Skin
tests (prick/intradermal) were performed
with DAP reagents including PPL and
MDM (Diater, Madrid, Spain), followed
by penicillin G, amoxicillin, aminocillin,
and the culprit betalactam. If skin tests
were negative, a single-blind oral provoca-
tion test (OPT) was performed with com-
mercial penicillins.
Results: A total of 205 subjects were
assessed, of whom 153 were patients with
suspected betalactam allergy. 71.2% were
female, with a median age of
37.69  13.46 years. Overall test positivity
was found in 34 (22.2%) patients; skin
tests with DAP in 12 (10.3%), and with
commercial drugs in 15 (9.8%). Three
patients displayed a positive reaction to
both PPL and MDM, while nine patients
had a positive reaction to either PPL or
MDM alone, using DAP. Fifteen patients
(9.8%) developed positive reactions in
OPT, with no significant difference
between the species. Eight patients in
whom a negative result was obtained with
the commercial reagents in skin tests had a
positive reaction to oral challenge. Sensitiv-
ity and specificity of skin tests using com-
mercial reagent kit and commercial drugs
are 33.3%–13.3%, and 96%–94.5%,
respectively. Moreover, positive and nega-
tive predictive value of both tests were
44.4%–18.2%, and 94%–92.2%, respec-
tively. The majority of the systemic reac-
tions was immediate type and mainly
belonged to skin.
Conclusion: Our results indicate that the
commercial reagent kit is a reliable tool for
the diagnosis of betalactam allergy, with
high specificity and negative predictive value.
This may be a safe alternative and a practical
option in adult patients, where skin tests with
commercial drugs are difficult to perform
and dangerous. However, both tests can be
preferred in exclusion of betalactam allergy,
rather than the diagnosis.
475
Estimating of tryptase and eosinophilic
cationic protein level in saline during
provocative test with local anesthetics
and dental materials: principals and
advantages
Lazarenko, LL1
1Pavlov State Medical University, Saint-Petersburg,
Russia
Background: The most reliable markers of
allergic inflammation of the type I are
tryptase and eosinophilic cationic protein
(ECP). Tryptase – a mediator of mast cells,
it mediates immediate hypersensitivity.
ECP is granular protein of eosinophils,
which is associated with chronic allergic
inflammation.
Method: Provocative test with determina-
tion of tryptase and ECP in saliva was per-
formed. Examined saliva samples from 28
patients with indications of intolerance to
local anesthetics (group A – 8 men and 4
women), and prosthetic materials (group B
– 5 men and 11 women). Determine the
initial level of tryptase and ECP and its
contents at 2 h after the application of a
local anesthetic or a prosthetic material in
the mouth. Studies carried out on the
equipment ImmunoCAP100 E and
reagents ImmunoCAP. Exclusion criteria
were the presence of systemic mastocytosis
and elevated baseline level of neurotrans-
mitters in the saliva.
Results: Tryptase levels in healthy donors
were 3.8  2.1 mg/l, ECP – 5.9  3.4 mg/
l.
In group A, the average level of tryptase
before provocation was 5.5  1.1 mg/l,
after provocation – 8.1  1.45 mg/l. Posi-
tive provocative test for lidocaine for tryp-
tase was detected in one patient (basal
tryptase 4.4 mg/l, after – 12.4 mg/l). In the
case history – introduction of lidocaine
cause the angioedema. Another patient
increased the level of ECP after mepiva-
caine provocation (before – 6.2 mg/l, after
– 29.3 mg/l). In the case history – makulo-
papular rash and bronchospasm after 3.5 h
treatment.
In group B the value of tryptase and
ECP before and after challenge were not
significantly different from baseline (tryp-
tase in saliva – before – 5.9  1.5 mg/l,
after – 6.4 mg/l; ECP – before –
6.9  1.3 mg/l, after – 9.7  2.2 mg/l).
Provocative tests were positive in three
patients: one nickel to ECP (before –
6.4 mg/l, after – 25.6 mg/l), the other on
the cobalt (ECP – before – 6.7 mg/l, after
– 31.3 mg/l). The third patient′s reaction to
the acrylic plastic accompanied by
increases in both the level of tryptase
(before – 4.8 mg/l, after – 14.7 mg/l), and
cationic protein (up to – 7.6 mg/l, after –
27.8 mg/l).
Conclusion:
1 A combination of determination of
tryptase and ECP allows you to fix two
different versions of immune system
response to drug allergen.
2 Tryptase and ECP can be determined
by standardised methods.
3 Detection of mediators in saliva before
and after allergen provocation in situ
can determine minimally invasive diag-
nostic rules for determining an allergic
reaction.
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Positivity criteria for the intradermal test
in chlorhexidine allergy
Opstrup, MS1,2; Mosbech, H2; Krøigaard, M2; Garvey,
LH2
1National Allergy Research Centre, Gentofte University
Hospital, Hellerup, Denmark; 2Danish Anaesthesia
Allergy Centre, Allergy Clinic, Gentofte University
Hospital, Hellerup, Denmark
Background: Diagnosis of allergy to the
widely used disinfectant chlorhexidine is
based on several tests including skin prick
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test (SPT), intradermal test (IDT), specific
IgE and histamine release test (HR), since
no standardised provocation model is
available.
Interpretation of IDT is often difficult
and several different positivity criteria
exist. Therefore, the aim of this study was
to evaluate three different criteria for posi-
tivity for IDT in patients diagnosed with
allergy to chlorhexidine in the Danish
Anaesthesia Allergy Centre (DAAC).
Method: In the period July 2004 – July
2012 a total of 343 patients were investi-
gated in DAAC and allergy to chlorhexi-
dine was diagnosed in 25 patients. Allergy
to chlorhexidine was diagnosed if a mini-
mum of two of the following tests were
positive: SPT with chlorhexidine digluco-
nate 5 mg/ml, specific IgE (Immunocap,
Phadia AB, Sweden) and HR (RefLab
ApS, Denmark). Criteria for positivity
were: SPT wheal ≥3 mm of the negative
control; specific IgE > 0.35 kUA/l; HR
class ≥1. Intradermal test with chlorhexi-
dine digluconate 0.002 mg/ml was per-
formed in duplicate in 333 patients. Three
different criteria for evaluating the IDT
were applied:
(1) diameter of wheal ≥ twice the negative
control
(2) diameter of wheal ≥ 3 mm larger than
negative control and
(3) diameter of wheal ≥ 8 mm (indepen-
dent of size of negative control).
Results:
(1) Diameter of wheal ≥ twice the nega-
tive control was positive in 16/25 with
allergy and 2/308 patients without
allergy. Specificity 99.4%. Sensitivity
64%.
(2) Diameter of wheal ≥ 3 mm larger
than negative control was positive in
22/25 with allergy and 4/308 without
allergy. Specificity 98.7%. Sensitivity
88%.
(3) Diameter of wheal ≥ 8 mm was posi-
tive in 23/25 patients with allergy and
16/308 without allergy. Specificity
94.8%. Sensitivity 92%.
Conclusion: There is no international con-
sensus on the criteria for a positive IDT
and in this study the results differ greatly
when applying different criteria. Our
results show that when diagnosing chlorh-
exidine allergy in DAAC the highest com-
bined specificity and sensitivity was
achieved by using either diameter of wheal
≥3 mm larger than negative control or a
wheal of a minimum of 8 mm. Unfortu-
nately, a validated provocation model is
not available for chlorhexidine allergy and
future studies should investigate the posi-
tivity criteria for IDT for other drugs with
a validated provocation model.
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The diagnostic value of basophil
activation tests in immediate
radiocontrast media hypersensitivity
Demirel, F1; Sener, O1; Musabak, U1; Gulec, M1; Kartal,
O1; Yesillik, S1; Baysan, A1; Pekel, A1; Sagkan, RI1
1Department of Internal Medicine, Division of
Immunology and Allergic Diseases, Gulhane Military
Medical School, Ankara, Turkey
Introduction: In this study, we aimed to
investigate the value of basophil activation
tests (BAT) in the diagnosis of immediate
radiocontrast media (RCM) hypersensitiv-
ity reactions and compare the results with
the previous studies.
Method: Four groups (G) of patients were
enrolled to the study. G1: seven patients
with a history of immediate RCM reaction
and with a positive RCM skin test; G2:
nine patients with a history of early RCM
reaction with a negative RCM skin test;
G3: nine healthy volunteers who were used
RCM without a history of RCM reaction;
G4: 17 healthy volunteers who never were
used RCM. CD63 and CD203c expressions
were determined on basophils using flow
cytometer. The percentages of active ba-
sophils, stimulation index (SI) and mean
fluorescence intensity (MFI) values were
used for comparisons after in vitro stimula-
tion with 1/100 RCM dilution.
Results: The BAT results of G1 are >5%
active basophil in four patients (57.1%), ≥2
SI in three patients (42.8%), increased
MFI value in five patients (71.4%) and the
BAT results of G2 are >5% active basophil
in two patients (22.2%), ≥2 SI in one
patient (11.1%), increased MFI value in
one patient (11.1%), respectively.
Conclusion: Our findings suggest that BAT
is not a useful tool based on the results of
% active basophil, SI and MFI values.
However, it may be considered as a prom-
ising technique when combined with RCM
skin tests.
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Sensitisation to proton pump inhibitors
Barasona Villarejo, MJ1; Garcia Nunez, I1; De Castro
Gomez, C1; Moreno Aguilar, C1; Guerra Pasadas, F1
1Hospital Reina Sofıa, Allergology, Cordoba, Spain
Background: Increasing consumption of
proton pump inhibitors (PPIs) in recent
years (especially omeprazole) is increasing
sensitisation to such drugs. We report a
study to specify existing concrete sensitisat-
ion and in turn offer an alternative as a
gastric protector.
Method: Four women with a mean age of
55 (44–69) showed reaction to different
drugs, and a proton pump inhibitor was
always involved. Only in one did the
reaction occur after taking lansoprazole
alone. The other three women had a total
of six episodes after taking different anti-
inflammatories together with omeprazole.
Of the seven episodes three presented dysp-
noea. Medical assistance was needed in
seven episodes.
The four patients underwent skin chal-
lenge test (SCT) and/or controlled expo-
sure test with another different PPI to the
one causing the reaction. A SCT was there-
fore carried out in two patients: one with
pantoprazole and another with pantopraz-
ole and omeprazole. Two patients were
administered omeprazole, another two pan-
toprazole, one lansoprazole and another
esomeprazole.
Results: In one patient the SCTs with
omeprazole were negative, but the con-
trolled challenge test (CCT) with omepra-
zole, the SCT with pantoprazole and the
CCT with esomeprazole were positive. In
another patient the CCT with omeprazole
was positive but with pantoprazole was
negative. In the third patient the SCT with
lansoprazole was positive but she tolerated
lansoprazole and the fourth patient was
diagnosed with sensitisation to omeprazole
and pantoprazole after positive CCT with
the latter.
Conclusion: We report four cases of sensi-
tisation to PPIs. Although the literature
explains that reactions due to the use of
these drugs are still infrequent, we must
take them into account as a possible cause
of reactions in order to recommend other




Rial Prado, MJ1; Rico Diaz, A1; Veleiro Perez, B1;
Gonzalez Guzman, LA1; Garcıa Paz, V1
1Abente y Lago Hospital, Allergy, A Coru~na, Spain
Background: Recently clavulanic acid aller-
gen extract has been added to the Spanish
market. The skin test with the extract can
be performed for diagnosis of betalactams
allergy.
Method: Skin tests with clavulanic acid
were performed on 34 patients with a his-
tory of allergy due to amoxicillin or amoxi-
cillin-clavulanic acid.
We performed prick test and intradermal
at three concentrations 0.5 mg/ml, 5 mg/dl
and 20 mg/ml with clavunacic acid and
with PPL, MDM, Penicillin, Ampicillin,
Amoxicillin and Cefuroxime. Patients with
positive skin test to clavulanic acid and
negative skin test to amoxicillin were chall-
lenged with Amoxicillin.
Results: From 23 patientes with a history
of allergy due to amoxicillin-clavulanic
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acid, eight patients had a positive skin tests
with clavulanic acid and negative result
with amoxicillin skin tests.
Three patients had positive intradermal
in all concentrations and five patients had
positive skin tests in the concentration of
20 mg/ml exclusively.
Challenge with amoxicillin was per-
formed in five of these patients with good
tolerance. No adverse reactions were found
with clavulanic acid skin tests.
Conclusion: Inclusion of clavulanic acid to
study betalactams allergy should be consid-
ered as it is safe and can help rule out
cases of allergy to amoxicillin.
However, further studies are needed to




Barasona Villarejo, MJ1; Garcia Nunez, I1; Perez
Rodrigo, I2; De Castro Gomez, C1; Moreno Aguilar, C1;
Guerra Pasadas, F1
1Hospital Reina Sofıa, Allergology, Cordoba, Spain;
2Hospital Reina Sofıa, Cordoba, Spain
Background: Although consumption of
high-dose salicylates has decreased in
recent years, there remain patients with
sensitisation to these drugs. We demon-
strate patients who are not NSAID intoler-
ant but are allergic to aspirin.
Method: Fourteen patients were studied –
all had come to the surgery due to reaction
associated with the use of aspirin. All sub-
jects underwent anamnesis with special
focus on tolerance to anti-inflammatories
tolerance and all patients underwent con-
trolled challenge test (CCT) with ibuprofen
600 mg and diclofenac 50 mg.
Results: The 14 patients studied, 7 women
and 7 men, mean age 43 years (20–71),
jointly presented 20 episodes of reactions
following the use of acetylsalicylic acid.
Except in one episode this always occurred
after the first dose and in 16 episodes treat-
ment in the emergency department was
needed to reverse the reaction. On no occa-
sion was there any anaphylactic shock but
in 12 episodes there were respiratory symp-
toms. In eight episodes the clinical diagno-
sis was labial, eyelid or facial angioedema
and in four cases there was generalised
urticaria. Twelve patients reported that
they had subsequently tolerated anti-in-
flammatories without salicylates. All
patients underwent controlled administra-
tion test with diclofenac 50 mg, and 12 of
them who reported no known tolerance to
ibuprofen underwent the CCT with the
same drug. Both tests were carried out
with a 1 week interval, with the results
being negative in all cases.
Conclusion: It is important to consider the
importance of a careful history in the study
of allergy to anti-inflammatories, which
will guide us to the existence or not of
intolerance, although the definitive
diagnosis of allergy to salicylates is given
by the administration of ibuprofen and
diclofenac.
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The clinical pattern of hypersensitivity to
non-steroidal antiinflammatory drugs
and outcomes of pertinent oral
challenges
Potika, M1; Guibas, G1; Koulias, C1; Zeliou, CG1; Chatz-
ipetrou, A1; Aggelides, X1; Makris, M1
1Medical School, Athens University, University Hospital
“Attikon”, Drug Allergy Outpatient Clinic, Allergy Unit
‘D. Kalogeromitros’, 2nd Department of Dermatology
and Venereology, Athens, Greece
Background: NSAIDs are one of the lead-
ing causes of adverse reactions to medica-
tions worldwide. Our aim is to present the
clinical characteristics and the allergologi-
cal evaluation of patients with suspected
NSAIDs hypersensitivity.
Method: One hundred-twelve patients (♀
84, mean age 48 years, range 19–84) who
were referred to us during a 4-year period
(2008–2012) with symptoms suggestive of
NSAIDs hypersensitivity were evaluated
retrospectively. A detailed medical history
(indication, atopy, other drug allergy, cul-
prit drug, time interval between drug
intake and reaction, clinical manifestations)
was recorded. Accordingly, single blind
oral challenges (OC) to the offending or
alternative agent and skin tests were per-
formed when necessary. Upon conclusion,
all patients were given written instructions
for avoidance and NSAID therapeutic
options.
Results: The usual culprit NSAIDs were:
aspirin 28/111(25.2%), mefenanic acid 23/
111(20.7%), paracetamol 17/111(15.2%)
and diclofenac 14/111(12.5%). Time to
reaction was <2 h in 75/112 patients and
>2 h in 22/112; data was missing for 15pts.
Systemic reactions were reported in 34/
112pts (30.3%); 95.5% of the patients
reported cutaneous manifestations, 24.3%
respiratory and 8.9% cardiovascular symp-
toms. Concurrent diseases were: allergy to
other drugs (48 cases), acute urticaria (33),
asthma (13), chronic spontaneous urticaria
(9 cases) and nasal polyps (5). Skin testing
was positive in two cases involving paracet-
amol. Sixty-six out of 112 pts refused to
undergo a provocation test or were lost in
follow-up. Sixty one OC were carried out
in 46 patients: 13/17 tolerated the suspect
drug, whereas 4/17 -all provoked with par-
acetamol- had positive OC, solely with skin
manifestations; OCs in aspirin or other
potent COX-1 inhibitor were also per-
formed to evaluate cross-reactivity (2/17
positive to aspirin, 15/17 negative).
Twenty-seven patients due to risk-benefit
considerations or denial to consent, under-
went OC with either the selective COX-2
inhibitor celecoxib (24/27) or the weak
COX-1 inhibitor nimesulide (3/27), all of
them uneventfully. Additionally, 5 aspirin
sensitive patients underwent successful de-
sensitisation due to coronary artery dis-
ease.
Conclusion: OC is the gold standard for
the assessment of hypersensitivity reactions
to NSAIDs. COX-2 or weak COX-1 inhib-
itors appear to be a safe alternative for
NSAIDs sensitive patients with cutaneous
manifestations.
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Corticosteroids adverse reactions: our
experience
Reyes, SM1; Arruti, N1; Mu~noz, D1; Audicana, TM1;
Longo, NM1; Villarreal, O1
1Hospital Universitario Araba, Allergy, Vitoria, Spain
Background: Corticosteroids are widely
used in the treatment of allergic disorders.
The first reactions attributed to these drugs
were described at the end of 1950s, since
then several cases of allergic reactions have
been published, being delayed type reac-
tions the most widely studied. Cases of
corticosteroid-induced adverse reaction
referred to our consultation during the per-
iod 2005–2011 are reviewed in this study.
Method: A total of 189 patients were
recruited, 77% (N 146) of them were
women between 24 and 89 years old. In
cases of drug- immediate reactions skin
tests were carried out with a corticoids bat-
tery, with reading of results after 20 min.
Wheals with 3 mm diameter were consid-
ered positive, as recommended by the
European Academy of Allergy and Clinical
Immunology. A basophil activation test
(BAT) was also performed in five cases. In
cases with history of delayed type reac-
tions, skin tests with readings at 20 min
and 24 h were performed. This group of
patient underwent patch tests with a corti-
costeroid baseline series.
Controlled oral challenge were per-
formed in the majority of the patients with
an alternative drug in cases with positive
results and with a drug involved in cases
with negative results.
Results: In the patients studied, 19 cases
showed a clinical history compatible with
immediate reaction after administration of
the corticosteroids, 14 out of them had a
negative result, in five patients the results
of the study were positive. Skin tests were
positive in four cases. The BAT was posi-
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tive in three cases and one of them was the
only case showing a positive test. In 32
patients the clinical manifestation pre-
sented was allergic contact dermatitis
(ACD), documented in 78% of cases by
skin test and/or patch test. In the remain-
ing cases the study was negative. Allergy to
corticosteroids were discarded in 138
patients using a controlled oral challenge
test with the involved drug. In 78 out of
138 cases the clinical reaction presented
was only flushing after administration of
corticoids, whithout involvement of an
immune mechanism.
Conclusion: ACD was present in 25% of
the cases, in this case a high diagnostic
yield of the study was obtained (78%),
being deflazacort, budesonide, betametha-
sone and dexamethasone, the mosts fre-
quently involved drugs.
The best tollerated corticosteroid in all
groups was methylprednisolone. The corti-
costeroid most frequently involved in all
the groups was dexamethasone.
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Hypersensitivity reactions to iodinated
contrast media: clinical features and
allergological work-up
Koulias, C1; Potika, M1; Chliva, C1; Aggelides, X1;
Chatzipetrou, A1; Makris, M1
1Medical School, Athens University, University Hospital
‘Attikon’, Drug Allergy Outpatient Clinic, Allergy Unit
‘D. Kalogeromitros’, 2nd Department of Dermatology
and Venereology, Athens, Greece
Background: Iodinated contrast media
(ICM) cause immediate and non-immediate
hypersensitivity reactions, despite the intro-
duction of nonionic, low osmolar ICM.
Immunological mechanisms have been
implicated recently in the pathogenesis of
these reactions, as indicated by positive
skin testing to ICM. Hence, skin testing
has been integrated to the allergological
work-up of patients presenting with ICM
hypersensitivity, yielding best results when
conducted within the time period of 2–
6 months after the reaction.
Method: Patients referred to our Unit for
ICM hypersensitivity reactions within the
last 2 years underwent an allergological
work-up consisting of: a/thorough medical
history b/skin prick tests (SPTs) to undi-
luted and intradermal tests (IDTs) with
100-fold and 10-fold diluted solutions of
the culprit ICM and at least two others -of
different class- up to seven ICM, c/Patch
tests (PTs) with the same battery of undi-
luted ICMs in cases of non-immediate
reactions. The severity of immediate reac-
tions was evaluated using the Ring and
Messmer grading system.
Results: Twenty six patients (12♂/14♀)
were evaluated: 10pts with immediate (4
grade 1, 4 grade 2, 1 grade 3 and 1 grade
4) and 16 with non-immediate reaction
(maculopapular exanthemas in all cases).
Atopy and drug allergies were reported by
7/26(27%) and 5/26(19%) pts respectively.
Mean age at reaction was 58.2(22–75)
years. The ICM was administered intrave-
nously in 8/10 of immediate reactions and
3/16 of non-immediate. Iodixanol was the
most common culprit drug (13/26), fol-
lowed by iopamidol (3/26). The mean time
to reaction after infusion was 10(1–30)
minutes for immediate and 38(4–156)
hours for non-immediate reactors.
Skin testing was negative in 25/26 cases.
Seven patients were tested 2–6 months
after the episode; the others (19/26)
delayed mostly due to late referral (8–
168 months, mean 45). One patient, with a
grade 2 immediate reaction 2 months ago,
was positive to all tested ICM (8 different
agents).
Conclusion: In our well-selected population
an extremely low percentage of positive
tests were observed, although they were
performed to various different ICM
according to prior described methodology.
The high time interval from reaction to
skin testing could serve as a possible expla-
nation for some cases, but not for all of
them.
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Drug reactions: results of 189 tests in
patients from Policlınica Geral do Rio de
Janeiro Allergic Clinic
Arcanjo, LC1; Goncalves, T1; Rios, JL1; Rios, J1;
Baroni, J1
1Policlinica Geral do Rio de Janeiro, Rio de Janeiro,
Brazil
Background: In recent years there has been
a better standardisation of allergy tests for
adverse drug reactions allowing a better
assessment of the patients who come to us
with this complaint.
The objective is to investigate the fre-
quency of positive suspected drugs tests, in
patients with history of Drug Reactions.
Method: A retrospective study of medical
records of patients treated at the Allergic
Clinic of Policlınica Geral do Rio de
Janeiro between September 2010 and Sep-
tember 2012. In this period, 189 drugs tests
were performed.
Results: One hundred forty-nine of the 189
patients were female (78.8%). The majority
of these women were between 41 and
60 years (48%), while in male the highest
concentration occurred between 21 and
40 years (44% of males).
The drugs more frequently tested were:
local anesthetics, 101 tests (54%); Antibiot-
ics, 32 (17%), NSAIDs, 27 (14%);
iodinated contrast media, 17 (9%); other
drugs 12 (6%).
Negative tests occurred in 179 (95%)
patients, wile 8 (4%, 6 female and 2 male)
presented positive tests and 2 (1%) showed
inconclusive results. Antibiotics were the
more frequent positive tests: 3 for penicillin
and one for amoxicillin, followed by 3
positive tests to NSAIDs and one for local
anesthetics.
One hundred and thirty-six (72%) of the
189 patients tested, presented complaints
strongly suggestive of adverse drug reac-
tion (ADR). All the positive tests occurred
among these patients and corresponded to
6% of them. No patient without a strongly
suggestive ADR history a positive test.
Conclusion: This study reveals that in face
a strongly suggestive history of adverse
drug reaction, the respective tests should
be performed, whereas in case of an
unclear history the tests for drug allergy
may be unnecessary.
486
Descriptive study of our betalactam
allergic patients diagnosed in the first
year after the last episode
Garcia Nunez, I1; Barasona Villarejo, MJ2; Algaba
Marmol, MA3; Moreno Aguilar, C2; Guerra Pasadas, F2
1Allergy Department, Hospital Quiron, Malaga, Spain;
2Allergy Department, Hospital Universitario Reina Sofia,
Cordoba, Spain; 3Distrito Sanitario Osuna, Centro de
Salud ‘El Almorron’, Ecija, Spain
Background: Betalactam allergy suspicion
is a very common problema referred by
our patients. A rapid diagnose after the
last episode could be cheaper and quickly
than a study more than 1 year after the
last episode. Our aim was to describe our
patients with betalactam allergy suspicion
in the first year after the episode and the
protocol we performed.
Method: All patients coming to our
Allergy Department from 2005 to 2009
with betalactam allergy and the last epi-
sode the year before the study were
selected. A detailed anamnesis including
specificity of involved penicillin, serum spe-
cific IgE (sIgE) levels and cutaneous tests
to betalactams (CTBL) PPL, MDM, peni-
cillin, ampicillin and amoxicillin-clavulanic
acid in all cases, by means of skin prick
test (SPT) and intradermal test (IDT). If a
cephalosporin was involved, cutaneous test
with cefuroxime, cephadroxile and ceftriax-
one were done too. When negative CTBL
response, we proposed to the patients a
controlled oral administration (DPT) with
amoxicillin-clavulanic acid.
Results: Forty-two patients (18 males and
24 females; mean age 42.61 years) were
included in this study. Twenty-eight
(66.66%) were diagnosed by specific IgE
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levels, 9 (21.42%) by Cutaneous Tests and
5 (11.90%) by DPT. Thirty six patients
(85.71%) referred an aminopenicillin as the
implicated drug. No retest was needed to
confirm the diagnose.
Conclusions:
• Specific IgE levels are very important
to diagnose patients referring symp-
toms less than 1 year after the last epi-
sode.
• Although several patients need a DPT
to confirm the diagnose, a rapid study
is cheaper and more safety than a study
several years after.
• Our protocol let us to diagnose quickly
patients referring the last episode few
months ago.
489
Heparin induced anaphylaxis in a dialysis
dependent patient
Santosa, A1; Tan, SH2; Cheng, YK2,3
1National University Health System, Singapore,
Singapore; 2Gleneagles Medical Centre, Singapore,
Singapore; 3Department of Medicine, Yong Loo Lin
School of Medicine, Singapore, Singapore
Background: Heparin has been widely used
for intra-dialytic anticoagulation since the
1940s. Heparin induced anaphylaxis can be
life threatening, mandating early recogni-
tion and intervention. However, due to its
relative rarity many physicians remain una-
ware.
Methods and Case Report: A 70-year-old
Chinese female with hypertensive kidney
disease was deemed to require dialysis. She
had no known allergies and never received
angiotensin converting enzyme (ACE)
inhibitors. Dialysis was commenced
through a permanent catheter with 500U
of heparin/hour. She tolerated 3 hemodial-
ysis sessions per-week in the initial
2 weeks. The following week she developed
hypotension and dyspnea at the start of
dialysis. First use syndrome (an anaphylac-
tic reaction to the dialysis membrane) was
the postulated cause and she was dis-
charged after observation and intravenous
hydrocortisone and antihistamines. How-
ever, she mounted a more severe reaction
at start of the subsequent dialysis session
2 days later. A serum tryptase level by
Fluorescent Enzyme Immunoassay (FEIA)
done immediately after the reaction was
elevated at 43.1 lg/l (ref < 11.4 lg/l). Hep-
arin was thought to be the cause for her
recurrent anaphylaxis. Further evaluation
to confirm the suspected heparin allergy
and determine safe alternatives was indi-
cated.
Results: Skin prick tests were done with
unfractionated heparin (5000 u/ml), daltep-
arin (2500 u/ml), enoxaparin (20 mg/
0.2 ml), tinzaparin (3500 IU/0.35 ml) and
fraxiparin (2850 IU/0.35 ml). The prick
test was positive for heparin but negative
for the rest. This was further substantiated
by a positive intradermal test with heparin
at 1 : 10 concentration (negative at
1 : 1000 and 1 : 100). Intradermal tests
were negative for dalteparin at all concen-
trations. This was followed by subcutane-
ous and intravenous challenges with
dalteparin at incremental concentrations,
reaching up to 250U of dalteparin. She has
tolerated hemodialysis with dalteparin for
the past 2 years.
Conclusions: The workup of a patient with
intra-dialytic anaphylactic reactions must
include a systematic evaluation. First use
syndrome is rare with increased standards
of sterilization and use of higher biocom-
patibility membranes. Similar reactions
have also been reported to heparin con-
taminated with oversulfated chondroitin
sulfate in 2008. Intra-dialytic anticoagu-
lants must always be considered as a
potential cause. Systematic workup to con-




Ortega, S1; Morales, C1; Lopez, R2; Martorell, C1; Radu-
can, I1; Pelaez, A1
1Hospital Clınico Universitario de Valencia, S. Alergia,
Valencia, Spain; 2Hospital Universitario La Fe, S.
Alergia, Valencia, Spain
Background: A 17-year-old woman with a
history of allergic rhinoconjunctivitis result-
ing from sensitisation to dust mites and
food allergy to peaches and cherries (LTP
Syndrome). Recently the patient has sought
medical care as she developed two episodes
of urticaria (November, 2011 and February,
2012) two hours after food ingestion and
approximately sixty minutes after taking 1 g
of oral paracetamol. The patient has no rec-
ollection of the episodes coinciding with
menstruation, exercise or other factors.
Thereafter she has tolerated the same kind
of food ingested on both occasions; she has
not taken paracetamol in between or after
the second food ingestion.
Method: The study was carried out
3 months after the last reaction. Intrader-
mal tests with paracetamol (up to a con-
centration of 1 mg/ml) in the patient and
in healthy controls.
Basophil activation test (BAT) (Basotest
Glycotope Biotechnology) with paraceta-
mol concentrations of 2 and 10 mg/ml.
Stimulation index (SI) >2.0 was considered
positive.
Oral provocation test with paracetamol
and ibuprofen.
Skin prick tests and serum specific IgE
related to the food ingested prior to the
episodes as well as specific IgE to omega-5
gliadin (Tria a 19) (UniCAP ThermoScen-
tific) were also performed.
Results: Skin tests and specific IgE to
food: negative.
Skin tests with paracetamol in patient
and controls: negative.
Oral provocation with paracetamol:
positive (generalised urticaria, otic itching,
throat inflammation and dyspnoea occured
ten minutes after a single 125 mg dose
administration).
Repetition of intradermal tests with par-
acetamol 45 days after the provocation:
positive (papule/erythema: 8/20 mm) to a
concentration of 0.1 mg/ml.
BAT with paracetamol: positive
(SI = 2.6).
Oral provocation with 600 mg ibupro-
fen: negative. Since February, 2012 the
patient has tolerated NSAIDs on several
occasions.
Conclusion: Allergic IgE reactions to par-
acetamol are not very frequent and often
the mechanism can not be proved. In our
case, the positive results of the skin tests as
well as the BAT have allowed to confirm
the IgE-mediated mechanism of the reac-
tion.
It is a known fact that skin test sensitiv-
ity depends on the time elapsed after the
reaction has ocurred to carrying out the
allergy study, which explains the negative
results of the first skin test.
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Insulin type III hypersensitivity reaction
Gomes, R1; Loureiro, C1; Calado, G1; Faria, E1; Segorbe
Luıs, A1
1Coimbra University Hospital Center, Coimbra, Portugal
Background: Insulin, a crucial therapeutic
agent for diabetes mellitus (especially in
type 1 patients) has been rarely associated
with hypersensitivity events and the major-
ity of the reported cases are IgE-mediated
reactions.
Case Report: A 33 years old female
patient, previously diagnosed with type 1
diabetes for about 8 years, was observed in
an imunoallergology outpatient clinic in
October 2012 for suspected insulin allergy.
She was daily medicated with long acting
insulin glargine (LantusTM) in the morning
and intermediate acting insulin lispro
(HumalogMix25TM) according to the carbo-
hydrates intake and glucose levels. In April
2012, for patient convenience, insulin ther-
apy via an external infusion pump with
insulin lispro was started. By the third
month, she developed an exuberant reac-
tion, at the infusion site, with nodulation,
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hematoma and pain, without systemic or
other associated symptoms. Perfusion was
stopped, switching back to the initial regi-
men with LantusTM and HumalogMix 25TM.
However, similar symptoms persisted
(painful nodule and bruising) at the injec-
tion site 4 to 6 h after administration,
resolving spontaneously in about 48 h. In
addition, higher insulin doses were needed
to achieve desirable glycemic control with
the notion the that the higher the dose the
more severe the local reaction observed.
Methods and Results: We performed skin
prick test to latex, skin prick-to-prick and
intradermal tests to regular human insulin
(Humulin RegularTM), human insulin Act-
rapidTM, an human insulin isophane sus-
pension (HumulinNPHTM), insulin glargine
(LantusTM) and a mixture of 75% insulin
lispro protamine suspension and 25% insu-
lin lispro (HumalogMix25TM), that were all
negative. Specific IgE for human, bovine
and porcine insulin, as also protamine,
were negative. Suspecting of an immune
complexes reaction type (type III hypersen-
sitivity reaction), we decided to perform a
skin biopsy (lesional and peri-lesional) that
revealed vasculitis with leukocytoclasia
compatible with the suspected diagnostic.
Conclusion: With the evidence of an
immune complexes-mediated reaction, de-
sensitisation is not possible. There are no
effective therapeutic attitudes described
and the patient cannot avoid this treat-
ment. Finally, the authors would like to
emphasize the rarity of this situation, the
likely misdiagnosis, the importance of a
skin biopsy when a type III hypersensitiv-
ity reaction is suspected and therapeutic
implications.
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Safety and efficacy of an adalimumab
desensitisation protocol
Gutierrez Fernandez, D1; Foncubierta Fernandez, A2;
Anguita Carazo, JL3; Fernandez Melendez, S4;
Fernandez Anguita, MJ5; Medina Varo, F6
1Hospital Universitario Puerta del Mar, UGC
Neumologia-Alergia, Cadiz, Spain; 2Distrito Sanitario
Bahia de Cadiz-La Janda, UGC Joaquin Pece, San
Fernando, Spain; 3Complejo Hospitatalario de Jaen,
UGC Alergia, Jaen, Spain; 4Hospital Universitario
Carlos Haya, UGC Alergia, Malaga, Spain; 5Hospital
Universitario Puerta del Mar, UGC Farmacia, Cadiz,
Spain; 6Hospital Universitario Puerta del Mar, UGC
Reumatologia, Cadiz, Spain
Background: We report the case of a 37-
year-old female patient, diagnosed with
rheumatoid arthritis refractory to conven-
tional therapies, who initiated therapy with
Adalimumab. Twelve days after the initial
40 mg subcutaneous dose, she experienced
generalised urticaria and bilateral eyelid
angioedema, attributable to a delayed reac-
tion to the medication, requiring treatment
with parenteral corticosteroids and H1-
antihistamines to resolve the symptoms.
Method: Full allergy testing was carried
out, including skin prick tests with Ada-
limumab, intradermal injections with 1 : 10
and 1 : 100 dilutions of the drug, patch
tests, total and specific IgE measurements,
and an 8-step desensitisation protocol was
implemented, to evaluate the safety and
efficacy of protocol.
Results: We recorded positive skin prick
test responses to house dust mites, cat and
dog dander, olive and grass pollen (and
negative responses to hamster dander and
latex). The prick tests with 50 mg/ml Ada-
limumab and with 1 : 10 and 1 : 100 dilu-
tions of the drug, produced a delayed
response, 5 days later, in the form of an
erythematous papular lesion at the prick
site. Total IgE level was 354 U/ml. Patch
tests with undiluted Adalimumab and with
Adalimumab diluted in saline to 5% and
10% concentrations were applied to the
original injection site in the upper back,
with negative results. Premedication of
20 mg oral dexamethasone and an intra-
muscular dose of 5 mg dexchlorphenir-
amine were administered one hour before
initiating the desensitisation protocol. The
protocol consisted of a total of 8 doses of
the drug, administered subcutaneously,
which gradually increased to a cumulative
dose of 40 mg (see Table 1). The protocol
was well tolerated by the patient, with no
immediate or delayed reactions to the vari-
ous doses.
Conclusion: The application of an Ada-
limumab desensitisation protocol proved to
be a safe and effective process which may
be employed in those patients for whom
there are few alternative therapies.
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Progesterone induced urticaria and
angioedema: induction of drug tolerance
(desensitisation)
Kopyltsova, Y1; Minikes, N1; Kaplan, B1
1North Shore LIJ Medical Center, Allergy Immunology,
Great Neck, NY, United States
Background: Progesterone induced urti-
caria and angioedema is a rare disorder,
characterised by cyclic skin eruptions 10–
14 days before the onset of menses. It is
related to the spectrum of conditions
termed autoimmune progesterone dermati-
tis. The manifestations range from
recurrent erythema multiforme, papulove-
scicular rashes, to urticaria and angioedem-
a. A clinical history of cyclic eruptions is
supported by positive skin test to proges-
terone or a progesterone challenge. Treat-
ment aims to suppress ovulation.
Method: We present a case of an 18-year-
old girl. With onset of regular periods, she
noticed intensely pruritic erythematous
lower extremity rashes, occurring 14 days
prior to her menses. The erythematous,
pruritic, non-vesicular rash lasted 2–3 days.
She also experienced nausea and vomiting
for 3 days prior to menses. All symptoms
resolved with onset of her period. A trial
of multiple oral contraceptive pills (OCPs)
did not improve her symptoms. Lupron
was started to suppress her cycles. After
the third cycle of Lupron, her cyclical
symptoms disappeared. In May of 2012,
she was given Lupron holiday. In the mid-
dle of her cycle she developed pruritic rash
on the lower extremities, as well as diffi-
culty swallowing and respiratory distress.
Lupron was restarted. She suffered from
hot flashes and significant weight gain over
sixty pounds. She was referred for possible
IDT to progesterone.
Results: Epicutaneous and intradermal
skin test with progesterone (Depo-Provera)
was positive at ID 1 : 10 dilution. The
patient underwent a 3 day progesterone
IOT, using Progesterone, immediate release
formulation. She was able to tolerate target
dose of 150 mg of Progesterone. Lupron
was stopped.
Conclusion: We present a case of success-
ful IOT to progesterone in a case of
progesterone induced urticaria and angioe-
dema in a patient, who failed other treat-
ments. At 5 months follow up, patient
continues to tolerate Progesterone without
any systemic allergic symptoms. Occasion-
ally she still gets mild rashes.
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Successful induction of drug tolerance
(desensitisation) to lopinavir/ritonavir in
a patient with multidrug-resistant AIDS
and drug hypersensitivity
Diaz, JM1; Kopyltsova, Y1; Kaplan, B1
1Allergy and Immunology, North Shore-LIJ Health
System, Great Neck, NY, United States
Background: Long-term antiviral therapy
is a standard of care for advanced HIV
disease. Reportedly, patients with HIV
have about a 100-fold greater risk of devel-










1 0.003 0.003 136/89 110 None
2 0.030 0.033 110/71 95 None
3 0.300 0.333 121/77 90 None
4 1.000 1.333 122/86 93 None
5 2.000 3.333 115/78 86 None
6 5.000 8.333 123/79 89 None
7 10.000 18.333 130/92 99 None
8 12.000 40.333 116/78 86 None
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oping a hypersensitivity drug reaction. In
this case we present a successful induction
of drug tolerance to lopinavir/ritonavir in
a multidrug-resistant patient with AIDS
and drug hypersensitivity.
Method: Case report.
Results: Our patient is a 41 year-old
female with AIDS (CD4 count: 27 and
viral load >27 000) who failed multiple an-
tiretroviral regimens due to viral resistance
and hypersensitivity reactions. In 2011,
8 days after starting lopinavir/ritonavir she
developed diffuse hives. Since then, she has
attempted to restart lopinavir/ritonavir
four times with similar reaction occurring
eight to twelve days into treatment. There
were no associated respiratory symptoms
or angioedema. Due to low CD4 count,
high viral load and extensive ART resis-
tance, it was imperative to her care to start
lopinavir/ritonavir. As part of IDT our
patient received eight doses of lopinavir/ri-
tonavir (80 mg/20 mg/ml suspension) at
twenty minute intervals on day one and
her goal dose on day two. The goal dose
for our patient was 400 mg lopinavir/
100 mg ritonavir. Our dosing increments
were based on lopinavir dose: 4, 8, 16, 24,
40, 64, 100 and 144 mg on day one. She
was monitored for an hour after final dose
without any adverse events. On day two
she was able to tolerate the full dose of
lopinavir/ritonavir (400/100 mg). Four
months after her IDT, she continues to tol-
erate lopinavir/ritonavir with improvement
in her CD4 count as well as a dramatic
drop in her viral load.
Conclusion: To our knowledge this is the
first case report of IDT to lopinavir/ritona-
vir in an AIDS patient. Through this case
we are able to provide a successful proto-
col for lopinavir/ritonavir induction of tol-




mecasermine in an allergic patient with
primary IGF-I deficiency
Gutierrez Fernandez, D1; Lopez Martinez, I2; Lechuga
Sancho, AM2; Foncubierta Fernandez, A3; Anguita
Fernandez, MJ2; Lechuga Campoy, JL4
1Hospital Universitario Puerta del Mar, UGC
Neumologıa-Alergia, Cadiz, Spain; 2Hospital
Universitario Puerta del Mar, UGC Pediatria, Cadiz,
Spain; 3Distrito Sanitario Bahia de Cadiz-La Janda, UGC
Joaquin Pece, San Fernando, Spain; 4Departamento
Materno Infantil y Radiologıa, Facultad de Medicina de
la Universidad de Cadiz, Cadiz, Spain
Background: Allergic reactions to mecaser-
mine have been reported in approximately
8% of patients receiving Mecasermine, for
various indications in several clinical trials.
However, only twice have such reactions
been published in patients with severe pri-
mary IGF-I deficit, which is currently the
only approved indication. We report a
patient with severe primary IGF-I deficit
and a history of respiratory and food aller-
gies who developed raised itchy wheals on
legs, arms and thorax on the tenth day of
treatment.
Method: Full allergy testing was carried
out, including skin prick test with 10 mg/
ml mecasermine, intradermal injections
with 1 : 10 and 1 : 100 dilutions of the
drug, total and specific IgE measurements.
We performed a desensitisation regimen on
eight steps with increasing concentrations
of mecasermine at 15 min intervals, up to
the 10 mg/ml concentration of the com-
mercial preparation. The protocol was
implemented at 0.12 mg/kg which is the
maximum required by the patient for
growth optimisation. Premedication with
deflazacort, dexchlorpheniramine and
montelukast was employed one hour prior
to implementation of the protocol.
Results: The skin prick test for neumoal-
lergens were positive to house dust mite.
Total IgE was upper 100 kU/l and specific
IgE tests were positive to house dust mite
and egg white. The prick test with 10 mg/
ml mecasermine and intradermal injections
with 1 : 10 and 1 : 100 dilutions of the
drug were negative. The 8-step desensitisa-
tion protocol, shown in Table 1, was com-
pleted in two hours. The patient has now
been under therapy for 4 weeks, with a
notorious growth response, and no further
allergic reactions of any kind.
Conclusion: We present the first successful
desensitisation protocol to mecasermine, to
our knowledge, in a patient with severe
IGF-I deficiency and an atopic background.
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Rapid response of severe acute
generalised exanthematous pustulosis to
infliximab
Yawalkar, N1; Lee, HY1; Heidemeyer, K1
1Department of Dermatology, University of Bern, Bern,
Switzerland
Background: Acute generalised exanthema-
tous pustulosis (AGEP) is a rare cutaneous
adverse drug reaction characterised by an
acute onset of widespread non-follicular
sterile pustules arising on erythematous
basis in association with fever and periph-
eral leukocytosis. AGEP has been linked
to intake of various drugs, most commonly
antibiotics. Clinical course of this reaction
is mostly benign and the majority of cases
resolve within 15 days after discontinua-
tion of the responsible medication.
Method: Report of a case. Immunohisto-
chemical analysis of TNF-a in a skin lesion
prior to therapy with a TNF-antagonist.
Results: We here describe a cases of
AGEP with development of multiple con-
comitant targetoid lesions resembling a
Stevens-Johnson syndrome-like reaction
induced by terbinafine. Since progression
of the exanthema despite cessation of the
causing drug and systemic corticosteroid
therapy was observed, therapy with inflix-
imab (5 mg/kg bodyweight), a TNF-antag-
onist, was initiated. Rapid resolution of
disease with clearance of pustular lesions
was noted within 3 days. Immunohisto-
chemical analysis of a skin lesion obtained
prior to therapy with infliximab demon-
strated strong expression of TNF-a.
Conclusion: This case demonstrates that
TNF-a plays a central role in the patho-
genesis of severe forms of acute generalised
exanthematous pustulosis and that TNF-
antagonists can be helpful in recalcitrant
cases.
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Successful desensitisation to rituximab
in four patients with autoimmune
diseases
Ramirez, LF1; Ca~nas, CA2; Tobon, GJ2; Bonilla, F2;
Serrano, CD1
1Fundacion Valle del Lili, Allergy Unit, Cali, Colombia;
2Fundacion Valle del Lili, Rheumatology Unit, Cali,
Colombia
Background: Rituximab is a chimeric
monoclonal anti CD20 antibody used fre-
quently in the treatment of some hematolog-
ic malignances and autoimmune diseases.
Infusion-related reactions are common and
no standardised strategy is approved to the
treatment of them, apart of premedication.
Underlying mechanism of reactions include
massive cytokine release, hypersensitivity,
immune or cytokine imbalance, cross reac-
tivity, and symptoms not directly affecting
the immune system. In the case of ritux-
imab, citokyne release seems to be the most
common. Our aims were to describe a new
short desensitisation protocol to rituximab
and to establish if IgE is involved in these
reactions.
Methods: Patients with autoimmune dis-
eases in which rituximab had induced
hypersensitivity reactions were included. A








1 0.01 0.01 None
2 0.02 0.03 None
3 0.04 0.07 None
4 0.08 0.15 None
5 0.16 0.31 None
6 0.32 0.63 None
7 0.64 1.27 None
8 1.15 2.42 None
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six hours intravenous desensitisation proto-
col was used. Premedication with hydro-
cortisone, loratadine and acetaminophen
were given to all patients one hour before
the onset of the infusions. Prick and intra-
dermal test were made at concentration of
1 mg/ml, previous to the first desensitisa-
tion in each patient.
Results: Four patients (three women and
one man) were included. Two of them had
systemic lupus erithematosus, one reumath-
oid arthritis, and one reumathoid arthritis
and Sjogren syndrome. Previous reactions
included skin manifestations (urticaria and/
or angioedema) in all of them and dyspnea
in one. None of the reactions were pre-
sented within the first cycle of rituximab
and all occurred between few minutes and
three hours of the onset of the infusion.
Prick test and IDR were negative in all. A
total of seven desensitisations were carried
out and all patients tolerated them. Minor
side effects were present in four of the
seven protocols (three patients). None of
the infusions had to be stopped at any
time.
Conclusion: In these patients, infusion-
related reactions to rituximab seem to be
not related to IgE sensitisation. However,
a short desensitisation protocol was suc-
cessful in them. Large scale studies are
needed to recommend the use of desensiti-
sation in patients with non allergic hyper-
sensitivity to rituximab.
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Multiple drug allergy due to polyethylene
glycols hypersensitivity
Badiu, I1; Nebiolo, F1; Pizzimenti, S1; Bussolino, C1;
Raie, A1; Rolla, G1
1Mauriziano Hospital, University of Torino, Torino, Italy
Background: Polyethylene glycols (macro-
gols or PEG) are condensation products of
glycols with ethylene oxide, leading to mol-
ecules of various length: polysorbate 80,
macrogol 400, 4000, 6000 ecc. Macrogols
are widely used as excipients in foods, cos-
metics, and topical and systemic drugs
because of their stabilising properties.
Immediate hypersensitivity reactions have
been reported after oral and parenteral
administration of products containing mac-
rogols, such as tablets, vaccines, and laxa-
tive oral solutions. We report here the first
case, to our knowledge, of a hypersensitiv-
ity reaction due to different polyethylene
glycols products.
Case Report: A 26-year-old woman, with
no previous history of allergy, reported
many episodes of generalised urticaria one
hour after the intake of antibiotics (amoxi-
cillin clavulanate and ciprofloxacin tablets)
and antinflammatory drugs (ketoprofen
granules and diclofenac tablets).
Diagnostic work-up: specific IgE anti-
body determinations (benzylpenicillin,
ampicillin, and amoxicillin), and skin tests
with major determinants (penicilloyl-poly-
lysine) and minor determinants (minor
determinant mixture) of benzylpenicillin
and amoxicillin-clavulanic acid resulted
negative. Oral challenge with amoxicillin
clavulanate caused diffuse urticaria 30 min
after assumption of 55 mg of drug. Prick
test 1/1000 for ciprofloxacin 10 mg/ml
resulted positive (wheal diam. 10 mm).
Oral challege with alternative antinflamma-
tory drugs (meloxicam, imidazole salicylate
and etoricoxib) caused diffuse urticaria
shortly after taking small doses of these
drugs. We noticed that all the test drugs
(including cutaneous ciprofloxacin) con-
tained PEG with different length (from 80
to 6000). Prick test resulted positive for all
polyethylene glycol derivates: polysorbate
80 (prick test 1/1000, wheal diam. 20 mm),
PEG 400 and 4000 (prick test 1/1000,
wheal diam. 10 mm), PEG 6000 (prick test
1/100, wheal diam. 20 mm). Basophil acti-
vation tests for polysorbate 80, PEG 400,
4000 and 6000 were all negative. Specific
IgE for ethylene oxide was negative. Oral
challenge with etoricoxib, amoxicillin cla-
vulanate and ciprofloxacin tablets with no
PEG were all well-tollerated.
Conclusion: Polyethylene glycols derivates
have been described responsible of non-
immunological reactions similar to those of
our patient. The case we report here is the
first case of multiple drugs reaction due to
different polyethylene glycols hypersensitiv-
ity, with mechanisms which remain elusive.
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Anaphylactoid reaction during
haemodialysis: a case report
Pin˜ero-Saavedra, M1; Prados Casta~no, M1; Gonzalez-
Quevedo Tejerina, T1; Leguisamo, S1; Quiralte, J1
1Virgen del Rocio University Hospital, Allergy Unit,
Sevilla, Spain
Background: Low-molecular weight hepa-
rins (LMWH) are important anticoagu-
lants. They are used in the prophylaxis and
treatment of thromboembolic disorders.
Allergic reactions to LMWH are rare. The
most common reactions involve erythema-
tous plaques and maculopapular exan-
thema. We present an anaphylactoid
reaction due to enoxaparin.
Method: A 51 year-old man with a history
of chronic kidney disease stage V pre-
sented, in the 5th session of his first cycle
of dialysis, after 5 min of the beginning of
the process: an intensive flushing, tachycar-
dia, bronchospasm, tightness, tachypnea
and dyspnea which required treatment with
corticosteroids and oxygen. Enoxaparin
was the only administered drug prior to
dialysis. In the following session we chan-
ged the protocol and administered the drug
only at the end of haemodialysis session.
The patient stayed asymptomatic all along
the session and symptoms only appeared
again 5 min after enoxaparin injection.
Our study included: tryptase levels on
acute episode, blood count cell and skin
prick test with enoxaparin, bermiparin, na-
droparin, dalteparin and fondaparinux. We
added basophil activation test (BAT) with
enoxaparin and fondaparinux, and after
informed consent, we proceed to controlled
oral challenge with fondaparinux.
Results: Laboratory test were normal,
including platelet count and tryptase levels.
Skin prick test and BAT were all negative.
The controlled oral challenge with fondo-
parinux has been well-tolerated.
Conclusion: Differently to inespecific and
delayed hypersentivity reactions, anaphy-
lactoid reactions to LMWH are very infre-
quents. In anaphylactoid reactions to
LMWH, when allergic study is negative,
unfractionated heparins could be a safe
option.
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Desensitisation to clopidogrel: a tailor-
made protocol
Barreira, P1; Cadinha, S1; Malheiro, D1; Moreira da
Silva, JP1
1Centro Hospitalar de Vila Nova de Gaia/Espinho, EPE,
Drug Allergy Unit, Allergy and Clinical Immunology
Department, Vila Nova de Gaia, Portugal
Background: Clopidogrel is an antiplatelet
drug widely used for treatment and preven-
tion of a variety of cardiovascular diseases.
Its combination with acetylsalicylic acid
(ASA) is considered essential to reduce the
risk of stent thrombosis.
Method: We report a successful desensiti-
sation to clopidogrel in a patient with
delayed hypersensitivity (HS).
Results: A 70-year-old Caucasian man
with allergic rhinitis, hypertension and di-
slipydemia was referred to our outpatient
clinic for suspected drug allergy. Long-
standing medication included ramipril,
carvedilol, nitrates, indapamide and ASA.
He was submitted to coronary catheteriza-
tion with placement of a stent and pre-
scribed clopidogrel 75 mg/d. After
2 weeks, he developed lip, hand and foot
swelling, erythematous papular non pru-
ritic lesions and arthralgias that were trea-
ted with corticosteroids and antihistamines.
Cutaneous lesions resolved in 5 days and
arthralgias in 3 weeks. Laboratory evalua-
tion revealed no abnormalities. Patch tests
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with different concentrations of clopidogrel
(10%, 30% and 50% pet) and oral chal-
lenge were negative. One week later, the
patient started continuous administration
of the drug and 24 h after a single dose
developed erythematous papular pruritic
lesions. Skin biopsy suggested drug related
dermatitis. He was advised to avoid clopi-
dogrel and treatment with ticlopidine was
started but it was not tolerated (gastroin-
testinal symptoms). Since dual antiplatelet
therapy was required and therapeutic alter-
natives to clopidogrel are limited, a 3 h de-
sensitisation protocol was started,
achieving a cumulative dose of 154 mg
without any reaction and a daily dose of
75 mg was recommended. On the 4th day,
the patient developed skin lesions similar
to the previously described. He was treated
with topical steroids and oral antihista-
mines and the daily dose of clopidogrel
was reduced to 20 mg. A new desensitisa-
tion protocol was established, with a slow
dose increment, according to the patient′s
response. It was only possible to achieve
the dose of 75 mg/d after 2 months. One
month later, although clopidogrel was well
tolerated, the patient decided to stop its
administration.
Conclusion: Although well tolerated by
most patients, HS reactions with clopido-
grel may occur. Since other treatment
options are limited and frequently not tol-
erated, desensitisation is rising as a safe
alternative in those patients. In delayed
reactions with cutaneous lesions, a slower
desensitisation protocol may be necessary.
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Allergic reaction to chlorpheniramine
maleate: a case report
Demirel, F1; Gulec, M1; Kartal, O1; Yesillik, S1; Baysan,
A1; Musabak, U1; Sener, O1
1Department of Internal Medicine, Division of
Immunology and Allergic Diseases, Gulhane Military
Medical School, Ankara, Turkey
Introduction: Despite the frequent use of
antihistamines in daily practice, allergic
reactions to these drugs are extremely rare.
Herein, a systemic reaction against chlor-
pheniramine maleate (CM) used for allergy
prophylaxis was reported.
Case report: A thirty-nine-year-old female
patient was given CM for a suspected ra-
diocontrast media allergy before coronary
angiography. The symptoms and signs of
systemic reactions occurred within minutes
after the intravenous administration. Four
weeks later, skin tests and basophil activa-
tion tests (BAT) with CM was performed
to evaluate the allergic status. The stimula-
tion index was 1.29 in BAT. Prick test
result was found negative with different
dilutions of CM. However, following intra-
dermal test with 1/100 W/Vol dilution of
CM both local and systemic symptoms
occurred in seconds. The patient was trea-
ted with adrenalin and steroid injections
intramuscularly.
Discussion and Conclusion: Although she
had never used antihistamines for any
reason previously, CM sensitisation can
be explained by a possible cross-reaction
with some other drugs such as flu
medications. It should be kept in mind
that widely used antihistamines treating





Immediate type hypersensitivity reaction
to levothyroxine and oral desensitisation
Demirel, F1; Gulec, M1; Kartal, O1; Tas, C2; Baysan, A1;
Yesillik, S1; Musabak, U1; Sener, O1
1Department of Internal Medicine, Division of
Immunology and Allergic Diseases, Gulhane Military
Medical School, Ankara, Turkey; 2Department of
Pharmaceutical Sciences, Gulhane Military Medical
School, Ankara, Turkey
Introduction: Hypersensitivity reactions
againts levothyroxine are very rare. In this
report, a levothyroxine hypersensitivity
reaction and subsequent successful desensi-
tisation process is presented.
Case report: A 35-year-old female patient,
who has already followed up by our clinic
because of multiple drug allergy, applied
with the symptoms of a systemic reaction
occurred within half an hour after the
intake of levothyroxine tablets. A stock
solution was prepared by dissolving
25 mcg levothyroxine tablet in 1 ml vol-
ume of 0.09% phosphate buffered saline
according to a previously published proto-
col to evaluate levothyroxine allergy. Prick
test performed with undiluated stock solu-
tion and intradermal test with 1/100 W/vol
were negative. Subsequently, intradermal
test with 1/10 W/vol concentration was
found positive and a desensitisation was
planned. Since any oral levothyroxine de-
sensitisation protocol was not found in the
literature, the desensitisation scheme was
planned according to the general desensiti-
sation rules. This process lasted 2 days and
she was able to take 75 lg levothyroxine
orally on the third day without any prob-
lem. Levothyroxine therapy has been con-
tinued successfully since then.
Conclusion: As far as we know, no oral
desensitisation protocol was defined for
levothyroxine in the literature. Current de-
sensitisation method can be used as an
example for levothyroxine allergy treat-
ment.





Pascolini, L1; Nucera, E1; Buonomo, A1; Pecora, V1;
Rizzi, A1; Aruanno, A1; Ricci, G1; Di Rienzo, A1; Mezzac-
appa, S1; Centrone, M1; Colagiovanni, A1; Schiavino, D1
1Universita Cattolica del Sacro Cuore, Rome, Italy
Background: Procarbazine is an alkylating
agent used for treatment of brain tumors.
It is often well tolerated, however, 6–8%
of treated patients developed macular-pap-
ular rashes or urticaria. Most of reactions
caused by procarbazine are non immune-
mediated. In the literature there are no
reports about tolerance induction to pro-
carbazine. We report a case of tolerance
induction in a pediatric patient with a clin-
ical history of hypersensitivity reaction to
procarbazine.
Method: This is a case of 6 years old child
affected by glioma. He was in therapy with
procarbazine (100 mg) and dexamethasone
(0.6 mg) daily. During the first cycle of
chemiotherapy he developed generalised
urticaria and so the treatment was stopped.
He started the second cycle but he pre-
sented generalised urticaria again so
patient was hospitalised.
Result: Patient referred to our Allergy
Department and he underwent to allergo-
logical examination. Procarbazine is only
available in capsule form so skin prick test
(SPT) were performed using undiluted
commercial preparation (50 mg/ml) pre-
pared by dissolving the powder in saline.
Histamine was used as a positive control.
Patch tests were performed using the same
drug as for SPT according to ENDA rec-
ommendations. SPT and patch tests
resulted negative and we concluded for a
nonallergic drug hypersensitivity reaction.
Previous parental authority, the patient
was underwent to a protocol of oral desen-
sitisation to procarbazine. Gradually
increasing doses of procarbazine were
administrated in 5 days. Each dose was
administered every 20 min. On the first
day, the patient received 0.15 mg of pro-
carbazine and the final dose of 100 mg was
achieved. Before the initiation of the proto-
col were administered cetirizine 10 mg/ml
(20 drops) every day. Patient received the
first desensitisation in our department and
continued to intake procarbazine at home
at the dose of 100 mg/day for 12 days
without adverse reactions.
Conclusion: In our case there is no chemo-
therapic drug as an alternative to procar-
bazine so the desensitisation was necessary.
Most of rechallenge with procarbazine in
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patients with adverse reactions were posi-
tive and the drug be stopped. Desensitisa-
tion is a high risk treatment and it is
mainly indicated in IgE-mediated reactions




propylthiouracil in two patients
Demirel, F1; Gulec, M1; Kartal, O1; Yesillik, S1; Baysan,
A1; Musabak, U1; Tas, C2; Aydogdu, A3; Sener, O1
1Department of Internal Medicine, Division of
Immunology and Allergic Diseases, Gulhane Military
Medical School, Ankara, Turkey; 2Department of
Pharmaceutical Sciences, Gulhane Military Medical
School, Ankara, Turkey; 3Department of Internal
Medicine, Division of Endocrinology and Metabolic
Diseases, Gulhane Military Medical School, Ankara,
Turkey
Introduction: Despite the frequent use of
antithyroid drugs, propylthiouracil and
methimazole, allergic reactions to these
drugs are very rare. Herein, a systemic
reaction to propylthiouracil and subse-
quent successful oral desensitisation was
presented in two patients.
Case report: A 41-year-old female and a
27-year-old male patients were referred to
our clinic with the histories of systemic
allergic reactions to both methimazole and
propylthiouracil. The symptoms and signs
of active hyperthyroidism were determined
at the physical examination. The skin tests
with propylthiouracil and methimazole
could not have been done because of ongo-
ing antihistamine therapy. The patients’
symptoms related to antihyperthyroid
drugs were thought to be caused by a pos-
sible type 1 hypersensitivity reaction. With
the importance of the continuation of anti-
hyperthyroid therapy, a desensitisation
process with propylthiouracil was per-
formed. Since any propylthiouracil desensi-
tisation protocol was not found in the
literature, the desensitisation scheme was
planned according to the general desensiti-
sation rules. This process lasted 1 day for
female patient and 2 days for male patient
and both of the patients were able to take
300 mg propylthiouracil orally at the end
of the desensitisation without any problem.
The propylthiouracil therapy has been con-
tinued successfully since then.
Conclusion: As far as we know, any desen-
sitisation protocol was not defined for pro-
pylthiouracil in the literature. This
desensitisation method can be used as an
example for propylthiouracil allergy treat-
ment.
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A pediatric protocol for monoclonal
antibodies rapid desensitisation
Caimmi, D1,2; Caimmi, S1; De Amici, M1; Bosa, L1;
Demoly, P2; Marseglia, GL1
1Pediatrics, University of Pavia- IRCCS Policlinico San
Matteo, Pavia, Italy; 2Pneumology and Addictology,
Ho^pital Arnaud de Villeneuve, Universite de
Montpellier, Montpellier, France
Background: Monoclonal antibodies are
important therapeutic tools, but their use-
fulness may be limited when patients expe-
rience acute hypersensitivity reactions.
Patients who have a history of reaction
risk to be ruled out of their therapeutic
protocol or have to switch to an alternative
drug. Drug desensitisation has proven to
be a highly effective strategy to re-adminis-
ter a drug in patients who experienced a
hypersensitivity reaction. It consists in
forcing the patient’s immune system to
accept and tolerate the allergen, but such a
procedure is still empiric for monoclonal
antibodies and not common in the pediat-
ric population. The aim of our study was
to demonstrate the clinical success of a
new protocol of rapid desensitisation to
infliximab in a pediatric patient, affected
by ulcerative colitis (UC).
Method: A 14 years old patient affected by
a severe form of UC experienced an anaphy-
lactic reaction, involving the skin and the
respiratory apparatus, at the third dose of
infliximab. The administered dose was 5 mg
of infliximab per kg (250 mg total dose).
Infliximab is a chimeric immunoglobulin
G1k monoclonal antibody that binds with
high affinity and specificity both to the solu-
ble form and to the membrane-bound TNF-
alpha. Infliximab is used both for induction
and maintenance of remission in Crohn’s
disease, and in the treatment of UC. After
the first reaction, the patient underwent skin
tests to infliximab (skin prick test at 10 mg/
ml, and intradermal test at 1 mg/ml), which
resulted negative, while a provocation test
to the drug resulted positive 6 min after
administration of the first dose (0.1% of the
total dose: 2.5 mg). The reaction included
dyspnea, bronchospasm, and angioedema of
the face. Tryptase levels resulted normal,
while histamine doubled compared to basal
levels; basophil activation test was negative.
We used a 13-steps protocol in which the
final cumulative dose was 250 mg, and the
first was 1/1 000 000 of the total dose. We
have tripled the dose at each step, every
15 min.
Results: Rapid desensitisation was not
interrupted for the appearance of any reac-
tion and the patient tolerated the drug. He
has already received twice his treatment
since we introduced this new protocol.
Conclusion: We hypothesise the patient
experienced a non-IgE mediated hypersen-
sitivity reaction to infliximab, but the pro-
tocol we used has been useful to
administer him the appropriate treatment.
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Drug induced recurrent angioedema in a
patient with active pulmonary
tuberculosis, chronic obstructive
pulmonary disease and history of chronic
urticaria
Leru, PM1; Bozdog, OB2
1Allergology, Colentina Clinical Hospital, Bucharest,
Romania; 2Dermatology, Elias Emergency Hospital,
Bucharest, Romania
Background: Acquired angioedema is an
allergic disease with increasing prevalence
in clinical practice and significant difficul-
ties regarding triggers and treatment. Com-
orbidities and complex medication
represent important risk factors for allergic
diseases in adult atopic patients.
Case: We present the case of a 48 years
old man, 30 pack-units smoker, with a
history of mild chronic urticaria, who
came for recurrent episodes of facial an-
gioedema and cutaneous pruritus. He was
diagnosed with active cavitary pulmonary
tuberculosis 1 month before and received
daily antituberculosis therapy with four
drugs, associated with allopurinol for
moderate hyperuricemia, omeprazole and
oral B6 vitamine. Chronic obstructive pul-
monary disease (COPD) stage II GOLD
was diagnosed based on chronic cough
and nonreversible obstruction on spirome-
try. Allergologic evaluation showed very
high plasma level of total IgE (2300 UI/
ml), with normal specific IgE to current
food and inhalant allergens. Immunologic
tests, complement fractions and serology
for viral, bacterial and parasitic infections
were normal. We performed basophil
degranulation test for all drugs used,
which gave significant high values for al-
lupurinol and moderate values for etham-
butol. The lymphocyte blast
transformation tests to drugs were nega-
tive. We administered combined nonsedat-
ing antihistaminic therapy in maximum
doses in order to avoid corticotherapy.
The episodes of angioedema continued
about 2 months, with progressive reduced
intensity and duration, even after discon-
tinuation of allopurinol and ethambutol.
The clinical, bacteriologic and imagistic
evolution after 6 month was good, with
sputum negativation and resolution of
pulmonary lesions. The total IgE
remained in high levels, probably due to
multifactorial ethiology. The skin tests will
be performed after the end of therapy and
stop of antihistamines, according to the
patient decision.
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Conclusion: Allopurinol is a well known
trigger for drug induced allergic diseases,
sometimes severe in association with other
chronic medication. We consider that mul-
tidrug therapy, associated with chronic dis-
eases and active infectious are important
triggers for recurrent angioedema in adults.
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Darbepoetin desensitisation: a case
report
Tahan, F1; Akar, HH1; Dursun, I2; Yılmaz, K2
1Department of Pediatric Allergy, Erciyes University
School of Medicine, Kayseri, Turkey; 2Department of
Pediatric Nephrology, Erciyes University School of
Medicine, Kayseri, Turkey
Human recombinant erythropoietins (EPO)
and darbepoetins are widely used for
anemias associated with chronic kidney
disease. Allergic reactions to erythropoetins
and darbepoetins have only occasionally
been reported. These skin reactions include
pruritus, wheals at the injection site, orofa-
cial anaphylaxis and anjioedema. In this
article, we report an 11 year-old female
who experienced generalised erithematous
skin eruption and desquamation after both
erythropoietin and darbepoetin treatments.
We successfully used darbepoetin with the
support of premedication and desensitisa-
tion. Because of the erythropoietin or dar-
bepoetin treatment was so necessary in
these allergic patients; our approach might
be a suitable option for them.
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Anaphylaxis in a tertiary adult allergy
clinic: a retrospective review of 516
patients
Gelincik, A1; Demirturk, M1; Yılmaz, E1; Ertek, B1; Unal,
D1; Colakoglu, B1; Buyukozturk, S1
1Department of Internal Medicine, Division of Allergy,
Istanbul University, Istanbul Faculty of Medicine,
Istanbul, Turkey
Background: Anaphylaxis is a life-threat-
ening acute allergic reaction that can occur
at any age. Our aim was to determine the
frequency, triggering factors and clinical
features of anaphylaxis among adult
patients who were referred to a tertiary
health care facility.
Method: A retrospective medical chart
review was performed including all patients
referred to the outpatient clinic of the
adult allergy department in our university
hospital between January 1, 2008 and
December 30, 2011 in order to determine
cases involving anaphylaxis.
Results: A total of 516 (2.11%) patients
among 24 443 admissions were diagnosed
with anaphylaxis. Although the second
highest frequency of anaphylaxis cases
took place in 2008, a gradual rise in the
frequency was determined from 2009 to
2011. Drugs (90.7%) were the most fre-
quent cause, followed by Hymenoptera
stings (5.4%), foods (1.6%), latex (0.4%)
and exercise (0.2%) respectively. The clini-
cal manifestations during anaphylaxis
reported by patients were cutaneous
(n:292, 56.6%), respiratory (n: 253, 49%),
cardiovascular (n: 212, 41%), neuro-psy-
chiatric (n:60, 11.6%) and gastrointestinal
(n: 52, 10.1%), respectively. Approximately
one-fifth of the patients received epineph-
rine whereas 43% of patients did not
receive epinephrine during their treatment
in the emergency room. An epinephrine
auto-injector was prescribed to 42 patients
(8.1%).
Conclusion: In this study, the second pat-
tern of NIAID/FAAN diagnostic criteria
for anaphylaxis predominated among adult
patients. Drugs were the leading triggering
factor followed by Hymenoptera stings,
foods, latex and exercise, respectively.
Atopy, asthma and allergic rhinitis were
rarely detected.
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Anaphylaxis and drug allergy: one year
evaluation
Gonzalez Ruiz, AM1; Moreno Montoya, A1; Moreno Ro-
dilla, E1; Ponce Guevara, LV2; Gracia Bara, MT2; Laffond
Iges, E1; Davila Gonzalez, I1
1Alergologia, Hospital Universitario de Salamanca,
Salamanca, Spain; 2Hospital Universitario de
Salamanca, Salamanca, Spain
Background: Anaphylactic reactions cause
the maximal grade of allergic reactions and
are potentially life-threatening. Drugs are
the most common agents involved in ana-
phylactic reactions of adults and betalac-
tam antibiotics seem to be the main cause.
Method: We studied 568 patients older
than fourteen years with suspected drug
allergy, seen in the allergy unit of the Uni-
versity Hospital of Salamanca (Spain),
throughout the year 2012. The aim of this
study was to describe the drugs involved
and methods used for diagnosing patients
who had suffered an episode of anaphy-
laxis related to drugs.
Results: A total of 37 Patients (6.5%) suf-
fered one episode of anaphylaxis. The prin-
cipal drugs involved in the anaphylactic
reactions were betalactam antibiotics
(62%), fluoroquinolones (9.5%), non-ste-
roidal antiinflammatory drug (NSAIDs)
(9.5%), iodinated contrasts (6%), and
other drugs (13%) such as local anaes-
thetic, sulfonamides and neuromuscular
blockers (rocuronium).
After the allergy work-up 16 (43%)
patients had positive skin tests (prick or
intradermal), one of those also had positive
specific IgE by InmunoCAP, 4 (11%) had
a positive specific IgE with negative skin
tests. Two (6%) of the patients with nega-
tive skin test and negative specific IgE had
a positive drug challenge. In 9 (24%)
patients the drug challenge was not per-
formed due to the medical history or con-
traindications to the drug challenge.
In five patients the final diagnosis was
idiopathic anaphylaxis after rule out drug
allergy by drug challenge with the sus-
pected drug. One patient was diagnosed of
exercise-induced anaphylaxis.
Conclusion: In our series betalactam anti-
biotics were the main drugs involved in the
anaphylaxis. We observed that the sensitiv-
ity of the skin tests was high in betalactam
allergy but low in the other cases.
The most common drug involved was
amoxicillin and not penicillin, this result is
in line with the tendency observed since
the 1980s. Fluoroquinolones and NSAIDs
were the following drugs implied and these
results support different studies indicating
an increasing tendency of allergic reactions
of these drugs.
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Three cases of lansoprazole anaphylaxis
with cross-reactivity to omeprazol: take
home lessons
Koca Kalkan, _I1; Kalpaklioglu, AF1
1Department of Immunologic and Allergic Diseases,
Kirikkale University Faculty of Medicine, Kirikkale,
Turkey
Background: Proton pump inhibitors
(PPIs) are widely used for the treatment of
acid-related gastrointestinal diseases,
because they reduce the gastric acid secre-
tion by blocking the H1/K1-ATPase. PPIs
are generally well tolerated, and side effects
occur in about 1% of the patients. There
have been several reports of hypersensitiv-
ity reactions, but anaphylaxis is very rare.
We present three patients with lansopraz-
ole induced anaphylactic reactions that
were diagnosed by skin tests and oral prov-
ocation tests (OPT).
Method: The first two patients referred to
our allergy department with a history of
adverse reactions to NSAIDs. First patient
had experienced an episode of urticaria,
angioedema in 30 min, while the second
patient had experienced pruritic generalised
skin rush with hypotension within two
hours of drug intake. But the OPT with
the culprit NSAIDs turned out to be nega-
tive. By detailing their clinical history, we
found out that they were using lansopraz-
ole along with NSAIDs. Third patient vis-
ited emergency room complaining of
pruritus on her arms, dyspnea, hypotension
and syncope in 30 min after taking lansop-
razole. Following written informed con-
sents, patients were challenged with
lansoprazole, and with other PPIs; omepra-
zole, esomeprazole, pantoprazole and rab-
eprazole, in order to offer a safe
alternative. Skin prick tests and intrader-
mal tests were done. If negative, single-
blind OPT were performed.
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Results: In first two cases intradermal
tests with omeprazol were positive and
they developed anaphylaxis after lansop-
razole during oral provocation test. Third
patient showed positive result only with
lansoprazole at skin prick and intrader-
mal test.
Conclusion: Diagnosis of PPI allergy is dif-
ficult, since they are frequently used in
combination with antibiotics or NSAIDs,
and even without medical prescription.
Therefore, a high index of suspicion should
always be kept in mind. We present three
patients with lansoprazole induced anaphy-
lactic reactions, whose clinical features of
the reactions suggest an IgE-mediated
mechanism, as demonstrated by a positive
skin test. Although previously lansoprazole
was offered as a valid alternative PPI for
omeprazole allergy, two of our patients
had positive skin tests to omeprazole. So,
we believe that there is no safe alternative
for PPI allergy and skin/oral challenge
tests should be done before offering a safe
alternative to the patients.
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Severe anaphylactic reaction after skin
prick tests to betalactam antibiotics
Zande, M1; Sinaniotis, A1; Xenochristou, P1; Panta, V1;
Psarros, P2; Syrigos, K3; Syrigou, E1
1Allergy, General Hospital ‘Sotiria’, Athens, Greece;
2Allergy, Athens Naval Hospital, Athens, Greece;
3Medical School, University of Athens, Athens, Greece
Background: Skin testing is the diagnostic
cornerstone for IgE-mediated allergies and
is considered extremely safe. It is usually
performed with the prick and the prick-to-
prick method. The aim of this study is to
report a case of systemic anaphylactic reac-
tion during skin prick tests (SPT) with b-
lactamic antibiotics and to underline that
anaphylaxis during SPTs is fortunately a
rare but existing possibility.
Method: A 43 years old male patient came
to our allergy outpatient clinic for drug
allergy evaluation approximately 6 months
after the initial incidence. According to his
medical history five minutes after the first
dose of amoxicillin in the reported episode,
he presented generalised redness, stomach
ache, tachycardia, dyspnea, difficulty in
swallowing, dizziness and loss of con-
sciousness. It is mentioned that he had
taken amoxicillin 10 years ago. Initially in
vitro tests were done for the detection of
specific IgE CAP/FEIA c1, c2, c5, c6, c7
and k82 which were all negative, total
IgE:30.2 KU/l. Patient medical history:
hypertension. Medication: olmesartan. He
was skin prick tested to various b-lactamic
antibiotics (all together PPL1:1, MDM 1:1,
amoxicillin:20 mg/ml, ampicillin:20 mg/ml,
cefuroxime:2 mg/ml, negative and positive
control).
Results: During the 5 min of the test he
complained for oropharyngeal pruritus,
abdominal pain and he developed general-
ised urticaria and conjunctivitis. The skin
tests to amoxicillin and ampicillin were
strongly positive (wheal 25 9 19, and
15 9 12 respectively) and positive to
MDM. The symptoms were treated with
administration of adrenaline (IM), corti-
costeroids and antihistamines (IV). The
ECG conducted was normal and he was
examined by an ENT doctor without any
abnormal finding. Blood samples were sent
for tryptase: 17.7 lg/l. The baseline mea-
surement was 5.2 lg/l. Since the patient
has fully recovered, he was discharged with
instructions of avoiding b lactam antibiot-
ics and a complete emergency set for ana-
phylaxis with written instructions.
Conclusion: Anaphylaxis after SPTs for b
lactams is a rare but possible, especially in
high risk patients, phenomenon. As a
result allergists should be always alert in
order to diagnose and treat properly this
life threatening condition.
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Biphasic anaphylaxis to gemifloxacin
Yilmaz, I1; Dogan, S2; Tutar, N1; Kanbay, A1;
Buyukoglan, H1; Demir, R1
1Department of Chest Diseases, Erciyes University
School of Medicine, Kayseri, Turkey; 2Department of
Gastroenterology, Erciyes University School of
Medicine, Kayseri, Turkey
Background: We report here in the case of
a 60-year-old male who was taking on
ACE inhibitor, a and b blockers and expe-
rienced a severe, resistant and biphasic
anaphlylactic reaction to gemifloxacin
mesylate.
Case history: Five minutes after the first
dose of gemifloxacin mesylate, he devel-
oped numbness around his mouth, itching
particularly localised in the palmar and
plantar regions, followed by fainting,
clammy sweating, shivering, shortness of
breath, dystasia, facial and hand swelling.
He was immediately admitted to the emer-
gency department. On admission: his blood
pressure was measured as 60/40 mmHg,
and his pulse rate was 65 beats/min. Epi-
nephrine was repeated three times with a
five minute interval (0.3, 0.3, 0.5, respec-
tively). Intravenous vasopressor treatment
(Dopamine) was started due to the
patient’s blood pressure not increasing
despite intravenous fluid and intramuscular
epinephrine treatment. The patient was
then promptly transferred to the intensive
care unit in our hospital. On physical
examination: Pulse rate of 60 beats/min,
blood pressure of 90/60 mmHg. He was
taking on angiotensin-converting enzyme
(ACE) inhibitor, Carvedilol and Tamsulo-
sin hydrochloride. Atropine (IM) and
ipratropium bromide monohydrate by neb-
uliser were added. Patient’s symptoms were
relieved; his blood pressure, pulse rate
returned to normal within a few hours. He
developed hypotension (blood pressure
decreased to 50/30 mmHg) and itching-ery-
thema five hours after the first reaction.
Epinephrine 0.1 mg/ml (IV) and atropine
0.5 mg (IM) were injected. Methylprednis-
olone 80 mg (IV), ranitidine 50 mg (IV),
and diphenhydramine 25 mg (IM) were
administered. Meanwhile, glucagon was
prepared. However, glucagon was not
injected because the episode was resolved
by the intravenous administration of aque-
ous epinephrined. One hour later, all of his
symptoms had resolved and dopamine was
stopped because of his experiencing high
blood pressure in the following period.
Conclusion: If shock is imminent or has
already developed, epinephrine needs to be
given by slow intravenous route. A severe,
resistant, biphasic anaphylatic reaction
must queried in cases with an ACE inhibi-
tor, alpha and beta blocker drug history.
Glucagon should be kept ready for patients
taking an a and/or b-adrenergic blocker
who have hypotension and bradycardia
and who do not respond optimally to epi-
nephrine and atropine.
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Anaphylaxis to atracurium: unusual
gastrointestinal features, data on timing
of allergy investigation and acute
tryptase sampling
Dua, S1; Brennan, LJ1; Jani, P1; Ewan, PW1
1Allergy Department, Addenbrooke’s Hospital,
Cambridge, United Kingdom
Background: Anaphylaxis during general
anaesthesia (GA) is a rare but life threaten-
ing event. During anaesthesia, anaphylaxis
most commonly presents with cardiovascu-
lar collapse or respiratory difficulty. To
our knowledge, gastrointestinal involve-
ment has not been reported in the litera-
ture. Investigation of anaphylaxis requires
the use of acute serum tryptase measure-
ment and skin tests to determine aetiology.
The timing of these tests is important
Method: A 64 year old man was admitted
for laser excision of a vocal cord tumour
under GA. Induction was with midazolam,
propofol, remifentanil and atracurium. He
immediately developed profound hypoten-
sion, erythema and a fall in oxygen satura-
tions. Anaphylaxis was diagnosed and
treated with IV hydrocortisone, chlorphe-
niramine, fluids and metaraminol.
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Cardiovascular collapse was easily reversed
and although adrenaline was drawn up it
was not given as it was not required. Sur-
gery was abandoned. Thirty minutes after
the onset of reaction, in recovery, he devel-
oped profuse diarrhoea and stomach
cramps which continued for a further
40 min.
Results: Acute tryptase was 194, 155, 22
and 11.4 ng/ml at 30 min, 1, 12 and 24 h
respectively. A clinic baseline taken 1 week
after the event was 6.8 ng/ml. Skin tests
were performed at 24 h post reaction and
were weakly positive to atracurium. Due to
the proximity to treatment skin tests were
repeated a week later and were again posi-
tive to atracurium and in addition to cisa-
tracrium and mivacurium (not
administered). Anaphylaxis to atracurium
was confirmed.
Conclusion: This case provides new data
on several issues. To our knowledge gas-
trointestinal involvement has never been
reported in the context of anaphylaxis due
to neuromuscular blocking agents. Fur-
thermore, in some allergy guidelines for
the investigation of GA anaphylaxis, a
delay of 6 weeks is suggested before allergy
testing can be undertaken, without sup-
porting data. This is the first data to show
that allergy testing can be undertaken early
after surgery and yield positive results.
Lastly data on the time course of tryptase
in acute reactions is limited with scarce
data on GA reactions. This case provides
time course data showing peak levels were
higher at 30 min than one hour, support-
ing sampling immediately after resuscita-
tion to ensure peak levels are not missed.
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Allergy to short-acting b2-agonists in a
patient with chronic obstructive
pulmonary disease
Valbuena, T1; Manso, L1; Padial, MA1; Reche, M1;
Pascual, CY1
1University Hospital Infanta Sofıa, San Sebastian de los
Reyes, Madrid, Spain
Background: Short-acting B2-agonists are
the first line drugs for treating reversible
airway obstruction, such as in asthma and
in certain patients with chronic obstructive
pulmonary disease (COPD). ‘Paradoxical’
bronchoconstriction following inhalation
of B2-agonists has been documented.
Methods and Results: A 60-year-old man
diagnosed with COPD, suffered a near-
fatal respiratory exacerbation during the
month of May. He was sent to our out-
patient clinic to study the possible implica-
tion of pollen allergy. At the time of his
visit in June, he was asymptomatic and
treated with salmeterol/fluticasone. We per-
formed skin prick tests (SPTs) for common
allergens (positive for Olea europea), spi-
rometry (measurement of forced expiratory
volume in 1 s [FEV1] and forced vital
capacity [FVC]) and measurement of the
improvement of lung function after inhala-
tion of bronchodilator. The spirometry val-
ues were normal: 3280 (89%), FEV1 4180
(84%), FEV1/FVC 78%, and the bron-
chodilator test was negative. We saw the
patient the following year and he did not
have any symptoms during the pollen sea-
son and was controlled of his COPD. We
repeated the measurement of lung function
and five minutes after 200 lg of inhaled
salbutamol, the patient experienced gener-
alised itching and erythema, chest tightness
with audible wheezes and a 46% drop in
FEV1 (from 2.45 to 1.52 l). SPT with salb-
utamol, terbutaline and latex were negative
and intradermal test with terbutaline was
also negative. As the patient had an ana-
phylactic reaction to salbutamol and he
needed a short-acting B2 agonist we
decided to perform a challenge with terbut-
aline. The patient signed an informed con-
sent statement for drug challenge and was
then administered one inhalation of terbut-
aline and five minutes after he felt breath-
less, had cough and audible wheezes and a
35% drop in VEF1 (to 1.78 l).A basophile
activation test (BAT) to salbutamol and
terbutaline was performed next, but no
activation was detected. As the patient had
had two positive challenges to short-acting
B2 -agonists we decided to perform chal-
lenges with long-acting B2-agonists (salme-
terol and formoterol) which were well
tolerated.
Conclusion: We present a case of an ana-
phylactic reaction after salbutamol admin-
istration and bronchoconstriction after
terbutaline administration in which the
immunological mechanism involved is
unclear.
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Anaphylaxis due to barley contained in a
chocolate
Uriarte, SA1; Bartolome, B2; Ruiz, M1; Cuesta, J1;
de las Heras, M1
1Allergy Department, Fundacion Jimenez Dıaz, Madrid,
Spain; 2Bial Arıstegui, I+D, Bilbao, Spain
Background: Chocolates and confectionary
products contain nuts, cereals, additives
and other ingredients capable to elicit aller-
gic reactions. The aim of the study is
describe a case of allergy due to barley
contained in a chocolate and identify the
responsible allergens.
Method: A 32-year old-man, with pollinosis
and allergy to fruits (peach and banana),
suffered oral pruritus, facial angioedema,
generalised urticaria, dysphagia an dizziness
immediatly after the ingestion of Maltesser
chocolates, which contain milk, cocoa, malt,
barley, wheat, soy and pectin, and are nut
free. He had previously allergic reaction to
beer. Skin tests, specific IgE determination
and oral challenge were performed. Aller-
gens were studied by SDS-PAGE, IgE-
immunoblotting and inhibition assays.
Results: Prick tests were positive to grass
pollens, cat epithelium, alternaria, peach,
banana, pear, nuts, cereals (barley, oat and
corn) and peach LTP. Prick-prick was
strongly positive to barley flour and seed,
beer and to the malt biscuit inside the
Malteser chocolate. Skin tests were negative
to cocoa, milk, pectin, soy, wheat, rye, rice,
enzymes, profiline and other fruits. Oral
challenge tests were negative to all raw and
roasted nuts. Specific IgE by CAP and
microarray ISAC was positive to lolium, Alt
a 1, Fel d 1, Pru p 3, Jug r 3, barley, malt,
oat, corn, banana and nuts. EAST IgE was
also positive to barley seed and to Maltesser
biscuit extract. SDS-PAGE and Immuno-
blotting under non-denaturing condition
revealed an extense IgE binding protein to
barley seed and Maltesser biscuit extracts,
mainly at 17 kDa and high mw protein
bands. IgE reactivity was also observed at
13–14 kDa common bands to banana and
walnut extracts. IgE-immunobloting under
reducing condition showed a single 10 kDa
and a prominent 14.5 kDa band in the bar-
ley seed and Maltesser biscuit extracts,
respectively. Barley seed extract caused a
complete inhibition of specific IgE-reactivity
to the 14.5 kDa Maltesser biscuit extract,
indicating the presence of cross-reactive
allergens. No inhibition to barley seed and
Maltesser biscuit IgE-immunoblotting could
be achieved with Pru p 3 patien serum pre-
incubation.
Conclusion: We present a patient allergic
to beer, peach and banana, with anaphy-
laxis to barley contained as an unexpected
allergen in a confectionary product. The
10 kDa responsible allergen could corre-
spond to barley LTP, despite no cross
reactivity could be demonstrated between
barley and Pru p 3.
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Acute urticaria following folic acid
injection
Zirbs, M1,2; Seifert, F1; Radopoulou, E1,2; Cifuentes, L1,2;
Pfab, F1,2; Ring, J1,2; Darsow, U1,2,3
1Dermatology, Klinik und Poliklinik f€ur Dermatologie
und Allergologie am Biederstein Technische Universit€at
M€unchen, Munich, Germany; 2Christine K€uhne Center
for Allergy Research and Education (CK-CARE),
Technische Universitaet Muenchen, Munich, Germany;
3Center of Allergy and Environment, Technische
Universitaet and Helmholtz Center, Munich, Germany
Background: Folic acid (pteroylmonoglu-
tamic acid) is the synthetic form of folate
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B vitamins, which naturally can be found
in leafy vegetables, liver, yeast and milk. It
is often added to multivitamin tablets and
other groceries. In case of deficiency, pure
folic acid is administered. Allergies to folic
acid have been occasionally published and
in one case could be verified by oral provo-
cation.
Method and Results: We present a 81-year-
old male patient, who suffered of an acute
urticaria and dyspnea after injection of dif-
ferent vitamins including folic acid.
Allergologic laboratory assessment
revealed a sensitisation against D. pter-
onyssinus and cat epithelia, as well as an
elevated total serum IgE of 333 IU/ml. In
the skin prick test a positive reaction was
seen with folic acid, with a strong wheal
(5 mm diameter) and flare (10 mm diame-
ter) reaction. The other vitamins tested
remained negative.
Patch testing with the accused sub-
stances was negative.
Double-blind, placebo-controlled titrated
oral challenge confirmed hypersensitivity
against folic acid (flush, pruritus, blurred
vision and dizziness). The other accused
vitamins and the placebo control were well
tolerated.
Conclusion: Natural sources of folic acid
in groceries (pteroylpolyglutamate and
pteroylmonoglutamate) didn’t have any
impact on the patient. These substances
are reduced in the intestine to tetrahydrof-
olic acid and probably have no allergenic
potential in our patient. Accordingly, an
allergy passport to synthetic folic acid was
issued.
We recommended to the patient to pay
attention to a sufficient supply of natural
folic acid in his daily food intake.
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Successful carboplatin desensitisation
Maghfour Martın, Y1; Porcel Carre~no, S1; Gomez
Nieves, E1; Ahmida, T1; Camara Hijon, C2; Hernandez
Arbeiza, J1
1Allergology Department, Virgen de la Monta~na
Hospital, Caceres, Spain; 2Immunology and Molecular
Genetic Department, San Pedro de Alcantara Hospital,
Caceres, Spain
Background: Severe allergic reactions by
chemotherapy drugs in oncologic patients
represent a problem when there are no
alternative treatment so desensitisation is
necessary in many cases.
Case Report: A 41 year old woman was
referred to our department due to a severe
anaphylactic shock reaction by cisplatin.
She had a previous history of adverse reac-
tion to radio-contrast media without any
other atopic conditions. She was diagnosed
of poor outcome stage IB2 high level cer-
vix carcinoma and treated with multiple
palliative chemotherapy regimens. She suf-
fered several episodes of systemic infusion
reactions by Taxanes and Carboplatin.
After a new Cisplatin protocol in the 4th
cycle she developed an immediate severe
reaction characterised by flushing, general-
ised pruritus, dizziness, dyspnea, diarrhea,
abdominal cramping, hypotension (85/
45 mmHg) and required emergency treat-
ment and hospitalisation in the Intensive
Care Unit. A tryptase level of 54.5 lg/l
was observed after about 6 h of the reac-
tion. Baseline levels were normal.
Method and Results: Skin tests:
Skin prick test (SPT) with common
inhalants and food allergenes: negative.
Carboplatin SPT (10 mg/ml) positive.
Cisplatin SPT (1 mg/ml) positive.
Oxaliplatin SPT (5 mg/ml) negative.
Intradermal test (0.5 and 5 mg/ml) nega-
tive.
Basophil activation test: Carboplatin
positive (activation 85%), Cisplatin posi-
tive (activation 75%), Oxaliplatin negative.
Controls negative.
A modified, previously reported, desensi-
tisation protocol was performed with
increasing Carboplatin doses at different
concentrations (Solution A 0.0028 mg/ml
in 50 ml; Solution B 0.028 mg/ml in 50 ml;
Solution C 0.288 mg/ml in 100 ml; Solu-
tion D 1.44 mg/ml in 500 ml) in continu-
ous infusion. A total cumulative dose of
720 mg was achieved in 7 h. Our patient
has received successfully 3 carboplatin
cycles with just mild reactions in the 2nd
and 3rd cycle.
Conclusion: We have demonstrated the
effectiveness of reported desensitisation
protocols in our high-risk patient with a





Zambonino Carreiras, MA1; Bobadilla Gonzalez, P1;
Garcia Menaya, JM1; Jimenez Ferrera, G1; Corrales
Vargas, SI1; Cordobes Duran, C2
1Allergy Service, Infanta Cristina Hospital, Badajoz,
Spain; 2Allergy Service, Merida Hospital, Merida, Spain
Background: H1-antihistamines are the
most used drugs in allergic diseases. Bilas-
tine is a new H1-antagonist used for the
symptomatic treatment of allergic rhino-
conjunctivitis and urticaria in adults or
children over 12 years old.
We present a case of anaphylaxis after
taking several antihistamines.
Method: A 44-year-old woman with a his-
tory of hemorrhoids (surgically treated
6 years ago) and hypothyroidism was trea-
ted with fosfomycin-trometamol for uri-
nary tract infection and started with anal
itching. She applied hemorrhoid creams in
anal region and took dexchlorpheniramine.
7–8 h later she developed generalised urti-
caria and pruritus. The creams were dis-
continued. Immediately after the next dose
of dexchlorpheniramine she developed gen-
eralised urticaria, pruritus, dizzy, decay,
diarrhea and breathlessness. The medica-
tion was discontinued and the symptoms
resolved completely in several hours with-
out treatment. Two months later she took
bilastine 20 mg and started 2 h later with
the same symptoms, not needing treatment
for this episode either. Four months later
took diphenhydramine to sleep and several
hours later began with generalised urticaria
improved without treatment.
Results: Skin patch-tests with standard
true-test and antihemorrhoidal cream were
performed with negative results after 48
and 96 h reading. Skin prick-tests with
desloratadine, cetirizine, loratadine, levoce-
tirizine, ebastine, dexchlorpheniramine, and
hidroxyzine (crushed and diluted in saline)
were negative. Oral and ocular challenge
tests with the same products, placebo, fos-
fomycin-trometamol, levocabastine and az-
elastine eye drops were negative except for
dexchlorpheniramine, bilastine and ebas-
tine, with a positive result. Basophil activa-
tion test (BAT) was positive for
diphenhydramine and ebastine.
Conclusion: We present a case of anaphy-
laxis with several antihistaminics that was
confirmed by oral challenge test. Although
the mechanism of hypersensitivity to anti-
histamines is unknown, BAT positivity
suggests an IgE-mediated mechanism in
our case.
To our knowledge this is the first case of
bilastine hypersensitivity.
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Ornipressin for the treatment of
adrenaline-resistant anaphylaxis due to
latex
Seedat, RY1; van der Westhuizen, J2
1Otorhinolaryngology, University of the Free State,
Bloemfontein, South Africa; 2Bloemfontein, Private
Practice, South Africa
Background: Anaphylaxis is defined as ‘a
serious allergic reaction that is rapid in
onset and might cause death’. Adrenaline
is the first-line treatment for anaphylaxis.
Method: We report the case of a patient
with intraoperative anaphylaxis who was
treated with intravenous ornipressin after a
failure to respond to adrenaline.
Results: A 36 year old female developed
anaphylaxis intraoperatively while under-
going an arthroscopy under general anaes-
thesia. She was known to have
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hypothyroidism Eltroxin and known to
have allergic rhinitis with sensitisation to
cat and dog hair but was not asthmatic.
During induction, she had received keta-
mine, propofol and sufentanil and received
ketotifen, dexamethasone and clindamycin
ten minutes later. Two minutes after this,
she developed flushing, bronchospasm, bra-
dycardia and hypotension. She was treated
with 0.5 mg of adrenaline intravenously
every 2 min, 6 mg of etilefrine and 1 l of
Ringer’s lactate. Despite receiving 2 mg of
adrenaline intravenously, she remained
hypotensive with a bradycardia. She was
also given 200 mg of hydrocortisone,
25 mg of promethazine and 50 mg of rani-
tidine intravenously. Following the admin-
istration of 1 IU of ornipressin, the
bradycardia and hypotension resolved.
ImmunoCAP RAST testing performed
after discharge from hospital was positive
with a specific IgE of 5.06 IU/ml.
Ornipressin is a synthetic vasopressin
analogue with potent and specific constric-
tor effect on the microcirculation and veins
through its actions on the V1 receptor
which is equal to, if not greater than, that
of vasopressin. It is used locally to induce
ischaemia and haemostasis at operative
sites during ENT, gynaecologic and uro-
logic procedures. Infusion of ornipressin
causes a rise in arterial blood pressure by
increasing the venous tone and decreasing
the capacity of the peripheral circulation
thus increasing peripheral vascular resis-
tance and shunting blood back to the vital
organs and the central circulation.
Conclusion: Although adrenaline-resistant
anaphylaxis is rare, clinicians need to be
aware of the entity and the role of orni-
pressin in its management.
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Two cases developing allergic reactions
with both meloxicam and nimesulide
Keren, M1; K€oyc€u, G1; €Oner Erkekol, F1
1Atat€urk Chest Disease and Thoracic Surgery Training
and Research Hospital, Immunology and Allergy
Department, Ankara, Turkey
Background: The patients who have non-
steroidal antiinflammatory drug (NSAID)
intolerance should be tested for safe anal-
gesic. In our country only the preferential
COX2 inhibitors (meloxicam and nimesu-
lide) are available. However, rare systemic
reactions to these COX-2 inhibits have
been presented. Two cases who had allergic
reactions with both of the drugs during
tests for safe alternative analgesic will be
presented. Their management plan will be
discussed.
Case Presentation: Both cases had asthma
and one of them had additional nasal
polyposis. Both patients gave multiple
allergic reaction history with different
NSAIDs. The first case had respiratory
and urticaria type intolerance reactions.
The second case described only respiratory
system symptoms with consumption of
NSAIDs. The first case developed runny
nose and sneezing after oral provocation
test (OPT) with meloxicam in the first
hour. Twenty days after that reaction, we
performed OPT with nimesulide. Five min-
utes after the first dose (a quarter of the
usual dose) nausea, vomiting, abdominal
pain and hypotension appeared. In the sec-
ond case; 5.5 h after the OPT with nimesu-
lide, the patient had shortness of breath.
Rhonchi in physical examination and a
25% fall in FEV1 were detected. One week
later we performed OPT with meloxicam.
Four hours after the test, we observed
flushing, hives, difficulty in swallowing and
a 20% fall in FEV1. Afterwards, taking
into account the patients’ need for analge-
sics, aspirin desensitisation performed. The
desensitisation processes were successfully
completed in both cases. After desensitisa-
tion the patient tolerated NSAIDs includ-
ing nimesulide and meloxicam.
Conclusion: Meloxicam and nimesulide
preferentially inhibit COX-2, however high
enough concentrations can inhibit the
COX-1 enzyme. The COX-1 inhibitor
activity of the drugs is the mechanism that
explains the cases. ASA desensitisation can
be an alternative treatment strategy for
patients who can not tolerate any NSA-
IDs.
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Collagen receptors: a1b1 and a2b1
integrins are involved in eosinophil
transmigration through human
microvascular endothelial cell lung
monolayer
Zuk, J1; Bazan-Socha, S1; Marcinkiewicz, C2; Zareba, L3;
Plutecka, H1; Mlicka, E1; Musial, J1
1Jagiellonian University School of Medicine, Krakow,
Poland; 2Temple University, Philadelphia, PA, United
States; 3University of Rzeszow, Rzeszow, Poland
Background: Recruitment of the inflam-
matory cells to the airways is mediated
by adhesive molecules. Among integrins,
the most important in cell trafficking are
those containing a4 and b2 subunits. We
hypothesised that in bronchial asthma
also collagen integrin receptors: a1b1 and
a2b1, may be involved in cell migration
to the inflammatory site. We recently
described increased expression of both: a1
and a2 subunits on blood eosinophils and
a2 on CD4 T lymphocytes in asthma.
The aim of the study was to analyse
effect of a1b1 and a2b1 integrin inhibition
on transmigration of eosinophils and
peripheral blood mononuclear cells
(PBMC) through human microvascular
endothelial cell lung monolayer in 12 ato-
pic asthmatics and 12 healthy controls.
We analysed also CD4/CD8 ratio in
PBMC population before and after trans-
migration assay.
Methods: PBMC were separated by gradi-
ent centrifugation; eosinophils by gradient
centrifugation and negative magnetic sepa-
ration. For inhibition purposes we used
snake venom derived anti-adhesive pro-
teins: viperistatin, VP12, VLO5 and VLO4
(potent and selective inhibitors of a1b1,
a2b1, a4b1 and a5b1 integrins, respectively).
Results: In both groups of subjects all
anti-adhesive proteins inhibited eosinophil,
but only VLO5 and VLO4 PBMC transmi-
gration; CD8 T cells migrated better than
CD4 in control samples, but their transmi-
gration was decreased after incubation
with anti-adhesive proteins.
Conclusion: Both studied collagen recep-
tors: a1b1 and a2b1 integrins are likely to
be involved in eosinophil transmigration to
the inflammatory site of asthmatic subjects.
The role of a2b1 on lymphocyte is proba-
bly different. As a stimulator of collagen
accumulation this integrin could be, at
least in part, responsible for asthma airway
remodelling.
524
In vitro MUC5AC production and the
effect of antioxidant in asthma
angiotensin converting enzyme
Shim, J-J1; Hur, G-Y1; Min, K-H1; Lee, S-Y1; Kang, K-H1
1Korea University College of Medicine, Seoul, Korea
Background: Both bronchial asthma and
chronic obstructive pulmonary disease
(COPD) are characterised by chronic per-
sistent inflammatory process, but the nat-
ure of the inflammation is different
markedly. However, in real practice, both
may occur concurrently in some patients,
and such conditions have been defined as
overlap syndrome. Therefore, we purposed
to evaluate the mucus production in
asthma, COPD and overlap syndrome in
airway epithelial cell line, and to analyze
the effect of antioxidants in mucus produc-
tion.
Method: Cigarette smoke extracts (CSE)
were withdrawn into a polypropylene syr-
inge (50 ml) at a rate of one puff/min (5
times) and then bubbled slowly. We used
NCI-H292 cell lines, stimulated by IL-13
(10 ng/ml), TNF-a (20 ng/ml) and cigarette
smoking extracts (CSE). MUC5AC pro-
duction was measured by immunoassay.
Epigallocatechin-3-gallate (EGCG; 10, 20,
and 50 uM; Sigma Co. St. Louis, MO,
USA) was pretreated 1 h before adding the
cigarette smoke extract or cytokines.
Results: Co-treatment of IL-13 and TNF-
a increased MUC5AC protein production
in NCI-H292 cells (P < 0.05). CSE treat-
ment also increased MUC5AC protein
level in cells (P < 0.05). Treatment with
IL-13, TNF-a and CSE more increased
MUC5AC level than single treatment of
them. Treated with EGCG (10, 20, and
50 uM) decreased MUC5AC level dose
dependently (P < 0.05, compared to
untreated).
Conclusion: Mucus production in airway
epithelial cells is increased in both asthma
and COPD model. In overlap syndrome
between asthma and COPD, mucus pro-
duction is more increased compared to sin-
gle asthma and COPD. Antioxidant
treatment may helpful to reduce airway
mucus secretion in overlap syndrome.
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Significant correlation between the
intensity of a positive skin prick tests
and the prevalence of asthma in patients
with pollinosis in Spain
Subiza, J1; Fernandez-Caldas, E2; Pola, J3; Moral, A4;
Feo, F5
1Subiza Asthma and Allergy Centre, Madrid, Spain;
2Inmunotek Lab, Madrid, Spain; 3Sagasta Policlinic,
Zaragoza, Spain; 4Virgen Del Valle Hospital, Toledo,
Spain; 5General Hospital, Allergy Unit, Ciudad Real,
Spain
Background: Some, but not all, pollinosis
patients with allergic rhinitis suffer from
asthma. One of the more plausible expla-
nations is the systemic propagation of the
inflammatory mediators from the nose to
the lower airways (Braunstahl GJ. JACI
2001, 107:469–476). Therefore, patients
with severe allergic rhinitis would be more
likely to suffer asthma. The aim of this
study was to investigate if there is a signifi-
cant correlation between the intensity of
positive skin pick tests and the prevalence
of asthma in pollinosis patients.
Material and Methods: Thirteen allergy
clinics from 13 Spanish cities participated
in this study. Patients were selected on the
basis of a history of seasonal, or perennial
allergic rhinitis and/or asthma. From this
group, 1536 patients (48% males and 52%
females) with positive skin prick tests to
pollens and seasonal symptoms were
selected. The mean age was 32 years (range
8–81 years).
All patients were skin tested with a bat-
tery of common aeroallergens at 50 HEP
(Inmunotek, Madrid, Spain). The pollens
included 25 representative species, based
on pollen counts. Steel lancets (Allergy
Pricker; DHS) were used. All skin test sites
were evaluated after 20 min.
The area of each wheal was measured by
plannimetry using the Prick-Film system
(Inmunotek). The skin prick test results
were expressed in mm2. A positive reaction
was defined as a wheal of at least half the
size of the histamine wheal in the absence
of a reaction to the negative control.
Additionally, we also obtained the
‘degree of atopy’ for each patient by add-
ing the wheal areas of the positive allergens
tested. A Spearman rank correlation coeffi-
cient was used to correlate the degree of
atopy with the prevalence of asthma.
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Results: We observed a rhinitis prevalence
of 93%, conjunctivitis 89% and asthma
41%. Sensitisation prevalence was as fol-
lows: grasses 87%, Olea 43%, Chenopodi-
um 27%, Platanus 22%, Cupressus 13%
and Parietaria 11%.
The prevalence of pollen polysensitisa-
tion was 75%.
Patients were divided into six groups
according to their degree of atopy using
the following ranges: 0–99 mm2; 100–
199 mm2; 200–299 mm2; 300–399 mm2;
400–499 mm2 and 500–599 mm2. The prev-
alence of asthma within these ranges was:
37%; 38%; 40%; 46%, 48% and 55%,
respectively (Spearman rank correlation
rs = 0.96 P < 0.05).
Conclusion: The prevalence of asthma
within this pollinosis population in Spain,
is significantly correlated with a greater
degree of atopy.
526
Lymphocyte populations in patients with
severe versus mild persistent atopic
asthma
Tsybulkina, VN1; Kurmaeva, N1; Skibo, Y2; Abramova,
Z2; Tsybulkin, N3; DuBuske, LM4
1Kazan State Medical University, Kazan, Russia; 2Kazan
Federal University, Kazan, Russia; 3Kazan State Medical
Academy, Kazan, Russia; 4Immunology Research
Institute of New England, Gardner, MA, United States
Background: Atopic asthma (AA) is a
chronic inflammatory disease with hetero-
geneity of clinical course and severity per-
haps related to different pathogenic
mechanisms involved in generation of
chronic airway inflammation.
Method: Patients 19 to 45 years old with
persistent AA in remission were divided
into two groups- mild (M-AA) and severe
(S-AA) with moderate cases excluded. The
control group (CG) consisted of healthy
subjects. Groups of comparable age and
gender and were 10 persons each. All sub-
jects had skin tests, IgE levels, bronchopro-
vocation tests, lung function and blood
counts with lymphocyte populations
assessed by flow cytometry (FASCalibur,
Becton Dickinson), identifying CD3, CD4,
CD8, CD16, CD56 (MultiTEST IMK,
Becton Dickinson).
Results: The clinical condition of patients
in both AA groups was comparable, their
lung function differed: FEV1 and FVC in
S-AA patients 44.3310.56% and
57.507.20% of predicted vs 89.008.05%
and 92.257.59% in M-AA group
(P < 0.05). Mean absolute number of T
cells (CD3+) in S-AA group
(2473.97940.30) was less than in M-AA
(3478.881427.29). Numbers of T helper
cells (CD4+) were similar in all groups
(1600.10628.10 in S-AA, 1770.15780.54 in
M-AA and 1704.50433.20 in CG), but their
proportion was significantly greater in S-
AA patients compared to M-AA
(48.758.10% vs 36.758.28%, P < 0.05).
Cytotoxic T lymphocytes (CTL) counts
were less in S-AA (755.38241.44) compared
to M-AA and CG (1516.85725.57 and
1302.83479.94 respectively) as were per-
centages which were 23.501.73% in S-AA
vs 31.383.74% in M-AA and 30.335.68%
in CG (P < 0.05). The CD4+/CD8+ ratio
was nearly twice greater in S-AA
(2.100.47) then in M-AA (1.190.33,
P < 0.05), while CG group was also less t
(1.390.32, P < 0.05).
Conclusion: Significant reduction of lung
function in S-AA patients in remission
indicates bronchial inflammation with an
increased proportion of CD4+ cells and
increased CD4+/CD8+ ratio suggesting a
major role of CD4+ cells in maintaining
inflammation in S-AA patients.
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Nocturnal continuous positive airway
pressure in severe asthma: a pilot study
D’ Amato, M1; Stanziola, AA1; Radicella, D1; Lanza, M1;
Vitale, C1; Caccavo, G1; Sofia, M1
1Federico II Napoli, I Clinica di Malattie Respiratorie,
Napoli, Italy
Background: It has been reported that
brief periods of nocturnal continuous posi-
tive airway pressure (CPAP) reduces air-
way reactivity in rabbits. This effect
persists 12–24 h after its discontinuation
(Xue Z. Et al. J Appl Physiol
2011;111:353–357). We evaluated short
term effects of nocturnal CPAP in severe
asthma.
Method: In this pilot study four nights
CPAP was applied to 10 patients (5M, 5F
mean age 50.9 (range 49–56 years) with
severe asthma. The patients were on regu-
lar treatment with LABA + inhaled corti-
costeroids (≥1000 mg fluticasone/day) and
5 of them with anti IgE treatment (Oma-
lizumab). Five patients were on systemic
corticosteroid treatment (Prednisone mean
daily dose 17 mg [Range 10–30 mg]). All
patients at polisomnography did not reveal
any significant breathing sleep disorder.
CPAP was titrated in autosetting with val-
ues between 4 and 20 cmH2O (mean
value = 6). Asthma control test (ACT)
baseline and after a month was measured
and daily peak flow (morning and evening
recorded) was measured from 2 weeks
before baseline to 2 weeks after the treat-
ment. PEF variability for each patient was
calculated as PEF amplitude% over 24 h
periods, amplitude% mean, defined as
(highest PEF-lowest PEF)/(mean value of
two) X100%, averaged over 1 week.
Results: Two patients were unable to toler-
ate nocturnal CPAP. In eight patients
baseline PEF amplitude resulted
37.6  2.8%; it significally decreased dur-
ing nocturnal CPAP (nCPAP) period to
26.5  3.5% and in the week after nCPAP
discontinuation (30  2.9 (P < 0.05 t test
improve). The baseline ACT was 11 (range
8–15); after 1 month it increased to 21
(range 15–25).
Conclusions: Brief period of nocturnal
CPAP reduce PEF variability and improve
control in severe asthma at a short term
evaluation. Larger and longer studies are
required to evaluate this kind of interven-
tion in severe asthma.
528
Silent gastroesophageal reflux disease is
frequent in children with uncontrolled
asthma but without clinical importance
Jedynak-Wasowicz, U1; Glodzik, I1; Cichocka-Jarosz, E1;
Lis, G1
1Chair of Pediatrics, Department of Pulmonology,
Allergy and Dermatology, Jagiellonian University
Medical College, Krakow, Poland
Background: Bronchial asthma and gastro-
esophageal reflux disease (GERD) may
coexist together. Also GERD may be
implicated in the recurrent respiratory tract
infections in children. The uncontrolled
asthma, infections and gastroesophageal
reflux may overlap and have the same clin-
ical presentation.
The aim of the study was to assess:
1 the prevalence of GERD in asthmatic
children without clinical symptoms of
GERD and in children with recurrent
respiratory tract infections;
2 the implication of the reflux episodes
(RE) in developing of respiratory symp-
toms in both studied groups.
Method: Thirty-eight children with uncon-
trolled asthma (27 boys, mean age
14.4  3.2 years) and 24 children with
recurrent infections of respiratory tract as
control group (15 boys, mean age
13.6  2.2 years) were enrolled into the
study. Twenty four-hour monitoring of
multichannel intraluminal impedance (MII)
with pH-metry was performed in all
patients. Children were asked to report any
episodes of cough, dyspnea or any respira-
tory distress, hoarseness, abdominal or
chest pain. The clinical exercise testing was
done during pH-impedance monitoring
also. The clinical symptoms and records of
pH-impedance probe were analysed before
and after exercise testing. Children with
recurrent infections were healthy at the day
of study. Asthma treatment was continued
during the investigation in all asthmatic
children.
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Results: Acidic GER was diagnosed in 15
(39.5%) asthmatic children and in six chil-
dren (25%) of control group. There were
no significant difference in any of analysed
MII parameter between both groups. The
exercise did not increase reflux episodes
during and 30 min after testing compare to
pH-impedance probe record 30 min before
testing and it did not significantly predis-
pose to any of analysed clinical symptom.
Cough was the most common reported
symptom in both groups (asthma group –
44.7% vs control group – 37.5%). But we
did not find correlation between cough and
episodes of proximal or distal reflux in
asthmatic children with acidic GER
(respectively Rho = 0.05 and Rho = 0.08).
We detected the slight increase in GER
events in LABA-treated asthmatic children
(P = 0.08).
Conclusion:
1 Silent acidic GER is frequent in chil-
dren with uncontrolled asthma.
2 Gastroesophageal reflux episodes were
not relevant to any respiratory symp-
toms in studied groups.
3 Short-lasting intensive exercise did not
induce reflux episodes.
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The roles of vitamin D and cathelicidin in
the development of acute asthma attacks
in children
Batmaz, SB1; Arikoglu, T1; Karaismailoglu, E2; Kuyucu,
S1
1Department of Pediatric Allergy and Immunology,
Mersin University Faculty of Medicine, Mersin, Turkey;
2Department of Biostatistics, Hacettepe University
Faculty of Medicine, Ankara, Turkey
Introduction: Recent evidence, about the
various effects of vitamin D (vit D) on
innate and adaptive immunity has led to
search for its role in asthma and allergic
diseases. The deffects in the innate immune
system, such as the capacity to increase the
production of broad spectrum antimicro-
bial peptides like cathelicidin may predis-
pose to infectious complications. The aim
of this study was to determine the role of
vit D and cathelicidin in the development
of acute asthma attacks among 7–17 years
old allergic asthmatic-children.
Material and Methods: The study included
35 patients with acute asthma exacerbation
triggered by an infection, 32 children with
controlled asthma and 21 healthy children,
all matched by sampling season and for
asthma subgroups, matched by mono-mite
sensitisation and previous severity and
medication score of asthma. In all groups,
a comprehensive questionnaire, serum 25-
OH vit D, vitamin D-binding protein
(VDBP) and cathelicidin levels, markers of
allergy, viral serology and spirometric indi-
ces were employed. Factors that influence
serum vit D levels and the development of
asthma attacks were evaluated with multi-
variate linear and logistic analysis.
Results: The mean serum vit D level was
14.09  5.75 in the attack group,
28.47  13.88 in the stable asthma group
and 12.95  7.15 in healthy controls. The
differences between attack and stable
asthma groups were highly significant
(P < 0.001). On the contrary, mean cath-
elicidin level was significantly higher in
acute asthma group than controlled asth-
matics (P = 0.002). Cathelicidin levels
showed a negative correlation with vit D
levels (P = 0.002, 0.380 spearman c.c).
Furthermore, there was a positive correla-
tion between the spirometric indices and
the level of vit D among asthmatics
(P ≤ 0.05). Multivariate analysis of risk
factors that may influence vit D levels
revealed that younger age (P = 0.046), high
BMI (P = 0.025), longer duration of sun
exposure (P ≤ 0.001), and high amount of
dietary vit D (P ≤ 0.001) independently
increased serum vit D levels. Furthermore,
multivariate analysis of risk factors that
may result in acute asthma vs controlled
asthmatics showed that the increase in
serum levels of vitamin D significantly
reduced the risk of asthma attacks
(P = 0.030, adjusted odds ratio 0.862) inde-
pendent of age, sex, allergic markers, use
of inhaled steroids, BMI, time spent out-
side (as a marker of activity level), serum
levels of cathelicidin and VDBP.
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Age-related changes in airway resistance
using an impulse oscillation system in
patients with asthma
Iwanaga, T1; Kume, H1; Okimoto, N1; Watatani, N1;
Imbe, S1; Miyajima, H1; Santo, H1; Sato, R1; Nishiyama,
O1; Sano, H1; Higashimoto, Y1; Nakajima, H1; Tohda, Y1
1Respiratory Medicine and Allergology, Kinki University
Faculty of Medicine, Osakasayama, Japan
Background: The characteristics of elderly
asthma include decreased pulmonary func-
tion, and in particular, airflow obstruction.
In the daily care of asthma, the degree of
airflow obstruction as measured through
spirometry is used as an index of asthma
control, but because the implementation of
spirometry requires the maximal forced
expiration of the subject, this examination
is a burden for elderly subjects. Impulse
oscillation system (IOS), which began to be
applied clinically in recent years, is able to
measure airway resistance under quiet
breathing using impulse waves, and is also
able to separate airway resistance into cen-
tral airway components and small airway
components through frequency analysis.
IOS is therefore useful for analyzing air-
flow obstruction in elderly or pediatric sub-
jects; however, the usefulness of evaluating
airway resistance in elderly asthmatics
using IOS is not clear. In this study, we
investigated the usefulness of IOS by mea-
suring airway resistance and the correlation
between IOS and spirometry in elderly
patients with asthma, and also to compare
the results with those of non-elderly
patients with asthma.
Method: IOS, spirometry and flow volume
curve were performed for 51 elderly
(65 years old or older) and 58 non-elderly
(below 65 years old) patients with asthma.
Results: The correlation between lung
function and IOS, there were significant
correlation between IOS parameters (R5,
R5-R20, Fres, X5) and lung function 〔%
FEV1 (forced expiratory volume in 1-s),%
Vdot50,%Vdot25,%MMF (maximal mid-
expiratory flow) 〕in each group. The cor-
relations between age and IOS parameters:
R5, R5-R20, X5 and Fres were signifi-
cantly correlated with age, with Fres show-
ing the strongest association. In the elderly
group, R5 was significantly higher than the
non-elderly group (0.30 vs 0.40, P < 0.01).
Significantly higher R5-R20 was exhibited
in the elderly group compared with the
non-elderly group (0.04 vs 0.10, P < 0.01).
X5 showed significantly low value in the
elderly group than in the non-elderly group
(0.11 vs 0.15, P < 0.05). Fres was a sig-
nificant higher in the elderly group than in
the non-elderly group (11.92 vs 15.83,
P < 0.05).
Conclusion: These results suggest that IOS
can be used to reveal small airway lesions
in elderly patients with asthma and is use-
ful as a method of evaluating airway
lesions in patients with asthma.
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Lung ventilation and capnometry in
patients with uncontrolled bronchial
asthma
Iashyna, L1; Feshchenko, Y1; Ishchuk, S1
1State Organization ‘National Institute of Physiology
and Pulmonology named after FG Yanovsky National
Academy of Medical Sciences of Ukraine’, Kiev,
Ukraine
Background: Gas exchange abnormalities
are the dangerous complication of uncon-
trolled BA. We investigated the relation-
ship between lung ventilation and
capnometry indices in patients with uncon-
trolled BA.
This study aimed to investigate capnom-
etry indices in patients with uncontrolled
BA compare to healthy subjects.
Method: Bodyplethysmography, capnome-
try. Data are presented as mean  SD.
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Results: A total of 30 subjects (age
51.6  2.8 years; 39% male) were enrolled:
BA group (n = 15, mean%FEV1 = 72.9%,
ACT = 12.9), control group (n = 15, mean
%FEV1 = 99.1%). All subjects were per-
formed bodyplethysmography and cap-
nometry, we compared the results between
groups.
All bodyplethysmography and capnome-
try indices of BA subjects were significantly
(P < 0.05) different from control. The
mean values Rtot,% was 161.8  16.1 and
99.6  7.8, ITGV,% was 109.9  5.8 and
91.7  4.0, RV,% was 131.6  8.8 and
102.6  4.7 in BA and control group
respectively. The capnometry results:
PeCO2, kPa (partial pressure CO2 in
expired air) was 2.7  0.1 and 3.3  0.1,
FeCO2,% (fraction CO2 in expired air) was
2.9  0.1 and 3.5  0.1, PetCO2, kPa (par-
tial pressure of end-tidal CO2) was
4.1  0.1 and 4.8  0.1, FetCO2,% (frac-
tion of end-tidal CO2) was 4.4  0.1 and
5.1  0.1 in BA and control group respec-
tively.
Conclusion: In uncontrolled BA patients
CO2 removal from the organism reduced
with degree of lung hyperinflation increas-
ing. Thus capnometry might be a useful
tool to detect the respiratory failure in BA
patients.
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Comparison of the bronchial sensitivity
and reactivity using impulse oscillometry
system between cough-variant asthma
and classic asthma in pre-school children
Jungwon, Y1; Hyeyoung, H1; Hyemi, J1; Manyong, H1
1Pedicatrics, CHA Medical Center, Seongnam, Korea
Background: Little data is currently avail-
able on the use of the impulse oscillometry
(IOS) parameter in analyzing the lung
function of pre-school children with cough-
variant asthma (CVA) and classic asthma.
The aims of this study were to compare
the bronchial sensitivity and bronchial
reactivity between patients with CVA and
those with classic asthma by IOS, and to
investigate if the IOS parameters can dis-
tinguish one group from the other.
Method: A methacholine challenge test
and a pulmonary function test were per-
formed in 43 children with classic asthma
and 28 children with CVA, using IOS, and
the respiratory resistance (Rrs) and reac-
tance (Xrs) were obtained. The bronchial
sensitivity of all subjects was assessed using
methacholine provocative concentration
causing a 80% increase in reactance at
5 Hz (PC80_Xrs5) and the concentration
with Z scores of reactance at 5 Hz going
beyond 0.2 values (Zs_Xrs5). The bronchial
reactivity was calculated from the degree
of dose-response slope (DRS) for airway
resistance and reactance.
Results: There was no significant differ-
ence in bronchial sensitivity between the
two groups. However, the classic asthma
group showed a significantly higher bron-
chial reactivity in reactance at 5 Hz
(DRS_Xrs5) compared with the CVA
group (P = 0.044).
Conclusion: DRS_Xrs5 is suggested to be a
useful marker in distinguishing CVA from
classic asthma through methacholine chal-
lenge testing using IOS in pre-school chil-
dren.
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Impact of sputum cells profile and
inflammatory markers on airway
responsiveness and asthma severity in
different asthma phenotypes in children
Nakonechna, A1; Antipkin, Y2; Umanets, T2; Lapshyn,
V2; Zadorozhnaja, T2; Pustovalova, O2
1Immunology, Hull and East Yorkshire Hospitals NHS
Trust, Neston, United Kingdom; 2Obstetrics and
Gynaecology, Institute of Paediatrics, Kiev, Ukraine
Background: Heterogeneity in asthma is
recognised by different inflammatory cell
patterns in airway secretions. However, the
role of sputum cells and inflammatory
markers in airway responsiveness in differ-
ent childhood asthma phenotypes is still
unclear.
Objective: Investigate whether the sputum
cell profile and expression of inflammatory
markers impact on airway responsiveness
and asthma severity in children with differ-
ent asthma phenotypes.
Method: Seventy eight children aged 6–
12 years with asthma and 25 age-matched
healthy controls were assessed including:
skin prick testing (SPT), lung function,
total and antigen specific IgE, induced spu-
tum analysis. Expression of CD4+, CD68+,
IgE, TNF-alpha and matrix metallopro-
teinase-1 (MMP-1) in sputum cells were
assessed using immunocytochemistry. Mul-
tivariate regression was used to determine
whether sputum cell profile, airway respon-
siveness and disease severity varied
between phenotypes.
Results: Among investigated children
69.2% had atopic asthma with increased
total and specific IgE levels, positive SPT
at least to one allergen. They had mild-to-
moderate asthma (87%) and induced spu-
tum eosinophilia along with increased level
of sputum lymphocytes, mast cells and
bronchial epithelial desquamation. Airway
hyperresponsiveness strongly associated to
higher level of eosinophils, highly elevated
expression of CD4+, IgE and CD68+, espe-
cially in moderate asthma (P < 0.05). In
contrast 30.8% children with non-atopic
asthma had moderate-to-severe asthma,
induced sputum neutrophilia and more sig-
nificant airway hyperreactivity in metacho-
line and exercise-induced tests, that both
correlated with high expression of CD68+,
MMP-1, TNF-alpha and asthma severity
(P < 0.05).
Conclusion: Sputum cell profile, inflamma-
tory markers and airway responsiveness
vary in different asthma phenotypes in
children. These findings suggest a role of
inflammatory markers (cells and receptors)
in the phenotypic classification of asthma
and determining the severity of disease and
therapy in childhood asthma management.
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The role of Coxsackie and adenoviral
receptor in TNF alpha driven
inflammation in lung epithelial cells
Hicks, AP1; Morton, P1; Parsons, M2; Santis, G1
1Asthma, Allergy & Lung Biology, Kings College
London, London, United Kingdom; 2Randall Division of
Cell and Molecular Biophysics, Kings College London,
London, United Kingdom
Background: The regulation and mainte-
nance of an intact epithelial cell layer is
crucial to the homeostasis of many differ-
ent tissues including the respiratory tract.
One of its key functions is the creation of
a physical barrier from the external envi-
ronment. This is achieved through the
combination of adherens and tight junc-
tions, known as the apical junctional com-
plex (AJC). In asthmatic patients there is
evidence of AJC disruption leading to
exposure of underlying dendritic cells and
consequently a greater risk of inflamma-
tory response. Coxsackie and adenoviral
receptor (CAR) is an important component
in these junctional complexes. Its role in
viral infection is well characterised, how-
ever, its physiological role in cell-cell junc-
tion stability and function is poorly
understood.
Method: We have set out to identify
whether CAR influences cell-cell junction
stability in response to inflammatory cyto-
kines. Human bronchial epithelial cells
(HBEC) expressing either CARGFP
(CARGFP) or a CAR specific shRNA
(CARKD) were used to develop an epithe-
lial tissue equivalent organotypic model in
which cells are grown on top of a collagen
gel containing fibroblasts over 10–14 days.
Initial experiments were performed probing
immunoprecipitated CAR with phospho-
tyrosine or phospho-ser/thr antibodies to
detect CAR phosphorylation downstream
of TNF. PKCd expression was silenced
using siRNA and levels of CAR phosphor-
ylation and PKCd were measured using
western blotting. Using a tissue equivalent
epithelial organotypic model allowed us to
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study the effect of CAR expression levels
on epithelial morphology in a physiologi-
cally appropriate environment.
Results: Using this model we have
observed dramatic changes in the structure
of the epithelium in CARKD but not
CARGFP cells. Moreover, biochemical
analysis demonstrates that CAR undergoes
phosphorylation within the cytoplasmic
domain in the presence of TNF alpha in a
manner dependent upon PKCd. We are
developing CAR phospho-specific antibod-
ies to enable us to determine the subcellu-
lar localisation of this modified species of
CAR.
Conclusions: Our data shows that CAR is
phosphorylated downstream of TNF, a
known mediator of inflammation in the
lung. This suggests a possible role for
CAR in the control of epithelial responses
to external inflammatory cues. Future
experiments will be aimed at analysing the
role of phosphorylated CAR in mediating
trans-epithelial-migration of inflammatory
cells, and the presence of phospho-CAR in
tissues of asthma patients.
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Lipopolysaccharide, Der p1 but not Fel d1
induce expression of selected
phospholipases A2 (PLA2s) in peripheral
blood mononuclear cells of asthmatics
Pniewska, E1; Sokolowska, M1,2; Kacprzak, D1;
Pawliczak, R1
1Department of Immunopathology, Medical University
of Lodz, Lodz, Poland; 2Critical Care Medicine, National
Institute of Health (NIH), Bethesda, MD, United States
Background: LPS and allergens affect the
initiation, course and exacerbation of
asthma. They can activate many intracellu-
lar signaling pathways. The phospholipase
A2 superfamily consists of 30 enyzmes
responsible for phospholipid hydrolysis.
The involvement of PLA2s in inflammatory
diseases relates to their enzymatic activity
reflected by their participation in produc-
tion of broad range of lipid inflammatory
mediators and their non-enzymatic proper-
ties focused on regulation of immunocom-
petent cells functions. Secretory and
cytosolic PLA2s are thought to have the
major role in asthma pathogenesis.
Aim: The aim of the study was to investi-
gate the changes in expression level of
selected PLA2s genes (PLA2G2A,
PLA2G4A, PLA2G5, PLA2G6, PLA2G7,
PLA2G10, PLA2G15, PAFAH1B1) in
PBMCs of asthmatics and healthy controls
after stimulation with LPS, recombinant
Der p1 and Fel d1.
Method: Four patients with severe asthma
and four healthy subjects were enrolled to
the study. The asthmatics were randomly
selected from patients treated in the
Department of Internal Medicine, Asthma
and Allergy of Medical University of Lodz.
Peripheral blood mononuclear cells
(PBMCs) (2 9 105) isolated from blood of
asthmatics and healthy subjects were stim-
ulated with rDer p1 (1 lg/ml), rFel d1
(1.25 lg/ml) for 6 days and LPS (100 lg/
ml) for 8 h. The control cells from the
same subjects were incubated in the same
conditions without these factors. After cell
stimulation total RNA was isolated. The
cDNA prepared from 400 ng of RNA was
used with TaqMan Low Density Arrays
(LDA). The changes in expression of 8
PLA2s genes involved in asthma pathogen-
esis were calculated by usage of 2DDCt
method.
Results: Expression of three studied PLA2s
genes (PLA2G4A, PLA2G6, PLA2G15)
were significantly changed in PBMCs after
stimulation with rDer p1 between patients
and healthy subjects. Only PLA2G15 gene
was expressed at significantly different level
after stimulation with LPS. Fel d1 did not
influence the expression of studied PLA2s
genes.
Conclusion: LPS and Derp1 can influence
expression of selected PLA2s genes in
PBMCs of asthmatics in comparison to
healthy volunteers. Der p1 seems to be the
most potent stimulator of PLA2s expres-
sion.
Funded by Polish National Science Cen-
ter grant N N402 516939.
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The alveolar parenchyma is subjected to
a mast cell associated tissue
inflammation and remodeling in patients
with uncontrolled allergic asthma, but
not in controlled asthmatic patients
Andersson, CK1; Weitoft-Lundstr€om, M2; Bergqvist, A1;
Westergren-Thorsson, G2; Bjermer, L1; Erjef€alt, JS2
1Department of Respiratory Medicine & Allergology,
Lund University, Lund, Sweden; 2Department of
Experimental Medical Science, Lund University, Lund,
Sweden
Background: A significant proportion of
patients with allergic asthma have persis-
tent symptoms despite treatment with
inhaled steroids. Little is however known
regarding the peripheral inflammatory
components in asthmatic patients. Our aim
was to study the phenotype of alveolar
mast cells, and the connection to tissue
remodelling and inflammation, in patients
with controlled and uncontrolled asthma
(treated with corresponding inhaled steroid
dose) compared to non-atopic healthy con-
trols.
Methods: Bronchial and transbronchial
biopsies from non-atopic controls (n = 8),
patients with controlled (n = 10) and
uncontrolled (n = 16) asthma were pro-
cessed for immunohistochemical identifica-
tion of mast cell subtypes and expression
of related mediators. Mast cell alteration
in relation to tissue remodelling and Th2
inflammation in peripheral lung was stud-
ied as well.
Results: Changes in mast cell densities
were not observed in the alveolar paren-
chyma in patients with controlled asthma
compared to healthy controls. However, in
the alveolar parenchyma in uncontrolled
asthmatics an increase in densities of both
MCTC (P = 0.05) and MCT (P = 0.003)
compared to controls was found. The
expression of the high affinity IgE receptor
(FceRI) as well as IgE bound to alveolar
mast cells was increased in uncontrolled
asthma compared to healthy controls
(P < 0.001). Changes in peripheral Th2
inflammation was observed in uncontrolled
asthmatics, but not in controlled asthma,
compared to controls. Increased densities
of collagen were observed in the alveolar
parenchyma in patients with uncontrolled
asthma (P = 0.007) but not in controlled
asthmatics (P = 0.7) compared to controls.
The increased number of alveolar MCTC in
the uncontrolled asthmatics was correlated
to the density of collagen in the alveolar
parenchyma (rs = 0.71, P = 0.03).
Conclusions: Our data suggest that steroid
treated uncontrolled atopic asthmatics, but
not patients with controlled asthma, have
an altered mast cell phenotype in the alve-
olar parenchyma. These alterations are clo-
sely connected to alveolar tissue
remodeling and Th2 inflammation. This
reflects an important involvement of mast
cells in development of inflammation in the
alveolar parenchyma in the uncontrolled
asthma response and underscores the need
to target peripheral lung inflammation in
this asthma phenotype.
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Role of exhaled breath temperature in
the monitoring of airways inflammation
in children
Barberi, S1; D’Auria, E1; Poli, P1; Di Vito, M1; Gualdi, C1;
Giovannini, M1
1Department of Pediatrics, San Paolo Hospital,
University of Studies of Milan, Milan, Italy
Background: The aim of the study is to
measure the temperature of the exhaled
breath (EBT) in asthmatic, rhinitic and
healthy children, assessing the potential
correlation between EBT and the individ-
ual’s clinical conditions, and to evaluate
whether the EBT is an effective means of
monitoring patients with uncontrolled
asthma.
Method: Three-hundred subjects have been
enrolled (M: 194; F: 106; 150 asthmatic, 98
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rhinitis and 52 healthy controls; age: 4–
18 years). All children have been visited
and to children’s parents it has been asked
to answer to two questionnaires polarised
on respiratory symptoms, previous thera-
pies and on exposition to tobacco smoke.
Spirometry and Skin Prick Tests were also
performed.
Results: Fifty-two of the 300 individuals
enrolled represented the control group; in
this group average EBT values were lower
(M: 29.71  1.04; F:2 9.42  0.99) com-
pared to the values found both among the
group of rhinitic (M: 31.03  2.09; F:
31.11  2.20) and the group of asthmatic
children (M: 32.55  1.83; F:
32.83  1.89). EBT values were partially
overlapping in asthmatic and rhinitic indi-
viduals but it was possible to highlight a
significant difference between the average
values of the EBT in both categories,
according to the symptoms shown at the
moment of measurement and according to
the symptoms control. In fact, an increase
of such values in the sub-group of asth-
matic was useful to differentiate asthmatic
patients with episodes of moderate-serious
dyspnea in the last period from those
asymptomatic or with mild symptoms,
according to clinical history, clinical exami-
nation and the answers to the survey filled
by parents. Similarly, within the category
of rhinitic individuals, we observed an
increase of values in symptomatic child
(nasal obstruction, rhinitis) at the time of
measurement.
Conclusion: The non-invasive monitoring
of EBT is a valid inflammation marker, in
particular to discriminate, among asth-
matic and rhinitic individuals, those with a
good control compared to those poorly
controlled, and to assess compliance with
the ongoing therapy and the development
of the pathology. EBT could therefore be
useful to monitor asthmatic children: it can
help to evaluate the seriousness of the dis-
ease and the response to treatment, partic-
ularly during the worsening phase of the
disease. However, there are still limits
about reproducibility, variability and sensi-
tivity. Further studies are necessary to
evaluate the importance of measuring the
EBT of each patient in their follow up.
540
Role of gastro esophageal reflux disease
in pulmonary fibroblast differentiation
Chiang, C-C1; Shih, WA1; Cheng, CM1
1Biomedical Science and Environmental Biology,
Kaohsiung Medical University, Kaohsiung, Taiwan
Background: GERD (gastro esophageal
reflux disease) is a reflux disease that gas-
tric content regurgitate into esophagus.
Epidemic studies indicated that micro aspi-
ration of gastric fluid in GERD patients is
associated with the prevalence of chronic
respiratory diseases. Inflammation in the
context of airway residential cells is now
generally recognised to be involved in the
immune modulation. We had previously
demonstrated that gastric fluid acts as an
inflammatory mediator in macrophages
and airway smooth muscle cells. In the
present study, we hypothesised that, in the
context of pulmonary residential cells,
micro aspiration of gastric fluid induces
inflammatory response and initiates the
fibroblast to myofibroblast differentiation.
Method and Results: Factors involved in
fibroblast differentiation were analyzed.
Using human normal bronchial epithelial
cells (NL-20), the inflammatory cytokine
and chemoknine expression were assessed
by a cytokine array analysis. The normal
pulmonary fibroblast cells (HFL-1) was
used to evaluate the fibrotic progression
induced by gastric fluid. Our data showed
that, gastric fluid treatment induced inflam-
matory cytokines and chemokines, such as
eotaxin, IGFBP-1, IGFBP-4, IL-5, IL-6,
MCP-2, MCP-3 and PDGF-BB expression
in pulmonary epithelial cells. Condition
medium collected from pulmonary epithe-
lial cells and macrophage cells induced
migration and a-SMA protein expression
in pulmonary fibroblast cells. By using RT-
PCR and Elisa assay, we also observed
that IL-6, IL-8 and transforming growth
factor-beta (TGF-b) were enhanced in pul-
monary fibroblast cells by gastric fluid and
condition medium treatment.
Conclusion: In summary, our current data
indicated that, gastric fluid alone or the
poor mixture of proinflammatory media-
tors induced by gastric fluid in the venue
of pulmonary context may cause the pul-
monary fibroblast cell inflammation,
migration, differentiation, suggesting that
chronic inflammation induced by gastric
fluid aspiration in pulmonary residential
cells has a causal relationship in the pul-
monary fibroblast differentiation and the
subsequent pulmonary fibrosis.
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Clinical characteristics of the elderly
asthma
Park, H-K1; Cho, EJ1; Lee, SE1; Mok, JH1; Kim, MH1;
Cho, WH1; Lee, K1; Kim, KU1; Jeong, YY2; Jeon, DS1;
Kim, YS1; Lee, MK1
1Internal Medicine, Pusan National University School of
Medicine, Busan, Korea; 2Internal Medicine,
Gyeongsang National University School of Medicine,
Jinju, Korea
Background: The prevalence of asthma has
increased annually, and the number of
elderly asthmatics has increased. It has
been well known that the prevalence of
depression and anxiety is higher in the
asthma patients than general population.
In this study, we evaluated severity of
asthma, comorbidities, degree of asthma
control in the elderly asthma patients. We
also evaluated whether there is any differ-
ence in depression and anxiety depending
on the degree of control of asthma in the
elderly asthma patients.
Method: Total of 280 patients with asthma
who had been treated more than 1 year
was enrolled. The elderly asthma was
defined as being more than 65 years old.
Demographic data, anxiety and depression
scores as well as the level of asthma con-
trol were evaluated. Patient-reported
depressive symptoms, anxiety were evalu-
ated using Beck Depression Inventory
(BDI), the State-Trait Anxiety Inventory
(STAI).
Results: There was no difference in the
severity or degree of control of asthma
between elderly and younger asthma
patients. Hypertension was significantly
more prevalent in elderly asthma patients.
Elderly asthma patients reported more
depressive symptoms than younger asthma
patients and healthy controls (P = 0.013).
Anxiety score was higher in the younger
patients (STAI-X1; P < 0.001, STAI-X2;
P = 0.036). There was no difference
regarding anxiety between elderly asthma
patients and the elderly healthy controls.
Conclusion: The elderly asthma patients
had higher degree of depression than youn-
ger asthma patients. Therefore, it would
improve the prognosis of the disease to
assess and treat depression early in the
elderly asthma patients.
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Remission in adult onset asthma and
contributing factors
Celebi Sozener, Z1; Aydin, O1; Mungan, D1; Misirligil, Z1
1Department of Pulmonary Diseases, Division of
Immunology and Allergy, Ankara University School of
Medicine, Ankara, Turkey
Background: The studies on the natural
history of adult onset asthma and the con-
tributing factors for its prognosis are few
in the literature. The aim of this study is to
review adult onset asthma patients; their
remission status and the contributing fac-
tors.
Method: Files of 168 asthma patients diag-
nosed in 2006 were evaluated. Among
them, 124 were contacted in 2012. The
patients were reviewed according to demo-
graphic data, treatment compliance, PFTs,
clinical symptoms and asthma control test.
Patients who were in complete control of
asthma without any medication for the last
2 year were classified as in remission. Fac-
tors affecting the remission were investi-
gated.
Results: The study group consisted of 124
patients (113F, 11M) were between 22 and
77 years of age. Seventy percent had a his-
tory of astma before 40 years of age.
Atopy ratio was 48%. Non compliance
rate was 23%. Thirteen percent had uncon-
trolled disease, 21% had partial control
and 64% had complete control. Remission
was observed in 8.87% (n:11) of the total
group. Median age was 42 years and the
age of asthma onset was 33 years in
patients with remission. Among this group;
8 had atopy, 7 had family history of
asthma and 7 had allergic rhinitis. They all
had been using inhaled corticosteroids with
a better compliance rate (64%).
Conclusion: According to 5 year follow up
data, the remission rate of asthma was
8.87% in our study group. Patients with
atopy, allergic rhinitis, earyl diagnosis and
good compliance seemed to have higher
chances of remission.
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Gender-specific impact of rhinitis on
eosinophilic airway inflammation in
adults with mild-to-moderate asthma
Imaoka, M1; Kishikawa, R1; Shimoda, T1; Iwanaga, T1
1Department of Internal Medicine, National Hospital
Organisation Fukuoka National Hospital, Fukuoka,
Japan
Background: The majority of patients with
asthma have a history or evidence of rhini-
tis, and rhinitis is associated with increased
asthma severity; potential gender specific
differences in the pathophysiology and
clinical presentation of both asthma and
rhinitis have been shown. The aim of this
study was to investigate the gender-specific
impact of rhinitis on eosinophilic airway
inflammation in steroid-na€ıve adults with
mild-to-moderate asthma.
Method: The subjects comprised 269 Japa-
nese asthmatic adults [100 men and 169
women, median (range) age 53 (20–90)
years, 79% with rhinitis] with mild-to-mod-
erate asthma who were untreated with
glucocorticosteroids and during attack-free
periods. We used the levels of fractional
exhaled nitric oxide (FeNO) as a marker of
eosinophilic airway inflammation. The
FeNO concentration was measured using
the recommended online method. We ret-
rospectively compared the levels of FeNO
between asthmatic patients with and with-
out rhinitis, separately for men and
women.
Results: In 100 men, 85 asthmatic patients
with rhinitis had significantly higher FeNO
levels compared with 15 asthmatic patients
without rhinitis (62.7  75.9 vs
42.4  23.4 ppb, respectively; P = 0.03);
in 169 women, there was no significant dif-
ference in FeNO levels between 128 asth-
matic patients with rhinitis and 41
asthmatic patients without rhinitis
(39.6  35.0 vs 41.7  44.7 ppb, respec-
tively; P = 0.39).
Conclusion: Our results suggest that rhini-
tis significantly increases eosinophilic air-
way inflammation in men but not in
women with mild-to-moderate asthma.
Other inflammatory cells than eosinophils
alone may play a major role in the patho-
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genesis in women with both asthma and
rhinitis.
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The change of the prevalence of asthma
and its association with rhinitis and
smoking in a survey of Japanese adults
Okada, C1; Tanimoto, Y2; Horiguchi, H1; Fushimi, K3
1Department of Medicine of the Headquarter, National
Hospital Organization, Tokyo, Japan; 2Department of
Hematology, Oncology, Allergy and Respiratory
Medicine, Okayama University Graduate School of
Medicine, Okayama, Japan; 3Tokyo Medical and Dental
University, Tokyo, Japan
Background: In Japan, the study about the
prevalence of asthma and its change in
adults was very few, compared to the stud-
ies in children. So, we investigated the
prevalence of asthma in adults and its
change in same area in Japan. And we also
investigate the risk factors which influence
the prevalence of asthma.
Method: The studies were performed in
same area in 2006 and 2011 with same pro-
cess using the ECRHS questionnaire, to
examine the prevalence of asthma. Two
thousand and four hundred people, who
were chosen with randomised procedure
from the citizen of Kurashiki-city (popula-
tion is about 470 thousand) in Japan, were
enrolled to these studies.
Results: The prevalence of asthma in 20–
44 years old adults is 9.1% (male 8.9%,
female 9.3%) in 2006 and 11.4% (male
12.5%, female 10.6%) in 2011. So, the
prevalence of asthma increased in 20–
44 years old adults after 5 years. But the
prevalence of asthma decreased in 20–
85 years old adults from 9.5% to 7.9%.
About the risk factors of asthma, the
result of the multivariate logistic regres-
sion analysis for association of rhinitis
and asthma is OR = 2.03 (P < 0.001), and
smoking and asthma is OR = 2.15
(P < 0.001) using 2006 data. And the
prevalence of current smoker in 20–
85 years old adults widely decreased from
60.9% in 2006 to 46.2% in 2011, in spite
of the prevalence of rhinitis increased
from 35% to 38.3%. These results may
suggest that the decrease of current smok-
ers as a risk factor influence the decrease
of the prevalence of asthma.
Conclusion: The prevalence of asthma in
20–44 years old adults increased after
5 years, 2006 to 2011, but decreased in 20–
85 years old adults. This result may indi-
cate that the prevalence of asthma in
elderly adults decreased. And the fact that
the current smokers decreased in 5 years
may influence this decrease. But, further
examination of other factors, the change of
medication etc. is necessary to confirm this
influence.
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Asthma severity and comorbid
conditions among elderly patients
Wardzyn´ska, A1; Kubsik, B2; Kosinski, S1; Bienkiewicz,
B1; Cieslak, M1; Lewandowska-Polak, A1; Makowska, J1;
Kurowski, M1; Jezdrzejczak-Czechowicz, M1; Smorawska,
E1; _Zarominska, D1; Kowalski, ML1
1Department of Clinical Immunology, Rheumatology
and Allergy, Medical Unversity of Lodz, Lodz, Poland;
2Public Health Care Centre, Gostynin, Poland
Background: The presence of comorbid
conditions may be related to asthma con-
trol and severity, especially in elderly
patients.
Goal: The aim of this study was to evalu-
ate the pattern of comorbidities and its
impact on elderly patients with asthma.
Method: Patients with asthma: 93 elderly
(above 65 years of age) and 78 younger
(30–50 years old) were randomly selected
from a group of 1700 asthmatics at the
University Hospital Asthma Clinic data-
base. Evaluation consisted of the question-
naire, Asthma Control Test (ACT),
spirometry and SPT testing. Asthma con-
trol was assessed based on the ACT and
GINA guidelines, asthma severity defined
using ATS workshop 2000 criteria.
Results: Overall asthma severity and
asthma control (including number of exac-
erbations over last 12 months) were similar
in both groups. Elderly asthmatics had
lower incidence of atopy compared to
younger subjects (35.8% vs 72.3%,
P < 0.001). The average number of diag-
nosed comorbidities was higher in elderly
asthma patients than in younger group (8.4
vs 4.7, P < 0.001). Elderly patients as com-
pared to younger had a higher incidence of
osteoarthritis (64.5% vs 25.6%,
P < 0.001), hypertension (64.5% vs 17.9%,
P < 0.001) and coronary heart disease
(52.7% vs 3.8%, P < 0.001). The average
number of prescribed medicines was higher
in elderly than in control group (7.4 vs 4.5,
P < 0.001). 87.1% of elderly asthmatics
and 44.9% of younger took more than five
medicines simultaneously (P < 0.001).
Prevalence of allergic rhinitis was lower in
elderly asthma patients as compare to
younger (33.3% vs 69.2%, P < 0.001), but
severity of allergic rhinitis (assessed accord-
ing to ARIA 2008 guidelines) in both
groups was comparable. The prevalence of
symptoms related to sinusitis as well as
diagnosis of sinusitis, nonallergic rhinitis
and nasal polyps were similar in elderly
and younger asthmatics. There was no sig-
nificant correlation between the presence of
doctor-diagnosed commorbid conditions
and asthma severity and control in the
older group.
Conclusion: In the elderly patients with
asthma treated by specialists the disease
control and severity may be similar to
younger asthmatics, and are not related to
the presence of comorbidities.
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Ascaris sensitisation is associated with
asthma severity in an urban population
of the tropics
Buendı´a, E1; Zakzuk, J2,3; Mercado, D1,3; Mantilla, A1;
Caraballo, L1,3
1Institute for Immunological Research, University of
Cartagena, Cartagena, Colombia; 2University of
Cartagena, Cartagena, Colombia; 3Fundemeb
Foundation for the Development of Medical and
Biological Sciences, Cartagena, Colombia
Background: Influence of Ascaris on
asthma is not clear. Information about its
role on disease severity is scarce and con-
troversial. We evaluated the influence of
Ascaris infection (ascariasis) and sensitisat-
ion on asthma severity in a group of
patients living in an urban area of the tro-
pics.
Method: Asthmatic patients (n = 312) liv-
ing in the poorest communes of Cartagena,
Colombia were recruited. Informed consent
was obtained. Clinical assessment included
questionnaires, allergy skin testing, spirom-
etry, parasite stool examination and IgE
serology. Asthma was defined according to
the GINA criteria. Total and specific IgE
to the extracts Ascaris, Blomia tropicalis
(Bt) and Dermatophagoides pteronyssinus
(Dp) and to the recombinant allergens Asc
l 3 and Asc s 1 were determined by Immu-
noCap and ELISA, respectively. Relation-
ships among Ascaris sensitisation and
measures of asthma severity (severe dysp-
nea, dyspnea with physical activity, lung
function parameters, nocturnal symptoms,
oral corticosteroid use and asthma exacer-
bations) were assessed by logistic regres-
sion. Age, gender, age of asthma onset and
tabaquism were analyzed as covariates.
HDM sensitisation was also included in
separate models.
Results: Prevalence of ascariasis was 4.1%,
but sensitisation was high, 63.3%. HDM
were frequent sensitisers (Bt, 66.7% and
Dp, 59.8%). No association was found
between infection and any outcome of
asthma severity. Even after adjustment by
HDM sensitisation, Ascaris sensitisation
remained associated with severe dyspnea
[aOR 2.58 95% CI 1.38–4.83; P = 0.003],
>4 emergency room visits in the last year
[aOR 2.15 (1.02–4.57), P = 0.045] and
dyspnea with physical activity [aOR 2.27
(1.20–4.04) P = 0.01]. However, association
with >12% change in FEV1 after bron-
chodilator use disappeared. When assessing
sensitisation to the components Asc s1
(80%) and Asc l 3 (22%), no significant
relationships were found.
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Conclusion: In this population of the tro-
pics with low intensity ascariasis, our
results support that Ascaris sensitisation
increase the risk of asthma severity. Since
most associations remained significant after
adjustment by HDM sensitisation, it seems
that Ascaris IgE response have indepen-
dent effects on this disease. IgE serology to
Asc s 1, led to know that most patients
were in fact exposed to this nematode, but
it was probably insufficient to detect rela-
tionships between the complete antigenic
extract and disease severity.
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Survey of diagnosing asthma symptoms
among medical students
Aliakhnovich, N1
1Clinical Immunology and Allergology, Vitebsk State
Medical University, Vitebsk, Belarus
Background: Bronchial asthma (BA)
affects approximately 300 million people
worldwide (5%), making it one of the most
common chronic diseases in the world. The
actual rate of BA prevalence among the
population of the country may vary from
the official medical statistics. It′s always
been a problem to estimate the number of
people suffering from the disease.
The aim is to survey the frequency and
severity of asthma symptoms among stu-
dents and identify those with high risk of
BA development.
Method: We developed a simple, pre-inter-
view screening questionnaire consisting of
12 questions. Every question has the own
value for its importance as the pathognom-
ic criterion or the severity level of a symp-
tom. Five hundred and twelve students
were enrolled in the study with the help of
the online variant of asthma questionnaire,
placed on the educational site www.
e-vsmu.by from 5/11/2012 to 12/11/2012.
Participants were divided in five subgroups
according to the total score gained.
Twenty-two persons were excluded as they
left some spaces blank.
Results: Four hundred and ninety persons
include 386 female (79%) and 104 male
students (21%), junior students (91%)
showed the greatest activity.
Four hundred and thirty-three (88.6%)
participants regarding the total score were
included into the first subgroup (0–3
points), i.e. they had no signs of BA.
Three persons (0.6%) entered the fourth
(19–23 points) and the fifth (24–30 points)
subgroups, having the maximum score and
therefore showing the obvious signs of the
disease.
Fifty-three persons (10.8%) entered the
second (26) and third (27) subgroups were
likely to have BA, their answers were
analyzed thoroughly. The data obtained
specified that 27 of them (51%) required
additional allergic survey; 7 (13.2%) need
the therapeutic consultation.
Conclusion: It is established that 5.5% of
responders had high risk of asthma devel-
opment or had signs of mild BA and
required additional allergic inspection;
1.4% – therapeutic survey for the suspicion
of nonspecific obstructive disease of lungs.
Regarding the level of risk group estab-
lished asthma specialists should be aware
of the great potential of questionnaires as
a method of diagnosing asthma on its early
stages
The data obtained from 300 participants
are similar to those obtained from the fur-
ther study of 500 participants. The results
are believed to be relevant for larger
groups of population and therefore the
questionnaire developed can be used as an
effective method of identifying asthma.
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House dust mite sensitisation is the main
risk factor for the increase in prevalence
of wheeze in 13–14 year old
schoolchildren in Guangzhou city, China
Li, J1; Wang, H1; Chen, Y2; Zheng, J1; Wong, GW3;
Zhong, N1
1Allergy and Clinial Immunology, The First Affiliated
Hospital of Guangzhou Medical College, Guangzhou,
China; 2Guangdong Pharmaceutical University,
Guangzhou, China; 3Paediatrics, The Chinese University
of Hong Kong, Hong Kong, China
Background: Little is known about time
trend of prevalence of asthma and the
association of its change with allergen sen-
sitisation in schoolchildren in China. The
purpose of this study was to determine the
changes in prevalence of asthma and aller-
gen sensitisation in schoolchildren in a per-
iod of over 15 years.
Method: A total of 6928 schoolchildren
aged 13–14 years in 2009 were recruited for
the study using the Phase III Protocol of the
International Study of Asthma and Allergic
disease in Childhood (ISAAC) and 2531 of
them underwent skin prick test for seven
common aeroallergens. The results were
compared with those obtained in the Phase I
(1994/95) and III (2001/02) ISAAC studies.
Results: The prevalence of asthma ever
and current wheeze increased from 3.9%
and 3.4% in 1994, to 4.6% and 4.8% in
2001 (P < 0.001), and to 6.9% and 6.1%
in 2009 (P ≤ 0.008). The prevalence of
higher degree of skin response to house
dust mites (HDMs) and cat, and atopic
index increased significantly in all children
in 2010 when compared with that in 2002
(P < 0.001). Prevalence of wheeze
remained unchanged in subjects without
sensitisation to any tested allergen includ-
ing HDMs (P > 0.05). Sensitisation to
HDMs, especially Dermatophagoides Pter-
onyssinus (Der-p) was associated with
increase in prevalence of wheeze.
Conclusion: The prevalence of wheeze and
sensitisation to common aeroallergens in
secondary schoolchildren in Guangzhou
China has remarkably increased since
1994. Sensitisation to HDMs, Der-p in
particular is an important risk factor for
the increase in prevalence of wheeze in this
group of population in Guangzhou city.
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Gender difference of asthma and its
comorbidities incidences – a 5-year
population survey
Yeh, K-W1; Yu, C-H2; Chan, P-C1; Horng, J-T2; Huang,
J-L1
1Division of Pediatric Allergy Asthma and
Rheumatology, Department of Pediatrics, Chang Gung
Memorial Hospital, Taoyuan, Taiwan; 2Department of
Computer Science and Information Engineering,
National Central University, Taoyuan, Taiwan
Background: The comorbidities of asthma
are not uncommon, and they would make
asthma hard to be controlled without con-
comitant management. The aim of this study
was to investigate the incidence of asthma
and its comorbid conditions of sleep apnea,
gastroesophageal reflux (GER), obesity,
sinusitis, bronchiectasis, chronic obstructive
pulmonary disease (COPD), and vocal cord
dysfunction (VCD) during 5 years period.
Method: This study was based on continu-
ous data from the Taiwanese National
Health Insurance Research Database which
contained 98% of registry files of all
22.60 million populations. Asthma was
selected with code 493.xx of the Interna-
tional Classification of Disease, 9th Revi-
sion, and Clinical Modification. Asthma
case was defined as the first-rank diagnosis
occurred more than three times within
6 months. A total 739 027 newly diagnosed
asthma patients (388 596 in male, 350 431
in female) and 22 822, 663 (11 574 319 in
male and 11 248 344 in female) non-
asthma populations during 2003 to 2008
were analysed. Each disease was defined
with corresponding ICD-9 code.
Results: Generally, asthma patients
encountered more bronchiectasis (OR 4.28,
P < 0.001), sleep apnea (OR 1.57,
P < 0.001), GER (OR 1.57, P < 0.001)
COPD (OR 4.01, P < 0.001), sinusitis (OR
2.11, P < 0.001) than non-asthma popula-
tions but not the case of obesity (OR 1.00,
P = 0.88). However, VCD was less com-
mon in asthma patients (OR 0.81,
P < 0.001). The most common comorbidity
of asthma was COPD in both genders; and
it was significant that male asthmatic
patients had higher incidence of COPD
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(12.7%) than females (7.19%, OD 1.88
P < 0.001). Although the incidence rates of
sinusitis were close (6.44% in males and
6.24% in females), it was more common in
male asthmatic patients. The incidence of
bronchiectasis was 3.33% in female
patients and 2.57% in males. Female
patients also had 1.3 and 2-fold of risk to
have VCD and obesity respectively than
males. The incidence of sleep apnea were
only 0.28% in males and 0.15% in females,
but it was significantly common in male
asthmatic patients (OR 1.93, P < 0.001).
Conclusion: Comorbid conditions were
common in asthma patients. Those sleep
apnea, sinusitis, and COPD were signifi-
cant in male patients. Female patients pre-
sented more common in GER,
Bronchiectasis, obesity and VCD.
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Levels of serum 25-OH vitamin D in low
income asthmatic children living in the
Colombian Caribbean area
Garavito, G1; Egea, G1; Dennys, R2; Visbal, L1; Leco-
mpte, N1; Navarro, E1; Bacerril, M3; Escamilla, JM4;
Sachez-Borges, M5; Egea, E1; Grupo de Investigacion
en Inmunologia y Biologıa Molecular
1Universidad del Norte, Barranquilla, Colombia;
2Fundacion Cardio Infantil, Bogota, Colombia; 3Centro
Medico La Raza, Mexico, Mexico; 4Universidad de
Cartagena, Cartagena, Colombia; 5Universidad Central
de Venezuela, Caracas, Venezuela
Background: Vitamin-D deficiency has been
described as a marker of astma severity in
children. To date there are no studies
searching level of ViTD in asthmatic colom-
bian children and little is known about the
relationship between vitamin-D and asthma
severity in pediatric asthma living in poor
and marginalized communities in Latin
America. The purpose of this study was to
determine the levels of vitamin-D and total
IgE in asthmatic pediatric patients with
asthma living in Barranquilla, a city of the
Colombian Caribbean area and associate
with the severity of the diseases.
Method: This was a case-control study.
Samples from 64 Asthmatic children, and
127 healthy controls, aged between 5 and
11 years, were enrrolled. Clinical variables
paraclinical results were recorded in a
modified questionnaire from ISAAC-2009.
The clinical diagnosis was made according
to the parameters described by GINA-
2009. Serum vitamin-D and total IgE con-
centrations were determined by ELISA.
The association between vitamin-D levels,
total IgE-levels, socioeconomic status, clin-
ical onset and severity of asthma was made
for differences in variance.
Results: The mean serum levels of vita-
min-D for the group of patients was
66.12 ng/ml. For the control group was
68.50 ng/ml. Only two patients and con-
trols had insufficient vitamin D levels
(<30 ng/ml). None of the subjets was VitD
deficient. Total IgE in patients was ele-
vated in 26 of 64 (40.1%), 36/127 controls
had elevated total IgE (28.3%). No signifi-
cant differences were found between VitD
levels in patients and controls (ANOVA
P = 0.220). Nor between total IgE levels
and VitD (ANOVA P = 0.087). Compar-
ing VitD against the socioeconomic, clini-
cal onset and severity of asthma, we found
no differences in these variables (ANOVA
P = 0.8244, P = 0.993 and P = 0.265,
respectively).
Conclusion: These preliminary results
seems to show that in asthmatic children
living in marginal and poor areas in the
colombian caribbean area have not hypovi-
taminosis-D. There was also no association
between vitamin-D levels and the severity
of asthma.
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Modelling and predicting trends in
childhood asthma hospital readmission
over time
Vicendese, DA1; Olenko, A2; Dharmage, SC3; Allen, KJ4;
Tang, ML4; Abramson, MJ5; Erbas, B1
1School of Public Health, La Trobe University,
Bundoora, Vic., Australia; 2Department of Mathematics
and Statistics, La Trobe University, Bundoora, Vic.,
Australia; 3School of Population Health, The University
of Melbourne, Carlton, Vic., Australia; 4Department of
Allergy & Immunology, Royal Children’s Hospital,
Parkville, Vic., Australia; 5Department of Epidemiology
& Preventive Medicine, Monash University, Melbourne,
Vic., Australia
Background: Little is known about child-
hood asthma re-admissions over time. Sea-
sonality is an important marker of total
environmental load or triggers such as high
pollen and pollution exposure and respira-
tory virus infections. Being aware of the
days/times of the year when childhood
asthma readmissions are expected to
increase may assist in the achievement of
better and more efficient health service
planning. Our objective was to model and
predict daily trends of childhood asthma
readmissions over time in Victoria, Austra-
lia and ascertain whether these trends var-
ied by age and gender.
Method: We used a large database of
75 000 childhood asthma admissions from
the Department of Health Victoria, Aus-
tralia between 1997 and 2009. Daily counts
of asthma hospital readmissions over time
were modelled using a semi parametric
Generalised Additive Model (GAM)
method and by sex and age group. We also
predicted daily readmissions using these
models.
Results: N = 2401 asthma readmissions
within 28 days occurred between fiscal
years of 1997 and 2009. Of these, n = 1358
(57%) were boys. Boys displayed greater
variability between season and age group,
P = 0.001. Autumn, tended to have a
greater risk of readmission for two groups:
6–12 year girls – borderline significant,
OR = 1.51, 95% CI 0.98–2.33, P = 0.06;
and 13–18 year boys OR 1.61, 95% CI
1.01–2.59, P = 0.047. Spring showed a dis-
proportionate risk only for 6–12 year boys
OR = 1.59, 95% CI 1.08–2.36, P = 0.02.
Readmissions during the grass pollen season
in Victoria were associated with all age
groups in boys, P = 0.01. The smooth
function of time was also significant,
P < 0.0005, and indicated that, after initial
declining readmission counts to about 2001,
they subsequently began to increase return-
ing to roughly initial levels at study end.
Predictions suggested readmissions would
continue to increase by up to 5% on aver-
age overall, with boys in the 2–5 year age
group experiencing the largest increase.
Conclusion: The strong seasonal compo-
nent in readmissions suggest that: clinical
services may need to revise procedures and
be alert to possible greater risk of readmis-
sion at certain times of the year, especially
for younger age groups; health services
management may need to adjust resource
allocation and planning.
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Nasopharyngeal bacterial colonization in
asthmatic children and healthy controls
Roumpedaki, E1; Xepapadaki, P1; Doudoulakakis, A2;
Lebessi, E2; Passioti, M1; Skevaki, C1; Taprantzi, P3;
Tsakanikos, M4; Tsolia, M3; Dutre, T5; Bachert, C5;
Lindholm, L6; Lukkarinen, H7,8; Jartti, T8; Albert, F9;
Graser, A10; Geißd€orfer, W9; Bogdan, C9; Zimmermann,
T11; Finotto, S10; Sobanska, A12; Kowalski, ML12;
Papadopoulos, NG1
12nd Pediatric Clinic, Allergy Department, National and
Kapodistrian University, Goudi, Athens, Greece;
2Department of Microbiology, P & A Kyriakou
Children’s Hospital, Athens, Greece; 32nd Pediatric
Clinic, National and Kapodistrian University, Goudi,
Athens, Greece; 4ENT Department, P & A Kyriakou
Children’s Hospital, Athens, Greece; 5Upper Airway
Research Laboratory (UGENT), Ghent University
Hospital, Ghent, Belgium; 6Department of Medical
Microbiology and Immunology, University of Turku,
Turku, Finland; 7Turku University Hospital, The
Research Centre of Applied and Preventive
Cardiovascular Medicine (CAPC), Turku, Finland;
8Department of Pediatrics, University of Turku, Turku,
Finland; 9Friedrich-Alexander Universit€at Erlangen-
N€urnberg, Microbiology Institute – Clinical
Microbiology, Immunology and Hygiene, Erlangen,
Germany; 10Friedrich-Alexander Universit€at Erlangen-
N€urnberg, Molecular Pneumology Institute
Universitaetsklinikum, Erlagen, Germany; 11The
Children’s Hospital in Erlangen, Allergy and
Pneumonology Department, Erlangen, Germany;
12Department of Immunology, Rheumatology and
Allergy, Faculty of Medicine, Central University
Hospital, Medical University, Lodg, Poland
Background: PreDicta (Post-Infectious
Immune Reprogramming and its associa-
tion with Persistence and Chronicity of
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Respiratory Allergic diseases), is an EU
FP7 funded project investigating the influ-
ence of viral and bacterial respiratory
infections on the persistence of asthma and
their correlation with underlying immune
responses. Part of this project involves a
2 year multi-centre childhood cohort study
across major cultural and climatic Euro-
pean regions, namely Athens (Greece),
Ghent (Belgium), Turku (Finland), Erlagen
(Germany) and Lodz (Poland). The aim of
the present study is to compare nasopha-
ryngeal bacterial colonization between
asthmatic children and healthy controls.
Method: To date, 131 cases with mild-
moderate persistent asthma (as per GINA)
aged 4–6 years old and 35 healthy controls,
matched per age, defined as children hav-
ing no history of asthma, wheeze and/or
atopic illness have been recruited. As part
of the baseline assessment, a nasopharyn-
geal swab was obtained (ESwab 482CE,
Copan, Italia), in the absence of an appar-
ent infection. Standard microbiology
procedures for the identification of Strepto-
coccus pneumoniae, Moraxella catarrhalis,
Haemophilus influenzae, Staphylococcus
aureus and Streptococcus pyogenes (Group
A strep) followed thereafter. Statistical
analysis was performed with the Graph-
Pad Prism5 software.
Results: One or more of five culprit bacte-
ria was isolated in 62% of cases and 75%
of controls. In 43.5% of asthmatic children
and 58.3% of controls only one of the five
indicator bacteria studied was identified, in
14.5% of asthmatic children and 16.7% of
controls two of these facultative respira-
tory pathogens were isolated, whereas in
4% of cases and none from the healthy
controls 3 or more bacteria were isolated.
37, 9% of cases and 25% of controls were
negative for all 5 culprit bacteria. Haemo-
philus influenzae was identified in 23.7% of
asthmatic children and 31.4% of controls,
Staphylococcus aureus in 26.7% of asth-
matic children and 17.1% of controls,
Moraxella catarrhalis in 18.3% of asth-
matic children and 20% of controls, Strep-
tococcus pyogenes in 0.8% of cases and
5.7% of healthy control, while Streptococ-
cus pneumoniae was isolated from 14.5%
of asthmatic children and 11.4% of healthy
controls. Differences between case and
control children were not statistically sig-
nificant.
Conclusion: In this population, bacterial
colonization at baseline is as frequent in
asthmatic children as in healthy controls.
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Risk factors for asthma in children with
history of respiratory syncytial virus and
rhino virus infections
Kartasasmita, CB1; Saptaputra, W2; Mutyara, K2;
Setiabudhiawan, B1
1Child Health, Universitas Padjadjaran, Bandung,
Indonesia; 2Research Unit, Universitas Padjadjaran,
Bandung, Indonesia
Background: Many respiratory viruses can
provoke acute asthma symptoms. Respira-
tory syncytial virus (RSV) and rhino virus
(RV) infections are associated with asthma
development. Recently, studies showed that
early RV infections are the important pre-
dictors for developing asthma in high risk
children. The aim of this study is to deter-
mine the risk factors of developing asthma
in children with history of RSV, RV and
RSV+RV infections.
Method: Interview on the health condition,
demography, history of atopy and asthma
in children and family, were obtained,
using structured questionnaires. A skin
prick testing (SPT) were performed accord-
ing to the method of the Australasian Soci-
ety of Clinical Immunology and Allergy
Inc (ASCIA). The allergens were obtained
from Statallergenes, Antony, France. The
skin prick testing was performed to 12
common standardised allergens: Blomia-
tropicalis, Dermatophagoides farinae, Der-
matophagoides pteronyssinus, Alternaria
alternata, Aspergillus mix, Cockcroach,
Egg white, Egg yolk, Chocolate, Cat dan-
der, Shrimp and Soya. Histamine was used
as a positive control and saline as negative
control. Skin prick test were read 15 min
after placement and are considered positive
when the induration diameter ≥3 mm than
the negative control of at least one aller-
gen.
Results: A total 86 children with history of
viral respiratory infections (35 RSV, 25
RV, 16 RSV+RV), and 246 control were
enrolled. Atopy was found in 60% RSV,
92% RV, 43.8% RSV+RV, and 75.2%
control respectfully. History of atopy
among children with RSV is 34.3%, RV
28%, RSV+RV 18.8% and control 28.9%.
Asthma, based on ‘history of wheezing in
the last 12 months’ was found in 17.1%
RSV, 8% RV, 6.3% RSV+RV, and 4.5%
control group respectfully. The number of
asthma was significantly higher in the RSV
group compared to control group
(P = 0.01), but not in the RV (P = 0.341)
and RSV+RV groups (P = 0.538). The risk
factors were low mother education
(P = 0.01), no home ventilation (P = 0.04),
smoking in the living room, and no venti-
lation (P = 0.02).
Conclusion: More atopy is found in RV
group, asthma is high in RSV group. The
risk factors for asthma are low mother
education, no home ventilation, smoking
in the living room, and no ventilation.
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Trends in asthma: dispensing of
medications, hospitalisations and
mortality from 1998 to 2011 in a Brazilian
city
Mello, LM1; Silva, AS1; Martinez, EZ1; Barros, CGC1;
Ferreira, JBB1; Vassimon, C2; Nunes, AA1
1Department of Social Medicine, Medical School of
Ribeir~ao Preto, University of S~ao Paulo, Ribeir~ao Preto,
Brazil; 2Municipality Health Department, Ribeir~ao Preto,
Brazil
Background: Several studies have linked
the poor control of asthma to lack of
proper treatment and situations that hinder
the uninterrupted access to the medication
are among the reasons of this inappropri-
ate control. Our purpose was to assess the
availability and consumption of medica-
tions for asthma, the hospitalisations and
mortality for asthma between December
1998 and December 2011, at the Public
Health System of a city in the Southeastern
of Brazil.
Method: A time series description of the
annual consumption of the aminophylline
(tablets), salbutamol sulfate (tablets and
oral solution), salbutamol (albuterol) spray
and beclomethasone dipropionate spray
was conducted from the records of the
Health Information System of the Health
Department of the city. The data about
hospitalisations and mortality for asthma
were obtained from the DATASUS records
(Ministry of Health, Brazil).
Results: Aminophylline (3100 tablets con-
sumed in 1998; 768 199 tablets consumed
in 2007 and 90 714 tablets in 2011) and
salbutamol sulfate (1159 tablets consumed
in 1998; 257 022 tablets consumed in 2007
and 90 714 tablets consumed in 2011; 102
vials consumed in 1998; 16 440 vials con-
sumed in 2004 and 6476 vials consumed
in 2011) have been available for treating
asthma in our country for several years
but their dispensing/consumption showed
a clear decrease. The salbutamol spray
and beclomethasone dipropionate spray
was made available to the users of the
public health system from 2004 what pos-
sibly explains the growing consumption of
this date (58 and 201 units consumed in
2005 to 13 310 and 9194 respectively in
2011). The number of hospitalisations for
asthma presented a decrease of 88% in
this period: from 682 admissions in 1998
to 81 admissions in 2012. Data suggests
that asthma mortality remained variable
but it outlined a downward trend. It was
observed 9 deaths in 1996, 5 in 1997, 7 in
1998, 8 in 1999, 12 in 2000, 6 in 2001, 6
in 2002, 10 in 2003, 3 in 2004, 5 in 2005,
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10 in 2006, 2 in 2007, 2 in 2008, 5 in
2009 and 7 in 2010.
Conclusion: The points of change in the
time series description of the dispensing/
consumption of the medications for asthma
and the decreasing trends of the indicators
on hospitalisations and mortality for
asthma probably reflect, among other fac-
tors, the public policies implemented in
past years that aim to ensure the provision
of first line medications and pharmaceuti-
cal care on asthma as well as the improve-
ment of the clinical practice on asthma.
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Patterns of adherence to asthma
medication among asthmatics with acute
exacerbations following up in a tertially
allergy institution in Kuwait
Al-Ahmad, M1; Arifhodzic, N2; Radha, P1
1Allergy Department, Al-Rashed Allergy Center, Kuwait,
Kuwait; 2Al-Rashed Allergy Center, Kuwait, Kuwait
Background: Asthma Exacerbation
remains a leading cause of asthma morbid-
ity. It is usually an indication of poor
asthma control, frequently related to non-
adherence to medical therapy.
Method: Adherence to the prescribed med-
ication was assessed in 1244 randomly
selected adult asthmatics with acute excer-
bation, being followed up in a tertially
allergy institute. Patients age 15 years and
above, both sex, with a physician diagnosis
of allergic or non-allergic asthma, on
established regular anti-inflamatory treat-
ment to maintain good asthma control,
were included. Compliance to the medica-
tion in different age groups (15–40, 41–60,
>60 years old), and among different
asthma severity grades, based on clinical
score, ER visits, and FEV1 values in the
previous year from patient′s records, were
compared.
Results: Allergic asthma was the most
common type of asthma phenotype in our
group of patients (72.9% vs 27.1%;
P < 0.0001). There was no gender differ-
ence (70.3% male vs 75.1% female;
P < 0.06). No difference has been found in
the type of sensitisation to inhalant aller-
gens between citizens and expatriates
(73.7% vs 71.2%; P < 0.35). Majority of
the patients had mild or moderate asthma
(34.6% &41.2%), while only 3.9% had
severe form. Adherence to asthma medica-
tion was in general very poor, but was sig-
nificantly more present in young age group
when compared with elderly (33.1% vs
47.1%; P < 0.001). Adherence was better
in citizens than in expatriates (42.9% vs
30.6%; P < 0.001). With regard to asthma
severity, patients with mild as well as
severe form of asthma, had the poorest
compliance (34.6% & 55.1%).
Conclusion: Non-adherence to asthma
medication is an important factor for poor
asthma control, not only in mild, but also
in more severe cases. Permanent education
to increase awareness is the cornerstone of
better asthma control.
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Inhibitory effects of staphylococcal
enterotoxin type A (SEA) and B (SEB) on
mice bone marrow eosinophil adhesion
in vitro
Ferreira-Duarte, AP1; Squebola-Cola, D2; Mello, G2; An-
tunes, E2; DeSouza, I1
1Biology and Physiology, Faculty of Medicine of
Jundiaı, Jundiaı, Brazil; 2Faculty of Medical Sciences –
State University of Campinas (UNICAMP),
Pharmacology, Campinas, Brazil
Background: Clinical evidences have
shown a strong correlation between SEA
and SEB on bronchial asthma exacerba-
tion. We have described that SEA and
SEB mice airways exposition aggravate the
pulmonary allergic inflammation by exacer-
bation of lung eosinophils (EO) infiltration
and increased bone marrow (BM) eosino-
poeisis. In the present study we evaluated
the influence of mice pulmonary SEA or
SEB exposition on BM EO in vitro adhe-
sion induced by eotaxin. Effect of the incu-
bation of BM EO from na€ıve animals with
SEA and SEB on in vitro adhesion induced
by eotaxin and RANTES was also evalu-
ated.
Method: BALB/C mice femurs were
removed after killing, flushing with 2.5 ml
of Iscove′s medium and submitted to gran-
ulocyte isolation protocol. The superna-
tants were collected, centrifuged (500 g for
10 min at 4°C), and the cell pellets resus-
pended to 4 9 106 cells/ml. Adhesion
assays were carried out in 96-well plates
pre-coated with recombinant mouse
VCAM-1 and ICAM-1 (2.5 lg/ml) for
30 min in the presence of eotaxin or RAN-
TES. The EO adhesion was calculated by
measuring EO peroxidase activity on
adherent cells.
Results: Mice airways exposition to SEA
for 48 h reduced the adhesive response of
BM EO in ICAM-1 coated plates (eotaxin/
untreated mice BM EO: 12.7  2.5; eo-
taxin/SEA treated mice BM EO: 8.0  0.1
OD/EOS9106 cells). Similar results were
observed with BM EO from SEB-treated
mice for 16 h (eotaxin/untreated mice BM
EO: 15.7  2.7; eotaxin/SEB treated mice
BM EO: 9.5  1.2 OD/EOS9106 cells).
BM EO from na€ıve mice incubated in vitro
with SEA or SEB for 2 h also exhibited
reduced adhesive response when stimulated
by eotaxin or RANTES (eotaxin/VCAM-1:
20.5  2.5; SEA: 12.3  1.0; SEB:
13.2  1.2; RANTES/VCAM-1:
10.7  0.8; SEA: 2.6  0.8; SEB:
5.2  0.6; eotaxin/ICAM-1: 14.0  1.3;
SEA: 10.2  0.9; SEB: 10.7  1.5; RAN-
TES/ICAM-1:11.9  1.1; SEA: 6.6  0.5;
SEB: 6.1  1.0 OD/EOS9 106 cells).
Conclusion: The inhibitory effect of SEA
and SEB on BM EO in vitro adhesion sug-
gests a role of these toxins on downregula-
tion of BM EO surface adhesion molecules
which contribute to clarify the mechanisms
involved on the association between Staph-
ylococcus aureus infections and allergic
respiratory disease.
Financial support: Fundac~ao de Amparo a
Pesquisa do Estado de S~ao Paulo (2009/
16522–0; 2012/05561–8).
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SEC14L3 is de-regulated in murine
experimental asthma via miRNA-
mediated down-regulation of CREB
Bartel, S1; Schulz, N1; Theis, F2; Alessandrini, F3; Take-
naka, S1; Eickelberg, O1; Krauss-Etschmann, S1
1Helmholtz Zentrum M€unchen, Comprehensive
Pneumology Center, University of Munich, Member of
the German Center for Lung Research, M€unchen,
Germany; 2Department of Genome Oriented
Bioinformatics, Helmholtz Zentrum M€unchen,
M€unchen, Germany; 3Helmholtz Zentrum M€unchen,
ZAUM-Center for Allergy and Environment, M€unchen,
Germany
Background: MicroRNAs are small non-
coding RNAs essential for immune func-
tion and lung development. Previously, we
found increased pulmonary expression of
miR-17, -144, -21 &-205 in ova-induced
asthma, which correlated with decreased
mRNA & protein levels of putative target
genes CREB1 and its co-activators CRTC
1&3. Here, we hypothesised that these
miRNAs regulate CREB/CRTC-mediated
gene transcription and sought to elucidate
this interdependency in vitro and identify
new CREB-dependent target genes relevant
for asthma.
Methods: To substantiate the miRNA-
mediated regulation of CREB and CRTCs,
miRNAs were overexpressed (precursor
miRNAS) or inhibited (antimiRs) in mur-
ine (MLE-12) or human bronchial epithe-
lial cells (16-HBE). Analysis was
performed by RT-qPCR & Western blot-
ting. Putative CREB1 targets relevant for
asthma were selected if decreased in lungs
of mice with ova-induced asthma and by
presence of CRE elements in their pro-
moter region. Periodic acid schiff (PAS)
stain and SEC14L3 immunostaining was
performed.
Results: The mRNA and protein level of
CREB & CRTCs were mediated by in vitro
overexpression and silencing of the respec-
tive miRNAs. Among the 35 candidate
CREB1 targets, we chose SEC14L3, a
transporter for hydrophobic ligands, for
further analysis. Its mRNA expression
could be modulated in vitro by miRNA
silencing in a CREB1-dependent manner.
Immunostainings of lung sections showed
specific SEC14L3 expression in ciliated air-
way epithelial cells, which was decreased in
asthmatic mice. This coincided with goblet
cell metaplasia and loss of epithelial integ-
rity.
Conclusion: Using miRNA profiles as pre-
selection tools, we identified SEC14L3 as
new target that might be useful for moni-
toring the integrity of the respiratory epi-
thelium in experimental asthma.
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A novel nDer p2-conjugated TLR7 down-
modulates Th2-associated lung
inflammation by using a therapeutical
protocol
Pratesi, S1; Nencini, F1; Petroni, G1; Cardilicchia, E1; Filı,
L1; Casini, A1; Guarna, A1; Romagnani, S1; Parronchi,
P1; Maggi, E1; Vultaggio, A1
1University of Florence, Florence, Italy
Background: Modified adenine (MA) bind-
ing TLR7 represent a new group of adju-
vants for immunotherapy. We investigated
the in vitro and in vivo effects of a synthetic
MA [4-(6-amino-9-benzil-8-idrossi-9H-pu-
rin-2-ilsulfanil) butirrico 2,5-diossopirroli-
din-1-il estere] called SA26E, chemically
conjugated to purified allergen (nDer p2).
In particular we analyzed the modulation
of Th2-mediated immune response in a
murine model of lung inflammation
through a therapeutical protocol.
Methods: C57Bl/6 mice were intraperito-
neal (i.p.) immunised with nDer p2 at d0
and d7. At d14 mice were intratracheally
challenged with nDer p2, while at d21 and
d28 mice were i.p. treated with an adminis-
tration of nDer p2-conjugate or nDer p2
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alone as control. At d49 and d53 mice
were again challenged with nDer p2 and
then sacrified at d56 for the analysis.
Results: SA26E stably conjugated to aller-
gen, maintained the ability to trigger
HEK293 cell line transfected with murine
TLR7. Moreover, it downregulated eosin-
ophils in bronchoalveolar lavage of mice
treated with nDer p2-SA26E conjugated
but not with nDer p2 alone. This effect
was associated with a shift in the antibody
profile from a type 2- (IgE and IgG1) to a
type 1-associated (IgG2a) humoral
response. A reduction of IL-13 and a par-
allel increase of IFN-c was observed in the
supernatants of lung mononuclear cells in
vitro stimulated with antigen. A concomi-
tant significant increase of IL-10 levels was
also found in the supernatants of nDer p2-
stimulated cells of spleen and draining
lymph nodes.
Conclusion: These data suggest that the
use of nDer p2-SA26E conjugated regu-
lates and redirects the immune response in
a therapeutical fashion and may constitute
an useful approach for immunotherapy of
allergic diseases.
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A novel mouse model for house dust
mite driven allergic asthma
Canbaz, D1; Logiantara, A1; van Ree, R1; van Rijt, LS1
1Academic Medical Center, Experimental Immunology,
Amsterdam, The Netherlands
Background: House dust mite (HDM)
allergens are a major cause of asthma
worldwide, by provoking an aberrant
immune response. Allergic asthma is a Th2
cell mediated disease. The airway epithe-
lium is considered to be essential for sensi-
tisation to HDM. HDM can trigger Toll
like receptor 4 on epithelial cells and
thereby activate dendritic cells (DCs).
These activated DCs migrate to lung drain-
ing lymph nodes to induce the polarisation
of Th2 cells in allergic asthma. We hypoth-
esised that mice could be sensitised by in-
tratracheal instillation of in vitro HDM
pulsed DCs without the mucosal exposure
to HDM.
Method: DCs were cultured from bone
marrow and were pulsed overnight with
100 lg/ml HDM. DCs were thoroughly
washed to remove residual HDM. Cyto-
kine production and phenotype of the DCs
were detected by ELISA and FACS,
respectively. Next, HDM-DCs or unpulsed
DCs were administered intratracheally in
Balb/c mice to induce sensitisation to
HDM. After 10 days, mice were challenged
with HDM intranasally. Two days later,
airway hyperreactivity (AHR) to metacho-
line was measured. One day later, eosino-
phil recruitment to the bronchoalveolar
space, Th2 cytokine production by lung
draining lymph nodes, HDM specific IgE/
IgG1 ratio in serum and airway histology
by PAS staining in lung slides were ana-
lyzed.
Results: DCs pulsed with HDM showed a
significant increase in IL-6 and IL-10 cyto-
kine production and upregulation of CD80
and CD86 co-stimulatory factors compared
with unpulsed DCs. We observed a trend
for an enhanced AHR to metacholine in
mice sensitised with HDM pulsed DCs
compared with control mice. In concor-
dance, eosinophil levels in the bronchoalve-
olar space and Th2 cell cytokines like IL-4,
IL-5 and IL-13 were increased. Airway his-
tology showed a significant increase in
eosinophilic inflammatory infiltrates and
mucus production. We did not observe a
significant difference in the serum HDM
specific IgE and IgG1 compared with the
control.
Conclusion: These results suggest that
HDM pulsed DCs are sufficient to induce
an eosinophilic airway inflammation in
response to HDM. This model can be used
to investigate how dendritic cells control
the HDM driven immune response.
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Influence of VEGF and TNF antagonism
on zonula occludens proteins in an
experimental asthma model
Yuksel, H1; Yilmaz, O1; Karaman, M2; Firinci, F3; Turkeli,
A1; Toprak Kanik, E1; Inan, S4
1Pediatric Allergy and Pulmonology, Celal Bayar
University, Manisa, Turkey; 2Multidisciplinary
Laboratory, Dokuz Eylul University Faculty of Medicine,
Izmir, Turkey; 3Pediatric Allergy and Immunology,
Dokuz Eylul University, Izmir, Turkey; 4Histology and
Embryology, Celal Bayar University, Manisa, Turkey
Background: Epithelial barrier dysfunction
is important in asthma and allergic
response pathogenesis. Therefore, it is a
new therapeutic target candidate. We
aimed to investigate influence of dexameth-
asone as classical therapeutic agent, anti-
TNF (etanercept) that is used in difficult
asthma and anti-VEGF (bevacizumab) that
is an angiogenesis inhibitor, on zonula oc-
cludens proteins in experimental asthma
model.
Methods: We developed experimental
asthma model using intraperioteal (IP) and
inhaled ovalbumin in 32 BALB/c mice
investigated in four groups. Each group
received either IP saline, IP etanercet, IP
bevacizumab or IP dexamethasone. Occlu-
din, claudin and junctional adhesion mole-
cule (JAM) were stained in left middle lobe
samples immunohistochemically with indi-
rect avidin-peroxidase method and semi-
quantified with H-score.
Results: We observed a significant differ-
ence of occluding, claudin and JAM H-
score between the four groups (P < 0.001).
Median H-scores were 93, 177, 280 and
198 for occludin; 82, 193.5, 274 and 202.5
for claudin; 130, 210, 288 and 210 for
JAM in groups 1 to 4 respectively. Com-
parisons in groups of 2 showed that, all
three zonula occludens protein H-scores
are significantly lower in saline group com-
pared to each treatment group. However,
H-scores of the zonula occludens proteins
were not significantly different between eta-
nercept and dexamethasone groups. More-
over, bevacizumab group had higher H-
scores for all proteins when compared to
dexamethasone group but only higer JAM
H-score when compared etanercept group.
Conclusion: Antagonism of VEGF restores
epithelial barrier to a higher extent when
compared to both dexamethasone and eta-
nercept. This result may be promising for
development of new therapeutic agents.
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Effect of CpGODN on the level of
interleukin-17 in ovalbumin allergic
asthma model of mice
Li, M1; Wu, C1; Zhang, H1; Li, C1
1The Second Affiliated Hospital & Yuying Children’s
Hospital of Wenzhou Medical College, Wenzhou, China
Background: Establishing mice acute
asthma model, interfered in CpGODN and
observing the variation of IL-17 levels in
blood serum and BALF, and investigate
the possible mechanisms of CpGODN’s
immunoregulatory.
Method: The asthmatic models were estab-
lished by ovalbumin (OVA) sensitised and
challenged to murine. 40 male Balb/c mice
were randomly divided into 4 groups,
including control group (group A), Asthma
model group (group B), Dexamethasone
control group (group C), CpGODN treat-
ment group (group D). Group B were sen-
sitised by OVA and establishing the acute
mice asthma model. Group A were sensi-
tised and challenged by Saline instead of
OVA, group C and D sensitised both by
OVA and to be administered with DXM
(0.5 mg/kg) and with CpGODN (50 lg
each one) by i.p. before challenging a day
and a hour respectively. After challenged
for 24 h in all groups, BALF and blood
serum were collected and the total cell
numbers in BALF were counted. Lung
were fixed and sections were used for histo-
pathological examination, the level of IL-
17 in BALF and blood serum were mea-
sured by Enzyme-linked immunosorbent
(ELISA).
Results: (1) The condition of inflammatory
cell in BALF and pulmonary histopathol-
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ogy: the total cell numbers, the absolute
numbers of EOS, the ratio of EOS to the
total cell numbers (EOS%) in group B
were markedly higher than those of group
A (P < 0.01 respectively); those of group C
and D compared with group B show signif-
icant decrease (P < 0.01 respectively).
There were little infiltration of inflamma-
tory cells in bronchial lumen, mucus secre-
tion decreased significantly, and no
obvious thickening of bronchial smooth
muscle in Group C and D compared with
group B.
(2) The level of IL-17 in BALF and
blood serum in group B (57.50  5.59 pg/
ml, 255.08  49.46 pg/ml), were signifi-
cantly higher than those in group A
(53.02  3.31 pg/ml, 217.52  36.30 pg/
ml) (P < 0.05); group C and group D
(52.62  4.11 pg/ml, 218.35  44.08 pg/
ml; 51.37  3.24 pg/ml,
207.20  20.08 pg/ml)were significantly
decreased compared with B (P < 0.01,
P < 0.01).
Conclusion: The level of IL-17 in BALF
and serum were significantly increased in
the mice acute asthma model sensitised by
OVA, by administered with CpGODN it
were significantly decreased and airway
inflammation were improved, similar to
Dexamethasone decreased the level of IL-
17 in the BALF and serum and improved
airway inflammation.
565
Effects of arginase inhibition and inhaled
L-arginine administration on airway
histology in a murine model of acute
asthma
Arıkan Ayyıldız, Z1; Karaman, M2; Firinci, F1; Kiray, M3;
Bagriyanik, A4; Yılmaz, O2; Uzuner, N1; Karaman, O1
1Department of Pediatrics, Division of Pediatric Allergy,
Dokuz Eylul University Faculty of Medicine, Izmir,
Turkey; 2Department of Experimental Animal
Laboratory, Dokuz Eylul University Faculty of Medicine,
Izmir, Turkey; 3Department of Physiology, Dokuz Eylul
University Faculty of Medicine, Izmir, Turkey;
4Department of Histology and Embriology, Dokuz Eylul
University Faculty of Medicine, Izmir, Turkey
Background: Increased arginase activity in
the airways decreases L-arginine and cause
deficiency of bronchodilating and antiin-
flammatory NO. It is suggested that argi-
nine and arginase inhibitors may have
therapeutic potential in the treatment of
asthma. We aimed to investigate the effects
of inhaled L-arginine and arginase inhibi-
tor Nx-hydroxy-nor-L-arginine (nor-
NOHA) on airway histology of acute
asthma using a murine model.
Method: Forty-two BALB/c mice were
divided into six groups; I, II, III, IV, V
(placebo) and VI (control). All groups
except the control were sensitised and chal-
lenged with ovalbumin. After metacholine
induced bronchoconstriction, the mice were
given inhaled L-arginine (Group I), nor-
NOHA (Group II), L-arginine-nor-NOHA
combination (Group III), budesonide
(Group IV) and placebo, respectively.
SaO2 was measured by pulse oximeter just
before (0 min) and 5 min after 25 mg/ml
concentration of methacholine. A third
measurement of SaO2 was also obtained
15 min after drug administration in these
five study groups. Inflammation in the lung
tissues of the sacrificed animals was scored
to determine the effects of the study drugs
(score 0; none, 1; mild, 2; moderate, 3;
severe).
Results: Inflammatory scores significantly
improved in groups receiving study drugs
when compared with placebo and they
were similar when compared with budeso-
nide. SaO2 had a tendency to increase after
L-arginine administration and this increase
was significant (P = 0.043).
Conclusion: In our study we demonstrated
that L-arginine and arginase inhibiton
improved inflammatory scores and L-argi-
nine improved SaO2 in acute model of
asthma. Combination treatment had no
additive effect on either of these therapies.
566
Murine asthma model has enhanced
response to ozone but not in sham
model
Uh, S-T1; Kim, YK1; Kim, KU1; Park, SW2; Jang, AS2;
Kim, DJ2; Park, CS2
1Soon Chun Hyang Univ. Seoul Hosp., Seoul, Korea;
2Soon Chun Hyang Univ. Bucheon Hosp., Bucheon,
Korea
Background: Ozone is well known as an
important component of ambient air pollu-
tants. Ozone can aggravate respiratory
symptoms in patients with bronchial
asthma, but, not in healthy persons. We
hypothesised asthma itself may show dif-
ferent response to ozone compared to non-
asthma. This study was performed to eval-
uate the differences of response to ozone
between normal mice and murine asthma
model in terms of oxygen toxicity.
Method: Three PPM of ozone was expo-
sured to OVA-albumin-induced murine
asthma model (OVA-model) for 3 h at 3,
7, 14, 21 days after completion of asthma
model. Airway responsiveness to methach-
oline was measured after completion of
asthma model. Bronchoalveolar lavage,
protein extraction from lung for Wetern
blot and immunositochemistry (IHC) of 4-
HNE, PCNA, Nrf-2 were performed at
before and each ozone exposure day.
Results: Airway responsiveness to meth-
acholine had significantly higher methacho-
line-induced Penh in OVA-model than that
in sham group (P < 0.05). The number and
percentages of eosinophil increased at base-
line, 3 and 7 days and returned to nearly
baseline at 14, 21 days after completion of
OVA-model. In sham group, the expres-
sion of 4-HNE increased at only 14 days,
but, in OVA-model, the expression of 4-
HNE more increased at baseline compared
to sham group, and ozone more increased
4-HNE expression at 3 days and 7 days. In
IHC of 4-HNE, staining majority cells
were bronchial epithelium, the intensity
were similar with the results of Western
blot. In both OVA-model and sham group,
PCNA expression was not different from
baseline to 21 days. But the expression of
PCNA was significantly increased in OVA-
model compared to those in sham group.
PCNA was significantly expressed in bron-
chial epithelium in OVA-model during
experimental period. Nrf-2 was not
expressed in sham model, but, in OVA-
model, Nrf-2 expressed at baseline, 3 and
7 days.
Conclusion: Asthma itself is vulnerable to





pulmonary inflammation in a dose
dependant manner
Sohn, J-H1,2,3; Lee, JH2,4; Choi, J-M3,5; Park, J-W2,4
1Department of Life Science, Research Institute for
Natural Sciences, Hanyang University, Seoul, Korea;
2Department of Internal Medicine and Institute of
Allergy, Yonsei University College of Medicine, Seoul,
Korea; 3Hanyang Biomedical Research Institute, Seoul,
Korea; 4Department of Internal Medicine, Division of
Allergy and Immunology, Yonsei Medical School,
Seoul, Korea; 5Department of Life Science, Research
Institute for Natural Sciences, Hanyang University,
Seoul, Korea
Background: Unmethylated CpG can
induce Th1 and regulatory T cell immune
responses and may modulate ovalbumin-
induced mouse allergic asthma. However,
the effects of CpG in a cockroach allergen
asthma model have not yet been eluci-
dated.
Objective: To evaluate whether unmethy-
lated CpG can prevent the development of
indoor allergen-induced allergic asthma,
and whether dose variation of unmethylat-
ed CpG can make difference in response.
Methods: Effects of CpG were determined
using a cockroach allergen-induced mouse
model. To make allergic asthma model,
Blattella germanica (CR) allergens were
administered six times over 3 weeks. For
low dose model, CpG (3 lg) was only once
treated at the last CR administration. For
high dose CpG model, CpG were
co-administered six times with CR.
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Methacholine airway hyperresponsiveness
(MCh-AHR), inflammatory cell quantifica-
tion and cytokine level in BAL fluid, and
lung histology were evaluated. Lung homo-
genates were analysed using FACSAria.
Result: Co-administration of CpG with
CR allergen prevented the development of
MCh-AHR and allergic inflammation in a
CR-induced asthma mouse model. Eosin-
ophils, lymphocytes, macrophages and neu-
trophils in BAL fluid were decreased by
the co-administration of unmethylated
CpG. In low dose CpG model, enhanced
Th1 response and reduced Th2 response
were demonstrated by increased level of
IFN-c and decreased level of IL-5. How-
ever, all of the levels of IL-5, IL-13, and
IFN-c were declined in high dose CpG
model. The expression of IL-10, IL-12p70,
IL-17 in BAL fluid and lung homogenate
was also affected by the CpG. Peribron-
chial, perivascular inflammation, and gob-
let cell hyperplasia in respiratory
epithelium were also markedly attenuated
by the CpG.
Th1, Th2 and Th17 responses were all
declined by high dose CpG treastment. On
the other hand, low dose CpG treatment
appeared to have therapeutic effect increas-
ing Th1 response and attenuating Th2 and
Th17 responses.
Conclusion: These findings suggest that un-
methylated CpG may have role in the
immune modulation of allergic asthma
induced by indoor allergens.
568
Sensitisation by subcutaneous route is
superior to intraperitoneal route in the
induction of asthma by house dust mite
in a murine model
Aun, MV1; Saraiva-Romanholo, BM2; Arantes-Costa,
FM2; Almeida, FM2; Martins, MA2; Kalil, J1;
Giavina-Bianchi, P1
1Division of Clinical Immunology and Allergy,
University of Sao Paulo School of Medicine, Sao Paulo,
Brazil; 2Internal Medicine, University of Sao Paulo
School of Medicine, Sao Paulo, Brazil
Background: Experimental animal models
have been the foundation of basic research
in asthma, aiming the better understanding
of its pathogenesis and the creation of new
strategies of treatment. We present a new
murine model of asthma by mite, compar-
ing two different routes of sensitisation.
Method: The protocol lasted 30 days.
BALB/c mice were divided into six groups,
which were sensitised subcutaneously (s.c.)
or intraperitoneally (i.p.), with saline (neg-
ative control) or Dermatophagoides pter-
onyssinus (Der p), 50 or 500 mcg, in three
injections. Subsequently mice underwent
intranasal challenge with Der p or saline
for 7 days and were sacrificed 24 h after
the last challenge. We measured specific
IgE anti-Der p, eosinophilic density in
peribronchovascular space and airway
remodeling.
Results: Both animals sensitised i.p. and
s.c. produced specific IgE, with no differ-
ence between them. Peribronchovascular
eosinophilia increased only in mice receiv-
ing lower doses of Der p. However, only
the group sensitised with 50 mcg of Der p
through s.c. route showed significant air-
way remodeling.
Conclusion: In this murine model of
asthma, both pathways of sensitisation led
to the production of specific IgE and eosin-
ophilia in the airways. However, only the
s.c. route was able to induce remodeling.
Furthermore, lower doses of Der p used in
sensitisation were better than higher ones,
suggesting immune tolerance. More studies
are needed to evaluate the development of
bronchial hyperresponsiveness in this
model, but it can already be replicated in
experiments to create new therapeutic
drugs or immunotherapeutic strategies.
569
The role of endoplasmic reticulum stress
in the pathogenesis of bronchial asthma
Lee, YC1; Kim, SR1; Kim, DI1; Lee, KS1; Park, SY1;
Jeong, JS1
1Department of Internal Medicine, Chonbuk National
University Medical School, Jeonju, Korea
Background: Despite of a plenty of studies
on endoplasmic reticulum (ER) stress in
various inflammatory diseases, there is
scarce information on ER stress in bron-
chial asthma. In this study, we aimed to
elucidate the role of ER stress in the path-
ogenesis of bronchial asthma.
Method: Using mice sensitised with oval-
bumin (OVA) and lipopolysaccharide
(LPS) and then challenged with OVA
(OVALPS-OVA mice) as well as OVA-sen-
sitised and-challenged mice (OVA-OVA
mice), we have investigated whether ER
stress is involved in the pathogenesis of
bronchial asthma. Moreover, we also
determined the level of an ER stress mar-
ker in blood from patients with asthma.
Results: The OVALPS-OVA mice showed
that the expression of ER stress markers
and the protein levels of unfolded-protein
response (UPR)-related markers in lung
tissues were significantly increased after
OVA challenge. Moreover, we found that
ER stress markers in peripheral blood
mononuclear cells from human asthmatics
were dramatically increased compared with
those from healthy controls. In OVALPS-
OVA mice, 4-phenylbutyric acid (4-PBA),
a chemical chaperone significantly reduced
the increases in ER stress, inflammatory
cytokines, dendritic cells (DCs) infiltration
with Toll-like receptor 4 (TLR4) expres-
sion, airway inflammation, and bronchial
hyperresponsiveness, while it further
enhanced the increase of IL-10. Addition-
ally, the established asthmatic features of
OVA-OVA mice were substantially attenu-
ated by 4-PBA administered after comple-
tion of OVA challenge.
Conclusion: These results indicate that ER
stress may be implicated in the pathogene-
sis of bronchial asthma, at least in part,
through modulation of immune responses.
570
Goblet cell metaplasia and mucus
production are airway-region specifically
regulated in murine allergic asthma
Vock, C1; Yildirim, A€O2; Wagner, C3; Wegmann, M4;
Fehrenbach, H1
1Member of the German Center for Lung Research,
Division of Experimental Pneumology, Airway Research
Centre North, Research Center Borstel, Borstel,
Germany; 2HelmholtzZentrum Munich, Member of the
German Center of Lung Research, Comprehensive
Pneumology Center, Institute of Lung Biology and
Disease, Neuherberg, Germany; 3Member of the
German Center for Lung Research, Division of
Invertebrate Models, Airway Research Centre North,
Research Center Borstel, Borstel, Germany; 4Member of
the German Center for Lung Research, Division of
Asthma Mouse Models, Airway Research Centre North,
Research Center Borstel, Borstel, Germany
Background: Goblet cell metaplasia (GC)
and mucus hyperproduction are major
hallmarks of allergic bronchial asthma, the
most common chronic inflammatory dis-
ease worldwide.
Exaggerated mucus production is a criti-
cal factor impairing lung function of asth-
matic patients. It might result in plugging
of small airways with detrimental impact
on ventilation of the connected alveoli.
In acute and chronic mouse models of
allergic asthma, GC and mucus hyperpro-
duction are seen in proximal but not distal
airways although expression of interleukin
(IL)-13, the main trigger of mucus hyper-
production, was significantly elevated
along the entire airway tree. Effects of IL-
13 are mediated by the IL13 receptor (IL-
13R) composed of the IL-4Ra and IL-
13Ra1 subunit and the down-stream sig-
nalling cascade. We therefore hypothesised
that differences in the IL-13/IL-13R signal-
ling cascade are responsible for airway-
region specific mucus production.
Methods: BALB/c mice were sensitised
with OVA/Alum and subsequently chal-
lenged with OVA for one (acute) or twelve
weeks (chronic). Systematic uniform sam-
ples obtained from lungs fixed with 4%
paraformaldehyde were embedded into
paraffin, sectioned and stained with peri-
odic acid Schiff (PAS) to analyse mucus
production. Lungs were inflated with
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RNAlater to microdissect proximal and
distal airways for qRT-PCR. Laser-based
microdissection (LCM) of airway epithelial
cells was performed on cryofixed lungs.
Results: QRT-PCR analyses of microdis-
sected airways and of LCM-derived airway
epithelial cells revealed significantly lower
abundance of IL-13Ra1 in distal airways,
whereas IL-4Ra mRNA levels were similar
between proximal and distal airways.
Investigations of major transcription fac-
tors implicated in GC and mucus produc-
tion down-stream the IL-13/IL-13R
signalling, displayed a significant airway-
region specific gene expression pattern: i)
expression levels of Spdef and FoxA3, both
known to promote GC and mucus produc-
tion, were barely expressed in distal air-
ways but significantly up-regulated in
proximal airways of OVA-treated mice; ii)
repressors of GC and mucus production,
namely FoxA2 and Nkx2-1, were both
higher expressed in distal airways of PBS
mice and repressed in proximal and distal
airways of OVA-treated mice.
Conclusion: We suggest that the attenua-
tion of the IL-13 dependent signalling cas-
cade in distal airways protects from mucus
plugging and thus, prevents impaired venti-
lation. Elucidating such protective mecha-
nisms may help identifying new targets for
asthma therapy.
571
Antigen-specific regulation of asthmatic
responses in mice by intratracheal
exposure to anti-ovalbumin monoclonal
antibody Fab fragments
Yoshino, S1; Mizutani, N1; Ammori, Y1; Torii, H1
1Pharmacology, Kobe Pharmaceutical University, Kobe,
Japan
Background: Fab fragments (Fabs) main-
tain the ability to bind to specific antigens
but lack effector functions due to the
absence of the Fc portion. In the present
study, we investigated whether Fabs of an
antigen-specific monoclonal antibody
(mAb) were able to regulate asthmatic
responses in mice.
Method: Asthmatic responses were
induced in BALB/c mice sensitised with
ovalbumin (OVA) on days 0 and 14 fol-
lowed by intratracheal (i.t.) challenge with
OVA on days 28, 29, 30, and 35. Fabs pre-
pared by the digestion of an anti-OVA
IgG1 (O1-10) mAb with papain were i.t.
administered 30 min before the last anti-
genic challenge on day 35. Normal IgG
Fabs were used as a control.
Results: I.t. administration of O1-10 but
not control Fabs markedly suppressed the
early and late phases of asthmatic
responses when the in vivo responses were
evaluated by specific airway resistance
(sRaw). The significantly reduced number
of neutrophils in bronchoalveolar lavage
fluids (BALF) was seen in mice treated
with O1-10 Fabs. The lung tissue of mice
administered with O1-10 Fabs also had
decreased infiltration of neutrophils as well
as less production of IL-1beta. The sup-
pression of asthmatic responses by O1-10
Fabs was associated with significantly
lower levels of mMCP-1 in sera as well as
complement C3a in BALF. Similar results
were obtained when Fabs of anti-OVA
IgG2b mAb (O2B-3) were i.t. administered.
In contrast, neither systemic injection of
O1-10 Fabs nor i.t. administration of
intact O1-10 affected the asthmatic
responses. In vitro studies revealed that the
capture of OVA by O1-10 Fabs resulted in
the prevention of the subsequent binding
of intact anti-OVA antibodies to the cap-
tured OVA when small but not large
amounts of the intact antibodies were pres-
ent.
Conclusion: Asthmatic responses appear to
be downregulated by the i.t. exposure to
Fabs of an antigen-specific mAb via a
mechanism involving the capture of anti-
gen by Fabs in the respiratory tract before
the interaction of intact antibody and anti-
gen that is essential for induction of asth-
matic responses.
572
The TLR3 ligand poly(I:C) promotes the
production of IL-17 by NKT cells
Nencini, F1; Vultaggio, A1; Pratesi, S1; Petroni, G1;
Romagnani, S1; Maggi, E1
1University of Florence, Florence, Italy
Background: Allergic asthma is associated
with a Th2-oriented response, even if
recently Th17 cells have been shown to
play a role in the pathogenesis of asthma,
favouring the recruitment of neutrophils
and the evolution to chronicity. The air-
way-targeted viruses consistently exacer-
bate bronchial asthma and the early
rhinovirus infection, rather than other
respiratory viruses, have been clearly asso-
ciated with wheezing and pediatric asthma.
In this study, we examined the activity
of the dsRNA poly(I:C) and the modified
adenine SA-2 (ligands of TLR-3 and TLR-
7, respectively) on the IL-17 production by
a-GalCer-activated iNKT cells, a model
mimicking the activity of both RNA
viruses and microbial antigens on inflamed
lung tissue.
Methods: The in vitro effect of poly(I:C)
on the release of IL-17A by spleen and
lung CD1d-activated iNKT cells with a-ga-
lactosylceramide (a-GalCer) has been ini-
tially evaluated.
The effect of TLR-3L was also investi-
gated in an a-GalCer-induced murine mod-
els of lung inflammation. The inhibition of
IL-17A by Toll-like receptor (TLR) 7 ag-
onists in the same in vitro and in vivo mod-
els has been lastly analysed.
Results: Poly(I:C) upregulated the in vitro
IL-17A production by CD1d-driven invari-
ant NKT cells, without modifying type 1
and type 2 cytokines. The two stimuli
selectively upregulated IL-17A serum levels
in vivo. Their i.t. administration resulted in
increased airway hyper-reactivity (AHR),
neutrophilia in bronchoalveolar lavage and
airway inflammation, which were inhibited
by anti-IL-17A antibody. Poly(I:C) effects
were attributable to IL1b and IL-23 release
from dendritic cells, as showed by inhibi-
tion with neutralising antibodies. TLR7 ag-
onists inhibited the IL-17A production by
poly(I:C) plus a-GalCer in the same mod-
els. Such effect was associated with the
increased production by DC of IL-17A-
inhibiting cytokines (IL-27 and IL-10) and
the dampening of IL-1b and IL-23.
Conclusion: Allergic asthma is worsened
by viral infections sustained by rhinovirus-
es, which express TLR3 sequences, while
are less related to other respiratory viruses
(influenza, respiratory syncytial), that
exhibited both TLR3 and TLR7 sequences.
These data suggest that IL-17A induced by
TLR3L is a relevant signal also for induc-
ing acute lung inflammation.
573
TLR-3 triggered aggravation of
experimental asthma depends on IL-17
Lunding, LP1; Webering, S1; Vock, C1; H€olscher, C2;
Fehrenbach, H1; Wegmann, M1
1Research Center Borstel, Airway Research Centre
North, Member of the German Center for Lung
Research, Priority Area Asthma & Allergy, Borstel,
Germany; 2Research Center Borstel, Priority Area
Infections, Borstel, Germany
Background: Exacerbations are a common
event in asthma patients that cause consid-
erable morbidity on patients. The inflam-
matory phenotype of these exacerbations
in sputum as well as broncho-alveolar
lavage (BAL) is characterised by a hetero-
geneous infiltrate with eosinophils and
large numbers of neutrophils. In epidemio-
logical studies viral infections of the respi-
ratory tract were identified as the main
trigger. During their replication all major
respiratory viruses produce double
stranded RNA (dsRNA) as an intermedi-
ate. This can be sensed by the immune sys-
tem via toll-like receptor 3 (TLR3).
Therefore, we propose a key role for TLR3
in the process underlying acute allergic
asthma exacerbations. Thus, it was the aim
of our study i) to establish a mouse model
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of TLR3-trigged asthma exacerbation and
ii) to investigate the responsible mecha-
nisms.
Method and Results: Local activation of
TLR3 by intra-nasal (i.n.) application of
synthetic ligand poly(I:C) induced an exac-
erbation of experimental allergic asthma in
mice characterised by increased release of
pro-inflammatory cytokines, enhanced
mucus production, and pronounced airway
hyperresponsiveness (AHR). Additionally,
considerable infiltration of neutrophils and
T helper 17 (TH17) cells was observed.
However, poly(I:C) failed to induce an
exacerbation in mice lacking IL-17A,
which indicates a central role for this cyto-
kine in mediating TLR3 triggered asthma
exacerbation. Furthermore, in IL-23p19
mice, which do not have any IL-17 produc-
ing cd T cells and TH17 cells, local appli-
cation of poly(I:C) again provoked asthma
exacerbation.
Conclusion: Therefore, we suggest IL-17
producing iNKT cells as main cell type
mediating the TLR3 triggered exacerbation
of allergic asthma in mice.
574
The effectiveness of Nigella sativa in
preventing the airway remodeling
through an immune response
modulation in the asthmatic mouse
model
Barlianto, W1; Chandrakusuma, H2; Widodo, A3;
Karyono, S3
1Division Allergy-Immunology Department of Pediatric,
Faculty of Medicine University of Brawijaya, Malang,
Indonesia; 2Division Respirology, Department of
Pediatric, Faculty of Medicine University of Brawijaya,
Malang, Indonesia; 3Department of Pharmacology and
Therapy, Faculty of Medicine University of Brawijaya,
Malang, Indonesia
Background: Chronic inflammation on
asthma is dominated by T CD4+ lympho-
cytes which secrete cytokines T helper-2
(Th2) type, playing a role in airway remod-
eling. Apart from a Th2 cell role, T
CD4+CD25+FoxP3+ lymphocytes, a T
regulator, plays a vital role in asthma. Ni-
gella sativa is potential as immunomodula-
tor, having an antiinflammatory effect.
This research aims to prove the efficacy of
Nigella sativa in preventing the airway
remodeling in the asthmatic mouse model.
Method: This research used female mice
aged 8–10 weeks. The experimented animal
was divided into 3 randomised groups,
group I was sensitised and challenged with
ovalbumin and served as a positive control,
group II was neither sensitised nor chal-
lenged and served as a negative control,
group III were sensitised and challenged
with ovalbumin and treated with Nigella
sativa (dosage 4.8 g/kg body weight/day).
Mice were sensitised to ovalbumin intra-
peritoneally and were challenged via nasal
inhalation with ovalbumin 1% for 6 weeks
to induce airway remodeling. Nigella sativa
was administered orally everyday and
started as the same time as sensitisation.
Twenty four hours after the final challenge,
mice were sacrificed and the lung was
taken for analysis. The left lung was exam-
ined for histopathological purpose while
another was for flowcytometry examina-
tion. Flowcytometry analysis was to mea-
sure the lymphocyte count of T CD4+ and
T CD4+CD25+FoxP3+. Bronchoalveolar
lavage fluid was collected to measure TGF-
b level.
Results: Nigella sativa administration
decreased the lymphocyte count of T CD4+
and raised the lymphocyte count of T
CD4+CD25+FoxP3+. The suppression of
T CD4+ lymphocytes was consistent with
apoptosis increase of T CD4+ lymphocytes
after Nigella sativa administration. The
increase of T CD4+CD25+FoxP3+ lym-
phocytes was correlated to the increase of
TGF-b level. The increased level of TGF-b
after Nigella sativa administration was influ-
ential in inducing T CD4+ into T
CD4+CD25+FoxP3+ lymphocytes. Histo-
pathological examination showed Nigella
sativa administration prevent the increased
epithel thickness, smooth muscle thickness,
subepithelial fibrosis thickness, and the
numbers of goblet cell.
Conclusion: Nigella sativa can prevent the
occurrence of airway remodeling in the
asthmatic mouse model via an immune
response modulation.
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A first sensitisation to food allergen
induces an aggravation of asthmatic
phenotype in a house dust mite
asthmatic model
Lair, D1,2,3; Roussey-Bihouee, T1,3,4; Rolland-Debord,
C1,2; Aubert, P3,5; Gourbeyre, P6; Cheminant, M-A1,2,3;
Sagan, C7; Neunlist, M3,5; Bodinier, M6; Magnan, A1,3,8
1INSERM, UMR 1087/CNRS 6291, Nantes, France;
2Universite de Nantes, IRS-UN, l’Institut du Thorax,
Nantes, France; 3Departement Hospitalo-Universitaire
DHU2020, Nantes, France; 4Departement de Pediatrie,
CHU Nantes, Nantes, France; 5INSERM U913, Nantes,
France; 6INRA, Unite BIA1268, Nantes, France; 7CHU
Nantes, Service d’Anatomie et Cytologique
Pathologiques, Nantes, France; 8CHU Nantes, l’Institut
du Thorax, Service de Pneumologie, Plate-Forme
Transversale d’Allergologie, Nantes, France
Background: The atopic march represents
the passage of atopic dermatitis in infants,
often with food allergy, to allergic asthma in
childhood or young adulthood. The objec-
tive of this work is to develop a murine
model of successive food and respiratory
allergy, in order to mimic the atopic march
and to investigate whether pre-existing food
allergy worsens the asthmatic phenotype.
Method: Balb c mice are first sensitised 3
times intraperitonealy then challenged 3
times intra gastrically to ovalbumin (OVA)
as food allergen. Thereafter, to induce
asthmatic phenotype, mice are sensitised 4
times transcutaneously and challenged 2
times intra nasally by an extract of Derma-
tophagoides farinae. Digestive analyses
consist in measurements of permeability in
vivo and ex vivo in Ussing chamber with
measurement of total transit time. Respira-
tory function is assessed with whole body
plethysmography. White blood cells, lung
cellularity and bronchoalveolar lavage
(BAL) composition are analysed by flow
cytometry. Local or systemic response is
analyzed by the cytokine secretion in BAL
or spleen. Total and specific IgE serum lev-
els are assessed by ELISA.
Results: In mice with food sensitisation
and respiratory allergy compared to mono-
allergic mice, we found a significant wors-
ening of the asthmatic phenotype with
(1) increased airway hyperresponsiveness,
(2) pulmonary and LBA hypercellularity
and
(3) a hypersecretion of proinflammatory
cytokines in the lung and BAL.
Moreover, this aggravation is also
reflected systemically with hypersecretion
of total and specific IgE. In the other hand
the digestive bi-allergic mice exhibit a ten-
dency to increased intestinal permeability,
without changing the total transit time.
Conclusion: In our new model, the asth-
matic phenotype is exacerbated by pre-
existing food allergy, assuming an
increased susceptibility in response to envi-
ronmental allergens. Now, this new charac-
terised model will be used in order to
understand the mechanisms which allow
the passage of food allergy to respiratory
allergy, and testing new therapies to pre-
vent this evolution.
577
Beneficial effects of arginase inhibiton
and inhaled L-arginine administration on
airway histology in a murine model of
chronic asthma
Arıkan Ayyıldız, Z1; Karaman, M2; Tuncel, T3; Kiray, M4;
Bagriyanik, A5; Yılmaz, O2; Uzuner, N3; Karaman, O3
1Dokuz Eylul University Faculty of Medicine, Izmir,
Turkey; 2Dokuz Eylul University Faculty of Medicine,
Department of Experimental Animal Laboratory, Izmir,
Turkey; 3Department of Pediatrics, Division of Pediatric
Allergy, Dokuz Eylul University Faculty of Medicine,
Izmir, Turkey; 4Department of Physiology, Dokuz Eylul
University Faculty of Medicine, Izmir, Turkey;
5Department of Histology and Embriology, Dokuz Eylul
University Faculty of Medicine, Izmir, Turkey
Background: Increased arginase activity in
the airways induces reduced bioavailability
of L-arginine and cause deficiency of bron-
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chodilating and antiinflammatory NO.
These also enhance formation of peroxyni-
trite and L-ornithine, which are all
involved in pathogenesis of asthma. There-
fore, arginine and arginase inhibitors may
have therapeutic potential in the treatment
of acute and chronic asthma. Using a mur-
ine model of chronic asthma, we investi-
gated the effects of inhaled L-arginine and
arginase inhibitor Nx-hydroxy-nor-L-argi-
nine (nor-NOHA) on airway histology of
asthmatic lung tissue.
Method: Forty-two BALB/c mice were
divided into six groups; I (control), II (pla-
cebo), III, IV, V and VI. Mice except con-
trol group were sensitised by an
intraperitoneal injection of ovalbumin with
alum adjuvant and then challanged with
an aerosol of ovalbumin on 3 days of the
week for 8 weeks beginning from the 21st
day of the study. Lung histology was eval-
uated after 7 days of treatment period with
inhaled L-arginine (Group III), inhaled
nor-NOHA (Group IV), L-arginine-nor-
NOHA combination (Group V), budeso-
nide (Group VI) and placebo. Interleukin-
4, IL-5 and IL-13 levels were studied in
lung homogenates with ELISA.
Results: Group I was similar with budeso-
nide group in lowering all histologic
parameters. Results of groups treated with
nor-NOHA (Group IV and V) were also
similar with budesonide group except epi-
thelial thickness. Decrease was only noted
in IL-4 in the group receiving nor-NOHA.
Conclusion: In our study we demonstrated
that inhaled L-arginine administration alle-
viated all histologic parameters similar to
budesonide and treatment with arginase
inhibitor improved not all but some of the
pathologic changes in chronic asthma.
Combination therapy had no additive
effect on either treatments.
578
The effect of anti-IL-33 antibody and
soluble ST2 in a murine model of allergic
asthma
Kang, HS1; Lee, HY1; Rhee, CK1; Lee, SY1; Moon, HS1;
Kwon, SS1
1Internal Medicine, The Catholic University of Korea,
Seoul, Korea
Background: Interleukin (IL)-33 is
involved in development of allergic inflam-
mation, and soluble ST2 (sST2) is a fusion
protein that neutralises IL-33 activity.
Therefore, we aimed to investigated
whether Anti-IL-33 and sST2 reduced
inflammation in asthma.
Method: Fourty BALB/c mice were used.
In group A (control group, n = 6), mice
were sensitised and challenged with saline.
Group B [ovalbumin (OVA) group, n = 6]
mice received subcutaneous and intranasal
OVA challenge. In group C (control goat
IgG group, n = 6), mice were injected
intraperitoneally with control IgG before
OVA challenge. In group D (anti-IL-33
group, n = 8), anti-IL-33 was injected
intraperitoneally before challenge. In group
E (control human IgG group, n = 6), mice
were injected intraperitoneally with control
IgG before OVA challenge. In group F
(sST2 group, n = 8), sST2 was injected
intraperitoneally before challenge. We eval-
uated the number of eosinophils, neutroph-
ils, lymphocytes and macrophages in
bronchoalveolar lavage (BAL) fluid; airway
hyperresponsiveness (AHR) to methacho-
line; and IL-4, IL-5, IL-10 and IL-13 in
BAL fluid.
Results: Anti-IL-33 treatment significantly
reduced the number of eosinophils in BAL
fluid. IL-4, IL-5, IL-10, and IL-13 in BAL
fluid were also significantly decreased after
Anti-IL-33 treatment. sST2 also signifi-
cantly reduced the number of eosinophils
in BAL fluid. IL-4, IL-5, IL-10, and IL-13
in BAL fluid were also significantly
decreased after sST2 treatment. Airway hy-
perresponsiveness to methacholine was
decreased when treated with both Anti-IL-
33 antibody and sST2.
Conclusion: Anti-IL-33 antibody and sST2
has a therapeutic potential for allergic
asthma.
579
The effect of influenza virus infection on
airway inflammation in a murine model
of asthma
Kim, H-H1; Chun, YH2; Yoon, J2; Lee, JS2
1Pediatric Allergy, Bucheion St. Mary’s Hospital,
College of Medicine, The Catholic University of Korea,
Bucheon-si Kyunggi-do, Korea; 2Pediatrics, The Catholic
University of Korea, Seoul, Korea
Background: Respiratory viral infection is
a leading cause for asthma exacerbation. It
is known that respiratory syncytial virus
(RSV) infection induces IL-5 dependent
eosinophilia and Th2-polarised immunity,
which are typical phenotypes of virus-
induced aggravation in allergic asthma.
However, although influenza infection,
accounts for a relatively high proportion of
severe cases, pathogenic mechanism of
asthma exacerbation is not well under-
stood. The purpose of this study was to
examine the mechanism of inflammatory
cells accumulation into the airways after
influenza infection in a murine model of
asthma by comparing typical cytokines
related to the production of eosinophils
and neutrophils.
Method: House dust mite (HDM)-sensi-
tised BALB/c mice were used as a model
of influenza-asthma exacerbations. The air-
way cholinergic hyperresponsiveness, pul-
monary histopathological changes, and
bronchioalveolar lavage fluid (BALF) anal-
ysis including cells and cytokine influx
were observed 24 h following intranasal
infection with influenza viruses.
Results: Following influenza infection in
asthmatic mice, the airway responsiveness
to inhaled methacholine was increased
(P < 0.05). Lung tissue showed enhanced
infiltration of neutrophils rather than eo-
sinophils. BALF analysis revealed a statis-
tically significant increase in neutrophils
and decrease in eosinophils in the influ-
enza-infected mice as compared to the
HDM-sensitised mice. These changes were
associated with an increased level of neu-
trophil chemotactic factor (CXCL1) in the
BALF (P < 0.05). However, the levels of
IL-1b -another important cytokine released
in response to increased neutrophils-
showed no changes. Regarding to eosin-
ophils, eotaxin levels found in the BALF
showed a significant reduction (P < 0.05).
However IL-5, and regulated and normal
T cell expressed and secreted (RANTES)
did not show significant changes.
Conclusion: Our results show that the
mechanism of asthma exacerbations by
influenza infection may result from neutro-
philic inflammation rather than eosino-
philic inflammation. Cytokines may play a
role in neutrophilic inflammation.
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Pre-olympic examination of six
Indonesian athletes in 2012: the
introduction of a short version allergy
questionnaire for athletes
Pramadita, D1; Kurniawan, AA2; Rahadian, B1; Munasir,
Z3,4
1Technology, and Sport Health, Center for Science, The
Ministry of Youth and Sport Affair, Jakarta, Indonesia;
2Indonesia Sports Medicine Center, Jakarta, Indonesia;
3Department of Child Health, Faculty of Medicine
University of Indonesia, Jakarta, Indonesia;
4Department of Child Health, Ciptomangunkusumo
Hospital, Jakarta, Indonesia
Background: Elite athletes especially Olym-
pic athletes have bigger prevalence of allergy
than general population up to 22% in
Olympic Winter Games. There has never
been a thorough examination of allergy in
Indonesian Olympic athletes. In year 2012
Indonesian medical team for Olympic
started to use questionnaire that has been
validated in Indonesian language using only
13 questions that could be scored to screen
allergic diseases in Indonesian athletes.
Method: From total 22 Indonesian athletes
went to Olympic 2012, only 6 athletes has
been thoroughly fulfill all examination
(blood test, urine test, Hepatitis B Antigen
and Antibody test, functional movement
screening test, ECG, spirometry) including
allergy questionnaire. The original ques-
tionnaire consisted of 25 questions and in
this examination we only use 13 questions
which have scores.
Results: There were 2 of 6 athletes scored
positive for the questionnaire (score 5 and
7). Both of them answer yes for question
related to rhinitis allergy (Do you fre-
quently sneeze, have a running, itchy nose
(apart from colds)?) that scored 5 which is
also minimum score for positive allergy.
And one of them had mild obstructive
abnormality according to spirometry result
with FEV1 was 69.13% and FEV1/FVC
was 65.68%. This athlete is a weightlifter
and he had history of smoking in the past.
Conclusion: Although some studies showed
that pulmonary function test in athletes
might have higher standard than general
populations, we found one athlete with
mild obstructive abnormality whom
weightlifter and had history of smoking.
Unfortunately this finding was found in
very small number of athlete underwent
complete medical examination. We do not
have enough published data about pulmo-
nary function test in Indonesian Olympic
athletes nor allergy examinations. In reality
enforcement of healthy habit such as quit
smoking is still a problem in Indonesian
athletes other than allergic diseases. Aller-
gic diseases were less found than injuries
and infections in athletes thus yet to be
priority in Indonesian athlete medical
examination. Recommendation of better
and holistic medical and physical examina-
tion of all Indonesian elite athlete espe-
cially Olympic athletes is needed,
considering the management system of
sports medicine is yet to be achieved well
at this moment.
581
Challenge with inhaled mannitol, 17 case
reports of chronic cough and dyspnea
with exercise
Burgos Montero, AM1; Gonzalez Sanchez, LA1; Candon
Morillo, R1; Ruiz Leon, B1; Moreno Mata, E1
1Allergy Department, Hospital La Mancha Centro,
Alcazar de San Juan, Spain
Background: The aim of this study is to
report 17 patients with respiratory disease
(chronic cough or dyspnea during exercise)
with previously normal spirometry, and the
outcome after inhaled mannitol challenge.
Method: We made challenge with mannitol
in 17 patients that come to Allergy Depart-
ment to study and evaluate cough causes and
their treatment. They had pathology of
coughing during rest or during exercise, with
normal spirometry and negative bronchodi-
lator previosly test for the realisation of
provocation. They were prepared by removal
of drugs that could interfere in the test and
were given an informed consent (in case of
teenagers, parents were given it). Neverthe-
less, all challenges were completed despite
the cough that occurs during the test.
Results: We made 17 challenges in our
patients. Among these, 10 patients come
for exercise-induced bronchospasm and 7
come for chronic cough with over
6 months of evolution. Seventy were
women and 30% were men. Over 41.1%
were adolescents and the rest, 58.8%, were
adults. Only two of them had gastric
pathology (11.7%) and six of them had
history of atopy (35.2%). One of patients
was smoker and two of them were ex-
smokers. As a result, we had 3 positive
challenges, two of them were teenagers and
the other was an adult, but all with the
diagnosis of exercise-induced broncho-
spasm and none of them had gastric
pathology. None of the patients with a
diagnosis of chronic cough was positive.
Conclusion: Bronchial challenge with man-
nitol can be used in daily practice, but it is
not yet a substitutive of other bronchial chal-
lenge tests. Although we have few cases in
this report, we observed that patients who
were positive in the test match in pathology
and almost in age (adolescents with exercise-
induced bronchospasm) and chronic cough
patients have a negative test, despite cough-
ing during the challenge. Maybe, we need
more patients and more studies to make con-
clusions, but in this report we can see that
these data suggest us that the mannitol test is
not very specific in the diagnosis of chronic
cough, but it can be more useful to exercise-
induced bronchoespasm.
582
Lifestyle factors as main causative
factors apart from allergen sensitisation
in the development of persistent nature
of asthma from an intermittent one
Purushotam, D1; Ahmed, M2
1Mandore Satt. Hospital, Allergy, Jodhpur, India;
2Paediatric and Allergy, Masha Medical Center,
Hyderabad, India
Background: We all know asthma as a
chronic inflammatory condition of allergic
etiology, so we tried to know factors
responsible for development of persistent
asthma in atopic patients who previously
were intermittently symptomatic.
Method: We took 25 patients of persistent
asthma as, of recent origin (criteria:- need
of regular preventive inhalational medica-
tions on regular basis since last 1–5 years)
and analysed their lifestyle of previous
5 years on 6 below mentioned points:
1 Change to sedentary life style.
2 Weight gain.
3 Any form of mental stress.
4 Change in dietary factors.
We took patients coming to our second-
ary ref feral hospital for continuous need
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of preventive inhalers, we took patients
from middle age I.e. from 30 to 35 years
of age only of both sex.
Results: Out of 25 patients results for vari-
ous factors were as follow:
1 Sedentary life style:-out of 25 patients,
20 developed need for regular medica-
tion use after their routine changed in
such a way that most part of their job
needed sedentary lifestyle and most of
them do not pursue any regular exer-
cise pattern.
2 Most of them gain weight in excess
after which they needed preventers on
regular basis.
3 Intesretingly many of them started
using preventers on regular basis after
a sever emotional stress of medium
duration, as determined by use of
hypnotics or antidepressant medication.
In our study we found that depression
was a major risk factor for develop-
ment of persistent symptoms in already
intermittently symptomatic patients.
4 Interestingly majority of patients
started needing preventers after they
switched their diet from home based
low fat diet to hotel based high fat diet,
from regular frequent small meals to
irregular large meals.
Conclusion: In conclusion we found that
apart from allergic sensitisation lifestyle
factors are key causative factors in trans-
formation from intermittent to persistent
symptomatology in allergic-asthmatic
patients, establishing that persistent asthma
is a chronic inflammatory disorder like dia-
betes and ischemic heart disease in geneti-
cally predisposed individuals needing
multidisciplinary measures to prevent ant
treat persistent asthma apart from allergen
avoidance and pharmacotherapy.
583
Comparison of two asthma control test
for children: Childhood Asthma Control
Test and Japanese Pediatric Asthma
Control program
Sato, K1; Oda, Y1; Suzuki, S1; Nezu, Y1; Matsura, T1;
Watanabe, H1; Nishimuta, T1
1National Shimoshizu Hospital, Pediatrics, Chiba, Japan
Background: Recent worldwide asthma
treatment guidelines and consensus reports
presented disease control as a goal of treat-
ment. Control tests were recommended to
assess asthma control simply and objec-
tively. Childhood Asthma Control Test (C-
ACT) was available for 4 to 11 aged chil-
dren with asthma among many countries
also in Japan. Japanese Pediatric Asthma
Control program (JPAC) was developed in
Japan locally, and had used as commonly
as C-ACT in Japan. We established differ-
ences between two control tests and rela-
tionship with health related quality of life
to take advantage of them.
Method: Children with asthma aged 4–11
and their care givers who visited National
Shimoshizu Hospital were recruited. Chil-
dren in asthma exacerbation were
excluded. Adequate children and care giv-
ers met doctor after they completed C-
ACT and Japanese Pediatric Asthma Qual-
ity of Life Questionnaire 2001(JAQLQ).
The doctors blinded to results of C-ACT
and JAQLQ completed JPAC with inter-
viewing about asthma control. Correlation
between C-ACT and JPAC score, differ-
ences in answers of equivalent questions,
and relationship with QOL were analyzed
statistically. SPSS software ver. Seventeen
were used for all statistical analysis.
Results: One hundred and ninety sets of
two hundred three were obtained. Mean
age of children was 7.4 years old. JPAC
score was correlated with C-ACT score
(r2 = 0.614, P < 0.01). Concordance rate
whether controlled or not among two con-
trol tests was 88.1%. Discordance between
two control tests were observed mainly in
case of not controlled. Differences between
child’s answer and caregiver’s were largest
in question about exercise induced bron-
chospasm or cough (discordance rate
29.8%). JPAC score was not well corre-
lated with JAQOL score (r2 = 0.282).
Conclusion: C-ACT and JPAC were in
another style but equivalent in outcome
measures. Knowledge about differences
between two tests and proper use is needed
to assess childhood asthma adequately.
584
Spirometry and eNO values in healthy
pre-school children from Navarra
Olaguibel, JM1; Alvarez Puebla, MJ1; Vela Vizcaino, C1;
de Esteban, B1; Uribe San Martin, P1; Cambra Contin,
K2
1SNS, Alergologia, Pamplona, Spain; 2Fundacion
Miguel Servet, Pamplona, Spain
Background: Pre-school children can pro-
duce reproducible spirometric maneuvers,
provided a well trained technician and
appropriate incentive software are avail-
able. Its use in clinical practice has, how-
ever, been limited by lack of consensus in
acceptability criteria nd reference data.
There was a lack of normal values for this
age range in our area, so a survey was con-
ducted to obtain spirometric reference val-
ues in a healthy pre-school children
population from Navarra along with
exhaled nitric oxide (eNO) values.
Method: Seventy five normal pre-school
children were included and of these 60
were able to produce acceptable and repro-
ducible maneuvers, according to quality
control criteria recommended by Aurora et
al. (1).
Results: The regression model of natural
lung function parameters and height had
the best correlation. After accounting for
height in the model, other physical traits
did not contribute significantly. FVC,
FEV1 and FEV0,5 all increase with height.
Correlation coefficients were 0.88, 0.87 and
0.86 respectively. Reference equations were
developed: FEVC = 2.4365 + 0.0347 *
height, FEV1 = 2.0678 + 0.0297 * height,
FEV0.5 = 1.5383 + 0.0225 *height. There
was a decrease in the ratio FEV1/FVC
with increasing height. eNO values (Niox
Minor/6 s) were obtained in 56 children.
Mean value was 10 ppb (SD 5.2), values
ranging from <5 to 18 ppb.
Conclusion: High quality spirometry can
be obtained in the majority of pre-school
children. Prediction equation for spirome-
try for pre-school children of our area, and
normal eNO values are presented.
1. Aurora P, Stocks J, Oliver C, et al.
Quality control for spirometry in pre-
school children with and without lung dis-
ease. Am J Respir Crit Care Med
2004;169:1152–9.
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Features of school-age children with
asthma according to aeroallergen
sensitisation and risk factors for
uncontrolled asthma
Yavuz, ST1; Kartal, O2; Arga, M1; G€ulec, M2; Gok, F3;
Sener, O2; Sekerel, BE4
1Department of Pediatric Allergy and Immunology,
G€ulhane Military School of Medicine, Ankara, Turkey;
2Department of Adult Allergy and Immunology,
G€ulhane Military School of Medicine, Ankara, Turkey;
3Department of Pediatrics, G€ulhane Military School of
Medicine, Ankara, Turkey; 4Pediatric Allergy and
Asthma Unit, Hacettepe University School of Medicine,
Ankara, Turkey
Background: Clinical phenotypes may vary
among children with asthma according to
the aeroallergen sensitisation status. The
aim of this study is to document the demo-
graphic and laboratory features of school-
age children with asthma and to determine
factors associated with uncontrolled
asthma.
Method: Children with physician-diag-
nosed asthma who attended to an outpa-
tient pediatric allergy and asthma center
were enrolled in the study. A questionnaire
including demographic features and
parameters to determine socioeconomic
status were applied. Asthma control status
of patients was evaluated according to
GINA criteria. Laboratory investigations
including complete blood counts with dif-
ferential, total IgE levels, skin prick tests
and pulmonary function tests were per-
formed.
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Results: A total of 159 children (96 male
(60.4%); with a median age [interquartile
range] of 8.0 [6.1–11.3] years were
included. 45.9% of children had aeroaller-
gen sensitisation. The age of onset of
asthma symptoms were later (2.8 years
[0.8–5.2] vs 5.5[2.0–7.2]), P = 0.004), family
history of allergic disease was more
frequent (52.1% vs 27.9%), total IgE levels
(52.6 kU/l [28.8–113.9] vs 20.1[4.0–84.8]),
P < 0.001) and eosinophil counts (250
[180–445] vs 145[110–243]), P = 0.001)
were higher in children with aeroallergen
sensitisation. Asthma was controlled in 50
children (31.4%), whereas partially con-
trolled and uncontrolled in 55 (34.6%) and
54 (34.0%) patients, respectively. Multivar-
iate logistic regression analysis revealed
history of previous hospitalisation (Odds
Ratio [Confidence Interval]) (2.49 [1.04–
5.93]; P = 0.04), female gender (3.09 [1.45–
6.56]; P = 0.005) and lymphocyte
counts>3210/mm3 (2.25 [1.06–4.75];
P = 0.034) were related with uncontrolled
status in school-age children with asthma.
Conclusion: Awareness of risk factors
related with uncontrolled asthma may alert
physicians who deal with asthmatic school-
age children and may help prompt and
rational intervention in order to achieve
proper asthma control.
586
Vitamin D levels in peripheral blood in
patients with mild to moderate bronchial
asthma
Torres, J1,2; Martınez, M3; Chavez, E3; Garcıa, D4;
Fabiano, F2; Hernandez, J5
1Pediatria, Hospital Vargas de Caracas, Caracas,
Venezuela; 2Instituto Docente de Inmunodiagnostico,
Caracas, Venezuela; 3Inmunologıa, Hospital Militar Dr.
Carlos Arvelo, Caracas, Venezuela; 4Inmunologia,
Hospital Militar Dr. Carlos Arvelo, Caracas, Venezuela;
5Centro Medico Fatima, Caracas, Venezuela
Background: Vitamin D plays a key role in
the immune response generated by lympho-
cytes and antigen presenting cells, their
role in regulating immune system cells has
been recognised by the discovery of the
vitamin D receptor (VDR) in almost all
cells of the immune system, including T
cells, B cells, neutrophils, macrophages and
dendritic cells.
Method: For this we took 30 patients with
mild to moderate asthma aged between 12
and 50 years of age, without severe associ-
ated pathologies and were asked measure-
ment of serum IgE levels, vitamin D and
spirometry were subsequently included in
tables double-blind randomisation to
receive vitamin D supplementation 1 g
daily or placebo for 2 months. At the end
they made new measurements of the above
parameters were found in the group of
patients receiving medication and culmi-
nated the study (17 patients).
Results: There was a significant improve-
ment in asthma symptoms according to
forced expiratory volume in the 1st minute
58.7% of patients with the use of vitamin
D supplementation with ap of 0.014 and
increased peak flow ap of 0.047 which is
statistically significant for these parameters,
just as was evident in 76.4% of the same
IgE levels decreased significantly after use
of the drug with a statistical significance of
p 0.017. Similarly, patients in the control
group who received placebo, also showed
decreased serum IgE, but Tifenau index
values (FEV1/FVC) significant differences
in improvement with statistics P = 0.028
and 0.017 respectively. there was a signifi-
cant improvement in asthma symptoms
according to forced expiratory volume in
the 1st minute 58.7% of patients with the
use of vitamin D supplementation with ap
of 0.014 and increased peak flow ap of
0.047 which is statistically significant for
these parameters, just as was evident in
76.4% of the same IgE levels decreased sig-
nificantly after use of the drug with a sta-
tistical significance of p 0.017. Similarly,
patients in the control group who received
placebo, also showed decreased serum IgE,
but Tifenau index values (FEV1/FVC) sig-
nificant differences in improvement with
statistics P = 0.028 and 0.017 respectively.
Conclusion: This opens a new field in the
treatment of asthma patients because they
can improve symptoms without the side
effects of traditional therapy while suggest-
ing new mechanisms in the pathophysiol-
ogy of this disease as complex and
common in our society.
590
Asthma control test: one size does not fit
all
Caminati, M1; Caimmi, C2; Schiappoli, M1; Dama, A1;
Senna, G1
1Allergy Unit, Verona University Hospital, Verona, Italy;
2Rheumatology School of Specialization, University of
Verona, Verona, Italy
Background: Pathophysiological variability
of asthma (airflow limitation, airway
inflammation and responsiveness) and the
impact of comorbidities may account for
the complexity of asthma monitoring and
control achievement. A recent meta-analy-
sis has confirmed Asthma Control Test
(ACT) validity in assessing controlled and
not well controlled asthma on the basis of
Global Initiative for Asthma (GINA) defi-
nition of control, that does not include nei-
ther reversibility nor inflammation
assessment, despite increasing evidence of
their importance as hallmark of asthma,
partially unrelated to clinical outcomes.
We aimed at exploring ACT validity
according to a definition of control based
on FEV1, reversibility test and airways
inflammation.
Method: Control of asthma was assessed
in 177 patients referring to our Unit. Con-
trol was defined as: FEV1 ≥ 80% and neg-
ative reversibility test and FeNO < 50 ppb.
Sensitivity, specificity, positive and negative
predictive value of ACT in assessing
asthma control on the basis of the defini-
tion above were examined. ACT perfor-
mance in specific subgroups of patients
was also evaluated by ROC curve analysis.
Results: ACT with cut-off score ≥ 20 shows
good positive predictive value (83.5%) but
low sensitivity (47.8%), specificity (66.7%),
and negative predictive value (26.5%). Sig-
nificant differences emerge when evaluating
ACT performance in single subgroups of
patients with different comorbidity and
asthma severity. ROC curves analysis indi-
cates that ACT in patients with mild inter-
mittent rhinitis is more reliable (AUC:
0.714; P < 0.05) than in patients with nasal
polyposis/chronic rhino-sinusitis (AUC:
0.176; P > 0.05). Considering asthma classi-
fication, the probability that ACT detects
patients with uncontrolled asthma (true
positive cases) is significantly higher in mod-
erate persistent asthma subgroup than in
mild persistent asthma one (OR 5.464; IC
95%: 2.5–11.9; P < 0.05).
Conclusion: According to a definition of
asthma control based on functional param-
eters and airways inflammation assessment,
ACT is reliable in detecting uncontrolled
asthmatic patients but it does not show the
same performance in identifying well con-
trolled patients. According to ACT out-
come, patients with mild persistent asthma
seem to underestimate their pathology.
Moreover, nasal comorbidity seems to sig-
nificantly affect asthma perception and
ACT performance. Our data suggest that
different asthma phenotypes require differ-
ent tools for an accurate follow-up.
592
Assessment of severity of asthma and
impulse oscillometry
Cekerevac, I1; Novkovic, G2; Novkovic, L1; Lazic, Z1;
Petrovic, M1; Mijailovic, Z3
1Clinical Center Kragujevac, Medical Faculty
Kragujevac, Clinical for Pulmonary Disaese, Kragujevac,
Serbia; 2RSA Borromea Mediglia Milano, Milano, Italy;
3Clinical Center Kragujevac, Medical Faculty
Kragujevac, Clinical for Infective Disaese, Kragujevac,
Serbia
Background: The Impulse oscilometry
(IOS) is non invasive test for measure
mechanical impedance (respiratory resis-
tance and reactance) of respiratory system
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and does not require considerable patient
cooperation compared to spirometric test.
Aim of this study was to estimate clinical
validity of IOS for the evaluation severity
of asthma in adults patients.
Method: A group of 40 patients with
asthma, which subdivided according to
GINA into three groups was analyzed
(Table 1). Asthma severity is classified on
the basis of the intensity treatment requ-
ried to achieve good asthma control.
Results:
Severity of asthma (n): Mild (14), Mod-
erate (15), Severe (11)
Age: 38.4  2.4, 43.5  3.6, 48  4.2
Male/female: 6/8, 7/8, 4/7
BMI: 25.7  3.5, 25.9  3.8, 28.3  3.6
FEV1:% 84.2  16.3, 69.2  12.3,
54.4  15.2
R5%: 123.2  4, 179.1  71, 262.6 
86
R20%: 119.5  32.7, 148.5  42.8, 190
 54.4
Fres: 14.4  5.6, 23.2  4.8, 29.2  5.5
The statistical significant highest values
of FEV1%, R5%, R20%, Fres were in the
group patients with severe asthma. We
found statistical significant negative corela-
tion between FEV1%, FVC% and R5%,
R20%. Patients with moderate (R5%
179.1  71.2, R20%/148.5  42.8) and
severe asthma (R5%/262.6  86.8, R20%/
190.0  54.4) had dominant distal airway
obstruction (resistance falls with increasing
frequency).
Conclusion: Measurement of the following
IOS parameters: R5%, R20%, Fres can be
used for assessment of asthma severity,
particularly in patients who cannot do co-
rect spirometry due to uncooperation or
severity of disease. Also, IOS can be used
for estimation of small airway involvement
in patients with asthma.
593
Clinical usefulness of impulse
oscillometry (IOS) for the evaluation of
stable asthma
Takahashi, K1; Ito, T1; Meguro, K1; Yokota, M1;
Kashiwakuma, D1; Yoshida, S1; Iwamoto, I1
1Asahi General Hospital, Department of Allergy and
Clinical Immunology, Asahi, Japan
Background: IOS is a new noninvasive
technique to assess lung function, but the
interpretation of IOS data has not been
well established. We thus determined the
usefulness of IOS data for the evaluation
of stable asthma.
Method: This is a single center retrospec-
tive evaluation of 258 stable asthma
patients. We collected detailed patient
characteristics, asthma control status,
blood eosinophil counts, exhaled nitric
oxide (FeNO) values, and lung function
values, and compared them with IOS data.
Additionally, we performed spirometry and
FeNO breath test (Sievers), followed by
IOS (MasterScreen IOS, Carefusion Tech-
nologies) on the same day.
Results: (1) IOS values were strongly cor-
related with height, age, and lung function
values of airflow obstruction. In particular,
resonant frequency of reactance (Fres) was
most strongly correlated with forced expi-
ratory volume in one-second (FEV1)/
forced vital capacity (FVC) ratio (FEV1/
FVC), FEV1/predictive FEV1;%FEV1,
maximal flow rate at 50% of FVC (V50)/
predictive V50;%V50 and maximal flow
rate at 25% of FVC (V25)/predictive V25;
%V25 (P < 0.00001, in all), and we
obtained a regression line of FEV1/FVC.
FEV1/FVC (%) = 160.82–0.30Age–
0.38Ht+0.083Wt0.44Fres (R2 = 0.476)
(2) The duration of years before the start
of inhaled corticosteroids and the disease
duration were significantly correlated with
the difference in respiratory resistance
between 5 Hz and 20 Hz (R5-R20), imped-
ance at 5 Hz (Z5), and resistance at 5 Hz
(R5) (R5-R20: P = 0.00011, 0.00072, Z5:
P = 0.0016, 0.00090, R5: P = 0.0027,
0.0018, respectively).
(3) In assessment of the relationship
between IOS data and treatment steps
based on Japanese guideline (JGL2009),
there was a significant difference in Fres
between step 2 and 3 treatment groups
(P = 0.027).
(4) Patients using bronchodilators
showed significantly high Z5, R5, R20 and
R5-R20 values (P = 0.0047, 0.0049, 0.012,
and 0.034, respectively).
Conclusion: It is suggested that in stable
asthma, Fres is the best parameter of air-
flow obstruction, and R5, R5-R20, and Z5
that are more informative parameters with
peripheral airway obstruction may reflect
airway remodeling.
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Experiences of living with asthma – a
focus-group study with teenagers and
parents to children with asthma
Jonsson, M1; Egmar, A-C2; Kull, I3
1Karolinska Institutet, Institute of Womans and
Childrens Health, Stockholm, Sweden; 2The Red Cross
University College, Stockholm, Sweden; 3Department of
Clinical Science and Education, S€odersjukhuset,
Stockholm, Sweden
Background: The goal for asthma treat-
ment is that every individual, as far as pos-
sible, shall live without symptoms and
exacerbations but many patients fail to
achieve this goal. Moreover, patients and
healthcare professionals sometimes have
different perceptions of what is of impor-
tance to achieve well-being. These aspects
need to be explored, from a patient per-
spective, to be able to develop good
asthma care.
Aim: To describe teenagers with asthma
and parents to young children with asthma
experiences of living with asthma.
Method: Four focus groups interviews
were performed, two in each group; par-
ents to children 2–12 years with asthma,
and teenagers with asthma. The data was
tape-recorded and transcribed verbatim
and analyzed qualitative according to sys-
tematic text condensation.
Results: The results were presented in
three themes relevant to the participant’s
experiences of living with asthma; asthma
management, limitations and needs. The
experiences for teenagers and parents to
children with asthma differed to some
extent. The teenagers focus was mostly on
how they managed the disease. They
wanted to be like others and did not want
to be seen differently because of the
asthma. Teenagers with asthma often used
different adaption strategies.
Parents to children with asthma empha-
sized on limitations and needs, expressed
as feelings of frustration and anxiety, lack
of knowledge and a need to meet profes-
sional competence both in health care and
in school. Both teenager and parents
expressed a need of support and under-
standing from healthcare professionals.
Conclusion: The experiences for teenagers
and parents to children with asthma dif-
fered to some extent. Teenagers focus was
on how to manage the disease and some-
times they endured the asthma symptoms
in contrast to parents who more expressed
limitation and needs.
Clinical implication: The health care pro-
fessionals but also teachers in nursery
school and school need an improved
understanding about teenagers and parents
experiences of how it is to live with an
asthma disease in daily life. A more
patient-centred education could be a way
to gain this understanding.
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Association between asthma and rhinitis
prevalence, use of health resources,
quality of life, and number of atopic
sensitisations
Christoff, GC1,2; Karova, EG3; Stoeva, IL4
1Department of Health Economics, Medical University –
Sofia, Faculty of Public Health, Sofia, Bulgaria; 2Allergy
Outpatient Clinic, Tokuda Medical Centre, Sofia,
Bulgaria; 3Faculty of Dental Medicine, Department of
Conservative Dentistry, Medical University – Sofia,
Sofia, Bulgaria; 4Faculty of Dental Medicine,
Department of Allergology, Physiotherapy and Clinical
Radiology, Medical Unieristy – Plovdiv, Plovdiv,
Bulgaria
Background: Atopy, defined as at least one
positive sensitisation to environmental
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allergens is the main characteristic of aller-
gic diseases. Its role as a risk factor for
asthma, rhinitis and dermatitis is well
known. On the other hand few data are
available on the relation between atopy
and social and economic determinants in
people with asthma and allergic rhinitis.
The objective of the current study is to
assess association between asthma and rhi-
nitis prevalence and atopic sensitisation
together with the putative relation with
changes in quality of life and use health
resources.
Method: Patients, 225 men and women,
aged 4–81 years consulting the outpatient
clinic of a major private hospital in Sofia,
because of a suspected IgE-mediated aller-
gic disease were included. All participants
completed a written questionnaire to define
asthma and rhinitis prevalence, frequency
of symptoms, quality of life and health
costs. Patients underwent skin prick testing
with 18 commercial allergen extracts using
individual lancets (Alyostal Prick, 100 IR-
IC/ml, Stallerpoint, Stallergenes, France;
Cow milk prick 1000 BU/ml Bul Bio-
NCIPD, Bulgaria). All test and reading
procedures were in line with published
practice guidelines.
Results: 72.7% of defined asthmatics are
atopic. Non-asthmatics are with lower per-
centage of sensitisation – 56.7%
(P = 0.025). Atopy is more frequent in
patients with rhinitis than in these without
– 70.4% vs 55% (P = 0.018). The most fre-
quent sensitisation in asthmatics is that to
four cereals – 35.7%, the least frequent –
to Cladosporium mix – 1.8%. There is no
difference between mean number of asth-
matics sensitisations- 6.9 and non-asthmat-
ics – 5.8 (P = 0.095) as well as in patients
with and without rhinitis – 5.92 vs 5.88
respectively (P = 0.067). No correlation is
found between quality of life indices in
patients with asthma and rhinitis and num-
ber of sensitisations. The study does not
show correlation between number of sensi-
tisations and health resources use in asth-
matics. Relative risk (RR) for asthma in
sensitised people is 2.04 (1040–3990),
P = 0.038, for rhinitis – 1.895 (1043–3445),
P = 0.036. Age and sex are not asthma
predictors. Rhinitis probability decreases
with 60% after the age of 44 – RR 0.394
(0.160–0.968), P = 0.042.
Conclusions: The study demonstrates high
rates of sensitisations to major inhalant
and food allergen in asthmatics and
patients with rhinitis. Sensitisation but not
sex and age is a potent risk factor for
asthma and rhinitis.
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Predictor risk factors for recurrent
wheezing in infants in a poor urban city
in south Brazil
Pereira, MU1; Ivancevich, JC2; Sole, D3; Mallol, J4; De-
laBianca, AC5; Aranda, C3; Wandalsen, GF3; Rosario, N6;
Chong, HJ6; Toledo, EC7; Oliveira, CM7; Moraes, LSL8;
Takano, OA8
1Catholic University of Rio Grande do Sul, Uruguaiana,
Brazil; 2Universidad del Salvador, Buenos Aires,
Argentina; 3Federal University of S~ao Paulo, S~ao Paulo,
Brazil; 4University of Santiago de Chile, Santiago, Chile;
5Federal University of Pernambuco, Recife, Brazil;
6Federal University of Parana, Curitiba, Brazil;
7University of S~ao Jose do Rio Preto, S~ao Jose do Rio
Preto, Brazil; 8Federal University of Mato Grosso,
Cuiaba, Brazil
Objectives: To identify the predictor risk
factors for recurrent wheezing in infants in
the city of Uruguaiana, RS, Brazil.
Methods: This is a cross-sectional study,
part of the EISL (International Study of
Wheezing in Infant). The parents or legal
guardians of infants aged 12–15 months
attending health centers for immunisation
were interviewed and administered the EISL
questionnaire (standardised and validated
instrument) with questions on demographic
characteristics, wheezing, respiratory infec-
tions and risk factors during the period
between January 2008 and July 2010.
Results: Sampled infants (n = 1.061) had a
mean age of 13.09 months and prevalence of
wheezing during their first year of life of 28.6%.
10.4% had 3–6 episodes. They lived in a poor
area of the city, with low maternal education
level (60% had less than 8 years of formal edu-
cation) with an income lower than US$ 500
(99.8%). Significant differences were observed
with respect to first cold younger than 3 months
(OR: 3.2 95%CI: 2.16–4.73), eczema in infants
(OR: 1.9 95%CI: 1.05–3.26), humidity in the
home (OR: 1.9 95%CI: 1.27–2.98), pets before
birth (OR: 1.5 95%CI: 1.03–2.27), and mother
smoking (OR: 2.4 95%CI: 1.54–3.81).
Conclusions: The prevalence of wheezing
among infants living in a poor area of
Uruguaiana is high. To identify the risk
factors for recurrent wheezing in this low
socio-economic population is mandatory
for the establishment of preventive actions,
early diagnosis of asthma and opportune
treatment for this condition.
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Assessment of compliance to treatment
in asthmatic children
Can, C1; Akkelle, E1; Go¨kmirza O¨zdemir, P1; Yazıcıoglu,
M1; S€ut, N2
1Department of Pediatric Allergy and Immunology,
Trakya University Faculty of Medicine, Edirne, Turkey;
2Department of Biostatistics, Trakya University Faculty
of Medicine, Edirne, Turkey
Background: Asthma is one of the most
common chronic diseases in childhood, yet
compliance to treatment is reported to be
50% or less. The aim of our study was to
evaluate the proper use of long-term
asthma control and quick-relief medica-
tions, and to determine the compliance to
treatment in asthmatic children.
Method: The study was conducted on 100
asthmatic children aged 6–18 years, moni-
tored by the outpatient clinic of the Pediat-
ric Allergy Department, Faculty of
Medicine, Trakya University, Edirne.
Patients with persistent asthma who had
used their control medications at least for
30 days were included in the study. Long-
term asthma control and quick-relief medi-
cations were prescribed, verbal and written
information on the use of medications was
given, and after one month patients and
their families were asked to answer a ques-
tionnaire on drug use.
Results: The mean age of the patients
(47% female) was 9.39  2.76 years. All of
the patients had persistent asthma. Sev-
enty-three percent of the patients reported
that they were using asthma controller
medications regularly. The mean age of
patients using preventive drugs regularly
was 9.05  2.5 years, with the mean age of
patients using them irregularly
10.29  3.26 years. This difference was
statistically significant (P = 0.047). Regular
use of preventive drugs did not differ
between sexes. Seventy-seven percent of the
patients with controlled asthma, 67.5%
with partly controlled asthma, and 66.6%
with uncontrolled asthma reported that
they were using preventive drugs regularly.
There was no difference in regular drug
use between the groups regarding the level
of asthma control. All of the patients who
were recommended to use long-term
asthma control medication identified their
drugs correctly. Ninty-three percent of
them described the dose accurately. There
was no difference in compliance when a
single drug or two drugs for prophylaxis
were used. When they were asked about
quick relief asthma medications, 62% of
the patients reported salbutamol, 28% ter-
butaline, and 1% inhaled steroids as their
quick-relief medication, while 9% of the
patients did not know the name of their
medication. Thirty-four percent of the
cases correctly described the dose of their
quick-relief medication.
Conclusion: The most important factor
affecting regular use of preventive drugs in
asthmatic children is age. This result sug-
gests that children have more effective
asthma treatment when it is under parental
control.
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Expression of ORMDL3 and CTLA4 genes
in childhood asthma and their
association with the antiasthmatic effect
of inhaled corticosteroids
Berce, V1; Kozmus, CEP2; Potocnik, U3
1Department of Pediatrics, University Medical Center
Maribor, Maribor, Slovenia; 2Institute for Molecular and
Cell Biology, University of Porto, Porto, Portugal;
3Center for Human Molecular Genetics and
Pharmacogenomics, Faculty of Medicine, Maribor,
Slovenia
Background: ORMDL3 and CTLA4 genes
affect the lung immune responses, which
are also the principal target of inhaled cor-
ticosteroids. Therefore we analyzed the
interactions between ORMDL3 and
CTLA4 genotype, gene expression and the
effect of therapy with inhaled corticoster-
oids in childhood asthma.
Method: We analyzed a case-control
cohort composed of 204 Slovenian children
with mild to moderate persistent atopic
asthma and 90 children with non-atopic
asthma. Lung function was measured
before and after 4–6 weeks of therapy with
fluticasone dry powder. We genotyped
functional polymorphisms CTLA4 CT60
and ORMDL3 rs2872507 and extended the
study to analyze the effect of genotype and
therapy on CTLA4 and ORMDL3 gene
expression.
Results: Forced expiratory volume in 1 s
(FEV1) increased by 13.3% of predicted
value after therapy in atopic subgroup of
asthmatics with ORMDL3 rs2872507 AA
genotype, compared to 4.9% increase in
GG homozygotes (P = 0.0176). Median
relative expression of ORMDL3 gene in
asthmatics with AA, AG and GG genotype
was 0.75, 1.05 and 1.21 respectively
(P < 0.0001). Treatment with inhaled corti-
costeroids significantly increased median
relative expression of ORMDL3 gene in
atopic asthmatics from 0.88 to 1.21
(P = 0.0032). Regarding CTLA4 CT60
FEV1 increased by 21.7% in atopic asth-
matics with AA genotype compared to
5.8% increase in GG homozygotes
(P = 0.0067). Median relative expression of
full length CTLA4 isoform in asthmatics
was 0.440, compared to 1.000 in healthy
controls (P < 0.0001), and of soluble
CTLA4 (sCTLA4) isoform in asthmatics
was 0.580 compared to 1.040 in healthy
controls (P < 0.0001). After treatment, the
sCTLA4 expression in asthmatics increased
from 0.435 to 0.645 (P = 0.049).
Conclusion: CTLA4 and ORMDL3 gene
expression is dysregulated in childhood
asthma. Functional variants in ORMDL3
and CTLA4 genes are associated with the
response to treatment with inhaled corti-
costeroids in children with atopic asthma,
probably by their influence on gene expres-
sion. Our findings identify new potential
biomarkers in asthma treatment and con-
tribute to the understanding of the phar-
macogenetics of corticosteroids in asthma.
602
Relationship of methacholine and
mannitol responsiveness with serum
levels of squamous cell carcinoma-
related antigens in children with asthma
Baek, H-S1; Lee, S-Y2; Lee, H-R2; Izuhara, K3
1Department of Pediatrics, Hallym University College of
Medicine, Seoul, Korea; 2Department of Pediatrics,
Hallym University College of Medicine, Anyang, Korea;
3Saga Medical School, Saga, Japan
Background: TH2 cytokines, which are
known to be involved in the pathogenesis
of allergic disorders, stimulate new synthe-
sis of squamous cell carcinoma-related
antigens (SCCA) in cultured human airway
epithelial cells. Increased serum levels of
SCCA have been observed in patients with
allergic disorders such as atopic dermatitis
and asthma. Effects of serum SCCA on
bronchial hyperresponsiveness (BHR) have
not yet been demonstrated in the human
airway. The aim of this study was to
address the relationship between serum
SCCA levels and BHR in children with
asthma.
Method: Seventy-nine children between the
ages of 6 and 12 years were included and
comprised the asthmatic group (n = 54)
and the healthy control group (n = 25). We
established new enzyme-linked immunosor-
bent assays (ELISAs) to specifically detect
SCCA1 or SCCA2. Mannitol and meth-
acholine provocation challenges were per-
formed. The response to methacholine was
expressed as a provocative concentration
causing a 20% decrease in FEV1 (PC20).
The response to mannitol was expressed as
a provocative dose causing a 15% fall in
FEV1 (PD15) and the response-dose ratio
(RDR).
Results: The children with asthma had a
significantly higher mean (SD) level of
SCCA1 than the controls (0.919  0.599
vs 0.768  0.261 ng/ml; P = 0.039). There
were no significant differences in serum
SCCA2 levels between the asthmatics and
the controls (0.565  0.254 vs
0.600  0.168 ng/ml; P = 0.265). Serum
SCCA1 levels were significantly correlated
with mannitol PD15 (r = 0.507,
P = 0.003) and RDR to mannitol
(r = 0.332, P = 0.032) but not with meth-
acholine PC20 (r = 0.183; P = 0.272).
Serum SCCA2 levels were also significantly
correlated with mannitol PD15 (r = 0.488,
P = 0.005) and RDR to mannitol
(r = 0.509, P = 0.001) but not with meth-
acholine PC20 (r = 0.227; P = 0.170).
Conclusion: Serum SCCA1 levels increased
in asthmatic children. Both SCCA1 and
SCCA2 levels were related to BHR to
mannitol but not to methacholine in asth-
matic children.
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Detection of IgE and IgG anticitrullinated
protein antibodies in asthmatic patients
Garriga Baraut, T1; Labrador-Horrillo, M1; Luengo, O1;
Guilarte, M1; Sala-Cunill, A1; Cardona, V1
1Hospital de la Vall d’Hebron, Allergy, Barcelona, Spain
Background: Persistent inflammation of
the airway is considered the main feature
of asthma. Nitric oxide (NO) is an inflam-
matory mediator which is an easy, repeat-
able and non-invasive marker of
eosinophilic bronchial inflammation
formed in biological systems from L-argi-
nine and oxygen by the nitric oxide syn-
thase (NOS). NOS converts L-arginine into
NO and L-citrulline. Citrulline can appear
in peptides against which anticitrullinated
protein antibodies (ACPAs) have been
described. Allergic asthma is associated
with increased exhaled nitric oxide (FeNO)
measurements. Therefore, asthmatic
patients with increased FeNO measure-
ments may also develop IgG and IgE AC-
PAs. Hence, the aim of this study was to
determine if IgG and IgE ACPAs are pres-
ent in sera of atopic asthmatic patients.
Method: Prospective cohort study. A
blood sample was obtained from atopic
asthmatic patients whose levels of FeNO
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were ≥ 50 parts per billion (ppb) (n = 37)
and from atopic non asthmatic patients
with levels of FeNO ≤ 50 ppb (control;
n = 6). All patients were tested for IgE and
IgG ACPAs using an ELISA technic (Pha-
dia, Germany) on the ImmunoCAP 100
instrument according to the manufacturer’s
instructions.
Results: Forty-three patients (25 female
and 18 male) with a mean age of 32 years
were included. IgG-ACPAs were detected
in only one asthmatic patient and in none
of the atopic controls. On the other hand,
IgE-ACPAs were detected in between
43.2% (n = 16) and 75% (n = 27) of the
asthmatic patients depending on the cut-off
point used and in one atopic non-asthmatic
control. Regarding relationship between
IgE-ACPAs and FeNO measurements,
patients with asthma with FeNO levels
between 100 and 150 ppb had increased
IgE-ACPAs values (P < 0.05).
Conclusion: This is first study in which the
presence of IgE-ACPAs has been described
in patients with extrinsic asthma and
increased FeNO measurements. However,
in humans, the potential role of ACPAs in
asthmatic patients has not yet been eluci-
dated.
607
Identification of serum biomarkers in
patients with asthma and other allergic
diseases in Venezuela
De Sanctis, JB1; Larocca, NE2; Moreno, D2; Garmendia,
J1; Martın-Rojo, J1; Talamo, C3
1Instituto de Inmunologıa, Universidad Central de
Venezuela, Caracas, Venezuela; 2Catedra de Patologıa
General y Fisiopatologıa, Universidad Central de
Venezuela, Caracas, Venezuela; 3Sevicio de
Neumonologıa, Universidad Central de Venezuela,
Caracas, Venezuela
Background: Asthma is a chronic inflam-
matory respiratory disease with a high
prevalence around the world. Several bio-
markers (particular induced sputum analy-
sis, pulmonary function tests as spirometry
and the fraction of nitric oxide in exhaled
air) have been tests to assess disease activ-
ity and predict potential response to ther-
apy. Currently, the value of serum
biomarkers remains controversial. Few
studies have evaluated serum biomarkers
in association with asthma and other aller-
gic diseases in our mixed-race population.
The aim of this study was explore the asso-
ciation between serum concentrations of
several cytokines and other soluble media-
tors in subjects with asthma and other
allergic diseases in Venezuelan population.
Method: We measured 20 serum biomar-
kers in 165 subjects with asthma, 65 aller-
gic subjects without asthma and 140
healthy controls, using serum samples and
differents commercial kits based in enzyme
inmmunoassay for detect follows mole-
cules: IgG and IgE antibodies for Toxo-
cara canis and Strongyloides stercolaris; C-
Reactive Protein (CRP); sCD54, sCD62L,
sCD154; nitric oxide (NO) oxidation prod-
ucts: nitrites, nitrates and nitrotyrosine;
proinflammatory cytokines: Tumor Necro-
sis Factor (TNF), IL-6 and IL-8; metallo-
proteinases: MMP-2, MMP-3 and MMP-9;
metalloproteinases inhibitors as tissue
inhibitor of metalloproteinase-1 (TIMP-1);
alpha-1 antitrypsin; malondialdehyde, glu-
tathione and antioxidized LDL antibody
(anti-oxLDL).
Results: We observed significant differ-
ences between asthmatics patients and ato-
pic and controls subjects; asthmatic
patients had higher levels of inflammatory
proteins (CRP, TNF), activation soluble
markers (sCD54, sCD62L and sCD154),
stress oxidative molecules (nitrotyrosine,
malondialdehyde and anti-oxLDL) and
metalloproteinases (MMP-3 and MMP-9)
(P < 0.01). In the group with asthma, we
also observed glutathione, nitrites and
nitrates levels lower than controls
(P < 0.01).
Conclusion: This study supports the
hypothesis that an imbalance between oxi-
dant-antioxidant and proteases-antiproteas-
es are associated to the oxidative stress
which plays a significant role in progres-
sion and severity of asthma. In the future
similar studies could evaluate the utility of
these biomarkers in clinical practice for to
make more accurate diagnoses, identify
individual′s disease phenotype and create
personalized therapies.
609
Correlation between asthma and plasma
omega fatty acids
Yoon, HR1; Ahn, YU1; Yeo, SH2; Kwon, SH3; Lee, SH3;
Lee, KR3; Kim, SH4; Chang, SI5; Yoon, HJ4
1College of Pharmacy, Duksung Women’s University,
Seoul, Korea; 2AB Applied Biosystems, Seoul, Korea;
3Seoul Medical Science Institute, Seoul, Korea; 4Internal
Medicine, Hanyang University College of Medicine,
Seoul, Korea; 5Sungae General Hospital, Seoul, Korea
Background: The purpose of study was to
conduct possible value of omega-3 fatty
acid supplementation in asthma was
sparked by Horrobin’s hypothesis that the
low incidence of asthma in Eskimos stems
from their consumption of large quantities
of oily fish, rich in omega-3 fatty acids. As
a first preliminary research, this study con-
ducted correlation between asthma and
plasma omega fatty acids in asthma
patients for the evidence for the preventive,
health effects of omega-3 fatty acids.
Method: A sensitive, de novo analytical
method was developed for the direct deter-
mination of omega fatty acids in plasma
without complicate preparation by MS/
MS. Five microlitre of a-linolenic acid
(ALA), docosahexaenoic acid (DHA), do-
cosapentaenoic acid (DPA), arachidonic
acid (AA) and eicosapentaenoic acid
(EPA) (50 ng/ml each) of standard solu-
tions were injected through guard column
into the source of negative ion electrospray
MS/MS was set with specific ions (ALA;
m/z 277.2?233.1, DHA; m/z 327.2?
283.3, DPA; m/z 329.1?285.3, AA; m/z
303.3?259.2, EPA; m/z 327.2?283.3)
using multiple reaction monitoring mode.
Calibration curve against 5 omega fatty
acids studied showed correlation coefficient
of more than 0.98 in the range of 5–
1000 ng/ml (n = 3) on plasma matrix.
Plasma concentration of omega fatty acids
was quantified using the new method.
Results: Plasma concentration of 5 omega
fatty acids for asthma group (n = 20) were
approximately less than 20% to the
healthy control group (n = 100). DHA; less
than 20% of normal, EPA and AA; less
than 16.6% of normal, ALA; less than
30% of normal, DPA; less than 18.8% of
normal.
Conclusion: This result speculates that defi-
cient concentration of plasma omega fatty
acids in asthma patients might one of the
causes of exacerbation of asthma.
610
Atopy, exhaled nitric oxide and body
mass index in patients with asthma
Sergeeva, G1; Leshenkova, E1; Kozireva, L1; Rebrova,
S1; Emelyanov, A1
1North-Western Medical University, Saint-Petersburg,
Russia
Background: We examined the relationship
between body mass index (BMI) and
exhaled NO (FeNO) as a marker of airway
inflammation in patients with atopic vs
non-atopic asthma.
Method: In 116 out-patients (aged 18–
81 years, mean age 52 years, 28% males)
with asthma spirometry and body mass
index (BMI) were measured. Skin prick
tests or serum specific IgE to common
inhalant allergens were used to assess ato-
pic status. FeNo was measured by Logan
4100 analyzer. Quality of life and asthma
control were assessed by using Russian ver-
sion of St. George’s Respiratory Question-
naire (SGRQ) and asthma control test
(ACT-test).
Results: Sixty-seven percent were atopic.
Only 4% of patients with asthma were
underweight, 30% had normal BMI, 37%
and 29% were overweight and obese, cor-
respondingly. BMI, severity of asthma,
asthma control and quality of life did not
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differ in atopic and nonatopic asthmatics.
In atopic steroid-na€ıve asthmatics FeNO
was higher than in nonatopic (50.4 vs
14.9 ppb, P < 0.01) and in atopic subjects
treated with ICS (50.4 vs 30.6 ppb,
P < 0.05). We found an inverse relation-
ship between BMI and FeNO (r = 0.36,
P < 0.05) in patients with atopic asthma.
There was a significant correllation
between BMI and FeNO (r = 0.51,
P < 0.05) in non-atopic asthmatics.
Conclusion: Atopy, overweight and obesity
are common in asthmatic patients. There
was a significant correlation between BMI
and FeNO according to atopic status that
may reflect different types of airway
inflammation in asthmatic patients.
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E-cadherin as an epithelial barrier
protein: relation to atopy in children with
asthma
Turkeli, A1; Yilmaz, O1; Taneli, F2; Dinc Horasan, G3;
Toprak Kanik, E1; Kızılkaya, MH4; Gozukara, C2;
Yuksel, H1
1Celal Bayar University, Pediatric Allergy and
Pulmonology, Manisa, Turkey; 2Biochemistry, Celal
Bayar University, Manisa, Turkey; 3Biostatistics, Celal
Bayar University, Manisa, Turkey; 4Department of
Pediatrics, Celal Bayar University, Manisa, Turkey
Background: Epithelium forms the most
important physical barrier of airway. It is
not permeable due to the tight junctions
(TJ) between cells. E-cadherin plays an
important role in development and mainte-
nance of epithelial cel-cell interaction in
the airway. Tight junction proteins ZO-1,
occludin and claudin delocalise and TJs
are distorted if E-cadherin is not ade-
quately expressed. Epithelial permeability
is significantly increased in asthma and
allergens and irritants reach basal layer
more easily. Exhaled breath condensate
(EBC) has been shown to be a reliable
noninvasive method to show biomarkers
specific to the airway in children with
asthma in various studies.
We measured soluble E-cadherin in EBC
in children with asthma to demonstrate
epithelial damage.
Methods: We enrolled 39 atopic and 39
nonatopic children with asthma in this
study. Atopic group consisted of children
who had skin prick test (SPT) positivity to
at least one of the aeroallergen extracts
with protease activity (mite, mold, olea)
Nonatopic group consisted of children who
had negative SPT. Exhaled breath conden-
sate was obtained for measurement of solu-
ble E-cadherin from all children enrolled.
Soluble E-cadherin levels were measured
with the ELISA method.
Results: Age, gender and asthma severity
was not significantly different among the
two groups. Mean levels of soluble E-cadh-
erin in EBC samples from children with
atopic and nonatopic asthma were 0.25
(0.29) ve 0.11 (0.09) ng/ml respectively
(P = 0.08).
Conclusion: Soluble E-cadherin levels were
higher in atopic children with asthma com-
pared to the nonatopic ones though the
difference was statistically insignificant.
This may indicate that E-cadherin slough
off from damaged epithelium is higher in
atopic children with asthma compared to
nonatopic children with asthma due to
allergen exposure.
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Overview on plasma cortisol levels in
asthma and allergy diseases at Manado –
Indonesia
Surachmanto, EE1,2
1Internal Medicine, Sam Ratulangi University, Manado,
Indonesia; 2Internal Medicine, RSUP Prof. R.D. Kandou
Hospital, Manado, Indonesia
Background: Cortisol is a hormone that
plays a role in regulating the immune sys-
tem. Primarily produced in the adrenal
cortex, cortisol secretion is regulated by
adrenocorticotropic hormone (ACTH) and
shows profound circadian rhythmicity and
responsiveness to physical and psychologi-
cal stressors. Recent studies have found
lower levels or reduced responsiveness of
endogenous cortisol to stress in asthma
and allergy. Activation of the hypotha-
lamic-pituitaryadrenal (HPA) axis with
glucocorticoid release is one characteristic
feature of the acute response to stress.
However, the association of endogenous
cortisol levels or responses with airway
inflammatory activity in stress remains
unexplored. The aim of this preliminary
study was to see the level of morning
plasma cortisol in patients with allergic dis-
eases.
Method: Seventy – four chronic allergic
patients (atopic dermatitis, atopic asthma,
rhinitis allergic, chronic atopic urticaria,
etc.), ranging 1–78 years old. All patients
that entered the study were never used or
had discontinued oral steroid at least one
month. Blood sample is collected at 8 am
and serum cortisol is examined by electro-
chemiluminescence immunoassay (ECLIA)
method.
Results: There were 74 chronic allergic
patients consisting of 40 women (54%), 34
men (46%). The allergy diseases were der-
matitis (35 cases), asthma (22 cases), rhini-
tis (7 cases), chronic urticaria (5 cases),
drug allergy (2 cases), food allergy (1 case)
and angioedema (2 cases). Data of the cor-
tisol was performed in the percentage of
the value from the upper limit of normal
cortisol level. Only 8 patients (10.8%) have
normal cortisol level, 66 patient (89.2%)
were below 50% of upper cortisol level, 17
(23%) patients were below normal range
of cortisol level.
Conclusion:
• 89.2% of chronic allergic patients have
cortisol values lower than 50% from
normal upper limit value.
• Blood sample should be taken earlier
at 6.00 am on awakening to have a
more appropriate values
• More sample is needed
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Clinical characteristics and treatment
outcome related with sputum
eosinophilia in Korean asthmatic patients
Choi, BW1; Yoo, J-H2; Jung, J-W1; Choi, J-C3; Shin, J-
W3; Kim, J-Y3; Park, I-W3; COREA (Cohort for Reality,
Evolution of adult Asthma) Research Group
1Department of Internal Medicine, Division of
Respirology and Allergy, Chung-Ang University
Hospital, Seoul, Korea; 2Department of Internal
Medicine, Division of Respirology, KyungHee University
Hospital at Gangdong, Seoul, Korea; 3Department of
Internal Medicine, Chung-Ang University Hospital,
Seoul, Korea
Background: Allergic diseases including
bronchial asthma can develop in individu-
als who are sensitised to indoor or outdoor
allergens, and subsequently induce immu-
nologic hypersensitivity reactions. Sensitiv-
ity to fungal allergens has been recognised
as a risk factor for the development of
asthma and may be related to persistent
asthma, severe asthma, and potentially
fatal asthma exacerbations.
We conducted this study to evaluate
baseline clinical characteristics and treat-
ment responses of asthmatics with and
without atopy and atopy to fungus in Kor-
ean asthma patients.
Method: The patients with bronchial
asthma who underwent skin prick test at
baseline were selected from COREA
cohort study population. Skin prick tests
were performed using 11 inhalant allergens
including Dermatophagoides pteronyssinus,
D. farinae, tree pollen mixture, grass pol-
len mixture, ragweed, mugwort, cockroach,
Alternaria, Aspergillus, cat and dog. Lung
function was evaluated every 12 months
during 36 months follow-up period. The
subjects received the treatment guided by
symptoms and spirometry according to
Global Initiative for Asthma recommenda-
tions.
Results: The mean age in atopic asthma
(n = 728) and non atopic asthma
(n = 1027) was 40.3 and 54.8 (P < .05).
FEV1 in non atopic asthma was signifi-
cantly lower than in atopic asthma (79.2%
vs 83.5%, P < .05). Paired T test of
FEV1% between baseline and 12, 24, and
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36 months of atopic asthma and non ato-
pic asthma presented significant improve-
ment after treatment (83.5%, 88.4%,
88.5%, 88.2% and 79.2%, 83.3%, 81.6%,
83.8%, respectively P < .0001). Among
patient with atopy, chronologic changes of
FEV1% compared with baseline FEV1%
in fungal sensitisation group were not sig-
nificant in 12, 24 and 36 months (81.4%,
85.5%, 83.1%, 77.4%, P > .05) unlike
atopy to other than fungus group (83.6%,
88.5%, 88.7%, 88.8%, P < .001).
Conclusion: Asthma with atopy to fungus
showed poor treatment outcome compared
with asthma without fungal allergy in
3 years follow-up of Korean asthma cohort
population.
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Nasal challenge with 50 mgs of L-aspirin
for diagnosis of ASA exacerbated
respiratory disease
Reyna, JM1
1Allergy and Clinical Immunology, Zambrano Hellion
Medical Center, Monterrey, Mexico
Background: The ASA exacerbated respi-
ratory disease is an aggressive and continu-
ous inflammatory disease of the airways,
combined with exacerbation of asthma and
rhinitis attacks, after ingestion of ASA and
most of the NSAIDs. The diagnosis can be
established with provocation test using
increasing doses of ASA. Oral challenge is
the most commonly performed, and has
the higher sensitivity. (1)
Method: We assigned three groups of 20
patients. Group 1 were patients with
AERD, group 2 were patients with asthma
and nasal polyps, and group 3 were
healthy volunteers. All the patients sus-
pended the asthma medication before the
nasal challenge and performed an initial
spirometry and rhinomanometry, with at
least an FVC in 80% and a 200 ml of
nasal flow.
We administrated 12.5 mgs of L-aspirin
in each middle tourbinate and 30 min after
we performed another spirometry and rhi-
nomanometry, the nasal challenge was con-
sidered positive if the FEV1 felt down
20% or more or the nasal flow decreased
40% or more, if not, the patients received
another 25 mgs of L-aspirin, and 30 min
later the patients performed another sip-
rometry and rhinomanometry. The nasal
challenge length was 4 h, and none of the
patients had a severe reaction.
At the same time we recorded the clini-
cal changes in the patients: nasal blockade,
change in the color of the turbinates,
sneeze, nasal pruritus, and rhinorrhea. We
gave 1–3 points depending on the severity
of the change, and considered it positive if
it scored 10 or more points.
Results: With the clinical changes we had
a sensibility of 38.2% and a specificity of
96.2% with a positive predictive value of
0.93 and a negative predictive value of 0.54
and 95 interval of confidence. If the FEV1
felt down at least 20% or more, it had a
sensibility of 50% and a specificity of
96%, a PPV of 0.94 and NPV of 0.59, and
if the nasal flow felt down at least 40%, it
had a sensitivity of 73.5% and a specificity
of 96%, a PPV of 0.96 and NPV of 0.73,
and if we had at least 1 positive result of
the three parameters we had a sensitivity
of 85% and a specificity of 96%, with a
PPV of 96.7 and a NPV of 0.83.
Conclusion: The intranasal challenge is a
safe and practical study for the diagnosis
of AERD, and has a sensitivity and speci-
ficity similar to the oral challenge without
the hospitalisations and the risk of severe
reactions.
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Urinary leukotriene E4 levels in atopic
and non-atopic pre-school children with
virus induced asthma: a potential marker
of atopic, virus induced asthma
phenotype?
Marmarinos, A1; Saxoni-Papageorgiou, P2; Manousakis,
E2; Tsentidis, C1; Cassimos, D3; Doxara, A4; Paraskakis,
I4; Gourgiotis, D1
1Laboratory of Clinical Biochemistry – Molecular
Diagnostics, 2nd Pediatric Clinic, Athens University
Medical School, Athens, Greece; 2Department of
Allergy, 2nd Pediatric Clinic, Athens University Medical
School, Athens, Greece; 3Pediatric Department, General
University Hospital of Alexandroupoli, Alexandoupolis,
Greece; 4Department of Clinical Microbiology, ‘P & A
Kyriakou’ Children’s Hospital, Athens, Greece
Aim: To determine the levels of urinary
leukotriene E4 (U-LTE4) in atopic and
non-atopic pre-school children with virus
induced asthma, in an effort to assess the
relationship of urinary LTE4 to particular
asthma phenotype in this age.
Method: Levels of urinary leukotriene E4
were measured by means of Enzyme
Immunoassay (EIA) and the results were
expressed in pg/mg of secreted Creatinine
in 96 pre-school children (mean 3 years)
with virus induced asthma, 52 atopic and
44 non-atopic, during exacerbation and in
remission. Atopy was determined by spe-
cific serum IgE measurement and skin
prick test to a panel of common allergens.
Urinary LTE4 was also measured in 36
age-matched, non-asthmatic, non-atopic
control children. The results were analyzed
using the non-parametric Mann-Whitney
U test.
Results: During exacerbation, U-LTE4
was significantly higher in all children, ato-
pic and non-atopic, with virus-induced
asthma in comparison to A. Remission:
642.20  268 vs 399.45  204, P
value < 0.001 and B. Controls:
642.20  268 vs 271.39  83 P
value < 0.001. Atopic patients demon-
strated significantly higher levels of U-
LTE4 in relation to non atopic, both dur-
ing exacerbation (872.13  246 vs
613.15  150 P value = 0.0013) and in the
remission phase (507.59  182 vs
283.59  160 P value < 0.001). During
remission, a highly significant difference of
U-LTE4 was found to persist when con-
trols were compared to atopic patients:
271.39  83 vs 507.59  182 P
value = 0.002 but not when compared to
non atopic ones: 271.39  83 vs
283.59  160 P value = 0.432.
Conclusion: Urinary leukotriene E4 (U-
LTE4) is a strong indicator of virus
induced asthma exacerbation in pre-school
children, more so in atopics. Increased
basal levels of urinary LTE4 occur only in
atopics. This suggests a potential role of
urinary LTE4 as a marker of atopic, virus
induced asthma in pre-school children.
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Effect of aspirin desensitisation on
cytokine release from T-lymphocytes and
plasma lipoxin levels
Aksu, K1; Kurt, E2; Alatas, €O3; G€ulbas, Z4
1Department of Chest Diseases, Division of Allergy and
Clinical Immunology, Ankara Numune Training and
Research Hospital, Ankara, Turkey; 2Department of
Chest Diseases, Division of Allergy and Clinical
Immunology, Eskisehir Osmangazi University,
Eskisehir, Turkey; 3Department of Biochemistry,
Eskisehir Osmangazi University, Eskisehir, Turkey;
4Department of Haematology, Eskisehir Osmangazi
University, Eskisehir, Turkey
Background: This study aims to evaluate
the release of cytokines from CD4+ and
CD8+ T-lymphocytes and plasma lipoxin
levels in aspirin-exacerbated respiratory
disease (AERD) and to observe the effect
of aspirin desensitisation on these cytokine
and lipoxin levels.
Method: Intracellular IL-4, 5, 10 and IFN-
c release from CD4+ and CD8+ T-lym-
phocytes and plasma lipoxin-A4, 15-epi-
lipoxin-A4 were studied in 23 patients with
AERD and 17 patients with aspirin toler-
ant asthma (ATA) who had been diag-
nosed and followed-up in allergy clinic
between 2009 and 2012 and 16 aspirin tol-
erant healthy controls. For clinical evalua-
tion of the patients spirometry, skin prick
test, asthma control test, nasal symptom
scores and smell scores were also assessed.
Fourteen eligible AERD patients under-
went aspirin desensitisation treatment and
in this group intracellular cytokine release
from T-lymphocytes and plasma lipoxin
levels together with clinical assessment
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were reevaluated after aspirin desensitisa-
tion followed by one-month daily aspirin
treatment.
Results: Among the intracellular cytokines
released from CD4+ and CD8+ T-lym-
phocytes CD4+IL-10 levels were signifi-
cantly higher in AERD patients compared
to healthy controls and CD4+IFN-c levels
were significantly higher in AERD patients
and ATA’s compared to healthy controls.
Plasma lipoxin-A4 and 15-epi-lipoxin-A4
levels were similar among the three study
groups. In AERD patients undergone aspi-
rin desensitisation followed by 1-month
daily aspirin treatment the clinical parame-
ters including asthma control test, nasal
symptom scores and smell scores improved
and CD4+IFN-c levels decreased signifi-
cantly. No significant change in lipoxin lev-
els was recorded. CD4+IFN-c and
CD4+IL-10 levels in AERD patients after
1-month daily aspirin treatment were simi-
lar with the levels in healthy controls.
Conclusion: This study confirms that aspi-
rin desensitisation treatment is an effective
therapeutic option in patients with AERD
and suggests that IFN-c and IL-10 release
from CD4+ T-lymphocytes might be
related to pathogenesis of AERD and
mechanism of action of aspirin desensitisa-
tion treatment.
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The first case diagnosed as both type III
hereditary angioedema and familial
Mediterranean fever
Buyukozturk, S1; Gelincik, A1; Demirturk, M1; Unal, D1;
Colakoglu, B1; Uyguner, Z2; Karaman, V2
1Department of Internal Medicine, Division of Allergy,
Istanbul University, Istanbul Faculty of Medicine,
Istanbul, Turkey; 2Department of Medical Genetics,
Istanbul University, Istanbul Faculty of Medicine,
Istanbul, Turkey
Background: Hereditary Angioedema
(HAE) and Familial Mediterranean Fever
(FMF) are inherited diseases which have
not been reported together before. We
present here the clinical and molecular
findings of a female patient with the con-
current occurrence of Type III HAE and
FMF.
Case report: A 23 year-old patient experi-
encing angioedema abdominal pain and
arthralgia attacks without fever for 5 years
was referred. Although serum inflamma-
tion markers were in normal range in
attack-free periods, they couldn’t be ana-
lyzed during attacks. Her attacks occurred
monthly in association with menstrual peri-
ods. Her mother and sister had similar but
milder symptoms. C1 INH level was 21
(N: 21–39 mg/dl), C4:8.21 (10–40 mg/dl),
C1 INH function: 59 (N:60–130%). Col-
chicine 1.5 mg per day was initiated empir-
ically. At the end of 1 month attacks of
abdominal pain, arthralgias were lessen,
although angioedema continued. Therefore
danazole 200 mg/day was initiated. Two
months later, at her next visit, all of her
symptoms were ceased while she was on
danazole and colchicum dispert daily.
Sequencing of exon 8 on chromosome 11
didn’t reveal any mutations which had
been described in Type I and Type II
hereditary angioedema. Sequencing of F12
revealed homozygous c.-4T>C in the 5′
UTR region of the gene. Targeted muta-
tion analysis of the patient by sequencing
the selected exons (2, 3, 5, 10) of mareno-
strin-encoding fever gene (MEFV gene)
(NM_000243.2; NP_000234.1) which was
shown to be related with FMF, revealed
homozygous alteration of c.605G>A in
exon 2 and heterozygous alteration of
c.2230G>T in exon 10.
Conclusion: Association of homozygous c.-
4T>C in the 5′UTR region of the F12 gene
and variation in factor XII level in plasma
was reported in the literature. It is already
revealed that gain of function mutations in
F12 gene causes HAE III by increasing
factor XII level in plasma. This genetic
alteration, familial nature of the symptoms
and treatment response to danazole suggest
that our patient has a Type III HAE. To
our knowledge this patient is the first case
having both HAE and FMF. Since little is
known for the genetic analyses of Type III
HAE, this patient may possibly represent
more than a coincidence.
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Type I and II hereditary angioedema:
clinical characteristics and treatment
response with human C1-inhibitor
(hC1-INH) in a French cohort
Bouillet, L1,2; Boccon-Gibod, I1,2; Launay, D2,3; Laurent,
J2,4; Floccard, B2,5; Martin, L2,6; Kanny, G2,7; Allaert,
FA8; Catovic, H9; Fain, O2,10; Gompel, A2,11; Pagnier,
A2,12
1Internal Medicine Department, Grenoble University
Hospital, Grenoble, France; 2National Reference Centre
for Angioedema, Grenoble, France; 3Internal Medicine
Department, Lille 2 University, Lille, France; 4Ho^pital
Pompidou and Institut Pasteur, Paris, France; 5Intensive
Care Unit, Edouard Herriot University Hospital, Lyon,
France; 6Dermatology Department, Angers University
Hospital, Angers, France; 7Allergology Unit, Nancy
University Hospital, Nancy, France; 8DIM, CHRU Dijon,
Dijon, France; 9CSL Behring, Paris, France; 10Internal
Medicine Department, Jean Verdier University Hospital,
AP-HP, Bondy, France; 11Gynecology Department,
Cochin University Hospital, AP-HP, Paris, France;
12Grenoble University Hospital, pediatrics, Grenoble,
France
Background: Type I and II hereditary an-
gioedema (HAE) are characterised by a
reduced production or functional deficiency
of C1-Inhibitor (C1-INH), respectively.
Here we report clinical data and treatment
response with hC1-INH in a French popu-
lation of patients with HAE-I/II.
Method: We conducted an analysis of
patients with HAE-I/II included in the
National Angioedema Reference network
from 2007 to December 2012. Data were
obtained from the recently established CO-
hortBeRinertAngiœdeme (COBRA) regis-
try study, which aims to collect
information on all C1-INH-treated patients
with HAE throughout France. The analy-
sis included retrospective data extracted
from patients’ medical records and pro-
spective data directly recorded in the elec-
tronic registry. Data on treatment response
were only available for documented attacks
after COBRA enrollment.
Results: Eighty-nine patients (women:
67.4%) with HAE-I/II treated with human
C1-INH for an average of 4.3  4.9 years
were included. At inclusion in the COBRA
registry, mean age was 35.5  18.2 years
old. The first HAE attack occurred at
13.0  11.3 years, and HAE diagnosis was
made at 18.2  14.1 years. Mean age at
first hC1-INH treatment was
31.4  17.4 years. Fifty-eight percent of
patients received tranexamic acid and 44%
danazol. During the last year before inclu-
sion in the COBRA registry, patients had a
mean 5.5  6.3 attacks. Among these
attacks, 1.0  2.8 were treated with human
C1-INH while 19% of patients received
human C1-INH for prophylaxis. The regis-
try allowed to describe 179 attacks, 164
were retrospective and 11 were prospective
(4 missing data). Localisation was abdomi-
nal in 40.2%, facial in 34.9%, laryngeal in
32.5% and peripheral in 18.9% of patients.
They were moderate (43.5%) or severe
(54.0%) with associated symptoms
(23.5%), essentially nausea/vomiting. A
trigger event was described in 24.0% of
patients, involving stress or trauma. Treat-
ment required 1000 IU in 72.2% of cases
and 1500 IU in 15.2%. After hC1-INH
infusion, HAE symptoms began to
improve within 1 h in 42.5% of patients
and disappeared within 24 h in 56.9% of
patients. Twenty-eight patients (89.3%
older than 18) were prophylactically trea-
ted (once in 64.3% and twice in 28.6%),
mainly before surgery (39.6%) or dental
work (27.9%). Prevention was successful in
97.1% of cases.
Conclusion: The COBRA registry provides
the opportunity to describe HAE-I/II
patients systematically treated with human
C1-INH and monitor its efficacy, either in
attack treatment or prevention.
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Oestrogen-independent type III
hereditary angioedema in a 10-year-old
boy
Bergmann, MM1; Caubet, J-C1; Eigenmann, PA1
1Department of Pediatrics, University Hospital of
Geneva, Allergy Unit, Geneva, Switzerland
Background: Hereditary angioedema
(HAE) is associated with an either quantita-
tive (Type I) or qualitative (type II) defi-
ciency of the protein C1 esterase inhibitor
(C1-INH). Recently HAE type III with nor-
mal C1-INH activity, occurring in woman
and influenced by oestrogens has been
described. HAE represent a rare but chal-
lenging differential diagnosis of acute an-
gioedema, particularly in children. Its
presentation can be similar to other more
frequent causes of angioedema due to hi-
staminic release.
Results: We report of a 10-year-old boy
who presented with subacute edema of the
eyelids, the right hand, the left foot and
the penis as well as dysphagia and epigas-
tric pain. He also presented itchy urticarial
lesions on both hands and feet for about
10 days. No triggering drug, food or infec-
tion could be identified. Six years prior to
this episode, he experienced a similar
attack of angioedema while taking ibupro-
fen for a viral upper airway infection.
Family history revealed maternal episodes
of angioedema in childhood. The sister of
the mother had also described similar
symptoms. No other family members were
affected. Physical examination was remark-
able for pale edema of the penis, the right
hand and left foot, the uvula and the ante-
rior peri-tonsillar pillars. Symptoms rapidly
disappeared after injection of icatibant
with complete regression after about 3–5 h.
Laboratory findings during acute episode
showed normal serum tryptase, fraction 3
and 4 of the complement levels, CH50 and
C1-INH function. Exploration of the
bradykinin metabolism showed an
increased spontaneous activity of kinin-
producing kininogenases. None of the two
known mutations (Thr328Lys/Arg) of fac-
tor XII (FXII) gene associated with an-
gioedema type III were present.
Conclusion: A diagnosis of hereditary an-
gioedema type III was suspected in presence
of a normal initial work-up including C1-
INH activity and C4 level. The pathogenesis
is thought to be mainly due to a gain of
function of the kinin-producing kininogen-
ases. Only a few pediatric cases of type III
HAE have been published so far, all
females. This is the first pediatric male case
of type III HAE published, showing that an-
gioedema with normal C1-INH might also
occur in pediatric population, independent
on gender and hormonal influence.
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Nanofiltrated C1-esterase-inhibitor in the
prophylactic treatment of hereditary
angioedema
Strassen, U1; Bas, M1; Hajdu, Z1; Buchberger, M1
1Klinikum rechts der Isar der Technischen Universit€at
M€unchen, Hals-Nasen-Ohrenklinik und Poliklinik,
Munich, Germany
Background: Hereditary angioedema is a
rare genetic disease induced by a deficiency
of the C1 esterase inhibitor. It is associated
with increased bradykinin levels leading to
raised vascular permeability. Consequently
patients develop recurrent edema of (sub-)
cutaneous and mucosal structures. Current
therapy consists of substitution of C1-
esterase-inhibitor concentrate or B2 brady-
kinin receptor antagonists. Prophylactic
therapy is recommended in severe cases.
Method: On demand therapy with Berinert
P 1500 units and/or Firazyr 30 mg was
compared with prophylactic therapy in
three patients. Prophylactic therapy con-
sisted of a dose of 1000 units Cinryze twice
weekly. Cinryze was self-administered by
patients intravenously. Patient diaries and
patient files were used to compare symp-
tom control, quality of life, adverse events
and administered dosage per month.
Results: We could show that prophylactic
therapy with Cinryze led to significant
improvement in symptom control and
quality of life. Drug dosage could be
reduced in both cases. Self-administration
was rated well by both patients. Except for
a local rash after injection of Firazyr no
adverse events were reported for either of
the drugs.
Conclusion: Long term prophylactic ther-
apy with Cinryze for severe forms of




experience with short term prophylaxis:
responses to an on-line questionnaire
survey
Bernstein, JA1; Singh, U1; Wilmont, J2
1Internal Medicine, University of Cincinnati, Cincinnati,
OH, United States; 2HAEA Organization, Honolulu, HI,
United States
Background: The objective was to assess
HAE patient experience with short term
prophylaxis (STP) before surgical/medical
procedures (SMP).
Method: An on-line questionnaire was dis-
tributed to HAE patients to obtain infor-
mation about STP and efficacy. The first
250 respondents were included however
only data from Type I and II HAE
patients (n = 219) were analyzed using
descriptive statistics.
Results: Demographics of respondents:
Average (AVG) age 40 years (range 7–82);
Type 1–182(73%), Type 2–37(15%); AVG
# of attacks/year 29 mostly extremities and
abdomen; 13% previously intubated; 74%
with prodromes of which 85% predicted
an attack; most frequent triggers (>50%)-
emotions (87%), physical stress (79%),
trauma (77%), spontaneous (74%), hor-
mones (54%); most frequent SMP triggers-
dental (40%), surgery (38%), pregnancy
(18%), labor and delivery (8%), endoscopy
(5%). Patients receiving prophylaxis: 36%
(73/201) Cinryze; 21%(43/201) androgens.
Patients receiving OD treatment: 42(21%)
Berinert, 17(8%) Kalbitor, 18(9%) Icati-
bant, 7(4%) fresh frozen plasma. 15%(33/
219) used STP: SPT alone used in 19/33
(58%) which was effective in 13/19(68%);
SPT+OD(x1) used in 14/30(42%) which
was effective in 5/14(36%); Only 1/8
(12.5%) requiring >1 OD treatment
responded.
Conclusion: A small percentage of HAE
patients reported experience with STP pos-
sibly due to fear of precipitating attacks.
42% receiving STP still required OD treat-
Table 1 Effectiveness of short term prophylaxis
PROCEDURE Total (n) Dental 4 Surgery 6 Endoscopy 1 Dental+Surg 8 Surg+Endo 1 Dental+Endo 6 Dental+Endo+Surg 7
STP n, Eff (%) n, Eff (%) n, Eff (%) n, Eff (%) n, Eff (%) n, Eff (%) n, Eff (%)
STP alone 2 2/2 (100%) 4 2/4 (50%) .. 3 3/6 (50%) 1 1/1 (100%) 5 5/5 (100%) 4 4/6 (67%)
STP+OD(x1) 0 1 1/1 (100%) 1 1/1 (100%) 3 3/3 (100%) .. .. 2 1/2 (50%)
STP+OD(x2) 1 0/1 (0%) .. .. .. .. .. 1 1/1 (100%)
STP+OD(x3) 1 0/1 (0%) .. .. .. .. .. 1 0/1(0%)
STP+OD(x4) .. .. .. 2 0/2 (0%) .. 1 0/1 (0%) ..
OD alone .. 1 0/1 (0%) .. .. .. .. ..
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ment supporting current recommendations
for STP before SMP and having OD treat-
ment readily available for breakthrough
attacks.
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Barriers to the treatment of hereditary
angioedema by self-administration:
results of a physician survey
Boysen, HB1; Bouillet, L2; Neri, S3; Hebert, J4; Craig, T5;
Ayg€oren-P€urs€un, E6; Martinez-Saguer, I7; Bethune, C8
1HAEi – International Patient Organization for C1
Inhibitor Deficiencies, Aarhus, Denmark; 2Grenoble
University Hospital and National Reference Centre for
Angioedema, Grenoble, France; 3University of Catania
Policlinico, Catania, Italy; 4Centre de Recherche
Appliquee en Allergie de Quebec, Quebec, Canada;
5Penn State University, Hershey, PA, United States;
6University Hospital Frankfurt, Frankfurt, Germany;
7H€amophilie-Zentrum Rhein Main, M€orfelden-Walldorf,
Germany; 8Derriford Hospital, Plymouth, United
Kingdom
Background: Hereditary angioedema
(HAE) treatment options include prophy-
laxis to prevent attacks and emergency
treatment to provide rapid relief or preven-
tion of complications during an attack. As
attack timing and severity are unpredict-
able, all patients should have an acute
attack management plan. The option of
self-administration is offered to patients
but uptake varies. Advice on current prac-
tice of self-administration and best practice
was discussed at an international HAE
expert meeting held in Geneva.
Method: A 16-question survey related to
HAE treatment and self-administration
was sent to 21 centres across Europe, the
United States and Canada. Ten centres
completed their questionnaires and results
were used to stimulate discussion at the
international HAE expert meeting to gain
an insight into current practice of HAE
self-administration, focusing on treatment
of acute attacks.
Results: Survey participants identified the
main barrier to self-administration as diffi-
culty in injection and infusion skill set
(mainly for intravenous treatment). Discus-
sions highlighted that more trained nurses
were required, especially in smaller centres.
Interestingly, most participants felt that
once patients were trained most retained
their skills long-term. Eligible patients
must be voluntary, adherent, be able to be
educated and present with sufficiently fre-
quent attacks to maintain their skills.
Although there were no major concerns
with offering self-administration, partici-
pants did discuss the possibility of infec-
tion as a potential risk; however, consensus
was that infection rates were no different
to those seen in the clinic. All participants
of the international HAE expert meeting
felt that quality of life was improved with
self-administration. Emphasising the bene-
fits associated with this could help with
patient motivation and encourage further
patients to adopt self-administration.
Conclusion: Barriers to the treatment of
HAE were identified by participants of the
international HAE expert meeting and
solutions proposed. Participants perceived
self-administration to be an advantage to
their patients, by improving quality of life
and enabling them to manage their disease.
The international HAE expert meeting par-
ticipants believed all patients should be
considered for self-administration; how-
ever, some patients may need more support
than others. Training programmes for
medical staff and patients should be imple-
mented to help with disease management.
624
Type-III hereditary angioedema-like
syndrome responsive to C1-esterase
inhibitor replacement therapy
O’Keefe, A1; Mccusker, C1; Ben-Shoshan, M1
1McGill, Pediatrics – Allergy and Immunology,
Montreal, QC, Canada
Background: Hereditary angioedema
(HAE) has been classified as a quantitative
(type I) or functional (type II) deficiency of
C1-esterase inhibitor (C1-INH). More
recently, a third type of HAE has been
described in patients with normal C1-INH.
While C4 levels are characteristically low
in HAE type I and II they are within the
normal range in patients with type III
HAE. Type III HAE is a highly heteroge-
neous and includes cases related to factor
XII mutation as well as cases with an
unknown genetic mutation. Further, high
estrogen levels are reported to trigger an-
gioedema in HAE type III.
We describe a case of recurrent oropha-
ryngeal angioedema in a 16- year old male
with a history of sickle cell disease and
thrombocytopenia with no family history
of angioedema. His angioedema resulted in
severe dyspnea requiring oxygen supple-
mentation. Endoscopy performed during
the episode revealed substantial upper air-
way obstruction.
Results: Emergency treatment of angioe-
dema with C1-INH provided immediate
relief, avoiding the placement of a surgical
airway. Further evaluation has shown nor-
mal levels of C3, C4 and normal levels and
function of C1-INH.
Conclusion: Our case exemplifies that
regardless of the etiology of HAE, prompt
treatment with C1-INH may be an effec-
tive and life saving management strategy.
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The impact of hereditary angioedema on
patients′ daily life
Gulbahar, O1; G€okmen, NM1; Erdogan, AP1; Erdogdu,
D2; Koc, ZP1; Sin, AZ1; Ardeniz, O1; Gurlek, F1; Buyukoz-
turk, S2; Gelincik, A2; Kokuludag, A1
1Internal Medicine Allergy & Immunology, Ege
University Medical Faculty, Izmir, Turkey; 2Division of
Allergy, Department of Internal Medicine, Istanbul
Faculty of Medicine, Istanbul University, Istanbul,
Turkey
Background: Hereditary angioedema is
characterised by C1-esterase inhibitor defi-
ciency resulting in unpredictable and recur-
rent subcutaneous edema and mucosal
swelling of respiratory and gastrointestinal
tracts. We performed this study to investi-
gate the impact of the disease on patients’
daily life.
Method: Twenty-nine patients were ques-
tioned about the effects of the disease on
their life using a 0–5 scale (0: no effect; 5:
insupportable).
Results: The majority of patients were
female (58.6%). The mean age was
39.10  13.62 years. The mean age at the
time of first angioedema symptom was
11.13  6.33 years. Age at the time of
diagnosis was 31.44  14.14. The main
triggering factor was stress (69%), followed
by trauma (65.5%). Thirty-one percent
reported no obvious factor for an attack.
In general 3.4% of the patients’ defined the
disease as insupportable and 13.8% very
severe. Severe to insupportable symptoms
were present in 55.1% of the patients for
abdominal attacks, followed by respiratory
(48.2%) and cutaneous (40%) symptoms.
Forty-eight percent reported that the dis-
ease had negative impacts on their future
projects. Thirty-four percent had a relative
that died because of this disease, and 6.9%
had witnessed to a death of a family mem-
ber. Only 44.8% of the patients reported
that the disease was under control with the
medications. Forty-seven percent of the
females defined the side effects of the drugs
(mainly anabolic steroids) as severe to
insupportable.
Conclusion: Hereditary angioedema has
serious impacts on patients′ lives. Every
attempt should be taken in consideration
to increase their quality of life.
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Two village screening of hereditary
angioedema on the basis of on index
case
Keskin, €O1; €Ozkars, MY1; Bayram, N2; K€uc€ukosmanoglu,
E1; Zeyrek, D3; Bayram, H2
1Pediatric Allergy, University of Gaziantep, G.Antep,
Turkey; 2Chest Diseases, University of Gaziantep,
G.Antep, Turkey; 3Pediatric Allergy, University of
Harran, S .Urfa, Turkey
Background: Inherited as an autosomal
dominant hereditary angioedema (HAE),
1/10 000–150 000 frequency is observed.
Characterised by recurrent episodes of an-
gioedema is a deadly disease. Basically, a
protein called C1 inhibitor deficiency or
insufficient due to function. Tend to
become worse with puberty and after the
disease lasts a lifetime. Diagnosis can be
an average of 10 years.
Method: Totally 124 person (60 male, 64
female) were screaned in two villages on
the basis of on index case. The frequency
and severity of symptoms were scored from
zer oto eight. C4 and C1 esterase inhibitor
protein (C1-INH) levels vere measured in
124 person.
Results: Low C4 levels were found in 42
persons, 82 persons were found healthy.
There were 35 patients with C1-INH defi-
ciency. There was a positive corelation
between C1-INH and C4 levels (N = 124,
P < 0.0001, r = 0.81).
There was a negative corelation between
C1-INH levels and symptom score in peo-
ple who are older than 18 years old
(P = 0.003, r = 0.417, N = 50).
Conclusion: It’s well known that there’s a
long term period of delay in the diagnosis
of HAE. Our study showed the importance
of screaning of HAE on the basis of on
index case noteworthy, none of the patient
with HAE was diagnosed before our screa-
ning. Additionally we showed the negative
correlation between C1-INH level and
symptom scored.
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Impact of C1 inhibitor self-administration
on clinical outcomes in hereditary
angioedema patients
Squeglia, V1; Bova, M1; Petraroli, A1; Staiano, RI1; Pa-
rente, R2; Marone, G1; Triggiani, M2; Del Mastro, A3
1University of Naples ‘Federico II’, Allergy and Clinical
Immunology, Naples, Italy; 2University of Salerno,
Division of Allergy and Clinical Immunology, Salerno,
Italy; 3University of Naples ‘Federico II’, Allergy and
Clinical Immunology, Naples, Italy
Background: Hereditary angioedema due
to C1-inhibitor deficiency (HAE) is a
genetic disorder characterised by recurrent
attacks of subcutaneous and/or submuco-
sal edema that resolve within 48 to 96 h.
Replacement therapy with intravenous
plasma-derived C1-inhibitor (pdC1INH) is
used to treat acute HAE attacks. New
guidelines indicate that home pdC1INH
self-administration programs should be
offered to patients We report our experi-
ence in the treatment of acute HAE attacks
with pdC1INH using home therapy under
clinical supervision.
Method: Sixty HAE patients are currently
seen in our Divisions. In the last 2 years
patients were offered the possibility to
attend self-administration courses. Courses
were attended by 17 patients and 10
patients’ relatives (parents were involved
for patients <18 years old). Thirteen of the
17 patients chose to participate in the
home therapy program: three patients
administered the drug themselves while in
the 10 remaining patients the infusion ther-
apy was administered by their relatives.
Results: The number of hospitalisations
for pdC1INH administration before home
therapy program was 131 on 323 attacks
(41%) per year, with an average of 10 infu-
sions per patient. The average time
between the onset of attack and infusion
of pdC1INH was 3.7 h while the average
time to initiation of relief and complete
resolution of symptoms was 1.4 h and
15.3 h, respectively. Lost days of work/
school were 245 per year with an average
of 18.8 for person and 0.8 for attack. After
self-administration courses the number of
hospitalisations was 36 on 285 attacks
(13%) per year, with an average of 2.8
infusions per patient. The average time
between the onset of attack and the infu-
sion was 2.5 h while the average time to
initiation of relief and complete symptom
resolution was 0.9 and 13.4 h, respectively.
The missed days of work/school were 87
per year with an average of 6.7 for person
and 0.3 for attack. Only 2 patients experi-
enced mild local side effects at the site of
injection.
Conclusion: Home treatment and self-
administration offer a good and safe alter-
native to the hospital treatment by provid-
ing a significant reduction in the rate of
hospitalisations and in the average loss of
work/school per person and attack. Fur-
thermore, self-administration shortens the
time between the onset of the attack and
the initiation of relief or complete resolu-
tion of symptoms.
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Hereditary angioedema: burden of
emergency department visits
Viegas, LP1; Soares, JB1; Ferreira, MB1,2; Spınola, AS1;
Barbosa, MP1,2
1Hospital Santa Maria – CHLN, Lisbon – Portugal,
Immunoallergology Department, Lisbon, Portugal;
2Faculdade de Medicina da Universidade de Lisboa,
Lisbon, Portugal
Background: Hereditary angioedema
(HAE) is a rare disease caused by C1
inhibitor (C1INH) deficiency leading to
recurrent attacks of edema of the skin, gas-
trointestinal or respiratory tracts, with var-
iable severity. Although many attacks are
managed at home by the patients, others
lead to Emergency Department (ED) visits.
Aim: Evaluate the burden of our hospital’s
ED visits of a HAE patients’ cohort from
Jan/2011 to Dec/2012.
Method: Retrospective study of ED visits
registered in ALERTTM electronic database
of our hospital. We evaluated the number
of ED visits per patient (pt), clinical mani-
festations, treatment received, duration of















Abdomen 37 (14) 12 14 1 7 3 374/345/136/947 12 25
Pharynx-
larynx
9 (8) 5 4 0 0 0 487/407/215/826 4 5
Face 7 (6) 1 4 1 0 1 358/335/47/580 3 4
Extremities 5 (5) 1 1 1 0 2 215/193/31/373 0 5
TOTAL 58 (24) 19 23 3 7 6 377/359/31/947 19 (13) 39 (11)
253© 2013 The Authors
Allergy © 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd, 68 (Suppl. 97), 189–336
Poster Session 13 – Innovative developments in hereditary angioedema
ED stay and outcome (hospital admission
or ED discharge).
Results: Of a total cohort of 97 HAE
patients followed in our Department, 24
(24.7%) pts visited the ED for an HAE
attack 58 times in the period studied (mean
2.4 visits/2 years/pt, median 1.5; min 1,
max 9).
Clinical manifestations were as follows:
abdominal – 37; pharyngolaryngeal – 9,
face – 7, extremities – 5. Pain scale assess-
ment was available in 30 pts with abdomi-
nal attacks: VAS score 0–2: 5 pts (16.7%);
3–5: 14 pts (46.6%); 6–10: 11 pts (36.7%).
Conclusion: Most of our HAE patients
didn’t have any ED visit in 2 years, reflect-
ing a good overall disease control of our
cohort. However 25% of our patients had
recurrent ED visits and/or hospital admis-
sions. Most ED visits were due to abdomi-
nal attacks, four times more frequent than
pharyngo-laryngeal attacks as a reason to
seek ED assistance. Early administration
of Icatibant or C1INH could imply reduc-
tion in ED length of stay and in patients’
pain in abdominal attacks. Furthermore,
some patients with abdominal attacks did
not receive adequate therapy, a fact that
underlines the usefulness of home therapy.
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Practicalities of intravenous C1-inhibitor
concentrate self-administration for
hereditary angioedema: discussion from
an international hereditary angioedema
expert meeting
Symons, C1; Sala-Cunill, A2; Cancian, M3; Rossi, O4;
Magerl, M5; Andritschke, K6
1Derriford Hospital, Plymouth Hospitals NHS Trust,
Plymouth, United Kingdom; 2Hospital Universitari Vall
d’Hebron, Barcelona, Spain; 3Clinica Medica 1,
University of Padua, Padova, Italy; 4University of
Florence, Florence, Italy; 5Charite – Universit€atsmedizin
Berlin, Berlin, Germany; 6HZRM, M€orfelden-Walldorf,
Germany
Background: Treatment options for heredi-
tary angioedema (HAE), an autosomal
dominant disease, have increased in recent
years. Until recently, it was common prac-
tice in most countries that patients had to
present at hospital for treatment of an
attack. However, the self-administration
option is increasingly being offered to
patients. Information on current practice
of self-administration of intravenous (IV)
C1-inhibitor (C1-INH), practicalities of
administration and initiatives to encourage
further use were discussed at an interna-
tional HAE expert meeting.
Method: To gain insight into current self-
administration practice with IV C1-INH in
HAE patients, a 16-question survey was
sent to 21 centres in Europe, the United
States and Canada. Ten centres completed
the survey. The results were used to stimu-
late discussion at the international HAE
expert meeting with the aim of identifying
best/current practice and guidance on how
best to advise patients on self-administer-
ing IV C1-INH treatment.
Results: International HAE experts dis-
cussed practicalities of treating and training
patients in the self-administration technique
of IV C1-INH. Self-administration was
identified as a way to intervene early in
acute attacks and give patients control of
their own treatment. Five out of 10 centres
reported 50–74% of their patients self-
administer treatment; 2/10 had 75–89%, 1/
10 had 25–49% and 2/10 had 10–24%. Staff
members were the main people responsible
for training patients (8/12 responses). Par-
ticipants highlighted that, in addition to
training, it was useful to provide guidance
on timing of administration and the impor-
tance of being fully hydrated. As an attack
can happen at any time, implementation of
a 24-hour nurse network/helpline (as avail-
able for haemophilia patients) was viewed
as a useful resource.
Conclusion: The practicalities of self-
administration, as discussed at an interna-
tional HAE expert meeting, highlighted
different practices across Europe. All par-
ticipants agreed the majority of patients
were learning the techniques faster than
expected. A nurse network/24-hour hel-
pline initiative, as available for haemo-
philia patients, may be a useful resource
for patients to rapidly obtain advice.
Training of healthcare providers was noted
as an area for improvement especially in
smaller centres where there may be few
experienced nursing staff. The number of
HAE patients being offered self-adminis-
tration is increasing, and more can be done
to encourage uptake.
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Successful prophylactic treatment with
C1-inhibitor-concentrate in a patient
suffering from high-frequency hereditary
angioedema attacks
Greve, J1,2; Dominas, N1; Arnolds, J1; Bas, M3; Hoff-
mann, TK1,2
1Department of Otorhinolaryngology, University
Hospital Essen, University Duisburg-Essen, Essen,
Germany; 2Department of Otorhinolaryngology,
University Hospital Ulm, Ulm, Germany; 3Department
of Otorhinolaryngology, Technische Universit€at
M€unchen, Munich, Germany
Background: Hereditary angioedema
(HAE) is a rare, autosomal dominant dis-
order caused by C1-INH deficiency (type I)
or qualitative defect (type II). It is charac-
terised by recurrent episodes of edema,
particularly in the abdomen, larynx and
skin, with a frequency which can range
from just a few attacks to >100 attacks per
year. For treating acute attacks, plasma-
derived C1-INH concentrates (Berinert,
Cinryze), a bradykinin B2 receptor antag-
onist (Firazyr), and a recombinant human
C1-INH (Ruconest) are available in Eur-
ope. Short-term and long-term prophylac-
tic treatments were conducted with C1-
INH (Cinryze) and attenuated androgens
(e.g. Danazol, Stanazol).
Method: We report the case of a 66-year-
old patient with type I HAE who suffered a
high frequency of edema attacks, particular
in the head and neck region who was treated
prophylactically with androgens for years
and now, since 2012, receives a prophylactic
therapy with Cinryze. Breakthrough
attacks during both prophylactic treatment
regimens were treated with Firazyr.
Results: Prophylactic therapy with Cin-
ryze resulted in a significant reduction of
attacks compared to a therapy with andro-
gens. Particularly acute, life-threatening
swelling of the head and neck area could
be effectively prevented.
Conclusion: Cinryze proved to be an
effective and save drug for the prophylactic
treatment in a patient with a high fre-
quency of acute HAE attacks.
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Icatibant for the treatment of repeated
attacks of hereditary angioedema: FAST-
3 trial open-label extension study phase
Lumry, W1; Levy, R2; Li, H3; Farkas, H4
1AARA Research Center, Dallas, TX, United States;
2Family Allergy and Asthma Center, PC, Atlanta, GA,
United States; 3Shire HGT Inc., Lexington, MA, United
States; 43rd Department of Internal Medicine,
Semmelweis University, Budapest, Hungary
Background: Hereditary angioedema
(HAE) is characterised by recurrent epi-
sodes of edema of the skin, gastrointesti-
nal, and/or upper respiratory tract. HAE is
caused by deficiency of functional C1-
inhibitor and angioedema is mediated by
elevated bradykinin levels. The clinical effi-
cacy and safety of icatibant, a bradykinin
B2 receptor antagonist, have been estab-
lished in the phase III For Angioedema
Subcutaneous Treatment (FAST)-3
(NCT00912093) study. Here we present
data from the controlled and open-label
extension (OLE) phase of that trial.
Method: FAST-3 was a randomised, dou-
ble-blind, placebo-controlled, multicenter
study of icatibant for the treatment of
adult patients during acute HAE attacks.
Patients with moderate to very severe cuta-
neous and/or abdominal symptoms or mild
to moderate laryngeal symptoms were
randomised to a single subcutaneous injec-
tion of icatibant 30 mg or placebo at the
time of their first HAE attack. For subse-
quent attacks, patients could receive open-
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label icatibant regardless of initial ran-
domisation. The primary endpoint was the
time from icatibant treatment to onset of
patient-reported symptom relief (skin swell-
ing, skin pain, and abdominal pain),
defined as a 50% reduction from the pre-
treatment score in the composite visual
analog scale (VAS) score. Time to onset
symptom relief using VAS score for a sin-
gle primary symptom and safety were sec-
ondary endpoints. Analyses were
performed on the first 5 icatibant-treated
attacks across controlled and OLE phases.
Results: Four hundred and eighty-nine
attacks overall and 435 attacks in the OLE,
were treated with icatibant. The majority of
OLE attacks (95%; n = 415/435) were trea-
ted with 1 icatibant injection. Across the
first 5 icatibant-treated attacks (281/489
attacks), the median time to onset of symp-
tom relief (composite VAS score) was
between 1.9 and 2.1 h, and median time to
onset of primary single symptom relief was
between 1.5 and 2.0 h. Serious adverse
events (SAEs) occurred in 1.1–5.4% of
patients with two patients reported as hav-
ing a possible drug-related SAE. Injection
site reactions were mostly mild to moderate
and transient; no deaths were reported.
Conclusion: These data demonstrated that
icatibant was efficacious over repeated
treatment of multiple HAE attacks. The
majority of attacks required only 1 injec-
tion, and sustained efficacy was observed
across the first 5 icatibant treated attacks.
The safety profile for icatibant was consis-
tent with other icatibant phase 3 trials.
632
A cross-sectional questionnaire survey to
assess physicians′ approach to short-
term prophylaxis in hereditary
angioedema patients
Bernstein, JA1; Singh, U2; Wilmont, J3
1Internal Medicine, University of Cincinnati, Cincinnati,
OH, United States; 2University of Cincinnati, Cincinnati,
OH, United States; 3Hereditary Angioedema
Association, Honolulu, HI, United States
Background: To assess the physician’s
treatment approach for HAE patients
undergoing elective invasive surgical/medi-
cal procedures (SMP).
Method: A retrospective cross sectional
on-line survey was administered to physi-
cians to assess use STP for Type I or II
HAE patients with history (Hx) or regard-
less of history (Hx) of trauma-induced
swelling during minimally invasive SMP
(MISMP; dental work, endoscopy), inva-
sive (ISMP; laporoscopy, surgery, C-sec-
tion) and normal vaginal deliveries (NVD).
STP and on-demand (OD) medications
included pdC1INH (Berinert or Cinryze),
Ecallantide, Icatibant, fresh frozen plasma
(FFP), anabolic steroids (AS) and anti-
fibrinolytic agents (AFA). Questionnaire
responses were analyzed using descriptive
statistics.
Results: Thirty-seven respondents treated
177 HAE patients requiring an ER visit in
the past year; 46 were hospitalised and 12
intubated. 32/37(86%) routinely prescribed
SPT and/or OD therapy for MISMP or
ISMP procedures. For SPT, 14 used Cin-
ryze, 6 AS and 1 AFA; for OD, 32 used I-
catibant, 5 Berinert, 4 FFP, 2 Ecallantide.
For OD-MISMP, OD-ISMP and OD-
NVD uses, Icatibant, Berinert, FFP, Eca-
llantide were prescribed from greatest to
least frequency. For all STP scenarios
(MISMP, ISMP, NVD Hx or Hx) Cin-
ryze was most commonly prescribed.
*OD [9] = number of additional OD
treatments.
Conclusion: SPT of HAE patients under-
going MISMP or ISMP procedures was
most effective in patients with Hx of
trauma induced swelling. The best outcome
was SPT with OD therapy readily available
for a breakthrough attack.
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Icatibant effectiveness and utilisation in
patients with hereditary angioedema:
results from the Czech Republic database
Krcˇmova´, I1; Skoupa, J2; Kuklınek, P3; Zachova, R4; Han-
zlikova, J5
1University Hospital Hradec Kralove, Institute of Clinical
Immunology and Allergology, Hradec Kralove, Czech
Republic; 2Medical Data Center, Charles University,
Prague, Czech Republic; 3Department of Clinical
Immunology and Allergology, University Hospital U
Svate Anny, Brno, Czech Republic; 4Department of
Immunology, Charles University and University
Hospital Motol, Prague, Czech Republic; 5Department of
Immunology and Allergology, University Hospital,
Plzen, Czech Republic
Background: Hereditary angioedema
(HAE) results in elevated plasma levels of
bradykinin, a key mediator of disease
symptoms. Icatibant is a selective bradyki-
nin B2 receptor antagonist which is
approved for HAE type I and type II use
in Europe and currently has temporary
insurance reimbursement in specified HAE
centers in the Czech Republic. The Icati-
bant Database: Czech Republic is a man-
datory registry for all patients prescribed
icatibant. To assess the effectiveness and
utilisation of icatibant, a retrospective
analysis of this database was conducted.
Method: Demographics, HAE history, cur-
rent therapy, frequency and location of
attacks during previous 12 months, and
healthcare utilisation were assessed at the
baseline visit (V0). For all subsequent visits
(V1+), number of attacks with and without
icatibant utilisation, time to recovery
(defined as time to perceived improvement
after injection as stated by the patient),
rate of self-injection, and healthcare utilisa-
tion were recorded.
Results: From March 18, 2011 to Septem-
ber 30, 2012, 113 patients were enrolled
(female: 42%; mean age: 40 years; prophy-
lactic treatment use (mainly danazol):
77%) with a mean time assessment of
465 days. The average number of HAE
attacks within the previous 12 months was
6.20 per patient. From the time of data-
base entry, 750 attacks were recorded; 232
attacks were treated with 239 injections of
icatibant (mean injection rate: 1.03 injec-
tions per attack). The average time to
Table 1 Physician Use of STP
Regimen
MISMP ISMP NVD
#Physicians Effective Regimen #Physicians Effective Regimen #Physicians Effective
n% n% n%
STP(Hx) 5 3(3/5) 60% STP(Hx) 3 2(2/3) 67% STP(Hx) 1 1(1/1) 100%
STP(Hx) + OD[91] 2 2(2/2) 100% STP(Hx) + OD[91] 1 1(1/1) 100% STP(Hx) + OD[91] 0
STP(Hx) 8 3(3/8) 38% STP(Hx) 12 3(3/12) 25% STP(Hx) 5 2(2/5) 40%
STP(Hx) +OD[91] 5 4(4/5) 80% STP(Hx) +OD[91] 9 8(8/9) 89% STP(Hx) +OD[91] 3 2(2/3) 67%
STP(Hx) +OD[92] 1 1(1/1) 100% STP(Hx) +OD[92] 1 1(1/1) 100% STP(Hx) +OD[92] 1 1(1/1) 100%
OD[91] only 2 2(2/2) 100% OD[91] only 0 OD[91] only 0
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recovery was 2 h and by V4, 100% of
patients self-injected. The percentage of
patients requiring hospitalisation, emer-
gency medical service, and rapid emergency
medical service was lower after icatibant
prescription than in the previous
12 months. A similar trend was seen for
percentage of attacks requiring healthcare
utilisation. The greatest difference was seen
in patients requiring hospitalisation (0.93%
of patients with icatibant vs 2.43% of
patients in previous 12 months) and
attacks requiring hospitalisation (0.93% of
attacks in patients with icatibant vs 2.85%
of attacks in previous 12 months).
Conclusion: This database represents a
patient population with HAE in the Czech
Republic. Results from this retrospective
analysis show that icatibant was used in
approximately 30% of all attacks, and
when icatibant was administered there was
a decrease in overall healthcare utilisation.
In addition, patients were readily able to
learn to self-administer icatibant.
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Comparison of costs for on-demand
treatment of hereditary angioedema
symptoms in the United Kingdom
Jolles, S1; Machnig, T2; Zbrozek, A3
1Department of Immunology, University Hospital of
Wales, Cardiff, United Kingdom; 2CSL Behring GmbH,
Marburg, Germany; 3CSL Behring LLC, King of Prussia,
PA, United States
Background: Treatment options approved
in the United Kingdom (UK) for on-
demand use for type I or II attacks of
hereditary angioedema (HAE) provide sim-
ilar efficacy. They differ, however, by the
doses administered per patient and price
per administration, weighted in part by the
need for re-dosing.
Method: A cost minimisation analysis was
used to compare the differences in pro-
cesses required to achieve resolution of
HAE attacks with four drugs approved in
the UK: Berinert (CSL Behring, Ger-
many), Cinryze (Sanquin, The Nether-
lands), Firazyr (Shire, United States), and
Ruconest (Pharming Group N.V, The
Netherlands). The differential costs were
compared indirectly using the official NHS
costs according to the All Wales Medicines
Strategy Group criteria. The results were
weighted by re-dosing frequency estimates.
Results: Based on clinical trial data, fre-
quencies for re-dosing with on-demand
treatment were estimated as 1% for Berin-
ert, 30.9% for Cinryze, 7% for Firazyr,
and 10% for Ruconest. Since Berinert is
dosed based on weight, its dosing in this
analysis ranged from 2 to 4 vials for
patients weighing 50 to 100 kg. An esti-
mated cost of care in hospital of £13 was
applied to Ruconest. Per attack, Berinert
was the least costly therapy when dosed
with either 2 or 3 vials. For patients with
higher body weight needing 4 vials of Ber-
inert, savings were maintained vs Cinryze
and Ruconest.
Conclusion: Berinert for on-demand treat-
ment of HAE in the UK appeared to be
the least costly therapy for a large propor-
tion of patients.
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Concurrent chronic idiopathic urticaria
and autoimmune hepatitis
Pe~na Arellano, MI1; Flores Martin, IM1; Martin Furio,
RM1; Berenguer Trives, E1; Exposito Barroso, F2; Miras
Bruno, JA2
1Hospital Vega Baja, San Bartolome, Spain; 2Hospital
Virgen de la Arrixaca, El Palmar, Spain
Background: Chronic urticaria is defined
as appearance of 24 h of duration wheals
for at least 6 weeks. It is a common skin
disease without clear etiology in most
cases. The presence of serum IgG autoanti-
bodies targeting IgE or the IgE receptor in
approximately 40% of chronic idiopatic
urticaria cases supports the theory of an
autoimmune basis for the disease.
Method: We present a 34 years old woman
who suffers chronic urticarial, since
2 years. She had been taken treatments
with loratadine, rupatadine and several
oral steroids cycles without clinic control.
Personal history: she has rhinitis in the
spring and autumn, without other chronic
disease or treatments associated. She didn′t
drink alcohol
Results: Prick test: positive to olive and
Chenopodiaceae pollen
Blood test: Hemogram and coagulation:
normalerythrocyte sedimentation rate: nor-
mal ALT, AST 114 U/l (0–37), ALT
260 U/l (0–42) Alkaline phosphatase
107 U/l (40–136), total bilirrubin: normal,
LDH 160 U/l (100–190), GGT 220 U/l (5–
85). Iron and ferritin: normal. Αfetopro-
tein:normalIg G: 2040 mg/dl (700–1600).
a1 antitripsin and ceruloplasmin normal-
copper levels in serum and urine: normal-
thyroid hormones: T3, T4, TSH:
normalmarkers of viral hepatitis: negative-
Antinuclear antibodies (ANAs) positive 1/
160, Smooth muscle antibodies (SMA)
positive 1/640, anti Ro-52 positive. AN-
CAs, AMA-M2 3E(BPO), Sp100, PML,
gp210, LKM-1, LC1, SLA/LP, antibodies
antiactin: negative
Liver ecography: light hepatic steatosis
Liver biopsy: lymphoplasmacytic infiltra-
tion with eosinophils in the portal tracts.
Ocasionally limiting erosion. The lobule:
histiocytic nodules, occasional apoptotic
hepatocytes and foci with sinusoidal lym-
phocytosis
Autoimmune Hepatitis Score: 15 proba-
ble autoimmune hepatitis. The patient is
assessed by digestive specialists who diag-
nosed her: Autoimmune Hepatitis. After
autoimmune hepatitis diagnosis the
patient was treated with prednisone and
azathioprine. After that, the hives disap-
peared and transaminase levels were nor-
malised, even after decreasing prednisone
doses.
Conclusion: The association of urticaria
and autoimmune disorders such as thyroid
disease, is well known, but there are few
cases reported with concomitant idiopathic
urticaria and autoimmune hepatitis. We
report a patient with chronic urticaria
clinic associated with autoimmune hepati-
tis, with well response from both entities
after starting treatment with prednisone
and azatioprine.
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Delayed urticaria induced by
antihistamines
Ruiz Leo´n, B1; Candon Morillo, R1; Burgos Montero, A1;
Moreno Mata, E1; Gonzalez Sanchez, LA1; Araque
Arroyo, P2
1Allergy Department, La Mancha Centro Hospital,
Alcazar de San Juan, Ciudad Real, Spain; 2Pharmacy
Department, La Mancha Centro Hospital, Alcazar de
San Juan, Ciudad Real, Spain
Background: H1-Antihistamines are widely
used drugs for allergic diseases. Antihista-
mines are the most commonly used drugs
in the treatment of urticaria, they can
rarely cause adverse cutaneous reaction,
however a few cases Antihistamines-
induced urticaria have been reported.
We report a case of a patient with epi-
sodes of urticaria induced by different clas-
ses of Antihistamines.
Method: The patient was a 52 year old
woman with a history of AAS and Pirazo-
lona allergic, and she presented since
3 month ago, wheal and flares with itching
on her forearms and after 4–5 h of taking
one tablet of levocetirizine 5 mg, she devel-
oped itching, wheal and flares urticaria
extended to the entire body surface.
Skin prick test were performed with a
series of commercially available common
inhalant, latex and Anisakis. To evaluate
hypersensitivity to H1 antihistamines, we
carried out skin prick tests, patch test and
a single-blind, placebo-controlled oral chal-
lenges with antihistamines agents.
Results: His physical examination was nor-
mal. The complete blood count, chemistry,
complement, thyroid hormones were nor-
mal. Subclinical sensitisation to Anisakis
simplex, salsola Kali, olea europea and
mites.





• Four-five hours after oral challenges
with Levocetirizine, Cetirizine, Dexclor-
pheniramine, Loratadine, Hidroxyzine,
Bilastine; she developed an generalised
urticaria reaction. The patient tolerated
an oral challenge with Ranitidine.
Consequently she was diagnosed with
urticaria induced by multiple H1-antihista-
mines.
Conclusion: We presented a patient who
developed delayed urticaria after the intake
of different families of antihistamines.
Adverse drug reactions to histamine H1
antagonists are rare, cutaneous adverse
reactions to orally administered antihista-
mines usually appear within 4–12 h. The
mechanism of AH induced urticaria has
not yet been elucidated; the reactions have
been classified as type I or IV on the basis
of the clinical history and time between
intake and reaction. We have established
the diagnosis by oral challenge.
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Chronic urticaria: a three year review
Moreira, AS1; Rosmaninho, I1; Guilherme, A1; Silva,
JM1
1Centro Hospitalar de Vila Nova de Gaia e Espinho,
Imunoalergologia, Vila Nova de Gaia, Portugal
Background: Chronic urticaria (CU) is an
increasingly prevalent and debilitating dis-
ease which requires effective treatment. The
aim of our study was to characterise the
patients with CU followed in the cutaneous
unit of our department, in the last 3 years.
Method: The following data were retro-
spectively collected from the CU patients
evaluated between January 2010 and
December 2012: gender, age, comorbidities,
duration of disease at first visit, eliciting
factors, urticaria types (UT) and response
to treatment.
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Results: We studied 165 patients, 73% of
which were females. Median age was
39 years (3–88). The main comorbidities
found were: allergic disease (27%), depres-
sion (10%) and thyroid disease (8%). The
disease duration at first visit was ≤1 year
in 54% cases, 1–5 years in 31%, 5–
10 years in 7% and ³ 10 years in 8%. The
most prevalent eliciting factors were pres-
sure (26%), stress (17%) and body temper-
ature increase (16%). 42% of patients had
widespread urticaria. The Urticaria Score
Activity was 3–4 in 52% of the cases. The
most prevalent UT were chronic spontane-
ous urticaria (CSU) 49%, physical urti-
caria 44% (dermographic urticaria (DU)
33%, cold urticaria 6%, delayed pressure
urticaria (DPU) 3%, solar urticaria 3%)
and cholinergic urticaria 16%. Different
UT were found simultaneously in 10% of
the cases. All UT were more prevalent in
females. 69% of patients responded to
treatment with antihistamines (AH) in
standard dosage, 20% to fourfold AH up-
dosing, 8% to leucotrieneantagonist+AH,
2% to association of 2 AH and one patient
to omalizumab. Angioedema was present
in 34% cases (80% of the cases of DPU,
41% of CSU, 33% of cholinergic urticaria,
24% of DU, 20% of solar urticaria and
11% of cold urticaria).
Conclusion: Gender and median age of the
patients studied were similar to those
referred in literature. The majority of
patients had their first visit when disease
duration was ≤1 year. The most prevalent
UT was CSU. Angioedema was more pre-
valent in DPU. Standard dosage of AH
was an effective treatment for the majority
of patients.
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Treatment with off-label omalizumab in
chronic idiopathic histaminergic urticaria
– angioedema resistant to high doses of
antihistamines
Rijo Calderon, Y1; Palao, P1; Prior, N1; Fiandor, A1;
Lopez-Serrano, MC1; Olalde, S1; Quirce, S1; Caballero,
T1
1Allergy Department, Hospital La Paz Institute for
Health Research (IdiPaz), Madrid, Spain
Background: Idiopathic chronic spontane-
ous histaminergic urticaria – angioedema
(ICSHU-AE) is frequently unresponsive to
treatment with high doses of antihista-
mines, needing long therapies with oral
corticosteroids or other immunosupres-
sants. Omalizumab has been reported to be
beneficial in the aforementioned patients.
Method: A retrospective descriptive analy-
sis was performed in patients diagnosed of
ICSHU-AE resistant to high doses antihis-
tamines, in whom off-label omalizumab
had been prescribed during 2011–2012 in
our department.
Results: Twelve patients were included (8
female, 4 male). The mean age at beginning
of symptoms was 35.5 year (M: 34, F: 39).
Six presented urticaria-angioedema (all
female), 4 angioedema (M: 3, F:1) and 2
urticaria (M:1, F: 1). Before the treatment
with omalizumab all the patients had been
treated with antihistamines plus corticoster-
oids and four patients also with dapsone.
The initial dose of omalizumab was
150 mg in five patients, 225 mg in 2
patients and 300 mg in five patients. The
initial interval was 4 weeks for 11 patients
and 2 weeks for one patient.
All the patients presented improvement
after the first dose, including two patients
diagnosed with urticaria-angioedema vas-
culitis. Five patients were asymptomatic
after first dose and seven continued with
mild symptoms. Six patients suspended the
treatment previous to omalizumab just
after the first dose, two patients after the
second one. Three of them continued with
antihistamines, one continued with oral
corticoids up to the seventh dose and other
was able to stop dapsone and to decrease
oral corticosteroid.
Initial omalizumab dose could not be
lowered in any patient, but the interval
between doses could be increased in three
patients (6 weeks in 1 pt; 5 weeks in 2
patients). Omalizumab was withdrawn
because of improvement after the sixth
dose in one patient.
Mild side effects were seen in seven
patients, being the most frequent drowsi-
ness (7 patients), followed by digestive,
cutaneous symptoms, and loss of weight (5
patients). Omalizumab was not stopped in
any patient because of them.
Serum total IgE geometric mean was
101.2 kU/l before treatment and 178.5
post-treatment. The average number of eo-
sinophils was 231.9 cells/mm3 prior to
treatment and 197.2 post-treatment.
Conclusion: Omalizumab was shown to be
effective and safe in patients with ICSHU-
AE unresponsive to other treatments.
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Acute urticaria in the emergency
department: assessment of 565 cases
Pitchon, R1; Reis, DP2; Reis, AP3; Chuster, A3; Monto-
vani, R4; Cunha, MP4; Magno, A4; Alves, V4; Fausto, P4
1Allergy Pediatrician, Hospital Mater Dei, Belo
Horizonte, Brazil; 2Pediatria, Universidade Federal de
Minas Gerai, Belo Horizonte, Brazil; 3Pediatria,
Universidade Ciencias Medicas, Belo Horizonte, Brazil;
4Pediatria, Hospital Mater Dei, Belo Horizonte, Brazil
Background: Assessment of patients admit-
ted with acute urticaria in the Pediatric
Emergency Department.
Methods: Uncontrolled study of 565 chil-
dren and adolescents aged from 0 to
15 years, from January 2012 to December
2012, with acute urticaria (ICD L50).
Results: In this period, a total of 64 203
cases were admitted in the Emergency
Department, of these 565 (0.88%) with
acute urticaria. The incidence was higher
in males (56%) and in children aged
between 1 and 3 years old, which corre-
sponded to 45.5% of the total of cases
diagnosed with acute urticaria. Hospital
medication was prescribed to 33.27% of
the patients. Sixty one cases (10.79%) were
diagnosed with associated diseases, and the
most frequent were infectious diseases in
45 cases (75%). The most common infec-
cious diseases were otitis, acute rhinofaryn-
gitis, acute sinusitis, influenza and acute
tonsillitis (see Table I). In a period of less
than 72 h after the hospital discharge, 19
patients (3.36%) were readmitted. Five
patients were hospitalised, one case associ-
ated with bacterial pneumonia and another
with cellulitis.
Conclusion: Performance measurement of
care quality allows the comparison of data
between institutions and the creation of
incentives for improving care quality stan-
dards. After the results, the staff did a pro-
tocol for the attendance of acute urticaria
and a discharge standard prescription for
the patient and his family.
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Is presence of MEFV gene mutation a
protective factor for chronic idiopathic
urticaria?
Sayın, S1; Taskın, G1; Koc, B1; Yesillik, S2; Arık, D3;
Demirel, F2; Arslan, E1; Tunca, Y3; Sener, O2; Saglam,
K1
1Department of Internal Medicine, Gulhane Military
Medical School, Ankara, Turkey; 2Department of
Internal Medicine, Division of Immunology and Allergic
Diseases, Gulhane Military Medical School, Ankara,
Turkey; 3Department of Medical Genetics, Gulhane
Military Medical School, Ankara, Turkey
Introduction: The structural changes of the
pyrene molecule due to mutations in the
MEFV gene, cause increased leukocyte
migration and a prolonged inflammatory
response to stimuli. Several studies had
shown the relationships between the muta-
tions in the MEFV gene and Behcet ′s Dis-
ease, Rheumatoid Arthritis, Inflammatory
Bowel Disease. Because of unknown etiol-
ogy, we investigated the relationship
between MEFV gene mutation and chronic
idiopathic urticaria (CIU).
Method: We included 42 patients who
were diagnosed as CIU. We compared the
patients with the control group for muta-
tion frequency. The patients with MEFV
gene mutation negative were also com-
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pared with MEFV gene mutation positive
patients.
Results: We determined heterozygous
MEFV gene mutations at six patients and
its frequency was 9.5%. The frequency of
carriage of MEFV gene mutations in
healthy individuals in Turkish society was
20%. There was no statistically significant
difference between the healthy carrier and
CIU patients for the frequency of MEFV
gene mutations. There was also no signifi-
cant difference between the patients with
MEFV gene mutation negative and MEFV
gene mutation positive for age at diagnosis,
disease duration, eosinophil count, sedi-
mentation time, and the incidence of urti-
caria of first-degree relatives.
Conclusion: Despite the detection of
MEFV gene mutation in CIU patients was
lower than healthy society carriers, there
was no statistically significant difference.
In addition, the MEFV gene mutation in
patients with CIU was not contributed to
familial inheritance of the disease, disease
duration and severity.
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Baseline characteristics of patients with
refractory chronic idiopathic/
spontaneous urticaria enrolled in two
phase III, randomised, placebo-controlled
trials of omalizumab
Rose´n, K1; Hsieh, H-J1; Bradley, MS1; Georgiou, P2;
Casale, T3; Maurer, M4
1Genentech, Inc., South San Francisco, CA, United
States; 2Novartis Pharmaceuticals UK Limited,
Horsham, United Kingdom; 3Creighton University
Medical Center, Omaha, NE, United States;
4Department of Dermatology and Allergy,
Charite-Universit€atsmedizin, Berlin, Germany
Background: The characteristics of patients
with refractory chronic idiopathic/sponta-
neous urticaria (CIU/CSU) have been min-
imally reported to date. Here we describe
the baseline characteristics of the study
populations from two Phase III trials
(Asteria-I and Asteria-II) of omalizumab,
an anti-IgE antibody in development for
the treatment of patients with CIU/CSU
who remain symptomatic despite H1-anti-
histamine treatment.
Method: Asteria-I and Asteria-II were glo-
bal, multicentre, randomised, double-blind,
dose-ranging, placebo-controlled studies
evaluating the efficacy and safety of oma-
lizumab in patients aged 12–75 years with
CIU/CSU (for ≥6 months) who remained
symptomatic on approved doses of H1-
antihistamines. Patients were randomised
1 : 1 : 1 : 1 to receive six (Asteria-I) or
three (Asteria-II), 4-weekly subcutaneous
doses of omalizumab (75, 150 or 300 mg)
or placebo over 24 and 12 weeks respec-
tively. The primary end point was Week 12
change from baseline in weekly itch sever-
ity score for both studies.
Results: A total of 640 patients (Asteria-I:
n = 318; Asteria-II: n = 322) were rando-
mised and received treatment. Baseline
demographic data are shown in the table.
In both studies, most patients were female
and white with a high body mass index.
The median duration of CIU/CSU was
>3 years. Angioedema was present in
>40% patients at baseline. Baseline charac-
teristics were generally consistent across
the treatment groups and both studies.
Mean urticaria and itch scores indicated a
high degree of disease activity.
Conclusion: In these two studies, the major-
ity of patients with CIU/CSU who remain
symptomatic despite H1-antihistamine treat-
ment were aged ~40 years and female. A
high incidence of angioedema was seen.
Despite H1-antihistamines, these patients
experienced moderate-to-severe symptoms.
The patient characteristics described in these
two studies mirror the characteristics of the
CIU/CSU patient population reported in
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A retrospective multicenter surveillance
of anaphylaxis in Korea
Jang, G-C1; Ye, Y-M2; Kim, MK3; Kang, H-R4; Kim, T-B5;
Sohn, S-W6; Koh, Y-I7; Park, H-K8; Kim, C-W9; Jee, Y-
K10; Hur, G-Y11; Kim, J-H12; Kim, S-H13; Choi, G-S14;
Lee, S-K15; Park, H-S2; KAAACI Work Group on Urti-
caria/Angioedema/Anaphylaxis
1NHIC Ilsan Hospital, Goyang, Korea; 2Ajou University
School of Medicine, Suwon, Korea; 3Chungbuk
National University, Cheongju, Korea; 4Seoul National
University College of Medicine, Seoul, Korea; 5College
of Medicine, University of Ulsan, Seoul, Korea;
6Dongguk University Ilsan Hospital, Goyang, Korea;
7Chonnam National University Medical School,
Gwangju, Korea; 8Pusan National University School of
Medicine, Pusan, Korea; 9Inha University College of
Medicine, Incheon, Korea; 10Dankook University College
of Medicine, Cheonan, Korea; 11College of Medicine,
Korea University, Seoul, Korea; 12Hallym University
College of Medicine, Anyang, Korea; 13Hanyang
University College of Medicine, Seoul, Korea; 14Kosin
University College of Medicine, Pusan, Korea; 15College
of Medicine, Dong-A University, Pusan, Korea
Background: Little is known about the
characteristics of anaphylaxis in Korea.
We evaluate the incidence of anaphylaxis
and the clinical features of patients with
anaphylaxis in Korean secondary and ter-
tiary care hospitals.
Method: We performed a retrospective
review of 1776 adult patients of anaphy-
laxis (ICD-10 code: T78.0, T78.2, T80.5,
T88.6, T63.4) with same eCRF, including
inpatients, outpatients, and emergency
department visitors, in 15 Korean second-
ary and tertiary care hospitals between
January 1, 2007, and Dec. 31, 2011.
Results: Among 1776 patients, 792 (44.6%)
had past history of allergic diseases and
16.8% had family history of allergic diseases.
Mean age was 46.0  16.0 (16–89) y. The
causes of anaphylaxes were drug (46.6%),
food (24.2%), insect stings (16.6%), exercise-
induced (5.9%), idiopathic (5.3%), and oth-
ers (1.4%). Radiocontrast media and buck-
wheat were the leading causes of drug and
food anaphylaxis, respectively. The organs
most frequently involved in the anaphylaxis
were cutaneous (84.0%), cardiovascular
(55.4%), respiratory (53.9%). general
(21.0%), and gastrointestinal (18.5%). The
rate of bee venom induced anaphylaxis was
relatively high in northern area than seoul
metropolitan area. The rate of food induced
anaphylaxis was relatively high in winter,
and bee venom induced anaphylaxis was rel-
atively high in summer than the other sea-
sons. The cases of annual anaphylaxis had
increasing pattern: 224cases (2007), 328cases
(2008), 334cases (2009), 390cases (2010), and
493cases (2011).
Conclusion: The incidence, and clinical fea-
tures of Korean patients with anaphylaxis
were similar to rates for patients from
other countries, despite some differences in
causative agents, regional distribution, and
seasonal variation.
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Clinical features of cold urticaria patients:
a nine-year retrospective analysis
Demirel, F1; Gulec, M1; Yesillik, S1; Baysan, A1; Kartal,
O1; Musabak, U1; Sener, O1
1Department of Internal Medicine, Division of
Immunology and Allergic Diseases, Gulhane Military
Medical School, Ankara, Turkey
Background: Cold urticaria (CU) is a sub-
type of physical urticarias which is charac-
terised by urticaria and/or angioedema
after cold exposure. We present demo-
graphical and clinical features of subjects
with CU followed by our clinic.
Methods: Detailed medical histories, labo-
ratory tests, cold stimulation test (CST)
and atopy test results were reviewed retro-
spectively.
Results: Seventeen patients (8 male and 9
female) with CU were reviewed. The med-
ian admission age was 38 (min: 20, max:
68) and the median duration of symptoms
were 3 (min: 1, max: 30) years. While 5
patients (29.4%) with CU had the lesions
on all body, 4 patients (23.5%) had on the
extremities and faces; 2 patients (11.8%)
had on faces and 6 patients (35.3%) had
on the extremities only. Seven patients (%
41.2) were suffering from CU during win-
ter, however 10 patients’ (% 58.8) lesions
were active all year long. All laboratory
tests (complete blood count, erythrocyte
sedimentation rate, C-reactive protein,
anti-nuclear antibody, rheumatoid factor,
antistreptolysin-O, cold agglutinins, cryo-
globulins, complement C4 and C3, syphilis,
hepatitis B and C and HIV serologies, thy-
roid hormones, and anti-thyroid peroxi-
dase) were within normal limits. Prick tests
with inhalant allergens revealed that 1
patient had pollen and cockroach allergy, 1
patient had pollen and latex allergy and 1
patient had only pollen allergy. CST was
positive in 9 patients (52.9%) and negative
in eight patients (47.1%).
Conclusion: CU is an important chronic
disorder and the pathogenesis is still
unknown exactly. Although CST is a use-
ful test for diagnosing the CU, it may not
be positive for all the patients. Detailed
personal medical histories still have a great
importance.
Keywords: Cold urticaria, cold stimulation
test
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Chemokines and biomarkers of
endothelial dysfunction in chronic
urticaria
Puxeddu, I1; Panza, F1; Bartaloni, D1; Pratesi, F1; Rocchi,
V1; Del Corso, I1; Migliorini, P1
1Pisa University, Pisa, Italy
Background: Chronic Urticaria (CU) is a
common and disabling disease character-
ised by recurrent itchy wheals with or with-
out angioedema for more than 6 weeks.
These symptoms are the consequence of
skin mast cells degranulation with release
of histamine and other vasoactive media-
tors. The aim of our study is to investigate
the potential involvement of chemotactic
mediators (CCL5/RANTES and CXCL8/
IL-8) and markers of endothelial dysfunc-
tion such as soluble VCAM-1 (sVCAM-1)
and soluble ICAM-1 (sICAM-1) in the
pathogenesis of CU, and their relation with
disease activity.
Method: We measured the levels of CCL5/
RANTES, CXCL8/IL-8, sVCAM-1 and sI-
CAM-1 in the sera of 87 patients with CU
and 61 sex- and age-matched normal
healthy subjects (NHS), using ELISA
assays. According to the results of the
autologous serum skin tests (ASST), CU
patients were classified in the ASST-posi-
tive and ASST-negative subgroups.
Results: We detected significantly higher
concentration of CCL5/RANTES
(P < 0.0001) but not of CXCL8/IL-8 in
the sera of CU patients compared to NHS.
The serum levels of sICAM-1 and
sVCAM-1 were significantly increased in
the CU patients compared to the control
subjects (P = 0.0121 and P = 0.0043,
respectively). No differences in either
chemokines and adhesion molecules levels
was detected in the ASST-positive and
ASST-negative subgroups. Positive correla-
tion has been found between sICAM-1 and
sVCAM-1 but not between them and
CCL5/RANTES.
Conclusion: Our study suggests the poten-
tial involvement of the C-C chemokine
CCL5/RANTES and of the biomarkers of
endothelial dysfunction sICAM-1 and
sVCAM-1 in the pathogenesis of CU.
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Omalizumab: an effective and rapidly
acting therapy in difficult-to-treat chronic
urticaria
Ohanyan, T1; Metz, M1; Church, M1; Maurer, M1
1Department of Dermatology and Allergy, Allergie-
Centrum-Charite, Charite -Universit€atsmedizin Berlin,
Berlin, Germany
Background: Omalizumab (anti-IgE) ther-
apy has been demonstrated to be effective
and safe in chronic urticaria (CU) in pla-
cebo-controlled clinical trials but practical
clinical data are scarce. This report details
the use of omalizumab in difficult-to-treat
CU patients in routine clinical practice.
Method: We assessed responder rates,
optimal dosage, response to up-/downdos-
ing, time to relief of symptoms, rates of
return and time to return of symptoms
after administration of omalizumab and
safety in 51 CU patients, 20 with chronic
spontaneous urticaria (CSU) alone, 21 with
different forms of inducible urticaria and
10 with both, CSU and inducible urticaria
attending the specialist urticaria clinic at
our department.
Results: Omalizumab treatment led to
complete responses in 83% of CSU and
70% of inducible urticaria patients. With a
starting dose of 150 mg omalizumab every
4 weeks, only 2/15 CSU patients and 7/17
inducible urticaria patients who went on to
show complete responses required updos-
ing to achieve this. In CSU, 57% of com-
plete responses occurred within week one,
most on day one after the first treatment.
Relapse times were between 2 and 8 weeks
in all but six patients, where they were
longer than 4 months. Omalizumab was
safe. Efficacy was not correlated to base-
line IgE levels. Omalizumab did not inhibit
codeine- or histamine induced wheal and
flare responses.
Conclusion: Our clinical experience from
more than 1250 injections in 51 patients
over 4 years clearly indicates that oma-
lizumab is a rapidly acting, highly effective
and safe drug in patients with CSU and
inducible urticaria. This supports the rec-
ommendation of the current EAACI/
GA2LEN/EDF/WAO guideline for the
management of urticaria to use oma-
lizumab as a third line treatment in diffi-
cult to treat urticaria patients.
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Sulfite-dependent excercise urticaria
De Luque Pi~nana, V1; Egu¨ez Hidalgo, MF1; Segura San-
chez, C1; Botello Borrego, MD1; Cabeza Rodriguez, N1;
Guardia Martinez, P1
1Allergy and Clinical Immunology Department, Virgen
Macarena University Hospital, Seville, Spain
Background: Within the exercise-induced
anaphylaxis syndrome two well differenti-
ated clinical forms are included: systemic
cholinergic urticaria and exercise induced
anaphylaxis in the strict sense which can
be shown by a classic form or a variant
form, more uncommon and with manifes-
tations similar to cholinergic urticaria.
Postprandial or food-dependent exercise-
induced anaphylaxis is a frequently identi-
fied subtype of these last cases.
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Method: A 38 year old woman with his-
tory of diabetes mellitus who consults by
wheals predominantly on the scalp, arms
and face and otic tamponade, with a fre-
quency of four episodes per year, specify-
ing emergency assistance and treatment
with corticosteroids and antihistamines.
Refers not apparent cause, except when
eating away from home or celebrations like
weddings, coinciding with the intake of
highly processed foods, spicy, rich in pre-
servatives or precooked. She tolerates all
foods and medicaments.
In the latest revision refers wheals after
ingestion of beef burger precooked fol-
lowed by physical exercise.
Results: Basic blood analysis, thyroid pro-
file, complement, total IgE, specific IgE
parasites, and tryptase, all within normal
limits. Skin prick tests to aeroallergens,
food, shrimp, clams, mussels, anisakis and
latex: Negative. Exercise test with spirome-
try control: negative without skin lesions.
Controlled oral challenge was performed
with sulfite at rest with negative results.
Is therefore requested an exercise provo-
cation test and spirometry control after
previous oral sulfites, ten minutes after
this, she presented pruritus and wheals in
neck, scalp, trunk, arms and retroauricular
region, requiring antihistamines and oral
corticosteroids.
The patient was diagnosed with exercise
urticaria dependent sulfites.
Conclusion: We present a case of exercise
urticaria dependent sulfites, not having
found in the literature so far published simi-
lar case. The combined ingestion of sensitis-
ing food and exercise is necessary to
precipitate symptoms, it can be necessary to
perform an exercise challenge test with and
without previous ingestion. The treatment is
preventive and it is based on avoiding the
food or the food allergen some hours before
the exercise. When it does not depend on
foods it is used a prophylactic farmacother-
apy with antihistamines, cromones or
sodium bicarbonate. The patient should be
well educated on the use of epinephrine in
the event of new reactions.
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Chronic urticaria: successful treated with
immunotherapy
Harfi, HA1,2; Ilescas, MM1
1National Center of Allergy, Asthma and Immunology,
Riyadh, Saudi Arabia; 2Immunology, Al Faisal
University, Riyadh, Saudi Arabia
Background: Urticaria is a common aller-
gic problem especially among females. The
underlying are numerous and sometimes
cannot be identified. Treatment at present
is mostly symptomatic. In this report we
successfully treated some patients with
immunotherapy with allergy vaccine.
Method: We prospectedly evaluated 25
patients with urticaria, by detailed history,
physical exam, complete blood count, thy-
roid profile and total and specific IgE by
skin prick test and or UNICAP in vitro
IgE for pollens and foods. Those with
positive reactions to pollens were started
on immunotherapy and were followed reg-
ularly and evaluated for symptoms, drugs
taken and by visual analogue both by
patients and physician.
Results: Twenty-five patients 18 females
and 7 males, their ages ranged from 8 years
to 56 years average 30.68 years. Duration
of urticaria was 10–17 years in six patients,
<1 year in 12 patients, and 1–2 years in
three patients and less than 6 weeks in four
patients, and in four patients the duration
was unknown. Urticaria alone diagnosis
was in seven patients, urticaria and bron-
chial asthma and allergic rhinitis was diag-
nosed in eight patients, and seven patients
had urticaria and allergic rhinitis, and two
patients had urticaria and asthma and one
patient had urticaria, allergic rhinitis and
thyroiditis. Four patients lost to follow up
and in four patients there was no improve-
ment on immunotherapy. Those who
improved, seven patients had visual ana-
logue of 100%, and became asymptomatic,
and six patients visual analogue was 80–
90% with occasional mild symptoms, and
three patients the visual analogue was 70%
and one patient the visual analogue was
505. The success rate of immunotherapy
was 81% and those who had 100%
improvement was 33%. Those who received
allergy vaccine for a longer time had the
highest improvement compared to those
who received it for a shorter period. Usually
some of our patients who show good clinical
response ignore follow up appointments.
Therefore we suspect that some of our four
patients who were lost to follow up may had
good clinical response and did not see the
need to come back.
Conclusion: Immunotherapy is highly suc-
cessful in patients with urticaria when there
are no other causes except allergy to pollens.
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Effect of two different drug regimens
containing higher than conventional
doses of levocetirizine in weaning
urticaria patients from systemic
corticosteroid treatment
Staevska, MT1; Gugutkova, MD1; Lazarova, TC1; Krali-
markova, TZ1; Dimitrov, VD1; Popov, TA1
1Clinical Centre of Allergy, Medical University – Sofia,
Sofia, Bulgaria
Background: Chronic urticaria may
assume a weary course in some patients
leading often to the prescription of corti-
costeroids. Discontinuation of the steroid
usually results in flare up of the urticaria
symptoms, which need to be managed with
alternative means to ensure acceptable
quality of life. European guidelines indicate
modern second generation H1-blockers in
higher than conventional doses as drugs of
choice for difficult-to-treat patients. British
guidelines, however, recommend sedating
antihistamine at night in addition to high
doses non-sedating antihistamine.
Method: We carried out a double-blind
randomised cross-over study to examine
these two different approaches: 5 day treat-
ment with 20 mg levocetirizine (Mono)
and 5 day treatment with 15 mg levocetiri-
zine + 50 mg hydroxyzine at bed-time
(Combo). Patients on 10–30 mg predniso-
lone equivalent were invited for the study;
their steroid was discontinued and the tol-
erability to doses 20 mg levocetirizine and
200 mg hydroxyzine was assessed on sepa-
rate days in hospital environment. Primary
variable was quality of life (QoL) measured
by urticaria specific questionnaire (CU-
Q2oL). Secondary variables were physi-
cian-assessed symptom scores (03) for
wheals and itch, night time sleep distur-
bance and daytime somnolence on separate
100 mm visual analogue scales (VAS).
Higher scores indicated worse symptoms.
Adverse events (AE), blood hematology
and biochemistry were monitored.
Results: Twenty-four patients completed
the study (mean age 45 years; range 19–68;
18 women). CU-Q2oL scores decreased sig-
nificantly, P < 0.001, for both Mono and
Combo, without significant difference
between the 2 regimens, P = 0.25. The
same pattern occurred for the symptom
scores. Nighttime sleep disturbance signifi-
cantly decreased with both Mono and
Combo. Difference emerged in the daytime
somnolence, which was significantly more
pronounced in the Combo group,
P = 0.026. No pathological lab and ECG
findings were registered. None of the
patients experienced serious or severe AE
during the trial.
Conclusion: Worsened QoL of patients
after discontinuation of steroid treatment
can be significantly improved with higher
than standard doses of second generation
antihistamine levocetirizine. Adding to it at
bed-time the first generation hydroxyzine
does not seem to have a benefit for the
patients but is associated with increased
daytime somnolence.
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Peripheral blood gamma delta T cells in
patients with chronic idiopathic urticaria
Khandjian, L1; Alpan, O1
1O & O Alpan LLC, Section on Immunopathogenesis,
Fairfax, United States
Background: Several small sized clinical
studies have shown changes in the percent-
age of peripheral blood gamma/delta T
cells in allergic disorders, in the absence of
any correlation with serum total IgE levels.
We looked at a large cohort of patients
with asthma, food allergies, allergic rhini-
tis, eosinophilic esophagitis and chronic
idiopathic urticaria (CIU), their IgE levels
and peripheral blood eosinophil counts to
assess if a correlation with the percentage
of peripheral blood gamma/delta T cell
exist.
Method: We performed a chart review of
71 adult and pediatric patients looking at
the percentage of CD3 positive gamma/
delta T cells in peripheral blood. Of these
patients, 18 had asthma, 17 had CIU, 18
had allergic rhinitis and 18 had eosino-
philic esophagitis. We compared the
gamma/delta T cell percentage of these
patients to that of 302 normal controls.
Results: Patients with CIU had a lower
percentage of gamma/delta T cells
(P = 0.029) compared to controls. The
control group had a mean of 4.9%
gamma/delta T cells with a standard devia-
tion of 3.22, whereas the group with CIU
had a mean of 2.8% with a standard devi-
ation of 1.66%. We found no correlation
between gamma/delta T cell numbers and
IgE levels or peripheral blood eosinophil
counts. The average gamma/delta T cell
percentage of patients with allergic derma-
titis was 6.5%, in asthma patients 5.4%,
EoE patients 5.2%, rhinitis patients 4.1%.
A control of 302 patients without allergic
disorders had an average of 5.6% gamma/
delta T cells.
Conclusion: Against our predictions,
changes in gamma/delta T cell percentages
were only seen in subjects with CIU and
with a decrease. Gamma delta T cells are
abundant in the skin, playing an important
role in antibacterial defense, tissue repair
and inflammation. Even though these cells
are abundant source of IL-4 and play
important role in allergic inflammation, to
our surprise, we did not see a correlation
with the more IgE medicated disorders.
One of the explanations for our observa-
tions in patients with CIU is that the
decrease we see in the blood may be sec-
ondary to these cells migrating to the skin.
Looking at gamma/delta T cells more clo-
sely, to determine if certain subsets such as
gamma/delta 1 (located in the dermis) and
subset Vgamma9/Vdelta2 (located in the
peripheral blood) show any variation sug-
gesting the presence of such a migration in
subjects with CIU.
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Corylus pollen season onset, peak and
diurnal variation in Vinnitsa, Ukraine
Slobodianiuk, LV1; Rodinkova, VV2; Motruk, II1; Mazur,
OI1; Kremenska, LV2; DuBuske, L3
1Pharmaceutical Chemistry, Vinnytsia National Medical
University, Vinnytsia, Ukraine; 2Pharmacy Department,
Vinnytsia National Medical University, Vinnytsia,
Ukraine; 3Immunology Research Institute of New
England, Gardner, MA, United States
Background: Corylus pollen (hazelnut) is
an international important airborne aller-
gen which has increased from the 1999
when the first monitoring was done in
Vinnitsa when rare Corylus pollen grains
were identified. Hazelnut plants have
increased as the nuts are used by confec-
tionery manufacturers around Vinnitsa.
There is increasing sensitivity to hazelnut
pollen grains due to early seasonal impact
and cross-reactivity with other Betulaceae
family members including Alnus, Carpinus,
Betula.
Method: Pollen counts were obtained at
Vinnitsa National Pirogov Memorial Medi-
cal University (VNMU) in 2010 through
2012 from March 1 until October 31 on
daily basis and in 2012 using a bi-hourly
mode volumetric method with a Burkard
trap on the roof at 25 m above ground.
This study was conducted in association
with the European Aeroallergen Network
(EAN).
Results: Corylus pollen seasonal onset was
March 10 to 17 with the earliest onset
March 10, 2011, and latest March 17, 2010
and March 14, 2012. Peak days were
March 17 to 23. The earliest and lowest
peak (49 p.g./m3) was March 17, 2012 and
the latest one in 2011 was the greatest
(78 p.g/m3). 2010 had a peak of 60 p.g./m3
on March 20. The pollen season lasted to
the end of April in 2011 and 2012 and
until April 13, 2010.
Diurnal data showed the greatest hazel-
nut pollen in the air from 3 a.m. to 5 a.m.
which decreased amounts during the day-
time. The most intense pollination with
concentrations greater than 20 p.g./m3 was
between March 15 to 31 for all years.
Hazelnut pollen allergy symptoms likely
increased during this time each year, with
cross reactive Alnus pollen also peaking at
the same time in Vinnitsa.
Conclusion: Corylus pollen has became an
important airborne allergen in Vinnitsa
recently with intense pollination seen from
March 15 to 31 since 2010 each year. This
pollen may be increasing due to planting
of hazelnut trees for the confection indus-
try. Symptoms due to hazelnut pollen may
be increased in some patients due to cross
reactivity with Alnus which pollinates at
the same time in Vinnitsa.
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Distribution and characteristics of
culturable airborne bioaerosols in a
Swiss milk powder processing facility
Mandal, J1; Lehner, A2; Fricker-Feer, C3; Ziegler, D4;
D€orig, G4; Tomczyk, A4; Stephan, R2; Brandl, H1
1Institute of Evolutionary Biology and Environmental
Studies, University of Z€urich,, Z€urich, Switzerland;
2Institute for Food Safety and Hygiene, University of
Z€urich, Z€urich, Switzerland; 3Hochdorf Nutritec AG,
Hochdorf, Switzerland; 4Mabritec AG, Riehen,
Switzerland
Background: Bioaerosols are part of air-
borne particles ranging from submicron,
<0.2 lm (virus, endotoxins, mycotoxins) to
multi-micron, 0.2–50 lm level (viable
organisms like fungi, bacteria and pollen
grains). These organisms when attached to
dust particles can travel around the pro-
cessing facility and may come in contact
with food products, containers, and other
food contact surfaces during processing.
The aim of the study was to provide
important data on the concentration level,
composition of culturable airborne micro-
organisms in a Swiss milk powder process-
ing facility.
Method: The airborne community (bacte-
ria and fungi) were sampled and character-
ised (concentration level, diversity,
seasonal changes) at different (six indoor,
one outdoor) sites within a dairy produc-
tion facility. Air samples were collected at
two seasonally different sampling dates,
one in February (winter) and the other in
July (summer) 2012 using laser particle
counter and impaction sampler. The isolates
were identified using mass-spectrometric
(MALDI-TOF) as well as molecular
(sequencing of 16S, 23S rRNA, rpoB
genes) based methods.
Results: In general the particle concentra-
tion, size distribution and total counts of
airborne bacteria and fungi were higher in
the winter time than in summer but
remained rather stable within each indoor
sampling site at both sampling times (Feb-
ruary/July) with two exceptions. Peak
(fungal) and bacterial concentrations
occurred at the logistic site with mean val-
ues at 391 + 142 during winter sampling
and 179 + 33 CFU/m3 during the summer
sampling. However, the total bacterial
counts from the outdoor site varied signif-
icantly with a > five time higher concen-
tration observed in the winter time
compared to the summer time sampling.
Numbers of culturable microorganisms
were generally very low (<100 cfu per m3
of air) during milk powder production.
The majority of the airborne bacteria
belonged to the genera Bacillus and
Staphylococcus but a total of 25 different
(gram positive as well as gram negative)
genera were identified in the air. Peniclli-
um camemberti, Penicillium glabrum and
Scropulariopsis brevicaulis were identified
as airborne fungi.
Conclusion: The data generated in this
study will help to evaluate the effectiveness
of the plant’s sanitation program and the
sources of airborne contamination may be




Cassia fistula L. pollen and its allergenic
relationship with Cassia occidentalis L.
pollen
Basak, T1; Pandey, N2; Bhattacharya, K1
1Department of Botany, Visva-Bharati University,
Santiniketan, India; 2Medilland Diagnostic Institute,
Kolkata, India
Background: The purpose of the present
work is to determine the concentration and
seasonal periodicity of Cassia fistula (CF)
pollen grains in the atmosphere of Santi-
niketan, West Bengal, India with an object
to identify the prevalence of sensitisation
to CF pollen among the respiratory allergic
patients in the city along with the IgE
binding proteins of CF pollen and also to
observe the allergenic cross-reactivity of
CF with airborne Cassia occidentalis pol-
len. This may be used further in clinical
and diagnostic purposes for immunother-
apy treatment.
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Method: An aerobiological survey was per-
formed with a personal Burkard volumetric
sampler over a year in Santiniketan of West
Bengal. The allergenic potential of the pol-
len was studied by skin prick tests (in vivo),
IgE-enzyme-linked immunosorbent assay
and IgE specific immunoblotting (in vitro)
methods. Soluble pollen protein in PBS (pH
7.3) was fractionated in 0–20%(CF1), 20–
50%(CF2) and 50–85%(CF3) using
(NH4)2SO4 precipitation. The total protein
resolved in 12% SDS-PAGE and IgE immu-
noblotting was done using sera from six
patients having ELISA p/n > 3.5. Cross-
reactivity of CF pollen with Cassia occiden-
talis was tested by using dot blot method
and inhibition immunoblotting.
Results: Cassia fistula pollen grains were
found to be prevalent in the air of Santi-
niketan from March to September. Skin
prick tests on 243 respiratory allergic
patients [Age range 22–61; M/F = 140/103]
showed 21.4% positive skin reaction, out
of which 6.99% showed +2/3 level of reac-
tion. When SPT was done using ammo-
nium sulphate fractions (CF1, CF2 &
CF3) a maerk change in skin sensitivity
was observerd.Total protein was resolved
into 12 bands in 12% SDS-PAGE and
25.5 kDa, 43 kDa, 64 kDa, 66 kDa,
69 kDa and 81 kDa proteins were found
to have shown positive IgE reactivity
through IgE immunoblotting. CF pollen
was found to be positively cross-reactive
with Cassia occidentalis (CO) and two anti-
genic components of molecular weight
64 kDa and 43 kDa were found to be
inhibited by CO pollen antigenic extract.
Conclusion: Three fractionation i.e. CF1
(0–20%), CF2(20–50%) and CF3(50–85%)
used for SPT also showed greater positiv-
ity, especially the fraction CF3. Six major
protein components of Cassia fistula have
shown sensitisation to atopic patients and
two of them have markedly shown aller-
genic cross reactivity with Cassia occiden-
talis pollen. This information can be
helpful for immunotherapy treatment.
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Surface modifications of SiO2
nanoparticles diminish inflammasome
activation and expression of selected
inflammatory genes
Marzaioli, V1; Thomas, C2; Wiemann, M3; Landsiedel,
R4; Wohlleeben, W4; Weichenmeir, I1; Behrendt, H1;
Traidl-Hoffmann, C1; Schmidt-Weber, C1; Groß, O2;
Gutermuth, J1; Alessandrini, F1
1ZAUM – Center for Allergy & Environment, M€unchen,
Germany; 2Klinikum rechts der Isar, TUM, M€unchen,
Germany; 3IBE R&D, M€unster, Germany; 4BASF,
Ludwigshafen, Germany
Background: Silica nanoparticles (SiO2
NPs) are widely used in diverse industrial
and biomedical applications. Their applica-
bility depends strongly on surface modifi-
cations, which can decrease potential
health hazards. Using a mouse model of
allergic lung inflammation, we have shown
that SiO2 and PEG-SiO2 NPs exert potent
adjuvant activity, leading to strong
increased lung inflammatory infiltrate after
intratracheal (i.t.) instillation of NPs prior
to allergen challenge. Yet, surface modifi-
cations with amino (-NH2) or phosphate
(-P) groups substantially decreased this
adjuvant activity in vivo. To evaluate the
underlying mechanisms, we assessed if
modifications of SiO2 NPs influence in-
flammasome activation and trigger selective
gene expression.
Methods: LPS-primed mouse bone mar-
row-derived dendritic cells (BMDCs) from
WT and NLPR3/ mice were incubated
for 5 h with 0.12–10 mg/ml of naked or
modified (PEG-, NH2- or P-) SiO2 NPs
and inflammasome activation was deter-
mined by IL-1b secretion by both ELISA
and western blot. In parallel, mice were
sensitised by four repetitive intraperitoneal
injections (1 lg OVA/alum), then i.t.
instilled with naked or modified SiO2 NPs
(50 lg/mouse), and subsequently aerosol-
challenged for 20 min with OVA. 5 days
later, gene expression was evaluated by
real-time PCR arrays in pulmonary tissue.
Results: SiO2 and SiO2-PEG dose-depen-
dently induced the secretion of the active
form of IL-1b in BMDCs, whereby the
effects of SiO2 were stronger compared to
SiO2-PEG. These effects were markedly
attenuated in mice lacking NLRP3. More-
over, both NPs enhanced Th2 pro-inflam-
matory milieu in sensitised mice, increased
the expression of pro-inflammatory cyto-
kines and chemokines, as well as markers
for alternative activation of macrophages
and for eosinophil activation. In contrast,
non-andjuvant -P and -NH2 surface modi-
fications diminished inflammasome activa-
tion and proinflammatory gene expression.
Conclusions: These observations lead to a
better understanding of the mechanisms
behind the reduced harmful effects of sur-
face modified SiO2 NPs.
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The pilot study of bio-aerosol level and
effectiveness of air filters in
Phramongkutklao Hospital
Mahakit, P1
1Phramongkutklao Hospital, Otolaryngology, Bangkok,
Thailand
Background: Bacteria and fungi are com-
mon among bio-aerosols leading to allergic
symptoms and URTIs. It depends on the
allergic reactivity and host defense. Level
and type of bio-aerosol may be contribut-
ing factors of both allergic and infectious
diseases.
Aims of study: 1) To detect type and level
of bio-aerosol of each unit in Phra-
mongkutklao Hospital, and
2) To assess the effectiveness of air filters
in eliminating or reducing bio-aerosols in
each unit.
Study design: Experimental study.
Method: 1) Collect air samples in selected
rooms with an air impacter RSC (Biotest)
for 2 min (200 l. evacuated air) at 150 cm
above the floor.
2) Record room dimensions, number of
occupants, people walking in and out, level
of humidity and room temperature.
3) Turn on air filter for 3 h and collect
air samples with the air impacter at 1, 2
and 3 h after turning on the air filter.
4) Culture media strips in the air impac-
ter were dislodged, sent to the microbiol-
ogy laboratory and incubated at room
temperature for 3 day. Fungal Identifica-
tion was performed by slide culture prepa-
ration technique.
Results: This study examined 9 units, i.e.,
the ICU, operating room, three inpatient
wards, the medical supply unit, waiting
lounge, laboratory unit and conference
room. Mean (SD.) amounts of bio-aero-
sols before and after air filtration 1, 2 and
3 h were 171.11 (77.06), 57.78 (34.11),
38.33 (22.78) and 37.14 cfu./m3 (17.04),
respectively. Mean (+/- SD.) levels of bac-
teria before and after air filtration were
117.78(41.32), 50.0 (24.6), 36.67
(20.01) and 35.71 cfu/m3 (15.12),
respectively. Staphyloccus coagulase nega-
tive, Micrococcus, Bacillus and Corynebac-
terium were the bacteria identified in this
study. Mean (+/-SD.) fungi before and
after air filtration were 53.3 (49.10), 7.78
(13.0), 1.67 (3.54) and 1.43 cfu/m3
(3.78), respectively. Aspergillus, Pennicil-
lium, Cladosporium and Curvunaria were
the fungi identified in this study. Level of
bio-aerosol depended on the level of
humidity, number of occupants and num-
ber of people walking in and out.
Conclusion: The bio-aerosol level in each
hospital unit depended on the level of
humidity, number of occupants and num-
ber of people walking in and out. Air fil-
ters were effective in reducing bio-aerosol
level in a closed space.
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Alternaria alternata: cloning and
sequence analysis of the cDNA sequence
of a Asp f 6- like allergen
Gabriel, MF1,2; Postigo, I1; Su~nen, E1; Gutierrez-
Rodrıguez, A1; Guisantes, JA1; Tomaz, CT2; Martınez, J1
1Department of Immunology, Microbiology and
Parasitology, Faculty of Pharmacy and ‘Lascaray’
Research Center, University of the Basque Country
UPV/EHU, Vitoria, Spain; 2Department of Chemistry and
CICS-UBI – Health Sciences Research Centre, University
of Beira Interior, Covilh~a, Portugal
Background: It is well known that Alterna-
ria alternata presents a significant level of
allergenic cross-reactivity with several other
phylogenetically related and non-related
allergenic moulds. Nevertheless, to date,
some of these phenomena and the partici-
pating molecules remain unclear. In one of
our previous studies on Alternaria alternata
a new 24 kDa immunoglobulin E (IgE)-
reacting protein, included in the protein
family of manganese-dependent superoxide
dismutase (MnSOD), was identified.
The aim of this study was to clone the
MnSOD gene from A. Alternata and to
analyse its homology with the GenBank
sequences of fungal IgE- binding MnSOD.
Method: A pair of degenerate primers was
designed following the homology shared by
the published nucleotide sequences of
MnSOD of fungal species. The MnSOD of
Aspergillus fumigatus (Asp f 6) was inserted
as the query sequence (Accession no:
U53561). The rapid amplification of cDNA
ends (RACE) was employed to generate
the gene sequence, using mRNA obtained
from 5-day-old A. alternata culture as tem-
plate source. Then, RACE products were
purified, cloned in pJET vector, sequenced
and compared with the sequences available
in the GenBank.
Results: A 665 bp cDNA sequence of
MnSOD was cloned from A. alternata by
means of the RACE technique for the first
time. Bioinformatic analysis revealed that
the translated coding sequence of the
cloned cDNA fragment had a conserved
C-terminal domain belongs to the iron/
manganese superoxide dismutase superfam-
ily. It presented high identities and a closer
relation with the IgE-binding MnSOD of
Curvularia lunata (79%), a phylogenetically
close specie to Alternaria and shared a
lower homology with the allergen Asp f 6,
the MnSOD of Aspergillus fumigatus
(61%), a phylogenetically non-related aller-
genic mould.
Conclusion: Results suggest that there is a
relationship between homology of MnSOD
sequence and fungal phylogeny that may
support the significantly higher levels of
IgE cross-reactivity between A. alternata
and phylogenetically related moulds than
with non-related ones. The obtained cDNA
will enable us to further production of the
recombinant MnSOD from A. alternata
and its molecular and immunologic charac-
terisation. This may provide a tool for a
better understanding of sensitisation, path-
ogenesis, polysensitisation or cross-reactiv-
ity phenomena as well as for improving the
molecular diagnosis of mould allergy.
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A subtilisin like serine protease of
Alternaria alternata: a potentially
cross-reactive allergen
Gabriel, MF1,2; Postigo, I1; Su~nen, E1; Gutierrez-
Rodrıguez, A1; Guisantes, JA1; Tomaz, CT2; Martınez, J1
1Department of Immunology, Microbiology and
Parasitology, Faculty of Pharmacy and ‘Lascaray’
Research Center, University of the Basque Country
UPV/EHU, Vitoria, Spain; 2Department of Chemistry and
CICS-UBI – Health Sciences Research Centre, University
of Beira Interior, Covilh~a, Portugal
Background: The presence of multiple
close allergen homologues across the fun-
gal kingdom carrying epitope orthologues
that are structurally indistinguishable from
IgE binding epitopes may raise a consider-
able problem in diagnostic and classifica-
tion of fungal allergy. The fungal pan-
allergens included in serine proteases (SP)
family, that have been reported as major
allergens in several fungi, including Curvu-
laria, Aspergillus, Cladosporium, Penicil-
lium, Rhodotorula and Trichophyton, but
not yet associated with Alternaria, could
provide one of the targets in the study of
cross-reactivity phenomena caused by
mould products. In this regards, we aimed
to provide evidence of the existence of the
SP gene and its expression in Alternaria
Alternata and to analyse its homology with
the published sequences of fungal SP.
Method: The SP cDNA of A. alternata
was isolated through a combination of
reverse transcriptase-polymerase chain
reaction and rapid amplification of cDNA
ends (RACE). The degenerated oligonucle-
otides primers used in these reaction were
designed according to the internal cDNA
sequence of SP of Curvularia lunata (Acces-
sion no: EU622631) and the conserved
sequences of fungal SP. The isolated
cDNA was purified, cloned in pJET vector,
sequenced and compared with the
sequences available in the GenBank. The
subtilisin enzymatic activity of a 10-day-
old A. alternata metabolic extract was
measured spectrophotometrically using the
subtilisin-specific substrate, Z-Ala-Ala-
Leu-pNA.
Results: In this study, we isolated and
cloned a 1104 pb cDNA from A. alternata.
Bioinformatic analysis revealed that the
theoretical SP primary sequence presents
serine protease motifs of subtilase family,
showing a high homology with allergenic
SP from various fungal sources, namely C.
lunata (92%), Cladosporium cladosporioides
(86%), Penicillium citrinum (81%), A. fu-
migatus (77%). Moreover, enzymatic activ-
ity of subtilisin was detected in metabolic
extract of A. Alternata.
Conclusion: The results obtained demon-
strate the existence of a subtilisin like SP
gene in A. Alternata and its in vivo expres-
sion. Moreover, since some reports postu-
late that in fungi all proteins with >50%
identity to known allergens that have been
studied are found to be either cross-reac-
tive or allergenic, homology results suggest
that this protein have a high probability to
be a potential cross-reactive allergen of
A. Alternata.
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Aerobiological data in the provinces of L′
Aquila and Teramo, Abruzzo
Pace, L1; de Martinis, M1; Sansonetti, G1; Sirufo, M1;
Casilli, M2; Ginaldi, L1
1l’Aquila University, l’Aquila, Italy; 2University of
L’Aquila, l’aquila, Italy
Background: Pollen and spore concentra-
tions are an important cause of allergies
and many other poor health conditions,
the main symptoms of which are usually
associated with respiratory problems. Pol-
len and spore concentrations were collected
in L’Aquila and Atri (Italy) from May
2004 to May 2005.
Method: Pollen and spore concentrations
measurements were collected in L’Aquila
(Italy) and in Atri (Te) from May 2004 to
May 2005. A time series of pollen and
spore concentrations has been collected
using a Lanzoni VPPS 2000 Hirst volumet-
ric sampler (Hirst, 1952) that was installed
20 m above the ground. The sampler has a
pump that ensures a constant flow. The
flow rate, corresponding to a human mean
breath rate of approximately 10 l/min,
ensures intake and delivery of particles on
a sampling surface. Melinex tape impreg-
nated with a 2% silicon solution was used
as trapping surface. Average daily pollen
and spore concentration estimations
(spores m_3) were carried out, the pollen
and spores were identified under a Leica
light microscope at 4000 magnification on
the basis of morphological characteristics;
the counting procedure of the bio particles
followed the model proposed by Mandrioli
et al. (1998).
Results: We report here our investigation
on the aerobiological data in two different
monitoring station of L’Aquila and Atri
(Te), expressed in p/m3.
L’AQUILA. Between May 2004 and
May 2005 the highest pollen concentration
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was calculated for Cupressaceae-Taxaceae
with 3337/m3, followed by Gramineae with
1263/m3, then Oleaceae (genera Fraxinus
and Olea) with 1048/m3 and then Fagaceae
(with genera Fagus, Castanea and Quercus)
and Urticaceae.
ATRI During the same period the high-
est pollen concentration was calculated for
Oleaceae with 2840/m3 followed by Cu-
pressaceae 2464/m3 and Graminae 2424/m3.
Conclusion: The observed values of daily
aerobiological particles can represent an
important information that can be used to
efficiently manage allergic patients in Ab-
ruzzo region.
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Monitoring of airborne allergenic pollen
grains and its impact in a subtropical
suburban city
Ghosal, K1; Bhattacharya, SG1; Pandey, N2
1Division of Plant Biology, Bose Institute, Kolkata, India;
2Allergy & Asthma Department, M. P. Birla Medical
Research Centre, Kolkata, India
Background: Many airborne pollen grains
are being loaded in air in huge amounts
with their allergenic properties causing bio-
pollution & human health hazards in peri-
odic interval. The purpose of investigation
was to determine the peak concentration of
dominating pollen grains and their impact
on human health.
Method: Bio-monitoring was done by Bur-
kard Volumetric Sampler in a suburban
subtropical area near to Kolkata, India
(22°82′ North, 88° 20′ East). Health prob-
lems during seasonal change of 500 local
people were documented in a survey.
Allergy & asthma related hospitalisation
was also recorded. Skin Prick Test (SPT),
ELISA (Enzyme Linked Immuno Sorbent
Assay), SDS-PAGE, IgE specific Immuno-
blotting were followed.
Results: Two years’ pollen calendar
showed 37 types of pollen grains where Po-
aceae were in highest number followed by
Lantana camara, Cyperus sp., Amarantha-
ceae-Chenopodiaceae etc. People reported
frequent sneezing & coughing along with
respiratory allergy in seasonal changes
which showed a positive correlation in
peaks of many species in the pollen fre-
quency graph of the 2 years. Age range of
11–30 years & female members showed
more susceptibility to seasonal changes
than male. The fuels for cooking may pro-
voke increasing of allergy symptoms. Rate
of hospitalisation showed parity with
blooming period of many dominant species
in 2 years. SPT & ELISA confirmed the
allergenically dominant species of Lantana
in air along with other arising species of
Poaceae & many others. IgE specific
Immunoblot from SDS-PAGE revealed the
most prominent & common reactive pro-
tein band of 38 kDa from Lantana.
Conclusion: Pollen grains acted major role
as bio-pollutants affecting a mass number
of people in the study area. Bio-monitoring
showing the significant presence of the exo-
tic Lantana sp. which grew abundantly in
locality replacing native species. Immuno-
biochemical tests confirmed its allergenic
properties. The way of living, poor knowl-
edge of sanitation, less awareness about
health hazards led to promote severe level
of allergy. The survey, bio-monitoring &
hospitalisation rate together proved that
pollen grains of Lantana are also a pro-
moting factor of respiratory allergy and
Lantana is a highly allergenic plant.
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Relationship between Platanus tree
density and the amount of Platanus
airborne pollen in an urban environment
Maya-Manzano, JM1; Silva-Palacios, I2; Gonzalo-Garijo,
MA3; Fernandez-Rodrıguez, S1; Tormo-Molina, R1; Cos-
mes-Martın, P4; Blanco-Perez, RM4; Domınguez-Noche,
C4; Fernandez-Moya, L5; Alfonso-Sanz, JV6; Vaquero-
Perez, P6; Perez-Marın, ML6
1Biology Department, University of Extremadura,
Badajoz, Spain; 2School of Agrarian Engineering,
University of Extremadura, Badajoz, Spain; 3Allergology
Department, Infanta Cristina University Hospital,
Badajoz, Spain; 4Allergology Department, Virgen del
Puerto Hospital, Plasencia Caceres, Spain; 5Allergology
Department, Zafra Hospital, Zafra Badajoz, Spain; 6IES
Donoso Cortes, Don Benito Badajoz, Spain
Background: Plane-trees (Platanus sp.) are
widely grown as ornamental in cities. Plat-
anus airborne pollen is abundant during a
short period in early spring and allergy to
Platanus pollen is a common problem. The
aim of our study was to evaluate the
amount of Platanus airborne pollen in rela-
tion to the number of plane-trees planted
in four sampling points.
Method: Airborne pollen was monitored
in four cities in South West of Spain: Bad-
ajoz, Plasencia, Don Benito and Zafra in
2012 using Hirst spore traps. Platanus trees
were counted and located in a map. Main
pollen season was calculated with the 5–
95% range. We did not observe pruning
trees near the spore traps.
Results: We identified two species of Plat-
anus genus, mainly P. hispanica and occa-
sionally P. orientalis, both only cultivated
as ornamentals. More than of 25 000 total
ornamental trees were counted in the four
cities and plane-trees were the most abun-
dant in the cities studied. Their density by
hectare was 3.3 in Badajoz, 4.1 in Plasen-
cia, 1.9 in Zafra, and 2.2 in Don Benito.
Pollen season lasted 26 days in Badajoz
and Don Benito, 25 days in Plasencia and
29 days in Zafra, from March 12 to April
4. Sum of daily pollen concentrations was
777 (Badajoz), 705 (Plasencia), 6794 (Don
Benito), and 633 (Zafra). Peaks of pollen
concentration recorded in grains/m3 were
93 (24/3 Badajoz), 76 (27/3 Plasencia), 744
(22/3 Don Benito), and 69 (24/3 Zafra).
The number of plane-trees around spore
traps in a radius of 100 m was 3 (Badajoz),
0 (Plasencia), 14 (Don Benito), and 10 (Za-
fra). The diameter of the plane-tree trunks
near spore traps in Don Benito was by
twice as Zafra ones.
Conclusion: Although plane trees density
was in a comparable range in the four cit-
ies studied, we found significant differences
in the amount of pollen recorded in a sam-
pling point, explicable in that case by the
highest number of plane-trees near of the
spore trap and also for being trees more
developed.
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Alternaria and Cladosporium spore
seasonal and bi-hourly distribution
patterns in Vinnitsa, Ukraine
Mazur, OI1; Rodinkova, VV2; Bilous, OS3; Slobodianiuk,
LV4; Motruk, II5; DuBuske, L6
1Pharmaceutical Chemistry, Vinnytsia National Medical
University, Vinnytsia, Ukraine; 2Pharmacy Department,
Vinnytsia National Medical University, Vinnytsia,
Ukraine; 3Vinnitsa Municipal Center of Primary Health
Care No 2, Biologists, Vinnitsa, Ukraine;
4Pharmaceutical Chemistry Department, Vinnytsia
National Medical University, Vinnitsa, Ukraine;
5Pharmaceutical Chemistry, Vinnytsia National Medical
University, Vinnytsa, Ukraine; 6Immunology Research
Institute of New England, Gardner, MA, United States
Background: Effective mold allergy control
requires knowing the seasonal and daily
patterns of mold distribution in the air.
This study assesses the most abundant air-
borne mold spores Alternaria and Clados-
porium in 2009–2012 on a daily basis and
in 2012 on a bi-hourly one as well, in
Vinnitsa, Ukraine.
Method: Spore counts were obtained at
Vinnitsa National Pirogov Memorial Medi-
cal University (VNMU) from 2009 to 2011
on a daily basis and in 2012 using a
bi-hourly mode employing volumetric
methods using Burkard trap on the roof at
25 m above ground.
Results: The average seasonal profile of
Cladosporium for 2009 through 2012
showed the most abundant mold counts
from mid-June through mid-August. The
greatest concentrations were recorded
between June 15 and July 15 with a sea-
sonal peak of 7000 spores/m3 noted on
July 15. An exception was seen in October,
2012 due to unusually warm weather with
5400 spores/m3 recorded on October 8.
The period of greatest Alternaria mold
spores was from July 1 to September 1
with the highest seasonal Alternaria mold
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concentrations seen from July 1 to 15, with
630 spores/m3 average observed on July
15. However, warm weather in 2012 led to
a peak of 670 spores/m3 on September 27,
2012. Alternaria spores had an even bi-
hourly average seasonal distribution within
the day (10–12.5 spores/m3 every 2 h) with
a decrease in concentration seen from 1700
to 2300 h to 8.5 to 9.5 spores/m3. Clados-
porium, in contrast, was characterised by
the well-defined diurnal maximums at 1300
and 1500 h of 150 spores/m3 and
140 spores/m3 respectively whereas
throughout the day Cladosporium concen-
trations varied from 85 to 105 spores/m3.
Conclusion: Alternaria and Cladosporium
molds showed greatest distribution during
the summer months with peaks in mid –
July. However, the period of active Alter-
naria distribution is briefer and later in
comparison with Cladosporium. Diurnal
data demonstrated a more constant pattern
of Alternaria mold spore distribution dur-
ing the day in contrast with Cladosporium
having the prominent afternoon peaks.
Molds, similar to pollens, require assess-
ment of seasonal distribution to optimise
allergy control.
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Assessment of CD8+ lymphocytes T
proliferation after specific and non-
specific stimulation of peripheral blood
cells using flow cytometry and CFSE
methods
Michalak, A1; Lewandowska-Polak, A2; Kowalski, ML1;
Grzegorczyk, JŁ1
1Department of Microbiology and Laboratory Medical
Immunology, Medical University of Łodz Department of
Immunology, Rheumatology and Allergy, Medical
University of Łodz, Łodz, Poland; 2Department of
Immunology, Medical University of Łodz,
Rheumatology and Allergy, Łodz, Poland
Background: Method of assessing cell
proliferation using flow cytometry enables
detection of cell division using CFSE flu-
orescence dye, which is permanently
bound to the protein found in the cyto-
plasm. Application of the appropriate
monoclonal antibodies conjugated with a
different dye allows to assess the pheno-
type of the proliferating cells. Therefore,
flow cytometry provides multiparameter
analysis, which allows the assessment of
both cell proliferation and cell subpopula-
tion.
Method: The study involved seven patients
allergic to birch pollen Bet.v.1 with a clini-
cal diagnosis of allergic rhinitis and con-
junctivitis. The control group consisted of
12 healthy subjects. Mononuclear cells
were isolated from peripheral blood and
cultured for 7 days at 37 ° C, 95% humid-
ity, 5% CO2 in the presence and absence
of Bet.v.1 (100 ng/ml) and PHA. The pro-
liferation of CD8 + T cells were differenti-
ated on the basis of low CFSE fluorescence
(CSFE low CD8 + ) and CD8 + molecule
expression and expressed as proliferation
index which is positive ≥ 2.
Results: Enhanced proliferation of T lym-
phocytes (CD8 + ) was observed after the
specific stimulation of Bet.v.1 and after
PHA stimulation. The average ratio pro-
liferation were: 45.12  23.43 (P < 0.01)
and 83.00  26.38 (P < 0.01), respectively.
Similar observations of increased prolifer-
ation have been made in the group of
healthy individuals. The average ratio of
proliferation were 8.98  3.72 (P < 0.01)
after Bet.v.1 stimulation and
32.81  17.64 (P < 0.01) after PHA and
were significantly lower than in patients
with allergy.
Conclusion: Flow cytometry using CFSE
dye may be considered to assess the prolif-
eration of CD8 + T lymphocytes.
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Anaphylaxis induced by inhalation of
Artemisia vulgaris pollen: case report
Regateiro, FS1,2; Tavares, B1; Loureiro, G1; Pereira, C1;
Segorbe-Luıs, A1
1Immuno-allergology, Coimbra University Hospital
Center, Coimbra, Portugal; 2Faculty of Medicine,
Immunology, University of Coimbra, Coimbra, Portugal
Background: Artemisia vulgaris (A.v.) is a
frequent weed in inland Portugal and other
southern European countries. Allergy to
A.v. pollen usually presents with respira-
tory symptoms. Pollen polisensitisation is
common and sensitisation to A.v. is above
20% among allergic rhinitis patients in
Portugal. Artemisia vulgaris allergens were
shown to cross-react with several food
allergens.
Case presentation: A 44-year-old male
patient living in a rural area in ‘Cova da
Beira’ region of Portugal was assisted in
Emergency during autumn for sudden
appearance of palmo-plantar pruritus
about 4 h after gardening. No systemic
symptoms occurred, namely nasal obstruc-
tion, congestion, wheezing or dyspnea, and
he was treated with parenteral antihista-
minic and corticosteroids.
One month later, again after gardening,
he developed widespread urticaria, facial
flushing, coughing and pharyngeal con-
striction. Self-administered oral cetirizine
did not improve the condition and he had
to be admitted to Emergency.
Careful anamnesis excluded the ingestion
of any relevant food allergens before crises.
The patient describes the appearance of
intermittent mild rhinitis symptoms one
year before, having sought no medical
help. Previous to that there were no aller-
gic complaints and no familiar history of
atopic disease. Palmar dyshidrotic eczema
was diagnosed.
To investigate the allergens involved,
several tests were performed one month
after the last crisis. Skin prick tests (mm)
to aeroallergens (GA2LEN panel) were
positive to: Artemisia vulgaris 12, Parietar-
ia judaica 6, Olea europaea 5, Chaenopodi-
um album 5, and cat dander (histamine 10).
Skin reactivity was negative to all tested
food allergens, including those that cross-
react with A.v.. Complete blood count
with differential, IgG, IgA and IgM were
normal. Total IgE was 237 UI/ml. Serum
specific IgE levels were: A. vulgaris
5.49 kU/l, nArt v 1 5.24 KU/l and C.
album 0.72 KU/l. Specific IgE for O. euro-
paea, ole e 1, rPru p 3, rPru p 4 and CCDs
were negative. Complement factors and
triptase levels were normal.
Conclusion: Considering the anamnesis,
the sensitisation prevalence and the peak
season pollen counts of A.v. in this region,
the laboratory findings support the diagno-
sis of anaphylaxis induced by pollen inha-
lation. However, the involvement of a
systemic urticaria syndrome via the palmar
dyshidrotic lesions cannot be excluded.
Life threatening anaphylaxis after inhalato-
ry contact with Artemisia vulgaris is an
exceptional allergy presentation to this
widespread weed.
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Acute asthma due to respiratory allergy
to ragweed misdiagnosed as idiopathic
anaphylaxis
Leru, PM1; Bozdog, OB2
1Allergology, Colentina Clinical Hospital, Bucharest,
Romania; 2Dermatology, Elias Emergency Hospital,
Bucharest, Romania
Background: Ambrosia Artemisiifolia (rag-
weed) is one of the most prominent aller-
genic weeds in Europe, with pollen grains
that induce hypersensitisation in about
20% of exposed population. The most fre-
quent allergic diseases induced are seasonal
rhinitis, rhinoconjuctivitis, rhinosinusitis,
bronchial asthma, but also angioedema,
anaphylaxis and urticaria. Ragweed exten-
sion and impact on human health in
Romania is increasing, with few available
data and has to be evaluated.
Case: We present a case of a 39 years old
woman, living in a rural area from Eastern
part of Romania, hospitalised for allergo-
logical evaluation of a recent episode of
acute respiratory failure, diagnosed as ana-
phylaxis with unknown cause. She has a
history of persistent rhinosinusitis, with
progressive seasonal autumn aggravation
during the last three years, associated with
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symptoms of seasonal asthma, that have
been ignored. No food, drugs or other trig-
gers of anaphylaxis could be identified.
The patient received high doses of oral cor-
ticosteroids and antihistamines, with clini-
cal improvement. The allergological
evaluation performed in our department
after two weeks showed high plasma levels
of total IgE and very high specific IgE to
ragweed (class 5). Basal spirometry was
normal and bronchial provocation test
with methacoline was not performed, due
to high risk. Skin prick tests to aeroaller-
gens will be done after discontinuation of
antihistaminic therapy. Based on the clini-
cal picture, serological tests and the notifi-
cation of ragweed in that region, we
considered the diagnosis of acute asthma
due to severe allergy to ragweed, associated
with rhinosinusitis. The antiasthma treat-
ment with inhaled corticosteroids, antileu-
kotrienes (montelukast) and antihistamines
was started. Specific sublingual immuno-
therapy to ragweed has to be initiated the
next year, if the allergenic exposure can
not be avoided.
Conclusions: We consider that the correct
diagnosis of allergic asthma instead of ana-
phylaxis is very important for the patient
regarding the long term management and
prognosis. This case is illustrative for the
importance of environmental evaluation of
respiratory allergies and development of
aerobiology in Romania.
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A case of chronic urticaria to cockroach
Bakiri, AH1; Mingomataj, E2; Gjata, E3; Hyso, E4
1Allergology Department, Hygeia Hospital Tirana,
Tirana, Albania; 2Allergology Department, Mother
Theresa School of Medicine, Tirana, Albania; 3District
Hospital of Lushnja, Lushnje, Albania; 4Regional
Hospital of Vlora, Vlora, Albania
Background: Exogenous common provok-
ing causes of chronic urticaria may be
drugs, foods, preservatives, infections,
physical factors, etc. But inhalant allergens
and chronic urticaria occurrence is extre-
mely rare as pollens and household aller-
gens often trigger rhinitis, conjunctivitis or
asthma. As related to the insects, there are
some cases in the literature prescribing
cockroach as inducer of hives.
Case report: A 20 year old student was
seen in our hospital for urticaria that had
begun two months ago. He did not refer of
having other allergic symptoms like rhinitis
or asthma. The patient had cutaneous ele-
ments every day apart from the days he
had was away from home. The develop-
ment of the hives was not related with the
physical factors like exposure to low tem-
perature, foods, etc. The skin prick test for
inhalant and food allergens resulted posi-
tive for cockroach (4–14 mm). He referred
to have plenty of them in their living
home. We prescribed him the proper treat-
ment with antihistamines, oral steroids and
advised to avoid cockroach. After insect
avoidance there was a significant clinical
improvement of symptoms.
Discussion: The etiology of chronic urti-
caria in most of the cases is quite uncertain
and quite difficult to determine. In some
studies a consideration number of cases
with chronic idiopathic urticaria demon-
strated sensitivity to cockroach, house dust
mites, pollens and animal dander. So we
suggest that in patients suffering from
chronic urticaria the cockroach, or other
mites hypersensitivity would be considered
as they may induce chronic urticaria.
Conclusions: Chronic urticaria may be due
to aeroallergens like cockroach. In these
cases reducing the cockroach allergen
exposure in homes would provide signifi-
cant role in the patient’s improvement.
Thus, skin prick test with aeroallergens
apart from food allergens is an important
diagnostic procedure in such cases, where
all other investigations have been fruitless.
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Does aeroallergen trigger anaphylactic
reaction? A case based discussion
Cavkaytar, O1; Soyer, UO1; Tuncer, A1; Sekerel, BE1
1Faculty of Medicine, Department of Pediatric Allergy,
Hacettepe University, Ankara, Turkey
Introduction: Animal epithelia or saliva
comprise substantial amount of aeroaller-
gens causing both acute onset hypersensi-
tivity symptoms and/or chronic
inflammation ending with allergic rhinitis
or asthma. However, allergy and anaphy-
laxis due to horse allergen exposure is
occasionally mentioned. Here we report a
patient with a hypersensitivity reaction
after horse exposure and discuss the mode
of occurrence of reaction.
Case presentations: Nine-year-old asth-
matic girl admitted to emergency room due
to sudden onset of dyspnea, cough, swell-
ing of upper eyelids, chemosis and wide-
spread urticaria. The symptoms occurred
within minutes after she had started to ride
a horse for the first time in a studfarm.
She was diagnosed as anaphylaxis and
treated with adrenaline, antihistamine, sys-
temic corticosteroid, and inhaled salbuta-
mol. Four years ago, she was interpreted
as sensitised to cat feather and grass pollen
by skin prick tests. In the current evalua-
tion, she was sensitised not only to grass
pollen mix (9 9 6 mm) and cat feather
(6 9 3 mm), but also to horse feather
(16 9 5 mm). Horse epithelia spesific IgE
was 6.64 kU/l (class 3). She was prescribed
an adrenaline autoinjector.
Discussion: The leading trigger of anaphy-
laxis in childhood is food. Aeroallergens
primarily acting on respiratory system are
seldom incriminated for anaphylaxis. How-
ever, they may cause conjunctival or cuta-
neous reactions by acting topically. It is
questionable that the reactions occurred
after exposure to such a high amount of
horse allergen are due to anaphylaxis or
they are the sum of local reactions affect-
ing both cutaneous and respiratory systems
simultaneously. Anaphylaxis due to horse
allergen is very rare both in childhood and
adulthood and has been reported in a six
year old girl and in an eight year old boy,
in whom both respiratory and cutaneous
systems were affected recalling locally
induced systemic reactions.
Conclusion: Although occasionally men-
tioned, horse allergy might pose a potential
cause of morbidity even in urban settings
ending up with multisystem involved reac-
tions in a previously nonsensitised patient.
Since it is an aeroallergen the multiple
reactions occurred after exposure might
still be locally induced multisystemic reac-
tions rather than anaphylaxis.
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Bronchial asthma by Chinchilla
Burgos Pimentel, AM1; Garcıa Navarro, DJ1;
de Montoro Francisco, AM1; Mateo Hernandez, B1;
Mateos Galvan, JM1; Fernandez Lopez, M1
1Hospital Central de la Defensa ‘Gomez Ulla’, Alergia,
Madrid, Spain
Background: Chinchilla (Chinchilla lani-
gera, order Rodentia, family Chinchilli-
dae), native to South America, is used in
the fur industry and in some laboratory
experiment; therefore It can be a potential
source of aeroallergens as a pet in the gen-
eral population. As pet, life expectancy
ranges between 10 and 12 years, although
up to 20 years in some cases. The cause of
allergies to these animals is proteins, which
are released to the atmosphere through the
skin flakes, saliva or urine thereof.
Method: A 11 year-old male, present with
a four years history of dyspnea, cough,
with exacerbation in March and April,
nasoculares asymptomatic. For the past
two years have a chinchilla as a pet. Those
dates suffered an exacerbation of respira-
tory symptoms, with repeated episodes of
bronchospasm, which forced him to go to
the emergency room several times. After
removal of the animal from home, no fur-
ther symptoms. His Skin tests were per-
formed with epithelia; an extract was
prepared with less than a gram of animal
hairs. Total and specific IgE for chinchilla
269© 2013 The Authors
Allergy © 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd, 68 (Suppl. 97), 189–336
Poster Session 16 – Aeroallergens and allergy
(Phadia), tryptase, ECP, lipocalin specific
IgE (Phadia ISAC).
Results: Allergy study: Prick a positive
common inhalant pollens, epithelium dog,
cat, hamster were positive. Skin tests chin-
chilla extract negative. Total IgE 161 kU/l,
specific IgE Chinchilla epithelium 1.35 ku/
l, cat 6.98 kU/l, dog 0.85 kU/l, and ham-
ster 0.99 ku/l, positive to lipocalins IgE.
Tryptase 1.35 lg/l. ECP 13.0 lg/l.
Conclusion: 1 A case of IgE-mediated
asthma to epithelium chinchilla, evolving
favorably upon removal of the animal
from home.
2 Five cases have been found in the liter-
ature in which the chinchilla epithelium
acts as the agent responsible for allergic
asthma.
3 We emphasize the presence of cross-





siboney and Blomia tropicalis in children
from three family physician’s offices
Gonzalez Leon, M1; Castro Almarales, RL2; Alvarez
Castello, M3; Labrada Rosado, A2; Oliva Dıaz, Y2; Mateo
Morejon, M2
1Familiar Medicine, ’Pedro Fonseca’ Docent Polyclinic,
Havana, Cuba; 2Allergen Department, National Center
of Bioproducts BIOCEN, Bejucal, Cuba; 3Allergology
Service, ’Calixto Garcıa’ University Hospital, Havana,
Cuba
Background: Morbidity of allergic diseases
mediated by IgE antibodies has increased
in the last 40 years. House dust mites have
been identified as a major ethiological
agent. In Cuba, the most common mites
are Dermatophagoides pteronyssinus (Dp),
Dermatophagoides siboney (Ds) and Blomia
tropicalis (Bt). The goal of this transversal
descriptive study fue to assess the allergic
sensitisation to these mites in a child popu-
lation and its relationship to house dust
exposure.
Method: One hundred and three allergic
children from the Guatao village, a subur-
ban area of Havana city, were selected and
classified in two groups according to the
degree of exposure to domestic dust, as
roughly assessed by a formulary adminis-
tered by clinical investigators. All of them
underwent the skin puncture test in both
forearms with standardised allergen
extracts: VALERGEN-BT (B. tropicalis),
VALERGEN-DS (D. siboney) and VA-
LERGEN-DP (D. pteronyssinus) at 20
000 BU/ml (BIOCEN, Cuba).
Results: Sensitisation to three mites was
significantly higher (P < 0.01) in the group
with greater exposure. In addition, the sen-
sitisation frequency was significantly higher
(P < 0.01) for Dermatophagoides species,
specially for Dp (87.9%), as compared to
Bt (33.3%) The Dp extract provoked a
mean size of the wheal higher than the
other products among the positive patients
of both exposure groups (P < 0.04).
Conclusion: The greater exposure of
patients to domestic dust is related to a
higher sensitisation intensity and frequency
to house dust mites, including Blomia trop-
icalis.
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Aeroallergens sensitisation profile in a
Spanish city population
Garcia Nunez, I1; Algaba Marmol, MA2; Barasona Villar-
ejo, MJ3; Escalona Pe~na, M4; Reina Ariza, E1
1Allergy Department, Hospital Quiron, Malaga, Spain;
2Distrito Sanitario Osuna, Centro de Salud ‘El
Almorron’, Ecija, Spain; 3Allergy Department, Hospital
Universitario Reina Sofia, Cordoba, Spain; 4Hospital
Quiron, Malaga, Spain
Background: The most important aeroal-
lergens causing clinical symptoms around
the world are house dust mites (HDM),
molds, pollens and animals epithelia. Every
city has got a different sensitisation profile,
being very different between cities sepa-
rated by a small distance in kilometers.
Our aim is to show the aeroallergen sensiti-
sation profile in our patients, the symp-
toms referred and the percentage of
monosensitised/polisensitised patients.
Methods: All patients living in Malaga
during the last 10 years coming to our
Allergy Department from September to
December 2012 referring respiratory symp-
toms were selected. A clinical report
focused in these clinical symptoms was per-
formed, plus skin prick test with the most
frequent aeroallergens (HDM, molds, pol-
lens and animal epithelia) and panallergens
(palm profilin and peach LTP), total IgE
and specific IgE to these aeroallergens.
Results: One hundred and sixty-two
patients (74 males and 88 females; medium
age 3488 years) were included, being 92
(56.79%) from 21 to 40 years old. Sixty-six
(40.74%) were asthmatic patients. One
hundred and six patients (65.43%) were
sensitised to HDM, 112 (69.13%) to Olea
pollen or 68 (41.97%) to cat dander. Fif-
teen patients (9.25%) were sensitised to
peach LTP and 20 patients (12.34%) to
palm profilin. Sixty seven patients
(41.35%) presented total IgE higher than
130 KU/l. Twenty patients (12.34%) were
monosensitised.
Conclusions:  Although Malaga is a typi-
cal beach city in Spain, Olea pollen is the
most frequent aeroallergen that cause sen-
sitisation.
The patient profile that came to our
clinic is a medium aged female with
asthma symptoms in an important percent-
age of patients.
More studies about relationship between
aeroallergen sensitisation and relevance in
clinical symptoms are needed to confirm
these results.
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Evaluation of Fel d 1 and Fel d 2 in 65
individuals allergic to cat dander utilising
specific IgE testing
Rossi, RE1
1Molecular Allergology, Universita Vita-Salute San
Raffaele, Milano, Italy
Background: Individuals allergic to cat
dander are usually to at least 8 allergens
when they areexposed to the allergen
source (i.e. Fel d 1, 2, 3, 4, 5, 6, 7, 8). Fel
d 1, uteroglobin and Fel d 2, serum albu-
min, can be found in cat hair, dander and
saliva.
Method: This retrospective study (during
the period 2010–2012) involved 65 patients,
mean age 28.3 years, range 4–53 years,
with a history of atopic dermatitis; allergic
rhino-conjunctivitis, allergic asthma, urti-
caria. All patients had positive skin test to
cat commercial allergen extract Specific
IgE antibodies directed to Fel d 1 and Fel
d 2 were evaluated by ImmunoCAP-Sys-
tem (Thermo Fisher Scientific).
Results: Sixty.five patients with positive
skin test results to commercial cat extract
had also serum specific IgE to Fel d 1
(100%), mean 14.97 kUA/l min 0.63 kUA/
l, max 100 kUA/l). On the contrary, of 65
patients with positive skin test to commer-
cial cat extract only three patients (4.6%)
had specific IgE to Fel d 2 (mean
0.14 kUA/l, min 0.01–0.53 kUA/l).
Conclusion: On the basis of our findings
we can conclude that, at least for the
majority of allergic population of this geo-
graphic area, Fel d 1 is a powerful inducers
of IgE production and marker of genuine
sensitisation to cat epithelium. On the con-
trary Fel d 2 is a poor inducers of specific
IgE in the majority of cat allergic subjects.
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Analysis of the reactions of type I
hypersensitivity to the nocturnal
Lepidoptera in a Costa Rican allergic
population, February 2011 – February
2012
Sandi, C1; Jaikel, D1; Riggioni, O2
1Universidad de Costa Rica, San Pedro, Costa Rica;
2Centro de Diagnostico y Tratamiento de Alergia,
Allergy and Immunology, Heredia, Costa Rica
Background: Allergic patients are routinely
tested for various allergens including
270 © 2013 The Authors
Allergy © 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd, 68 (Suppl. 97), 189–336
Poster Session 16 – Aeroallergens and allergy
molds, food, cockroaches and house dust
mites; however, there are patients who
present allergy symptoms but show nega-
tive results in Prick tests, with the available
allergens. Therefore, this study aims to
determine the percentage of patients sensi-
tised to the nocturnal Lepidoptera and its
role as an important environmental aller-
gen.
Method: A retrospective analysis was car-
ried out in which we determined the per-
centage of patients allergic to nocturnal
Lepidoptera, house dust mites (Blomia
tropicalis, Dermatophagoides pteronyssinus
and Tyrophagus putrescentiae) and insects
(Periplaneta americana and Musca domes-
tica). Also, we analyzed the demographics
and symptoms of the patients.
Results: We found that 63.4% of the
patients were allergic to house dust mites,
39.2% to nocturnal Lepidoptera, 27.7% to
Periplaneta Americana and 23.6% to
Musca domestica. Also, that 2.3% were
monosensitised to nocturnal Lepidoptera.
Conclusion: We strongly recommend that
Costa Rican allergist constantly test for
noctural Lepidoptera.
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Urban vegetation and allergy risk
Thibaudon, M1; Faucherand, L1; Oliver, G1
1RNSA, Brussieu, France
Background: If chemical pollutants causing
air pollution may be subject to control
measures, it cannot be the case of biologi-
cal particles, such as pollen, from vegeta-
tion.
In quantitative and qualitative terms,
most pollens inhaled by the population
and measured by the volumetric downhole
pollen traps of RNSA (National Network
for Monitoring Aerobiological) are from
natural plant species.
On the other hand, in urban area, public
garden or park, the composition of the air
in terms of pollen is modified by the com-
position of plant species in their surround-
ing pollination periods.
Method: At the request of the French
Health and Ecology authorities, RNSA
published in 2008, an electronic guide ‘veg-
etation in Town’ (http://www.vegeta-
tion-en-ville.org) that aims to inform
public and private decision makers on the
need to take into account the health com-
ponent in the choice and maintenance of
plant species introduced in urban or peri-
urban areas.
This methodological guide contains a num-
ber of information about: - Allergy, its
clinical manifestations and its impact on
everyday life and cost for health.
- Allergies and plants: allergenic poten-
tial of pollen species.
- How to act in diversifying species,
maintaining in the periods where it is pos-
sible to limit the production of pollen.
- For shrubs and trees: indication of spe-
cies to avoid and proposed substitutions
depending on the type of use (hedges,
banks, alignment).
- For herbaceous: description of species
to avoid depending on their allergenicity:
The online guide is downloadable in PDF
format, it contains 68 pages of valuable
information.
Conclusion: This guide allows local deci-
sion makers, landscapers and architects to
avoid mistakes which will need many years
to recover uniform plantations of birch
trees in public parks. It also allows firms
to question or ask to RNSA about the
allergenic potential of target species and
allergic risk potentially induced by revege-
tation.
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Acrolein suppresses allergic sensitisation
and promotes tumor growth in BALB/c
mice
Roth-Walter, F1; Willensdorfer, A1; Stremnitzer, C2;
Schultz, C2; Diesner, S2,3; Szalai, K4; Fazekas, J2; Birn-
leitner, H1; Jensen-Jarolim, E1,2
1Messerli Research Institute, University of Veterinary
Medicine Vienna, Medical University of Vienna,
University of Vienna, Vienna, Austria; 2Department of
Pathophysiology and Allergy Research, Medical
University of Vienna, Vienna, Austria; 3Department of
Pediatrics and Adolescent Medicine, Medical University
of Vienna, Vienna, Austria; 4University of Veterinary
Medicine Vienna, Medical University of Vienna,
University of Vienna, Messerli Research Institute,
Comparative Medicine, Vienna, Austria
Background: Allergic sensitisation has been
linked to smoking. Hence, we sought to
investigate the contribution of acrolein
during nasal sensitisation, since acrolein is
one of the components generated in large
amounts when smoking cigarettes. More-
over, we investigated impact of acrolein in
tumor promotion.
Method: BALB/c mice were nasally sensi-
tised five times in biweekly intervals with
KLH alone or in conjunction with moder-
ate amounts of acrolein. Airway hyperreac-
tivity as well as KLH-specific anaphylactic
reaction was monitored. Immune response
was analyzed on the level of specific anti-
bodies and by cytokine determination from
splenocytes after antigen-specific stimula-
tion. Further, D2F2-tumor cells were
implanted to the right flank and tumor
growth was monitored in mice previously
exposed to acrolein or buffer.
Results: In the absence of adjuvant, nasal
application of KLH alone was sufficient to
induce KLH-specific antibody-titers of
IgG1, IgG2a, IgG2b, IgA and IgE,
whereas nasal sensitisation with KLH in
the presence of moderate amount of acro-
lein significantly reduced antibody forma-
tion. Similarly, only mice sensitised to
KLH, but not in combination with acro-
lein showed increased airway-hyperreactivi-
ty and had a significant drop in body
temperature upon allergen challenge. Fur-
ther only splenocytes of KLH-sensitised
mice secreted elevated levels of IL5, IL13,
IL10 and IFN-g. Impaired immune
response also led to a significant tumor
promotion in mice exposed previously to
acrolein.
Conclusion: Nasal application of acrolein
prevented nasal sensitisation to KLH and
blocked antigen-specific antibody forma-
tion. Moreover, tumor growth was signifi-
cantly promoted in mice previously nasally
sensitised to acrolein, but not in controls.
Acrolein in smoke decreases the risk of
allergic sensitisations and inhibits immune
activation, thereby likely affecting suscepti-
bility to infections and promoting tumor
growth in smokers.
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Endogenous biosensors in allergy:
cytochrome P450s and the aryl
hydrocarbon receptor
Effner, R1; Pusch, G1; Brockow, K2; Behrendt, H1;
Schmidt-Weber, C1; Buters, JTM1
1Technical University and Helmholtz Center Munich,
ZAUM – Center of Allergy and Environment, Munich,
Germany; 2Department of Dermatology and Allergy,
Technical University Munich, Munich, Germany
Background: Lipophilic substances like
environmental pollutants and drugs can
induce their own metabolism by activating
xeno-sensitive transcription factors like the
aryl hydrocarbon receptor (AhR). This
transcription factor induces genes coding
for xenobiotic-metabolising enzymes,
including cytochrome P450 (P450). P450s
are involved in the degradation of lipo-
philic compounds and the highest abun-
dance of metabolizing enzymes is located
in the liver. Little is known regarding the
extra-hepatic xenobiotic metabolism. The
AhR is receiving much attention in
immune cells and therefore metabolising
enzymes are investigated here as a system
for fine-tuning the immune response.
Method: Human primary mast cells were
isolated from foreskins of boys aged 1–
15 years (n = 7). Basophils, monocytes, B
cells, CD8+ T cells, CD4+ T cells and
CD4+CD45RO+ T cells were isolated
from peripheral blood mononuclear cells
(PBMCs) of non-atopic individuals (n = 7).
RNA was analyzed by TaqMan Low Den-
sity Arrays (TLDAs) specifically designed
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for the characterisation of the metabolising
system.
Results: Human primary foreskin mast
cells, located in the subepidermal dermis
show a clear transcription for the AhR-reg-
ulated CYP1 family members CYP1A1 and
CYP1B1. CD14+ cells and basophils
revealed a very similar transcription of dif-
ferent genes. CYP2S1, CYP4F3, MGST1
and PTGS2 genes differ most among the
lymphoid cell populations. Of all primary
cells, B cells were negative for the tran-
scription of CYP4F22.
Conclusion: We showed that different
immune cells transcribe characteristic pat-
terns of genes coding for metabolising
enzymes. Regulation of different P450s and
cytokines in human immune cells by AhR
ligands and P450 inhibitors could explain
how environmental pollutants predispose
the human immune system to become
allergic.
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Soluble CD14, a-and b-defensins in breast
milk: association with the emergence of
allergy in a high risk population
Savilahti, EM1; Kukkonen, AK2; Kuitunen, M3; Savilahti,
E3; Flora Study
1Childrens Hospital, University of Helsinki, HUS,
Helsinki, Finland; 2Skin and Allergy Hospital, Helsinki
University Central Hospital, Helsinki, Finland;
3Childrens Hospital, University of Helsinki, Helsinki,
Finland
Background: Innate immunity factors in
breast milk modulate infants’ immune
responses, and may influence the develop-
ment of allergy.
Our objective was to study the associa-
tion of soluble CD14 (sCD14) and defensin
levels in breast milk with the emergence of
allergy in childhood.
Methods: The randomly selected group of
260 mother-child pairs were part of a
randomised, double-blind placebo-con-
trolled trial where 1223 mothers with
fetuses in high risk for allergy received for
the four last weeks of pregnancy a mix-
ture of four probiotics (Lactobacillus
rhamnosus GG, L rhamnosus LC705, Bif-
idobacterium breve Bb99, and Propioni-
bacterium freudenreichii ssp. shermanii JS)
or placebo, and after birth, their child
received the treatment for 6 months. Chil-
dren were followed for the emergence of
sensitisation and allergic symptoms for
5 years, with medical examinations at the
ages of 2 and 5 years and in the case of
allergic symptoms. We measured levels of
sCD14, human neutrophil peptide (HNP)
1–3 and b-defensin 2 (HBD2) in colos-
trum and in breast milk 3 months post-
partum with enzyme linked immunosor-
bent assays.
Results: High soluble CD14 levels in
breast milk 3 months post-partum were
associated with children developing an
IgE-mediated allergic disorder by the age
of 5 years (P < 0.03). Breast milk sCD14
levels decreased from 0 to 3 months post-
partum (P < 0.0001). HNP1-3 and HBD2
were detected in colostral samples. They
decreased to levels below detection level by
3 months post-partum. Breast milk HNP1-
3, HBD2 or sCD14 levels were not associ-
ated with probiotic treatment.
Conclusions: Soluble CD14 in breast milk
may influence the emergence of allergy in
children with atopic heredity.
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Molecular spreading in birch allergic
children with hay fever – a longitudinal
analysis of evolution of the molecular IgE
response in childhood
Hatzler, L1; Panetta, V2; Lau, S1; Sabina, I3; Bauer, CP4;
Hoffman, U4; Forster, J5; Zepp, F6; Schuster, A7; Keil,
T8; Wahn, U1; Matricardi, PM1
1Department of Paediatric Pneumology and
Immunology, Charite University Medical Centre Berlin,
Berlln, Germany; 2L’Altrastatistica srl, Consultancy and
Training, Biostatistics Office, Rome, Italy; 3Department
of Pulmonary and Allergy, University Children’s
Hospital Munich, LMU, Munich, Germany; 4Department
of Pediatrics, Technical University of Munich, Munich,
Germany; 5Department of Pediatrics St. Hedwig, St.
Josefs Hospital, Freiburg, Germany; 6Department of
Pediatrics and Adolescent Medicine, Johannes
Gutenberg University Medical Centre, Mainz, Germany;
7Department of Pediatric Cardiology and Pneumology,
Heinrich-Heine-University, D€usseldorf, Germany;
8Charite University Medical Centre Berlin, Institute of
Social Medicine, Epidemiology and Health Economics,
Berlln, Germany
Background: The concept of molecular
spreading, i.e. the sequential IgE sensitisat-
ion against the molecules of an allergenic
source, could be shown for children with
grass pollen related hay fever. In order to
test whether this phenomenon can also be
observed in other airborne allergies we
have analyzed the data of children from
the German Multicenter Allergy Study
(MAS) birth cohort with seasonal allergic
rhinitis against birch pollen (SARb).
Method: The MAS study, a prospective
birth cohort study starting in 1990,
included 1314 children in 5 German cities.
During the first 13 years of follow-up the
children underwent eight blood drawings.
Symptoms have been assessed each year
according to a standardised ISAAC ques-
tionnaire. 820 subjects with complete clini-
cal data of at least eight follow ups have
been included in the analysis. Children
with symptoms of allergic rhinitis and con-
junctivitis in April (and/or March for
Southern-West Germany) at least three
times in the period between 3 and 13 years
of age or at least two times from 11 to
13 years of age have been defined as SARb
cases. Blood samples with positive IgE
(≥0.35 kUA/l) detected with ImmunoCAP
(Thermo Fisher Scientific) have been tested
with the ISAC allergen microarray
(Thermo Fisher Scientific).
Results: Among 820 children 94 subjects
developed SARb. A positive IgE response
could often be detected before the disease
onset. In children suffering from SARb a
progressive IgE response against birch pol-
len was observed
(i) on extract level reflected by rising IgE
levels against birch extract as well as
(ii) on molecular level showing an
increase of the number of sensitisations
against birch pollen molecules.
Bet v 1 was detected in the preclinical
phase in most of the children. The preva-
lence of sensitisations to the other mole-
cules Betv2 and Betv4 which are available
on the ISAC increased with time but
within a slower trend and lower incidence
compared to Betv1. A typical sequence
with Betv1 as the first recognised molecule,
followed by Betv2 and then Betv4, was
confirmed in the analysis of the within-
patients individual sensitisation progression
performed with three different approaches
(scoring system, hierarchic incidence, Kap-
lan-Meier curves).
Conclusion: The sensitisation against birch
pollen can start years before onset. With
respect to the three available molecules on
the ISAC it could be shown that with the
progression of the disease the molecular




CD14/TLR4 polymorphisms and use of
antibiotics in infancy increases the risk of
allergic rhinitis in Korean pre-school
children
Park, KS1; Lee, HY1; Seo,J-H2; Kim,H-Y3; Kang,M-J4;
Kwon,J-W5; Kim,B-J6; Lee,S-Y7; Hong,S-J3
1Presbyterian Medical Center, Jeonju, Korea; 2Korea
Cancer Center Hospital, Seoul, Korea; 3Asan Medical
Center, University of Ulsan College of Medicine, Seoul;
4University of Ulsan, Asan Institute for Life Sciences,
Seoul, Korea; 5Seoul National University Bundang
Hospital, Seoul, Korea; 6Inje University Haeundae Paik
Hospital, Busan, Korea; 7Hallym Sacred Heart Hospital,
Hallym University College of Medicine, Anyang, Korea
Background: Antibiotics use by newborns
alters infant microbiota profiles including
long-term reduction in microbiota diver-
sity. We investigated the interaction
between CD14 -159C/T (rs2569190) and
TLR4 + 8595C/T (rs1927911) polymor-
phisms and use of antibiotics in infancy on
the development of allergic rhinitis in Kor-
ean pre-school children.
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Method: A cross-sectional study (n = 933)
aged 3–5 years was conducted with ISAAC
questionnaire. Polymorphisms of CD14
and TLR4 were genotyped by TaqMan
assay.
Results: Antibiotic use during infancy was
significantly associated with allergic rhinitis
(AR) diagnosis (aOR 2.030, 95% CI
1.429–2.884). When we analyzed interac-
tion between use of antibiotics and geno-
type of the CD14 and TLR4, there was a
significant association with development of
allergic rhinitis. Children using antibiotics
in infancy and TT or TC+CC genotype of
the CD14 AR diagnosis had increased
(aOR 3.244, 95% CI 1.615–6.516 and aOR
2.474, 95% CI 1.326–4.619,respectively)
compared with children having TT geno-
type of the CD14 and no antibiotics use.
Children using antibiotics in infancy and
CC or CT+TT genotype of the TLR4 had
increased AR diagnosis (aOR 2.872, 95%
CI 1.425–5.787 and aOR 2.119, 95% CI
1.129–3.978,respectively) compared with
children having CC genotype of TLR4 and
no use of antibiotics.
Conclusion: The use of antibiotics in
infancy is important risk factors for the
development of allergic rhinitis in pre-
school children. The interaction of gene
(CD14 159C/T and TLR4 + 8595C/T
polymorphism) and use of antibiotics in




symptoms and home exposure to
mould/dampness in eight Italian cities
Simoni, M1; Canciani, M2; Carrer, P3; Baldacci, S1; Big-
geri, A4; Indinnimeo, L5; Brunetti, L6; Cibella, F7; Pini,
C8; Viegi, G1,7
1CNR Institute of Clinical Physiology, Pulmonary
Environmental Epidemiology, Pisa, Italy; 2Udine
University, Udine, Italy; 3Milan University, Milano, Italy;
4Florence University, Florence, Italy; 5Rome University,
Rome, Italy; 6Bari University, Bari, Italy; 7CNR Institute
of Biomedicine and Molecular Immunology, Palermo,
Italy; 8ISS, Rome, Italy
Background: In the framework of a study
(in progress) on health effects of indoor air
quality in the Italian schools, data concern-
ing home characteristics have been also
collected.
Methods: We assessed the effects of home
exposure to mold/dampness on past year
asthmatic/rhinitic symptoms in 2036
schoolchildren (51% males, mean age
10  1.8) from 8 cities (Udine, Sondrio,
Milan, Pisa, Rome, Bari, Cagliari,
Palermo). Data are from a questionnaire
filled in by the parents.
Results: Diagnosis of asthma and rhinitis
are reported for 7% and 11% of the chil-
dren, respectively (3% only asthma, 7%
only rhinitis, 4% both). About 21% of the
children are exposed to passive smoking at
home. Presence of visible moulds on the
walls, mould odor, and dampness/conden-
sation on the windows in winter, are
reported in 18%, 6% and 24% of cases.
Reported prevalences are 7.9% for wheez-
ing, 22.5% for nocturnal dry cough, 10%
for breathlessness, and 20.3% for frequent
nasal problems. Regression analyses
accounted for gender, age, passive smok-
ing, asthma/rhinitis diagnosis and familiar-
ity, showed the following significant
associations: visible mould with breathless-
ness (odds ratio, OR 2.01, 95% Confidence
Interval, CI 1.38–2.92); mould odor with
nocturnal dry cough (OR 1.88, 95% CI
1.23–2.86) and breathlessness (OR 2.72,
95% CI 1.59–4.64); dampness/condensa-
tion on the windows with nocturnal dry
cough (OR 1.27, 1.00–1.64), breathlessness
(OR 1.51, 95% CI 1.06–2.15), and frequent
nasal problems (OR 1.33, 95% CI 1.01–
1.76). Visible moulds and mould odor were
also related, at borderline significance, to
frequent nasal problems (OR 1.32, 95% CI
0.97–1.80, and OR 1.52, 95% CI 0.93–
2.48, respectively).
Conclusion: These preliminary analyses
confirm that not only reported visible
mould/dampness, but also mould odor, are
associated with asthmatic/rhinitic symp-
toms.
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Is nasal provocation test important for
children with non-allergic rhinitis
Duman, H1; Bostanci, I2; Ozmen, S2
1Peditaric Allergy, Dr. Sami Ulus Research and Training
Hospital of Women’s and Children’s Health and
Diseases, Ankara, Turkey; 2Dr. Sami Ulus Research and
Training Hospital of Women’s and Children’s Health
and Diseases, Ankara, Turkey
Background: Local allergic rhinitis is char-
acterised by the local production of specific
IgE antibodies in the nasal mucosa of
patients with symptoms of allergic rhinitis
in the absence of a positive skin test and
specific IgE. It is aimed in this study to
investigate the presence of local allergic
rhinitis in children by performing a nasal
provocation test with grass mix, DP and
DF allergens.
Method: Twenty-eight patients and 30
healthy children were included in the study
in a pollen free season. The total symptom
score, visual analog scale, nasal eosino-
philia and pulmonary function tests were
evaluated before and after each NPT.
Results: The nasal provocation test was
positive in seven (25%) of the patient
group (two with grass mix, and three with
DP and two with DF). There was no posi-
tivity in any patient in the control group.
In the NPT positive group there was a sta-
tistically significant decrease for the nasal
flow at the concentration of 10 and
100 IR/ml for DF (respectively P = 0.026,
P = 0.031). In the NPT positive group
total nasal resistance for DP was increased
at the concentration of 0.1 IR/ml and
10 IR/ml; and for DF at 10 IR/ml and
100 IR/ml (respectively P = 0.049,
P = 0.041, P = 0.022, P = 0.035).
Conclusion: In our study 25% of those
patients with nonallergic rhinitis were diag-
nosed as LAR. We showed that LAR can
also be diagnosed in childhood. Nasal
provocation test with anterior rhinoma-
nometry is a noninvasive, cheaper, more
repetitive and more helpful means of diag-
nosis in children. We emphasize that the
diagnosis of LAR should be taken into
consideration by the pediatricians and chil-
dren′s allergy specialists.
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Subanalysis of clinical efficacy in children
with 6–11 years weighing ≥25 kg with
persistent allergic rhinitis: rupatadine
results
Potter, P1; Maspero, J2; Vermeulen, J3; Barkai, L4; Bail-
lieau, RA5; Nemeth, I6; Garde, JM7; Giralt, J8; Domen-
ech, A8; Izquierdo, I8; Nieto, A9
1University of Cape Town, Cape Town, South Africa;
2Fundacion CIDEA, Buenos Aires, Argentina; 3Parow
Research, Cape Town, South Africa;
4Gyermekegeszsegugyl Kozpont, Miskolc, Hungary;
5Centro de Alergia, Mar de Plata, Argentina; 6Szent
Erzsebet Korhaz, Jaszbereny, Hungary; 7Universidad de
Elche, Elche, Alicante, Spain; 8Department of Clinical
Development, J Uriach y Cia S.A., Palau Solita i
Plegamans, Spain; 9Hospital Materno Infantil La Fe,
Valencia, Spain
Background: Clinical trials with the newer
2nd generation antihistamines in children
under the age of 12 years have been per-
formed previously but further studies are
needed in order to show efficacy and
safety in the most unfavourable clinical
conditions such as persistent allergic rhi-
nitis (PER). Rupatadine oral solution was
developed for children with allergic
rhinitis in view of its rapid onset of
action and its lack of relevant side
effects. These advantages were confirmed
previously in a phase III study in chil-
dren 6–11 years.
Objective: To assess the efficacy and safety
of rupatadine (RUP) oral solution in a
subgroup of children between 6 and
11 years weighing ≥25 kg with PER
Methods: A subanalysis was performed
from a previous placebo-controlled study
carried out in patients between 6 and
11 years diagnosed as PER according to
ARIA criteria. This analysis included
patients with a positive prick test, weight
≥25 kg and basal nasal symptoms score
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(including rhinorrhea, nasal blockage,
sneezing and nasal itching assessment) ≥24
obtained in 4 days throughout the 2-week
screening period. Patients were allocated to
treatment with either RUP oral solution
(1 mg/ml) or placebo solution during
6 weeks. The dose was 5 ml of oral solu-
tion. The main efficacy endpoint was the
change from baseline of the nasal (4TSS)
and with ocular symptoms (5TSS) at 4 and
6 weeks of treatment.
Results: The subgroup analysed was a
total of 266 randomised to rupatadine
(n = 131) or placebo (n = 135). The pri-
mary endpoint 4TSS showed statistically
significant differences between placebo and
RUP at 4 (P < 0.01) and 6 weeks
(P < 0.01). T5SS decreased also at 4 and
6 weeks (P < 0.01). All individual symp-
toms (nasal and ocular) improved at 4 and
6 weeks, mainly nasal congestion, sneezing
and ocular symptoms.
Conclusion: Rupatadine oral solution
(1 mg/ml) was significantly more effective
than placebo in improving nasal and ocu-
lar symptoms at 4 and 6 weeks. This is the
first clinical evidence of the efficacy of a
second H1-antihistamine compound in
children with PER.
686
Subanalysis of quality of life in children
with 6–11 years weighing ≥25 kg with
persistent allergic rhinitis: rupatadine
results
Potter, P1; Maspero, J2; Vermeulen, J3; Barkai, L4;
Baillieau, RA5; Nemeth, I6; Giralt, J7; Domenech, A7;
Santamaria, E7; Izquierdo, I7; Nieto, A8
1University of Cape Town, Cape Town, South Africa;
2Fundacion CIDEA, Buenos Aires, Argentina; 3Parow
Research, Cape Town, South Africa;
4Gyermekegeszsegugyl Kozpont, Miskolc, Hungary;
5Centro de Alergia, Mar de Plata, Argentina; 6Szent
Erzsebet Korhaz, Jaszbereny, Hungary; 7Department of
Clinical Dev elopment, J Uriach y Cia S.A., Palau solita
i Plegamans, Spain; 8Hospital Materno Infantil La Fe,
Valencia, Spain
Background: Clinical trials with the newer
2nd generation antihistamines in children
under the age of 12 years have been per-
formed previously but further studies are
needed in order to show efficacy and safety
in the most unfavourable clinical condi-
tions such as persistent allergic rhinitis
(PER). Rupatadine oral solution was
developed for children with allergic rhinitis
in view of its rapid onset of action and its
lack of relevant side effects.
Objective: To assess the quality of life
(QoL) of rupatadine (RUP) oral solution
in a subgroup of children between 6 and
11 years weighing ≥25 kg with PER
Methods: A subanalysis was performed
from a previous placebo-controlled study
carried out in patients between 6–11 years
diagnosed as PER according to ARIA cri-
teria. This analysis included patients with a
positive prick test, weight ≥25 kg and basal
nasal symptoms score (including rhinor-
rhea, nasal blockage, sneezing and nasal
itching assessment) ≥24 obtained in 4 days
throughout the 2-week screening period.
Patients were allocated to treatment with
either RUP oral solution (1 mg/ml) or pla-
cebo solution during 6 weeks. The dose
was 5 ml of oral solution. The main sec-
ondary efficacy endpoint was the assess-
ment of QoL at baseline, 28 and 42 days
of treatment by means of Paediatric Rhi-
noconjunctivitis Quality of Life Question-
naire (PRQLQ).
Results: The subgroup analysed was a
total of 266 randomised to RUP (n = 131)
or placebo (n = 135). PRQLQ overall score
showed statistical significant differences
between RUP and placebo at 4 weeks
(P < 0.01) and 6 weeks (P < 0.05). At
4 weeks, all domains including: nose symp-
toms, eyes symptoms, practical problems,
other symptoms and activity limitation
showed statistical significant (P < 0.05). At
6 weeks only nasal symptoms (P < 0.01)
and activity limitations (P < 0.05) achieved
statistically better values than placebo.
Conclusion: QoL evaluation is a relevant
measure of the AR treatment efficacy par-
ticulary in children. Rupatadine has been
found in this study the first clinical evi-
dence of a H1-receptor antagonist in chil-
dren between 6–11 years over 25 kg with
PER.
687
Disagreement of different estimates of
rhinitis prevalence in pre-school children
Pereira, AM1,2,3; Santos, N1,2; Branco-Ferreira, M4,5;
Nunes, C4,6; Fonseca, JA1,7,8; Bousquet, J9; Morais-
Almeida, M2,4
1Allergy Department, Centro Hospitalar S~ao Jo~ao,
E.P.E., Porto, Portugal; 2Immunoallergy Department,
Hospital CUF-Descobertas, Lisbon, Portugal;
3Department of Health Information and Decision
Sciences, Faculty of Medicine of the University of
Porto, Porto, Portugal; 4Sociedade Portuguesa de
Alergologia e Imunologia Clınica, SPAIC, Lisbon,
Portugal; 5Immunoallergy Department, Centro
Hospitalar Lisboa Norte, Lisbon, Portugal; 6Centro de
Imunoalergologia do Algarve, Centro de
Imunoalergologia do Algarve, Portim~ao, Portugal;
7Allergy Unit, Instituto and Hospital CUF Porto, Porto,
Portugal; 8Faculty of Medicine of the University of
Porto, CINTESIS – Centre for Research in Health
Technologies and Information Systems, Porto,
Portugal; 9Department of Allergy and Respiratory
Diseases, University Hospital and INSERM, Montpellier,
France
Background: There is not a single set of
universally accepted and validated defini-
tion to assess rhinitis prevalence and differ-
ent studies adopt diverging questions. The
definition used in the ISAAC study is the
most frequently used in epidemiological
studies. However, without clinical correla-
tion, misclassification is likely (Kim H,
Ann Allergy Asthma Immunol 2012). The
aims of this study were 1) to compare the
prevalence of current rhinitis in pre-school
children using two different definitions
(ISAAC’s vs. an alternative definition
which implies a combination of nasal
symptoms), and 2) to evaluate the agree-
ment between these definitions and
between them and patient-reported physi-
cian-diagnosed rhinitis (PR-PDR) and
medication use in the previous 12 months.
Methods: Cross-sectional, nationwide,
population-based study of 5018 children
aged 3–5 years. Data was collected by
face-to-face interview to caregivers using
an adaptation of the ISAAC questionnaire.
Current rhinitis – ISAAC (CR-I) was
defined as the presence of one out of three
rhinitis symptoms (repeated sneezing and/
or itchy nose, blocked nose for longer than
1 h or runny nose without having a cold
or flu), in the last 12 months; current rhini-
tis – alternative (CR-A) implied the pres-
ence of at least 2 out of the same 3
symptoms, in the previous 12 months. The
presence of PR-PDR and the use of rhini-
tis medication were self-reported by the
respondents. The percent agreement (%A)
was presented and results evaluated with
Cohen’s kappa (j).
Results: The prevalence estimate using
CR-I was 43.5% [95%CI (42.1–44.9)] and
using CR-A 20.4% [95%CI (19.3–21.5)].
The proportion of agreement between these
definitions was 77.0% (j = 0.500,
P < 0.001).
Rhinitis medication was used by 11.7%
and 11.7% referred PR-PDR; eleven per-
cent (n = 544) reported both PR-PDR and
medication need. When considering CR-I,
the%A with PR-PDR was 67.7%
(j = 0.067); it was 67.6% with medication
need (j = 0.066) and 67.1% with PR-PDR
combined with medication need
(j = 0.265). When considering CR-A, the
%A were, respectively, 82.5% (j = 0.051),
82.9% (j = 0.052) and 82.7% (j = 0.355).
Conclusion: In the same study sample, the
use of different definitions was associated
with widely different estimates of rhinitis
prevalence. The diagnostic accuracy of
these definitions needs to be evaluated
against clinical examination.
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Online medical consultations applied to
pediatric allergy
Alvarez-Puebla, MJ; Tabar, AI; Garcıa, BE; Echechipıa,
S; Lizaso, MT; Arroabarren, E
Servicio de Alergologıa, Complejo Hospitalario de
Navarra, Pamplona, Spain
Background: We developed a model of
Online Medical Consultations (OMC)
between Allergists and Primary Care Pedi-
atricians. We aimed to reduce the numbers
of children sent to our Allergy Department
whose evaluation would have no added
value.
Method: We designed an specific form of
OMC linked to the Electronic Medical
Record that was filled by pediatrician and
emailed to the Allergist. Within 48 h, the
allergist answered it with the indication of
‘referring’ or ‘not referring’ the patient to
our consults. In some instances, the aller-
gist gave advise about patient′s treatment
and care and, only if these advises were
ineffective, the child was referred.
Results: From May/2005 to May/2011, we
answered 186 OMC corresponding to chil-
dren under 14 years. The reasons of OMC
were food allergic reactions (FAR) (30%),
respiratory symptoms (26%), Drug adverse
reactions (DAR) (12%), cutaneous symp-
toms (11%), Immunotherapy doubts (2%)
and miscellany (19%). In 50% of the
OMC referral was not needed, specially in
those with cutaneous symptoms (71%),
Immunotherapy doubts and miscellany
(100% each). DAR (63%), FAR (53%)
and respiratory symptoms (39%) were the
main causes of advice for referral.
Conclusion: OMC implementation is possi-
ble in Allergy pediatric consults. OMC
improves communication between physi-
cians from Primary and Specialised Care
and reduces in 50% referral to specialised
care consults. So, OMC can reduce the
number of spezialized care consults with
no adde value for patients, decreasing in
that way both, direct and indirect health
costs.
689
Vitamin D deficiency in Asian children:
prevalence and association with total
and allergen-specific IgE in the PATCH
study
Yao,T-C1,2; Tu,Y-L1,2; Chang,S-W3; Tsai,H-J4,5;
Huang,J-L1,2; PATCH Study Group
1Department of Pediatrics, Chang Gung Memorial
Hospital, Taoyuan, Taiwan; 2Department of Pediatrics,
Chang Gung University College of Medicine, Taoyuan,
Taiwan; 3Clinical Informatics and Medical Statistics
Research Center, Chang Gung University College of
Medicine, Taoyuan, Taiwan; 4Division of Biostatistics
and Bioinformatics, National Health Research Institutes,
Institutes of Population Health Sciences, Maioli,
Taiwan; 5Department of Pediatrics, Feinberg School of
Medicine, Northwestern University, Chicago, IL, United
States
Background: New evidence show high
prevalence of vitamin D deficiency in many
countries and some studies support a possi-
ble link between low vitamin D status and
atopy-related phenotypes in children. The
objective of this study was to determine
the prevalence of vitamin D deficiency in a
population sample of Asian children and
to investigate the association between
serum 25-hydroxyvitamin D [25(OH)D]
concentrations and total and allergen-spe-
cific immunoglobulin E (IgE) levels.
Methods: Serum 25(OH)D concentrations
were measured by a new automated elect-
rochemiluminescense-based assay, Elecsys
Vitamin D total assay (Roche Diagnostics,
Mannheim, Germany), in a population-
based sample of 1315 Asian children aged
5–18 years in the Prediction of Allergies in
Taiwanese CHildren (PATCH) study.
Serum levels of total and allergen-specific
IgE were determined by ImmunoCAP and
ImmunoCAP Phadiatop Infant, respec-
tively.
Results: The mean concentration of serum
25(OH)D was 20.4 ng/ml (SD: 7.1 ng/ml).
Vitamin D insufficiency (defined as serum
25(OH) D < 30 ng/ml) was observed in
90.3% of children. Vitamin D deficiency
(defined as serum 25(OH) D < 20 ng/ml)
was present in 51.0% of children. The
serum 25(OH)D concentration was not sig-
nificantly associated with total IgE
(P > 0.05) or allergic sensitisation, defined
as a positive Phadiatop Infant test result,
(P > 0.05). Older age, female gender,
higher body mass index, winter/spring
months, and environmental tobacco smoke
exposure were associated with low vitamin
D concentrations (all P < 0.01).
Conclusion: Vitamin D deficiency is
remarkably common in this population-
based sample of Asian children, suggesting
that millions of Asian children living in
Taiwan may have suboptimal levels of
vitamin D. This population-based study
provides evidence against the association
of vitamin D status with either total IgE
levels or allergic sensitisation in Asian chil-
dren. The relationship between vitamin D
status and allergic diseases merits further
study.
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Free cortisol in 24 h urine as indicators of
the impact of long-term therapy with
medium doses of inhaled corticosteroids
on the hypothalamic-pituitary-adrenal
axis in children with asthma
Baumann, SF1; Baumann, SS2; Kanacki-Stankovic, S1;
Pakaski, S3; Deanovic, M3
1Children Department, General Hospital Pancevo,
Pancevo, Serbia; 2Medical School of Belgrade,
Belgrade, Serbia; 3Health Center Pancevo, Pancevo,
Serbia
Introduction: Suppression of hypotha-
lamic-pituitary-adrenal (HPA) axis is a
potential systemic effect of inhaled corti-
costeroids (ICS). The concentration of uri-
nary free cortisol (UFC) is a good
indicator of the ICS effects on the HPA.
Objective: The aim of this study is to ver-
ify with UFC analysis does long-term use
of high doses of ICS (Budesonide, Cicleso-
nid, Fluticasone) affects the HPA.
Methodology: The study includes 94 chil-
dren aged 5–17 years (average 10.8) with
persistent asthma with the long-term Th,
from 3 to 108 months (10.5) with moderate
doses of ICS (lg): Budesonide (300–600),
Ciclesonide (120–240) and Fluticasone
(250–500).
The control group consisted of 73 child
without ICS Th, 5–17 years old (11.3). In
all children was determined UFC in 24 h
urine with CLIA method (Chemilumines-
cent immunoassay). Reference Values:
26.2–408.3 nM.
Results: Budesonide has a average value of
the UFC in nM: 245.7 (range: 9.1–2442.3),
Ciclesonide: 302 (24.7–981), Fluticasone:
191.1 (16.3–320, 8), control group 272.4
(30.6–951.4). UFC values below the mini-
mum has 5 (5.32%) children. On the Buse-
nonide 3, Ciclesonide 1, Fluticasone 1.
Values above the maximum has 8 (8.51%)
children. On the Budesonide 4, Ciclesonide
4, while with Fluticasone isn’t registred
value above the maximum. The control
group was not registered under the mini-
mum value, and 10 (13.70%) children had
a value above the maximum. With high
values of UFC 11 (61%) children are
actively involved in sports, six without and
five with the ICS-Th.
Discussion: The lowest and highest values
of the UFC is recorded at Budesonide. In
children with ICS-Th were recorded spo-
radically low values of UFC, who are on
the border of significance P = 0.05, and
higher have been recorded in the children
who play sports. Serum cortisol in children
with low and high values of the UFC was
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normal. Clinically, we didn’t notice hyper-
cortisolism and suppression of HPA. Bu-
desonide and Fluiticason has a lower
average value of the UFC compared to the
control group, Ciclesonide higher.
692
Decreased vigorous physical activity in
school age children with asthma
symptoms: differing gender associations
Sevenoaks, H; Belgrave, D; Lowe, L; Kopec-Harding, K;
Simpson, A; Custovic, A; Murray, CS
NHS Foundation Trust, University of Manchester,
Manchester Academic Health Science Centre,
University Hospital of South Manchester, Manchester,
United Kingdom
Background: The rise in prevalence of
asthma has coincided with changes in life-
style and environment. One factor which
has been implicated is physical activity lev-
els. Studies investigating physical activity
and the association with asthma have
reported inconsistent effects. Within a pop-
ulation-based birth cohort study (Manches-
ter Asthma and Allergy Study) we
examined the association between physical
activity and asthma in children age
11 years.
Methods: Children attending age 11 fol-
low-up underwent body habitus measure-
ments, lung function testing (pre/post
bronchodilator spirometry; methacholine
challenge) and skin prick testing. Parents
completed a validated respiratory question-
naire. Subjects were fitted with an acceler-
ometer [Philips Respironics, Murrysville,
USA] to their non-dominant wrist and
wore continually for 7 days. Children with
idle periods >4 h or failure to complete
7 days were excluded. Hourly activity
counts and minutes spent in vigorous activ-
ity per hour produced a longitudinal data
set. Initial analyses identified significant
factors (e.g. gender, fat percentage, day of
week) associated with activity. These fac-
tors were then incorporated into multi-level
linear and Poissonian regression models to
assess whether the presence of asthma
(answered positively to 2 out of: doctor
diagnosis asthma; asthma medication;
wheeze in last 12 months), asthma medica-
tion use, lung function and atopic state
could predict activity levels.
Results: 476 children were fitted with
accelerometers. Data was complete in 275
children (male n = 135; median age
11.5 years). Boys were significantly more
active than girls; female gender predicted
11% less overall activity (P = 0.03) and
61% less vigorous activity (P < 0.01).
Higher body fat percentages predicted less
activity (P < 0.01), but only in boys. Thus
girls and boys were analysed separately.
Hourly activity counts were not signifi-
cantly associated with asthma or asthma
medication use. However, girls with
asthma had a 34% reduction in vigorous
activity (P = 0.04) and those on asthma
medications had a 37% reduction
(P = 0.02) compared to non-asthmatic
girls. Only boys who reported using
asthma medications with exercise had a
significant reduction in vigorous activity
(33%, P = 0.04). Activity levels were not
associated with atopy or lung function.
Conclusion: Diagnosis and treatment of
asthma is associated with a significant
reduction in the level of vigorous physical
activity particularly in girls.
693
The reliability, validity, and
responsiveness of TRACK questionnaire
in Turkish pre-school children
Buyuktiryaki, B1; Sahiner, UM1; Yavuz, ST1; Cavkaytar,
O1; Arik Yilmaz, E1; Soyer, OU1; Tuncer, A1; Sekerel,
BE1
1Department of Pediatric Allergy, Hacettepe University
Faculty of Medicine, Ankara, Turkey
Background: ‘Test for Respiratory and
Asthma Control in Kids (TRACK)’ ques-
tionnaire is the first to measure both the
risk and impairment domains of the cur-
rent guidelines in pre-school children. We
aimed to measure the reliability, validity,
responsiveness, and minimally important
difference (MID) of the Turkish version of
the TRACK.
Method: A total of 268 children (69.8%
boys) were included in the study. Caregiv-
ers filled in three TRACK questionnaires,
one at each of three clinical visits (initial,
1st month, and 3rd month). At each visit,
physicians determined the control level and
the treatment step based on the GINA
guideline recommendations.
Results: The internal consistency reliability
of the Turkish version of the TRACK
questionnaire was found to be 0.74, 0.74,
and 0.76 at each of the three visits, respec-
tively (reliability statistics, Cronbach’s
alpha a). There was a significant difference
between the mean TRACK scores of the
patients in different asthma control status
categories (P < 0.001). The test-retest reli-
ability was 0.90. The optimal cut-off
scores, according to the Youden index, for
uncontrolled and very poorly controlled
children, were 80 and 60 points, respec-
tively. The MID mean estimates, deter-
mined using the 0.5 SD and 1 SEM
distribution-based methodology, were 10.9
and 10.8, respectively.
Conclusion: The Turkish version of the
TRACK is an accurate and reliable tool
for evaluating asthma control status
among pre-school Turkish children. Its
widespread use may help physicians cor-
rectly assess control levels among children
and may improve quality of life for both
patients and their caregivers.
694
Wheezing in young children and
development of asthma in school age:
use of the Asthma Predictive Index in a
subtropical environment
Albuquerque, LA1; Silva, JM1; Camara, A1; Arruda, LK2;
Ferriani, VP1
1Department of Pediatrics, School of Medicine of
Ribeir~ao Preto, University of S~ao Paulo, Ribeirao Preto,
Brazil; 2Department of Medicine, School of Medicine of
Ribeir~ao Preto, University of S~ao Paulo, Ribeirao Preto,
Brazil
Background: We have evaluated the sensi-
tivity and specificity of the Asthma Predic-
tive Index (API) for development of
asthma in 9–11 year-old-children after an
index wheezing episode in infancy.
Method: Sixty one of 76 children who had
been seen at the Emergency Room for an
episode of wheezing in infancy (6–24 m)
were included and their parents completed
a questionnaire on respiratory symptoms.
52 of them underwent skin prick testing to
inhalant and food allergens and 48 of
those performed methacoline challenge
tests. Children were considered asthmatic if
they presented previous physician-diag-
nosed asthma, or at least one of the fol-
lowing symptoms in the past 12 months:
wheezing, cough or chest tightness with
exercise, or dry cough without colds,
accompanied by bronchial hyperrespon-
siveness, as detected by a PC20 < 4 mg/ml
on methacoline challenge test. A positive
API score (at least one major criteria: phy-
sician-diagnosed eczema or parental
asthma; or 2 of 3 minor criteria: physician-
diagnosed allergic rhinitis, wheezing with-
out colds or peripheral eosinophilia ≥4%)
was defined based on information collected
when the children were seen for the index
episode (between 6 and 24 months). Sensi-
tivity, specificity and confidence intervals
(CI) of the API index for the diagnosis of
asthma at 9–11y were calculated.
Results: Among the 48 children evaluated
at school age, 20 (41.7%) were diagnosed
with asthma; 13 of them (65%) had posi-
tive API index at the time of the index
wheezing episode. Of the 28 wheezing
babies that did not develop asthma at 9–
11y, only 9 (32.1%) had positive API. Sen-
sitivity and specificity of the API index
were 65% (IC = 40.8–84.6) and 67.9%
(47.7–84.1), respectively.
Conclusion: Using simple parameters as
proposed by the API index, the develop-
ment of asthma can be reasonably pre-
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dicted in wheezing infants living in a sub-
tropical environment.
695
Quality of life of children with food
protein induced gastrointestinal allergies
Meyer, R1; Godwin, H1; Dziubak, R1; De Koker, C1;
Gloria ,D-O1; Yerlett, N1; Skrapac,A-K1; Shah, N1
1Great Ormond Street Hospital, London, United
Kingdom
Background: Children with a peanut
allergy have been shown to have a worse
quality of life (Qol) compared to those
with insulin dependent diabetes. No such
data is available for children with food
protein induced gastrointestinal allergies
(FPIGA). We therefore set out to study
the impact on QoL of this allergic disor-
der, compared to healthy children and
those with cardiac disorders.
Method: Parents of children (2–12 years)
diagnosed with FPGIA at Great Ormond
Street Hospital were prospectively recruited
to complete the parent proxy PedsQL 4.0
questionnaire. This questionnaire provides
a mean score of Qol (0–100) as well as a
score on physical, psychosocial, emotional
and social functioning and nursery/school
for age categories: 2–4, 5–7 and 8–12. We
compared our data to a published cohort
of healthy children with matched age cate-
gories and also compared children ages 2–4
to a published cardiac group.
Results: Thirty four questionnaires were
completed. The pooled data indicated that
children with FPIGA had a significantly
worse Qol than healthy children except for
social functioning (Table 1). However, in
the 2–4 year olds (n = 12) with FPIGA
compared to children with cardiac disor-
ders, the Qol was significantly worse
(P < 0.0001) in all categories, including
social functioning.
Conclusion: This study indicates that FPI-
GA have a significant impact on the QoL,
which clinicians need to take into account
in their management. The pooled data
indicated that social functioning was not
impaired when compared to healthy con-
trols, but in the 2–4 age group social func-
tioning was lower than children with
cardiac disorders. This is an interesting
finding, which indicates that most parents
of children with FPIGA perceive their
child as having normal social functioning
in spite of dietary restrictions which often
affect children’s socialisation. Although
our results may have been influenced by
the low number of subjects, it may be that
the QoL of children with FPIGA is
affected in different ways depending on the
age of the child. Further data is being col-
lected to answer these questions.
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Why is pediatric anaphylaxis not
managed according to guidelines?
Harlow, G1; Richardson, J1; Dowling, N1; Makwana, N1
1Department of Paediatrics, Sandwell and West
Birmingham NHS Trust, West Bromwich, United
Kingdom
Background: Anaphylaxis is a severe, life-
threatening type I hypersensitivity reaction.
NICE issued guidance in December 2011
on the management of suspected anaphy-
laxis. The authors attributed suboptimal
management to inadequate understanding
by health care professionals.
We evaluate medical students′ and junior
doctors′ knowledge of anaphylaxis and the
management of anaphylaxis in a large UK
NHS trust.
Method: 1. A paper questionnaire, based
on APLS guidelines, was presented to final
year medical students and medical trainees.
Participants were asked to assign twenty
clinical features to ‘allergy’, ‘suspected ana-
phylaxis’ or ‘neither’, and to select suitable
management options.
2. Case notes of patients under 17 years
old with a final diagnostic code of anaphy-
laxis were reviewed retrospectively. Their
anaphylaxis management was compared to
NICE guidance.
Results: The results of the survey are
shown in Table 1.
Emergency medicine trainees and medi-
cal students scored lower on the recogni-
tion of anaphylaxis than General Practice
and Paediatric trainees. Medical students,
general practice trainees and senior paedi-
atric trainees had the worst scores on the
management of anaphylaxis.
Initial anaphylaxis management of the
71 analysed cases was poor; 66% received
intramuscular adrenaline (33% pre-hospi-
tal, 33% in-hospital), 37% oxygen and
17% intravenous fluids. For the reviewed
cases, 66% had a known allergy; 72% were
admitted with a reaction to one of their
known allergens. Of the children who carry
an adrenaline autoinjector, 55% used it
correctly during their presenting episode.
None of these patients received discharge
information meeting full NICE criteria on
discharge.
Conclusion: We demonstrate that lack of
trainee knowledge translates into subopti-
mal clinical management of anaphylaxis.
Our results support the urgent need for
allergy to be reinforced in the national
medical curriculum, with the aim of
improving anaphylaxis management and
doctors’ ability to educate patients and rel-
atives.
Table 1 for abstract 695
Category FPIGA Cohort SD Healthy Cohort SD P-Value
Total 74.30 15.2 82.70 15.40 0.0015
Physical 75.92 16.6 84.48 19.51 0.0106
Psychosocial 73.40 16.3 81.65 15.22 0.0016
Emotional 67.79 21.3 81.31 16.50 0.0001
Social 82.94 16.3 83.70 19.43 0.8201
School 68.85 19.4 78.83 19.95 0.0031




Number of respondents 94 184
Mean clinical
features score (maximum 20)
11.9 11.2
Mean anaphylaxis features score
(maximum 8)
7.0 6.5
Mean management score (maximum 6) 5.1 4.4
Percentage identifying need for admission
under paediatrics
85% 86%
Percentage identifying need for allergy clinic follow up 88% N/A
Percentage who felt competent to teach autoinjector
technique
63% N/A
Percentage who felt confident at recognising anaphylaxis
independently
N/A 56%
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Anaphylaxis planning and preparation in
schools following local re-structuring of
secondary education
Acomb, H1; Kerrin, D1
1Paediatric Department, Barnsley Hospital NHS
Foundation Trust, Barnsley, United Kingdom
Background: There is a GALEN position
statement with standards for allergy man-
agement in schools. Most schools in the
United Kingdom contain students at risk
of anaphylaxis, but provision of care varies
widely. Our secondary care local allergy
service has reported care plan consistency,
but not yet explored preparedness of local
schools. There has been recent major
restructuring of secondary schools in
Barnsley (none now under local authority
control).
Concerns from school nurses prompted
review of allergy care in schools.
Method: Secondary schools approached
by email and letter. Structured interview
with nominated school representative.
Standardised questions asked regarding
standards from position statement. Ques-
tionnaire to each schools public health
nurse.
Results: Eight of ten schools made contact
and were interviewed, all Advanced Learn-
ing Centres in new builds, two are mergers
of existing schools. Seven schools had writ-
ten allergy plans available for all allergic
students. Three schools had no system in
place for staff to readily identify an allergic
child. Only three schools had a system
using photos. All schools offered staff
training in allergy recognition and
response, all had emergency medication on
site. Only two schools had a policy regard-
ing allergy safety in catering, both were
currently providing allergen free meals for
specific pupils. One school met all five
standards audited, five schools met 4
(range 2–5 standards met.) The two
schools that were mergers both did well
despite having the most recent opening
dates. Two of the three schools open for
the longest achieved the poorest results.
Nurses responses often discussed uptake
of staff training only. Two schools
reported our audit had stimulated organi-
sational changes prior to interview.
Conclusion: Changes in school organisa-
tion, accountability, staff and catering
arrangements can all have a significant
impact on ensuring safety of allergic chil-
dren. It was concerning that some schools
did not engage with the audit at all, and
there was significant variation in prepared-
ness amongst schools. School readiness did
not seem adversely affected by merging
schools; worse outcomes were seen in
schools just moving sites. Moving from
local authority control to individualised
catering arrangements runs risks of allergy
safety being overlooked without clear poli-
cies in place. The process of survey and
feedback has hopefully raised the profile of
this issue at a time when schools may have
other priorities.
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Factors influencing primary care
physicians in the treatment of allergic
rhinitis
Murgia, N1; Baldacci, S2; Casciari, C3; Maio, S2; Abbritti,
G1; Viegi, G2,4; Spinozzi, F3; ARGA
1Section of Occupational Medicine, Respiratory
Diseases and Toxicology, University of Perugia,
Perugia, Italy; 2Pulmonary Environmental Epidemiology
Unit, CNR Institute of Clinical Physiology, Pisa, Italy;
3Laboratory of Experimental Immunology and Allergy,
University of Perugia, Perugia, Italy; 4CNR Institute of
Biomedicine and Molecular Immunology ‘A. Monroy’,
Palermo, Italy
Background: Undertreatment or no treat-
ment of allergic rhinitis is still a problem
despite the socio-economical burden of this
disease and its relationship with asthma.
Some studies are suggesting that primary
care physician could play a pivotal role in
allergic rhinitis management. The objective
of this study is to evaluate factors that
could influence primary care physician to
undertreat/no treat allergic rhinitis
patients.
Method: 518 allergic rhinitis patients
recruited by their primary care physicians
in Region Umbria, Italy, as a part of the
ARGA study, funded by the Italian
Agency of Drug (project no. FARM-
JY5SA), completed a questionnaire on
allergic rhinitis symptoms and treatment.
Undertreatment/no treatment was defined
as being inadequately treated or having
no treatment despite rhinitis symptoms.
Chi-square test and logistic regression
were performed to assess risk factors for
allergic rhinitis undertreatment/no treat-
ment.
Results: 26.2% of the patients had no
treatment despite the symptoms and 13.5%
were inadequately treated. Patients who
had also asthma (OR 0.47, 95% CI 0.30–
0.75) and conjunctivitis (0.44, 95% CI
0.27–0.71) were at lower risk of allergic
rhinitis undertreatment/no treatment: in
asthmatics this reduction was related
mainly to the concomitant asthma treat-
ment (OR 0.19, 95%CI 0.10–0.37). Asth-
matics undertreated/no treated for rhinitis
had the highest prevalence of rhinitis-
related quality of life impairment.
Conclusions: Undertreatment/no treatment
for allergic rhinitis is still rather frequent
among primary care physicians. The simul-
taneous presence of asthma and an anti-
asthmatic therapy are able to influence
positively physicians to treat adequately
their patients. Anyway targeted interven-
tions toward a better knowledge of the
importance of allergic rhinitis, even if with-




information needs in primary care based
on requests for sIgE determinations
Brakel, TM1,2; de Flokstra-Blok, BMJ1,2; Elberink, JNG2,3;
Schuttelaar, MLA4; Christoffers, WA4; Roerdink, EM5;
van der Molen, T1,2; Dubois, AEJ2,5
1Department of General Practice, University Medical
Center Groningen, Groningen, The Netherlands;
2GRIAC Research Institute, Groningen, The
Netherlands; 3Department of Allergology, University
Medical Center Groningen, Groningen, The
Netherlands; 4Department of Dermatology, University
Medical Center Groningen, Groningen, The
Netherlands; 5Department of Pediatric Pulmonology
and Pediatric Allergy, University Medical Center
Groningen, Groningen, The Netherlands
Background: For many patients suspected
of allergy, management is initially and
often ultimately the responsibility of gen-
eral practitioners (GPs). However, previous
studies have shown that GPs find that pro-
viding such care is difficult, especially when
anaphylactic symptoms occur. An area of
concern is the interpretation of sIgE tests.
The purpose of this study is to obtain
insight in characteristics of primary care
patients for whom an IgE test was
requested, with a view to developing a sys-
tem for providing additional information
to the GP together with the test results.
Method: Patients who were sent to a labo-
ratory for one or more sIgE tests received
a questionnaire which was completed at
home. This questionnaire was specifically
developed and tested to obtain key infor-
mation about the patients’ medical allergy
history. Parents reported about their
child’s allergy.
Results: From the patients (n = 118,
Mage = 31.7 years; range 12 months to
81 years) 40% was male. For 55% of the
patients no diagnosis had been established.
A single allergy diagnosis had been made
for 26.5% of the patients and 19%
reported to have multiple allergies. Of the
patients for whom one or more diagnoses
were reported, 15.4% had asthma, 23.9%
rhinitis, 18.8% eczema, 4.3% food allergy,
and 6.8% had an unspecified allergy. The
main reasons for requesting a sIgE test
were rhinitis and asthma, 51% and 26%
respectively. Less frequent referrals for IgE
testing were: eczema 15%, food related
allergy 9%, non-food induced anaphylaxis
1%, and other allergy disorders 18%.
Conclusion: Although previous studies
show that GPs feel more comfortable man-
aging asthma and rhinitis than patients
with food allergy and anaphylaxis, this is
not reflected in the request for sIgE testing.
A management support system for GPs
should therefore include information on
airway allergy as well as anaphylaxis.
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Frequency of normal serum total IgE in
allergic diseases in children
Buterleviciute, N1; Paltarackiene, V1; Rudzeviciene, O1,2
1Vilnius University Faculty of Medicine, Vilnius,
Lithuania; 2Children’s Hospital, Affiliate of Vilnius
University Hospital Santariskiu Klinikos, Vilnius,
Lithuania
Background: The total serum immuno-
globulin E (IgE) concentrations are rela-
tively crude method of detecting allergic
disorders. Normal values will not exclude
the presence of allergic disease. The aim of
our study was to evaluate the frequency of
normal total IgE in various allergic dis-
eases in children and the frequency of nor-
mal total IgE level in children with raised
specific IgE levels.
Method: Retrospective observational study
was performed. A total of 134 patients (78
boys) 40.8  45.7 months old were en-
roled. The majority of patients (45.5%)
were with atopic dermatitis only, 14.8% –
atopic dermatitis with allergic rhinitis and/
or asthma, 10.4% – dermatitis due to
ingested food, 9.0% – asthma, 20.3% –
other allergic diseases. The total IgE and
allergen specific IgE were detected using
ImmunoCap (Phadia, Sweden), total IgE
was compared with age specific reference
ranges.
Results: The total IgE level was normal in
54 (40.3%) patients. Normal serum total
IgE level was found in 29 (47.5%) patients
with atopic dermatitis only, in 2 (10.5%)
children with atopic dermatitis and con-
comitant allergic diseases, in 11 (78.6%)
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children with dermatitis due to ingested
food. The total IgE level was normal more
frequent in patients with atopic dermatitis
(n = 29, 47.5%) than in patients with ato-
pic dermatitis and concomitant diseases
(n = 2, 10.5%) (P = 0.004), also in patients
with dermatitis due to ingested food
(n = 11, 78.6%) than in patients with ato-
pic dermatitis (n = 29, 47.5%) (P = 0.04).
In children with increased specific IgE
(n = 57, 42.5%), normal total IgE was in 8
(14%) children.
Conclusion: The total IgE level was normal
significantly more frequent in patients with
atopic dermatitis than in patients with ato-
pic dermatitis and concomitant allergic dis-
eases and in patients with dermatitis due to
ingested food than in patients with atopic
dermatitis. One seventh of children with
increased specific IgE levels had normal
total IgE.
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Cesarean section delivery and the
development of food sensitisation, food
allergy, and atopic dermatitis in infants:
COCOA birth cohort study
Lee, S-Y1; Ahn, K-M2; Kim, KW3; Shin, Y-H4; Lee, G-S5;
Kwon, J-W6; Kim, B-J7; Kim, H-B8; Kim, W-K9; Yu, J5;
Hong, S-J5
1Hallym University Sacred Heart Hospital, Hallym
University College of Medicine, Pediatrics, Anyang,
Korea; 2Samsung Medical Center, Sungkyunkwan
University School of Medicine, Seoul, Korea; 3Yonsei
University College of Medicine, Severance Children’s
Hospital, Seoul, Korea; 4CHA University School of
Medicine, Seoul, Korea; 5Childhood Asthma Atopy
Center, Asan Medical Center, University of Ulsan
College of Medicine, Seoul, Korea; 6Seoul National
University Bundang Hospital, Sungnam, Korea; 7Inje
University Heundae Paik Hospital, Pusan, Korea; 8Inje
University Sanggye Paik Hospital, Seoul, Korea; 9Inje
University Seoul Paik Hospital, Seoul, Korea
Background: It has been hypothesised that
changes in the gut microbiota resulting
from cesarean section delivery could
increase a child’s risk of developing allergic
diseases. We sought to examine the rela-
tion between birth by cesarean delivery
and food sensitisation, food allergy and
atopic dermatitis in infants.
Method: We examined the relation
between mode of delivery and the develop-
ment of food sensitisation, food allergy,
and atopic dermatitis among 412 infants
based on a prospective birth cohort study.
Food allergy and atopic dermatitis were
monitored prospectively by pediatric aller-
gist during the first year of life. At age
1 year, a blood sample was taken for the
quantification of specific IgE to milk and
egg white.
Results: After adjustment for other covari-
ates, infants born by cesarean section had
2-fold higher odds of atopic dermatitis
than those born by vaginal delivery (odds
ratio, 2.15; 95% CI, 1.1–4.2). In multivari-
ate analyses, there were no differences in
the prevalence of food allergy and food
sensitisation according to mode of delivery.
Conclusion: Cesarean delivery increases the
risk for atopic dermatitis in infancy, while
delivery mode may not be associated with
the development of food allergy. The bio-
logic mechanisms underlying these findings
still need to be elucidated.
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Dynamics of sensitisation to cow′s milk
and soy proteins in infants with atopic
dermatitis during last two decades
Makarova, S1; Borovick, T1; Namazova, L2; Gribakin, S3;
Sergeeva, S2; Garankina, T2; Gevorkian, A2
1Scientific Center of Children’s Health RAMS, Moscow,
Russia; 2Research Center of Children’s Health, Russian
Academy of Medical Science, Moscow, Russia;
3Russian Medical Academy of Postgraduate Training,
Moscow, Russia
Background: Cow,s milk proteins (CMP)
and egg ovalbumin are the major food
allergens in infancy. Sensitisation to gluten,
peanuts and soy protein (SP) occupies the
second position in the list of the main
allergens for infants. We analyzed the
dynamics of incidence of CMP and SP
allergy in pediatric patients (infants) trea-
ted at the Research Center of Children,s
Health at different periods of time during
the last two decades.
Method: Three hundrand and Fifty-eight
infants with atopic dermatitis (AD) were
distributed into five groups according to
the studies performed in our Center in dif-
ferent years. 1st group (n = 92) was
observed in 1989–1992, 2nd group (n = 86)
in 1990–1994, 3rd group (n = 68) in 1995–
1998, 4th group (n = 54) in 2004–2008 and
the 5th group (n = 58) was observed and
treated in 2008–2011. All groups were
comparable by the age and severity of
symptoms. The level of specific IgE was
detected by ELISA test.
Results: The comparison of results of dif-
ferent years shows that the incidence of
detection of specific IgE to CMP was sta-
ble in studies 1989–1998 (1st group –
72.7%, 2nd group – 68.6%, 3rd group –
72.9%) and tends to decrease (P = 0.03)
during recent few years (4th group –
57.4%, 5th group – 53.4%). The lower
incidence of IgE-mediated sensitisation to
CMP in infants with AD can be explained
by active food allergy prevention by means
of wide usage of preventive HA-formulas.
The incidence of SP sensitisation was 6.8%
and 5.8% in 1st and 2nd groups and
increased in the middle of 1990s
(P < 0.001) when soy protein isolate based
formulas were widely used but CM protein
hydrolysates were not common. The high-
est level of sensitisation to SP was
observed in 1995–1998 (3rd group –
26.2%). During the last decade SP sensiti-
sation level decreased to 11.1% and later
to 7.4% (P < 0.001) which is explained by
no use of soy-based formulas during first
six months of age of patients.
Conclusion: The incidence of sensitisation
to CMP and SP in pediatric patients dur-
ing last two decades has a typical dynam-
ics. Based on clinical studies performed in
our center in different years we come to
the conclusion that both incidence of CMP
sensitisation and of SP sensitisation has
decreased in recent years in comparison to
1990s. A significant decrease of SP sensiti-
sation reflects the efficacy of current nutri-
tional strategies in the management of
food allergy in children.
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The diagnostic challenge of non-allergic
skin disease
Muresan, A-M1
1Regina Maria Medical Centers, Bucharest, Romania
Background: Allergic skin disease is one of
the most common reasons for consultation
in an allergy clinic. However, allergy diag-
nosis is not always confirmed.
Method: We present a few illustrative case
reports of non-allergic skin disease, initially
considered as ‘allergy’ either by the patient
or by the primary care physician.
Results: The clinical diagnosis were
rubella, pityriasis rosea Gilbert, scarlatini-
form exanthema, molluscum contagiosum,
seborrheic dermatitis and oral lichen pla-
nus.
Conclusion: Viral infections of skin and
non-atopic/contact dermatitis represent a
frequent ‘allergy’ misdiagnosis. A thorough
knowledge of dermatology is often
required in allergy praxis and a differential
diagnosis should always be considered.
704
Diagnosing hypersensitivity reactions to
non-steroidal anti-inflamatory drugs in
children
Zambonino, MA1; Mu~noz, C1; Requena, G1; Mayorga,
C1; Urda, A1; Corzo, JL1; Blanca, M2; Torres, MJ2;
FIS-Thematic Networks Co-operative Research Centres:
RIRAAF (RD07/0064)
1Pediatric Service, Carlos Haya Hospital, Malaga, Spain;
2Allergy Service, Carlos Haya Hospital, Malaga, Spain
Background: Hypersensitivity reactions to
non-steroidal antiinflammatory drugs
(NSAIDs) are the most frequent reported
reactions. They can be induced by pharma-
cological mechanism (cyclooxigenase
inhibition), being patients classified as
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cross-intolerance (CI), and by specific
immunological mechanisms (IgE or T cell),
being considered as selective reactors (SR).
The aim of the study was to analyse a
large group of children with a history of
NSAID hypersensitivity that were diag-
nosed by drug provocation test (DPT).
Method: Sixty three children with a history
of NSAIDs hypersensitivity were evaluated
by DPT. Patients were classified as CI or
SR depending on the acetyl salicylic acid
response. The atopic status was assessed by
prick tests to a standard of common inhal-
ant allergens and total IgE in serum.
Results: The 68.2% were confirmed as
having hypersensitivity, and from this
58.1% classified as CI and 41.9% as SR.
From a total of 119 DPT performed, 73
were positive (53.4% positive to Ibuprofen,
37% to AAS, 8.2% to metamizol and 1.4
to paracetamol), being angioedema the
clinical symptoms presented in 86.3% of
cases alone or accompanied with urticaria.
All CI cases tolerated the administration of
paracetamol. There was a significant num-
ber of atopic subjects in those with CI
(72%) compared with those with SR
(27.7%) and non-allergic controls (30%).
Conclusion: In children CI hypersensitivity
to NSAID is more frequent reaction, being
ibuprofen the drug most often involved,
the most common entity was angioedema,
being atopy frequently associated. DPT
resulted to be a safe approach for diagnos-
ing these patients.
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Diagnosis of nonimmediate allergy to
betalactams in children
Caubet, J-C1; Frossard, C2; Fellay, B3; Eigenmann, P1
1Department of Child and Adolescent Medicine,
University Hospitals of Geneva, Geneva, Switzerland;
2University Hospitals of Geneva, Geneva, Switzerland;
3Central Laboratories, Cantonal Hospital of Fribourg,
Fribourg, Switzerland
Background: Urticarial or maculo-papular
skin rashes are frequently observed in chil-
dren treated by betalactams (BL). Such
manifestations are more likely to be related
to the underlying infection rather than to
an allergic reaction due to the antibiotic
(less than 10%). Accurate diagnosis of
antibiotic allergy is important not only to
prevent life-threatening reactions, but also
to avoid unnecessary drug restriction asso-
ciated with increased resistance and health
costs. Based on a large cohort of patients,
the aim of this study was to evaluate the
utility of clinical diagnostic tests in chil-
dren developing a benign rash during a BL
treatment.
Method: Patients with a history of urticar-
ial or maculo-papular rash during and up
to 72 h after a treatment with BL, and a
positive oral provocation test (OPT) with
the culprit antibiotic were prospectively
recruited at the Geneva University Hospi-
tal between 2006 and 2010. Subjects under-
went intradermal skin tests (IDT) for BL.
In addition, lymphocyte transformation
test (LTT) were performed by measuring
(3) H-thymidine incorporation after 7 days
of incubation with the incriminated antibi-
otic. Basophils activation tests (BAT) were
done according to manufacturer protocol
(Buhlmann, Switzerland).
Results: We analyzed data from 14
patients with an antibiotic allergy con-
firmed by a positive OPT (median age of
4.8 years, range 1.1–12.3) and 82 negative
controls (median age of 1.7 years, range
0.5–14.5). Delayed-reading IDT were nega-
tive in all tested patients. Immediate-read-
ing IDT were positive in seven patients
with a positive OPT (50%) and seven
patients with a negative OPT (8.5%). The
overall sensitivity determined for immedi-
ate-reading IDT was 50% and the specific-
ity was 91.5%. The negative and the
positive predictive values were 91.5% and
50%, respectively. Data were available for
the LTT in nine patients with a confirmed
BL allergy (median age of 2.0 years, range
1.1–8.5) and 15 negative controls (median
age of 3.1 years, range 0.5–11.1). We
observed an overall higher lymphocyte pro-
liferation rate in allergic patients compared
to non-allergic children (mean counts per
minute (cpm) of 2352 and 1355, respec-
tively). The BAT were negative in the six
tested patients with a positive OPT.
Conclusion: Both skin tests and in vitro
tests (i.e. LTT and BAT) are of limited
value and an OPT should be considered in
all children who develop a delayed-onset
urticarial or macula-papular rash during
treatment with a BL.
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Stevens Johnson syndrome triggered by
combination of clobazam, lamotrigine
and valproic acid in a child
Balamtekin, N1; Kılıc, S2; Arslan, M3; Fidancı, MK4;
Yavuz, ST5; Yapıcı, AK6; Kalman, S7
1Department of Pediatric Gastroenterology and
Nutrition, G€ulhane Military School of Medicine, Ankara,
Turkey; 2Department of Pediatrics, G€ulhane Military
School of Medicine, Ankara, Turkey; 3Department of
Pediatric Neurology, G€ulhane Military School of
Medicine, Ankara, Turkey; 4Department of Pediatric
Cardiology, G€ulhane Military School of Medicine,
Ankara, Turkey; 5Department of Pediatric Allergy and
Immunology, G€ulhane Military School of Medicine,
Ankara, Turkey; 6Department of Plastic Surgery,
G€ulhane Military School of Medicine, Ankara, Turkey;
7Department of Pediatric Nephrology, G€ulhane Military
School of Medicine, Ankara, Turkey
Introduction: Stevens-Johnson Syndrome
(SJS) is an acute life-threatening dermato-
sis characterised by conjunctivitis, oral
ulcerations, fever and erythematous ma-
cules. The most important etiological fac-
tors are infections and drugs including
anticonvulsants and non-steroidal antiin-
flammatories. Clobazam related SJS has
been reported rarely in the literature.
Herein, we report a case of SJS triggered
by combination of clobazam, lamotrigine
and valproic acid.
Case report: An 8-year-old boy was admit-
ted to our department with a 10-day his-
tory of fever, oral mucosal ulcerations and
skin lesions. The patient was under the
treatment of valproic acid (350 mg bd) and
lamotrigin (50 mg bd) for 4 years due to
epilepsy. Because of the increase in seizure
frequency, clobazam (10 mg bd) was added
to therapy one month ago. Physical exami-
nation revealed oral mucosal ulcerations,
hemorrhagic crust on the lips, bilateral hi-
peremic conjunctivas and purpuric lesions
on the trunk. Laboratory tests, including
CBC, serum electrolytes, liver and renal
function tests, urine analysis and sedimen-
tation rate were within normal limits. The
patient was diagnosed with SJS and treated
with methylprednisolone and antibiotics.
All anticonvulsants were withdrawn and
the patient was treated with phenytoin for
seizures. The lesions progressively resolved
in 7 days and methylprednisolone therapy
was terminated.
Conclusion: Stevens-Johnson Syndrome
has been reported with the use of valproic
acid and lamotrigine in the literature. Dur-
ing the treatment of valproic acid and
lamotrigine for about four years, no skin
rash was reported in our patient, but SJS
developed after clobazam was added to the
treatment protocol. The risk of SJS may
increase in children who undergo combined
antiepileptic therapy. Pediatric patients
taking multiple antiepileptic drugs should
be informed of possible cutaneous adverse
effects and treatment should be terminated
in case of any cutaneous symptoms includ-
ing mucous membranes.
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Prurigo simplex? Papuler urticaria?
Akar, HH1; Tahan, F1; Balkanlı, S2; Ozcan, SS2
1Department of Pediatric Allergy, Erciyes University
School of Medicine, Kayseri, Turkey; 2Department of
Pathology, Erciyes University School of Medicine,
Kayseri, Turkey
Case report: Subacute prurigo clinically
presents as excoriated papules mostly in a
symmetrical distribution on the extensor
surfaces of the extremities, neck, lower
trunk, and buttocks. Some patients may
have an atopic background. Exogenous
toxic factors such as parasites, bacteria,
topically or orally administered drugs
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deposited on the skin which can induce
itching. Skin manifestations are similar to
papular urticaria. A 4-year-old boy pre-
sented with a 2-month history of intense
pruritus and excoriated papules on trunk
and extremities. The percentage of eosin-
ophils was 5.7%. IgE level was normal.
Skin Prick Test was negative. Cutaneous
manifestations were refractory to treat-
ment. Punch biopsy showed prurigo sim-
plex.
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The influence of allergen-specific
immunotherapy on cognitive functions
among hay fever children
Muradova, O1; Namazova-Baranova, L2; Karkashadze,
G2; Maslova, O2; Torshoeva, R2; Tomilova, A2;
Alekseeva, A2
1Department of Cognitive Pediatrics, Federal State
Budgetary Institution ‘Scientific Centre of Children
Health’ under the Russian Academy of Medical
Sciences, Moscow, Russia; 2Federal State Budgetary
Institution ‘Scientific Centre of Children Health’ under
the Russian Academy of Medical Sciences, Moscow,
Russia
Background: The prevalence of allergic rhi-
nitis comes up to 15% for children 6–
7 years old and up to 30% for teenagers
13–14 years old (MI. Asher et al., 2006)
according to the ISAAC program. It is
marked out that the children, which suffer
for a long time from allergic rhinitis with
grave and medium grave condition clinical
course, have cognitive functions abnormali-
ties in 95.3%.
Method: The complex estimation of the
cognitive function condition for 97 children
from 8 to 17 years old suffering from hay
fever during remission has been carried
out. Depending on ASIT the children has
been divided on two groups. The 1st group
has contained 54 children without having
ASIT previously; the 2nd group has con-
tained 43 children having ASIT previously.
Both groups were comparable on age and
gender. The general clinical allergist and
immunoassay has been carried out for all
children under investigation. The improved
version of the computer psychophysiologi-
cal system ‘Psychomat’ model has been
used to estimate the child cognitive func-
tion.
Results: The investigation results show
that the children from the 1st group suffer-
ing from hay fever and not having ASIT
have the decreasing of cognitive functions
at 61% cases, but the children from the
2nd group having ASIT previously have
the decreasing of cognitive functions dur-
ing remission only at 18.6% cases. The
decreasing of cognitive activity in the 2nd
group is connected with the long intervals
(more than 2 years) between the previously
conducted ASIT courses and addition of
grave condition allergic rhinitis. For chil-
dren from the 1st group with hay fever
having the associated all-year allergic rhini-
tis the abnormality of cognitive functions
is detected in 77.7% cases. At this time it
is proved that the associated disease as
bronchial asthma (53%) and as seasonal
bronchial asthma (57%) within the scope
of hay fever do not give rise to more evi-
dent decreasing of cognitive functions that
simply uncomplicated clinical course of
hay fever (51%).
Conclusion: The regularity in the cognitive
function decreasing depending on previ-
ously conducted ASIT to patients with hay
fever is discovered. The regularity of influ-
ence duration and gravity concurrent dis-
ease as allergic rhinitis on the cognitive
activity decrease is confirmed. The influ-
ence of the hay bronchial asthma and all-
year asthma on cognitive functions is
refuted without depending on duration and
gravity of disease.
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Comparative analysis of allergic
pathology in the structure of somatic
diseases in children from radiation-
exposed families and in their fathers
affected by the Chernobyl accident
Nesterenko, ZV1; Ivanina, YY2; Dobrokhotova, AV2;
Pokryshka, LA3; Pilipenko, IA4; Zaitseva, SY2; Lysyh, YV3
1Department of Pediatrics, State Institution ‘Lugansk
State Medical University’, Lugansk, Ukraine; 2Lugansk
Municipal Children’s Hospital #2, Lugansk, Ukraine;
3Lugansk Regional Clinical Hospital #2, Lugansk,
Ukraine; 4Lugansk Regional Children’s Hospital,
Lugansk, Ukraine
Background: Increased morbidity rates in
children affected by the Chernobyl accident
make the study of probable follow-up risks
of long-term health effects in offspring of
persons exposed to radiation (PER) to be
of a particular interest.
Aim: To study the frequency of allergic
diseases (AD) in the structure of somatic
pathology in children from radiation-
exposed fathers with conducting compara-
tive analysis with the AD frequency rates
and concomitant somatic pathology in the
fathers-PER.
Method: The results of retrospective clini-
cal study of pediatric patients aged 0–18,
born to radiation-exposed fathers (group
A, n = 74), their fathers, PER by the Cher-
nobyl accident (group B, n = 74) and chil-
dren of control group (CG, n = 107) are
presented.
Results: AD were found in all groups: A –
27(36.5%), B – 4(8.1%) and CG – 7
(7.5%). Asthma (A) was more frequently
observed in group A – 11(14.9%) patients,
allergic skin diseases (ASD) were revealed
in 17(23%), 9(12.2%) and 14(13.1%)
patients of groups A, B and CG respec-
tively. Diseases of endocrine system (ES),
respiratory (RS), nervous (NS), cardiovas-
cular system (CVS), skin and subcutaneous
tissue (SST) occurred more frequently in
children of group A – in 27(100%), 25
(92.6%), 24(88.9%), 22(81.5%) and 22
(81.5%) patients respectively, while in their
fathers diseases of nervous system (NS),
cardiovascular (CVS), urinary (US) and
digestive system (DS) took the leading
places in the structure of their somatic
pathology – 26(96.3%), 24(88.9%), 23
(85.2%) and 22(81.5%) respectively.
Conclusion: 1. AD were 4.8 times more
frequent in children of affected parents
than in children of CG and 4.5 times more
frequent than in their radiation-exposed
fathers, that is probably due to role of
radiation exposure in the development of
AD in the offspring of affected parents in
the absence of AD manifestations in their
fathers-PER.
2. A and ACD were most frequently
diagnosed AD in the offspring of affected
parents.
3. Diseases of ES, RS, NS, CVS and
SST occurred more frequently in children
with AD, while diseases of NS, DS, US in
their fathers took leading places in the
structure of their somatic pathology.
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Familial Churg Strauss Syndrome in
mother and her daughter
Harmanci, K1; Konak, N2; Kocak, AK1
1Pediatric Allergy and Immunology, Eskisehir
Osmangazi University, Eskisehir, Turkey; 2Eskisehir
Osmangazi University, Eskisehir, Turkey
Churg-Strauss syndrome (CSS), or allergic
granulomatous angiitis, is a rare syndrome
that affects small- to medium-sized arteries
and veins. However, results of several
genetic studies have suggested some predis-
posing hereditary factors. Until now one
familial (two sisters) cases of CSS has been
reported.
Case 1 (Mother): A 45-year-old woman
acquired moderate bronchial asthma at the
age of 32 years that was complicated by
sinusitis. In May 2011, at the age of
45 years, she complained about slight
fever, weight loss of approximately 12 kg
within 6 months, paresthesia and paralysis
of the lower legs, dyspnea, and skin erup-
tion. Laboratory tests revealed a leukocy-
tosis of 18,500/mm3, 29.1% of which was
eosinophils, and a negative perinuclear
anti-neutrophilic cytoplasmic antibody (p-
ANCA). Eosinophils in bronchoalveolar
lavage fluid was found to be 20%. CSS
was diagnosed in accordance with the crite-
ria of the American College of Rheumatol-
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ogy. After treatment with corticosteroids
and cyclophosphamide, the pulmonary
infiltration and skin eruption improved.
Case 2 (Daughter): A 17 year girl acquired
moderate bronchial asthma at the age of
12 years. By the age 17 years, her asthma
was under control; she complained about
weight loss, dyspnea, artralgia, and sinusi-
tis. Her mother had been diagnosed with
CSS before. The daughter came to our
clinic to find out whether there is a similar
disease like her mother. Laboratory tests
revealed a leukocytosis of 19,800/mm3,
69.1% of which was eosinophils, and a
negative perinuclear anti-neutrophilic cyto-
plasmic antibody (p- ANCA) result. An
open lung histopathological examination of
biopsy specimens taken from alveoli and
interstitium infiltration of eosinophils, his-
tiocytes, and erythrocytes was observed,
and the pathology has reported the ‘eosin-
ophilic vasculitis, Churg-Strauss syndrome
in the foreground, collagen vascular dis-
eases can be considered. The patient was
given 0.5 mg/kg/day of prednisolone Sig-
nificant improvement was seen clinically
and radiologically
Conclusion: Familial cases of systemic vas-
culitis associated with p-ANCA-positive
vasculitis and Wegener granulomatosis
have been reported by several authors,
CSS pathogenesis is unknown, and there is
no evidence that genetic factors influence
susceptibility to this disease. We have pre-
sented a case of familial CSS in mother
and her daughter with atopic-type bron-
chial asthma and negative perinuclear anti-
neutrophil cytoplasmic antibody results.
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Anaphylaxis in an infant caused by
menthol containing cologne
Arikan Ayyildiz, Z1; Akg€ul, F2; Yılmaz, S2; Ozdemir, D2;
Uzuner, N1
1Division of Pediatric Allergy, Department of Pediatrics,
Dokuz Eylul University Faculty of Medicine, Izmir,
Turkey; 2Department of Pediatrics, Dokuz Eylul
University Faculty of Medicine, Izmir, Turkey
Case report: Severe allergic reactions to
cologne or perfumes are rarely reported.
We report the case of an infant who devel-
oped anaphylaxis after application of
cologne to his face by his mother. An
otherwise healthy 2-month-old infant was
admitted to the emergency department
because of facial edema, shortness of
breath and cyanosis after application of
menthol containing cologne to his face. On
physical examination, edema of face, eye-
lids and lips and urticarial lesions on
cheeks were noted. Cyanosis and respira-
tory difficulity was apparent. He was trea-
ted with intramuscular epinephrine,
methylprednisolone, diphenhydramine and
nebulised salbutamol. He was hospitalised
for observation and discharged after his
urticarial lesions and angioedema
regressed. The parents refused any diag-
nostic evaluation with the cologne or mint/
menthol products. Avoidance of menthol
containing products is recommended to the
parents.
To our knowledge, this is the first case
of anaphylaxis caused by a cologne in an
infant. There was only one case of anaphy-
laxis to perfume spray reported in a health
care worker. There are allergic reactions of
menthol (cyclic alcohol derivative of mint)
reported in the literature. Immediate hy-
persensitiviy reactions to menthol ranges
from urticaria and rhinitis to asthma. Ana-
phylaxis to the menthol containing tooth-
paste has also been reported.
This is a rare case of an infant with ana-
phylaxis to menthol containing cologne. It
emphasizes the possibility of an allergen in
a form of cologne and investigation of the
contents could make a way to the diagno-
sis in relevant cases.
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Acute urticaria at the pediatric age,
during year 2012, visit at Department of
Dermatology-Allergology, Out-Patient
Unit Nr 3, Tirane, Albania
Denizi, V1; Gjoni, B2
1Alergology, Out-patient, Unit Nr 3, Tirana, Albania;
2Dermatology, Out-patient, Unit Nr 3, Tirana, Albania
Background: Acute urticaria is caused by
IgE Immunology mechanism, characterised
by itching and 5% of the pediatric popula-
tion will develop pruritus during some time
in its life. The disease lasts for the short
period of time and responds effectively to
the elimination of the responsible factor
and at the usual antihistaminic therapy.
Method: In our study we examined the
children from January 2012 until Decem-
ber 2012 in base of medical history, objec-
tive examination, basic and specific
laboratory control. We recorded informa-
tion according to age, sex, seasonal distri-
bution and the cause of the diseases and
the appearance of the accompanied angi-
omatic oedema.
Results: We visit 228 children 0–14 age, 98
boys (42.9%) and 130 girls (57.1%). Sea-
sonal acute urticaria appeared 46 children
(20.1%) during the autumn, 78 children
(34.2%) during the winter, 40 children
(17.5%) during the spring, 64 and children
(28%) during the summer. The most com-
monly referred caused of urticaria were
food (51.0%), medicines (35.7%) and ny-
gma of insects (13.3%). It was found out
that 216 children (94.7%) developed urti-
caria and only 12children (5.3%) angiom-
atic oedema were hospitalised.
Conclusion: The urticaria diagnosis is usu-
ally simple the medical history and the
physical examination most of the times are
sufficient for the diagnosis. Urticaria is
more often in the winter and shows greater
frequency in the females than the males.
Food allergen is more frequent and direc-
tion should be given from specialist’s doc-
tors to avoid and minimise the
complication.
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Angioedema of the hands and feet in
infants under the age of 6 months: an
atypical presentation of cow milk allergy
Mistry, R1,2; Adams, G3; Potter, PC2,4
1Allergy, Red Cross Children’s Hospital, Cape Town,
South Africa; 2Allergy Diagnostic & Clinical Research
Unit, University of Cape Town Lung Institute, Mowbray,
Cape Town, South Africa; 3Red Cross Children’s
Hospital, University of Cape Town, Allergy, Cape Town,
South Africa; 4Department of Medicine, Observatory,
University of Cape Town, Cape Town, South Africa
Background: Cow’s milk allergy (CMA)
results from an immunological reaction to
one or more milk proteins. The prevalence
being between 2.5 and 7% and higher in
children than in adults. It usually presents
with mild urticaria, gastro intestinal symp-
toms, rhinitis, eczema or severe and poten-
tially life-threatening anaphylaxis. The
reactions which occur in less than 2 h are
urticaria, angioedema, and acute flare up
of atopic eczema.
Method: We present three infants below
the age of 6 months who all presented with
isolated angioedema of the hands and feet
after first exposure to cow’s milk protein.
Patient 1 was a 4 month old infant who
was exclusively breast fed. On introduction
of a formula feed developed angioedema
on the face within the first 2 h. This subse-
quently resolved and after 48 h was
brought to the hospital with swollen hands
and feet. Patient 2 was a 1 month old who
presented with swelling of the hands and
feet and no other skin lesions prior to that.
On history it was found that 6 days previ-
ously he was commenced on a formula
feed containing cow milk protein. Patient 3
age 2 months was exclusively breast fed
and presented with swelling of the hands
and feet within 7 days of the initial expo-
sure of a formula feed containing cow’s
milk protein.
Results and Conclusion: Immunocap RAST
for cow’s milk and b lacto globulin was
elevated in all three patients. They all
responded rapidly to elimination of cow’s
milk, with no recurrence of the oedema of
hands and feet.
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Serum 25-hydroxyvitamin D levels and
allergic rhinitis/hay fever in Norwegian
adults – the HUNT study
Mai, X-M1; Chen, Y2; Langhammer, A1
1Norwegian University of Science and Technology,
Trondheim, Norway; 2University of Ottawa, Ottawa,
ON, Canada
Background: The impact of low vitamin D
status on development of allergic rhinitis/
hay fever is unclear. We aimed to study
the influence of serum 25-hydroxyvitamin
D [25(OH)D] levels on incidence of allergic
rhinitis/hay fever.
Method: The study included a random
sample from an adult cohort population
who participated in the Nord-Trøndelag
Health Study (HUNT) surveys 2 and 3
(HUNT2, 1995–97 and HUNT3, 2006–
2008) in Norway. Serum 25(OH)D levels
were measured in blood samples collected
at baseline (HUNT2). In 1351 adults who
did not report allergic rhinitis/hay fever at
baseline, incident allergic rhinitis/hay fever
was identified by having or having had
allergic rhinitis or hay fever from question-
naires at follow-up. Allergic rhinitis/hay
fever was also defined by a stricter defini-
tion based on affirmative answers to ques-
tions on allergy at a subsequent interview.
Odds ratio (OR) and 95% confidence
intervals (CI) were calculated after adjust-
ment for self-history of asthma, family his-
tory of allergy, age, smoking, physical
activity, socio-economic status, body mass
index, and season. The analyses were per-
formed in men and women separately.
Results: 13% (9% and 15% for men and
women) of the adults developed allergic
rhinitis/hay fever during the follow-up per-
iod. Among men, serum 25(OH)D level
<50 nM was associated with an increased
risk of incident allergic rhinitis/hay fever
(OR 2.55; 95% CI 0.99–6.53); each 25 nM
reduction of 25(OH)D level was associated
with an OR of 1.87 (95% CI 1.19–2.95) for
allergic rhinitis/hay fever and an OR of
4.57 (95% CI 1.88–11.11) when the out-
come is more strictly defined. We also
found that low serum 25(OH)D level was
significantly associated with allergic rhini-
tis/hay fever with a positive allergy condi-
tion specially to pollen. However, the
associations were not significant in women.
Conclusion: Low serum 25(OH)D levels
may play a role in development of allergic
rhinitis among men but not women.
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The effect of relation between the grass
pollen and hazelnut sensitisation on the
frequency and severity of allergic
rhinoconjunctivitis and IgE to rCor a 8
Cavkaytar, O1; Buyuktiryaki, B1; Kizilpinar, I1; Arik
Yilmaz, E1; U. Soyer, O1; Tuncer, A1; Sackesen, C1
1Faculty of Medicine, Department of Pediatric Allergy,
Hacettepe University, Ankara, Turkey
Background: The high frequency of pollen
sensitisation has been reported among pea-
nut and treenuts sensitised patients in our
previous study. The antigen homology of
peanut and hazelnut with betula was previ-
ously shown. The aim of this study is to
find out the relation of the frequency and
the severity of allergic rhinoconjunctivitis
(ARC) with grass pollen and hazelnut sen-
sitisation in children.
Method: Seventy children diagnosed with
ARC, food allergy or egzema are divided
into three groups as ‘only grass pollen sen-
sitised’, ‘only hazelnut sensitised’ or ‘both
grass pollen and hazelnut sensitised’.
DBPCFC tests determined the status of
hazelnut allergy. Symptoms and medica-
tions for ARC and asthma were scored
from 0 to 3 during the spring season from
1 April to 31 July 2012. Symptom and
medication scores for ARC and asthma
were analyzed by Area Under Curve,
Number Cruncher Statistical System ‘p for
trend’, Kruskal-Wallis and Spearman tests.
IgE to rCor a 8 and rPhl p 4b were mea-
sured by ImmunoCAP method.
Results: ARC symptom scores (ARCSS)
and medication scores were lower in ‘both
hazelnut and pollen sensitised’ group [162,
(98–526)] (median, interquartile range)
compared to ‘only pollen sensitised’ group
[128, (60–201)] (P < 0.05). There was a ten-
dency for decrement of ARCSS among
four groups; ‘only pollen sensitised’ [117,
(87–388)], ‘both pollen and hazelnut sensi-
tised but tolerant to hazelnut’ [136, (25–
182)], ‘both pollen and hazelnut sensitised
but allergic to hazelnut’ [74, (35–118)] and
‘only hazelnut sensitised’ [20, (0–52)]
(P < 0.0001, p for trend). IgE to rCor a 8
was higher in ‘both hazelnut and pollen
sensitised’ group [9.7, (0.04–7.4 kU/l)]
compared to ‘only hazelnut sensitised’
group [0.03 (0.05–0.78)], P = 0.009. There
was a positive correlation between IgE to
rCor a 8 and both grass pollen mixture
IgE (r = 0.53, P = 0.001) and rPhl p 4b
IgE (r = 0.54, P = 0.03). When patients
with ARC but without asthma were inves-
tigated nasal symptom scores, ARCSS and
medication scores were all significantly
lower in ‘both pollen and hazelnut sensi-
tised group’ compared to ‘only pollen sen-
sitised group’ (P = 0.003).
Conclusion: Grass pollen sensitisation is
common among hazelnut sensitised chil-
dren. Our results denote that the severity
of seasonal ARC may change according to
the presence of hazelnut sensitisation and
its clinical reactivity. Moreover IgE to rCor
a 8 levels have a tendency to be high in
children with both hazelnut and grass pol-
len sensitisation.
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Systemic inflammation and quality of life
in Romanian patient with allergic rhinitis
Bujor, IA1; Deleanu, D2; Bocsan, IC2
1Immunology Allergology, University of Medicine and
Pharmacy Cluj Napoca, Cluj Napoca, Romania;
2University of Medicine and Pharmacy Cluj Napoca,
Cluj Napoca, Romania
Background: Allergic rhinitis is the most
frequent allergic disease and it involves
local and sometimes systemic inflamma-
tion.
The aim of this study was to evaluate
systemic inflammation in patient with aller-
gic rhinitis and to see the influence of
inflammation markers in quality of life
parameters.
Method: Seventy-nine patients were evalu-
ated in our clinic using: total symptoms
score, quality of life questionnaire (RQLQ)
and visual analog scale (VAS). Serum lev-
els of adhesion molecules (E-sel, ICAM-1,
VCAM-1) were also measured in allergic
rhinitis patients.
Result: Medium age in our patients was
30.44  9.9; 49.36% were women and
83.54% were from urban area. 55.69% of
the pts were sensitised to outdoor and
indoor allergens. The majority of the pts
(70.88%) had moderate-severe allergic rhi-
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nitis (MSAR). Number of years since the
beginning of the disease was significant
higher in pts with MSAR (P = 0.04).
Serum values of adhesion molecules were
significantly higher in allergic rhinitis
patients towards healthy subjects for
ICAM-1(P = 0.001) and VCAM-1
(P = 0.001) but not for E-sel (P = 0.764).
Symptoms score had a good and statistical
significant correlation with RQLQ
(P = 0.000) and VAS (P = 0.000). Systemic
inflammation was not correlated with the
severity of the disease and with quality of
life scores.
Conclusion: In Romania, allergic rhinitis is
a young adult disease from urban area.
The most frequent form is moderate-severe
allergic rhinitis. The severity of the disease
is well correlated with quality of life scores,
but not with systemic inflammation.
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Persistent allergic rinitis was frequently
over-diagnosed by specialists in a
nationwide cross-sectional study
Larenas-Linnemann, DE1; Dinger, H2; Shah-Hosseini, K2;
Michels, A2; Moesges, R2; Rodriguez Perez, N2; Ambriz,
M2; Nereida Lopez, D2; Arias, A2; Pizano, L2;
Monteverde Maldonado, A2; Lopez, JDR2; Medina, A2;
Garcia Imp, DA2; Mexican Study Group on Allergic
Rhinitis SPT Sensitivity
1Allergy, Hospital Medica Sur, Mexico, Mexico; 2IMSIE,
University of Cologne, Cologne, Germany
Background: Allergic rhinitis (AR) symp-
tom phenotypes have been described and
two classifications exist: the seasonal
-perennial (SAR-PAR) one and the ARIA
one: intermittent-persistent (INT-PER) and
mild-moderate/severe. International treat-
ment recommendations are based on the
ARIA classification. How the categorisa-
tion of these two compare and relate to a
Visual Analogue Severity Scale (VAS) and
how their diagnosis differs between
patients and allergists has not been
described before on the American conti-
nent.
Method: Skin prick test positive confirmed
AR patients seen nationwide by Mexican
allergists, filled in a validated AR question-
naire, demographic data and marked sever-
ity on a VAS. Moreover, their AR
phenotype was documented by their physi-
cian. Pearson’s X-squares were used (with
Yates’s correction) to compare AR pheno-
type prevalence and Spearman’s rho to
analyze correlation with VAS.
Results: Of 524 patients, most had INT
(56.5%), PAR (82.2%) and moderate-
severe (84.7%) AR. However, 57% of the
INT-PAR patients was misdiagnosed as
persistent-PAR by their physician
(P < 0.0001). PER is a different phenotype
with specific patient’s characteristics:
patients have statistically significant longer
clinical history, more PAR, more nose and
eye symptoms and more severe disease,
with a higher VAS-score and only 7% mild
symptoms. VAS values ≥7.45 relate to
PER (sensitivity 68%, specificity 65%).
VAS score ≤6.2 indicated mild and VAS
≥6.4 moderate-severe AR. Just as for
adults, for 2–11 year, 12–17 year and
18+year age-groups perennial, intermittent,
moderate-severe rhinitis was the most fre-
quent, but children had more INT
(P < 0.01) and mild (P < 0.03) symptoms;
adults had more SAR (P = 0.03) and less
physician’s diagnosed asthma (P < 0.05).
Patients from public health care, where ser-
vices are without charge, have more INT
(P = 0.016).
Conclusion: Especially in the PAR group
physician’s classification of INT vs PER
often goes astray, as is seen in other publi-
cations in which physicians -not patients-
are asked to classify AR. This finding is of
significance, as treatment is based on
ARIA classification. A simple 5-items
patient-directed questionnaire (in multiple
languages on ARIA web-site) might help
to properly diagnose AR phenotypes. In
subjects seen by allergists in Mexico rhini-
tis symptom phenotypes differ per age-
group and between private versus public
health care. PER is a more severe pheno-
type. VAS is useful to evaluate severity.
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Allergic and non-allergic rhinitis in
children: association of symptoms and
sensitisation with age, gender, season,
and other factors
Back, JH1; Han, MY1; Lee, SY2; Kim, WK3; Park, YM4;
Kim, JH5; Ahn, K5; Hahm, M-I6; Chae, Y7; Lee, K-J8;
Kwon, H-J7
1CHA University School of Medicine, Seongnam, Korea;
2Hallym University College of Medicine, Anyang, Korea;
3Inje University College of Medicine, Seoul, Korea;
4Konkuk University School of Medicine, Seoul, Korea;
5Sungkyunkwan University School of Medicine, Seoul,
Korea; 6Soonchunhyang University, Asan, Korea;
7Dankook University College of Medicine, Cheonan,
Korea; 8Korea National Open University, Seoul, Korea
Background: To evaluate the prevalence
and clinical characteristics of school chil-
dren with allergic rhinitis (AR) and non-
allergic rhinitis (NAR), and to estimate the
effect of gender, age, and aeroallergen sen-
sitisation on the severity of symptoms.
Method: This was a cross-sectional study
of 7637 Korean school children who were
tested for sensitisation to 19 common ae-
roallergens. Children with symptoms of
rhinitis were classified as having AR or
NAR based on skin prick testing.
Results: The overall prevalence of rhinitis
was 46.9%, with 59% of these children
having AR and 41% having NAR. The
prevalence of children with rhinitis was
similar in 6–7 year-olds and 12–13 year-
olds (P = 0.115). However, the prevalence
of AR was greater in older children
(23.2% vs. 31.9%, P < 0.001), especially
seasonal AR (3.2% vs. 5.0%, P < 0.001),
whereas NAR was more prevalent in youn-
ger children (22.9% vs. 15.7%, P < 0.001).
AR was more common in males (15.8%
vs. 11.8%, P < 0.001), children exposed to
second-hand smoke (15.4% vs. 11.5%,
P = 0.01), and children with more severe
symptoms (2.2  0.7 vs. 1.9  0.6,
P < 0.001). Symptoms of AR were more
severe in children who were sensitised to
more allergens. Relative to children with
NAR, those with AR experienced more
severe rhinitis, sneezing, rhinorrhea, and
itching (P < 0.001 for all), but similar
severity of nasal obstruction (P = 0.754).
Conclusion: The present findings regarding
the factors influencing the prevalence and
severity of AR and NAR may be helpful
that understanding of clinical characteris-
tics and course of disease.
722
Rhinoconjunctivitis and epidemic asthma
by guinea pig
Garcia Navarro, DJ1; Burgos Pimentel, A1; de Montoro
Francisco, A1; de Membrillo Novales, FJ2; Fonseca
Avenda~no, J1; De Mateo Hernandez, B1; Chivato Perez,
T1; Jimenez Garofano, C1; Fernandez Lopez, M1; Jare~no
Esteban, JJ3
1Allergology, Hospital Central de la Defensa ‘Gomez
Ulla’, Madrid, Spain; 2Internal Medicine, Hospital
Central de la Defensa ‘Gomez Ulla’, Madrid, Spain;
3Pulmonology, Hospital Central de la Defensa ‘Gomez
Ulla’, Madrid, Spain
Background: The guinea pig Cavia porcel-
lus is a rodent from South America where
it is ingested as a typical food. Also used
as a laboratory animal, where described up
to one third of cases of allergies to these
animals among workers, being the guinea
pig sensitisation which produces more (up
to 31%). The most common symptoms are
rhinoconjunctivitis, with or without more
severe reactions such as asthma or even
cause urticaria, angioedema, contact der-
matitis, and anaphylaxis.
Method: We report the involvement of
three members of a family of five, caused
by the presence of a guinea pig as a pet,
causing them those symptoms:
Mother, 42: rhinoconjunctivitis and
asthma.
Daughter, 21: rhinoconjunctivitis,
asthma, generalised pruritus and contact
urticaria.
Son,19: rhinoconjunctivitis, asthma and
contact urticaria.
All them improved after removal of the
animal from home, being moved to the
next floor, where the mother of the new
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family begins with rhinoconjunctivitis
symptoms in the presence of the animal.
Skin tests with epithelia total and spe-
cific IgE (Thermofisher), ECP and basal
tryptase.
Results: Mother, positive skin tests to dog
dander 5.5 mm, total IgE 1773 kU/l, spe-
cific IgE guinea pig epithelia 78.6 kU/l (5),
dog 3.71 (3), cat 0.87 (2), hamster <0.35.
Daughter, positive skin tests to pollens,
dander negative, total IgE 473 kU/l, speci-
fies guinea pig IgE > 100 KU/l (6), dog
1.95 kU/l, cat 1.73 kU/l, rest negative.
Son, positive skin tests to pollens, dog
4 mm, total IgE 95 KU/l, guinea pig IgE
1.67 kU/l, dog 0.65 KU/l.
Conclusion: 1 We present three cases in a
family of rhinoconjunctivitis, asthma and
urticaria due to guinea pig ephitelium sen-
sitisation.
2 We highlight the importance of the
guinea pig as allergenic source that gets to
produce rhinoconjunctivitis-asthma cases
in both homes and in laboratories.
3 In this case, it has been shown that the
guinea pig was responsible for many cases
of allergies and specified guinea pig
IgE > 100 kU/l values. After removal of
the animal from home and transfer to the






1Immunoallergy, Hospital Juarez del Centro, Mexico,
Mexico
Background: Mexico City is mainly hori-
zontal, covers an area of 3500 km2. Has a
population of 21 million people with high
population migration within the country.
This makes a mosaic allergenic modifica-
tions are made to the environment where
these groups are established. The city cen-
ter features allergenic very particular about
the lack of green areas, air pollution levels,
the brutal deforestation and changes made
to the environment by man. The Juarez
Hospital Center is located in the city cen-
ter, serving patients living in these areas so
we selected patients with allergic rhinitis
and / or allergic asthma diagnosed in the
Allergy Department.
Method: We perform skin tests for imme-
diate reading scarification with 40 pollen
allergen extracts of grass and weeds, trees,
mold spores and indoor-allergens previ-
ously selected by their frequency in this
area and 15 min reading. We took as posi-
tive response + + + + and + + + and to
record the results and use descriptive statis-
tics. We employ 300 patients without sepa-
ration of sex or age who using 1757 total
tests.
Results: Ambrosia elatior 117 positive
tests
Prosopis juliflora 95 positive tests
Quercus rubrum 87 positive tests
Mites 74 positive tests
Atriplex bracteosa 69 positive tests
Plehum pratense 68 positive tests
Artemisia vulgaris 66 positive tests
Fraxinus americana 59 positive tests
Taraxacum officinale 59 positive tests
Amaranthis palmeri 56 positive tests
Alternaria alternata 53 positive tests
Cynodon dactylon 53 positive tests
Ambrosia trıfida 52 positive tests
Hellaintus annus 52 positive tests
Penicillium notatum 50 positive tests
Conclusion: We found an increased fre-
quency of wild herbs and grasses, inter-
preted by developing vacant lots and a
large decrease in trees because of deforesta-
tion. Intense suffering our city for its
inhabitants and reduced green areas.
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Are rhinitis and asthma associated in
elderly?
Pite, H1; Morais-Almeida, M1; Pereira, AM2; Todo-Bom,
A3; Nunes, C4; Bousquet, J5; Fonseca, J6
1Immunoallergy Department, Hospital CUF Infante
Santo and Hospital CUF Descobertas, Lisbon, Portugal;
2Allergy and Clinical Immunology Department, Hospital
S. Jo~ao EPE, Porto, Portugal; 3Immunoallergy
Department, Hospitais da Universidade de Coimbra,
Coimbra, Portugal; 4Centro de Imunoalergologia do
Algarve, Portim~ao, Portugal; 5Department of Allergy
and Respiratory Diseases, University Hospital and
INSERM, Montpellier, France; 6CINTESIS – Center for
Research in Health Technologies and Information
Systems, Porto, Portugal
Background: Allergic rhinitis is a frequent
chronic respiratory disease in both children
and adults. It is considered an important
risk factor for asthma. However, few data
on rhinitis prevalence and its association
with asthma is available in elderly popula-
tions. Thus, we aimed to assess the associa-
tion between rhinitis and asthma in
individuals with 65 years or older.
Method: Data was obtained from a cross-
sectional, nationwide, population-based
survey, accomplished through face-to-face
questionnaire application to responders
aged above 65 years old, in Portugal, who
gave their informed consent. Current rhini-
tis was defined as the presence of at least
two out of three rhinitis symptoms
(repeated sneezing and/or itchy nose,
blocked nose for more than 1 h or runny
nose without having a cold or flu), either
usually or in the last 12 months. Current
rhinitis was further classified according to
the ARIA recommendations. Asthma was
defined by a positive answer to the ques-
tion ‘Has a doctor ever said you have
asthma?’. Univariate analysis was used to
assess associations between current rhinitis
and asthma and results were presented as
odds ratio (OR) with 95% confidence
interval (95%CI).
Results: Data was obtained from 3678
responders, 58.5% females, mean (standard
deviation) age of 74.1 (7.0) years old. The
prevalence of current rhinitis was 29.8%
(95%CI 28.4–31.3%); no statistically sig-
nificant differences were found for gender,
age or urban/rural living area. Asthma was
reported by 29.6% of subjects with current
rhinitis. Current rhinitis had a strong asso-
ciation with asthma (OR 13.9, 95%CI
10.7–18.0). This association was evident in
all rhinitis types: mild intermittent (OR
8.3, 95%CI 6.1–11.4), moderate-severe
intermittent (OR 14.6, 95%CI 10.4–20.5),
mild persistent (OR 16.5, 95%CI 9.7–28.0)
and strongest in subjects with persistent
moderate-severe rhinitis (OR 39.9, 95% CI
27.5–58.0).
Conclusion: Rhinitis is frequent in the
elderly. Consistent with the results from
earlier studies addressing different popula-
tion age groups, we found a strong associ-
ation between rhinitis and the presence of
asthma, also in elderly. This reinforces the
need to address upper airway symptoms in
elderly population and to evaluate older
patients with rhinitis for asthma, especially
those with persistent and more severe rhi-
nitis forms.
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The Canadian allergy, genes and
environment network of centres of
excellence: AllerGen
Denburg, J1,2; Keith, PK1,3
1AllerGen NCE Inc, Hamilton, ON, Canada; 2Allergy &
Immunology, McMaster University, Hamilton, ON,
Canada; 3Medicine, McMaster University, Hamilton,
ON, Canada
Background: AllerGen NCE Inc. is a
national research network of Canada’s
leading experts in allergic diseases, asthma
and anaphylaxis.
Methods: By collaborating with research
institutions, multi-sectoral organizations
and stakeholders, AllerGen works to
address unmet biomedical needs; mobilise
knowledge for new evidence-based public
health policies and tools; discover new
diagnostic tests and therapies; and, increase
the number of allergy and clinical immu-
nology professionals by providing interna-
tional exchange opportunities to build
capacity and promote multi-network interac-
tions. AllerGen aims to improve the quality
of life for allergy and asthma sufferers and
their families, lessen the socio-economic
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burden and reduce the risks of these dis-
eases.
Results: AllerGen has completed its first
7 year mandate, and has been renewed
for a second term, during which it will
focus on 3 major Legacy Projects,
already developed and launched: A
national, multi-disciplinary birth cohort
to follow the development of allergies
and asthma from pregnancy to childhood
and beyond, the Canadian Healthy Infant
Longitudinal Development (CHILD)
Study, which has recruited almost 4000
families; A multi-centred clinical trials
consortium with international outreach,
the Clinical Investigator Collaborative
(CIC), in partnership with biopharmaceu-
tical and biotechnology firms; and, a
multi-centred, trans-disciplinary food
allergy research consortium, The Cana-
dian Food Allergy Strategic Team (Can-
FAST). These three national initiatives
are complemented by Enabling Platforms
of research that AllerGen has established
across Canada and internationally: Gene-
Environment Interactions, working to
apply genetic, environmental and epige-
netic research innovation to discover
novel therapies and diagnostics, and
novel public health interventions and pol-
icies; Biomarkers and Bioinformatics,
using standard operating protocols and
animal models to develop a world-lead-
ing, systems-biology approach for devel-
opment and commercialization; and,
Patient, Policy and Public Health
research, to provide patient and health
professional outreach, and develop educa-
tional disease management tools.
Conclusion: AllerGen has become a leader
in mobilizing research, catalyzing social
innovation and enabling knowledge trans-
lation to help prevent, manage and treat
allergy, asthma, and anaphylaxis. The
model adopted by AllerGen is open to the
global community to further develop
allergy research and innovation.
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What does the general population know
about allergology?
Barasona Villarejo, MJ1; Barasona Villarejo, ML2; Garcia
Nunez, I1; Algaba Marmol, MA3; Guerra Pasadas, F1
1Allergology, Hospital Reina Sofıa, Cordoba, Spain;
2Centro Universitario de Magisterio Sagrado Corazon,
Cordoba, Spain; 3Hospital Reina Sofıa, Cordoba, Spain
Background: A high percentage of the
population presents symptoms compatible
with allergy. The diverse forms of presenta-
tion of allergy and difficulty in accessing
specialists led to set ourselves the task of
finding out if the general population knows
our specialist area and determining the
knowledge they have of general allergology
concepts.
Method: Participants were asked to com-
plete an anonymous questionnaire which
asked about basic sociodemographics (age,
sex, educational level, allergies, habitat),
and different questions about the allergist′s
specialist field (general block, respiratory
allergy block, food, hymenoptera, medi-
cines, treatment and aeroallergens), using
44 questions with three options and only
one correct answer. These were evaluated
with +1 for the correct answer; incorrect
1 and 0 don′t know/no answer.
Results: Three hundred people completed
the questionnaire (116 males, 39%), with a
mean age of 23 years. Ninety-nine (33%)
considered themselves allergic and 100% of
these had been seen by a doctor for this
reason. Only 24 were undergoing immuno-
therapy. One hundred and ninety-two
(64%) were university students. One hun-
dred and twenty-one (40%) felt that the
topic of allergies was quite interesting. The
final average score was 13 points. Ninety-
five had searched the Internet about health
questions. Eighty-five percent knew who
the allergist is, 28% associated the word
spring with allergy even with high fever,
16% were unaware that someone with
allergy to bee stings can die after being
stung, 225 (75%) were unaware that alter-
naria is a fungus, only 10% knew that
asthma can be cured by vaccination and
17% believed that people with allergy to
olive trees cannot eat olives.
Conclusion: The general population has
limited knowledge of allergology. The low
percentage of correct answers to some
questions suggests that we need to empha-
size the importance of health education on
increasingly prevalent diseases in the gen-
eral population.
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Use of epinephrine in a tertiary hospital
Ponce Guevara, V1; Moreno Rodilla, E1; Gonzalez Ruiz,
A1; Mu~noz-Bellido, F1; Laffond Yges, E1;
Da´vila Gonza´lez, I1
1Allergology, Hospital de Salamanca, Salamanca, Spain
Background: Anaphylaxis is a serious aller-
gic reaction of rapid onset that might cause
death. Epinephrine is considered the treat-
ment of choice. Nevertheless, the use of
epinephrine for the treatment of anaphy-
laxis in the emergency departments (ED) is
not well-known. We evaluate the use of
epinephrine in a prospective study of
patients that were assisted for an anaphy-
lactic reaction in the ED of a tertiary hos-
pital.
Method: Patients with anaphylaxis were
identified reviewing the diagnosis of
patients that were assisted in the ED from
September 2011 to August 2012. Initially,
the medical records of patients discarded
with any of the following diagnosis [Inter-
national Classification of Disease, Ninth
Revision (CIE 9)] were selected: Anaphy-
lactic shock caused by food (995.60–
995.69), other anaphylactic shock (995.0),
angioneurotic edema (995.1), urticaria
(708), allergic urticaria (708.0), idiopathic
urticaria (708.1), an unspecified adverse
effect caused by the correct administration
of a drug, medicinal, and biologic sub-
stance (995.2) or an unspecified allergic
reaction (995.3), other specified urticaria
(708.8), unspecified urticaria (708.9), edema
of larynx (478.6), edema of pharynx or
nasopharynx (478.25) and the toxic effect
of venom (989.5). All these medical records
were revised to chose those compatible
with anaphylaxis as proposed by the
National Institute of Allergy and Infectious
Disease and the Food Allergy and Ana-
phylaxis Network. For this study, data
were collected on age, sex, and hypoten-
sion, use of epinephrine in ED and pre-
scription of epinephrine auto-injector at
discharge.
Results: During the follow-up period,
148 712 patients consulted the ED. A total
of 89 (0. 06%) patients fulfilled the NI-
AID/FAAN diagnostic criteria for anaphy-
laxis. Overall, 50.6% of the study sample
was male. The median age of the study
population was 44 years. From the global
sample of patients only 41.6% received epi-
nephrine. From the 29% of patients that
had hypotension only 58% received epi-
nephrine. Among patients discarded from
the ED only 5.6% received a prescription
for self-injectable epinephrine.
Conclusion: Although epinephrine is the
treatment of choice of the anaphylactic
shock, it was only administered to half of
patients that had a severe anaphylaxis and
the prescription of self-injectable epineph-
rine was extremely low.
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The education program for parents of
children with allergic diseases
Golysheva, E1,2; Mokronosova, M1,2
1Mechnikov Research Institute of Vaccines and Sera,
Moscow, Russia; 2Allergology, Mechnikov Research
Institute of Vaccines and Sera, Moscow, Russia
Background: Children suffering from ato-
pic dermatitis (AD) and bronchial asthma
(BA) are known to develop itchy skin,
respiratory disorders, disruptions of nor-
mal sleep patterns, psychological problems,
such as irritability and restlessness. The
reception of a patient usually lasts 20 min,
thus giving the allergologist hardly any
288 © 2013 The Authors
Allergy © 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd, 68 (Suppl. 97), 189–336
Poster Session 19 – Studies on epidemiology of allergic diseases
time to educate the parents on skin care
essentials and asthma monitoring. The
above problem can be solved through edu-
cation at schools for parents of children
suffering from AD and BA.
Method: The education courses for 156 par-
ents of children suffering from AD and BA
were conducted in the 2011–2013 period.
The courses included the following lectures:
‘Skin Care for AD in Children’, ‘Dietary
Therapy for Allergic Children’, ‘Asthma
School’, and ‘The Road to Hypoallergenic
Home’. The 40-min lectures were followed
by question-answer sessions that lasted
20 min. The parents were asked to fill out
the before and after-course questionnaires
to identify any mistakes they could make in
the care of children with allergy; the disease
severity assessment and QLQ were offered
before and after the course.
Results: The pre-course questionnaire-
based survey has shown that all the par-
ents made mistakes in their care of the
allergic children. The main mistakes in the
allergic disease management included the
incorrect topical skin treatment, inhalation
technique, application of antihistamines,
administration of hypoallergenic diets,
measures aimed to decrease the level of
inhalant allergens in patients’ homes. Most
of the course students believed that the
first generation antihistamines were safer
than those of the second generation, that
topical steroids were harmful to children,
that non-traditional therapy methods were
more effective than the conventional ones,
that they could find ‘a hypoallergenic cat
or a dog’. Some of them had psychological
problems caused by their fear of a severe
allergic reaction to a particular food or
medication. They didn’t know how to
behave in emergency situations. The ques-
tionnaires completed 6 months after the
education course have shown positive
changes: The parents corrected their previ-
ous mistakes regarding the allergic child
care. The monitoring has demonstrated a
decrease in the disease symptom severity
score and an improvement in QL of 127
children.
Conclusion: Educational courses conducted
at schools for the parents of children with
allergy are an essential component of aller-
gology practices.
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National project for community based
atopyㆍasthma friendly school in Korea
Chung, EH1,2; Seo, H-J2; Jou, H-M2; Suh, S-H3; Jeong,
J-Y4; Lim, YS2; Ghim, Y-A5; Kim, YT3; Park, HK2
1National Medical Center, Pediatrics, Seoul, Korea;
2Division of Chronic Disease Surveillance, Korea
Centers for Disease Control and Prevention, Osong,
Korea; 3Center of Infection Disease Control, Korea
Centers for Disease Control and Prevention, Osong,
Korea; 4Korea Health Promotion Foundation, Seoul,
Korea; 5Division of Health and Nutrition Survey, Korea
Centers for Disease Control and Prevention, Osong,
Korea
Background: In Korea, there has been an
increase in the prevalence of allergic dis-
ease among the children and adolescents.
Attention has focused on the system to
monitor and manage the current situation.
Schools are an attractive and popular set-
ting for implementing interventions for
adolescents. Therefore, the government has
planned the pilot project for the prevention
of atopy and asthma.
Method: The schools, kindergarten and
day-care center interested in this project
were selected. Principals and school health
nurses (or child care teachers) in this
schools were invited to register workshops
informing specifics regarding the operation
of AtopyㆍAsthma Friendly School. School
health nurses were taught the way to deal
with emergency situation related to asthma
and to make use of emergency kit (Vento-
lin, Spacer, Emergent treatment leaflets
and Moisturizers). Students with atopy or
asthma were selected and throughly moni-
tored by trained teachers. The patients and
parents participated in counseling sessions
on the prevention, and treatment of aller-
gic disease. Data were collected with ques-
tionnaires on 166 school health nurses
working at AtopyㆍAsthma Friendly School.
Results: From 2008 to 2012, participating
schools were 18, 144, 238, 355, and 474
respectively. In 2012, the number of students
was raised up to 156 870 from 56 011 in 2009.
The prevalence rates of asthma in these
schools were 7.0%, 7.3%, and 7.4% of inves-
tigated students for 2008, 2009, and 2010
respectively. The prevalence rates of allergic
rhinitis were 28.0%, 29.3%, and 31.7% of
investigated students for 2008, 2009, and 2010
respectively. The prevalence rates of atopic
dermatitis were 28.2%, 28.3%, and 26.3% of
investigated students for 2008, 2009, and 2010
respectively. In 2011, emergency kits were
provided to 266 AtopyㆍAsthma Friendly
Schools, 29 schools (10.9%) had used Vento-
lin at least once. Ninety-two percent of 166
school health nurses working at Atopyㆍ
Asthma Friendly Schools said that this pro-
ject was necessary. The questionnaires showed
that they needed education programs for stu-
dents and guardians (28.9%), establishment
of hospital linked system (23.9%), education
on disease (21.1%), and manual on emer-
gency situation (19.6%).
Conclusion: AtopyㆍAsthma Friendly
School provides a model for addressing the
asthma and atopy-related problems among
children and adolescents. AtopyㆍAsthma
Friendly School was effective in improving
school life and overall health status of chil-
dren and adolescents.
734
Evaluation of allergic diseases among
students of university in Moscow
Kozulina, I1; Kurbacheva, OM1; Pavlova, KS1
1Institute of Immunology of the Federal
Medicobiological Agency, Moscow, Russia
Backround: Allergy represent global prob-
lems for all age groups. About 30% of all
adult population and about 50% of chil-
dren has different types of allergy: allergic
rhinitis, atopic asthma, atopic dermatitis,
food and insect allergy etc. The aim of this
study was to analyze the epidemiology situ-
ation in group of young people (birth
1990–1995) in Moscow.
Method: 350 students of university (212
males and 138 females, birth 1990–1995)
were surveyed with the help of random
sampling using the ‘Questionnaire to iden-
tify the structure and distribution of allergy
disease amount residents of Moscow’.
Results: Thirty-two males (15%) and 11
females (7%) have atopic asthma, which was
diagnosed in 3–15 years old. 35 of them
(81%) take asthma therapy. In 56 males
(26%) and 46 females (33%) reported symp-
toms of rhinitis and conjuctivities during the
period of flowering, during cleaning the house
and in contact with the animals, and 35 of
them all (34%) do not pass a particular aller-
godiagnostic. In addition 10 cases in male
group and in six cases in female group we can
suggest an atopic disease. In 40 males (18%)
and 38 females (27%) has symptoms of food
intolerance, 26 males (12%) and 24 females
(17%) has symptoms of drug intolerance,
especially for antibiotics. In 39 respondents
(22%) in each gender group has allergic skin
symptoms: 17%- atopic dermatitis, 35%-
symptoms of no diagnostic urticaria. In 70
(20%) of all respondents has a genetic predis-
position in atopic diseases.
Conclusion: The incidence of allergy among
young people is high. Despite increasing
incidents, the rate of timely diagnoses and
detection of allergy is low. To improve diag-
nosis and early treatment of patients with
different forms of allergy should be more
careful approach to the diagnosis and iden-
tification of patients with allergy.
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Four year experience of national
campaign for the diagnosis and
prevention of allergic skin diseases in
Bulgaria
Darlenski, R1; Gergovska, M2; Yankova, R3; Hristakieva,
E4; Kadurina, M5; Tonev, S5; Gospodinov, D6; Demerdji-
eva, Z1; Nikolova, A2; Brambarova, D3; Tsankova, L5;
Grozeva, D6; Gancheva, D4; Todeva, V4; Gospodinova,
K6; Tsankov, N1; Kazandjieva, J2; Dermatoallergology
Section of the Bulgarian Dermatological Society
1Dermatology and Venereology, Tokuda Hospital Sofia,
Sofia, Bulgaria; 2Dermatology and Venereology,
Medical University-Sofia, Sofia, Bulgaria; 3Dermatology
and Venereology, Medical University Plovdiv, Plovdiv,
Bulgaria; 4Medical Faculty, Dermatology and
Venereology, Trakia University-Stara Zagora, Stara
Zagora, Bulgaria; 5Dermatology, Venereology and
Allergology, Medical Military Academy Sofia, Sofia,
Bulgaria; 6Medical Faculty, Dermatology and
Venereology, Medical University-Pleven, Pleven,
Bulgaria
Background: Allergy is considered as one
of the epidemics of the XXI Century. The
prevalence of the most allergic diseases is
increasing in the past decades. Skin accom-
plishes the contact with the surrounding
environment and is often affected by aller-
gic diseases. Herein we present the intro-
duction and the four-year-experience of the
Bulgarian Dermatological Society in orga-
nizing National campaign for the diagnosis
and prevention of allergic skin diseases in
Bulgaria.
Method: Free of charge dermatologic
consultation and skin allergy testing were
provided in 6 university hospitals and
dermatology clinics in the biggest cities.
The doors were open for 5 days, each
November. In addition, a press confer-
ence aiming to attract the community’s
attention on the social and economical
impact on skin allergy was organized
each year.
Results: The summary of the results
showed an increase in the number of the
consulted patients starting 420 people in
2009 and exceeding 500 in 2012. In vivo
skin testing was performed in 220 patients
in average, the majority of them patch test-
ing with European baseline series. The
analysis of the results showed that nickel
was the most common contact allergen
each year followed by other metals, PPD,
preservatives and perfume ingredients.
Conclusion: Sharing our experience in
organizing the campaign and discussing the
strong and weak points is a safe ground
for developing such activities in other
countries.
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Prevalence of eczema and parent
reported triggers in early and late
childhood
Venter, C1,2; Patil, VK1,3; Glasbey, G1; Grundy, J1; Dean,
T1,2; Arshad, SH1,3
1David Hide Asthma & Allergy Research Centre,
Newport, United Kingdom; 2University of Portsmouth,
Portsmouth, United Kingdom; 3University of
Southampton, Southampton, United Kingdom
Background: Eczema is a common allergic
condition in childhood. We investigated
the prevalence of reported and diagnosed
eczema and also parent reported causes of
eczema in early childhood and later child-
hood.
Methods: The FAIR (Food Allergy and
Intolerance Research) birth cohort
(N = 969) was established on the Isle of
Wight (UK) between September 2001 and
August 2002 to prospectively study the
natural history of food allergy. Participants
were followed up at 1, 2, 3 and 10 years of
age. We looked at the prevalence of
reported and physician diagnosed at 1 and
10 years. For the children with physician
diagnosed eczema, we explored parent
reported triggers (defined by ‘Have you
identified a cause for the eczema?). Out-
comes of 1 year and 10 year follow up
were analysed.
Results: At 1 year 898/969 (92.7%) and at
10 years 826/969 (85.2%) children were
followed up and parents completed a ques-
tionnaire which included the above ques-
tions on eczema. At 1 year 225/898
(25.1%) parents reported eczema in their
child and 168/898 (18.7%) reported physi-
cian diagnosed eczema irrespective of
reported symptoms. Of the 225 who
reported eczema, 165 (73.3%) were diag-
nosed by a physician. Of the 168 with diag-
nosed eczema, 32 (19%) parents reported
to have identified a cause; food was identi-
fied in 8 (25%), (6 milk and 2 egg),6
(18.8%) said soap or washing powder as
cause, 12 (37.5%) identified ‘teething’ as
cause and the remaining parents reported
other causes. At 10 years 254/826 (30.8%)
parents reported eczema in the children
and 258/826 (31.2%) reported their child
to have been diagnosed with eczema in the
first 10 years of life. Of the 254 who
reported symptoms at 10 years, 210
(82.7%) were diagnosed with eczema. Par-
ents of 74/258 (29.2%) children with diag-
nosed eczema had identified a cause; aero-
allergen by 17 (23.2%), food allergen by 3
(4%), weather or temperature in 19
(25.7%), soap (shower/bath) or washing
powder in 12 (16.2%), central heating in 4
(5.4%) and stress in 2 (2.7%).
Conclusion: In the first year of life a quarter
of parents reported eczema symptoms and
three quarters of those had a physician’s
diagnosis of eczema. At 10 years of age
almost a third of parents reported eczema
symptoms and 82% have been diagnosed
with eczema. Triggers reported by parents
varied between early and late childhood;
food, teething and soap/washing being the
common ones at 1 year and weather/tem-
perature, aeroallergen and soap/washing
being common at 10 years of age.
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Characteristics of phenotypic clusters in
atopic dermatitis from population based
school-aged cohort
Kwon, JW1; Kim, YH1; Jung, YH2; Lee, E2; Yang, SI2;
Kim, HY2; Seo, JH3; Kim, BJ4; Kim, HB5; Lee, SY6; Yu,
J2; Kwon, HJ7; Hong, SJ2
1Department of Pediatrics, Seoul National University
Bundang Hospital, Seongnam, Korea; 2Department of
Pediatrics, Childhood Asthma Atopy Center, Research
Center for Standardization of Allergic Diseases, Asan
Medical Center, University of Ulsan College of
Medicine, Seoul, Korea; 3Department of Pediatrics,
Korea Cancer Center Hospital, Seoul, Korea;
4Department of Pediatrics, Inje University Haeundae
Paik Hospital, Busan, Korea; 5Department of Pediatrics,
Inje University Sanggye Paik Hospital, Seoul, Korea;
6Department of Pediatrics, Hallym University Secred
Heart Hospital, Suwon, Korea; 7Department of
Preventive Medicine, College of Medicine, Dankook
University, Cheonan, Korea
Background: Atopic dermatitis is a patho-
physiological heterogeneous disease com-
posed by several clinical phenotypes
sharing common clinical features. Unbi-
ased multidimensional methods to classify
phenotypes of atopic dermatitis have a
possibility for individualised approach. We
evaluate the characteristics of atopic der-
matitis in general population based pri-
mary School children cohort using cluster
analysis.
290 © 2013 The Authors
Allergy © 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd, 68 (Suppl. 97), 189–336
Method: A TwoStep cluster analysis was
performed in 461 subjects who had a cur-
rent atopic dermatitis using eight impor-
tant variables (gender, body mass index,
history of asthma, history of allergic rhini-
tis, parental history of atopic dermatitis,
atopic sensitisation, log total IgE, and
blood eosinophil%) affecting to childhood
atopic dermatitis. We compared differences
in demographic and biologic characteristics
between clusters.
Result: Four clusters were extracted from
425 children with atopic dermatitis after
excluding missing values. The first cluster
(n = 99) was non-atopic female group (0%
atopy) with low total serum IgE (log
IgE = 1.90  0.53, P < 0.001) and rela-
tively late onset (78.3% after 12 months of
age). The second cluster (n = 158) was asso-
ciated with higher rate of parental history of
allergic diseases (55.7%, P < 0.001) and
combined history of allergic rhinitis (100%,
P < 0.001) and asthma symptom (24.7%,
P = 0.009). The third cluster (n = 87) was
comprised of atopic eczema (100% atopy)
with higher level of bronchial hyperrespon-
siveness (log PC20 = 1.12  0.64,
P = 0.002) and serum total IgE (log
IgE = 2.35  0.52, P < 0.001), and multiple
sensitisations (57.5%, P < 0.001). The forth
cluster (n = 81), non-atopic male group, was
associated with lower level of total IgE and
bronchial hyperresponsiveness. Use of anti-
biotics in infancy was associated with the
second cluster (51.7%, P < 0.001), and the
exposure to environmental tobacco smoke
with the third and the forth cluster (59.3%,
59.0%, P = 0.046).
Conclusion: Atopy, gender, and the history
of respiratory allergic disease are important
factors to determine the subtypes of cur-
rent atopic dermatitis in childhood. Some
environmental factors are associated with
specific phenotypes of atopic dermatitis.
This study was supported by a grant of
Ministry of Environment, Republic of
Korea. ‘Children’s Health and Environ-
mental Research’.
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Time changes in eczema and
environmental risk factors in Skopje, The
Republic of Macedonia
Vlaski, E1; Stavric, K2; Kimovska, M3; Seckova, L1;
Kirovski, I1
1Department of Pulmonology and Allergology,
University Children’s Clinic, Skopje, FYR Macedonia;
2Department of Immunology, University Children’s
Clinic, Skopje, FYR Macedonia; 3University Children’s
Clinic, Intensive Care Unit, Skopje, FYR Macedonia
Background: Decreased or leveled eczema
symptom prevalence in young adolescents
in some developed countries with previ-
ously high prevalence rates and further
increase in formerly low-prevalence devel-
oping countries have been recently
reported. The role of environment and its
changes seem to be important. The aim of
the study was to assess the 4-year time
changes in eczema and some environmental
risk factors among young adolescents in
Skopje, the capital of the Republic of Mac-
edonia as a developing country with low
prevalence of eczema.
Method: Self-reported data obtained
through ISAAC phase 3 written question-
naires by 3026 13–14-year-old adolescents
in 2001–2004 survey and by 1088 same-
aged adolescents in 2005–2008 survey from
randomly selected primary schools in Sko-
pje was analysed. Chi-square test was per-
formed to test for statistical significance in
comparisons related to eczema and envi-
ronmental factors prevalence rates between
the two surveys and results were expressed
as odds ratios (OR, 95%CI) in logistic
regression.
Results: In 2005–2008 survey, compared to
2001–2004 survey, significantly higher prev-
alence of severe eczema symptoms (2.5%
vs. 1.5%, P = 0.03) and non-significantly
lower prevalence rates of eczema symptoms
and ever-diagnosed eczema were estab-
lished. Adolescents in 2005–2008, com-
pared to 2001–2004 survey, reported higher
intake of fish (6.2% vs. 3.6%; 1.90, 95%CI
1.38–2.62), vegetables (70.9% vs. 55.6%;
1.95, 1.68–2.27), rice (9.2% vs. 6.1%; 1.54,
1.19–1.99) and nuts (16.8% vs. 13.1%;
1.34, 1.10–1.62), and lower intake of milk
(62.7% vs. 68.3%, 0.78, 0.67–0.90), marga-
rine (24.9% vs. 28.9%; 0.82, 0.69–0.96),
eggs (20.3% vs. 23.6%, 0.83, 0.69–0.98),
cat and dog ownership (13.5% vs. 24.1%;
0.49, 0.41–0.60 and 22.0% vs. 27.7%; 0.74,
0.62–0.87) and wood home heating (10.8%
vs. 18.0%; 0.55, 0.45–0.68), respectively.
Conclusion: The two cross-sectional sur-
veys 4-year apart showed slight decrease in
eczema symptoms and diagnosis, and
increase in severe eczema symptoms.
Changes in lifestyle such as diet, pets own-
ership and indoor airpollution as well
rapid westernization in Macedonia, as a
developing country, may have some contri-
bution to the time changes in eczema.
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Moscow newborns-2011: prevalence of
allergies in families and the outcome
Treneva, M1; Munblit, D2; Ivannikov, NY3; Pampura, A1
1Allergy Department, Moscow Institute of Paediatrics
and Child Surgery, Moscow, Russia; 2Imperial College
London, Paediatrics, London, United Kingdom;
3Moscow No.1 Maternity Hospital, Moscow, Russia
Background: Knowledge of the family
allergy history is of an extreme importance
for the primary prevention of allergic dis-
eases in children. Self-reported parents and
siblings allergy symptoms can be valuable
for the future allergy diagnosis of a new-
born child and are useful for allergy pro-
phylaxis.
Objective: To evaluate the prevalence of
allergic symptoms in parents and siblings
of newborn children and to evaluate poten-
tial targets for the primary allergy preven-
tion.
Methods: Thirteen visits to the Postnatal
Department of Moscow No.1 Maternity
Hospital were carried out in Oct-Dec 2011.
Women delivered within the preceding
48 hours were interviewed. Mothers pro-
vided research team member with informa-
tion on relatives of a newborn in regards
to clinical manifestations of food allergies,
atopic dermatitis, eczema, urticaria, an-
gioedema, allergic rhinitis, allergic conjunc-
tivitis, asthma and episodes of drug
allergy. Information on parents and sib-
lings of 393 newborns was collected.
Results: Mothers of Moscow newborns-
2011 have self-reported allergies in 24.94%
(95%CI 20.25…29.62), fathers in 16.03%
(95%CI 12.02…20.05), sisters (n = 100) in
30.00% (95%CI 19.68…40.32), brothers
(n = 120) in 31.67% (95%CI 22.20…
41.13). Allergy primary prevention group
in newborns is 16–32% if one close relative
have allergies and 14.5% if two close rela-
tives have allergies.
Conclusion: More than 15% of families of
Moscow newborns-2011 have allergies.
Prevalence of allergy in siblings exceeds
those in parents. A group for primary pre-
vention of allergy is about 15–30% of new-
borns.
740
Prevalence of allergic diseases based on
medical claim data from National Health
Insurance Corporation in Korea
Lim, DH1,2; Seong, HU3; Kim, JH1; Son, BK1
1Inha University, College of Medicine, Incheon, Korea;
2Environmental Health Center, Ministry of Environment,
Inha University Hospital, Incheon, Korea; 3Inha
University Hospital, Incheon, Korea
Background: It is widely known that aller-
gic diseases progress through a sequential
course known as the allergic march. How-
ever, there have been no recent reports in
Korea regarding the progress of allergic
diseases based on the medical claim data
of the National Health Insurance Corpora-
tion.
Method: Medical claim data of 2005 and
2008 from the National Health Insurance
Corporation were used. Data was classified
according to the administrative districts of
metropolitan cities and provinces, and
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divided according to age in increments of
5 years.
Results: The mean prevalence of allergic
rhinitis is 7.79% in 2005 and 9.08% in
2008. The prevalence of atopic dermatitis
is 2.33% in 2005 and 2.18% in 2008. The
prevalence of asthma is 4.61% in 2005 and
4.57% in 2008. Figure 1 shows the pattern
of change of prevalence of allergic diseases
(allergic rhinitis, atopic dermatitis, and
asthma) according to the age.
Conclusion: According to the nationwide
survey on the prevalence of allergic dis-
eases using the medical claim data from
the National Health Insurance Corpora-
tion, the prevalence of allergic rhinitis had
significantly increased in 2008 compared to
2005. More survey studies should be con-
ducted in the future using the medical
claim data of the National Health Insur-
ance Corporation.
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Influence of environmental and infectious
factors on difference of prevalence of
allergy in urban and rural children in
Guangdong, China
Feng, M; Pan, L; Yan, C; Li, J
State Key Laboratory of Respiratory Disease,
Department of Allergy and Clinical Immunology,
The First Affiliated Hospital of Guangzhou Medical
College, Guangzhou, China
Background: Higher rates of asthma and
allergen sensitisations have been reported
in urban than in rural areas. The purpose
of this study was to investigate the impact
of environmental and infectious factors on
the prevalence of asthma in urban and
rural children in Guangdong province of
China
Method: Three hundred and seventeen
children (188 from urban Guangzhou, 129
from rural Conghua) with self-reported
asthma symptoms and 537 healthy subjects
were selected from schools according to
the ISAAC Phase I screening question-
naires. All subjects were completed a
detailed questionnaire and medical examin-
ations including skin prick test to 8 com-
mon aeroallergens, lung function test,
histamine bronchial provocation test,
peripheral blood for hepatitis A virus anti-
body and salmonella antibody ELISA.
House dust samples were collected from
living room and mattresses of 156 of these
children (Guangzhou 76, Conghua 80) for
detection of endotoxin and allergen.
Results: The prevalence rate of wheeze in
Guangzhou and Conghua schoolchildren
were 6.9% and 3.4% respectively by
screening questionnaire (P < 0.001). The
prevalence of wheeze symptom, asthma,
nasal symptoms and allergic rhinitis in the
children of Guangzhou were significantly
higher (1.72%, 1.66%, 3.97%, 2.77%,
respectively) than those of Conghua
(0.38%, 0.19%, 2.31%, 0.46%, respec-
tively, P < 0.01) according to detail ques-
tionnaires. Endotoxin concentrations in
dust samples in homes of Conghua were
significantly higher (1794 EU per square
meter, 10.95 EU endotoxin/g dust) than
those of Guangzhou (508.8 EU per square
meter, 6.45 EU endotoxin/g dust,
P < 0.01). Logistic regression analyses
showed a positive association between
endotoxin levels and PD20-FEV1
(r = 0.174, P < 0.05), and a negative asso-
ciation (P < 0.01) between endotoxin levels
and the wheal sizes of skin response to
Dermatophagoides pteronyssinus (Der. p)
and Dermatophagoides farinae (Der. f).
The univariate logistic regression analyse
showed a positive association between
HAV-antibody and nasal symptoms. Sal-
monella antibody positive rate in children
in Guangzhou was significantly higher than
those in Conghua (29.2% and 21.9%,
respectively, P < 0.05).
Conclusion: Exposure to environmental
endotoxin might contribute to the lower
risk of allergic sensitisation, and the previ-
ous infectious history may influence the
development of allergic diseases.
The study is supported by Chinese
National Science Funding (NSFC-AF-
DFG 81261130023).
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Autumn pollen induced allergic rhinitis
and seasonal asthma: the progression
and potential implications of serum
specific IgE levels
Cui, L1; Yin, J1
1Allergy, Peking Union Medical College Hospital,
Chinese Academy of Medical Sciences & Peking Union
Medical College, Beijing, China
Background: A close relation between rhi-
nitis and asthma has been well docu-
mented. However, the coexistence of
autumn pollen induced allergic rhinitis and
seasonal asthma has drawn scant attention.
We used cross-sectional data and later the
follow-up data to investigate the frequency
of seasonal asthma in patients with
autumn pollen induced allergic rhinitis and
the implications of specific IgE levels for
asthma onset.
Method: 1085 patients with fall allergies
were face-to-face interviewed from 2001 to
2003 and underwent serum specific IgE
tests to inhaled allergens. The temporal
sequence of allergic rhinitis and asthma
was documented. In 2011 a follow-up
study of 450 former participants without
asthma at baseline was done by telephone
to investigate asthma developing between
the two surveys. Multinomial logistic
regression was used to examine the effect
of specific IgE levels on the onset of
asthma in patients with autumn pollen
induced allergic rhinitis.
Results: By the end of the follow-up, there
were 56 new cases of asthma. Of the 1028
participants with a positive IgE test to
either Artemisia or Humulus and complete
data for allergic rhinitis and asthma, 619
(57.1%) had a history of allergic rhinitis
which preceded or occurred at the same
time as asthma. 394 (36.3%) had allergic
rhinitis only. The most majority of partici-
pants presented with allergic rhinitis and
asthma only during the autumn pollen sea-
son. After controlling for sex, age at onset
of allergic rhinitis, parental history of
asthma, IgE levels 3~6 to Humulus or IgE
levels 5~6 to Artemisia was associated with
a higher risk of asthma onset at the same
time as allergic rhinitis (P < 0.05). Simi-
larly, allergic rhinitis with IgE levels 3~6 to
Humulus or IgE levels 4~6 to Artemisia
was at increased risk for asthma develop-
ing (P < 0.05).
Conclusion: Autumn pollen induced aller-
gic rhinitis often coexist with seasonal
asthma. The probability of asthma
increased with increasing specific IgE lev-
els.
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Atopy prevalence and incidence in a
cohort of children with recurrent
wheezing: from pre-school age to
adolescence
Pereira, AM1,2,3; Gaspar, A2; Morais-Almeida, M2
1Allergy Department, Centro Hospitalar S~ao Jo~ao,
E.P.E., Porto, Portugal; 2Immunoallergy Department,
Hospital CUF-Descobertas, Lisbon, Portugal;
3Department of Health Information and Decision
Sciences, Faculty of Medicine of the University of
Porto, Porto, Portugal
Background: The aims of this study were
to estimate baseline atopy prevalence in a
cohort of pre-school children with recur-
rent wheezing (RW), to assess personal
and socio-demographic factors associated
with atopy in wheezers, and to estimate
atopy incidence over a 13 years follow-up
period.
Methods: This cohort study included 308
children observed as 1st appointments in a
tertiary hospital’s outpatient clinic in 1993.
All children aged <7 years old and with
RW (≥3 wheezing episodes responsive to
bronchodilator in the previous year with
symptom-free intervals in-between) were
included. They were evaluated in an allergy
consultation and skin-prick tests (SPT) to
airborne allergens, including mites (Dp,
Df), pollens (grasses, parietaria), moulds
and pets (cat, dog), were performed. Atopy
was defined as having at least one positive
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SPT. The included children were reassessed
in 2001 (n = 249; 225 with SPT) and 2006
(n = 170; 39 with SPT). A multiple logistic
regression model was developed to study
factors associated with atopy at pre-school
age; results were presented as odds ratio
(OR) with 95% confidence interval (CI).
Results: In 1993, the prevalence of atopy
was 47% (95% CI[41–53]); 99% (n = 143)
of the atopic wheezers had positive SPT to
mites while only 8% (n = 12) were sensi-
tised to pollens. Atopy at pre-school age
was positively associated with rhinitis diag-
nosis (18.7[8.6–41.0]), wheezing beginning
at ≥48 months of age (7.9[2.0–30.9]) and
paternal history of asthma/rhinitis (2.7[1.2–
6.5]); having recurrent respiratory infec-
tions (0.3[0.1–0.7]) and a pet at home in
the 1st year of life (0.5[0.2–0.9]) presented
a negative association. Maternal history of
asthma/rhinitis and exposure to maternal
tobacco smoke during pregnancy were not
significantly associated with atopy. When
considering the period 1993–2001, 60 chil-
dren (out of 119 previously nonatopic that
were tested in 2001) had de novo atopy
diagnosis (incidence 50%). In the same
period, the incidence of sensitisations to
pollens was 27% (58/217) and to mites it
was 46% (55/121). In 2001–2006, only 2
children had new atopy diagnosis (out of
9; incidence 22%).
Conclusion: The prevalence of atopy in
pre-school children with recurrent wheez-
ing was high and mites were the most pre-
valent sensitisers. Having a pet in the 1st
year of life and presenting recurrent respi-
ratory infections were negatively associated
with atopy. Half of the wheezers without
atopy at pre-school had de novo sensitisa-
tions at school age.
744
Prevalence of seasonal allergic rhinitis in
schoolchildren in the years 1995, 2001,
2006 and 2011
Emeryk, A1; Chojna, E1; Kowalska, M1; Markut-Miotla,
E1; Bartkowiak-Emeryk, M2; Postepski, J1
1Department of Lung Diseases and Rheumatology,
University of Medicine in Lublin, Lublin, Poland;
2Department of Clinical Immunology, University of
Medicine in Lublin, Lublin, Poland
Background: Allergic rhinitis (AR) is a
common disease in children and adults
worldwide. The increasing prevalence of
AR in children have been reported from
different part of the world in the recent
decades. The aim of our study was to esti-
mate the prevalence of seasonal AR (SAR)
in schoolchildren from urban region in
Eastern Poland (Lublin) in 2011 and to
compare the results with those of 2006,
2001 and of 1995.
Method: A repeated cross-sectional epide-
miological study was performed in 1995
(n = 599), 2001 (n = 565), 2006 (n = 548)
and 2011(n = 465) in the population of
children aged 6–13 randomly selected from
the same primary school in Lublin, and
with the use of the same written question-
naire. The questionnaire was based on the
European Community Respiratory Health
Survey (ECRHS) questionnaire (Emeryk A
et al. Ann Agric Environ Med 2004;11:63–
66). SAR was defined as: lifetime typical
seasonal symptoms of AR plus positive
skin prick test results with grass or/and
trees or/and weeds pollen allergens. Diag-
nosis was confirmed by allergologist or
pneumonologist. The response rate was
81.0%, 71.2%, 73.1% and 78.9% in 1995,
2001, 2006 and 2011, respectively. The
cumulative prevalence of SAR was esti-
mated.
Results: The principal results of the study
are presented in the Table. Cumulative
prevalence of SAR increased significantly
from 5.5% in 1995 to 13.6% in 2001
(P < 0.0001). Although we observed the
global trend of high prevalence in years
2001, 2006 and 2011 there were no statisti-
cal differences in the prevalence between
these years (13.6 vs. 14.2% vs.15.9%
respectively) (P > 0.05).
Conclusion: The prevalence of SAR has
been estimated at high levels since 2001
but no significant changes in prevalence
have been observed since then.
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Prevalence and ARIA classification of
rhinitis in pre-school children in Portugal:
a nationwide cross-sectional study
Santos, N1,2; Pereira, AM1,2,3; Branco Ferreira,M4,5;
Nunes, C4,6; Fonseca, JA1,7,8; Bousquet, J9;
Morais-Almeida, M2,4
1Allergy Department, Centro Hospitalar S~ao Jo~ao,
E.P.E., Porto, Portugal; 2Immunoallergy Department,
Hospital CUF-Descobertas, Lisbon, Portugal;
3Department of Health Information and Decision
Sciences, Faculty of Medicine of the University of
Porto, Porto, Portugal; 4Sociedade Portuguesa de
Alergologia e Imunologia Clınica, SPAIC, Lisbon,
Portugal; 5Immunoallergy Department, Centro
Hospitalar Lisboa Norte, Lisbon, Portugal; 6Centro de
Imunoalergologia do Algarve, Centro de
Imunoalergologia do Algarve, Portim~ao, Portugal;
7Allergy Unit, Instituto and Hospital CUF Porto, Porto,
Portugal; 8Faculty of Medicine of the University of
Porto, CINTESIS – Centre for Research in Health
Technologies and Information Systems, Porto,
Portugal; 9Department of Allergy and Respiratory
Diseases, University Hospital and INSERM, Montpellier,
France
Background: Information concerning the
epidemiology of rhinitis in young children
is scarce. The aims of this study were to
estimate the prevalence of current rhinitis
in preschool children using the ISAAC def-
inition, to describe individual rhinitis
symptoms, to classify rhinitis according to
the ARIA recommendations and to report
socio-demographic characteristics associ-
ated with rhinitis in this age group.
Methods: Cross-sectional, nationwide,
population-based study including children
aged 3 to 5 years. Data was collected by
face-to-face interview to caregivers using
an adaptation of the ISAAC questionnaire.
Current rhinitis was defined as the presence
of at least one out of three rhinitis symp-
toms (repeated sneezing and/or itchy nose,
blocked nose for longer than 1 h or runny
nose without having a cold or flu), in the
last 12 months; children with symptoms
lasting at least 4 days/week and more than
4 consecutive weeks were considered to
have persistent rhinitis. Mild rhinitis inter-
fered ‘not at all’ or ‘a little’ in the child’s
daily activities; moderate-severe disease
interfered ‘a moderate amount’ or ‘a lot’
Results: Overall, 5018 children were
included. The prevalence of current rhinitis
was 43.5% [95%CI (42.1–44.9%)] and that
of physician-diagnosed rhinitis was 11.7%
[95%CI (10.8–12.6%)]. Of children with
current rhinitis, 67% reported blocked
nose, 48% rhinorrhea and 46% sneezing/
itchy nose; 24% had symptoms with mod-
erate to severe impact in daily routine.
Considering the ARIA recommendations,
70% had mild intermittent disease, 6%
mild persistent, 17% moderate-severe inter-
mittent and 7% moderate-severe persistent.
Children living in a rural region had a
significantly lower prevalence of ‘current
rhinitis’ (36% vs. 46% in those living in
Table 1: The prevalence of SAR in schoolchildren in years
Allergic rhinitis
Prevalence (%)
1995 2001 2006 2011
(n = 599) (n = 565) (n = 550) (n = 465)
SAR 5.5 13.6 14.2 15.9
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urban regions, P < 0.001). Children with
current rhinitis had more current wheezing
(39% vs. 14% of those without rhinitis,
P < 0.001), physician-diagnosed asthma
(8% vs. 2%, respectively, P < 0.001), self-
reported food allergy (8% vs. 6%, respec-
tively, P = 0.003) and family history of
allergic disease (35% vs. 24%, respectively,
P < 0.001). These characteristics were also
associated with more persistent and severe
forms of rhinitis.
Conclusion: Rhinitis is a common but fre-
quently underdiagnosed disease in pre-
school children. This was the first
epidemiological survey classifying rhinitis
according to ARIA guidelines in this age
group. About one-forth of the children
with current rhinitis presented moderate-
severe disease.
746
Trends of prevalence of asthma and
allergy in the western part of Georgia
Abramidze, T1; Gotua, M1; Lomidze, N1; Mgaloblishvili,
N1; Kulumbegov, B1; Gamkrelidze, A1
1Center for Allergy and Immunology Research, Tbilisi,
Georgia
Background: Given the considerable bur-
den of asthma and allergy on children
worldwide the prevalence studies that cha-
racterise these chronic disorders are invalu-
able. In 2003 and 2012, we performed
cross-sectional studies in Kutaisi (western
part of Georgia) schoolchildren aged 6–7
and 13–14 year., using the validated
ISAAC methodology, aiming to provide
the prevalence trends of asthma and allergy
in this population.
Method: Both cross-sectional studies were
carried out in the same city, same season
and used identical methodologies. In 2003,
number of participants in 6–7 and 13–
14 years old groups were 2666 (RR-
92.8%) and 2650 (RR- 90.2%) correspon-
dently. In 2012, number of participants in
6–7 and 13–14 years old groups were 3039
(RR- 84.7%) and 2339 (RR- 72.4%) corre-
spondently.
Results:
Conclusion: The prevalence of asthma and
allergies markedly increase among both
age groups of schoolchildren in the western
part of Georgia. The exact reasons for
such trends remain to be explored.
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Early sensitisation to dog and cat in a
cohort of food allergic infants
Sugimoto, M1; Nagao, M1; Tanaka, A2; €Onell, A2; Bor-
res, MP2; Fujisawa, T1
1Institute for Clinical Research, Mie National Hospital,
Tsu, Japan; 2ImmunoDiagnostics, Phadia AB,
ThermoFisher Scientific, Uppsala, Sweden
Background: Prevalence of sensitisation to
pets increases with increasing exposure. On
the contrary, recent studies suggest that
early perinatal exposure to pets protects
from pet sensitisation/allergy later in life.
In addition, it has been shown that the
prevalence of sensitisation is increasing, the
number of multisensitised patients are
increasing and the onset of sensitisation
tend to start earlier in life than previously
observed.
Objectives: To describe the prevalence of
pet sensitisation in young children and to
explore the relationship between pet sensi-
tisation and natural history of allergic dis-
ease.
Methods: The IRAM (Impact of Allergic
Rhinitis on Atopic March in Children)
cohort (UMIN000004157) from Japan
enrolling 305 children <2 year of age with
diagnosed food allergy and/or atopic der-
matitis, and without diagnosed asthma,
was studied. Physician-diagnosed asthma,
symptoms of allergic rhinitis, histological
analysis of nasal mucosa, and specific IgE
(ImmunoCAP) to common food and air-
borne allergens were prospectively studied
for 2 years. Interim results of sensitisation
to dog/cat at entry (13.7 months old) and
at 1 year for 221 children are presented
here.
Results: Of the 221 children 72% were
diagnosed with atopic dermatitis and 89%
with food allergy. In addition, 80%, 45%
and 27% of the cohort avoided egg, milk
and wheat based on doctors’ diagnosis,
respectively. Pet ownership (any) was
reported for 12% of the children, and 10%
kept dogs, while only 1% kept cats in their
household. The prevalence of sensitisation
(defined as specific IgE level>0.34 kU/l) to
dog dander was 42% and 48%, and to cat
dander 22% and 27% at entry and at
1 year follow-up, respectively. Sensitisation
to house dust mite (HDM), the most pre-
valent inhalant allergen in Japan, was
found in 36% and 63% of the subjects at
entry and 1 year. The correlation of IgE to
dog dander and milk was stronger than for
IgE to dog dander and HDM, with Spear-
man’s correlation coefficients of 0.52 and
0.32, respectively.
Conclusions: We found a surprisingly high
prevalence of dog and cat sensitisation in
this atopic cohort of small children
although the pet ownership was relatively
low. Further studies will focus on commu-
nity distribution of pet allergens and possi-
ble cross-reactivity of pet and food
allergens.
748
The pattern of respiratory allergy among
underprivileged children from the city of
Ica, Peru, South America
Holloway, EH1; Yonz Pineda, PO2
1Department of Paediatric Allergy, St. Thomas’
Hospital, London, United Kingdom; 2Centro Nacional
de Salud Intercultural (CENSI), Instituto Nacional de
Salud, Lima, Peru
Background: The city of Ica, Peru, is a
regional capital in the arid coastal zone of
Peru 350 km south of the capital, Lima.
Common poverty-related diseases such as
malnutrition and tuberculosis are endemic.
However, there is also a high incidence of
chronic respiratory symptoms attributed to
allergy. These children are invariably
blindly diagnosed without allergy testing.
We sought to carry out skin prick tests to
identify children who have genuine respira-
tory allergy and would therefore benefit
from allergen reduction measures with/
without medication.
Table 1 Demonstrates the prevalence (% with 95% CI) of asthma, allergic rhinitis and eczema in 2003 and 2012.
2012 (6–7 year) 2003 (6–7 year) 2012 (13–14 year) 2003 (13–14 year)
Diagnosed asthma 5.4 (4.7–6.1) 3.3 (2.7–3.9) 5.6 (4.7–6.5) 3.3 (2.7–3.9)
Current wheezing 10.7 (9.6–11.8) 6.9 (6.0–7.8) 12.0 (10.7–13.4) 5.1 (4.3–5.9)
more than 4 asthma attacks/past yr. 1.1(1.0–1.2) 0.9 (0.8–1.0) 1.3 (1.1–1.5) 0.7 (0.5–0.9)
Diagnosed hay fever 7.0 (6.1–7.9) 2.8 (2.3–3.3) 8.6 (7.5–9.7) 3.8 (3.2–4.4)
Current sneezing 16.4 (15.0–17.8) 8.7 (7.6–9.8) 28.4 (26.3–30.5) 15.3 (13.9–16.7)
Current rhinoconjunctivitis 5.2 (4.5–5.9) 2.9 (2.4–3.4) 9.6 (8.4–10.8) 4.5 (3.8–5.2)
Diagnosed eczema 4.4 (3.7–5.1) 1.8 (1.5–2.1) 2.3 (1.8–2.8) 1.6 (1.3–1.9)
Current itchy rash 4.4 (3.7–5.1) 3.4 (2.8–4.0) 7.2 (6.2–8.2) 2.5 (2.0–3.0)
Flexural dermatitis 3.6 (3.0–4.2) 2.4 (1.9–2.9) 5.0 (4.2–5.8) 1.8 (1.5–2.1)
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Method: Children attending free medical
clinics (run by MedICA, a local NGO) at
two locations in Ica had a focussed allergy
history taken and were offered the oppor-
tunity to have skin prick tests to 5 respira-
tory allergens: D. pteronyssinus (Dp), D.
farinae (Df), Blomia tropicalis (Bt), Peri-
planeta americana (Pa) and Blatella germa-
nica (Bg).
Results: 37 children underwent complete
skin prick testing. 36 results were obtained
of which 8 were positive. 5 children tested
positive both to Df and Dp, 1 to Dp alone,
1 to Bt alone, 1 to Bg alone. No children
had histories suggestive of pollen-related
allergy. 1 child had a history also sugges-
tive of dog allergy.
Of the 20 children who had been pre-
scribed medication (anti-histamines/oral
corticosteroids) only 6 (30%) tested posi-
tive. Of the 7 children who had been pre-
scribed multiple medications, none tested
positive. Nasal inflammation/obstruction
was the most predictive clinical sign/symp-
tom (4 of 7 were positive, 57%) whereas
rhinorrhea, daytime or nightime cough
were poorly predictive of testing positive
(23%, 22%, 7% respectively). There was a
discrepency in percentage of postive tests
between the two clinic locations (29% for
inner city disrtict of Manzanilla, 15% for
shanty town district of Parcona).
Conclusion: To the best of our knowledge,
this is the first study of Paediatric respira-
tory allergy conducted in Ica, Peru. We
have shown that many children being pre-
scribed anti-histamines (mostly sedating
type) and/or oral corticosteroids do not
test positive to HDM or cockroach despite
perennial symptoms. These children most
likely have symptoms attributable to envi-
ronmental irritants and pollutants than
genuine allergic disease. We conclude that
children should have allergy testing before
being prescribed potentially harmful medi-
cation. Nasal obstruction is an important
clinical sign that may predict respiratory
allergy in this population.
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Cord blood LC-PUFA composition and
allergic diseases during the first 10 years
of life. Results from the longitudinal
LISAplus study
Standl, M1; Demmelmair, H2; Koletzko, B2; Heinrich, J3
1IBE Chair of Epidemiology, Helmholtz Zentrum
Muenchen, Neuherberg, Germany; 2Dr. von Hauner
Children’s Hospital, University of Munich Medical
Centre, Munich, Germany; 3Helmholtz Zentrum
M€unchen – German Research Centre for Environmental
Health, Institute of Epidemiology I, Neuherberg,
Germany
Background: It has been suggested that n-
6 and n-3 long-chain polyunsaturated fatty
acids (LC-PUFAs) in blood are associated
with allergic diseases, although results are
inconclusive. Low levels of n-6 LC-PUFA
and high levels of n-3 LC-PUFA are antic-
ipated to have beneficial effects. Pregnancy
and lactation period may be critical. In this
study, we examined whether n-6 and n-3
LC-PUFA levels in serum cord blood are
associated with atopy and allergic diseases
up to the age of 10 years.
Method: This analysis included 406 chil-
dren from the Munich LISAplus birth
cohort study. Information on doctor-diag-
nosed asthma, hay fever and eczema was
collected using questionnaires completed at
the ages 6 and 10 years, and for eczema
additionally at 2 years. Specific IgE against
inhalant allergens was measured at 6 and
10 years. Fatty acid composition was mea-
sured in cord blood and in blood collected
at 2, 6 and 10 years. Associations between
n-3 and n-6 LC-PUFAs in cord blood and
allergic diseases or atopy were assessed
using generalised estimating equations
(GEE) considering the longitudinal struc-
ture. Models were adjusted for parental
education, sex, BMI, time of follow-up (2,
6 or 10 years), age, maternal BMI before
pregnancy, maternal atopy, and for PUFA
composition at follow-up as sensitivity
analysis.
Results: Cord blood n-6 LC-PUFA con-
centration had a significant protective
effect on hay fever [adjusted OR (95%-CI):
0.73 (0.57–0.93), P = 0.0125], which did
not change after adjusting for LC-PUFA
composition at follow-up [0.73 (0.57–0.94),
P = 0.0141]. The protective effect on aller-
gic sensitisation against inhalant allergens
were marginally significant [0.87 (0.75–
1.02), P = 0.0861], also after adjustment
for LC-PUFA composition at follow-up
[0.86 (0.74–1.00), P = 0.0507]. Neither cord
blood n-3 nor n-6 LC-PUFA was associ-
ated with eczema. There was no significant
association between n-3 or n-6 LC-PUFAs
in cord blood and asthma.
Conclusion: There is no indication of a
beneficial effect of increased n-3 LC-PUFA
in cord blood on the development of any
of the disease entities.
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Long-term effect of cow milk protein
hydrolysates in high-risk children.
Results from the 10-years follow-up of
the GINI study
von Berg, A1; Filipiak, B1; Koletzko, S2; Kr€amer, U3;
Hoffmann, B3; Link, E3; Beckmann, C1; Hoffmann, U4,5;
Reinhardt, D2; Gr€ubl, A4; Heinrich, J5; Wichmann, E5;
Bauer, CP4; Berdel, D1
1Marien-Hospital-Wesel, Pediatrics, Wesel, Germany;
2Ludwig-Maximilians-University, Dr. von Haunersches
Kinderspital, Munich, Germany; 3IUF – Leibniz Research
Institute for Environmental Medicine at the Heinrich-
Heine-University D€usseldorf, D€usseldorf, Germany;
4Department of Pediatrics, Technical University of
Munich, Munich, and LVA Oberbayern, Munich,
Germany; 5Helmholtz Zentrum Munich, German
Research Center for Environmental Health (GmbH),
Institute of Epidemiology I, Neuherberg, Germany
Background: The long-term impact of
early intervention with hydrolysed infant
formulas on allergic manifestations in high
risk children is uncertain.
Objective: To investigate the effect of feed-
ing children at risk for allergic diseases
with different hydrolysed infant formulas
in the first four months of life on allergic
phenotypes until school-age.
Method: We used data of the ongoing
German Infant Nutritional Intervention
program (GINI) after 10 years of follow-
up. Between 1995–1998, 2252 newborns
with a familial risk for atopic diseases were
recruited to participate in the prospective,
randomised, double-blind intervention
study GINI. At birth, children were ran-
domly assigned to receive for the first
4 months one of four blinded formulas as
breast milk substitute if necessary: partial
(pHF-W) or extensive whey hydrolysate
(eHF-W), extensive casein hydrolysate
(eHF-C), or standard cow milk formula
(CMF). Children were followed by modi-
fied ISAAC questionnaires and physical
examinations at regular intervals. Out-
comes were parent reported physician diag-
nosed atopic diseases. To examine the
potential influence of the study formulas
on the cumulative incidence from birth to
10 years in longitudinal analyses general-
ised estimation equation models were used.
The prevalence at school-age (age 7–
10 years) was estimated as period preva-
lence in the participants of the 10 year fol-
low-up and analyzed by binomial
regression models.
Results: In the intention-to-treat analysis
(n = 2252) the relative risk (95% confi-
dence interval) for the cumulative incidence
of any atopic disease was 0.87 (0.77–0.99)
for pHF-W, 0.94 (0.83–1.07) for eHF-W
and 0.83 (0.72–0.95) for eHF-C compared
with CMF. The corresponding figures for
atopic eczema were 0.82 (0.68–1.00), 0.91
(0.76–1.10) and 0.72 (0.58–0.88), respec-
tively. The effects were stronger in the per-
protocol analysis (n = 988). The period
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prevalence of atopic eczema at 7–10 years
was significantly reduced with eHF-C in
the per-protocol analysis. There was no
preventive effect on asthma or allergic rhi-
nitis.
Conclusion: The significant preventive
effect on the cumulative incidence of atopic
diseases, particularly eczema, with pHF-W
and eHF-C persisted until 10 years without
rebound, while eHF-W showed no signifi-
cant risk reduction. There is insufficient
evidence for ongoing preventive activity at
7–10 years.
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In silico investigation of oligonucleotide
single stranded RNA immunostimulatory
motifs as a major cause of CpG
dinucleotide depletion in Human
rhinovirus genomes
Megremis, S1; Demetriou, P1; Manoussaki, A1; Passioti,
M1; Trochoutsou, K1; Taka, S1; Papadopoulos, NG1
1Allergy Department 2nd Pediatric Clinic, University of
Athens, Athens, Greece
Background: We have recently demon-
strated that Human rhinovirus (HRV) ge-
nomes are characterised by a marked
depletion of CpG dinucleotides. Basic viral
evolutionary constraints such as codon
usage or RNA secondary structures could
not be incriminated in this process. The
coding regions of many human innate
immunity genes, particularly type I inter-
ferons, also have an extremely low CpG
content, and mRNAs heavily expressed
during the acute phase of the innate
response have a bias towards low CpG
content. We hypothesise that both HRV
and host genes involved in the innate
immune response have evolved to have low
CpG content to avoid a CpG RNA sensing
receptor.
Method: To test this hypothesis, 115 HRV
fully sequenced genomes were investigated
computationally for their capacity in hex-
amer-CpG/UpA-rich oligonucleotide motif
sequences (6mer-ORN7) which have been
implicated in the specific activation of
Toll-like receptor 7 (TLR7) by ssRNA
viruses.
Results: The genome distribution of 6mer-
ORN7s follows the exact distribution of
CpG dinucleotides in all HRV groups
implicating sequence dependent recognition
of HRV by the innate immune system as a
major candidate for the observed CpG
genome depletion and as a major viral evo-
lution selective pressure. The analysis
showed a differential motif-sequence orga-
nization between HRV-A and HRV-B ge-
nomes (P < 0.05). Inter-genome region-
specific differences (P < 0.05) were
observed in 5’UTR, 3A, 3C, 3D and
3’UTR among HRV-A and HRV-B, in
VP4, 2B, 3A and 3B between HRV-A and
HRV-C and in 5’UTR, 2B, 3A and 3D in
HRV-B and HRV-C. The non structural
3D genome region was differentially rich in
6mer-ORN7s in all three HRV groups.
The most 6mer-ORN7-enriched genome
region was the 5’UTR, while VP4 was
almost totally depleted from these
sequences in all three HRV clusters fol-
lowed by extremely low motif numbers in
the rest of the capsid encoding sequence.
Sequence alignments indicated that HRV-
A 6mer-ORN7s have the highest distribu-
tion in different genome locations. The
highest 6-ORN7 motif homology was
observed in 5’UTR in all three HRV
groups (60–90%) with HRV-B genomes
having a second distinctive motif with
homology reaching 60%.
Conclusion: This study provides novel evi-
dence that innate immune stimulation by
viral ssRNA CpG ORNs is a strong HRV
selective pressure.
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Rhinovirus-induced type I interferon
responses and viral load in primary nasal
epithelial cells of subjects with or
without atopic rhinitis and asthma
Spyridaki, IS1; Skevaki, CL1; Trochoutsou, AI1; Megre-
mis, S1; Taka, S1; Roumpedaki, E1; Manoussaki, AE1;
Emmanouil, P2; Bakakos, P2; Loukides, S3;
Papadopoulos, NG1
12nd Department of Pediatrics, University of Athens,
Athens, Greece; 21st Respiratory Medicine Department,
University of Athens, Athens, Greece; 32nd Respiratory
Medicine Department, University of Athens, Athens,
Greece
Background: Defective type I interferon
(IFN) production and consequent
enhanced viral load have already been
described in the bronchial epithelium of
atopic asthmatic patients. The aim of the
present study was to evaluate rhinovirus
(RV) mediated IFN-b expression and RV
load in upper airway epithelial cells of
individuals with or without atopic rhinitis
and asthma.
Method: Primary nasal epithelial cells were
collected with the use of a curette from
adults with atopic rhinitis (n = 7), atopic
rhinitis and asthma (n = 11) and from non-
atopic, healthy volunteers (n = 8). Donors
were subjected to skin prick testing and a
brief medical history was recorded for the
assessment of allergic sensitisation and rhi-
nitis. Lung function was evaluated by
means of spirometry. Cells were exposed to
1 multiplicity of infection of RV1b or con-
trol medium. Culture supernatants and
total RNA were harvested after incubation
for 6–72 h. RV-induced cytotoxicity was
evaluated by a crystal violet colorimetric
assay and RV-mediated RANTES release
in cell supernatants was determined with
the use of ELISA. In order to investigate
viral load we evaluated the intracellular
RV RNA levels by real-time PCR. RV-
induced IFN-b expression was also mea-
sured by real-time PCR.
Results: RV infected cells did not exhibit
significant differences in terms of cytotoxic-
ity between the three groups at any time-
point examined. RV-mediated RANTES
production by rhinitic donors was higher
than control cells at 72 h post-infection
(P < 0.001) and there was a trend for
accentuated release by asthmatic donors
that did not reach statistical significance.
Infected cells from asthmatic donors dis-
played enhanced RV RNA levels at 24 h
compared to the other two groups
(P < 0.05), while at 48 h we found no sig-
nificant differences. IFN-b mRNA expres-
sion at 6 h and 8 h after RV infection was
significantly higher among rhinitic as com-
pared to healthy individuals (P < 0.05).
Cells from asthmatics expressed signifi-
cantly lower IFN-b (P < 0.05) at 6 h, while
at 8 h they reached similar to the control
group expression levels.
Conclusion: Impaired IFN-b antiviral
response of asthmatic nasal epithelium
may account for the presence of higher RV
load in this clinical group. Additional data
are required to explain the enhanced IFN-
b expression by RV-infected cells of
patients with allergic rhinitis, resulting to
viral loads comparable to the control
group.
754
IL-10 interaction with innate IFNs in
rhinovirus-infected monocyte-derived
macrophages
Bocsan, IC1; Makrinioti, H2; Nikonova, A2; Buzoianu,
AD1; Stanciu, L2; Johnston, S2
1Clinical Pharmacology, University of Medicine and
Pharmacy, Cluj Napoca, Romania; 2NHLI, Imperial
College, London, United Kingdom
Background: Rhinoviruses (RVs) consist
the major cause of asthma exacerbations in
both children and adults. Our group and
others have shown that asthmatics have
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deficient innate and adaptive immune
response to rhinovirus. IL-10 is involved in
down-regulation of mediators associated
with Th1 responses and antiviral activity.
It has been reported that the IL-10 gene
expression has been up-regulated in mono-
cytes/macrophages from patients with
virus-induced asthma exacerbations, sug-
gesting that IL-10 may play a significant
role in rhinovirus-induced asthma exacer-
bations.
Aim: The aim of the study was to deter-
mine in vitro whether IL-10 treatment of
RV-infected macrophages decreases innate
IFNs.
Method: Monocytes were prepared from
PBMCs and differentiated to macrophages
by culturing with GM-CSF for 7 days.
MDMs were exposed to RV16 1 MOI for
1 h and after that were treated with IL-10
in different concentrations (1, 10 and
100 ng). Cell lysates and supernatants were
collected at various time points after the
infection (0, 2, 8, 24 and 48 hours). RNA
was extracted from cells and used to assess
viral RNA and IL-10, IFN-a/b/k mRNA
expression by qPCR Taqman. Superna-
tants will be used to titrate RV16 release
and to measured cytokines production by
ELISA.
Results: RV16 increases the interferon’s
level in infected MDM at 8 and 24 hours
after infection. IL-10 10 and 100 ng signifi-
cantly decrease RV-induced IFN-alpha and
beta mRNA expression at 8 hours and for
IFN alpha at 24 hours also. Both concen-
trations significantly decrease also the
expression of mRNA for IL-28 and Il-29,
especially at 8 hours. The higher concen-
tration of IL-10 decreases also the gene
expression for IFN lambda at 24 hours.
The IFN alpha and beta levels are reduced
significantly by the IL-10 100 ng at 24 and
48 hours, while the level of IL-29 is
decreased only at 48 hours. The virus titer
is increased at 8 hours in IL-10 100 ng
treated MDM.
Conclusion: IL-10 increases virus titer and




delta T-lymphocytes, stimulated ex vivo
with M.tuberculosis antigens, in whole
blood of adolescents with active and
latent tuberculosis infection
Mordovskaya, LI1; Vladimirsky, MA2; Aksenova, VA2
1SBI ‘Research-Practice Center ‘Phthisiatry’’ of the
Sakha Republic Yakutia, Yakutsk, Russia; 2Research
Institute of Phthisiopulmonology, I.M. Sechenov First
Moscow State Medical University, Moscow, Russia
Background: Exploration of the role of
gammadelta T-cells during infectious pro-
cess is gaining more and more importance.
In tuberculosis (TB) infection gammadelta
T-cells are found circulating in blood and
infiltrating the lung tissue, and represent
one of the components (possibly the most
important component at early infection
stage) of both the innate and acquired cell-
mediated antimycobacterial resistance. The
induction, and subsequent proliferation
and expansion, of these T-cells is induced
by a wide spectrum of protein and non-
protein (pyrophosphoric monoesters)
mycobacterial antigens directly, bypassing
MHC molecules.
Method: Immunophenotyping and analysis
of the percentage of CD3 + gam-
madelta+IFN-gamma+ cells in 21 adoles-
cent with active pulmonary TB and in12
adolescents with latent TB infection prior
to antibacterial therapy have been per-
formed, to assess the intracellular produc-
tion of IFN-gamma by PPD- and ESAT-6-
stimulated gammadelta T-cells during
short-time (6 hour) incubation in periph-
eral whole blood samples. Composition of
peripheral blood lymphocytes was analyzed
by direct immuno-fluorescence test, using
monoclonal anti-bodies.
Results: Percentage of CD3 + gam-
madelta+ cells was significantly lower in
blood of patients with pulmonary disease,
than those with latent infection: 2.53  0.3
and 4.93  0.8 (P < 0.05), respectfully. But
when antigen-induced (PPD and ESAT-6)
production of IFN-gamma was analyzed,
the percentage of CD3 + gam-
madelta+IFN-gamma+ cells was signifi-
cantly higher in pulmonary disease,
compared to latent infection, both in con-
trol blood samples without antigen
(4.2  0.8% vs. 1.55  0.3%, P < 0.05),
and in samples induced with PPD and
ESAT-6 (9.3  1.0% and 8.7  0.7% vs.
3.8  1.2% and 4.5  1.5%, P < 0.05,
respectfully).
Conclusion: We found increased number
of IFN-gamma producing T-cells during
active TB, compared to that in latent TB
infection. Gammadelta T-cell subset count
decreases during active TB, but within this
subset, the proportion of IFN-gamma pro-
ducing cells is considerably higher in active
TB, and the proportion of IFN-gamma
producing cells in samples incubated in the
presence of M.tuberculosis antigens was
likewise increased. Immunophenotyping of
T-cells, and gammadelta T-cell subset in
particular, opens additional opportunities
for assessment of specific immune response
and for differentiation between active and
latent tuberculosis infection.
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Triggering receptor expressed on
myeloid cells -1 (TREM-1) expression on
neutrophils and monocytes in pregnancy
at risk of preterm delivery
Ierullo, AM1; De Amici, M2; Perotti, F1; Torre, C2; Spin-
illo, A1
1Fetal Medicine Unit, Fondazione I.R.C.C.S Policlinico
San Matteo, Department of Obstetrics & Gynecology,
Pavia, Italy; 2Fondazione I.R.C.C.S. Policlinico San
Matteo, Department of Paediatrics and Neonatology,
Pavia, Italy
Background: Triggering receptor expressed
on myeloid cells -1 (TREM-1) is a pattern-
recognition receptor expressed on neu-
trophils and monocytes. It participates in
innate immune responses and it is activated
in the event of disseminated bacterial infec-
tions being and its expression is up-regu-
lated leading to production of
proinflammatory mediators. We aimed to
test the hypothesis that TREM-1 expres-
sion may be elevated during pregnancy as
manifestation of physiologic activation of
the immune response and to compare those
values in those pregnancies at higher risk
of pre-term delivery before 34 weeks of
gestational age.
Method: Venous serum samples were col-
lected from 17 pregnancies at risk of pre-
term delivery (PTD) (Group C) diagnosed
before 34 weeks’ gestational age (GA), 26
normal GA-matched pregnancies (Group
B), and 41 fertile non pregnant women
(Group A). TREM-1on neutrophils was
measured with a Quantikine ELISA
(R&D Systems, Minneapolis, MN, USA).
Results: The TREM-1 values (pg/ml)
[mean;SD] showed no differences among
the groups [(A = 3196;103);
(B = 3093;716); (C = 2479;613); ]. Serum
IL-8 [mean;SD] appears to be elevated in
the uncomplicated pregnancies than in
PTD [(65.3; 81.9) vs. (34.2;60.5) n.s ]. Cer-
vical length is shorter in the PTD than in
complicated pregnancies [(18; 8.8) vs.
(39.6;7.4) n.s ].
Conclusion: TREM-1 values expressed on
neutrophils appeared to be similar in non
pregnant women, in singleton uncompli-
cated pregnancies and in those at high risk
of pre term delivery. On the contrary IL-8
production appeared to be elevated in
uncomplicated singleton pregnancies.
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Effects of penicilin and montelukast Na
on middle ear mucosa in rats with
experimental acute otitis media
Secil Ucar Topalsan, S1; Yalcin, AD2; Tural Huseynov,
T1; Sarıoglu, S3; Serbetcioglu, B1
1Dokuz Eylul University, Medical School, Department of
Otorhinolaryngology, Izmir, Turkey; 2Clinical
Immunology and Allergy Unit of Department of Internal
Medicine, Antalya Training and Research Hospital,
Antalya, Turkey; 3Dokuz Eylul University, Medical
School, Department of Pathology, Izmir, Turkey
Background: To develop an experimental
acute suppurative otitis media model and
compare the responses of rats to penicillin
and combinations of leukotriene antagonist
with respect to histopathological observa-
tions conducted at both early and late
phases.
Method: Fifty six female Wistar rats
(weight 200–250 g) were used for this
study. They were kept under standard lab-
oratory conditions and given food (pellets)
and water ad libitum. All ears of the rats
examined by otomicroscopy and 83 ears
that are free of middle ear infections were
included. All animals were anesthetized
with a combination of 50 mg/kg ketamine
hidrochloride (Ketalar) and xylazine
hydrochloride given intraperitoneally. All
prosedure were performed under sterile
conditions. Pneumonococcal otitis media
was induced in each ear by transtympanic
inoculation with 0.03 ml of suspension of
type 3 Pneumococci (ATCC 49619), at a
concentration of 109 CFU /ml). The ani-
mals were initially examined at 48 hours
post-inoculation by otomicroscopy and
confirmed the presence of otitis media. The
animals were randomly divided into four
groups: Group A (Antibiotic-treated group):
Two days after inoculation, 14 animals (20
ears), were treated with intramusculer pe-
nicilin G 160.000 U/kg once daily for five
days. Group B (Antibiotic and montelukast
co-treated group): Two days after inocula-
tion 14 animals (23 ears), were treated with
Pen G and Montelukast Na (10 mg/kg/
day, 21 days, (Y)) intraperitoneally. Group
C (montelukast treated group): Two days
after inoculation 14 animals (21 ears), were
treated with Montelukast Na (10 mg/kg/
day, 21 days) and Group D (placebo
group): Two days after inoculation, 14 rats
(20 ears), were not given any medication,
only 2 cc phosphate saline intraperitone-
ally. Two rats, one in antibiotics and
montelukast co-treatment group, one in
infected controls were died, and excluded
from the study.
Results and conclusion: No significant dif-
ference was found between the groups,
apart from mucosal vascularization with
respect to mucosal and TM parameters at
early phases. However, statistically
significant differences were found for the
improvement of TM thickness with the
help of penicillin treatment. Furthermore,
considerable deviations were observed for
the recuperation of TM and mucosal
inflammation for groups where subjects
were injected with montekulast as com-
pared to other groups of the study.
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In vitro antifungal effect of cyclosporine
A against Malassezia pachydermatis
isolated from the skin of dogs with
atopic dermatitis
Brazıs, P1; Ramio-Lluch, L1; Cerrato, S1; Puigdemont, A2
1Univet, I+D, Barcelona, Spain; 2Universitat Autonoma
de Barcelona, Department of Pharmacology, Toxicology
and Therapeutics, Barcelona, Spain
Background: Malassezia yeast is usually
part of the dogs’ skin resident microflora.
Under certain conditions, Malassezia
pachydermatis, the most commonly isolated
specie in dogs, can become pathogen exac-
erbating atopic dermatitis (AD) signs. In
dogs, ketoconazol is considered the treat-
ment of choice against Malassezia. Previ-
ous studies have demonstrated that the
calcineurin inhibitor tacrolimus inhibits
Malassezia growth. The mechanism of
action seems to be related to the presence
of a calcineurin homologue in the fungal
cells. Cycloporine A (CsA), another calci-
neurin inhibitor, has been recently formu-
lated using nanotechnology techniques to
allow their topical treatment of AD lesions
in dogs.
The aim of this study was to evaluate
the in vitro antimicrobial efficacy and the
minimal inhibitory concentration (MIC) of
this new topical formulation of CsA, in
comparison to ketoconazol and tacrolimus.
Method: Ten Malassezia isolates were
obtained from the skin of dogs with AD
from the Clinical Hospital of the Veteri-
nary School of Barcelona. Ketoconazol, ta-
crolimus and CsA were diluted in
Sabouraud broth to obtain final concentra-
tions ranging from 0.016 to 128 lg/ml.
Malassezia isolates were inoculated to Sab-
oraud-treated and control (drug-free) broth
and incubated in the dark at 35°C for
7 days. Yeast growth in treatment and
control samples was recorded every 24 h
according to a scale from 0 (no growth) to
4 (growth similar to control).
Results: All Malassezia strains were sensi-
tive to the 3 tested drugs. Ketoconazole
showed MICs values (MIC range from
0.016 to 0.032 lg/ml) significantly lower
than calcineurin inhibitors. New CsA for-
mulation and tacrolimus also showed a sig-
nificant antifungal effect against
Malassezia strains, with MIC values rang-
ing from 32 to 128 lg/ml. Moreover, 70%
of the Malassezia strains were inhibited at
a MIC of 64 lg/ml by both drugs.
Conclusion: This is the first study evidenc-
ing the potential antifungal effect of CsA,
against Malassezia pachydermatis. CsA has
been used in human and veterinary medi-
cine to control AD. Given that Malassezia
usually exacerbates AD, the growth-inhibi-
tory effect of CsA against this yeast, rein-
forces its usefulness as a topical treatment
in atopic dogs skin.
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Analysis of the clinical features and
treatment response of toxocariasis in
adults
Kim, J-H1; Park, S1; Hwang, YI1; Jang, SH1; Jung, K-S1;
Kim, D-G1
1Division of Pulmonary, Allergy, and Critical Care
Medicine, Department of Medicine, Hallym University
Sacred Heart Hospital, Hallym University College of
Medicine, Anyang, Korea
Background: Toxocariasis is a zoonotic
infection caused by Toxocara canis (T.
canis) and Toxocara catis, which can cause
blood eosinophilia and eosinophilic infiltra-
tion in internal organs. This study was to
investigate clinical features and treatment
response of toxocara infection in adult
patients.
Method: We enrolled the subjects diag-
nosed as having toxocara infection from
2007 to 2012, one tertiary hospital in
Korea. A diagnosis of toxocariasis was
made by enzyme-linked immunosorbent
assay (ELISA) using that secretory-excre-
tory antigen from the T. canis larvae. Lab-
oratory data were collected including
peripheral eosinophil count, total IgE, and
ELISA tests for parasites (Cysticercus, Pa-
ragonimus westermani and Clonorchis sinen-
sis). Computed Tomography (CT) scan of
chest or liver was performed to find tissue
infiltration at diagnosis. Clinical, labora-
tory and radiologic data were followed up
after treatment with an interval of
3 months.
Results: A total of seventy three patients
were enrolled in this study. Fifty eight
patients had lung involvement (79.5%,
group I), eight with liver involvement
(11.0%, group II) and seven with asymp-
tomatic blood eosinophilia (9.6%, group
III). 30.1% of all subjects were asymptom-
atic. Patients in group I showed clinical
symptoms such as hemoptysis, chest pain,
and cough compared to those of group II
and III (P = 0.018). The median values of
eosinophil count and total IgE level in
group II were highest among three groups
at diagnosis (P < 0.001 for eosinophil
count and P = 0.018 for total IgE, respec-
tively). All patients showed decreased
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eosinophil counts with symptom improve-
ment after treatment with a 7-day course
of albendazole (400 mg twice daily,
P < 0.0001). During the follow-up period,
forty three patients were taken serial CT
scan, showing 81.4% of them disappear-
ance of tissue infiltration in their lung or
liver. However, eight patients (13.7%) in
group I and one (12.5%) in group II failed
to complete radiological regression, requir-
ing an additional course of albendazole
with systemic corticosteroid.
Conclusion: The most common clinical
manifestation of toxocariasis in adults was
a lung infiltration with mild respiratory
symptoms, whereas systemic eosinophilic
inflammation was more prominent in
patients with liver infiltration. A 7-day
course of albendazole was effective in most
cases; however, 10% of the patients needed
systemic corticosteroid for both clinical
and radiological resolution.
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Combination of a corticosteroid and an
anti-viral intranasal therapy
Nakowitsch, S1; Koller, C1; Kurz, M1; Fazekas, T2; Muel-
ler, CA3; Prieschl-Grassauer, E1
1Marinomed Biotechnology, Vienna, Austria; 2St. Anna
Children’s Hospital, Vienna, Austria; 3Department of
Otorhinolaryngology, Medical University of Vienna,
Vienna, Austria
Background: Intranasal corticosteroids
(INCS) provide potent, localised treatment
for allergic rhinitis, idiopathic rhinitis, rhi-
nosinusitis and nasal polyposis with mini-
mal risk of systemic exposure. However,
corticosteroids cause immunosuppression
and can decrease the anatomical barrier
function of the skin. Consequently, infec-
tion and multiplication of all types of
pathogens (bacteria, viruses and fungi)
may occur, while alleviating inflammation.
Here we introduce the concept of creating
a protective physical barrier in the nasal
cavity with an antiviral polymer (carra-
geenan) that works as inhibitor against
respiratory virus entry for prophylaxis and
therapy. Independent clinical trials in
adults and children revealed that the intra-
nasal administration of iota-carrageenan
significantly reduced the time to disease
clearance of patients with common cold
and decreased the virus load in nasal la-
vages. Iota-carrageenan is already mar-
keted in Europe as antiviral active
component of medical device nasal sprays
under different brand names.
Method: We suggest the combination of
budesonide, a well described corticosteroid
with a long history of use as intranasal
drug, with iota-carrageenan in a nasal
spray. A combined formulation of budeso-
nide and iota-carrageenan was in vitro-
tested for its antiinflammatory activity by
inhibiting TNF-alpha release of LPS
induced whole blood. Accessorily, the com-
bination was tested for its anti-viral effec-
tiveness against human rhinovirus (HRV1a
and HRV8) on HeLa cells and influenza
virus on MDCK cells.
Results: Both substances – budesonide and
iota-carrageenan – showed irrespectively of
their combination an unmodified mode of
action in vitro.
Conclusion: Thus, patients would benefit
from a fast treatment of symptoms of rhi-
nitis together with an efficient anti-viral
prophylaxis and treatment.
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Azithromycin is able to augment
interferon and interferon stimulated gene
responses to rhinovirus in vitro
Porter, JD1; Macintyre, J1; Sykes, A1; Gupta, A1; Shoe-
mark, A1; Bossley, C1; Davies, J1; Khaitov, M2; Mosh-
kovskii, S3; Kon, OM4; Saglani, S1; Bush, A1; Johnston,
SL1; Edwards, MR1
1Imperial College London, NHLI, London, United
Kingdom; 2NRC Institute of Immunology FMBA,
Moscow, Russia; 3Department of Proteomics, Institute
of Biomedical Chemistry Moscow, Moscow, Russia;
4Imperial College London, NHS Trust, London, United
Kingdom
Background: Asthma exacerbations (AE)
carry a high rate of patient hospitalisation
and also a high economic burden. Current
therapies for AE are only partially effective
in controlling mortality and morbidity
associated with the disease and thus novel
therapies are sought-after. Rhinovirus
(RV) infection strongly associates with AE
and asthmatic-derived cells have been
shown to be deficient in interferon (IFN)
production in response to RV in vitro, thus
IFNs may provide a novel therapeutic for
RV-associated AE. Macrolides have anti-
viral and anti-inflammatory effects. Azi-
thromycin is able to augment the expres-
sion of RV-induced type I and type III
IFN (IFNb and IL-28/IL-29) and several
interferon stimulated genes (ISGs) in pri-
mary human bronchial epithelial cells
(HBECs). In this study we attempt to
understand the mechanism of Azithromy-
cin and assess it’s effects on atopic asth-
matic cells, we hope to determine whether
azithromycin would be suitable as a novel
therapeutic course in the treatment of RV-
induced AE.
Method: Normal HEBCs or cells from
bronchial brushings of mild/moderate asth-
matic adults or severe asthmatic children
were cultured with Azithromycin for 24 h
prior to infection with RV1b. qPCR and
western blots were used to determine gene/
protein expression. Virus replication was
measured by TCID50 of HeLa cells cul-
tured with titrated HBEC supernatants.
Results: Azithromycin augmented RV16
and RV1b-induced expression of IFNs;
IFNb (1.40 and 1.75 fold), IL-28 (1.10 and
2.05 fold), IL29 (1.19 and 2.68 fold) and
anti-viral ISGs; Viperin (4.40 and 2.11
fold), MxA (3.12* and 4.26* fold)
(*P < 0.05 n = 7) in atopic asthmatic
HBECs. Azithromycin can reduce viral
release in these cells by 42%* after 48 h
(*P ≤ 0.05, n = 6). Azithromycin had no
effect on the expression IFNs or ISGs
when used alone and only augmented RV-
induced IFN expression. Azithromycin
augmented IFN responses in normal
HBECs via the RIG-like helicase pathway,
possibly by preventing degradation of the
RIG-I/MDA-5 adapter protein Mitochon-
drial-associated Anti-Viral Signaling pro-
tein (MAVS).
Conclusion: Azithromycin is able to aug-
ment IFN responses in primary HBECs
from asthmatics when infected with RV,
the observed decrease in viral replication
with azithromycin highlights a novel virus-
dependent therapeutic avenue for the treat-
ment of RV-associated AE. The mecha-
nism if action is still not fully understood
however our data suggests that the IFN
augmenting effects of Azithromycin are via
the RIG-like helicase pathway in HBECs.
764
The level of Ig E in patients with cystic
fibrosis associated with Pseudomonas
aeruginosa pulmonary infection
Sciuca, S1; Dimitrova, O1; Cotoman, A1; Eremciuc, R1;
Lupusor, N1; Macovei, T1
1State University of Medicine and Pharmacy ‘Nicolae
Testemitanu’, Pediatric, Chisinau, Moldova
Background: About 60% of people with
cystic fibrosis have a chronic respiratory
infection caused by a bacteria called Pseu-
domonas aeruginosa. Once it sets up house
in the respiratory tract, Pseudomonas aeru-
ginosa is hard to get rid of and on long
time persistance it can cause immunopath-
ological disorders.
Aim: The study of reaginic imunopatho-
logical mechanisms in patients with cystic
fibrosis (CF) with Ps. aeruginosa pulmo-
nary infection.
Method: The research included 53 patients
with cystic fibrosis with age variety from 1
till 25 years, most of them (22) younger
then 7 years old. The group of study was
divided in two lot of studies, the first one –
40 children with Ps.aeruginosa, and the
second – 13 children without Ps.aerugin-
osa. Clinical associations between cystic
fibrosis and bronchial asthma were repre-
sented in six children, allergic rhinitis in 10
children in the first group of study by com-
parison with any case of the second group.
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The severity of immunopathological disor-
ders is confirmed by the high level of IgE.
In more of 1/2 cases the growth and the
development disturbances were presented.
The determination of summary IgE in
serum was carried out by immunoenzyme
method with the utilisation of standard
tests.
Results: The concentration of IgE in
serum for all children from the lot of study
with pulmonary infection with Ps.aerugin-
osa was considerable increased –
252.76  11.47 UI/ml (P < 0.001) in com-
parison with the lot without Ps.aeruginosa
(65.9  5.77 UI/ml). Immunological
researches in the lot of study with Ps.aeru-
ginosa had determinated hyperimmuno-
globulinemia E in 54.8% children with
46.4–1358.6 UI/ml varieties. Also, the level
of hyperimmunoglobulinemia E grows with
the age of children: in 45.71% – younger
then 7 years was determinated the average
level of IgE – 44.6 UI/ml; in 28.57% pupils
with the age between 7–14 years with the
average level of IgE – 290.6 UI/ml and in
25.71% – adolescents older then 14 years
with the average level of IgE – 548.13 UI/
ml.
Conclusion: We had observed that the level
of IgE depends of the long time persistence
of the infection with Ps.aeruginosa. The
immunopathological mechanism of the hy-
perimmunoglobulinemia E in children with
cystic fibrosis is determinated by the pres-
ence and the long time persistence of the
lung infection with Ps.aeruginosa which
one explain the increased incidence of
bronchial asthma.
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Distinguish cross reactivity from true co-
sensitisation is crucial for the
immunotherapy of weed pollenosis
patient
Park, H-J; Park, KH; Lee, J-H; Hong, C-S; Park, J-W
Division of Allergy and Clinical Immunology,
Department of Internal Medicine, Yonsei University
College of Medicine, Seoul, Korea
Background: Ragweed and mugwort are
the major allergenic weed pollens in Korea.
Allergen specific immunotherapy (IT) is
available for these two pollen allergies. To
select culprit allergens for IT, detection of
sIgEs against responsible allergens are cru-
cial. In this study, we evaluated clinical rel-
evance of measurement of specific IgE to
group 1 major allergens of these pollens.
Method: We enrolled 107 patients who
have allergic symptoms in last summer and
divide them into three groups according to
their skin prick test (SPT) results; ragweed
mono-sensitisers (RMS), mugwort mono-
sensitiser (MMS) and co-sensitised patient
to both allergens (CS). We measured sIgEs
to whole extract of ragweed and mugwort
pollens, and group 1 major allergens (Amb
a 1 and Art v 1, respectively). And to dis-
tinguish cross reactivity from true sensiti-
sation, we performed CAP inhibition
assay.
Results: In RMS group (n = 27), detection
rates of sIgE of whole ragweed and Amb a
1 allergen were 63.0% and 55.5%, and two
patients were Amb a 1 sIgE positive with
negative response to ragweed. In MMS
group detection rate of sIgE to whole mug-
wort and Art v 1 were 67.6% and 54.1%,
and all Art v 1 positive patients were also
positive to mugwort sIgE. In CS group,
concordance rate between sIgE of ragweed
and Amb a 1 is 53.5%, mugwort and Art
v 1 is 74.4%. In the discordance sera with
positive to ragweed but negative to Amb a
1 sIgE (n = 7), CAP inhibition test using
mugwort allergen as a inhibitor, t ragweed
sIgE were inhibited more than 50% in six
patients (85.7%), In and In discordance
serum with positive sIgE to mugwor but
without Art v 1 sIgE (n = 2), ragweed
allergen inhibited mugwort sIgE more than
60% in all two patients.
Conclusion: SPT may insufficient to detect
genuine culprit allergens of weed pollenosis
patients. Measurement of of sIgE of crude
extract and single major allergen is supple-
mental for diagnosis of weed pollen aller-
gen, and presence of group 1 major
allergen of ragweed and mugwort may
imply true sensitisation and helpful for dis-
tinguish it from cross-reactivity in Korea.
766
Allergenic characterisation of a novel
allergen, homologous to chymotrypsin,
from German cockroach
Jeong, KY1; Son, M1; Kim, BJ2; Lim, K-J2; Lee, J-H1;
Hong, C-S1; Park, J-W1
1Internal Medicine, Yonsei University College of
Medicine, Seoul, Korea; 2ProteomeTech Inc., Seoul,
Korea
Background: IgE reactive components are
known to be rich in cockroach feces. Vari-
ous protease allergens were identified by
the proteomic analysis of German cock-
roach fecal extract in a previous study. In
this study, we characterised a novel aller-
gen, a chymotrypsin-like serine protease.
Method: A cDNA sequence homologous
to chymotrypsin was obtained by the anal-
ysis of German cockroach expressed
sequence tag (EST) clones. The recombi-
nant protein was expressed in Escherichia
coli using pEXP5NT/TOPO vector system,
and its allergenicity was investigated by
ELISA.
Results: Deduced amino acid sequence
showed 32.7–43.1% identity with mite
group 3 (trypsin) and group 6 (chymotryp-
sin) allergens. Sera from 8 of 28 subjects
(28.6%) showed IgE binding to the recom-
binant protein. IgE binding to the recombi-
nant cockroach chymotrypsin was
inhibited by house dust mite chymotrypsin
Der f 6, while it showed minimal inhibition
to German cockroach whole body extract.
Conclusion: A novel allergen homologous
to chymotrypsin and cross-reactive with
Der f 6 was identified from German cock-
roach.
767
Evaluation of a non-commercial rapid
point of care test for mast cell markers
using tryptase as a model protein
Rydell, N1; Broberg, J1; Strandberg, N1; Thorell, L1;
Sj€olander, A1
1ThermoFisher Scientific, Uppsala, Sweden
Background: A rapid point of care test
was investigated for its suitability to detect
and quantify mast cell proteins in serum or
plasma. Tryptase was used as a model pro-
tein. Tryptase is the most abundant protein
in mast cells. Immature tryptase constitu-
tively leaks into the plasma. Constantly
elevated levels of tryptase may reflect an
increased burden of mast cells and are
associated with blood disorders such as
mastocytosis. Upon mast cell activation
(e.g. anaphylaxis), stored mature tryptase
is released resulting in transiently elevated
levels of tryptase with peak values typically
between 15 and 120 min after the mast cell
activation. The use of rapid point of care
test with tryptase as a model protein was
investigated and compared to a commer-
cially available laboratory immunoassay
for total tryptase.
Method: A capillary flow membrane assay
was established. An antibody specific for
all forms of tryptase was immobilised as
thin bands on nitrocellulose membrane
strips (one band per strip). A different
antibody, also specific for all immature
and mature forms of tryptase, was coupled
to gold particles and used as detection
antibody.
Serum samples and tryptase calibrators,
20 lL respectively, were applied to the
strips and allowed to migrate by capillary
flow. The gold conjugate and wash liquids
were subsequently added to reveal red col-
ored bands on the strips where the conju-
gate had bound. Evaluation of the assay
was performed either visually or with a
photometric color reader.
Using the color reader, a calibration
curve was established that could be used to
determine the tryptase concentration in
serum. The results were compared with a
commercial tryptase assay.
Results and Conclusion: Proof of principle
was shown for a new rapid point of care
assay for the measurement of mast cell
proteases in serum or plasma using tryp-
tase as a model protein. Assay results
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could be obtained within 30 min using
only 20 lL serum or tryptase calibrators
and showed excellent conformity to the
commercial tryptase assay.
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An inhibition ELISA for the determination
of major allergen group 1 in different
grass species
Kerkvliet, E1; Sinnige, N1; Warmenhoven, H1; Ak-
kerdaas, J2; van Ree, R2; van den Hout, R1
1HAL Allergy BV, Development, Leiden, The
Netherlands; 2Academic Medical Center, Amsterdam,
The Netherlands
Background: Allergy induced by grass pol-
len can be reduced by means of sublingual
allergen-specific immunotherapy (IT). One
of the major allergens in grass pollen is
grass Group 1. Two antibody-based meth-
ods, a sandwich-ELISA and an inhibition
ELISA, were developed for the quantifica-
tion of grass Group 1 in grass pollen
extracts. Both methods were compared in
order to determine the most appropriate
assay for use of quantification of Group 1
in a grass pollen IT product that consists
of four different grass pollen extracts.
Method: The sandwich ELISA uses two
specific monoclonal antibodies (7E7 and
1B8) against Lol p1 major allergen, one on
the solid phase and one as detecting anti-
body. The inhibition ELISA (iELISA) uses
one specific monoclonal antibody (7E7)
that is mixed with grass pollen extract and
recombinant Phleum p1 allergen on the
solid phase. The products tested were pol-
len extracts of four different grass species,
i.e. Phleum pratense, Lolium perenne, Poa
pratensis and Secale cereale. The standards
used are well characterised grass Group 1
allergens (Phl p1, Lol p1, Poa p1 and Sec
c1) purified from grass pollen extracts.
Results: The sandwich ELISA showed dif-
ferent curves (e.g. non-parallel lines, differ-
ent OD maxima) when grass pollen
extracts from different grass species were
analysed, while the iELISA showed similar
curves for all four grass species. Further
development of the sandwich-ELISA
would involve separate development of 4
methods with different conditions, while
only one method could be used with the
iELISA for these extracts of 4 grass spe-
cies. Therefore, the iELISA was chosen for
further development and qualification.
Qualification showed that the iELISA gen-
erates reproducible results with low varia-
tion.
Conclusion: Quantification of grass Group
1 major allergen in four different grass spe-
cies can be done with one method using an
iELISA. The sandwich ELISA was less
suitable since different test conditions were
needed when testing different grass species.
The newly developed iELISA can precisely
quantify Group 1 allergen in pollen
extracts from Phleum pratense, Lolium per-
enne, Poa pratensis and Secale cereale.
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Sensitisation to Act d 2 in patients
allergic to Alternaria alternata: an
epiphenomenon without clinical
significance?
Sanchez-Lopez, J1; Pascal, M2; Gomez-Casado, C3;
Mu~noz-Cano, R1; Rueda, M1; Vilella, R2; Valero, A1;
Dıaz-Perales, A3; Bartra, J1
1Pulmonology and Respiratory Allergy, Hospital Clinic,
Barcelona, Spain; 2Hospital Clinic, Immunology,
Barcelona, Spain; 3Centro de Biotecnologia y Genomica
de Plantas UPM-INIA, Campus de Montegancedo,
Pozuelo de Alarcon, Spain
Background: In the last few years, the
introduction of microarrays in the diagno-
sis of type I allergy is allowing the clini-
cians to have a much more accurate
picture of their allergenic profile. However,
the simultaneous measurement of specific
IgE to multiple molecules can show unex-
pected sensitisations, without knowing
their clinical relevance. For instance, we
have been observing a high prevalence
(74%) of sensitisation to Act d 2 (the
thaumatin of kiwifruit) in patients sensi-
tised to Alt a 1 (major allergen of Alterna-
ria alternata) with a confirmed allergy to
this mould. The aim of the present study
was to clarify if there was any clinical rele-
vance in this finding.
Method: We selected patients allergic to A.
alternata (rhinitis and/or asthma) with a
positive specific IgE (sIgE) to Alt a 1 and
Act d 2 in the allergen microarray immu-
noassay (ImmunoCAP ISAC, ThermoFish-
er Scientific).
Skin prick tests (SPT) were performed
with the commercial available A. alternat-
a and kiwifruit extracts (Laboratorios
LETI), a purified nAct d 2 protein and a
prick by prick with fresh kiwifruit. Total
IgE and sIgE (UniCAP, ThermoFisher
Scientific) to kiwifruit and A. alternata
were obtained, and an open oral food
challenge (OFC) with kiwifruit was also
carried out.
Results: Eighteen patients were selected,
nine of them were skin prick tested and
orally challenged. 9 men, 9 women, median
total IgE 195 kU/l (intercuartile range
(IQR) 128–542). sIgE to kiwi was negative
in all cases, median sIgE to A. alternata
was 9.86 kU/l (IQR 5.5–16.8), median sIgE
to Act d 2 was 1.9 ISU (0.9–4.6), and sIgE
to Alt a 1 was 9.8 ISU (2.5–20.4). A corre-
lation was found between sIgE to Act d 2
and sIgE to Alt a 1 (Rho Spear-
man = 0.686; significance = 0.01).
SPT to A. alternata extract was positive
in all cases, SPT to commercial kiwi, prick
by prick with fresh fruit and nAct d 2 were
all negative. OFC with kiwifruit was well
tolerated in all patients.
Conclusion: In our population, sensitisat-
ion to Act d 2 in the context of an allergy
to A. alternata has no clinical relevance.
This sensitisation could only be seen with
the microarray immunoassay, SPTs and
sIgE to kiwi failed to detect it.
A significant correlation was found
between sIgE to Act d 2 and Alt a 1. Fur-
ther studies are needed to confirm if this
sensitisation is real and in second place, to
figure out if there could be any other link
between both allergens rather than the clin-
ical one.
770
Stability of purified nsLTP prick tests by
in vitro analysis
Moya, R1; Lopez-Matas, MA1; Carnes, J1
1Laboratorios LETI, R & D, Tres Cantos, Spain
Background: The use of purified allergens
as a diagnostic for skin prick test allows
the identification of real sensitisation to a
specific allergen present in a protein extract
and it is a very useful tool for the study of
cross-reactivity. However, the quality of
these products has to be demonstrated. In
that sense, there is no studies about the
stability of purified proteins as reagents for
diagnosis. The objective of the study was
to determine the stability of purified nsLTP
prick tests under different storage condi-
tions.
Method: Pru p 3 and Cor a 8 were purified
in an €AKTAexplorer FPLC and used to
prepare prick tests with a concentration of
30 lg/ml of total LTP. A mixture of puri-
fied LTPs (15 lg/ml of Pru p 3 and 15 lg/
ml of Cor a 8) was selected in order to
increase the diagnosis efficacy. After for-
mulation, pricks were stored at three tem-
peratures (room temperature, 4° and
20°C) and they were analysed monthly
by SDS-PAGE and immunoblot. Pru p 3
or Cor a 8 polyclonal rabbit antibodies
were used in immunoblot experiments.
Finally, pH and glycerol valuation was
also carried out.
Results: SDS-PAGE and immunoblot
results showed that there were not impor-
tant differences in protein molecular
weights or protein band intensity between
the 3 temperatures and during the whole
period of study (6 months). Immunoblot
results showed a slight decrease in the
intensity of Cor a 8 recognition after
6 months. Regarding pH and glycerol val-
ues, both parameters were maintained in
the range of 7.5–8.5 and 45–55%, respec-
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tively, during the whole period and in the
three temperature conditions.
Conclusion: Skin prick tests composed by
purified Pru p 3 and Cor a 8 were stable
after 6 months of being stored at room
temperature, 4° and 20°C in terms of
protein integrity, pH and glycerol content.
Stability of purified LTPs as reagents for
diagnosis is recommended in 6 months.
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Recombinant production and
immunologic characterisation of the
allergen Sal k 1, a diagnostic marker for
sensitisation to Salsola kali
Mas, S1; Barderas, R1; Boissy, P2; Monsalve, R2; Colas,
C3; Rodrıguez, R1; Villalba, M1
1Biochemistry and Molecular Biology I, Complutense
University of Madrid, Madrid, Spain; 2Research and
Development Department, ALK-Abello, Madrid, Spain;
3Hospital Clınico Universitario ‘Lozano Blesa’, Zaragoza,
Spain
Background: Plants from Chenopodiaceae
family are becoming important allergenic
pollen releasers as the land desertification
occurring in many countries is spreading
these weeds and amplifying these allergies.
The most relevant allergenic members of
this family are Salsola kali and Chenopodi-
um album. The marker of sensitisation to
S. kali pollen is the major allergen Sal k 1,
a highly polymorphic protein belonging to
the pectin methylesterase enzyme family.
The natural form of the protein is being
used in diagnostic protocols as the Immu-
noCAP ISAC or the Advia-Centaur immu-
noassay system. However, low amounts of
the protein, many isoforms, and a rather
cumbersome process of purification make
difficult to obtain it from the pollen.
Objectives: To produce the recombinant
Sal k 1 (rSal k 1) in Escherichia coli and to
determine its biochemical and immunologi-
cal equivalency with the natural protein
isolated from S. kali pollen.
Methods: rSal k 1 was obtained in E. coli
and purification achieved taking advantage
of the histidine tag at the C-terminal end
of the protein. Biochemical characterisa-
tion was performed by spectroscopic analy-
sis and immunologically using monoclonal
and polyclonal antibodies raised against
nSal k 1 by ELISA and immunoblotting.
The natural protein was used as reference.
Eighty-nine sera from S. kali sensitised
patients were used.
Results: rSal k 1 was purified to homoge-
neity by affinity chromatography using a
Ni-NTA column with yields of about
5 mg/l of cell culture. Circular dichroism
experiments confirmed that rSal k 1 was
properly folded at secondary structure
level. Immunological assays performed
with monoclonal and polyclonal antibodies
revealed similar IgG binding for both pro-
teins. The population of 89 patients’ sera
and monoclonal antibodies tested showed
very close immunological behaviour for
rSal k 1 and nSal k 1 in immunoblotting.
However, certain variability of the IgE
binding was observed between both pro-
teins in ELISA, perhaps due to the
involvement of conformational epitopes.
Conclusions: Recombinant and natural Sal
k 1 showed similar immunological proper-
ties, indicating that rSal k 1 is able to
cover most of the IgE epitopes of nSal k 1.
Accordingly, rSal k 1 could be used as
diagnostic tool in clinical protocols instead
of the natural form due to its easy produc-
tion and purification.
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Profilins sensitisation is a marker of
clinical risk in children affected by
pollinosis?
Verini, M1; Cingolani, A2; Nigro, R3; Scaparrotta, A3;
Consilvio, NP2; Cerasa, M2; Di Pillo, S3; Chiarelli, F2;
Molecular Allergology
1Paediatric School of Medicine, University of Chieti,
Chieti, Italy; 2Paediatric Department, University of
Chieti, Chieti, Italy; 3University of Chieti, Chieti, Italy
Background: Profilins are gastrolabile and
thermolabile proteins contained into
eukaryotic cells of vegetables world
involved in cellular movement pro-
cesses.They are considered ‘pan-allergens’
because contained both in pollen of many
allergen’s source (grasses, pellitory, olive
tree, birch, absinthe and ambrosia) than in
fresh and dry fruits (melon, tomato, pine-
apple, orange, apple, pear, banana, cherry,
strawberry,peanuts, hazelnut and soy).
While profilins’ dangerous effects in adult
is still discussed there are not yet studies
about their effect in paediatric age.
Method: Sensitisation to profilins was
studied in 295 children (mean
age = 9.88  3.69 years) affected by pol-
lens’ rhynitis and/or asthma (Skin Prick
Test and specific IgE positive for grasses,
pellitory and olive tree),by Specific IgE Im-
munocap against Phleum Pratense and
Birch molecular allergenes Phl p12 and
Betv2. A comparison between children
with Phlp12 positivity and Phlp12 negativ-
ity has been made to analyse the differ-
ences in pattern of vegetables sensitisation
and in incidence of vegetables ingestion
related symptoms as SOA, urticaria or
anaphylaxis.
Results: In our serie 68 children (23%)
were sensitised to profilins (Phlp12 and Bet
v2) while 227(76%) were not. The group of
profilins sensitised children showed these
differences wth not sensitised group:
1) Statisticaly higher specific IgE levels
against wheat, tomato and peanuts;
2) Statistically higher extra-respiratory
symptoms score (gastrointestinal: abdomi-
nal pain, vomit; cutaneous: urticaria; sys-
temic: angioedema and anaphylaxis): 2.04
vs 1.65 (P = 0.05),
3) Statistically higher incidence of vege-
tables related symptoms (Oral Allergic
Syndrome/ urticaria /angioedema /anaphy-
laxis): children with Phlp12 positiv-
ity = 22.4% vs children with Phlp12
negativity = 5.28% X2 = 8.9, P < 0.01. No
differences conceirnig asthma and rhinitis
score were observed between the groups
under study.
Conclusion: This study shows the relation
between Phlp12 and Betv2 profilins sensiti-
sation with the risk of allergic symptoms
related to vegetables’ ingestion in pollens
sensitised children.
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Proteomic tools for characterisation of
allergen products
Spiric, J1; Engin, A1; Karas, M2; Vieths, S1; Reuter, A1
1Division of Allergology, Paul-Ehrlich-Institut, Langen,
Germany; 2University of Frankfurt, Institute of
Pharmaceutical Chemistry, Frankfurt, Germany
Background: The most common causes of
spring pollinosis in northern and central
Europe are reactions toward pollen from
trees of European white birch. Allergic dis-
eases are diagnosed and treated using aller-
gen extracts prepared from natural sources.
Currently applied methods for characteri-
sation of allergen products have limitations
regarding the identification and quantifica-
tion of allergens at isoform level in an
extract (e.g. ELISA). Quantification of
allergen content is one of the main aspects
for product characterisation as major aller-
gens effect the potency of allergen prod-
ucts. Therefore, the aim of this study was
to develop a novel method capable of
determining relative abundance of proteins
in a single run, recording a quantitative
protein profile and quantifying all relevant
allergens and their isoforms in a sample.
Method: 2D-PAGE coupled with mass
spectrometry (MS) was used to study iso-
form distribution in birch pollen extract,
which gave the basis for development of a
liquid chromatography (LC) -ESI-MS
method capable of quantifying allergens,
isoallergens, and recording quantitative
protein profile.
Results: 2D-PAGE revealed the presence
of five birch pollen allergens Bet v 1, Bet v
2, Bet v 4, Bet v 6, and Bet v 7. There were
up to seven different isoforms of Bet v 1
identified per spot, and more than one spot
was identified for other birch pollen aller-
gens. Furthermore, the number and the
type of allergens identified in 2D correlates
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with allergens detected by label free MS.
Quantitative values were obtained for all
betula verrucosa allergens and several non
allergenic proteins. This allows quantitative
comparison of the entire protein profile of
allergen products.
Conclusion: The present study indicates
that this LC-MSE method for characterisa-
tion and quantification of proteins in birch
pollen provides a great perspective and
appears to be a dependable tool that could
be applied for identification and quantifica-
tion of allergens and isoallergens in paral-
lel. Our study suggests that this promising
technology could replace current assays for
allergen and protein profile detection in the
field of allergology and especially in the
field of allergen product characterisation.
Moreover, this methodology could be
applied to characterise also other protein
based medicine products, and might con-
tribute to enhance safety and efficacy of
biomedicinal products.
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Prevalence of skin sensitisation to LTP
from peach: comparison between
different ethnic groups
Carre~no-Rojo, A1; Merida-Fernandez, C1; Ramırez-
Hernandez, M1; Pajaron-Fernandez, MJ1; Huertas-
Amoros, AJ1
1Allergy, Complejo Hospitalario Universitario de
Cartagena, Cartagena Murcia, Spain
Background: The aim of this study was to
compare the prevalence of skin sensitisat-
ion to LTP from peach (LTPp) between
childrens and adults from different ethnic
groups: Natives (Caucasian race), Maghre-
bians and South American people, residing
in the Southeast of Spain.
Method: Native, Maghrebian and South
American patients attending for the first
time to our department from May 2011 to
December 2012 suffering from respiratory/
cutaneous symptoms or food allergy were
included. Other ethnic group individuals
were excluded. We divided patients into
two groups: ≤12 years old and >12 years
old.Skin prick tests with standard neu-
moallergens and food allergens including
LTPp (ALK- Abello) were performed in
all patients.
Results: The 2.226 individuals (53.7%
females and 46.3% males, mean age
29.7  17.7 year old) were included: 1937
(87%) natives, 148 (6.6%) Maghrebians
and 141 (6.3%) South Americans.455
(20.4%) patients were ≤12 years old and
1771 (79.6%) >12 years old.Skin prick test
with LTPp was positive in 198 (8.9%)
patients.Prevalence of skin sensitisation to
LTPp depending on the age and ethnic
group is showed in the table 1. Ethnic
group≤ 12 years oldPatients (n) /lLTPp +
(n/%) >12 years oldPatients (n) /LTPp +
(n/%) Natives380/33 (8.7%)1557/158
(10.1%)Maghrebians35/2 (5.7%)113/1
(0.9%) South Americans40/2 (5%)101/2
(2%)Total patients455/37 (8.1%)1771/161
(9.1%) Table 1 Statistical differences
(P < 0.0001) in the prevalence of skin sen-
sitisation LTPp between native, Maghre-
bian and South American adults were
found but not in the group ≤12 years old.
Conclusion: Prevalence of skin sensitisation
to LTPp is higher in native adults than in
Maghrebian and South American. No dif-
ferences were found in the prevalence of
LTPp in younger patients of different eth-
nic groups. These results suggest that sensi-
tisation to LTPp could be caused by
environmental factors and/or dietetic hab-
its in early childhood.
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Expression and IgE reactivity of the fatty
acid binding protein from the shrimp
Litopenaeus vannamei
Puerta, L1; Munera, M1; Pacheco, E1; Martınez, D1; Zak-
zuk, J1; Caraballo, L1
1Institute for Immunological Research, University of
Cartagena, Cartagena, Colombia
Background: The allergenic properties of
fatty acid binding proteins (FABP) from
arthropods such as domestic mites and
cockroaches have been demonstrated. The
allergenic role of this highly conserved pro-
tein in other allergenic sources such as
shrimp is unknown.
Method: The nucleotide sequence of FABP
from shrimp L. vannamei (Lv FABP),
(GenBank: ADK66280.1) was optimised
for codon utilisation in E. coli expression
systems and obtained by gene synthesis,
then cloned into the expression vector and
transformed into E. coli to produce the
recombinant protein. Twenty eight allergics
to shrimp were selected based on clinical
history of allergy and positive skin test.
IgE reactivity to shrimp allergenic extract
and recombinant Lv FABP were deter-
mined by ELISA, in addition IgE reactivity
to Blomia tropicalis extract and Blo t
13.0101 allergen were analyzed. Basophile
activation assays were determined by flow
cytometric in whole blood samples.
Results: The recombinant Lv FABP was
obtained with N-terminal Hisx6 tag as
inclusion bodies, requiring solubilization
with urea followed by oxidative refolding.
The purified protein showed a molecular
weight of 16 KD. Frequency of positive
IgE reactivity in sera from allergy subjects
to shrimp was 25.0%, (7/28) and IgE levels
ranging from 0.12 to 0.43 optical density.
No IgE reactivity was detected in 13 sera
from non allergic subjects. All sera with
positive IgE reactivity to Lv FABP, were
also positive to the homologue allergen
from B. tropicalis mite, Blo t 13 01.101.
Basophile activation to recombinant Lv
FABP, indicated by a stimulation index
equal or greater than 2, was observed in
two of three allergic individuals analyzed.
Conclusion: We report the obtaining of the
recombinant FABP from L. vannamei, and
demonstrated its IgE reactivity in shrimp
allergy individual, this molecule represents
a novel allergen from shrimp with homol-
ogy to group 13 mite allergens.
776
Component resolved diagnosis: recording
of discrepancies between single and
multiplex IgE analysis
de Boer, D1; Bons, JAP1; Nieuwhof, CM2; Menheere,
PPCA1
1Central Diagnostic Laboratory, Maastricht University
Medical Centre, Maastricht, The Netherlands; 2Digestive
Diseases Department of Internal Medicine, Maastricht
University Medical Centre, Maastricht, The Netherlands
Background: ISAC (Immuno Solid-phase
Allergen Chip) is a multiplex assay used in
Component Resolved Diagnosis (CRD).
By measuring specific IgE against >100
allergen components in one single run a
CRD profile is established using simply
20–30 ll of sample. Applying the Immuno-
CAP assay also CRD can be achieved, but
in one single run only one component can
be analyzed using 40 ll of sample. In prin-
cipal the manufacturer claims that the
results of ImmunoCAP and ISAC tech-
niques are standardised towards the WHO
IgE 75/502 standard. However, as both
techniques differ significantly, an equiva-
lent performance requires more than stan-
dardisation. In this study we report
discrepancies between ImmunoCAP and
ISAC analysis for some allergen compo-
nents as observed in our daily routine anal-
ysis.
Method: Patients (n = 86) suspected for
food and/or insect allergy, for which CRD
was applied because of diagnostic reasons,
were included. ImmunoCAP and ISAC103/
112 analyses were performed according to
the instructions of the manufacturer.
Recording of discrepancies between identi-
cal allergen components were focused on
selected milk (nBos d 8; casein), soy (rGly
m 4; PR-10 protein) and wasp venom (rVes
v 5; antigen-5) components. If required
supplemental ImmunoCAP or ISAC analy-
sis was performed. While the ImmunoCAP
assay is a quantitative assay, the ISAC
assay is a semi-quantitative assay. There-
fore, ISAC results were interpreted in com-
bination with its analytical uncertainty as
established in a separate study. A
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discrepancy was defined as a result that in
the correlation of ImmunoCAP and ISAC
results was out-side the 99% ISAC analyti-
cal uncertainty limit.
Results: With respect to rGly m 4 (three
out of eight patients), nBos d 8 (7 out of
13 patients) and rVes v 5 (2 out of 9
patients) allergen components the discrep-
ancies were 38%, 54% and 33%, respec-
tively. For those discrepancies, the ISAC
results were always significantly lower than
that of ImmunoCAP. No consistent cause
could be assigned. The observed differences
may have a multifactorial background,
although some differences are inherent to
samples themselves.
Conclusion: In CRD and despite the lim-
ited number of observations, a significant
number of discrepancies were observed
between the results of rGly m 4, nBos d 8
and rVes v 5 ImmunoCAP versus ISAC
analysis. ISAC gave in all of those cases
considerably lower values. Understanding
of the cause of these discrepancies is neces-
sary for an adequate interpretation of
ISAC results.
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IgE to Der p 1 and Der p 2 as predictors
of airway response to house dust mite
Minami, T1; Fukutomi, Y1; Taniguchi, M1; Saito, A1;
Yasueda, H1; Nakayama, S2; Tanaka, A2; Mitsui, C1;
Hayashi, H1; Tsuburai, T1; Maeda, Y1; Mori, A1; Hasega-
wa, M1; Akiyama, K1
1Clinical Research Center for Allergy and
Rheumatology, Sagamihara National Hospital,
Sagamihara, Kanagawa, Japan; 2Phadia AB Thermo
Fisher Scientific, Uppsala, Sweden
Background: Component-resolved diagnos-
tics has recently been introduced into clini-
cal practice. However, few data are
available regarding the clinical usefulness
of measuring IgE to allergen components
from house dust mite (HDM) in the diag-
nosis of genuine HDM allergy. Broncho-
provocation challenge using allergen
aerosol is considered to be a more specific
indicator of allergen-specific airway reactiv-
ity than other allergy tests.
Objective: To evaluate the diagnostic effi-
ciency of measuring the levels of IgE to
allergen components from Dermatophago-
ides pteronyssinus (DP) as a predictor of
immediate asthmatic response (IAR) after
bronchoprovocation challenge.
Method: Sixty-five asthmatic patients who
reported asthmatic symptoms upon house
dust exposure underwent bronchoprovoca-
tion challenge using DP extract. The levels
of serum-specific IgE to crude DP and
nDer p 1, rDer p 2 and rDer p 10 in
patients who showed IAR (n = 41) were
compared with those in patients who
showed no IAR (n = 24).
Results: The levels of IgE to crude DP,
nDer p 1, rDer p 2 were significantly
higher in patients showing IAR than in
those not showing IAR (crude DP,
P < 0.01; nDer p 1, P < 0.01; rDer p 2,
p < 0.01). Receiver operating characteris-
tics (ROC) analysis showed that the levels
of IgE to nDer p 1 and rDer p 2 predict
the outcome of a bronchoprovocation
challenge similaly to IgE to crude DP (area
under the ROC curve: crude DP, 0.953;
nDer p 1, 0.949; rDer p 2, 0.945). The
specificities of IgE to nDer p1 and rDer p
2 were 67 and 75%, respectively, which
were higher than that to crude DP (46%).
Conclusion: Specific IgE to nDer p 1 and
rDer p 2 was an excellent and a more spe-
cific predictor of IAR. These findings vali-
date the clinical usefulness of IgE to nDer
p 1 and rDer p 2 as a diagnostic tool for
genuine house dust mite allergy.
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Immunoreactive recombinant Alt a 1
expressed in Pichia pastoris
Wu¨nschmann, S1; Koid, A1; Lohman, M1; Chapman, M1
1INDOOR Biotechnologies Inc., Charlottesville, VA,
United States
Background: The three-dimensional struc-
ture of recombinant Alt a 1 expressed in
Escherichia coli has recently been deter-
mined by X-ray crystallography (Chruszcz
et al., JACI, 2012). However, this E.coli-
expressed rAlt a 1 is no longer commer-
cially available. Our goal was to produce
rAlt a 1 in Pichia Pastoris, a eukaryotic
system more closely related to Alternaria
alternata.
Method: Recombinant Alt a 1 was
expressed in Pichia pastoris and purified by
gel filtration chromatography. Pichia-
expressed rAlt a 1 was compared to E.coli-
expressed rAlt a 1 by SDS-PAGE, CD
spectroscopy, monoclonal antibody ELISA
and chimeric-IgE antibody ELISA.
Results: SDS-PAGE of Pichia- and E.coli-
expressed rAlt a 1 identified the Alt a 1
monomer at the expected molecular weight
of ~15 kD as well as the dimer at 30 kD.
Following gel filtration, Pichia-expressed
Alt a 1 presented primarily as a dimer on
non-reducing SDS-PAGE. The two forms
of rAlt a 1 showed overall comparable CD
spectra and similar reactivity in mAb- and
IgE-Ab ELISAs. Specific IgE from all sera
of Alternaria alternata allergic patients
reacted to both forms of rAlt a 1 with
excellent correlation (n = 34, R2 = 0.93,
p < 0.001).
Conclusion: Pichia-expressed Alt a 1 is
almost identical to E.coli-expressed Alt a 1
in mAb and IgE binding assays. Alt a 1
produced in a eukaryotic system is a useful
reagent for diagnostic assays to determine
sensitisation to Alternaria, and has other
applications in T-cell studies, histamine
release assays and mouse models of
asthma.
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Reproducibility analysis of multiplex IgE
analysis
Martınez-Aranguren, RM1; Lizaso, MT2; Goikoetxea,
MJ1; Garcıa, BE2; Cabrera-Freitag, P3; Trellez, O4; Sanz,
ML1; Research Network in Adverse Reactions to Aller-
gens and Drugs (RIRAAF)
1Department of Allergology and Clinic Immunology,
Clınica Universidad de Navarra, Pamplona, Spain;
2Allergology Service, Complejo Hospitalario de
Navarra, Pamplona, Spain; 3Department of Allergology
and Clinic Immunology, Clınica Universidad de
Navarra, Madrid, Spain; 4Department of Computer
Architecture, Universidad de Malaga, Malaga, Spain
Background: The ImmunoCAP ISAC-
CDR-112 (ThermoFisher, Uppsala, Swe-
den) is a fluoro-enzyme-immunoassay that
allows detection of specific IgE to 112
molecular components from 51 allergenic
sources. However, few studies of reproduc-
ibility have been carried out. We studied
the reproducibility of this technique intra-
and inter- assay, as well as interbatch- and
interlaboratory-assay.
Method: Twenty samples were studied,
nineteen sera from polysensitised allergic
patients, and the technique calibrator,
CTR02. The CTR02 is composed of
known concentrations of specific chimeric
antibodies to 15 allergens and is used to
create the calibration curve of each new
assay. We measured the sIgE from CTR02
and three patients′ sera ten times in the
same and in different assays. Furthermore,
all samples were tested in two laboratories
and with two batches of ISAC kit. To ana-
lyse the reproducibility and the agreement
of the results obtained, we calculated the
intraclass coefficient correlation (ICC) to
each allergen and the coefficient of varia-
tion (CV) of the 15 allergens of the calibra-
tion curve. The level of agreement
calculated by ICC, is expressed according
to the classification of Fleiss: very good
(ICC >0.91), good (0.91–0.71), moderate
(0.71–0.51), poor (0.51–0.31) and bad (ICC
<0.31). The CV is expressed in% as median
and interquartile range.
Results: The agreement in the intra- and
inter-assay analysis was very good to 94
allergens and good to one, whereas in the
17 allergen resting, the ICC could not be
calculated because all their determinations
were cero. In the interlaboratory analyse,
we obtained a very good agreement to 73
allergens, good to 22, moderate to 6 aller-
gens, and poor to two. And in the inter-
batch analyse, the agreement was very
good to 82 allergens, good to 14, moderate
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to 5, and poor and bad in one allergen.
The CV in the determinations performed
of sera from allergic patients were 9.9%
(6.8–23.7), 27.1% (17.3–95), 20.3% (16–
29.8) and 17.8% (12.3–34.2) in the intra-
and inter-assay, interlaboratory and inter-
batch analyse, respectively. Moreover, the
CV% of the results obtained with CRT02
were slightly lower: 7.7% (6.3–9.1), 7.8%
(5.7–15.6), 7.3% (5.9–9.5) and 6.8% (3.7–
10.6), respectively.
Conclusion: The allergen microarray
immunoassay, ISAC CRD112, is a repro-
ducible in vitro diagnostic tool for determi-
nation of sIgE to a wide variety of
allergens and these have a low variability
in the results.
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Clinical and IgE profiling of birch (Betula
verrucosa) allergic individuals suffering
from allergic reactions to raw fruits and
vegetables
Tolkki, L1; Alanko, K1; Petman, L2; Skydtsgaard, MB3;
Gronager, PM3; Seppala, U3; Ranki, A1
1Department of Skin and Allergic Diseases, Skin and
Allergy Hospital, Helsinki University Central Hospital,
Helsinki, Finland; 2Allergy Testing Unit, Department of
Skin and Allergic Diseases, Skin and Allergy Hospital,
Helsinki University Central Hospital, Helsinki, Finland;
3Global Research, ALK-Abello, Horsholm, Denmark
Background: Birch pollen allergic individu-
als often report having mucosal symptoms
after consuming raw fruits and vegetables.
The aim of the present study was to assess
clinical and specific IgE profiles in individ-
uals suffering from birch pollen allergy and
concomitant immediate type allergic reac-
tions to raw fruits and vegetables.
Methods: A total of 59 adults with clinical
and skin prick test (SPT) confirmed birch
pollen allergy were included in the study.
All subjects were interviewed using a struc-
tured questionnaire and examined in vivo
by an open challenge test, applying the
appropriate fruit and vegetable(s) crushed
on ventral side of arm skin and/or with
labial challenge. ImmunoCAP and Immu-
noCAP ISACTM were used as in vitro diag-
nostics to demonstrate IgE based
sensitisation profiles for each individual
and principal component analyses (PCA)
were used to analyses of the IgE data sets.
Results: Out of 59 birch allergic individu-
als 54 (92%) had positive prick-prick test
with raw potato, carrot, apple and/or
hazelnut and the SPT was always positive
when the corresponding skin challenge was
defined positive. The majority 67% (36/54)
reported history of immediate skin contact
symptoms such as itching, redness or urti-
carial reactions when handling raw potato,
carrot, apple and/or hazelnut. Although
the ImmunoCAP ISACTM inhibition assays
with rMal d 1 and rBet v 1 demonstrated
that Bet v 1 is driving the sensitisation
against pathogenesis related -10 (PR-10)
proteins, the PCA demonstrated that spe-
cific IgE raised against pollen allergens
could not be used to predict in vivo sensiti-
sation to fruits and vegetables.
Conclusions: Among the birch allergic
individuals allergic reactions to fruits and
vegetables are not limited to the oral
mucosa. In our study most of the individu-
als reported and showed immediate skin
symptoms when handling raw fruits and
vegetables and/or challenged with appro-
priate food. The present study also shows
that component based IgE profiling does
not enhance the diagnostic potential in
case of pollen-food syndrome. Careful clin-
ical characterisation of allergic individuals
as well as identification of additional sensi-
tising allergens is still needed to identify
individuals suffering from pollen related
food allergies. Misdiagnosis of food aller-
gies may lead to unnecessary avoidance
diets which may result in impaired quality
of life of affected individuals.
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Comparison of two methods for
determination of allergen-specific IgE in a
population sample of Asian children:
PATCH study
Chang, S-W1; Tu, Y-L2,3; Tsai, H-J4,5; Huang, J-L2,3; Yao,
T-C2,3
1Clinical Informatics and Medical Statistics Research
Center, Chang Gung University College of Medicine,
Taoyuan, Taiwan; 2Division of Allergy, Asthma, and
Rheumatology, Department of Pediatrics, Chang Gung
Memorial Hospital, Taoyuan, Taiwan; 3Department of
Pediatrics, Chang Gung University College of Medicine,
Taoyuan, Taiwan; 4Division of Biostatistics and
Bioinformatics, Institutes of Population Health Sciences,
National Health Research Institutes, Miaoli, Taiwan;
5Feinberg School of Medicine, Department of
Pediatrics, Northwestern University, Chicago, IL, United
States
Background: There has been growing
interest in the application of microarrays
for the measurement of allergen-specific
immunoglobulin E (IgE) in the past few
years. Specifically, BioIC, a recently
developed microfluidic microarray immu-
noassay, permits simultaneous determina-
tion of specific IgE to multiple allergens in
a single step using small amount of serum,
at a relatively low cost. This study aimed
to assess the performance of BioIC in com-
parison with that of a well-established
assay, ImmunoCAP, in a population sam-
ple of Asian children.
Methods: An inter-assay comparison of
BioIC AD40 panel and ImmunoCAP
was performed using serum samples from a
population-based sample of 190 atopic
children aged 5–18 years participating in
the Prediction of Allergies in Taiwanese
CHildren (PATCH) study. We compared
the performance of the two assays for
detecting specific IgE to twelve major
inhalant and food allergens (Dermato-
phagoides pteronyssinus, German cock-
roach, dog dander, cat dander, egg white,
milk, codfish, shrimp, crab, wheat, peanut
and soybean).
Results: A total of 2280 paired assay
results were analyzed. High agreement was
observed between the results of both assays
for detecting allergen-specific IgE, with an
average total agreement rate of 81.5%
(95% CI: 76.0–87.0%), ranging from
66.3% (95% CI: 59.6–73.0%) for egg white
to 96.3% (95% CI: 93.6–99.0%) for soy-
bean. The one-class agreement rate ranged
from 60.5% (95% CI: 53.6–67.5%) for D.
pteronyssinus to 99.5% (95% CI: 98.4–
100.0%) for soybean, with an average of
92.9%.
Conclusion: These data demonstrate high
agreement between the results of BioIC
and ImmunoCAP in a population-based
setting, indicating that BioIC may serve
as an accurate and cost-effective alternative
for multiplexed determination of allergen-
specific IgE.
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Validation of an ELISA method for the
quantification of Amb a 1
Arilla, C1; Ibarrola, I1; Brena, S1; Zamarre~no, J1;
Martınez, A1; Asturias, JA1
1Bial Arıstegui, R&D, Zamudio, Spain
Background: Amb a 1, a pectate lyase of
38 kDa, is the Ambrosia artemisiifolia most
relevant allergen, since 95% of ragweed-
sensitive individuals react to this protein in
skin tests and show high serum IgE anti-
body titers. Allergen manufacturing pro-
cess should involve the measurement of
this relevant allergen in order to maintain
its level in the freeze dried pollen extracts.
The aim of this study was to validate a
double phase ELISA to quantify Amb a 1
according the Guideline of Validation of
Allergen Products: Production and Quality
Issues’ (CHMP/BWP/304831/2007) and to
confirm the manufacturing process consis-
tency.
Method: Amb a 1 ELISA kit (Indoor Bio-
technologies Ltd) was used following the
manufacturer′s instructions. It was based
in rabbit polyclonal IgG antibodies raised
against short ragweed allergen Amb a 1
purified by affinity chromatography to cap-
ture, and the same biotinylated antibodies
for detection. The major allergen concen-
tration of the A. artemisiifolia extracts was
measured by interpolation in the linear
portion of an Amb a 1 standard curve
(62.5–1 ng/ml) in the validation assays.
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The parameters studied were repeatability,
intermediate precision, accuracy and limit
of quantification. Amb a 1 content was
tested in five batches of the freeze-dried
Ambrosia artemisiifolia pollen extract from
three different pollen suppliers.
Results: The study meets the requirement
of repeatability since the coefficient of vari-
ation (CV) of the percentages of Amb a 1
calculated from 9 curves of the extract and
performed under the same operating condi-
tions by two different analysts was less
than 8.5%. In the intermediate precision,
neither different analysts nor different days
of analysis had a significant effect on the
result. The method had the required level
of accuracy because texp 1.502 was lower
than the ttab. The limit of quantification of
the A. artemisiifolia pollen extract was
83 ng/ml which meets the requirements of
precision (CV = 12.8%) and accuracy (rel-
ative error = 0.9%). The content of the rel-
evant allergen Amb a 1, was similar in all
the batches, and fall between 73% and
100% of the IHRP content which are
much less than allowed by the Eur. Ph.
(50–200%).
Conclusion: The two-step ELISA method
is suitable for quantifying Amb a 1 because
it provides consistently and repeatedly
results that meet the established specifica-
tions.
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Effect of cryopreservation, cryostorage
and thawing on mononuclear cell
populations: detailed examination of
CD4+ T cell subsets
Collier, F1,2; Tang, M3,4; Southall, C1,2; Kennedy, D1,2;
Vuillermin, P1; BIS Investigator Group
1Barwon Health, Child Health Research Unit, Geelong,
Vic., Australia; 2Barwon Health, Barwon Biomedical
Research, Geelong, Vic., Australia; 3Murdoch Childrens
Research Institute, The Royal Children’s Hospital,
Parkville, MO, United States; 4The University of
Melbourne, Melbourne, Vic., Australia
Background and objective: Samples of
blood mononuclear cells (MNC) are often
cryopreserved for extended periods of time
prior to analysis. This allows them to be
batch analysed at a later date for both
phenotypic and functional studies. While
cryopreservation is a useful tool, it is not
known whether it can affect cell function
or distribution of cell phenotypes. We
aimed to determine whether cryopreserva-
tion, storage and thawing altered MNC
populations of lymphocytes, including T
cells, subsets CD4+ and CD8+, CD4+
recent thymic emigrants (RTE) and regula-
tory T cells (Treg).
Method: MNC collected from infants par-
ticipating in the Barwon Infant Study were
isolated from cord blood. Small numbers
of cells were stained with a panel of anti-
bodies and remaining MNC cryopreserved
in liquid nitrogen. Selected samples were
then thawed and stained with the same
panel of antibodies, re-analysed by flow
cytometry and compared to freshly isolated
MNC. Cell number and viability was
determined using Trypan Blue. Data was
compared using Wilcoxon matched-pairs
signed rank test.
Results: Cells were frozen for periods
ranging from 1 to 12 months. After thaw-
ing 60  6% of the MNC cells were suc-
cessfully retrieved with 93  1% viability
(meansem, n = 11). Flow cytometric
analysis of the CD4+ T cells showed a sig-
nificant decrease in CD25+ T helper cells
(activated phenotype) (P = 0.01), however,
measures for the remaining T cell popula-
tions: T cells (CD3+), T cell subsets
(CD4+, CD8+), na€ıve CD4+ T cells
(CD45RA+), CD4+ Recent Thymic Emi-
grants (CD45RA+, CD31+) were
unchanged. In addition, using both surface
(CD127low) and intracellular (FoxP3+)
markers there was no change in the per-
centage of Treg subsets.
Conclusion: In comparison to results
obtained from fresh cord blood samples,
cryopreservation, storage and thawing was
associated with a reduction in CD25+ acti-
vated T helper cells, but no change in the
proportion of other T cell subsets including
the specialised immune suppressors, Tregs.
These results indicate that, in our labora-
tory, the use of cryopreserved cells will
yield similar cell populations to freshly
processed cells.
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Type I drug allergy: comparison of two
basophile activation tests
Micaletto, S1; Ballmer-Weber, B1; Schmid-Grendelmey-
er, P1; Petrausch, U1
1Allergology, University Hospital of Zurich, Z€urich,
Switzerland
Background: In case of suspected IgE
dependent drug reactions, skin testing is
most commonly used to establish the diag-
nosis of drug hypersensitivity. Sensitivity
of skin testing is low especially for drugs
not belonging to beta-lactam antibiotics.
Flow CAST can be performed in addition
to skin testing as in vitro diagnostics. The
test is intended to detect basophil activa-
tion in response to the culprit drug by flow
cytometry. Until now the marker combina-
tion CCR3 and CD63 was used by Flow
CAST to measure activated basophils. To
increase sensitivity of in vitro basophil acti-
vation testing, Flow CAST highsens, was
established. Activated basophils are now
measured by CCR3, CD63 and CD203c.
Method: In this study 21 consecutive
patients with clinically suspected type I
allergic reaction were included. Flow
CAST and Flow CAST highsens were
performed with the culprit drug and com-
pared. In all patients skin tests were per-
formed. We tested NSAIDs, muscle
relaxants and antibiotics.
Results: Activated basophils in the reac-
tion to the culprit drug were found in 12
of 21 patients. In 9 of these positive results
only the Flow CAST highsens was posi-
tive, while the regular Flow CAST was
negative. In two patients the regular test
was positive with a negative result in the
highsens test. Surprisingly, all patients with
a positive Flow CAST highsens had a
negative skin test for the culprit drug. We
also found positive skin tests in two
patients with negative in vitro tests.
Conclusion: Our data suggest a substantial
higher sensitivity of that Flow CAST
highsens when compared to the regular
Flow CAST. From the in vitro data we
would have to estimate a sensitivity of
approximately 50%. In vitro tests should
be combined with the skin tests to maxi-
mise the sensitivity. To definitely determine
the sensitivity of Flow CAST highsens
comparisons with drug provocation tests in
prospective clinical trials should be
addressed.
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A quantitative ELISA for determining
Antigen 5 content in wasp venom
van Deursen, D1; van den Hout, R1; van Ree, R2;
Kerkvliet, E1
1Development, HAL Allergy BV, Leiden, The
Netherlands; 2Academic Medical Center, Experimental
Immunology, Amsterdam, The Netherlands
Background: Allergy induced by wasp
venom can be treated by means of aller-
gen-specific immunotherapy. For wasp
venom, the main allergen reported is the
protein Antigen 5, known by the allergen
nomenclature as Ves v 5 (for Vespula vul-
garis) or Ves g 5 (for Vespula germanica).
We developed a major allergen ELISA and
investigated the Antigen 5 content in dif-
ferent wasp venom products.
Method: 96-well plates are coated with
monoclonal antibodies directed against Ves
g 5. After blocking, dilution ranges of
wasp venom preparations are added and
detection is done with a polyclonal anti-
body from rabbit directed against Ves g 5.
Subsequently, incubation is performed with
an HRP-conjugated goat-anti-rabbit anti-
body. The 96-well plates are stained with
TMB and the concentration Antigen 5 is
calculated by the use of the standard curve.
The new method uses the four-parameter
non-linear regression model for determin-
ing the Antigen 5 content in test prepara-
tions. The standards used in the ELISA is
Antigen 5 protein purified from wasp ven-
oms, which was characterised and quanti-
fied by amino acid analysis, FPLC, SDS-
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PAGE and protein determination. Antigen
5 concentration was determined in one
drug product and three different suppliers
of raw materials.
Results: The standards showed good four-
parameter dose response curves with high
correlations (r > 0.99) and the samples
tested showed high intra- and inter assay
precision (CV≤ 8%). The Antigen 5 con-
tent of the wasp venom batches tested was:
1.8% (drug product; Vespula spp.), 1.8%
(supplier A; Vespula spp.), 1.7% (supplier
B; Vespula spp.), 1.9% (supplier C; Vespula
vulgaris) and 2.0% (supplier C; Vespula
germanica). This is in accordance with data
from the literature.
Conclusion: The ELISA method is a suit-
able technique to quantify Antigen 5 con-
tent in different wasp venom products (raw
materials and drug product).
787
Defining the optimal cut-off values for
flow-assisted basophil activation test in
children with respiratory allergy to
Dermatophagoides pteronyssinus
Gregorius, A1; Czarnobilska, E2; Spiewak, R1
1Department of Experimental Dermatology and
Cosmetology, Jagiellonian University Medical College,
Krakow, Poland; 2Department of Clinical &
Environmental Allergology, Jagiellonian University
Medical College, Krakow, Poland
Background: To ensure the quality, bio-
equivalence and comparable performance
of diagnostic allergy tests, their cut-off val-
ues should be established individually for
each particular allergen and population in
question. Here, we demonstrate the process
of searching for the optimal parameters in
case of testing for house dust mite allergy
in children and adolescents.
Method: The study involved 60 children
and adolescents with respiratory allergic
disease (asthma and/or allergic rhinitis)
divided into 2 groups: 30 patients with
confirmed, clinically relevant D. pteronyssi-
nus allergy (qualification for specific immu-
notherapy following EAACI guidelines
served here as the gold standard) and 30
sex and age-matched controls with respira-
tory allergy to seasonal allergens (birch,
timothy). Values of the COV most effec-
tively separating children sensitised to D.p.
from those non-sensitised were established
based on the receiver-operator curve
(ROC) analysis for a range of variables,
including basophil stimulation at 5 allergen
concentrations ranging from 22.5 ng/ml
down to 0.00225 ng/ml, and area under
curve (AUC) calculations made in attempt
to combine two or more raw results in one
parameter. The CD63-based commercial
kit Flow2CAST together with commercial
D.p. allergen (Buhlmann) was selected for
this study, as the only certified for in vitro
diagnosis (IVD) that was available at the
start of this study.
Results: The best COV in the analysed
group was 9.76% activated basophils
(allergen response minus background) at
D.p. allergen concentration of 2.25 ng/ml
(98.3% correctly classified cases), followed
by the COV of 18.01% at 22.5 ng/ml
(96.7% correctly classified cases), and
AUC2 combining results for 22.5 ng/ml
with 2.25 ng/ml (COV of 14.23% activated
basophils) and AUC3 combining results
for 22.5 ng/ml, 2.25 ng/ml, and 0.225 ng/
ml (COV 15.14%) – each 96.7% correctly
classified cases. The sensitivity/specificity
rates were respectively: 96.7% and 100%,
100% and 93.3%, and each 100% and
93.3%.
Conclusion: Using the Flow2CAST, a sin-
gle measurement of basophil stimulation
with allergen at 2.25 ng/ml seems most
efficient and economical for the confirma-
tion or exclusion of respiratory allergy to
Dermatophagoides pteronyssinus in chil-
dren.
788
Possible use of the basophil activation
test as a biomarker for allergen
immunotherapy
De Amici, M1; Benzo, S1; Labo, E1; Caimmi, S1; Caimmi,
D1; Marseglia, A1; Torre, C1; Marseglia, GL1
1Pediatrics, University of Pavia- IRCCS Policlinico San
Matteo, Pavia, Italy
Background: Allergen specific immunother-
apy (AIT) is the only treatment able to act
on the causes and not merely on the symp-
toms of allergy. AIT may mainly be
administered in two forms, subcutaneous
(SCIT) and sublingual (SLIT). Several tri-
als have highlighted the efficacy and safety
of both forms in allergic rhinitis and
asthma, but no study has provided a defin-
itive biomarker that may allow monitoring
the clinical course of patients and demon-
strating from both a biological and clinical
point of view the effectiveness of the ther-
apy. The aim of the present study was to
evaluate the utility of the basophil activa-
tion test (BAT) as a biomarker for AIT
effectiveness.
Method: We compared BAT in the diag-
nosis of graminaceae allergy with skin tests
and measurement of specific IgE and we
investigated whether basophils sensitivity
can predict the outcome of AIT. A pro-
spective study has been designed for the
follow-up of allergic patients undergoing
SLIT therapy. A retrospective study has
been also designed to investigate a possible
correlation between basophils sensitivity
and clinical symptoms severity.
Results: 11 patients have been enrolled for
the prospective study, eight with seasonal
allergic rhinoconjunctivitis and three with
asthma. BAT was carried out before the
beginning of AIT (T0) to set the specific
basal sensitivity of the patients’ basophils.
BAT has been repeated yearly for the
entire duration of the therapy. For the ret-
rospective study, 20 patients have been
enrolled, 13 with seasonal allergic rhino-
conjunctivitis and seven with asthma.
These patients lack the evaluation of BAT
at T0, and they were only tested during
therapy. BAT results in both groups will
be compared to clinical symptoms and spe-
cific IgE measurements. We also tested the
evolution of BAT in 10 allergic patients,
who didn’t undergo allergen specific immu-
notherapy, as control group.
Conclusion: The aim of this study is to
understand if BAT is a useful biomarker of
AIT. This would allow evaluating safety
and efficacy of the therapy in order to pos-
sible decide to continue or stop the pre-
scribed immunotherapy. Our results might
also help us identify different subgroups of
patients that could show a good or bad
response to AIT.
789
Phleum pollen sensitisation pattern for
major allergen components in Southern
Romania grass pollinosis
Vieru, M1; Popescu, F-D1; Tudose, AM1; Dumitrescu,
NV2
1Allergology, University of Medicine and Pharmacy
‘Carol Davila’, Bucharest, Romania; 2Allergology,
Hospital ‘Nicolae Malaxa’, Bucharest, Romania
Background: In the Romanian plain, sensi-
tisation to grass pollen is higher compared
with other pollens significant as aeroaller-
gens. Timothy grass pollen is a source of
important major allergens: Phl p 1 and Phl
p 5.
Method: We collected sera of patients
from the south part of Romania with a
history of seasonal pollen allergy (present-
ing symptoms of rhinoconjunctivitis with
or without asthma) in the grass flowering
period of the region and positive skin prick
tests to grass pollens, with or without sen-
sitisation to other plant pollens with partial
temporal overlap for their pollination sea-
son. Specific IgE antibodies against recom-
binant Phleum allergen components (Phl p
1, Phl p 5, Phl p 7, Phl p 12) were detected
using a novel multiparameter immunoblot
test system, based on single purified aller-
gen components, SPAC Pollen1.
Results: From eighteen adult and children
patients with positive skin prick tests to
Phleum pratense pollen, 94.44% were sensi-
tised to Phl p 1 beta-expansin and/or Phl p
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5 allergen components. Sensitisation to Phl
p 7 and Phl p 12 cross-reactive allergen
components was less significant.
Conclusion: Specific IgE antibodies
against major specific allergen compo-
nents Phl p 1 and Phl p 5 detected by
SPAC Pollen 1 can be used as a marker
to genuine grass pollen allergy, important
in the decision for allergen-specific immu-
notherapy.
790
Development of a multiplex assay for the
determination of specific and total IgE
and IgG4 for 65 different targets
Feizkhanova, GU1; Filippova, MA1; Talibov, VO1; Demet-
ieva, EI1; Fooke-Achterrath, M2; Zasedatelev, AS1; Rubi-
na, AY1
1Russian Academy of Sciences, Engelhardt Institute of
Molecular Biology, Moscow, Russia; 2DR. FOOKE
Laboratorien GmbH, Neuss, Germany
A promising technique for modern allergy
diagnostic is a biological microchip provid-
ing a multiplexed, highly sensitive quantita-
tive assay. This system allows the
simultaneous determination of different
antibodies of different subclasses to multi-
ple allergens in a single assay format. The
AllergoChip, a biochip – an array of gel
elements containing a large set of immobi-
lised allergens -allows the determination of
IgE and IgG4-antibodies in a single test
using a minimal sample volume. The Aller-
goChip is manufactured by photoinduced
copolymerization of different molecular
probes with gel-forming monomers result-
ing in the formation of three-dimensional
hydrogel elements (1 nl gel drops), a tech-
nology invented at the Engelhard Institute
of Molecular Biology, Russian Academy of
Sciences.
In the present setup the AllergoChip for
the simultaneous assay of sIgE and sIgG4
for 65 allergens and total IgE and IgG4
contains different groups of allergens,
recombinant allergens, extracts and anti-
bodies to IgE and IgG4. The three dimen-
sional hydrogel allows for native
conformation and full accessibility of all
epitopes. During the serum incubation spe-
cific complexes of sIgE and sIgG4 to the
allergens in the gel are formed. The
immune complexes are visualised using a
mixture of anti-IgE-Cy5- and anti-IgG4-
Cy3-conjugates and concentrations of sIgE
and sIgG4 for specific allergens are deter-
mined simultaneously on the basis of the
recorded fluorescence signals. In addition,
concentration of total IgE and IgG4 is
determined in the same assay. The Allergo-
Chip is read out using the fluorescence
Chip analyzer and the interpretation is per-
formed using the ImageAssay software
(Engelhard Institute of Molecular Biology),
which allows simultaneous analysis of two-
wavelengths fluorescence images.
Comparative parallel assay of serum
samples using AllergoChip and REAST
method (ALLERG-O-LIQ, Dr. Fooke
Laboratorien GmbH) showed good corre-
lation between the two methods (correla-
tion coefficients 0.89–0.92).
The AllergoChip will be further devel-
oped since the format of a biochip pro-
vides the unlimited increase of the number
of allergens.
791
Molecular profiles of specific IgE to
individual allergens of Phleum pratense
in Spain
Beitia, JM1; Lopez-Matas, MA2; Vega, A1; Alonso, A1;
Cardenas, R3; Mateo, B1; Carne´s, J2
1Allergy Section, Hospital Universitario de Guadalajara,
Guadalajara, Spain; 2Laboratorios LETI, R & D, Tres
Cantos, Spain; 3Allergy Unit, Hospital de Ciudad Real,
Ciudad Real, Spain
Background: Advances in molecular biol-
ogy have allowed the use of a large spec-
trum of purified allergens for routinely
diagnostic purposes. Component Resolved
Diagnosis (CDR) is a tool that characteris-
es each patient’s IgE antibody (sensitisat-
ion) profile to individual allergen
components.The objective of the study was
to determine the molecular profile of sIgE
to individual allergens of P. pratense in a
population from the centre of Spain.
Method: A population of 137 individuals
from Guadalajara (centre of Spain) was
included in the study. All of them were
previously skin prick tested with a standar-
dised extract of grasses (Laboratorios
LETI SL). Patients with positive wheal size
(>7 mm2) were included in the study and
serum sample obtained. Specific IgE to a
mixture of grasses and P. pratense allergens
(Phl p 1, Phl p 2, Phl p 4, Phl p 5b, Phl p
6, Phl p 7, Phl p 11 and Phl p 12) were
measured by CAP.
Results: Most patients were sensitised to
Phl p 1 (beta expansin) (96.4%) and Phl p
4 (berberine bridge enzyme) (91.2%). The
lower percentage was obtained for Phl p 7
(calcium-binding protein, polcalcin) (8%).
One patient was negative to all allergens
tested (0.7%). Average values for the spe-
cific IgE ranged between 23.0 kU/l for Phl
p 5b (ribonuclease) and 4.2 for Phl p 12
(profilin). Thirty one different molecular
profiles were found in the studied popula-
tion.
Conclusion: Phl p 1 and Phl p 4 were the
allergens with higher prevalence of sensiti-
sation which is surprising in comparison
with other studied populations. The less
frequent was Phl p 7. The highest values
for the specific IgE were obtained with Phl
p 5b, Phl p 1 and Phl p 7. There are a
great variety of different profiles that could
hamper the SIT with individual allergens.
794
Usefulness of molecular diagnosis
Caimmi, S1; de Amici, M1; Trovamala, V1; Caimmi, D1;
Testa, G1; Marseglia, A1; Licari, A1; Marseglia, GL1
1Pediatrics, University of Pavia- IRCCS Policlinico San
Matteo, Pavia, Italy
Background: Molecular diagnosis (MD)
has started a new era, but it is important
to understand the clinical utility of the
available tests. Since the appearance of
molecular analysis in allergy, a systemic
study of the main allergens has been per-
formed, including the evaluation of possi-
ble cross-reactivity processes involved in
allergic reactions. These new forms of com-
ponent-resolved diagnosis reveal the anti-
body reactivity profile of allergic patients
and highlight the specific molecules
involved in the allergic diseases. The aim
of the present study was to evaluate the
diagnostic/therapeutic utility of molecular
diagnosis in patients allergic to common
allergens.
Method: Two hundrand and five patients
were enrolled in the study: 54 patients pre-
sented with allergic rhinitis or asthma
(diagnosed on the basis of the ARIA and
GINA guidelines), 56 patients with cutane-
ous signs (CS) and 95 patients with food
allergy (FA). We compared the medical
history and the results of skin prick tests
(SPTs) with their pattern of molecular sen-
sitisation through microarrays in order to
analyse the clinical and therapeutic utility
of MD in confirming the allergic disease.
Serum specific IgEs were measured by the
ImmunoCAP ISAC in a microarray
image analysis and expressed by Standar-
dised Units for specific IgE (ISU-E).
Results: Medical history, SPTs and ISAC
were in agreement in 60% of the patients.
Considering the different diagnosis, in the
95 patients with FA, ISAC resulted to be a
good diagnostic tool (80% of agreement),
and a helpful tool for a therapeutic
approach. ISAC results were extremely
consistent (99%) with medical history and
SPTs in patients presenting with severe
forms of FA. This finding was less consis-
tent in patients presenting with respiratory
or cutaneous symptoms, with the exception
of those patients presenting respiratory
food-pollen related allergies (53%). On the
other hand, it has to be underlined that in
10% of patients with FA, molecular find-
ings were in contrast both with clinical his-
tory and SPTs.
Conclusion: The present study shows that
MD has good diagnostic and monitoring
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value in those patients presenting with
severe forms of FA but it is also helpful in
pts with food-pollen related allergy and
gives the pattern of possible cross-reactivity
between pollen and food. Further investi-
gations will be necessary in order to detect
the proper indication for allergen-specific
immunotherapy before and after perform-
ing a MD in allergic patients.
795
Molecular diagnosis in dog allergy
Uriarte, SA1; Sastre, J1
1Allergy Department, Fundacion Jimenez Dıaz, Madrid,
Spain
Background: Allergy to dog is a frequent
cause of rhinitis, asthma or contact urti-
caria. Dander, saliva and urine are sources
of dog allergens. Currently, the prevalence
of sensitisation to different dog allergens is
not well known.
Objetive: To measured specific IgE to
different dog allergens.
Method: The pattern of IgE sensitisation
dog allergens, Can f 1, Can f 2, Can f 3,
and Can f 5 was evaluated in 172 patients
sensitised to dog. ImmunoCAP and
microarray ISAC (ThermoFisher Scien-
tific, Sweden) was used to measured spe-
cific IgE. A value >0.35 kU/l or >0.3 ISU
was considered as positive for Immuno-
CAP or ISAC respectively. Skin prick test
was performed with an ALK-Abello
extract (Denmark).
Results: Specific IgE to Can f 1 was found
in 66% (115) of patients, followed by Can
f 5 in 33% (57), Can f 2 in 18% (31) and
Can f 3 in 9.3% (16). Of note, a consider-
able amount of patients were monosensi-
tised to Can f 5 (15% n = 26). The wheal
diameters of skin test with commercial
extract of dog were smaller in patients
monosensitised to Can f 5. From a clinical
point of view, most patients sensitised to
any dog allergens referred symptoms when
exposing to dogs.
Conclusion: In this study we show different
pattern of sensitisation to dog allergens
that are commercially available. Interest-
ingly, a high prevalence of monosensitisa-
tion to Can f 5 was demonstrated. Can f 5
is an arginine esterase or prostatic kallik-
rein that is found only in male dogs. This
finding could be of clinical interest because
may explain differences in development of
symptoms when exposed to male or female
dogs. Further studies are necessary to
establish if different patterns of sensitisat-
ion to dog allergens may have clinical con-
sequences and response to immunotherapy.
796
Use of recombinant hymenoptera venom
molecular allergen for specific IgE
detection
Chuang, T1; Bogdanovic, J1; Bocsusis, N1; Ruivo, J1;
Kubota, H1; Sinha, S1; Jaggi, K1; Timmons, M1; Hovan-
ec-Burns, D1
1Siemens Healthcare Diagnostics Inc., Tarrytown, NY,
United States
Background: IgE-mediated allergic reac-
tions to insect venoms from the order
Hymenoptera presents a serious anaphylac-
tic risk for sensitised individuals. Studies
using major and minor Hymenoptera aller-
gens have been limited due to the number
of component allergens available for analy-
sis of specific IgE to both honey bee
venom (HBV) and yellow jacket venom
(YJV). In this study, we measure the aller-
gen specific IgE profiles of suspected
Hymenoptera allergic individuals using the
following recombinant and synthetic com-
ponents from HBV and YJV: phospholi-
pase A2 (rApi m 1*), hyaluronidase (rApi
m 2*), acid phosphatase (rApi m 3*), me-
littin (sApi m 4*), phospholipase A1B (rVes
v 1*), and antigen 5 (rVes v 5*).
Methods: rApi m 1, rApi m 2, rApi m 3,
rVes v 1, and rVes v 5 allergenic proteins
were expressed in Sf9 insect cells, purified,
and conjugated to biotin. Biotinylated sApi
m 4 peptide was prepared using a peptide
synthesiser. Sera from 18 subjects with a
clinical history of venom allergy or known
specific IgE reactivity to whole extract
HBV or YJV allergens were tested for IgE
to the component venom allergens using
the IMMULITE 2000 3gAllergyTM Spe-
cific IgE assay. Assessment of the specific-
ity of reactivity to HBV and YJV
component reagents was determined by
inhibition testing.
Results: Out of the 18 samples examined,
10 demonstrated IgE sensitivity to both
HBV and YJV whole extracts. Three of the
10 double sensitised samples showed non-
detectable (ND) IgE results to rVes v 1
and rVes v 5. On further examination of
the 3 ND samples, 2 were found reactive
to rApi m 2 while the third had low spe-
cific IgE to YJV extract (0.29 kU/l). All
reactivity to HBV and YJV component
allergens was confirmed by >70% signal
inhibition in the presence of homologous
inhibitors.
Conclusions: Detailed examination using
HBV and YJV components allergens gives
more information to help distinguish cross
reactivity or true IgE sensitisation when
results are confounded by clinical history
or double sensitivity to whole extracts.
*For Research Use Only. Not for use in
diagnostic procedures.
797
Correlation between specific IgE to single
allergen components of timothy pollen
and clinical expression of allergy to grass
pollen
Savi, E1; Peveri, S1; Dell’Albani, I2; Incorvaia, C3; Frati,
F2
1Allergology Department, G. Da Saliceto Hospital,
AUSL Piacenza, Piacenza, Italy; 2Medical and Scientific
Department, Stallergenes Italy srl, Milan, Italy; 3Allergy/
Pulmonary Rehabilitation Unit, ICP Hospital, Milan, Italy
Background: The currently available com-
ponent resolved diagnosis (CRD) allows to
measure the specific IgE (sIgE) to the sin-
gle components of an allergen source. We
evaluated the possible correlation between
the level of sIgE to the different compo-
nents of timothy grass (Phleum pratense)
and the clinical data of respiratory allergy
to grass pollen.
Method: One hundred forty patients with
grass pollen allergy were included in the
study. All patients were clinically classified
according to ARIA guidelines for allergic
rhinitis (AR) and to presence or absence of
asthma. SIgE to Phl p 1, Phl p 5, Phl p 7,
and Phl p 12 from P. pratense were mea-
sured by CAP System Thermofisher. The
correlation between the ARIA stage of AR
and the presence of asthma was analyzed
by the Spearman Rank test; the correlation
between the clinical data and the levels of
sIgE to single allergen components was
analyzed by multivariate logistic regression
concerning IgE and ARIA stage, while uni-
variate logistic regression was used for IgE
and asthma due to the dichotomic classifi-
cation of asthma as present or absent.
Results: Clinically, 10 patients had inter-
mittent AR, 48 had mild persistent AR,
and 82 had moderate-severe persistent AR.
Asthma was present in 86 patients and
absent in 54. The correlation was signifi-
cant (P < 0.01) for moderate-severe persis-
tent AR and presence of asthma. The
mean level (SD) of sIgE to the single aller-
gen components were 23.41 (29.46) kU/l
for Phl p 1, 16.04 (25.57) for Phl p 5, 0.55
(2.42) for Phl p 7, and 3.04 (8.46) for Phl p
12. The only significant correlation was
found for low values of sIgE to Phl p 5
and absence of asthma (P < 0.01).
Conclusion: These findings confirm the
clinical association between more severe
AR and occurrence of asthma. No correla-
tion was found between sIgE levels to sin-
gle allergen components and ARIA stage
of AR, while the significant correlation
between absence of asthma and low values
of sIgE to Phl p 5 suggests a possible use
as surrogate marker of this parameter.
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Allergenic molecules as markers in
epidemiology – Italy macro-regional
prevalence
Mari, A1; Zuzzi, S1; Santoro, M1; Ferrara, R1; Bernardi,
ML1; Zennaro, D1; Alessandri, C1; Dell’Albani, I2;
Palazzo, P1; Rafaiani, C1; Incorvaia, C3; Frati, F2
1Center for Molecular Allergology, IDI-IRCCS, Rome,
Italy; 2Medical and Scientific Department, Stallergenes
Italy srl, Milan, Italy; 3Allergy/Pulmonary Rehabilitation
Unit, ICP Hospital, Milan, Italy
Background: Current epidemiology of
allergic sensitisation to inhalants is still
based on the use of allergenic extracts by
mean of skin testing or singleplex IgE
detection.
The recent introduction of both aller-
genic molecule preparations and the micro-
array technology allows us to undergo
multiplex testing of each patient, using
allergens as markers, and performing the
testing in a routine fashion.
The aim of this preliminary study was to
show how the above reported combination
supported by an innovative information
technology infrastructure (based on the Al-
lergome platform) might set an innovative
manner of studying allergic sensitisation
epidemiology.
Method: All patients referred to the Center
for Molecular Allergology, IDI-IRCCS,
Rome, Italy, were tested using the ISAC
microarray starting in 2006 up to 2012.
Several versions of the ISAC have been
used, bearing an increasing number of mol-
ecules from 76 to 112. Demographical and
clinical data were collected during the first
consult by a certified allergist.
Results: Collected data have been divided
according to 5 Italian macro-regions
(north-western, north-eastern, center,
southern, islands). Depending on the aller-
gen marker considered, tested subjects ran-
ged from 30,550 (Phl p 4) to 58,033 (Bet v
1, Phl p 1). The Italian distribution of IgE
sensitisation profiles towards the 10 main
major allergens greatly varies from north
to south. The most prevalent IgE sensitisa-
tions are: vs Amb a 1 (15.6%) and Bet v 1
(25.8%) in north-western; vs Bet v 1
(17.3%) in north-eastern; vs Cup a 1
(27.9%) in center; vs Cup a 1 (21.3%), Ole
e 1 (15.8%) and Par j 2 (20.7%) in south-
ern; vs Ole e 1 (17.3%) and Par j 2
(20.4%) in islands. The distribution of IgE
sensitisation vs Phl p 1-p 5, Der p 1, Der f
1, Der p 2, Der f 2, Can f 1, Fel d 1 e Alt
a 1 is similar throughout the country.
Conclusion: Current epidemiology of aller-
gic sensitisation is facing a new ‘molecular
era’ which might lead to a detailed allergy
‘geography’. Italy is characterised by a
different distribution of IgE sensitisation
profiles vs allergenic molecules, contribut-
ing to a global molecular vision of allergic
sensitisation.
799
Simultaneous detection of total and
allergen-specific immunoglobulin-E in
human plasma using multiplex array
technology
Lohman, MJ1; Chapman, MD1; King, EM1
1Indoor Biotechnologies, Inc., Charlottesville, VA,
United States
Background: Methods used for quantita-
tive measurement of immunoglobulin (Ig)-
E in human serum or plasma such as
ELISA or FEIA analyze one analyte per
test, requiring a large sample volume for
multiple analyses. Chip-based technology
provides semi-quantitative results for fixed
selection of multiple analytes. The aim of
this study was to develop a flexible, quanti-
tative multiplex array for total and specific
IgE that simultaneously detects multiple
analytes. The array was validated by com-
paring results with streptavidin-Immuno-
CAP.
Method: IgE concentration in human
plasma was detected using fluorescent
microspheres covalently coupled to anti-
bodies that were saturated with purified
allergens. Human plasma samples (n = 79)
were analyzed by 12-plex array and using
purified allergen-specific streptavidin-Im-
munoCAP to determine total IgE as well
as IgE specific to Der p 1, Der f 1, Der p
2, Der f 2, Fel d 1, Can f 1, Mus m 1, Rat
n 1, Bet v 1, Phl p 5, and Alt a 1. Perfor-
mance criteria and reproducibility of the
multiplex array as well as inter-method
concordance were evaluated.
Results: IgE measurements by 12-plex
array were reproducible both within and
between assays: mean coefficients of vari-
ance (CV%) were 16.1% for intra-assay
triplicates, and 12.6% for triplicate inter-
assay analysis. The array demonstrated
good parallelism between serial dilutions
within the dynamic range (CV = 27.6%).
Results obtained by multiplex array versus
streptavidin-ImmunoCAP correlated clo-
sely (mean r = 0.83, P < 0.001), with a
mean CV of 43.1%, and a concordance of
74.0%. The total sample volume required
for the 12-plex test was 30 ll compared to
700 ll required for ImmunoCAP.
Conclusion: The multiplex array provides
reproducible quantitative total and aller-
gen-specific IgE measurements in human
serum or plasma, while using only a frac-
tion of the sample volume required in
other quantitative methods. Our results
suggest that fluorescent multiplex technol-
ogy may facilitate future studies of allergic
sensitisation. The multiplex platform can
be adapted to include additional allergens
and for measurement of IgE antibodies in
animal models.
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Highlighting potential targets of house
dust mite allergenic proteases
Campisi, V1,2; Herman, J1; Bouaziz, A1; Chevigne, A2;
Galleni, M1; Dumez,ME1
1Laboratory of Biological Macromolecules, Center for
Protein Engineering, University of Liege, Liege,
Belgium; 2Laboratory of Retrovirology, Public Research
Center for Health, Strassen, Luxembourg
Background: The three allergenic proteases
Der p 1 (a papain-like cysteine protease),
Der p 3 and Der p 6 (serine proteases from
the trypsin-like and the chymotrypsin-like
family respectively) are secreted from the
Dermatophagoides pteronyssinus house dust
mite (HDM) specie. Their proteolytic
activities represent adjuvant factors of the
HDM-induced allergy pathogenesis, mainly
through the cleavage of cell surface pro-
teins which are directly involved in the out-
break and the chronicity of the allergic
response.
Method: The interplay between a prote-
ase and its substrates is controlled in var-
ious ways, including the substrate
recognition by the catalytic cleft. A good
understanding of a protease specificity
could be useful to identify its putative
relevant human targets. We choose to
characterise the extended substrate speci-
ficities of Der p 1, Der p 3 and Der p 6
using the ‘substrate phage display’ tech-
nology in order to predict in silico their
targets that would play a potential role
in allergy and inflammation.
Results: We engineered three phage dis-
play libraries in the fd-Tet-DOG phage,
namely ‘NNK’, ‘ARG’ and ‘TWT’. In
these libraries, phage particles express ran-
dom nonapeptides (positions P5-P4’ totally
randomised in the ‘NNK’ library) or par-
tially random nonapeptides (position P1
restricted to a Lys or Arg residue in the
‘ARG’ library and to a Phe or Tyr residue
in the ‘TWT’ library) which are in fusion
with their surface exposed plll protein. A
simple screening protocol providing good
enrichment rates was established. Three
rounds of selection using the proteases
were performed. It allowed us to highlight
their different cleavage patterns and to
build their specificity models. These models
were then introduced into the Prediction of
Protease Specificity (PoPS) bioinfomatic
tool in order to predict the potential sub-
strates of Der p 1, Der p 3 or Der p 6 in
the human proteome.
Conclusion: Among these substrates, we
have highlighted new potential targets
which are manly cellular receptors. We are
now trying to classify them by phage
ELISA in order to select the best sub-
strates of the HDM proteases for further
studies. This could help us to characterise
the adjuvant role of allergenic proteases in
the HDM-induced allergy pathogenesis.
802
New allergens involved in shrimp-mite
cross reactivity
Gamez, C1,2; Mazzeo, C1,2; del Pozo, V1,2; Boquete, M3;
Sastre, J2,4
1Immuno-allergy, IIS-Fundacion Jimenez Dıaz, Madrid,
Spain; 2CIBER de Enfermedades Respiratorias, Palma
de Mallorca, Spain; 3Allergy, Hospital General de Calde,
Lugo, Spain; 4Allergy, IIS-Fundacion Jimenez Dıaz,
Madrid, Spain
Background: Tropomyosin is the major
allergen described in seafood-arthropods
cross-reactivity. Other allergens implicated
in this cross-reactivity remain unknown.
We sought to identify new allergens from
Solenocera melantho shrimp and which of
them are involved in shrimp-mite cross-
reactivity.
Method: Thirty-six patients from a dry city
with continental climate (Madrid) and 37
patients from the coast (Lugo) were stud-
ied. The allergenic profiles to S. melantho,
and to Dermatophagoides pteronyssinus
were analyzed by immunoblotting. The
most prominent IgE binding proteins were
analyzed by mass spectrometry. Also, inhi-
bition assays were performed.
Results: The patients were classified in 2
groups: mite-seafood (MS) and seafood (S)
allergic patients according to the clinical
symptoms, skin prick tests and specific
IgE. The patients IgE reactivity pattern (al-
lergogram) to S. melantho extract showed
prominent bands that were analyzed by
mass spectrometry. Tropomyosin, arginine
kinase, sarcoplasmic calcium binding pro-
tein and new allergenic proteins like a-
Actinin (~ 99 kDa), b-Actin (~ 47 kDa),
Fructose biphosphate aldolase (~ 45 kDa)
and Ubiquitin (~ 5 kDa) were identified.
When we compared S. melantho to D.
pteronyssinus allergograms, several differ-
ences between MS and S groups were
found.
Interestingly, a-Actinin and Ubiquitin
were recognised by both populations and
in both extracts, suggesting that these pro-
teins could be allergens implicated in mite-
shrimp cross-reactivity. This data were
confirmed by inhibition immunoblottings.
Conclusion: We have identified several new
shrimp allergens: b-Actin, Fructose biphos-
phate aldolase, a-Actinin and Ubiquitin.
Among these allergens, a-Actinin and
Ubiquitin could be implicated in shrimp-
mite cross-reactivity.
803
Reduction of the enzymatic activity in
pollen native allergenic extracts after
depigmentation and polymerization
Leonor, JR1; Morales, M1; Iraola, V1; Lopez-Matas, MA1;
Gallego, MT1; Carnes, J1
1Laboratorios LETI, R & D, Tres Cantos, Spain
Background: The presence of different
enzymes in allergenic extracts, including
pollen, is important from two points of
view. First the enzymatic activity plays a
role in the pathogenesis of allergy; and the
second point is the influence of these
enzymes in the stability of the extracts. It
has been demonstrated that Depigmented-
polymerized (Dpg-Pol) extracts have a
reduced enzymatic activity compared to
their respective native extracts in mites, but
there is little information regarding pollen.
The objectives of this study were to cha-
racterise, and to compare the enzymatic
activity of both type of extracts from dif-
ferent pollen extracts.
Method: Native and their corresponding
Dpg-Pol extracts of pollen of five grass
species (Dactylis glomerata, Festuca elatior,
Lolium perenne, Phleum pratense, and Poa
pratensis), one weed (Salsola kali) and one
tree species (Olea europaea) were manufac-
tured, and characterised by Lowry and
SDS. The gelatinolytic activity was deter-
mined by Gelatin zymography in reducing
and non-reducing conditions, the Cysteine
protease activity by using the L-1460 pep-
tide (Pyr-Phe-Leu-pNa) as substrate and
papain as the standard, and 19 different
enzymatic activities by the Api-Zym sys-
tem.
314 © 2013 The Authors
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Results: Gelatinolitic activity was detected
in non-reducing conditions in native
extracts from all species (except for S. kali)
mainly around 45, 65 and above 100 kDa
bands, but it was not detected in their cor-
responding Dpg-Pol extracts. Similarly,
cysteine protease and most of the enzy-
matic activities detected by Api-Zym in
native extracts from all species, were inacti-
vated almost totally in the Dpg-Pol
extracts.
Conclusion: In native pollen extracts from
different species diverse enzymes are pres-
ent, including proteases. The depigmenta-
tion-polymerization of the pollen extracts
eliminates most of the enzymatic activity,
suggesting a higher safety and stability in
these chemically modified extracts.
804
Induction of Th2 cytokines by the
cysteine protease allergen Der f 1 from
murine basophils via G-protein coupled
receptor dependent pathways
Yi,M-H1; Jeong, KY2; Kim,HP1; Kim, TY1; Kim,CR1;
Yong,TS1
1Environmental Medical Biology, Institute of Tropical
Medicine, Arthropods of Medical Importance Resource
Bank, Yonsei University College of Medicine, Seoul,
Korea; 2Department of Internal Medicine, Institute of
Allergy, Yonsei University College of Medicine, Seoul,
Korea
Background: Der f 1, a major allergen of
house dust mite, is a member of papain-
like cysteine protease family whose proteo-
lytic activity can provoke Th2 immune
response. However, the innate immune rec-
ognition mechanisms and immune cells
associated with the initiation of Th2
responses have not been investigated in
detail. The objective of this study is to
evaluate the effect of G-protein coupled
receptors (GPCRs) on mouse bone mar-
row-derived basophils (BMBs) by the stim-
ulation of cysteine protease allergen, Der f
1.
Method: Mouse bone marrow-derived ba-
sophils were stimulated with proteolytically
active recombinant Der f 1 (rDer f 1)
expressed in the yeast Pichia pastoris. Then
the expressions of Th2 cytokines, IL-4 and
IL-13 were examined by real time PCR
and ELISA.
Results: Transcription of both IL-4 and
IL-13 in mouse basophils was induced by
the treatment of rDer f 1 with a cysteine
protease activity assessed by real time
PCR, whereas inactive rDer f 1 did not.
Proteolytically active rDer f 1 induced pro-
duction of IL-4 and IL-13 from basophils
as measured by ELISA, while heat-treated
rDer f 1 did not able to induce cytokine
productions. However, Der f 1-induced IL-
4 and 13 secretion in mouse basophils were
dramatically inhibited by the treatment of
GPCR with Pertussis toxin .
Conclusion: These findings suggest that
GPCRs are involved in secretion of TH2
cytokine such as IL-4 and IL-13 by cyste-
ine protease activity of Der f 1.
805
A preliminary proposal for the clustering
of olive pollens into model cultivars on
the basis of their allergenic content
Marco, FM1; Morales, S2; Castro, AJ2; Salmeron, C2;
Rodrıguez-Garcıa, MI2; Alche, JDD2
1INMUNAL SAU, R&D, Alcala de Henares, Spain;
2Department of Biochemistry, Cell and Molecular
Biology of Plants, Estacion Experimental del Zaidın,
Spanish National Research Council (CSIC), Granada,
Spain
Background: Olive pollen (Olea europaea
-OE-) is a major cause of respiratory
allergy among Mediterranean countries
and elsewhere in the world. Olive germ-
plasm is exceptionally wide, with more
than 250 cultivars only in Spain. Impor-
tant allergenic differences have been
recognised among pollen from different
cultivars, involving most relevant aller-
gens like Ole e 1. These differences may
influence the clinical performance of OE
extracts depending on the sensitivity of
individual patients to specific allergens,
hence cultivar origin should be taken into
account in the manufacture of allergen
extracts. As handling and characterisation
of a large number of cultivar extracts is
impracticable under industrial and clinical
standards, the present work intends to
define a limited number of cultivar mod-
els, characterised by distinctive pollen
allergen profiles.
Method: The Ole e 1, Ole e 2, Ole e 5 and
Ole e 9 content was analyzed using specific
antibodies in OE extracts prepared from
pollen of ten olive cultivars: ′Picual′, ′Man-
zanilla′, ′Arbequina′, ′Blanqueta′, ′Cornic-
abra′, ′Verdial′, ′Lechın′, ′Hojiblanca′, ′
Lucio′ and ′Loaime′. Allergen semi-quanti-
zation was performed by SDS-PAGE and
immunoblotting densitometry (Quantity
One, Bio-Rad Laboratories), normalizing
data for each allergen against the cultivar
with the higher concentration. Threshold
percentages were defined in order to cha-
racterise individual levels of an allergen for
each cultivar as low, average and high.
Results: Levels of Ole e 2 and Ole e 5 were
not informative. Based on Ole e 1 and Ole
e 9 expression cultivars could be grouped
in three categories:
High Ole e 1; high Ole e 9: ′Hojiblanca
′; ′Loaime′
High Ole e 1; low Ole e 9: ′Picual′; ′
Manzanilla′, ′Lucio′, ′Cornicabra′, ′
Lechın′, ′Blanqueta′
Low Ole e 1; low Ole e 9: ′Arbequina′; ′
Verdial′
Conclusion: In this study we have defined
a strategy for grouping of OE cultivars
on the basis of differences in relevant
allergen expression. This could add speci-
ficity to the use of OE extracts in diag-
nosis and therapy. This preliminary
proposal should be implemented by fur-
ther analyzing additional olive pollen
allergens and other relevant cultivars, and




contributes to Act d 2 allergenicity
Gomez-Casado, C1; Palacın, A1; Tordesillas, L1; Garrido,
M1; Blanca, N2; Blanco, C3; Cuesta-Herranz, J4;
Sanchez-Monge, R1; Dıaz-Perales, A1
1Centre for Plant Biotechnology and Genomics
(Technical University Madrid), Pozuelo de Alarcon,
Madrid, Spain; 2Allergy Service, Hospital Infanta
Leonor, Madrid, Spain; 3Allergy Service, University
Hospital La Princesa, Madrid, Spain; 4IIS-Allergy
Service, Jimenez Dıaz Foundation, Madrid, Spain
Background: Allergens are responsible for
the Th2 response in patients as part of
complex mixtures of proteins, fatty acids
and other molecules. Plant allergens have
hitherto been included in several protein
families that share no common biochemical
features. Their physical, biochemical and
immunological characteristics have been
widely studied, but no definite conclusion
has been reached about what makes a pro-
tein an allergen. N-glycosylation is charac-
teristic of plant allergen sources but is not
present in mammals.
Methods: In this work, we report the isola-
tion of the protein fraction (by chemical
deglycosylation) and the N-glycan fraction
(by extended treatment with proteinase K)
of the major kiwifruit allergen, the thaum-
atin-like protein (TLP) Act d 2 and cha-
racterise their allergenic role.
Results: The comparison of the allergenic
activity in vitro (ELISA) and ex vivo
(basophil activation test), as well as the
ability to activate cells from the immune
system (as measured by T lymphocyte acti-
vation assays and monocyte derived den-
dritic cell maturation assays) have
demonstrated the existence of IgE epitopes
in the sugar moiety and their importance
in recognition by antigen-presenting cells,
inducing the maturation of these cells.
Conclusion: The sugar moiety of some
plant allergens is also involved in inducing
Th2 sensitisation, although the protein
fraction is necessary to maintain it over
time. These findings could influence the
development of new strategies for allergy
immunotherapy.
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Immunological and proteomics study to
identify allergens from date palm
(Phoenix sylvestris) pollen
Saha, B1; Pandey, N2; Bhattacharya, SG1
1Division of Plant Biology, Bose Institute, Kolkata, India;
2Allergy and Asthma, MP Birla Research Centre,
Kolkata, West Bengal, Kolkata, India
Background: Allergy to pollen grains has
been well document. Date palm (Phoenix
sylvestris) trees are found in large quanti-
ties in and around Kolkata, India. Apart
from its fruit being used as a food and del-
icacies its pollen grain is reported to be
highly allergenic though not much has
been researched on it. Allergy clinics in
Kolkata receive a substantial number of
patients who are tested to be severely aller-
gic to this pollen. An immunoproteomics
approach has been employed to identify
IgE reactive proteins from this pollen.
Method: The pollen grains were isolated
by passing flower through mesh of differ-
ent sizes. A crude pollen protein extract in
phosphate buffer is prepared which is fur-
ther purified by salting out and G25 Col-
umn elution. IgE specific ELISA and
western blotting with patient specific sera
from 10 patients was done. Alongside total
protein was profiled on a 2D gel electro-
phoresis using 3–10 as well as 4–7 PI
range. Immunoblotting was performed to
specifically detect IgE reactive protein
spots. Mass spectrometry employing
MALDI TOF/TOF was used to identify
the allergenic spots. Biochemical tech-
niques like glycoprotein staining and perio-
date modification was carried out. In silico
allergenicity prediction was also done with
the identified proteins.
Result: Clinical data of 10 patients selected
for study showed high specific IgE titer,
SPT of +2 and +3 with the pollen extract.
Western blotting confirmed the presence of
numerous allergenic bands differentially
expressed with patient sera. Two bands of
62 Kd and 29 Kd was found to be domi-
nant in all. 2D gel with coomassie staining
showed an average of 85 and 154 protein
spots in 3–10 and 4–7(PI) respectively.
Western blotting proved presence of 8 (3–
10) and 15(4–7) IgE reactive proteins with
three overlapping spots. No reactive spots
were present in control sera. Mass spec-
trometry identified the protein spots and
was validated by in silico allergenicity pre-
diction tools. One of the dominant proteins
was identified to be pectin esterase. Four
allergic spots were found to be glycopro-
tein in nature and their glyco moeity was
found to be necessary for allergenicity.
Conclusion: Phoenix sylvestris is an impor-
tant aeroallergen causing severe allergic
rhinitis in a susceptible population in
India. The 62 Kd and 29 Kd is the major
allergen. Mass spectrometry identified the
62 Kd allergen as pectin esterase. All the
identified proteins are validated as potent
allergens by predicting softwares.
808
Relevant allergens across species –
similarities and differences
Swan, NJ1; Hutchings, JW1; Newland, BJ1; Mwange,
JD1; Hewings, SJ1; Bullimore, AD1; Skinner, MA1
1Allergy Therapeutics, R&D, Worthing, United Kingdom
Background: Allergens can be categorised
into homologous groups, however the
method of grouping can be performed in a
number of different ways.
Methods: A selection of diagnostic prod-
ucts were investigated using SDS-PAGE,
trypsin digestion and mass spectroscopy.
The peptide fragments were then searched
against well-established protein databases
through MASCOT in order to confirm the
presence of proteins and allergens. The pro-
teins and allergens that were found within
the products were then analysed to find sim-
ilarities and differences between the selected
products. The proteins and allergens were
analysed through taxonomic grouping,
function and where possible structure.
Results: All of the samples returned good
matches to proteins or allergens within the
database, with >20% sequence coverage
and high peptide and protein scores
according to MASCOT. It was possible to
group proteins and allergens into various
different categories; this resulted in some
unexpected similarity between species and
highlighted the differences between prod-
ucts and allergens. For products where
there are no sequenced allergens, some of
the proteins fell into categories with known
allergens. Indicating that they shared a
common property, depending on the num-
ber and type of shared properties an
insight was provided for the characteristics
of the protein and its potential for further
investigation.
The categories allowed a different per-
spective for grouping allergens and show
what properties are widespread and not so
common between allergens of different spe-
cies. This method of analysing and catego-
rising has provided more characterisation
information on the grouping of allergens
and offers indirect data for allergens that
may have not previously been extensively
studied.
Conclusion: Through looking at grouping
of allergens in a different way, new investi-
gatory allergen targets have been found.
Re-grouping allergens according to a vari-
ety of different properties has led to a




heterogeneity of biological profile of
grasses within the family of sweet
grasses and improved patient relevance
of grass mix products
Bullimore, AD1; Batten, TN1; Skinner, MA1
1Allergy Therapeutics, R&D, Worthing, United Kingdom
Background: Biochemical profiles of multi-
ple grass species commonly found across
Europe have been assessed to identify the
advantages of multiple grasses in broad
spectrum grass immunotherapy. The bene-
fits for inclusion of multiple grasses in
immunotherapy and potential limitations
of Timothy grass exemplar therapy have
also been identified by selectively blocking
specific grass reactivities within patient
serum.
Methods: A number of biochemical meth-
ods have been used to assess key parame-
ters relating to similarities and differences
in allergens from multiple grass species.
Each grass was analysed for major aller-
gen, IgG and IgE reactivity by inhibition
ELISA and total protein content. Using
sera from grass sensitive patients we have
selectively blocked reactivity to specific
grass allergens. This assay platform
allowed us to distinguish whether there
were any allergens in other grasses which
were not cross-reactive with timothy grass
exemplar allergens.
Results: Each of the grass species investi-
gated is distinct in having a unique allergen
fingerprint and biochemical profile as
determined by radar graph. This suggests
therapy composed of a mix of grasses
potentially contributes protection to a
more diverse grass sensitive population.
Selective blocking of specific grass reactivi-
ties within patient serum showed that the
majority of patients demonstrated reactiv-
ity to multiple grass allergens which were
not present in timothy grass exemplar
allergen extracts.
Conclusion: The biochemical and serologi-
cal attributes of specific grass allergen reac-
tivity support inclusion of multiple grasses
for use in broad spectrum grass allergy
immunotherapy.
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Growth characteristics and major
allergen (Blo t 5) content of custom
manufactured and commercially available
Blomia tropicalis mite cultures
Ardusso, L1; Maspero, J2; Bullimore, AD3; Skinner, MA3
1Allergy and Immunology Department, Rosario School
of Medicine, Rosario, Argentina; 2Fundacion CIDEA,
Buenos Aires, Argentina; 3Allergy Therapeutics, R&D,
Worthing, United Kingdom
Background: Blomia tropicalis (Bt) is
highly prevalent in Latin America and
therefore incidences of allergy are high.
However, obtaining sufficiently potent
allergen extracts can be difficult due to the
potency and major allergen content being
influenced by culture techniques and
growth media. It is common that yeast is
thought to be necessary in order to obtain
highly populated cultures, however it is
undesirable to include yeast grown mites in
an immunotherapy. In this work we
describe three different cultures grown with
different media and the results obtained
from the characterisation of these cultures
and the resulting extracts in terms of the
content of major allergen Blo t 5.
Methods: Two cultures were manufactured
simultaneously; one grown on fish food
with added yeast and the other with desic-
cated Porcine liver with no yeast. Once the
crop reached the final phase of develop-
ment, the culture was frozen at 20°C to
kill the mites. Thereafter the culture was
passed through graded sieves with different
pore sizes.
The mites were separated from faecal
matter and remaining culture media and
desiccated for 2 weeks. These two cultures
were compared against a commercially
available B. tropicalis culture for Blo t 5
content via identically produced extrac-
tions.
Results: Blo t 5 content varied across cul-
ture type. The commercially available
extract contained less than half the Blo t 5
of the culture grown on Fish food with
yeast supplements and more than four-
times less than the culture grown on desic-
cated Porcine liver (26307.3 ng, 70705.5 ng
and 148885.7 ng respectively).
Conclusions: It is possible to grow B. tropi-
calis cultures without yeast supplementa-
tion on desiccated Porcine liver and
achieve higher concentrations of Blo t 5
than when grown on yeast supplemented
media.
811
Determination of HDM group 1 and 2
isoforms using different antibody based
assays
€Osterberg, M1; Skydtsgaard, MB2; Christensen, LH2;
Hansen, GN2; Larsen, G2; Andersen, LB2; Bergmann, K2;
Lund, L2; Henmar, H2
1ALK-Abello, Hørsholm, Denmark; 2CMC Research, ALK-
Abello, Hørsholm, Denmark
Background: Major allergens are often
quantified by assays using antibodies, how-
ever as allergens often exists as different
isoforms, parts of these allergens may not
be quantified, as the antibodies may not
bind to all isoforms. In these experiments
we have investigated several antibodies
capability of binding to different isoforms
of group 1 and 2, in Dermatophagoides
pteronyssinus and Dermatophagoides farinae
extract.
Method: Mite extract were subjected to
Iso Electric Focusing (IEF) by using an
Offgel Fractionator to separate the iso-
forms. The instrument only separate with
regard to pH, therefore we can only con-
clude on mutations which do have an
effect on the pH. These fractions were
analysed in rocket immuno electrophoresis
using both poly and monospecific poly-
clonal antibodies (pAbs), and in specific
ELISA assay and Biacore using monoclo-
nal antibodies (mAbs). Finally the isoform
variation of group 1 and 2 in the fractions
were explored by Mass spectrometry (MS).
Results: From the IEF of the two extracts,
we were able to define the fractions where
either group 1 or 2 were present using a
polyclonal antibody raised towards the
whole extract. This result was compared
with the specific allergen ELISA results
and Biacore data using mAbs. From these
data we can conclude, that some mAbs can
bind to a similar spectre of isoforms as the
pAb. Further similar ratio between the dif-
ferent isoforms was detected with both
pAbs and mAbs. MS analysis identified the
fractions containing group 1 or 2 and this
correlated well with the findings in the
antibody based assays.
Conclusion: We were able to identify, that
the monoclonal antibody tested could iden-
tify the same range of isoforms as the poly-
clonal antibody. Further the pAb and
mAbs assays correlated well with regard to
level of these isoforms.
812
Immunological characterisation of the
bacterial Bet v 1 homologues from
Thermus thermophilus and
Streptococcus mutans
Ackerbauer, D1; Smole, U2; Gepp, B1; Breiteneder, H1
1Department of Pathophysiology and Allergy Research,
Medical University of Vienna, Vienna, Austria; 2Johns
Hopkins Bloomberg School of Public Health, Baltimore,
MD, United States
Background: The major birch pollen aller-
gen Bet v 1 is a member of the pathogene-
sis related protein family 10. The structures
of Bet v 1 and the bacterial homologues
from Thermus thermophilus, a gram-nega-
tive thermophilic bacterium, and Strepto-
coccus mutans are closely related although
they possess only low sequence similarity.
S. mutans is a gram-positive oral bacterial
pathogen whereas exposition to T. thermo-
philus is highly unlikely. The aim of this
study was to produce and characterise the
Bet v 1-related proteins SMU.440 (PDB
3IJT) of S. mutans and TTHA0849 (PDB
2D4R) of T. thermophilus and to elucidate
a possible link between antibody responses
to Bet v 1 and its bacterial homologues.
Method: The proteins SMU.440 and
TTHA0849 were expressed in E. coli BL21
(DE3) cells. After cell lysis by French Pres-
sure Cell Press and ammonium sulfate pre-
cipitation, the proteins were purified by
consecutive hydrophobic interaction, anion
exchange and gel filtration chromatogra-
phy. The secondary structures of the pro-
teins were evaluated by circular dichroism
(CD) spectroscopy. The purified proteins
were tested for their IgE, IgG, IgG4 and
IgA reactivity in direct ELISA using the
sera of birch pollen, house dust mite and
grass pollen allergic patients as well as nor-
mal human sera (NHS).
Results: The purified SMU.440 and
TTHA0849 were detected as single 16 kDa
and 17 kDa protein bands in SDS-PAGE,
respectively. The bacterial homologues
showed secondary structures in CD spec-
troscopy similar to recombinant Bet v 1.
Neither SMU.440 nor TTHA0849 showed
IgE reactivity with sera of 16 birch pollen
allergic patients. Interestingly, IgG and
IgG4 specific for SMU.440 and TTHA0849
could be detected in sera of birch pollen,
house dust mite and grass pollen allergic
patients as well as in NHS. SMU.440 also
showed IgA binding.
Conclusion: In this work, supported by
grant SFB-F4608 from the Austrian Sci-
ence Fund, we obtained first insights into
the immunological properties of the bacte-
rial Bet v 1 homologues SMU.440 and
TTHA0849.
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Purification and characterisation of the
major allergens from house dust mite
€Osterberg, M1; Friberg, L2; Hansen, GN2; Amondsen, P2;
Giselsson, A2; Christensen, LH2; Henmar, H2
1ALK-Abello, Hørsholm, Denmark; 2ALK-Abello, CMC
Research, Hørsholm, Denmark
Background: Inhalation allergy to house
dust mite is among the most prevalent
respiratory allergies worldwide. More than
20 allergen molecules have so far been
identified and characterised from house
dust mites. We have by conventional meth-
ods purified the major allergen, group 1
and 2, from Dermatophagoides pteronyssi-
nus (Der p) and farinae (Der f) and char-
acterised these allergens with respect to
purity, folding, isoform variation and mass
spectrometry (MS) analysis.
Method: Acetone precipitated mite culture
were used as starting material for the puri-
fication of the allergens. By a combination
of several different columns such as hydro-
phobic interaction, affinity (chelate) and
size exclusion we were able to purify the
major allergens. The purified allergens were
characterised by Crossed immuno electro-
phoresis (CIE), SDS-PAGE, Isoelectric
focusing (IEF), Circular Dichrosim (CD)
and MS.
Results: The major allergens (mix of iso-
forms) were visualised as one dominant
band in a SDS-PAGE and 1–2 more faint
bands. CIE showed only one distinct pre-
cipitate. All bands from SDS-PAGE were
identified as the respective major allergen
in MS analysis. CD analysis showed that
Der p 1 and Der f 1 had predominantly a-
helix structure, whereas group 2 allergens
showed a b-sheet structure. IEF of the
major allergens showed that group 1 iso-
forms are found from pI 4.9 to 7.3 and
group 2 isoforms from pI 5.9 to 8.3. Fur-
ther we found that the spectre of isoforms
were similar to the isoforms found in the
starting material.
Conclusion: It is possible from a mite
extract to purify the group 1 and 2 aller-
gens using conventional methods. The
purified allergens were identified by MS.
The major allergens from Der p and Der f
contained several isoforms, which could be
group by MS. It is important in quantifica-
tion assay to develop assays which can
quantify all isoforms.
814
German cockroach extract modulates
MMP-9 and tight junction integrity in
human airway epithelial cells
Lee, KE1; Hong, JY1; Kim, MN1; Heo, WI1; Kim, KW1;
Kim, KE1; Sohn, MH1
1Institute of Allergy, Biomedical Science Institute, Brain
Korea 21 Project for Medical Science, Yonsei University
College of Medicine, Pediatrics, Seoul, Korea
Background: Exposure and sensitisation to
cockroach allergens are associated with the
development of acute asthma morbidity.
Matrix metalloproteases (MMPs) have
been suggested to play an important role
in remodeling of the airways in disease.
However, the mechanism by which cock-
roach-driven MMP activity leads to
asthma pathogenesis and remodeling
remains unclear. Thus, we investigated
whether German cockroach extract can
directly trigger MMP-9 and the MMP-9
activation affects the change of tight junc-
tion protein integrity.
Method: In this study, MMP-9 protein
was measured by ELISA against human
MMP-9. Specific antibodies to tight junc-
tion proteins were used for Western blot-
ting. Pharmacological inhibitors for
protease from German cockroach and
MMP activity were incubated with cells
before German cockroach treatment.
Results: In human airway epithelial cells,
German cockroach extract increased
MMP-9 mRNA and protein depending on
time and dose. However, tissue inhibitor of
metalloprotease (TIMP1) expression was
not significantly detected. Moreover,
twenty four hours after German cockroach
extract treatment, tight junction proteins
such as ZO-1 and Occludin gradually
decreased on Western blotting analysis.
Pretreatment with either serine protease
inhibitor or Ro32-3555, a specific MMP
inhibitor significantly prevented the MMP-
9 protein production and the tight junction
protein decrease.
Conclusion: Taken together, these data
suggest that German cockroach extract
directly induces MMP-9 in human airway
epithelial cells and may contribute to dis-
ruption of epithelial barrier function.
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Evaluating the potential risk of allergy
from a new pest resistant genetically
modified soybean line
Lu, M1; Kong, XX2; Ladics, GS3; Goodman, RE1
1Food Allergy Research and Resource Program,
University of Nebraska-Lincoln, Lincoln, NE, United
States; 2Statistics, Pioneer Hi-Bred International,
Johnston, IA, United States; 3DuPont Experimental
Station, Regulatory Sciences, Wilmington, DE, United
States
Background: The Codex Alimentarius
Guideline (2003) for food safety assessment
of GM plants recommends evaluating
potential changes in endogenous allergen
expression if the plant is a common source
of food allergy. The European Food Safety
Authority (EFSA) now asks for direct
enzyme-linked immunosorbent assay
(ELISA) and both 1D and 2D immuno-
blotting using individual allergic sera for
IgE binding comparisons to evaluate
diverse epitope recognition. Because the
natural variability in the expression of
endogenous allergens between varieties is
unknown, a new pest-resistant genetically
modified (GM) soybean, a near-isogenic
line and five non-GM commercial lines of
soybeans grown in multiple geographical
regions were compared for IgE binding.
Method: Qualitative differences were eval-
uated from IgE binding to proteins sepa-
rated under reducing and non-reducing
1D-SDS-PAGE and 2D-IEF x SDS-
PAGE. Quantitative differences were com-
pared by direct ELISA. Eleven individual
soybean allergic sera and five non-soybean
allergic control sera were tested.
Results: Minor IgE binding differences
were observed between the GM and near-
isogenic soybeans as well as some commer-
cial lines for some subjects by immunoblot-
ting. The IgE binding measured by ELISA
was not statistically different between the
GM and near-isoline control soybeans and
was within the range of variation of the
other commercial soybeans lines with dif-
ferent genetic backgrounds.
Conclusion: The evidence suggests that this
GM soybean line does not present an
increased risk of allergy as the variation in
IgE binding was similar to commercial soy-
bean lines. More importantly, soybean
allergic consumers should avoid consump-
tion of foods containing any soybeans,
thus the relevance of the required testing is
not clear.
816
Comparison of two extensively
hydrolyzed formulas with probiotics for
the treatment of cow’s milk protein
allergy
Vandenplas, Y1; Steenhout, P2,3; Planoudis, Y3; Grat-
hwohl, D2,3; Hauser, B4; Althera Study Group (J. Chris-
tens, C. Halut, B. Hauser, T. Devreker, S. Mullier, P.
Mari€en, G. Veereman, K. Kamoen, S. Peeters, F. Smets,
F. Bury, M. Verghote, P. Bollen, O. Beauraind, P. Lenoir,
S. Colinet, M. Van Winckel)
1UZ Brussel, Pediatrics, Brussels, Belgium; 2Nestle
Nutrition, Vevey, Switzerland; 3Nestle Clinical
Development Unit, Lausanne, Switzerland; 4Althera
Study Group, Brussels, Belgium
Background: According to guidelines, the
recommended treatment of cow’s milk pro-
tein allergy (CMPA) is a strict elimination
diet with an extensive (cow’s milk based)
hydrolysate. Whether the best option is a
whey or a casein hydrolysate is a matter of
debate.
Methods: We compared the efficacy of an
extensive whey to that of an extensive
casein hydrolysate both enriched with (dif-
ferent) probiotic strains, in a double-blind,
randomised, trial. Efficacy was assessed
with a novel clinical score. The score
encompasses crying, regurgitation, stool
consistency, atopic eczema, urticaria and
respiratory symptoms. The score ranges
from 0 to 33. The primary hypothesis of
the trial was to show non-inferiority
between the whey and casein hydrolysate
in means of the score. The inclusion crite-
rion of the trial was a clinical suspicion of
CMPA because of a score ≥ 12. Specific
and total IgE and skin prick test (SPT)
were performed at baseline. The composi-
tion of the gastrointestinal flora was analy-
sed at baseline and after one month.
Results: One hundrand and sixteen infants
with a clinical score of ≥12 were included.
There was a statistical and clinical signifi-
cant decrease of the score during the first
month: 8.32 in the whey and 7.82 in
the casein hydrolysate group. The treat-
ment difference at one month was 0.879
(95% CI 2.79, 1.03), confirming that the
whey hydrolysate is non-inferior to the
casein hydrolysate. An open challenge was
performed in 85 (74%) infants and was
positive in 59/85 (69%); there were less late
reactions in the whey (8/41 (20%)) than in
the casein hydrolysate group (18/44 (41%),
P = 0.037). No significant differences were
found for total and specific IgE, and for
the SPTs. No significant differences were
found in the score-composing items: cry-
ing, regurgitation, stool consistency, atopic
eczema, urticaria, respiratory symptoms.
The whey hydrolysate, which was enriched
with bifidobacteria, did lead to more bifi-
dobacteria, enterobacteria and total bacte-
ria but to less lactobacilli. The casein
hydrolysate, which was enriched with lac-
tobacilli, resulted in higher lactobacilli lev-
els. The whey hydrolysate leads to better
growth (weight and weight for age z-
scores); the casein hydrolysate leads to
smaller head circumferences.
Conclusion: In daily practice, the clinical
score of ≥12 is a useful tool to select
infants with a high risk of IgE and non-
IgE mediated CMPA. The extensive whey
and casein hydrolysates are equally effec-
tive in the treatment of CMPA.
817
Clinical reactivity to baked milk (cake)
and products with pasteurised milk
(yoghurt, feta cheese) may determine
different phenotypes of cow’s milk
allergy
Arik Yilmaz, E1; Cavkaytar, O1; Buyuktiryaki, B1; Soyer,
OU1; Tuncer, A1; Sackesen, C1
1Department of Pediatric Allergy, Hacettepe University
Faculty of Medicine, Ankara, Turkey
Background: Prior studies determined that
thermal processing largely destroyed IgE
binding epitopes in milk allergic children.
Recently few studies have shown that
approximately 80% of children with milk
allergy were tolerant to baked milk.
According to our observations, some chil-
dren who were reacted to direct milk were
tolerant to baked or pasteurised milk prod-
ucts like cake, yoghurt and feta cheese.
Our aim is to identify characteristics of
cow’s milk allergic children who are toler-
ant to baked or pasteurised milk products.
Method: Children with IgE-mediated cow’s
milk allergy who had clinical reaction dur-
ing DBPCFC tests with milk or positive
history of anaphylaxis with milk in last
319© 2013 The Authors
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6 months were included in this study.
Open food challenge tests were performed
with baked milk (a piece of cake contain-
ing 1 gr milk protein) and products of pas-
teurised milk (a cup of yoghurt containing
0.9 gr milk protein and feta cheese con-
taining 1.5 gr milk protein).
Results: Thirty-three children
(4.1  0.4 years, mean  SEM) with posi-
tive DBPCFC or history of anaphylaxis in
the last 6 months underwent open food
challenge tests with cake, yoghurt and feta
cheese, respectively. Eighteen children
(54.5%) were tolerant to baked milk (cake)
and products of pasteurised milk (yoghurt
or feta). Fifteen children had clinical reac-
tion; 4 during baked milk challenge (cake),
11 during products of pasteurised milk
challenge (yoghurt, feta). Initial cow’s milk
sIgE levels were 29.8  7.2 kU/l in toler-
ant group; 40.7  14.7 in reactive group
with yoghurt/feta and 67.4  21.6 in reac-
tive group with cake. Similarly total IgE
levels were 245.7  87.1 kU/l,
266.6  75.2 and 425.5  155 in tolerant
children and reactive children with
yoghurt/feta and reactive with cake,
respectively. Skin prick test (SPT) reactiv-
ity with direct milk was 8.6  0.8 mm,
7.4  0.8 and 14.8  4.7 in groups, respec-
tively. But SPT reactivity with milk aller-
gen was similar in three groups. Cow’s
milk sIgE at open food challenge tests were
22.1  6.7 kU/l; 27.3  9.9 and
75.9  30.1 in groups, respectively. The
amount of milk that was tolerated at
DBPCFC test was 48.4  11.7 ml,
11.2  3.1 ml and 6.4  4.3 ml in groups,
respectively.
Conclusion: Our results show that skin
prick test reactivity with milk but not milk
allergen, the amount of milk that can be
tolerated and initial, follow-up milk sIgE
measurements may define children who are
reactive to baked milk (cake) or products
containing pasteurised milk (yoghurt and
feta cheese).
818
Development of a measure to determine
the impact of food allergies on the daily
lives of food allergic adults
Peniamina, R1; Mirosa, M1; Bremer, P1; Conner, T2
1Department of Food Science, University of Otago,
Dunedin, New Zealand; 2Department of Psychology,
University of Otago, Dunedin, New Zealand
Background: Research on the quality of
life of food allergic adults generally
involves the use of health-related quality of
life questionnaires (both generic and food
allergy specific). A limitation of this
approach is that it requires participants to
accurately recall and report on past experi-
ences. The reality of autobiographical
memory is that even relatively important
events in people’s lives can be forgotten
over time and frequent behaviours are unli-
kely to be remembered on an individual
basis. The aim of the current study was to
develop a quantitative real-time data cap-
ture method that enables participants to
report on their current behaviours and
experiences, thus removing the bias intro-
duced by autobiographical memory.
Method: Four focus groups were held with
food allergic adults (total n = 29, age 20–
77, variety of different food allergies) to
obtain an in-depth understanding of the
food allergy-related issues impacting on
their quality of life. Thematic analysis of
the focus group transcripts was completed
using the NVIVO 9 software package. A
short questionnaire was developed based
on the focus group results.
Results: The resulting questionnaire was
designed to be administered online on a
daily basis for a given period of time (e.g.
across two weeks). The 24 food allergy-
related items (grouped within seven catego-
ries: allergen-free eating, financial cost,
time cost, personal cost, external influ-
ences, physical effects, psychological issues)
were derived from the themes identified
from the focus groups data. Participants
can select which items impacted their lives
on that day. The three items with the most
impact that day can then be rated (in terms
of perceived stress imparted and impact on
ability to participate in normal daily tasks).
Additional items assess perceived mood
and stress levels for the day.
Conclusion: This new measure can accu-
rately provide information on the fre-
quency and level of impact (stress imparted
and impact on ability to participate in nor-
mal daily activities) of different issues in
the daily lives of food allergic adults. Such
food allergy knowledge may lead to the
development of interventions that will ben-
efit the daily experience and well-being of
food allergic individuals. In combination
with demographic and food allergy infor-
mation it will also be possible to learn
more about different sub-groups within the
food allergic population.
819
Quantitative evaluation of antigenicity of
cooked egg and egg products at antigen
component level for the use of dietary
counseling
Ito, S1
1Food Science and Nutrition, Doshisha Women’s
College of Liberal Arts, Kyoto, Japan
Background: The diagnosis of offending
antigen in food allergy is going to be
pursued adequately according to Japanese
Pediatric Guideline for Food Allergy 2012
in Japan. Hen’s egg is the most prominent
allergen in Japanese infants with both
infantile atopic dermatitis and anaphylaxis.
Ovalbumin (OVA) and ovomucoid (OM)
are known as major allergens of hen’s egg.
In our clinical data about 1793 infants
with positive egg white specific IgE anti-
body, which is equivalent to OVA specific
IgE antibody, only 66.3% of them showed
positive OM specific IgE antibody. More-
over, antigenicity of OVA and OM change
independently for each other by cooking.
To pursue dietary counseling safely and
effectively for the purpose of early induc-
tion of tolerance, quantitative evaluation
of egg antigen in cooked egg and egg prod-
ucts at antigen component level is requir-
ed.The purpose of this study is to make a
list of egg allergen exchange based on
quantitative evaluation of OVA and OM
in cooked egg and egg products. The list is
to be made for patients with positive and
negative OM specific IgE antibody respec-
tively.
Method: Quantitative evaluation of OVA
and OM in cooked egg and egg products
was made using sandwich ELISA system
developed for the detection of food antigen
in processed food. By modification of this
system, quantitative evaluation of OVA
and OM in cooked egg and egg products
was made.
Results: The discrepancy of antigenicity
between OVA and OM was biggest in
boiled eggs. The total amount of OVA in a
hard-boiled egg of 50 g was 1.2 mg and
that of OM was 1000 mg. This data imply
that most of egg allergic patients with no
OM specific IgE antibody in sera can toler-
ate one hard-boiled egg, but may not toler-
ate even one bolo which contain 2~8 mg of
OVA and OM respectively in a bolo of
0.5~1 g. The antigenicity of egg and egg
products can be classified into three
groups. Group 1 (OVA:OM = 1:1,000):
OM predominant group such as a hard-
boiled egg, Chawan-mushi (A custard-like
egg and vegetable dish steamed in a cup),
Group 2: (OVA:OM = 1:1): OVA and OM
express their antigenicity equally such as
scrambled egg, cookies, bolos, and Group
3: (OVA>OMA): OVA predominant group
such as baumkuhen, sponge cake. chiffon
cake. Lists of OVA and OM exchange was
made from these data.
Conclusion: Lists of egg allergen exchange
based on the major allergen OVA and OM
was made. These lists will make it possible
to apply the result of food challenge test to
dietary counseling aiming at outgrow.
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Review of baked egg challenges at a
tertiary pediatric allergy centre
Turner, PJ1,2; Mehr, S3; Joshi, P3; Tan, J3; Wong, M3;
Kakakios, A2,3; Campbell, DE2,3
1Paediatric Allergy, Imperial College London, London,
United Kingdom; 2Paediatric Allergy & Immunology,
University of Sydney, Sydney, Australia; 3Paediatric
Allergy & Immunology, Children’s Hospital at
Westmead, Sydney, Australia
Background: Many children with IgE-med-
iated allergy to egg can tolerate egg in
baked foods. This removes the need for
strict avoidance of egg in the diet and may
significantly improve quality of life. The
clinical characteristics and severity of reac-
tions of egg allergic children who react to
baked egg at oral food challenge (OFC)
are not well defined.
Methods: All children presenting to our
tertiary referral clinic with a diagnosis of
egg allergy (on the basis of convincing
clinical reaction in past 12 months and/or
serum specific IgE or skin prick test
(SPT) to egg >95% PPV) were offered
OFC to baked egg. Challenges were per-
formed with incremental dosages to a
total of one baked muffin containing 1/6
egg (equivalent to 1 g egg protein) follow-
ing a standardised protocol and recipe.
Data was collected prospectively from
2009–2012.
Results: OFC were carried out on 240 chil-
dren who were strictly avoiding egg in their
diet and met the above inclusion criteria.
31 (13%) had experienced previous ana-
phylaxis to egg. 87 children (36%) reacted
to their challenge. 13 children (15%)
reacted to 60 mg protein or less, 35 (39%)
to less than 250 mg (equivalent to ¼ muf-
fin). 71% of children with prior anaphy-
laxis to egg passed OFC to baked egg. Of
those children who reacted, 14% experi-
enced anaphylaxis to baked egg, according
to WAO criteria (5% of total cohort).
Four of these children reacted to less than
100 mg protein. Intramuscular adrenaline
was administered to five children, one of
whom required a second dose due to per-
sistent hypotension.
The most common reported reactions
were: urticaria (37%), itchy mouth and/or
throat (31%), abdominal pain (28%) and
vomiting (20%). 94% of reactions occurred
within 1 h of the initiation of the chal-
lenge, the remainder were gastrointestinal
symptoms.
The size of the SPT to egg white in chil-
dren with positive reaction on muffin chal-
lenge (mean 9.0 mm, SD 3.7) was not
significantly different from those with neg-
ative challenges (8.7 mm, SD 3.1). Chil-
dren with positive OFC were more likely
to have had anaphylaxis to other foods
(21% vs 10%). Multiple food allergies or
asthma (on preventer therapy) was not pre-
dictive of challenge outcome.
Conclusion: The majority of children with
IgE-mediated allergy to egg are able to tol-
erate small amounts of baked egg. A pro-
portion of children in this cohort reacted
with symptoms of anaphylaxis. We there-
fore recommend that OFC to baked egg
should take place under medical supervi-
sion.
822
Parental knowledge of anaphylaxis
treatment and epinephrine autoinjector
for children with food allergy
Contreras-Porta, J1; Ruiz-Baques, A2; Capel, F3; Ari~no,
M4; Zorrozua, A5; Lopez-Serrano, M6
1Hospital Universitario La Paz, Servicio de Alergia,
Madrid, Spain; 2Ideas en Salud, Barcelona, Spain;
3AEPNAA, Murcia, Spain; 4Inmunitas Vera, Barcelona,
Spain; 5Elikalte, Bilbao, Spain; 6Hospital Universitario
La Paz, Madrid, Spain
Background: The purpose of this study
was to gain a clearer understanding of
Spanish parents’ knowledge on how to
treat anaphylactic reactions and epineph-
rine autoinjector (EA).
Method: An online anonymous-question-
naire format was used to collect details on
treatment of food anaphylaxis and knowl-
edge of epinephrine autoinjector (EA). The
25 items survey had been developed under
patient-centered care, self-management and
the partitipatory medicine model, agreed
upon by the Spanish patient associations
(AEPNAA, Immunitas Vera and Elikalte)
and by health professionals and research-
ers. 215 parents of food-allergic children
between the ages of 1 and 15 (87 male and
128 female) answered an ad-hoc question-
naire.
Results: The majority (72%) had had one
or more anaphylactic reactions and only
26% had received treatment with epineph-
rine. Almost all of parents knew EA
(97%), were not prescribed in emergency
departments nor primary health offices,
but mainly prescribed by allergy specialists
(74%). 15% carry EA sometimes, 64%
always and 21% almost always. Only 25%
of the families never received a demonstra-
tion of the use of EA, but 45% received
demonstration by the physician of allergy
office and 34% by a patient association or
both, not in emergency departments. 70%
of parents felt that they could know when
to use an EA in an emergency. Only 24%
of parents considered nurses and doctors
as the main source of information on food
allergy, and below 40% patients’ associa-
tions and 32% internet sources respec-
tively.
Conclusion: Epinephrine Auto-injector is
under-used in parents of food allergic
children. Anaphylaxis treatments are often
poorly known, and patients’ associations
are considered as the main source of infor-
mation on food allergy.
823
Multicenter validation of a mouse model
for cow′s milk allergy to assess the
allergenicity of hydrolysed cow′s milk
based infant formulas; phase III
van Esch, BCAM1; van Bilsen, J2; van Gros-Hest, M3;
Jeurink, PV4; Garssen, J1,4; Smit, JJ5; Pieters, RHH5;
Knippels, LMJ4
1ImmunoPharmacology, Utrecht Institute for
Pharmaceutical Sciences, Faculty of Science, Utrecht
University, Utrecht, The Netherlands; 2TNO, Risk
Analysis for Products in Development, Zeist, The
Netherlands; 3FrieslandCampina DOMO, Ingredients
Innovation, Wageningen, The Netherlands; 4Danone
Research Centre for Specialised Nutrition, Wageningen,
The Netherlands; 5Institute for Risk Assessment
Sciences, Utrecht University, Utrecht, The Netherlands
Background: This study is part of a multi-
phase project which aims to validate a
mouse model to assess the potential aller-
genicity of hydrolyzed cow′s milk based
infant formulas (claim support EC-direc-
tive 2006/141/E). Previous results showed
its transferability and its ability to discrimi-
nate between the sensitising properties of
whey protein and extensively hydrolysed
whey protein (eWH). In this phase the sen-
sitising properties of three partially hydro-
lyzed whey proteins (pWH-A,-B,-C) were
included.
Method: Mice received intragastric admin-
istration of PBS, whey, pWH or eWH at
weekly intervals for 5 weeks using cholera
toxin as an adjuvant. One week after the
last sensitisation, anaphylactic shock symp-
toms, body temperature and an acute aller-
gic skin response were determined as
allergic parameters upon intradermal ear
injection of whey. Subsequently, mice were
challenged intragastrically with whey after
which serum was analyzed for whey-spe-
cific antibodies and mMCP-1 as a reflec-
tion of mast cell degranulation. All
protocols, test substances and procedures
were standardised.
Results: Consistent with phase I and II,
elevated levels of whey-specific IgE/IgG1
were detected in whey sensitised mice in all
participating centers. In the current study,
three out of four centers showed allergic
symptoms in the positive control upon
whey challenge measured as anaphylactic
shock symptoms, a drop in body tempera-
ture, serum mMCP-1 or acute allergic skin
responses. No allergic symptoms were
observed in pWH-A sensitised mice
although levels of whey-IgE were measured
in a few animals. Individual animals sensi-
tised with pWH-B and pWH-C showed
minor clinical symptoms in addition to
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whey-IgE, although the group mean values
of mMCP-1, anaphylactic shock symp-
toms, body temperature an acute allergic
skin response did not differ from non-sen-
sitised mice. In contrast, none of the evalu-
ated parameters were altered in eWH-
sensitised mice.
Conclusion: In contrast to eWH, individ-
ual animals sensitised with pWH showed
minor allergic symptoms. Measurement of
clinical symptoms in addition to IgE is
indispensable to predict allergenicty of hy-
drolysed whey proteins. Centers were able
to discriminate between the sensitising
properties of whey protein, pWH and
eWH. The results demonstrate the dis-
criminatory power of the mouse model
and thereby the potential to evaluate the
allergenicity of hydrolysed cow′s milk for-
mulas although the value of the different
parameters measured need to be evalu-
ated.
824
Removal of peanut allergen from
different surfaces with household and
hospital cleaning wipes
Watson, WT1; Woodrow, AM2
1Pediatrics, Dalhousie University/IWK Health Centre,
Halifax, NS, Canada; 2IWK Health Centre, Halifax, NS,
Canada
Background: A diagnosis of peanut allergy
in children cause caregivers major concern
as exposure to even small amounts could
trigger an allergic reaction. Accidental con-
tamination of toys and other products in
areas where individuals have eaten may
occur in places such as hospital cafeterias
and waiting rooms. We explored whether
cleaning peanut contaminated products
with a common household and hospital
cleaning wipes would remove peanut aller-
gen.
Method: A nonporous table surface, plas-
tic doll, textured plastic ball, book cover
with a smooth surface, book cover with a
textured surface, and a standard hospital
tray were sampled for peanut allergen Ara
h 1 at baseline. All items were smeared
with peanut butter in a standard fashion.
After drying for 5 min all products except
the hospital tray were cleaned with a com-
mon household wipe (Clorox disinfecting
wipes, active ingredients n-alkyl dimethylb-
enzyl ammonium chloride 0.145%, n-alkyl
dimethyl ethylbenzyl ammonium chloride
0.145%, isopropanol 1–5%), or two hospi-
tal cleaning wipes (UltrawipesTM, active
ingredient didecyl dimethyl ammonium
chloride 0.1%; PerCept RTU WipesTM,
active ingredient hydrogen peroxide 0.5%).
The hospital tray was washed within 24 h
by a standard hospital automatic dish-
washer. After cleaning all products were
sampled for Ara h 1.
Results: At baseline, no Ara h 1 was
found on any product. Detectable Ara h 1
was found on all products after applying
peanut butter. All wipes successfully
removed all detectable Ara h 1 from all
products. Standard washing of the hospital
tray also removed all detectable Ara h 1.
Conclusion: Table surfaces, book covers
and plastic toys can be successfully cleaned
to remove peanut allergen using common
household or hospital cleaning wipes. This
should help reduce caregivers concerns in
places where books and toys may be used
by many children. Regular cleaning of
these products or cleaning prior to use
should be promoted to reduce risk of acci-
dental peanut exposure.
825
Modern approaches to the treatment of
cow′s milk protein allergy in infants of
first year of life
Namazova-Baranova, L1,2; Vishneva, E1; Alekseeva, A1,2;
Levina, J1,2; Borovik, T1,2; Makarova, S1,2
1Scientific Center of Children Health, RAMS, Moscow,
Russia; 2First Moscow State Medical University named
by IM Sechenov, Moscow, Russia
Background: Prevalence of food allergy,
especially to cow′s milk protein, amongst
infants of first year of life increases every-
where. Hypoallergenic formulas, which do
not cause allergy (in 90% of children,
according to ESPGHAN&ESPACI) have
been recommended for noninvasive diag-
nostics and treatment.
The objective of the study was an evalu-
ation of effectiveness and safety of using of
the amino-acid based formula in the real
clinical practice.
Method: An open prospective study has
been conducted in 2010. There were 60
children participating ranging in age 1–
11 month with various degree of cow′s
milk protein allergy. Amongst them 52%
had cutaneous and gastrointestinal (GI)
allergy signs, 38% had respiratory signs in
addition to it, 5% had cutaneous and
respiratory signs and 5% had only cutane-
ous signs. 90% of children had GI signs of
cow′s milk protein allergy of various inten-
sity.
Results: The conducted analysis of patients
diet showed that prior to visiting the Cen-
ter′s pediatrician or neonatologist, 43% of
the children received soy formula, 13%
goat milk based formula, 12% partially
hydrolyzed formula and 32% extensively
hydrolyzed formula.
All children were prescribed an amino-
acid based formula for 14–28 days. Before
the beginning of the study and after 14–
28 days of therapy, including being on
amino-acid based formula, the extent of
symptoms of cow′s milk protein allergy
was evaluated using a specially designed
questionnaire. The intensity of symptoms
before and after administration of the
amino-acid based formula was: GI signs
5  1.2 and 0.6  0.08 points (accord-
ingly, P < 0.001), skin signs – 3.9  1.15
and 0.5  0.08 p. (accordingly, P < 0.01),
respiratory signs – 0.7  1.12 and 0  0.08
p. (accordingly, P < 0.01).Negative side
effects were noted in five children (8%):
restlessness and nap disturbance in 1 child
(unable to find a cause-and-effect relation-
ship with the prescription of the amino-
acid based formula), refusal to eat in 1
(11 month) child (implied reason – taste),
black stool in 2 and bloating in 1 child.
Treatment had to be discontinued in two
cases: 1-due to the lack of effect and 2-due
to financial constraints.58 out of 60 chil-
dren (97%) completed the diet course with
a positive result and after 14–28 days were
switched to the extensively hydrolyzed for-
mula.
Conclusion: The use of the amino-acid
based formula opened the prospect of fast,
effective and safe treatment, as well as
non-invasive and affordable diagnostics of
cow′s milk protein allergy in babies.
826
Effects of dietary counselling on protein
intake and plasmatic protein profile in
children with food allergy
D’Auria, E1; Barberi, S1; di Dio, F1; Palazzo, S1; Giovan-
nini, M1
1Department of Pediatrics, University of Studies of
Milan, San Paolo Hospital, Milan, Italy
Background: To investigate the protein
intake and plasmatic protein profile in chil-
dren with food allergy (FA) on elimination
diet.
Method: The study included 40 children
(19 boys, 3–36 months of age), all affected
by FA on elimination diet for at least
30 days. Measurement of total protein,
albumin, prealbumin and evaluation of
plasma aminoacidogram (in order to calcu-
late plasma nonessential to essential amino
acid ratio) were carried out at enrollment
(t0) and after 6 months (t1) of dietary
counselling by registered dietician. 20 non
allergic children (10 boys, 3–36 months of
age) were enrolled at t0 as control group to
investigate protein intake in non allergic
children. Dietary protein intake was
assessed by a 3-day diary in all 60 children
at t0 and only in allergic children at t1.
Results: Protein intake in FA children
exceeded the Italian recommended intake,
according to national dietary recommenda-
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tions, as in non allergic children. The ratio
between the mean value of protein intake
(g/kg) in allergic children and the recom-
mended protein intake (g/kg) decreased sig-
nificantly from t0 to t1 [t0 = 1.60 (0.7–3),
t1 = 1.31 (0.9–2); P = 0.05] after nutritional
counselling. There were no significant dif-
ferences in protein intake between allergic
and non allergic children at t0. The com-
parison of the measurements of plasmatic
protein profile [mean (min-max)] observed
in the allergic population during the two
times of evaluation showed no significative
difference between plasmatic total protein
[t0 = 6.71 g/dl (6.14–7.47), t1 = 6.82 g/dl
(5.88–7.52); P = 0.076], albumin
[t0 = 4.56 g/dl (4.14–5.14), t1 = 4.51 g/dl
(4.11–4.81); P = 0.464], prealbumin
[t0 = 19.08 mg/dl (13.40–24.40),
t1 = 18.13 mg/dl (13.70–24.50); P = 0.241],
However, it showed a significative differ-
ence between plasma nonessential to essen-
tial amino acid ratio [t0 = 2.35 (1.20–4.33),
t1 = 2.17 (1.03–3.67); P = 0.031] with a sig-
nificative increase of two essential amino-
acids [Isoleucine: t0 = 52.99 lM (36.18–
85.97), t1 = 56.41 lM (40.89–105.13);
P = 0.012. Valine: t0 = 216.10 lM (129.98–
385.42), t1 = 226.96 lM (161.02–427.17);
P = 0.018].
Conclusion: An unbalanced diet is a fre-
quent feature in allergic children, as well as
in healthy children. This condition could
be prevented and resolved by an adequate
nutritional counselling. In our population
the dietary intervention has been demon-
strated to improve the quality of protein
intake as shown by the decrease of the
plasmatic non essential/essential aminoac-
ids ratio.
827
Failure of peanut reintroduction in
children
van Erp, FC1; Boot, J1; Knulst, AC2; Pasmans, SGM3;
van der Ent, CK1; Meijer, Y1
1Pediatric Pulmonology and Allergology, University
Medical Center Utrecht, Utrecht, The Netherlands;
2Dermatology, University Medical Center Utrecht,
Utrecht, The Netherlands; 3Pediatric Dermatology and
Allergology, University Medical Center Utrecht, Utrecht,
The Netherlands
Background: A negative food challenge
(FC) should normally be followed by suc-
cessful reintroduction of the challenged
food. Several problems can occur; refusal
of food that long has been avoided is a
common problem in children. Failure of
reintroduction could also indicate false
negative FC outcome. This study describes
reintroduction problems and risk factors
for reintroduction failure in children.
Method: Parents of children with a nega-
tive peanut challenge in 2008–2010 were
invited for a telephonic interview up to
three years after FC. The parents were
questioned about the current diet, symp-
toms and problems during reintroduction
and accidental reactions to peanut. Infor-
mation about the history of peanut allergy
and elimination diet and FC result was
obtained from medical records. Successful
reintroduction was defined as eating pea-
nut or products containing peanut as
ingredient on a regular basis.
Results: Follow-up data were obtained in
103 (94%) of children with a negative pea-
nut challenge. In 33 (32%) of these chil-
dren reintroduction failed. Refusal of
products containing peanut was the reason
of reintroduction failure in 15 (45%) chil-
dren. In 11 (33%) children objective symp-
toms after the ingestion of peanut during
reintroduction resulted in a prolonged
elimination diet. A previous elimination
diet for more than two years and a post-
poned reintroduction of more than
1 month after FC were significantly associ-
ated with reintroduction failure.
Conclusion: In children reintroduction fail-
ure after negative peanut challenge is com-
mon. Follow-up after FC should therefore
be intensified to stimulate and monitor
reintroduction and objectify accidental
reactions. When symptoms after ingestion
of peanut reoccur, revision of FC outcome
should be considered.
828
Oral immunotherapy for treatment of
egg allergy. Double blind placebo
controlled study and post desensitisation
follow-up
Caminiti, L1; Porcaro, F1; Chiera, F1; Pajno, GB1
1Department of Pediatrics- Allergy Unit, University of
Messina, Messina, Italy
Background: Hen’s egg is common in
infancy and currently avoidance of this
food is the only approved treatment. We
evaluated oral immunotherapy (OIT) using
egg- white powder for the treatment of
children with egg allergy. Once desensitisa-
tion was achieved a post- desensitisation
follow-up was carried out.
Method: In this double blind, randomised
placebo controlled study, 30 children 4–
11 years of age with egg allergy received
oral immunotherapy (17 chidren) or pla-
cebo (13 children). Initial dose escalation,
build-up, and maintenance phases were fol-
lowed by an oral food challenge with egg
with powder and boiled egg. The children
who achieved desensitisation (N. 16) did
the withdrawal of egg for two months;
afterwards these children underwent an
oral food challenge with powder egg and
boiled egg to test the tolerance.
Results: After about three months of OIT
none of children who received placebo
and 94% of the children who received
powder egg, achieved desensitisation.
Among 16 desensitised children, after two
months of egg withdrawal: 65% achieved
tolerance and 35% lost desensitisation and
‘recalled’ again food allergy. Of the
immune markers measured small wheal
diameters on skin- prick testing and
increases in egg specific IgG4 antibodies
levels were associated with both desensiti-
sation and tolerance.
Conclusion: These results show that OIT
can desensitise a very high proportion of
children with egg allergy and induce in the
majority of them (65%) a true tolerance.
829
The effectiveness and safety of specific
oral immunotherapy in children with
food allergy at stratification
Takahashi, M1,2; Taniuchi, S1; Soejima, K1; Hatano, Y1;
Nakano, K1; Kaneko, K1
1Pediatrics, Kansai Medical University, Osaka, Japan;
2Pediatrics, Izumiotsu Municipal Hospital, Osaka, Japan
Background: Although several clinical tri-
als have been conducted on specific oral
immunotherapy (SOIT), their effectiveness
and safety has not been established thus
far. We aimed to elucidate the effectiveness
and safety of SOIT in children with food
allergy who were stratified by age and the
threshold dose in the food challenge test.
Method: In total, 149 children with food
allergy (hen’s egg, 67 children; wheat, 41
children, and cow’s milk, 41 children),
which were confirmed by the positive food
challenge test, were enrolled in this study.
The median ages of children with hen’s
egg, wheat, and cow’s milk allergy were
6.2, 7.0, and 5.0 years at the start of the
study (range 2.1–14.3 years, 1.3–12.3 years,
and 2.7–14.3 years). The enrolled children
were classified into two groups based on
their age and threshold dose for food aller-
gens at the food challenge test. Rush SOIT
was performed in children aged more than
5 years using less than 1 g, 10 g, and
10 ml of the threshold dose of hen’s egg,
wheat, and cow’s milk, respectively. Slow
SOIT was performed in for the other chil-
dren. The target dose for hen’s egg, wheat,
and cow’s milk was set as 50 g, 200 g, and
200 ml, respectively.
Results: One year after SOIT, 79% of chil-
dren with hen’s egg allergy, 80% of those
with wheat allergy and 93% of those with
cow’s milk allergy were able to consume
the target dose of the respective foods.
During SOIT, four patients required adren-
aline treatment (total, 8 times) for serious
reactions.
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Conclusion: The study suggests that SOIT
is effective and safe for children with food
allergy at stratification.
830
Interest of a pocket scale used for oral
immunotherapy at home
Asbati, Z1; Dano, D1
1Department of Internal Medicine, Clinical Immunology
and Allergology, University of Lorraine, Faculty of
Medicine, Nancy, France
Background: Oral immunotherapy (OIT) is
a major opportunity as a therapy of IgE-
mediated food allergy. OIT protocols are
generally established on several weeks or
months using progressive doses starting
with small doses below the threshold dose
determined by a Double Blind Placebo
Controlled Food Challenge (DBPCFC). In
food laboratory, the preparation of OIT
protocols especially dose weighing is some-
times time-consuming. On the other hand
home weighing can be difficult and inaccu-
rate particularly for small doses (less than
100 milligram).
Method: In order to facilitate the estab-
lishment of OIT at home, we set up an
individual pocket scale from OHAUS YA
Series (model: YA102) with a precision
ranging from 0.01 to 100 g. The efficiency
of the scale was checked by a metrology
professional. OIT using the scale was pro-
posed to a 13 years old patient with a per-
sistent food allergy to hazelnut. According
to patient’s clinical data, the protocol was
established on 24 weeks period of time;
with increasing doses from 50 mg to 10 g
of raw hazelnut flour in the end of the pro-
tocol.
An emergency kit was given and instruc-
tions for use explained to the patient. A
satisfaction questionnaire was filled by the
patient allowing the evaluation of this pro-
cedure for immunotherapy application, as
well as to evaluate the convenience for
patients self-use at home.
Results: The patient completed with suc-
cess the protocol and no severe reaction
has occurred during the desensitisation per-
iod. Practically the protocol was clear and
the daily weighing was easy, the patient
confirmed the facility of use and transpor-
tation of the scale.
The results of the questioner support the
idea of the scale’s utility for OIT daily
employ at home.
Conclusion: Numerous studies are support-
ing the interest of immunotherapy to
improve the security and quality of life of
the allergic patient and his family. The
therapeutic education of the patient based
on home weighing using an individual
pocket scale can be a solution in order to
reduce difficulties related to OIT protocol’s
management.
831
The influence of IgE-mediated cow’s milk
allergy to cow’s milk consumption in
childhood
Mitropoulou, K1; Politis, P2; Trigka, M1
1Paediatric Allergy Unit, Dept of Paediatrics, General
University Hospital of Patras, Patras, Greece; 2General
Hospital of Aegion, Aegion, Greece
Background: Cow’s milk (CM) represents
a major source of high nutritional quality
protein as well as of calcium and is of pro-
found significance for bone metabolism. In
developed countries CM optimal daily
intake should be around 500 ml, ade-
quately complemented with other nutri-
ents.
Aim: To evaluate whether children with a
history of IgE-mediated cow’s milk allergy
(CMA), who have outgrown it, consider
CM acceptable and consume similar daily
quantities to non-CMA controls.
Patients and methods: Subjects were chil-
dren between 3.8 and 13.5 years diagnosed
with CMA in the first year of life. Diagno-
sis of CMA was based on history, clinical
findings and CM-specific IgE status,
detected via skin prick test and/or CAP
system technology. Healthy siblings 4–
17 years, without any food allergy, were
selected as controls. Mothers were con-
tacted via telephone and asked to indicate
their children’s preference for CM and if
they consume <400 ml or ≥400 ml/day.
Results: Forty-three subjects (mean age
7.24  2.55 years, 39.5% boys) and 48
controls (mean age 8.15  3.15 years, 50%
boys) participated in the study. Twenty-six
of 43 subjects (60.6%) reported dislike for
milk and drinking <400 ml/day, compared
with 7 of 48 controls (14.6%). Chi-square
test = 20.6 P < 0.001 [odds ratio 8.96; 95%
confidence intervals 3.27–24.55].
Conclusion: A significant proportion of
subjects with CMA in infancy dislike CM
and consume sub-optimal amounts in
childhood. We propose that early taste
experiences through CMA per se or the
milk hydrolysate formulas influence the
children’s subsequent preferences.
832
Comparison of clinical characteristics of
oral allergy syndrome between children
grouped according to age
Matsuura, M1; Inomata, N1; Nomura, Y1; Aihara, M1
1Department of Environmental Immuno-Dermatology,
Yokohama City University School of Medicine,
Yokohama, Japan
Objective: To evaluate the clinical charac-
teristics of oral allergy syndrome (OAS)
according to age in children.
Method: Children aged 10 years or under
with a diagnosis of OAS were divided into
two groups according to age and analyzed
with regard to causative foods and IgE lev-
els for pollen allergens, including allergic
components, such as rBet v 1 and rBet v 2,
which have been known to be cross-reac-
tive to plant-derived foods, measured by
ImmunoCAP.
Results: Group A (under 6 years of age)
included four cases (mean age 3.3 years,
M:F = 1:3) and Group B (age 6 years or
over) included seven cases (mean age
7.3 years, M:F = 5:2). The mean level of
total IgE was 1264 IU/ml and 834 IU/ml
in Groups A and B, respectively. The fre-
quent causative foods were kiwi (n = 2)
and cashew nuts (n = 2) in Group A
whereas apples (n = 4), strawberries
(n = 3), peaches (n = 3), and melons
(n = 3) were causative foods in Group B.
The prevalence of atopic dermatitis and
pollinosis was 75% and 0% in Group A
and 57.1% and 85.7% in Group B, respec-
tively. Positivity for specific IgE for pollen
allergens was 25% and 100% in Groups A
and B, respectively. The pollen allergens
sensitised were orchard grass (n = 1) in
Group A and alder (n = 7), cypress
(n = 7), and orchard grass (n = 5) in
Group B. Furthermore, in three cases in
Group B, positivity for specific IgE for
rBet v 1 and rBet v 2 was 100% and
33.3%, respectively.
Conclusion: Although there is the limita-
tion of the small number of subjects in the
current study, the results indicated that
OAS in most Group B cases, that is, the
older age group, could be due to cross-
reactivity to pollens, a finding not observed
in Group A.
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Component resolved analysis of sera
from peanut sensitised patients reported
to the Norwegian Food Allergy Register
show age related sensitisation profiles
Namork, E1; Stensby, BA1; Løvik, M1,2
1Dept. Environmental Immunology, Norwegian Institute
of Public Health, Oslo, Norway; 2Norwegian University
of Science and Technology, Trondheim, Norway
Background: Peanut is a common and
potent allergen and is the leading cause of
fatal allergic reactions to food worldwide.
The prevalence of peanut allergy appears
to be increasing, especially in children. The
National Register of Severe Allergic Reac-
tions to Food was established in 2000 with
the purpose of gaining information about
food allergy in Norway. Cases of patients
allergic to peanut reported to the Food
Allergy Register amount to about 20%,
which is the highest cause of severe allergic
reactions reported.
Method: Analysis using recombinant pea-
nut allergens allows differentiation between
severe, persistent primary peanut allergy
and cross-reactivity due to primary allergy
to pollen that may cause oral allergy syn-
drome (OAS). Specific IgE reactivity to the
stable storage proteins Ara h1, 2/6 and 3,
lipid transfer protein (LTP) Ara h9 and
the labile birch pollen homologue Arah8
were tested in 95 sera positive to whole
peanut extract.
Results: The majority of the 95 sera con-
tained IgE to Ara h8 (55%). Sensitisation
to the storage proteins Ara h1, 2/6 and 3
were found in 22%, 28% and 22%, respec-
tively, while 11% were sensitised to LTP
Ara h9. The age distribution showed two
peaks; one group of children aged 2–
15 years and one adult group 30–40 years
old. Examination of the two age groups
separately, showed that 70% of the chil-
dren were sensitised to the storage proteins
Ara h1, 2/6, and 3 or to Ara h9 in differ-
ent combinations and 21% were positive to
both Ara h8 and birch. A few sera were
negative to all the peanut components and
birch, but positive to timothy. In the adult
group, only 13% were sensitised to the
storage proteins or to LTP. A majority of
64% was sensitised to both Ara h8 and
birch, while 23% were negative to all the
components, but positive to timothy pollen
and/or nuts like cashew and walnut.
Conclusion: Component analyses of sera
from peanut allergic patients show two age
groups with different sensitisation profiles.
Specific IgE mainly to the stable peanut
components indicates increased risk of
severe peanut allergy for children up to
15 years of age. Oppositely, the result for
the adult group indicates primary pollen
allergy to mainly birch but also some to
timothy or nuts causing cross-reactivity to
peanut. Patients suffering from peanut
allergy will benefit from this information
since cross-reactions are less often associ-
ated with systemic reactions but more
often with milder and local symptoms like
OAS.
834
Clinical relevance of sensitisation to
profilin in Japanese patients with plant
food allergy
Minami, T1; Fukutomi, Y1; Taniguchi, M1; Saito, A1;
Yasueda, H1; Nakayama, S2; Tanaka, A2; Mitsui, C1;
Hayashi, H1; Tsuburai, T1; Mori, A1; Hasegawa, M1; Ak-
iyama, K1
1Clinical Research Center for Allergy and
Rheumatology, Sagamihara National Hospital,
Sagamihara, Kanagawa, Japan; 2Phadia AB (Thermo
Fisher Scientific), Uppsala, Sweden
Background: Profilin is a cross reactive
pan allergen that induces pollen-food
allergy syndrome. However, the clinical rel-
evance of profilin in IgE cross-reactivity is
still controversial, and pollen as an allergen
source contributing to profilin sensitisation
has not been established.
Objective: To identify the source pollen
causing profilin sensitisation and elucidate
the clinical relevance of profilin as a food
allergen in the Japanese population.
Method: Sixty-nine Japanese patients with
plant food allergy were studied in terms of
their sensitisation to various allergen com-
ponents using ImmunoCAP ISAC (Pha-
dia). Patients sensitised to Phl p 12
(timothy profilin, P+ patients) were com-
pared with those not sensitised to Phl p 12
(P- patients), in term of their cosensitisa-
tion to other allergen components, types of
offending food, number of offending
foods, and symptoms provoked after eat-
ing such offending foods.
Results: Among 69 patients, 19 patients
(28%) were sensitised to Phl p 12. P+
patients were more likely than P- patients
to be sensitised to Cyn d 1 (89% vs 46%,
P = 0.01), Phl p 1 (79% vs 44%,
P = 0.009), and Phl p 5 (42% vs 18%,
P = 0.042), which are diagnostic marker
allergens for identifing genuine grass-pol-
len-sensitised patients. On the other hand
the prevalences of sensitisation to Bet v 1,
Amb a 1, and Art v 1 were not different
between the two patient groups. Allergic
symptoms were more frequently triggered
by melon, tomato, eggplant and banana in
P+ patients than P-patients. The number
of causal foods was larger in P+ patients
than in P- patients, indicating that profilin
sensitisation is related to a broader clini-
cally relevant cross-sensitisation to plant
foods. P+ patients were more likely to
experience diarrhea, lower abdominal pain,
and unexpected food-related allergic symp-
toms.
Conclusion: These findings suggest that, in
this study population, the main source of
profilin sensitisation was grass pollen, and
profilin sensitisation was related to clini-
cally relevant cross-sensitisation to plant-
derived foods.
835
Accuracy of alcohol-dissolved wheat
extract for the diagnosis of IgE-mediated
wheat allergy
Pacharn, P1; Siripipattanamongkol, N1; Pannakapitak,
N1; Visitsunthorn, N1; Jirapongsananuruk, O1;
Vichyanond, P1
1Pediatrics, Siriraj Hospital, Mahidol University,
Bangkok, Thailand
Background: Wheat allergy is a common
allergic condition in Asia, including Thai-
land. Since wheat allergens are alcohol-dis-
solvable, commercially water-soluble may
not be sufficient for the diagnosis of wheat
allergy. We sought to determine the accu-
racy of in-house, alcohol-dissolved wheat
extract in Thai children with immediate
type wheat allergy.
Method: Thirty children (aged from
15 months to 13 years) with history of
immediate reaction to wheat underwent
skin tests with commercial and in-house
wheat extract (dissolved wheat with alco-
hol 70%) along with determination of spe-
cific IgE for wheat and omega-5 gliadin.
Eighteen patients underwent open
325© 2013 The Authors
Allergy © 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd, 68 (Suppl. 97), 189–336
challenge with 25 gm of wheat. Twelve
patients who had history of wheat anaphy-
laxis were considered wheat allergic and
did not undergo challenging. The receiver-
operator characteristic (ROC) curves and
predictive decision points of skin prick
tests and specific IgE were determined.
Results: Eleven out of 18 children (61%)
had positive result for wheat challenge test.
The in-house wheat extract has a good cor-
relation with commercial wheat extract
(r = 0.89). The wheal size of 3 mm for
both in-house wheat extract and commer-
cial wheat extract gave the best diagnostic
value (AUC 0.92, and 0.88, respectively).
However, at these criteria, the in-house
wheat extract gave sensitivity 91.3%, speci-
ficity 71.4%, PPV 91.3%, and NPV
71.4%, whereas commercial extract gave
sensitivity 73.9%, specificity 100%, PPV
100%, and NPV 53.8%. The accuracy of
commercial wheat extract, in-house wheat
extract, specific IgE for wheat, and omega-
5 gliadin were 80%, 86.7%, 86.7%, and
80%, respectively.(P = 0.03).
Conclusion: Using in-house, alcohol-dis-
solved wheat extract for skin prick test
appeared to produce improved accuracy
for diagnosing immediate type wheat
allergy, compared to commercial extract.
837
Monitoring of heart rate variability
during oral food challenge could improve
patient safety and diagnostic yield
Twomey, N1; Temko, A1; Cullinane, C2; Daly, D2;
Marnane, WP1; Hourihane, JO2
1University College Cork, Electonic and Electrical
Engineering, Cork, Ireland; 2University College Cork,
Paediatrics and Child Health, Cork, Ireland
Background: International consensus is
that an Oral Food Challenge (OFC)
should continue until objective, predeter-
mined clinical stop criteria are met. OFC
can cause anaphylaxis. Anaphylaxis
appears more common late in OFC, after a
large cumulative dose of test allergen,
rather than early in OFC after very small
doses. Heart rate variability (HRV) is
noted before the clinically observable onset
of sepsis and seizures in hypoxic ischaemic
encephalopathy and other immune medi-
ated disorders.
Method: We retrospectively examined
HRV, using fully automated computer-
based detection of ECG signals, during 24
clinically-indicated open OFC. Baseline
HRV was examined before the 1st dose of
OFC was given and epochs of HRV during
OFC were compared to this baseline, using
18 known HRV factors. OFC was stopped
or continued to top dose, according to
clinical practice, blind to the HRV data.
Results: Fifteen OFC were positive, 9 were
negative. HRV was stable in all negative
OFC (100% specificity) and HRV changes
were noted in 12/15 positive OFC (80%
sensitivity). Use of HRV detection during
OFC could have led to 70% reduction in
cumulative doses administered during posi-
tive OFC.
Conclusion: Detection of complex features
of Heart Rate Variability during oral food
challenge can be automated at the bedside.
This finding has potential to widen the
adoption of diagnostic OFC, by reducing
premature termination of OFC due to sub-
jective symptoms and by improving safety
in positive OFC by prompting termination
of positive OFC at lower doses of test
allergen.
838
Specific IgE does not predict allergy to
specific species within an adult fish
allergic population
Schulkes, K1; Klemans, R1; Knigge, L1; de Bruin-Weller,
M1; Bruijnzeel-Koomen, C1; Marknell DeWitt, A2;
Lidholm, J2; Knulst, A1
1Dermatology/Allergology, University Medical Center
Utrecht, Utrecht, The Netherlands; 2Thermo Fisher
Scientific, Uppsala, Sweden
Background: Fish is an important cause of
food allergy. Studies on fish allergy are
scarce and in most cases limited to serolog-
ical evaluation. Our objective was to study
patterns of both clinical allergy and sensiti-
sation to 13 commonly consumed fish spe-
cies.
Method: Thirty-eight adult patients with
allergy to different fish species completed a
questionnaire regarding general allergy
characteristics, age of onset of fish allergy
and symptoms to 13 fish species. Patients
were included if they reported symptoms
after ingestion of fish in combination with
a positive challenge or sensitisation; a sIgE
level to cod ≥0.35 kUA/l and/or a positive
skin prick test (SPT) to at least one of the
tested fish species. Specific IgE to all 13
fish species were analyzed by Immuno-
CAP.
Results: Median age of onset of fish
allergy was 8.5 years. Severe reactions
were reported by the majority of patients
(42% respiratory, 16% cardiovascular
symptoms). After diagnosis, 66% of
patients eliminated all fish. Allergy to all
13 species was reported by 59%. Cod
(84%) and herring (79%) were the most
frequently reported culprit species while
tuna (58%), hake (57%) and swordfish
(55%) were the least frequent. Among
those who reported symptoms to a par-
ticular species, the frequency of detectable
sIgE to the same species ranged between
50% (swordfish) and 100% (hake). Nega-
tive sIgE results among those who
reported tolerance ranged from 0%
(hake, pollock and swordfish) to 75%
(sardine). For cod, the agreement between
sIgE test results and reported symptoms
or tolerance was 82% and 25%, respec-
tively. Sensitisation to cod parvalbumin
(Gad c 1) was present in 77% of all
patients.
Conclusion: Serological cross-reactivity
between fish species is frequent, but clinical
relevance appears limited to some species.
Cod and herring are the most frequent
causes of fish allergy. A well-taken history
or food challenge is required for discrimi-
nation between allergy to different fish spe-
cies.
839
Clinical evaluation of component
sensitisation in children and young adult
with peanut allergy
Kitabayashi, T1; Adachi, M2
1Pediatrics, International University of Health and
Welfare Mita Hospital, Tokyo, Japan; 2Sanno Hospital,
Tokyo, Japan
Background: We confirmed there are two
patterns of peanut allergy in our previous
study. The purpose of the study is to inves-
tigate sensitisation pattern to peanut com-
ponents between peanut allergy and peanut
sensitised patients.
Methods: Specific IgE antibodies to five
peanut components in sera from patients
referred to our clinic between 2011 and
2012 were measured by ImmunoCAP.
Forty-five children and young adults with
suspected peanut allergy were enrolled in
the study. Fifteen of those (1.1–20.5 years)
were Oral Allergy Syndrome (OAS) after
ingestion of peanut. Twenty-two (1.5–
15.4 years) were immediate systemic (IM)
type of peanut allergy. Eight were peanut
sensitised children without allergic symp-
tom to peanut (NoPA).
Results: IM type had significantly higher
levels of specific IgE to Ara h 2 comparing
to OAS type and NoPA. Patients of OAS
type were frequently sensitised to PR-10
and LTP (Ara h 8: 47%, Ara h 9: 40%)
comparing to IM type. NoPA were sensi-
tised high positive rate to Ara h 3 com-
pared with IM patients and OAS type
(IM:55%, OAS: 20%, NoPA: 75%).OAS
type were frequently sensitised to other
food and pollen components (Cor a 1, Cor
a 8, Ber e 1, Gly m 4, Bet v 1) comparing
to IM type. There is a high correlation
among Bet v 1 and Ara h 8, Cor a 1, Gly
m 4. But there is no correlation between
Ara h 9 and Cor a 8.
Conclusion: The results indicated that
there are characteristic pattern of sensiti-
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sation and concentration by clinical entity.
Allergen component testing is a useful in
identifying peanut allergy.
840
Serological characterisation of milk
allergic patients – can severity be
predicted by components?
Petersen, TH1; Eller, E1; Mortz, CG1; Bindslev-Jensen, C1
1Department of Dermatology and Allergy Center,
Odense Research Center for anaphylaxis, Odense
University Hospital, Odense, Denmark
Background: Cow′s Milk Allergy (CMA) is
one of the most frequent allergies in
infancy affecting approximately 2% of
children. The majority will outgrow it
before the age of 4. The oral food chal-
lenge is the gold standard for diagnosing
CMA but is time consuming and costly.
Component resolved diagnostics by mea-
suring IgE to specific milk proteins (com-
ponents) are reported to be promising as
replacement for the oral food challenge in
other types of food allergies (e.g. peanuts).
The aim of this study is to evaluate com-
ponents and their ability to: 1) Predict the
outcome of oral challenge in CMA. 2) Dis-
tinguish patients outgrowing their CMA
from patients with persistent CMA. 3) Pre-
dict the severity of the allergic reaction.
Method: Data from 85 patients followed
at the Allergy Center, Odense University
Hospital, Denmark, were retrospectively
evaluated. Forty-six patients had a nega-
tive first challenge and 39 one or more
positive challenges. Of these 26 patients
developed tolerance to milk (negative chal-
lenge). Challenges were performed accord-
ing to EAACI guidelines. s-IgE to cow′s
milk and cow′s milk components (Lactofer-
rin, a-lactalbumin, b-lactoglobulin and
Casein) were measured with ImmunoCap
(Thermo-Fisher Diagnostic).
Results: We found a strong correlation
(r = 0.98, P < 0.01) between s-IgE and the
sum of the four measured components. We
were not able to differentiate between posi-
tive and negative challenges neither by s-
IgE nor by the four measured components.
The subgroup of children with persistent
CMA after 8 years of age had significantly
higher levels of s-IgE, a-lactalbumin, b-lac-
toglobulin and casein (P < 0.01) than the
ones with a negative challenge.
We found for all positive challenges a
correlation between the levels of s-IgE to
cow′s milk, the components and the sever-
ity of the allergic reaction during oral food
challenge, although with large individual
variations.
Conclusion: Our results indicate that IgE
antibodies to milk protein components are
not able to replace oral challenges in the
diagnosis of cow′s milk allergy or to distin-
guish patients outgrowing their CMA from
patients with persistent CMA. The levels
of s-IgE to cow′s milk correlate to the
severity of the allergic reaction when per-
forming food challenges.
842
IgE and IgG4 antibody levels towards
milk components are associated with
outcome of oral immunotherapy in
Finnish milk allergic children
Englund, H1; Kuitunen, M2; Moverare, R1,3; Borres,
MP1,4; M€akel€a, M2
1Thermo Fisher Scientific, Uppsala, Sweden;
2University of Helsinki, Skin and Allergy Hospital,
Helsinki, Finland; 3Department of Medical Sciences,
Respiratory Medicine and Allergology, Uppsala
University, Uppsala, Sweden; 4Department of
Pediatrics, Institute for Clinical Sciences, The
Sahlgrenska Academy at the University of Gothenburg,
Gothenburg, Sweden
Background: IgE-mediated cow’s milk
allergy (CMA) is a common food allergy
in young children. The majority of children
outgrow CMA, but for approximately 20
percent the symptoms persist beyond the
age of five. For these children, the use of
oral immunotherapy (OIT) to induce toler-
ance is an option.
Objective: To investigate IgE and IgG4
antibody levels to milk and milk allergen
components before and after OIT, and
relate it to clinical outcome of OIT.
Methods: Finnish children (n = 81) above
six years of age and with persistent CMA
were subjected to a six months OIT proto-
col (according to Meglio et al, Allergy,
2004). The target dose was tolerance of
200 ml milk. Patients were food chal-
lenged, carefully examined and blood sam-
ples were collected before and after OIT.
IgE and IgG4 antibody levels towards
milk, a-lactalbumin, b-lactoglobulin,
casein, lactoferrin and bovine serum albu-
min were analyzed with ImmunoCAP. The
sample material was divided into two
groups, those who reached the 200 ml tar-
get dose (n = 66) and those who did not
(n = 15).
Results: OIT was successful in 81% of the
patients (66/81). Patients who did not
reach the 200 ml target dose (15/81)
showed, as a tendency, higher concentra-
tions of IgE towards b-lactoglobulin and
casein before start of treatment. The 81%
who reached the target dose during OIT
had a larger increase in IgG4-levels
towards a-lactalbumin, b-lactoglobulin,
casein and lactoferrin during treatment,
than those with only partial or no toler-
ance.
Conclusion: Measurement of IgE and IgG4
antibody levels to milk components may
be useful for predicting outcome and moni-
toring therapeutic efficacy when treating
milk allergic children with oral immuno-
therapy.
843
Cross-reactivity between peach (Prunus
persica) and Phleum pratense, Olea
europaea and Parietaria judaica pollen
Abel-Fernandez, E1; Ferna´ndez-Caldas, E1; Cases, B1;
Tudela, JI1; Esteban Lopez, MI2; Casanovas, M1;
Subiza, JL1
1Research and Development, Inmunotek S. L., Alcala de
Henares, Spain; 2Hospital General de Segovia, Segovia,
Spain
Background: Cross-reactivity frequently
occurs among pollens and between vegeta-
bles and pollens. In Spain, Rosaceae fruits
induce 70% of food plant allergies, being
peach (Prunus persica) the most important
allergenic fruit. Grass (Phleum pratense),
olive (Olea europaea) and wall pellitory
(Parietaria judaica) also present high rates
of sensitisation. Cross-reactivity between
pollen and food plants has important clini-
cal implications. The aim of the present
study was to analyze in vitro cross-reactiv-
ity between peach and Phleum, Olea and
Parietaria pollen extracts.
Method: Nineteen patients (mean age
25.89  11.18) showing clinical symptoms
of respiratory and food allergy and posi-
tive cutaneous and immuno-CAP tests to
peach or related fruits, grass, olive and/or
wall pellitory were evaluated; six sera were
selected based on high specific IgE levels to
these allergens. Specific IgE to the extracts
and to individual allergens was determined
by ELISA, immunoblots and ISAC. Aller-
genic extracts of peach peels, grass, olive
and wall pellitory pollens were also ana-
lyzed by electrophoretic profile determina-
tion and protein identification
(LC-MALDI MS/MS). Cross-reactivity
was evaluated by ELISA inhibition assays.
Results: Inhibition assays showed cross-
reactivity between peach and the three pol-
len species analyzed. The analysis of the
allergen extracts revealed the presence of
the major allergens, as well as other aller-
genic and non-allergenic proteins and pan-
allergens.
Conclusion: Significant cross-reactivity
between peach and Phleum, Olea and
Parietaria was detected using the serum of
peach and pollen allergic patients. The role
of major and minor allergens and of aller-
gens with a high molecular weight should
also be considered.
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Allergy to fish and cross-sensitivity
between fish species
Witten, M1; Malling,H-J1; Bindslev-Jensen, C2; Schnoor,
HJ1; Poulsen, LK1
1Dermato-allergological Department K, Allergy Clinic,
Gentofte University Hospital, Hellerup, Denmark;
2Dermato-allergological Department, Allergy Center,
OUH, Odense, Denmark
Background: Fish allergy is believed to be
present in approximately 0.4 percent of the
adult population in Denmark and is sus-
pected to be a lifelong condition. It is com-
mon practice that patients are tested for
codfish and if positive the patients are
advised to avoid all fish types according to
the assumption that there is a considerable
amount of cross-sensitivity between the dif-
ferent fish species. There is, however an
increasing number of patients, who report
being allergic to a different fish species
than codfish, or are allergic to codfish, but
can tolerate other species. The aim was to
examine fish allergic patients as to which
species they react towards and to examine
whether Standard Prick Test (SPT), specific
IgE or Histamine Release (HR) are suffi-
cient to diagnose allergy to both codfish
and other fish species, defined by a positive
food challenge (DBPCFC).
Method: Up to 40 patients age 18–65, sus-
pected of fish allergy were tested with SPT
and IgE for 19 different fish species and
Anisakis simplex. Eight patient suspected
of fish-allergy were challenged with double-
blinded, placebo-controlled food challenges
(DBPCFC) with at least three different
fish-types: codfish, tuna and salmon.
Exclusion criteria were pregnancy, signifi-
cant other disease or betablockers.
Results: DBPCFC’s in eight patients
showed that for two patients no culprit fish
could be identified. For the six patients
with a reaction in the DBPCFC only three
reacted classically towards codfish. The
other three patients were species-specific
and did not react to codfish however they
reacted to tuna, salmon or herring respect-
fully. For the SPT the sensitivity was 100
percent however five patients had a posi-
tive test without a matching positive chal-
lenge. For the specific IgE two patients
had a positive challenge towards a fish-
type without increased IgE.
Conclusion: There is a need for food chal-
lenges of fish allergic patients with different
fish-types according to the medical history,
since many patients are only being tested
with SPT or IgE for one or two fish types,
and there is increasing evidence, that not
all species cross-react. Particularly patients
who have never been challenged or chal-
lenged several years ago can have been
misdiagnosed or have outgrown their
allergy. SPT showed high sensitivity and
low specificity which was expected, how-
ever both specific IgE and HR showed
both low sensitivity and specificity indicat-
ing that the food challenge is of great
importance.
845
Unespected isolated IgE reactivity to
native walnut vicilin-like protein (nJug
r2) on ISAC microarray: is it clinically
relevant or due to cross-reactive
carbohydrated epitopes?
Conte, M1; Asero, R2; Martelli, P1; Da Re, M1; Stella, S1;
Villalta, D1
1Allergy and Clinical Immunology, A.O.’ S. Maria degli
Angeli’, Pordenone, Italy; 2Allergy Unit, Clinica San
Carlo, Paderno Dugnano, Italy
Background: Since the introduction of the
last version of the microarray-based Immu-
noCAP ISAC 112TM, three native walnut
(Juglas regia) molecules are tested: 2S albu-
min (nJug r1), vicilin (nJug r2) and lipid
transfer protein (nJug r3). In the daily
practice we found many unespected cases
of isolated sIgE reactivity to nJug r2: the
aim of this study is to evaluate if this reac-
tivity is clinically relevant or due to CCDs
(cross-reactive carbohydrated determi-
nants) positivity.
Method: Sera from 320 consecutive outpa-
tients afferring to our Allerology Unit
tested by ImmunoCAP ISAC 112TMfrom
dicember 2011 to dicember 2012 were con-
sidered for the study. All nJug r2 positive
patients were reviewed to assess allergy or
tolerance to walnut. A linear regression
analysis was performed to evaluate the cor-
relation between nJug r2 and CCDs
(nMUXF3) sIgE values and a CAP inhibi-
tion assay was used to confirm the possible
cross-reactivity between the two molecules.
Results: 11.6% of the 320 collected sera
(37) were positive to nJug r2. 8.1% (3) and
21.6% (8) were positive to nJug r1 and
nJug r3 respectively. 73% (27) sera showed
an isolated nJug r2 reactivity. Walnut
allergy was clinically relevant only in nJug
r1 positive patients. 67% (25/37) nJug r2
positive sera were simultaneously positive
to nMUXF3 and showed a significant cor-
relation (P < 0.001) in IgE levels between
nJug r2 and nMUXF3 (r2 = 0.787). A
complete IgE reactivity inhibition to both
nJug r2 and nMUXF3 was showed after
incubating a nJug r2 positive serum with
nMUXF3.
Conclusion: The unespected isolated sIgE
reactivity to nJug r2 revealed by Immuno-
CAP ISAC 112TMis clinically irrelevant and
frequently due to reactivity to cross-reac-
tive carbohydrate epitopes.
846
Comparison of skin prick test and
specific IgE to hazelnut extract, Cor a 1
and Cor a 8 in predicting clinical
reactivity in children with hazelnut
allergy
Buyuktiryaki, B1; Cavkaytar, O1; Sahiner, UM1; Arik Yil-
maz, E1; Yavuz, ST1; Soyer, OU1; Tuncer, A1; Sackesen,
C1
1Department of Pediatric Allergy, Hacettepe University
Faculty of Medicine, Ankara, Turkey
Background: Hazelnut allergy is the most
common nut allergy in Turkish children.
The cross-reactivity between hazelnut Cor
a 1 and Betula Bet v 1 is well-known in
Europe and USA and this cross-reactivity
was shown to increase the level of IgE to
Cor a 1. Recently, a lipid transfer protein,
Cor a 8, was shown to be responsible for
the severe reactions. Our aim was to deter-
mine the cut-off levels of diagnostic tests
to predict clinical reactivity and to investi-
gate the cross-reactivity of hazelnut aller-
gens with pollens.
Method: Based on the presence of hazelnut
SPT≥3 mm and sIgE >0.35 kU/l, 56 chil-
dren who underwent DBPCFC and 8 chil-
dren who experienced anaphylaxis in the
last 6–12 months were included. Serum
IgE levels to hazelnut extract, Cor a 1, Cor
a 8, and Bet v 1 were measured. Wheal
sizes and sIgE values were analyzed by
ROC curves.
Results: The median [interquartile range
(IQR)] age of 64 children was 3.4 (2.1–7.2)
years. Twenty-four of 56 DBPCFC tests
were positive, 10 children had anaphylaxis
at DBPCFC test and 8 children had ana-
phylaxis after accidentally hazelnut intake.
The cut-off hazelnut sIgE level that pre-
dicts clinical reactivity with 75% sensitivity
and 90.6% specificity was found 3.15 kU/l.
The cut-off hazelnut skin prick test wheal
size that predicts clinical reactivity at the
highest sensitivity (59%)+ specificity (90%)
was 7.5 mm. Multivariate logistic regres-
sion analysis revealed hazelnut prick test
wheal size as a significant risk factor for
anaphylaxis (OR:1.4, 95%CI:1.0–2.1,
P = 0.028). Thirty children (55.6%) had
concomitant aeroallergen sensitisation. The
median of IgE to Cor a 1 was 0.01 (0–
0.03) (max = 0.15). The median of IgE to
Bet v 1 was 0.03 (0.01–0.05), all results
were under 0.39 kU/l. In children older
than 2 years of age, IgE to Cor a 8 was
significantly higher in children with grass
pollen sensitisation [0.21 (0.05–2.47)] com-
pared to children without sensitisation
[0.02 (0–0.08)] (P = 0.001).
Conclusion: This is the first study denoting
the cut-off value of hazelnut sIgE to pre-
dict clinical reactivity with a history sug-
gestive for hazelnut allergy in children.
Skin prick test reactivity revealed more
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reliable marker than hazelnut sIgE in the
case of predicting anaphylaxis. Our results
show that Betula sensitivity is not seen in
Turkish children with hazelnut allergy but
grass pollen sensitisation appears to influ-
ence the level of IgE to Cor a 8.
847
Diagnostic utility of IgE antibodies to
omega-5 gliadin and three other gluten
derived wheat components in wheat
allergic children
Nilsson, N1; Sj€olander, S2; Baar, A3; Pahr, S3; Valenta,
R4; Vrtala, S3; Morita, E5; Berthold, M2; Hedlin, G1;
Borres, M6; Nilsson, C7
1Q204 Lung/Allergy Department, Karolinska University
Hospital, Stockholm, Sweden; 2ImmunoDiagnostics,
Thermo Fisher Scientific, Uppsala, Sweden; 3The
Christian Doppler Laboratory for the Development of
Allergen Chips, Medical University of Vienna, Vienna,
Austria; 4Division of Immunopathology, Department of
Pathophysiology and Allergy Research, Medical
University of Vienna, Vienna, Austria; 5Department of
Dermatologi, Shimane University Faculty of Medicine,
Shimane, Japan; 6Department of Pediatrics, Institute for
Clinical Sciences, The Sahlgrenska Academy at the
University of Gothenburg, Gothenburg, Sweden;
7Department of Clinical Science and Education,
Karolinska Institutet and Sachs Children’s Hospital,
Stockholm, Sweden
Background: One common food causing
allergy in children is wheat. IgE-antibodies
(IgE-ab) to wheat have been reported to
correlate poorly to the outcome of oral
wheat challenge tests. Wheat contains
many allergens and one of them is x-5 gli-
adin. IgE-ab to x-5 gliadin is associated
with WDEIA in adults and immediate
wheat allergy in children. IgE-ab to other
wheat components in relation to wheat
allergy has not been studied in detail.
Aim: To correlate IgE-ab to x-5 gliadin
and three other gluten derived allergen
components with the outcome of oral
wheat challenge in children with a diagno-
sis of wheat allergy.
Method: Sixty-three children (0–18 year)
with a doctor′s diagnosis of wheat allergy,
IgE-ab to wheat and on a wheat elimina-
tion diet, were subjected to an open oral
wheat challenge with doses from 0.05 g to
17 g of white bread. The children were
observed during, and up to two hours after
the provocation and the severity of allergic
symptoms were scored according to Astier
from 0 to 5 while a negative test was
defined as no objective allergic symptoms.
Blood samples were taken before the chal-
lenge and were analysed for IgE-ab using
ImmunoCAP to recombinantly produced
x-5 gliadin, low molecular weight glutenin
(LMW-glutenin), high molecular weight
glutenin (HMW-glutenin) and a native gli-
adin preparation containing a, b, c, and x-
5 gliadin.
Results: Thirty-one children had a negative
challenge and 32 had a positive challenge.
Thirteen had score 1, four score 2 and fif-
teen score 4. The IgE-ab levels to all four
allergen components were significantly
higher in the challenge positive compared
to the challenge negative children
(P < 0.0001). In the challenge positive
group 21/32 had IgE-ab to x-5 gliadin, 25/
32 to LMW-glutenin, 30/32 to gliadin and
31/32 to HMW-glutenin, The 11 children
that were negative to omega-5 gliadin all
had IgE-ab to one or more of the three
other components. Children with symptom
score 4 had significantly higher IgE levels
specific for all four components compared
to children with less severe symptoms
(P < 0.05).
Conclusion: Analysis of IgE-ab to wheat
components derived from the gluten frac-
tion may increase the ability to identify
children suffering from wheat allergy. In
this study analysis of IgE-ab to three glu-
ten derived wheat allergens supplemented
the analysis of IgE-ab to omega-5 gliadin
as all wheat allergic children had IgE-ab to
one or more of the four components.
848
Examination of 47 cases’ provocation
tests with food-dependent exercise-
induced anaphylaxis
Asaumi, T1; Yanagida, N1; Iikura, K1; Koike, Y1; Okada,
Y1; Ogura, K1; Shukuya, A1; Ebisawa, M1
1Department of Allergy, Sagamihara National Hospital,
Kanagawa, Japan
Background: Little has been reported
regarding standardised methodology of
provocation tests with food-dependent
exercise-induced anaphylaxis (FEIAn). In
the Japanese Pediatric Guideline for Oral
Food Challenge in Food Allergy 2009 (the
Japanese OFC guideline), premedication of
aspirin prior to challenge test is recom-
mended. We examined the usefulness, the
positive rate, and the safety of them.
Methods: A retrospective chart view was
performed on children who underwent
provocation tests with FEIAn in our hos-
pital from 2006 to 2012. Ergometer stress
tests were administered after taking sus-
pected foods. Aspirin was used based on
the Japanese OFC guideline.
Results: A total of 210 tests were per-
formed for 47 cases. We diagnosed 23
cases as definite FEIAn out of 47 cases. Of
the 210 tests, 37 tests (18%) evoked objec-
tive symptoms. It occupied 59% in the
positive tests that symptoms were induced
by more than 1 food. Causative foods were
as follows; wheat four cases, combination
of wheat and shrimp four cases, peach case
cases, tangerine two cases, combination of
wheat and apple two cases. Within 60 min
from the beginning of exercise, 97%
evoked symptoms. Of patients who failed
tests, there were 78% cutaneous, 27%
lower respiratory, 8% gastrointestinal,
14% pharyngolaryngeal, 19% eye, 11%
upper respiratory, 8% cardiovascular, 3%
neurological reactions, and then 7%
involved more than 1 organ system. Of 37
positive tests, we treated 32%of them, and
administered adrenaline in 19% of cases.
After discharge from hospital, negative
cases had no symptoms of FEIAn by foods
which were provoked, but some were dif-
ferently diagnosed as chronic urticaria or
bronchial asthma.
Conclusions: Though provocation tests
with FEIAn sometimes induced severe
symptoms, they were performed almost
safely in admission. Half cases could lead
to definite diagnosis, and the other half
cases to exclusive diagnosis, thus FEIAn
provocation tests with aspirin were very
useful for diagnosis and daily life guidance
of patients.
849
Ara h 2 is the best predictor for peanut
allergy in both children and adults but
cannot be used to accurately exclude
peanut allergy in an adult population
Klemans, R1; Broekman, H1; Knol, E1,2; Bruijnzeel-
Koomen, C1; Otten, H2; Pasmans, S1,3; Knulst, A1
1Dermatology/Allergology, University Medical Center
Utrecht, Utrecht, The Netherlands; 2Immunology,
University Medical Center Utrecht, Utrecht, The
Netherlands; 3Center for Paediatric Allergology,
Wilhelmina, Children’s Hospital, University Medical
Center Utrecht, Utrecht, The Netherlands
Background: Specific IgE (sIgE) to Ara h
2 as clinical predictor for peanut allergy in
children has a diagnostic value comparable
to a prediction model containing gender,
skin prick test (SPT), sIgE to peanut
extract and total IgE minus sIgE. In
adults, the diagnostic value of peanut com-
ponents has not been studied yet. The aim
of our study was to validate a pediatric
prediction model in an adult population.
In addition, to define the diagnostic value
of sIgE to peanut components and com-
pare this value with a pediatric population.
Methods: Validation was performed by
discrimination with an area under the
receiver operating characteristic curve
(AUC) and calibration with the Hosmer-
Lemeshow test. The diagnostic value of the
peanut components was assessed with the
AUC.
Results: Validation of the pediatric model
in 94 adults showed poor discrimination
(AUC 0.64) but good calibration (P = 0
.48). sIgE to Ara h 2 was the best diagnos-
tic predictor (AUC 0.76, compared to 0.90
in 100 children). By using a cut-off value
with a 100% positive predictive value
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(≥1.75 kU/l), 28% of patients could be
accurately diagnosed. Highest negative pre-
dictive value (NPV) was 63%. A higher
NPV could not be calculated for any other
test. In the children data, a 100% PPV was
found at a cut-off value ≥5.16 kU/l and
was applicable to a similar number of
patients (26%). In children also a 100%
NPV could be calculated using a cut-off
value of <0.07 kU/l. In this way peanut
allergy could be accurately excluded in
24% of the suspected peanut allergic
patients.
Conclusion: sIgE to Ara h 2 has the best
discriminative ability of all peanut specific
components in both adults and children. It
can accurately diagnose peanut allergy in
28% (adults) and 26% (children) of
patients, respectively, but cannot be used




peanut allergy in Japanese children
Ito, K1; Kando, N1; Nakayama, S2; Tanaka, A2; Borres,
MP3
1Department of Allergy, Aichi Children’s Health and
Medical Center, Obu, Japan; 2Phadia KK (Thermo
Fisher Scientific), Tokyo, Japan; 3Phadia AB (Thermo
Fisher Scientific), Uppsala, Sweden
Background: Peanuts are one of the most
common foods causing allergic reactions in
Japanese children. The storage proteins in
peanuts, Ara h 1, 2, 3, contribute to the
anaphylactic reactions to peanuts. Oral
allergy syndrome (OAS) to peanuts is
known to be caused by the Bet v 1 related
peanut allergen, Ara h 8. On the other
hands, there are many peanut-sensitised
(PS) children without allergic reactions to
peanuts, mostly due to the cross-reactivity
to legume families, such as soybeans. Com-
ponent-resolved diagnostics (CRD) may
help the safe and appropriate diagnosis of
peanut allergies (PA).
Method: Serum samples from 35 children
with PA (aged 6.7  3.0 years old) and 34
PS children (6.1  3.3 years old) were ana-
lyzed sIgE to peanut (F13), soybean (F14),
Ara h 1, 2, 3, 8, 9, bromelain (representing
CCD) and Bet v 2 (representing profilin).
F13/F14 ratio was evaluated to show if
sIgE recognises both peanut and soybeans,
or predominantly peanuts. The compo-
nent-specific IgE titer was divided by F13,
and the dominant component (DC) was
defined as the ratio ≥ 50%.
Results: F13/F14 ratio was significantly
higher in PA (16.1  17.7) than in PS
(2.0  1.8, P < 0.001). Sensitivities of posi-
tive sIgE (≥0.35 kUA/l) were Ara h 2:
83%, Ara h 1: 49% and Ara h 3: 46%.
Two PA patients showed positive sIgE to
Ara h 8 (4.53 and 65.1 kUA/l) and one to
Ara h 9 (41.57 kUA/l) without sensitisat-
ion to Ara h 1, 2, 3 (except one 0.48 kUA/
l to Ara h 2). Ara h 2 was found to be the
DC in 16 PA patients, but only in 3 PS
children. On the other hands, Bet v 2
(n = 10) and CCD (n = 8) were the DC in
PS children.
Conclusion: CRD was expected to contrib-
ute not only to the diagnosis of PA, but
also to the subtype classification of PA.
851
Comparison of skin prick tests with raw
milk, ultra heat treated milk and
commercially-prepared cow’s milk in
atopic children
Harmanci, K1; _Ipar, N2; Kanbur, S1; Kocak, AK1
1Pediatric Allergy and Immunology, Eskisehir
Osmangazi University, Eskisehir, Turkey; 2Eskisehir
Osmangazi University, Eskisehir, Turkey
Background: In recent years, evidence has
emerged suggesting that the majority of
children with milk allergy can tolerate
these food when they are extensively
heated (EH). Extensive heating alters the
allergenic proteins to which IgE antibodies
typically form and allergenicity is attenu-
ated in cases of certain allergens such as
milk. We investigated in atopic 500 chil-
dren whether they have differences in skin
prick test sensitivity. Ultra heat treated
cow’s milk, commercial extracts of cow’s
milk and raw milk.
Material and Method: The study included
500 children who consulted our department
for any allergic reason (Asthma, Atopic
dermatitis, Allergic rhinitis, Urticaria). In
this study we performed skin prick test in
500 children with against the three types of
cow′s milk. The anterior surface of the
forearm was used for skin prick testing
with commercially-prepared cow’s milk,
raw milk (Whole milk Unheated and
untreated) and ultra heat treated (UHT
Whole milk heatred at 140 c for 1–2 s),)
milk extract testing solutions (Omega La-
barotories Limited). Two drops of milk
extract, a negative control, and a positive
histamine control were applied to the fore-
arm. The drop was pricked using a Hollis-
ter-Stier lancetter and the tests were read
after 15 min.
Results: Forty-six patients (9.2%) devel-
oped a skin prick test positivity to raw
milk. 31 patients (6.2%) developed a skin
prick test positivity to. Ultra heat treated
cow milk. 20 patients (4.0%) developed a
skin prick test positivity to commercial
extracts of cow’s milk. There were 19 cases
in which only raw milk skin test was posi-
tive. In these cases UHT milk and com-
mercial extracts of cow’s milk skin test
positivity were not observed.
Conclusion: In our study, the rate of find-
ing positive skin prick test against raw
milk was significantly higher than other
milks (UHT and commercial preparation).
This high rate is also observed in all
groups of allergic diseases (Asthma, Atopic
dermatitis, Allergic rhinitis, Urticaria).
UHT milk and commercial milk protein
structure torn down and reduces the possi-
bility of allergic reactions seen. Therefore,
searching for cow′s milk allergy. We
should not only use commercial extracts of
cow’s milk but also we should use raw
milk.
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Establishing the use of hypoallergenic
formulae with cow’s milk protein
induced gastrointestinal allergies
Yerlett, NC1;Meyer, R2; Dziubak,R1; DeKoker, C1; Domingez
Ortega, G1; Skrapac,A-K1;Godwin, H1; Shah,N1
1Nutrition and Dietetics, Great Ormond Street Hospital
for Children NHS Trust, London, United Kingdom;
2Gastroenterology, Great Ormond Street Hospital for
Children NHS Trust, London, United Kingdom
Background: The mainstay of treatment
for food protein-induced gastrointestinal
allergy (FPIGA) to cow’s milk is the
avoidance of cow’s milk protein (CMP). In
the absence of breast milk, a hypoaller-
genic formula (HF) is required. No official
guidance in the UK exists for appropriate
first-line HF in infants with FPIGA. We
set out to establish HF use in FPIGA
patients.
Methods: Dietetic records of children (0–
5 years), seen by the gastroenterology
department (2009–2012), who were pre-
scribed HF for suspected FPIGA to CMP,
were assessed to establish: HF choice, tol-
erance, number of feed changes, and num-
ber of symptoms. Feed choices were
categorised as: amino acid formula (AAF),
extensively hydrolysed formula (EHF), and
partially hydrolysed formula (PHF).
Results: Sixty-one patients (37 male, med-
ian age 16 months (range 2–52 months))
were included. 40/61 (66%) showed total
improvement on the chosen HF; The
remaining 21 patients showed partial (10/
61, 16%) or no improvement (11/61.18%).
Of the 40 children who improved on HF:
14 (35%) were tried on EHF, with success
in 8/14. The remaining six improved when
switched to AAF. In 14/40 (35%) symp-
toms resolved when directly prescribed
AAF, and 8/40 (20%) improved on an
alternative formula. The remaining 10%
improved on PHF. Patients who improved
on EHF had a median of 4.5 symptoms,
and 2 feed changes. However, patients who
failed EHF and subsequently improved
with AAF, had a median of three symp-
toms, with an average of only 1 feed
change.
Conclusion: 66% of patients presenting
with gastro-intestinal symptoms, had total
resolution of these symptoms after the
implementation of HF. Resolution of
symptoms was achieved in 50% by AAF,
20% by EHF, 20% by other formula, and
10% by PHF. Patients prescribed directly
onto AAF had a lower number of feed
changes, as compared to those who suc-
cessfully resolved on EHF, although the
latter resolved more symptoms; questioning
whether direct prescription of AAF was
appropriate in these cases. A tailored care-
pathway specific for FPIGA is required.
This will guide appropriate, cost-effective,
first-line HF prescription choice. Particu-
larly, as the rate of EHF feed failure is
43% in this population.
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Racial differences in eosinophilic
gastrointestinal disease: a systematic
review
Ito, J1,2; Fujiwara, T1,2; Nomura, I3
1Department of Social Medicine, National Research
Institute for Child Health and Development, Tokyo,
Japan; 2Department of Social Medicine, Mie University
Graduate School of Medicine, Tsu, Mie, Japan;
3Department of Allergy and Immunology, National
Research Institute for Child Health and Development,
Tokyo, Japan
Background: Although empirical evidence
showed that the prevalence of eosinophilic
esophagitis (EoE) is higher in the Western
countries than in Asian countries, whereas
eosinophilic gastroenteritis (EGE) is more
prevalent in Asian countries than in Wes-
tern countries, no systematic review investi-
gated the differences. We investigate racial
differences of eosinophilic gastrointestinal
disease (EGID) in terms of involved gas-
trointestinal tract by a systematic review.
Method: We conducted systematic litera-
ture using PubMed in September 2012.
Studies were excluded non-English, no
abstract, or review articles, and those
which did not contain information of race
except articles from, Japan, Korea, China,
and Taiwan. Further, we limit the articles
which used single race (at least 95% of
sample were same race), either Caucasian
or Asian.
Result: Among 687 studies hit in PubMed,
129 studies fulfilled the criteria. In a total
of 2619 EGID patients were collected
(Caucasian, n = 2010; Asian, n = 382).
About 93% of Caucasian was EoE
(n = 1873), and the percentage is signifi-
cantly higher than Asian (n = 105, 28%).
The same trend was confirmed even after
patients were stratified by age, i.e, among
children aged less than 21 years old and
adults. Percentage of eosinophilic positive
esophagus among Caucasian EGID was
87%, which is significantly higher than
among Asian (26%). However, percentage
of eosinophilic positive stomach, small
intestine, and colon among Asian were 27,
48, and 24%, respectively, all of them were
significantly higher than among Caucasian
(9, 7, and 2%, respectively). Among EoE
cases, Caucasian was 3.54 or 3.09 times
significantly more likely to have dysphagia
or heartburn than Asian, respectively. In
contrast, Asian was 5.48 times significantly
more likely to vomit than Caucasian.
Among EGE cases, Caucasian was 3.07
times significantly more likely to vomit
than Asian. There was no statistical differ-
ence about abdominal pain and diarrhea
between Caucasian and Asian among EGE
cases.
Conclusion: We confirmed that in EGID
cases, esophagus is more likely to be
involved among Caucasian, whereas lower
gastrointestinal tract is more likely to be
Table 1: Number of feed changes and number of symptoms
Median number of feed changes Median number of symptoms
Improved on EHF 2 4.5
Improved on PHF 2.5 3
Failed EHF, improved with AAF 3 3
Straight to AAF and improved 1 4
Improved on alternative milk (1 modular, 1 soya, 6 coconut/oat milk) 2.5 5
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involved among Asian. Furthermore, even
in the same disease (EoE or EGE), symp-
toms are different between these races. The
racial differences of specific eosinophilic
positive intestinal tract among EGID sug-
gest further genetic and environmental
studies for etiology of EGID.
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Characteristics of infants with food
protein-induced enterocolitis syndrome:
one center’s experiences with 17 cases
Arik Yilmaz, E1; Cavkaytar, O1; Buyuktiryaki, B1; Soyer,
OU1; Tuncer, A1; Sackesen, C1
1Department of Pediatric Allergy, Hacettepe University
Faculty of Medicine, Ankara, Turkey
Background: Food protein-induced entero-
colitis syndrome (FPIES) is a non-IgE-
mediated food allergy characterised by pro-
fuse, repetitive vomiting, often with watery
diarrhea with blood/mucus. Although it is
a very rare disease, its prevalence is
increasing in the last decade. In this study
we aimed to determine the clinical and lab-
oratory features of FPIES in 17 infants
who were diagnosed as FPIES.
Method: FPIES was diagnosed in the pres-
ence of gastrointestinal symptoms; such as
repetitive vomiting, watery diarrhea with
mucus or blood, abdominal distention
within 24 h after the ingestion of incrimi-
nated foods, without any other cause for
the symptoms; or a positive open food
challenge result with causative food (con-
taining 0.15 gr/kg food protein) or removal
of causative food from the diet resulting in
the resolution of symptoms in infants with
age less than 9 months.
Results: We analyzed 17 patients with
FPIES [7 (41.2%) male; 10 (58.8%)
female)] in last 2 years (December 2010-
December 2012). The age of onset of initial
symptoms was 2.5  0.5 months (mean
SEM). Cow’s milk was determined as
trigger of FPIES in 16 (94.1%) patients
and rice was in 1 (5.9%) patient. Blood in
stool was the most common clinical feature
(n = 12; 70.6%) followed by diarrhea
(n = 11; 64.7%), vomiting (n = 9; 52.9%),
mucus in stool (n = 9; 52.9%), abdominal
distention (n = 7; 41.2%), weight loss
(n = 7; 41.2%) and lethargy (n = 5;
29.4%). Three patients had been hospita-
lised 6 times because of FPIES symptoms.
Weight and height percentiles of patients
were in normal ranges except one. Only
two patients had atopic dermatitis. Total
IgE levels were in normal ranges in
patients (18  7.6 kU/l) but eosinophil
count was slightly high as 666  182.1.
Symptoms resolved with removal of
incriminated foods from diet in all
patients. Oral food challenge test was per-
formed in 11 (64.7%) patients and 7 of
those (63.6%) resulted positive. Only one
patient had medical treatment (i.v hydra-
tion) at open food challenge.
Conclusion: Our results show that the most
common symptoms of FPIES are vomiting
and bloody stool. Our observations
denoted that cow’s milk is the most com-
mon trigger and rice may rarely induce the
symptoms of FPIES.
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Retrospective study of patients with
eosinophilic esophagitis
Cando´n Morillo, R1; Moreno Mata, E2; Burgos Montero,
AM2; Ruiz Leon, BM2; Gonzalez Sanchez, LA2
1Allergy Department, Hospital La Mancha Centro,
Alcazar de San Juan, Spain; 2Hospital La Mancha
Centro, Alcazar de San Juan, Spain
Background: Analyze epidemiological and
clinical characteristics and the treatment of
the patients, diagnosed of Eosinophilic
Esophagitis (EE).
Method: We reviewed the record of 40
patients with EE of our allergy unit.
Results: Patients: 36 adults and four chil-




Rhinoconjunctivitis and asthma (12%)
Respiratory allergy and food allergy
(24%)


















Fluticasone and proton pump inhibitor
(PPI) (12.5%)
Elemental diet and PPI (2.5%)
Conclusions: The media age in our study is
32.3 years old and we observed that males
are more commonly affected than females.
Atopic disease seems to be a risk factor in
EE, mainly rhinoconjunctivitis followed by
asthma.
Clinical manifestations of EE differ
according to age of patient. Most patients
controlled the symptoms with fluticasone.
Elemental diets are effectives but difficult
to carry out them, so this is the reason that
they are little recommended in daily clini-
cal practice.
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The role of food allergens in eosinophilic
esophagitis. Preliminary results
Zande, M1; Angelakopoulou, A2; Pitsios, K1; Politi, E3;
Kleanthous, K4; Panagiotou, I5; Roma-Giannikou, E5;
Syrigou, E1
1Allergy, General Hospital ‘Sotiria’, Athens, Greece;
2Gastroenterology, The Hospital for Sick Children, GOS,
London, United Kingdom; 3Cytopathology, Areteio
University Hospital, Athens, Greece; 4Peadiatrics,
University Hospital Attikon, Athens, Greece; 5Children’s
Hospital ‘Agia Sofia’, 1st Paediatric Clinic University of
Athens, Athens, Greece
Background: Eosinophilic esophagitis
(EoE) is a chronic inflammatory disease of
the esophagus immune/antigens mediated.
It is clinically characterised by symptoms
related to esophageal dysfunction and
associated with eosinophil-predominant
esophageal inflammation. The role of
atopy has been clearly demonstrated both
in epidemiological and experimental studies
and has important implications for diagno-
sis and therapy.The aim of this study was
to assess the relationship between food
allergy and eosinophilic esophagitis in the
pediatric population, as well as the effect
of dietary modifications in patients’ clinical
symptoms.
Method: Thirty-six children aged 7 months
to 12 years (median age 80 months), with
EoE (esophageal symptoms, biopsy with
>15 eosinophils/HPF after the patients
have been treated with a PPI for at least
8 weeks and other causes have been
excluded), were considered as group I.
Twenty age and sex matched, apparently
healthy, infants and children were studied
as control group (group II). Serum specific
IgEs to cow milk, egg, wheat, rice, corn,
soy, chicken, potato, beef, peanut and pork
were measured with the CAP-FEIA. Skin
prick tests and atopy patch tests (using
fresh foods) were performed for the same
allergens.
Results: All children in control group had
negative CAP, SPT and APT to all food
allergens. In group I 30/36 children (83%)
had positive APT. Of these, 12/30 (40%)
had also positive SPT and 16/30 (53%)
had also positive CAP. Of the 30 positive
children 4/30, (13%) had positive APT to
one food allergen, 2/30 (7%) had positive
APT to two food allergens and 23/30
(77%) to 3 or more food allergens. In the
APT-positive children, in group I, with-
drawing the suspected food allergens for
an 8 week period resulted in the improve-
ment of symptoms.
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Conclusion: Food allergens seem to be a
significant etiologic factor for eosinophilic
esophagitis in infants and young children.
Skin tests are able to identify, in most of
the cases, the responsible food allergens
leading to dietary modifications and symp-
tom remission.
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The role of allergy in the etiology of
functional dyspepsia
Bozkurt, B1; Nadir, I2; S€ozen, M2; Yalcın, KS3; Ikizek, M3;
T€urkay, C2
1School of Medicine, Immunology and Allergic
Diseases, Fatih University, Ankara, Turkey; 2School of
Medicine, Gastroenterology, Fatih University, Ankara,
Turkey; 3School of Medicine, Internal Medicine, Fatih
University, Ankara, Turkey
Background: Functional dyspepsia (FD) is
a condition that causes an upset stomach
or pain or discomfort in the upper belly,
near the ribs. The exact cause for func-
tional dyspepsia is still unknown.The aim
of this study was to evaluate the role of
allergy in the etiology of FD.
Method: The study included 100 patient
admitted to our Gastroenterology outpa-
tient clinic with the diagnosis of FD
between April 2011 and 2012. 79 of these
patients were evaluated for the history of
allergic diseases. And the skin prick tests
(SPT) with common aeroallergens and
food allergens were performed.
Results: The mean age of the patients
was42.  13.4 years and 62% were male.
SPT were positive in 51 of 79 patients.A-
mong these, 21 patients were sensitive to
food allergens 43.5% of the patients were
active smokers. There were only five
patients with mild asthma. Most common
allergic diseases were; seasonal allergic rhi-
nitis (51.6%), metal allergy (24.2%), food
hypersensitivity (19.4%) and drug hyper-
sensitivity (8.1%). Most common aeroaller-
gen was pollens (49.4%) and cockroach
(32.9%). Most common food allergens
were peanut (8.9%) and soybean (7.6%).
Conclusion: The allergic diseases were
commonly seen in patients with FD. The
higher rates of seasonal allergic rhinitis
(51.6%) and pollen allergy (49.4%) in FD
might show the presence of gastrointestinal
involvement in these patients as in oral
allergy syndrome. The increased rate of
cockroach allergy (32.9%) in FD might be
due to contamination of food and food
additives with these allergens leading
hypersensitivity in gastrointestinal tract.
The increased rate of metal allergy (24.2%)
in these patients might show hypersensitiv-
ity to metal containing foods. The patients
diagnosed with FD should be further eval-
uated for allergic diseases by skin pick tests
for aeroallergens and food allergens and
patch tests for metal allergens.
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Gastrointestinal food allergy assessment
by a symptom questionnaire
Dominguez-Ortega, G1; Meyer, R1; Dziubak, R1;
De Koker, C1; Godwin, H1; Yerlett, N1; Skrapac, AK1;
Acton, N1; Shah, N1
1Great Ormond Street Hospital, London, United
Kingdom
Background: Clinical history and symp-
toms form the cornerstone for the suspi-
cion of Gastrointestinal food allergy
(GIFA), which is confirmed with an elimi-
nation diet and challenge. However, symp-
tom improvement following an elimination
diet is often ambiguous. The use of a Lik-
ert scale GIFA symptom questionnaire
(GIFASQ) to aid the decision process has
not been studied in GIFA. We therefore
set out to determine the impact on symp-
tom improvement of dietary elimination,
additional medication or both using the
GIFASQ.
Method: This prospective observational
study was conducted in a tertiary paediat-
ric gastroenterology department. The GI-
FASQ was developed from symptoms of
437 children with proven GIFA. Parents
completed the questionnaire before com-
mencing the exclusion diet and/or medica-
tion and repeated this after 4 weeks. The
type of intervention was determined by an
expert pediatric gastroenterologist. The GI-
FASQ measured nine symptoms individu-
ally from 0 (no symptoms) to 5 (most
severe) and globally from 0 to 45.
Results: Data from 77 participants was
analysed, median age 29.9 months, male 51
(66.3%). Fifty three patients (69%)
required only a dietary elimination, 14
(18%) additional medications and 10
(13%) diet and medications. The majority
were on different combinations of milk,
soy, egg and wheat free diets and four
required further elimination. The most fre-
quently used medications were Ketotifen
(15, 62%) and Nalcrom (13, 54%). Forty
five patients (58%) achieved ≥ 50%
improvement and 5 (6.5%) total improve-
ment in global score after intervention.
From the 14 prescribed additional medica-
tions, 12 showed further improvement.
Conclusion: The GIFASQ aids in assessing
symptom improvement objectively in sus-
pected GIFA. It is a quick and easy tool
that can be used in clinical practice in a
condition that is difficult to diagnose. It
also helps identify children who only par-
tially respond to an elimination diet and
who could benefit from the addition of
adjuvant medications.
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Clinical characteristics of gastroallergic
anisakiasis: a case-control study in Jeju
Lee, JJ1; Lee, JH1; Kim, M1; Chung,Y-B2
1Internal Medicine, Jeju National University, Jeju,
Korea; 2Parasitology, Jeju National University, Jeju,
Korea
Background: Acute gastric anisakiasis is an
incidental gastrointestinal infestation of
third-stage Anisakis spp. larvae (anisakis),
which is suggested as one of the causative
substances for food hypersensitivity. In the
recent literatures, it is called as gastroaller-
gic anisakiasis. However, it is still in doubt
whether it is one of the independent dis-
ease entities, which can be discriminated
from acute gastric anisakiasis. We investi-
gated clinical and immunological features,
diagnostic implications of anisakis-specific
IgE testings and IgE binding components.
Method: In a geographic region where eat-
ing of raw marine seafood is common and
habitual in public, a prospective case-con-
trol study was designed. Case subjects clin-
ically diagnosed of gastroallergic
anisakiasis were selected; clinical presenta-
tions of hives, swollen face, abdominal
pain, shortness of breath, or diarrhea








Improvement a) + b)
n (%)
Abdominal Pain 3 16 38 16 54 (74)
Flatus 2 17 28 19 47 (71)
Bloating/ Distension 5 12 18 19 37 (68)
Diarrhoea 6 6 24 13 37 (75)
Costipation 4 7 13 23 36 (77)
Food aversion 5 6 19 15 34 (75)
Vomiting 1 6 7 28 35 (83)
Back Arching 1 4 17 20 37 (88)
Rectal bleeding 2 1 4 16 20 (87)
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within hours of raw seafood ingestion, and
when the causative substance is not identi-
fied. Control subjects who never experi-
enced those symptoms among raw seafood
lovers were screened by a questionnaire.
Clinical and immunologic features were
compared in atopic status, sensitisation
rates to anisakis and serum titer of anisa-
kis-specific IgE and IgG.
Results: Seventeen cases and 135 controls
were enrolled. The cases experienced gas-
trointestinal symptoms after raw seafood
ingestion, followed by mucocutaneous,
respiratory, and multi-systemic symptoms.
Their raw seafood dishes were reported
diverse. Cases were more frequently sensi-
tised to both anisakis excretory secretory
product (ESP) and crude extracts than
controls. (76.4% vs. 28.1%, 88.2% vs.
36.3%, respectively) Cases showed signifi-
cantly higher titer of serum anisakis-spe-
cific IgE. Detection of sensitisation by skin
prick tests or serum specific IgE with titer
might be useful diagnostic testing. Some
IgE binding components identified by wes-
tern blot might have diagnostic implica-
tions.
Conclusion: Gastroallergic anisakiasis is a
food hypersensitivity to live Anisakis spp.
larvae. Among the patients suspicious of
gastroallergic anisakiasis, the diagnosis
might be strongly supported by detection
of anisakis-specific IgE. Once gastroallergic
anisakiasis is diagnosed, a medical treat-
ment for food hypersensitivity is cautiously




activation test may help in differential
diagnosis?
Boni, E1; Scacchetti, AT2; Pepe, P3
1Dermatology, University of Parma, Azienda
Ospedaliero-Universitaria Policlinico di Modena,
Modena, Italy; 2Department of Clinical Pathology,
NOCSAE, Modena, Italy; 3Dermatology, Azienda
Ospedaliero-Universitaria Policlinico di Modena,
Modena, Italy
Background: The main forms of gluten-
related disorders are wheat allergy (WA),
autoimmune disease (celiac disease, derma-
titis herpetiformis and gluten ataxia) and
possibly immune-mediated disease (gluten
sensitivity). IgE antibodies play an essential
role in the allergic disease. For celiac dis-
ease (CD) the available tests are anti-tissue
transglutaminase (tTG) IgA, anti-endomy-
sial antibodies (EMA) and deamidated gli-
adin peptides (DGP) antibodies especially
IgG class. For other immune-mediated dis-
orders there is currently no available test.
There is evidence that the basophil activa-
tion test (BAT) reveals IgE and non-IgE
mediated reactions. The BAT based on
CD63 detection on whole blood sample
showed significant higher sensitivity and
specificity and diagnostic accuracy com-
pared to the assay based on separated leu-
kocytes.
Method: We present a case of a woman
with wheat-related disorder manifesting
clinical signs, intestinal symptoms (chronic
diarrhea, weight loss) and extraintestinal
symptoms (chronic orticaria-angioedema,
fatigue). Skin Prick test (SPT) (Lofarma),
in vitro specific IgE (Thermo Fisher Scien-
tific), DGP IgG and tTG IgA antibodies
(Thermo Fisher Scientific), EMA (Eurospi-
tal), HLA (Euroimmune) were investi-
gated. The BAT (Beckman Coulter) with
wheat extract was also performed. The
patient underwent endoscopy of the diges-
tive tract.
Results: SPT and serum s-IgE assays
excluded wheat allergy: SPT was negative
for wheat; S-IgE: f4 ≤ 0.10 kUA/l, f79 ≤
0.10 kUA/l, g2 ≤ 0.10 kUA/l, g8 = 0.54
kUA/l. DGP IgG and tTG IgA, AGA
IgA/IgG, EMA were in range of normality.
HLA-DQ2/DQ8 was negative. Normal
digestive endoscopy was documented. The
BAT (52.9%; c.o. positive≥15%) demon-
strated a stimulation of the basophils
exposed to wheat extract.
Conclusions: The patient was recom-
mended to undergo a strict gluten-free diet.
Shortly after diet, the patient′s clinical con-
dition improved. All the data excluded an
allergic or autoimmune disease. The fact
that the clinical signs and symptoms com-
pletely resolved after the diet, demonstrates
the implication of gluten exposure in the
pathogenesis. We diagnosed gluten sensitiv-
ity (GS) on the basis of the algorithm for
the differential diagnosis of gluten-related
disorders, including CD, GS and WA pro-
posed by Sapone et al. In this case, we
believe that BAT confirms a hypersensitiv-
ity reaction to wheat not IgE-mediated not
CD. Further studies will have to demon-
strate the mechanism through which wheat
plays a pathogenic role.
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A case of eosinophilic colitis causing
partial obstruction of colon
Lee, SM1; Park, S2; Kang, SM1; Kim, YJ1; Kyung, SY1;
Park,J-W1; Jung, SW1; Lee, SP1
1Department of Medicine, Gachon University Gil
Medical Center, Incheon, Korea; 2Ewha Womans
University, Mokdong Hospital, Seoul, Korea
Background: There are many documents
regarding eosinophilic colitis, but eosino-
philic colitis causing total or partial
obstruction of colon has been rarely
reported. We report a case of eosinophilic
colitis causing partial obstruction of
colon.
Case report: A man aged 72 years had
difficulty in defecation for a month. He
received intermittent enema, but symptom
was aggravated. He underwent colonos-
copy, abdominal computed tomography
(CT), and angiography of inferior mesen-
tery artery (IMA). Colonoscopy showed
an ulcerative lesion approximately 40 cen-
timeter above the anal verge. Abdominal
CT showed thickened wall of proximal
sigmoid colon and rectum with diffuse
fecal retention, but without definite transi-
tional zone. Angiography of IMA did not
yield significant stenosis or occlusion.
IMA-preserving sigmoidectomy was per-
formed, and pathologic study revealed
chronic active inflammation with many
eosinophil accompanied by ulcer and
seven reactive pericolic lymph node.
Peripheral blood eosinophil was normal
range (96 /lL) before operation, but
mildly increased to 581 /lL six weeks
later. Total serum IgE, and eosinophilic
cationic protein (ECP) were also elevated
(904 U/ml and 17.8 lg/l, respectively)
Conclusion: We might consider the possi-
bility of eosinophilic colitis when the thick-
ened wall of colon causes subacute partial
obstruction of colon accompanied by the
elevation of peripheral blood eosinophil,
total serum IgE, or ECP.
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Rice sensitisation in patient with
eosinophilic esophagitis
Flores Martı´n, IM1; Pe~na Arellano, MI1; Miras Bruno,
JA1; Exposito Barroso, F2
1Allergy, Hospital Vega Baja, Orihuela, Spain; 2Hospital
Vega Baja, Orihuela, Spain
Background: Eosinophilic esophagitis rep-
resents a chronic, inmune/antigen-mediated
disease characterised clinically by symp-
toms related to esophageal dysfunction and
histologically by eosinophil-predominant
inflammation.
Method: A 51 years old man was referred
for allergy review after being diagnosticat-
ed Eosinophilic esophagitis by gastroenter-
ology.The patient had suffered in the last
year several episodes of food impaction
and a prolonged history of dysphagia after
eating.
Upper gastrointestinal endoscopy was
undertaken with two esophageal biopsies,
finding
Basal cell hyperplasia, edema of squa-
mous epithelium and intraepithelia eosin-
ophils.
The patient fullfilled the diagnostic crite-
ria for EOSINOPHILIC ESOPHAGITIS
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The patient began treatment with swal-
lowed fluticasona without resolution of
symptoms.
In allergy anamnesis the patient refered
dysphagia symptoms with bread, chicken
and rice. Skin prick test with a large food
battery was performed with rice positive
result.
Results: The patient was treated with rice
free diet and continued with swallowed flu-
ticasone. One month after treatment the
symptoms disappeared. The patient rein-
troduced rice diet resubmitting dysphagia.
Actually the patient is asymptomatic with
rice free diet and swallowed corticosteroid.
Conclusion: Eosinophilic esophagitis preva-
lence is increasing.Therapeutic options
include:
* Chronic dietary elimination
* Topical corticosteroids
* Esophageal dilatation
It is important to identify food sensiti-
sation in order to improve the symptoms
without needed agressive therapies. The
reversibility of esophageal remodelling and
subepithelial fibrosis with standard treat-
ments is still unknown, but it is possible
that an earlier diagnosis in the current
patient might have resulted in earlier treat-
ment and preventing stricture formation.
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Gastrointestinal manifestations in
children with respiratory allergy
Bakiri, AH1; Mingomataj, EC2
1Allergology Department, Hygeia Hospital Tirana,
Tirana, Albania; 2Allergology Department, Mother
Theresa School of Medicine, Tirana, Albania
Background: Although there are few inves-
tigations reporting gastrointestinal (GI)
manifestations in asthmatic children like
diarrhea, vomiting, abdominal pain, etc.,
little interest is shown on their relationship.
In some studies are demonstrated duodenal
histological changes similar to those of
bronchial mucosa.
Case reports: Hereby we will present two
cases:The first one presents a boy of
11 years old who came in our hospital with
episodic abdominal pain. He referred to
have had allergic rhinitis and mild symp-
toms of atopic dermatitis, while his aunt
suffers from allergic rhinitis. He has been
treated for the abdominal pain with anal-
gesics and myorelaxants, antihistamines
and nasal corticosteroids also.In the second
case we will report the history of a
12 years old girl who suffered from asthma
since from her childhood. The girl arrived
to hospital without asthma symptoms but
abdominal pain. In the second episode the
girl complained of intermittent pain that
begun a day before. Lung auscultation
revealed sibilance. The GI manifestations
were present right after her classroom is
being cleaned. The patient begun regular
treatment with inhalant corticosteroids, b2
agonists and subcutaneous immunotherapy
(without abdominal pain related to the
injection) 2 years ago. The patient suffered
from atopic eczema and referred of mild
regurgitation episodes also.
Methods and Results: Physical and labora-
tory examinations were within normal
range. Skin prick test revealed sensitisation
to house dust mite for both patients. The
girl atopy patch test resulted positive for
mites.
Discussion: There might be several reasons
for the relationship between asthma GI
symptoms like: asthma itself induces GI
symptoms, drugs like glucocorticoids and
b2 agonists decrease the esophageal sphinc-
ter pressure or the inhalation of the aller-
gen may induce abdominal pain.
Conclusion: GI symptoms appear to be
common in atopic children with asthma
but further studies are needed to shed light
on this relationship.
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Eosinophilic esophagitis in a
Mediterranean area
Merida-Fernandez, C1; Ramırez-Hernandez, M1; Pajaron-
Fernandez, MJ1; Carre~no-Rojo, A1; Huertas-Amoros, AJ1
1Allergy, Complejo Hospitalario Universitario de
Cartagena, Cartagena (Murcia), Spain
Background: Eosinophilic esophagitis is
defined as a chronic, immune/antigen-med-
iated esophageal disease characterised clini-
cally by symptoms related to esophageal
dysfunction and histologically by eosino-
phil-predominant inflammation. It usually
affects children and adults in their 20s or
30s and it is more common in males. The
majority of patients has the concurrent
allergic disease, especially food or aeroal-
lergen sensitisation.
Method: We describe 14 patients (9 (64%)
males and 5 (36%) females) who were
diagnosed with eosinophilic esophagitis.
The mean age was 33.2 years.
Skin prick test with foods were done in
all patients.
Skin prick test with neumoallergens were
done in 11 patients (three patients did not
complete the study).
Results: Dysphagia (42.8%) and food
impaction (42.8%) were the most common
symptoms referred by the patients.
11 (78.5%) patients were sensitised to
any food. Allergies to dry fruits (63.6%),
paprika (45.5%) and peach (36.4%) were
the most common.
Four out of 11 patients sensitised to any
food, referred symptoms in relation with
the ingestion of the food positive in skin
prick test.
6 (42.8%) patients had associated rhini-
tis and/or asthma.
Skin prick tests positives to any neumo-
allergen were found in 8 (57%) patients.
Pollen (81.8%) was the most common
aeroallergen followed by dust mites
(27.3%).
Conclusion: Eosinophilic esophagitis is a
relatively new entity with a significant
increased recognition over the last decade.
In our population:
The majority of patients were sensitised
to dry fruits, paprika and peach.
Pollen is the aeroallergen more com-
mon.
Rhinitis and/or asthma were associated
in 42.8%.
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Histamine modulates toll-like receptor
responses in peripheral blood
mononuclear cells from inflammatory
bowel disease patients
Smolinska, S1; Konieczna, P2; Jutel, M1; O’Mahony, L2
1Department of Clinical Immunology, Wroclaw Medical
University, Wroclaw, Poland; 2Swiss Institute of Allergy
and Asthma Research (SIAF), Davos, Switzerland
Background: Histamine plays an important
role in chronic inflammatory responses due
to its immune-modulatory effects. Hista-
mine exerts it functions through its four
different receptors HR1-HR4. Toll-like
receptors (TLRs) are involved in innate
immune response due to their ability to
recognise PAMPs (pathogen associated
molecular patterns) and are essential for
protection against infection.
Method: Fourteen patients diagnosed with
IBD, seven with Crohn’s disease (CD) and
seven with ulcerative colitis (UC), and six
healthy volunteers were investigated.
Peripheral blood mononuclear cells
(PBMCs) were isolated from all subjects
and gene expression for TLRs and hista-
mine receptors (H1R, H2R, H4R) were
quantified by RT-PCR. In addition,
PBMCs were stimulated with various TLR
ligands in the presence or absence of hista-
mine. Cytokine levels (IL-12, TNF-a, IP-
10) were determined in culture superna-
tants after 24 h stimulation.
Results: PBMCs from UC and CD
patients showed significantly reduced gene
expression of TLR-1, TLR-2, TLR-4,
TLR-6 and TLR-9 compared to healthy
volunteers. Similarly, the expression of his-
tamine receptors H1R, H2R and H4R
were significantly lower for the IBD
patients (particularly in the CD group).
PBMCs from IBD patients secreted signifi-
cantly more pro-inflammatory cytokines,
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compared to healthy volunteers, after stim-
ulation with each of the TLR ligands.
Within the IBD group, cytokine secretion
was higher in patients with CD compared
to patients with UC. In the presence of his-
tamine, TLR-stimulated pro-inflammatory
cytokine secretion from PBMCs was signif-
icantly reduced for both IBD patients and
healthy volunteers. Histamine suppression
of cytokine secretion by PBMCs from IBD
patients tended to be less effective as that
seen for healthy volunteers. Mean suppres-
sion of the LPS-stimulated IL-12 secretion
was 90% for healthy volunteers, 65% for
CD patients and 74% for UC patients,
P = 0.08).
Conclusion: PBMCs from IBD patients
display significant alterations in the expres-
sion of both TLRs and histamine receptors
genes, which are associated with a stronger
pro-inflammatory cytokine response to
TLR-ligands. Histamine-stimulation effec-
tively dampers pro-inflammatory TLR-
associated responses in IBD patients. Fur-
ther examination of this anti-inflammatory
effect may contribute to the development
of new therapeutic strategies in chronic
inflammatory bowel disorders.
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